Citrus Sinensis ID: 038707

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------
Protein Sequence
RICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccEEEEcccccccccccccccEEEEEEcEEEEEEEEEEEccccccccccccccccccccccEEcccccEEEEEccccEEEEccccccEEccEEcccccccccccccccccccccccccccccccEEEEEcccccccccEEEEEEcccccccccccHHHHHcccccccEEEEccccccccccccccccccEEcccccEEEccccccEEEcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHcccccccccEEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHHcccccEEcEEcEEcccccEEEEEEEcccccHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccEEEEEEcccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccEEEcccccccccccccccEEEEEcccccccccccccEEEEEEEccEEEEEEEEEEEccEEEEcccccccccccccccEEEcccccEEEEEEccEEEEccccccccEccccccccccccccccccccccccccccHHHcccccccccccccccccEEEEEEEccccccEEccccccccccccEEcEEEccEHccHHHHHccccccccccccccccEEEEccccEEccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHccccccccccccEEcHHHHHHHHccccccccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccEccccccEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcHHHcEEEccccccccccccccEEEccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
ricqsecgnisisypfgighecflDKSFEVICNysgkypkaylpginnlelldgdsyyestirvnfpiislknpsnargvnlsgspftfsnisnrfaaigcddyhtvdinsstvfggclaistcdpasrrgcYDFLCALSSNITQVFNANLSYIYSqnisrgcrSVSVVEenwvgskylenplvlKQQARDipalldwgedighcaedfslystticgdgeyrcsitfgsgyicrcrttyrtdgfcagcgggLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQElssnesniektklftSKDLEKATdnynanrilgqggqgtvykgmltdgrIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGccletevpllvyefipngtlYQYIHNQIEEFPITWELLLRIAVEVSGALFylhsaasipiyhrdiksanillddkyrakvsdfgtsrsvmvdqthlttkvqgtfgyvdpeyfqssqfteksdvYSFGVVLVEILtgqkpiraintdedKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLnlngkmrpTMKEVTNELggirtsig
Flexible Loop (DISEMBL)
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
Low Complexity Region (SEG)
RICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDgfcagcggglgllfllvgIWWLYKFVKRRKEIKLKQKFFKRngglllqqelssnesnIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG
Disordered region (IsUnstruct)
*****ECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVL*******************CAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLL**************************DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNG*********************
Disordered Region (DISOPRED)
*ICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAI**********CYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFV************************************LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV***NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS**
Disordered Region (DISEMBL)
RICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG
Disordered Region (DISPRO)
*ICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGK**PT*KEVTN**********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
RICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	597	2.2.26 [Sep-21-2011]
Q8RY17	751	Wall-associated receptor	yes	no	0.976	0.776	0.445	1e-140
Q9SA25	720	Wall-associated receptor	no	no	0.984	0.816	0.444	1e-138
Q9S9M2	761	Wall-associated receptor	no	no	0.973	0.763	0.422	1e-138
Q7X8C5	748	Wall-associated receptor	no	no	0.557	0.445	0.639	1e-134
Q9S9M5	730	Wall-associated receptor	no	no	0.542	0.443	0.636	1e-132
Q8VYA3	769	Wall-associated receptor	no	no	0.974	0.756	0.418	1e-132
Q9C9L5	792	Wall-associated receptor	no	no	0.663	0.5	0.573	1e-132
Q9LN59	788	Putative wall-associated	no	no	0.582	0.441	0.653	1e-131
Q9LMT9	764	Putative wall-associated	no	no	0.651	0.509	0.573	1e-129
Q9S9M3	730	Wall-associated receptor	no	no	0.564	0.461	0.625	1e-125

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  500 bits (1288), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 299/671 (44%), Positives = 404/671 (60%), Gaps = 88/671 (13%)

Query: 3   CQSECGNISISYPFGIGH-ECFLDKSFEVICN--YSGKYPKAYLPGINNLELLDGDSYYE 59
           C   CG I I +PFGIG  +CFL+  +EV+CN   SGK    +L  IN  EL+       
Sbjct: 37  CNRICGGIEIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKINR-ELVS--ITLR 93

Query: 60  STIRVNFPIISLKNPSNARG----------VNLSG--SPFTFSNISNRFAAIGCDDYHTV 107
           S+I  ++ ++ +K+P  + G          +NL+G  SPF F   SNR  ++GCD+   +
Sbjct: 94  SSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPF-FITDSNRLVSVGCDNRALI 152

Query: 108 -DINSS----------------TVFGGCLAISTCDPASRRGCYDF-LCALSSNITQVFNA 149
            DI S                  + GG        PA R       L +   N TQ  N 
Sbjct: 153 TDIESQITGCESSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLESSGGNTTQGGNC 212

Query: 150 NLSYIYSQNISRG---------CRSVSVVEENW---VGSKYLENPLVLKQQA-------- 189
            ++++ ++  S               +V+E  W        L NP+              
Sbjct: 213 KVAFLTNETYSPANVTEPEQFYTNGFTVIELGWYFDTSDSRLTNPVGCVNLTETGIYTSA 272

Query: 190 -------------------------RDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYRC 224
                                    R  P L     DI  C E   L S      GE  C
Sbjct: 273 PSCVCEYGNFSGFGYSNCYCNQIGYRGNPYLPGGCIDIDECEEGKGLSSC-----GELTC 327

Query: 225 SITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKR 284
               GS + C      +      G   G  LLFL++GIW L KFVK+R++I  K+ FFKR
Sbjct: 328 VNVPGS-WRCELNGVGKIKPLFPGLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKR 386

Query: 285 NGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV 344
           NGGLLL+Q+L++   N++ +K+F+SK+LEKATDN+N NR+LGQGGQGTVYKGML DGRIV
Sbjct: 387 NGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIV 446

Query: 345 AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI 404
           AVK+SK++DE  VE+FINEV +LSQINHRNIVKL+GCCLETEVP+LVYE IPNG L++ +
Sbjct: 447 AVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRL 506

Query: 405 HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           H+  +++ +TW++ LRI+VE++GAL YLHSAAS P+YHRD+K+ NILLD+KYRAKVSDFG
Sbjct: 507 HHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFG 566

Query: 465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           TSRS+ VDQTHLTT V GTFGY+DPEYFQ+SQFT+KSDVYSFGVVLVE++TG+KP   + 
Sbjct: 567 TSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMR 626

Query: 525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
            +E++ LV +F +A+ +NR+ + +D+R+ +    E+++ VA LA+RCL+L GK RP M+E
Sbjct: 627 PEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMRE 686

Query: 585 VTNELGGIRTS 595
           V+ EL  IR+S
Sbjct: 687 VSVELERIRSS 697

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1

 Score =  492 bits (1266), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 285/641 (44%), Positives = 386/641 (60%), Gaps = 53/641 (8%)

Query: 1   RICQSECGNISISYPFGIGHECFLDKSFEVICNYSG-KYPKAYLPGINNL--ELLDGDSY 57
           R C   CGN+S+ YPFGIG  C+ +K FE++C  S  + P   LP I         GD +
Sbjct: 31  RNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRAVTSFNLGDPF 90

Query: 58  YESTIR---VNFPIISLKNPS----NARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDIN 110
             S      +  P+     P+    ++  +NL GSPF  S  +N+F A+GC++   +++ 
Sbjct: 91  SISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAVGCNNKAFMNVT 149

Query: 111 SSTVFGGCLAISTCDPASRRG----CYDFLCALSSNIT----QVFNANLSYIYSQNISRG 162
              + G C      +  S +G    C  + C   +       QVF+A +  +      +G
Sbjct: 150 GLQIVG-CETTCGNEIRSYKGANTSCVGYKCCQMTIPPLLQLQVFDATVEKLEPNK--QG 206

Query: 163 CRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEY 222
           C+   + +    GS  L  P  L + +      L+W  D+ +      L       +  Y
Sbjct: 207 CQVAFLTQFTLSGS--LFTPPELMEYSEYTTIELEWRLDLSYMTSKRVLCKGNTFFEDSY 264

Query: 223 RCS----------ITFGSGYICRCRTTYRTDGFCAGCGGGLG------------------ 254
           +CS          I  G   I  CR  +        C   LG                  
Sbjct: 265 QCSCHNGYEGNPYIPGGCQDIDECRDPHLNKCGKRKCVNVLGSYRCEKTWPAILSGTLSS 324

Query: 255 -LLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLE 313
            LL L+ G+W L K  ++RK  K K+KFF+RNGGLLLQQ+ S    ++ +TK+F+S DLE
Sbjct: 325 GLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLE 384

Query: 314 KATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR 373
            ATD +NA+RILGQGGQGTVYKGML DG IVAVKKSK + E N+E+FINE+++LSQINHR
Sbjct: 385 NATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHR 444

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           N+VK+LGCCLETEVP+LVYEFIPN  L+ ++HN  E+FP++WE+ L IA EV+ AL YLH
Sbjct: 445 NVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLH 504

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           SA SIPIYHRD+KS NILLD+K+RAKVSDFG SRSV +D THLTT VQGT GYVDPEY Q
Sbjct: 505 SAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQ 564

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
           S+ FT KSDVYSFGV+L+E+LTG+KP+  +   E + L  YFL+A+  +RL E LDAR+ 
Sbjct: 565 SNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIK 624

Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
           +E  +EE++ VA LA+RCL+LN + RPTM++V  EL  +++
Sbjct: 625 EECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQS 665

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  491 bits (1265), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 288/682 (42%), Positives = 400/682 (58%), Gaps = 101/682 (14%)

Query: 2   ICQSECGNISISYPFGI-GHECFLDKSFEVICNYSGKYPKAYLPGIN----NLELLDGDS 56
           +C   CG ISI +PFGI G EC+L+  +EV+CN +   P  +L  IN    N+ L D   
Sbjct: 32  LCNRVCGGISIPFPFGIGGKECYLNPWYEVVCNTTTSVP--FLSRINRELVNIYLPDPTE 89

Query: 57  YYES-TIRVNFPIIS------LKNPSNARGVNLS--GSPFTFSNISNRFAAIGCD-DYHT 106
           YY +  + +  P+ S         P   + +N++  GSP+  ++  N   A+GC+     
Sbjct: 90  YYSNGVVHIKGPVTSSGCSTGTSQPLTPQPLNVAGQGSPYFLTD-KNLLMAVGCNVKAVM 148

Query: 107 VDINSSTVFGGCLAISTCDP--ASRRGCYDFLCA--------LSSNITQVFNANLSYIYS 156
           +D+ S  +  GC   S+CD   +S +   + +C+        +     QV   N+    +
Sbjct: 149 MDVKSQII--GCE--SSCDERNSSSQVVRNKICSGNKCCQTRIPEGQPQVIGVNIEIPEN 204

Query: 157 QNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGED--------------I 202
           +N + G   V+ +  N   S  +  P         +   L W  D              +
Sbjct: 205 KNTTEGGCKVAFLTSNKYSSLNVTEPEEFHSDGYAV-VELGWYFDTSDSRVLSPIGCMNV 263

Query: 203 GHCAEDFSLYSTTICGDGEYRCSITFGSGY---ICRCRTT-YRTDGFCAG-------CGG 251
              ++D    S TIC      CS  + SG+    C C +  Y  + F  G       C  
Sbjct: 264 SDASQDGGYGSETIC-----VCSYGYFSGFSYRSCYCNSMGYAGNPFLPGGCVDIDECKL 318

Query: 252 GLG--------------------------------------LLFLLVGIWWLYKFVKRRK 273
            +G                                      LL    GI+ LYKF+K+++
Sbjct: 319 EIGRKRCKDQSCVNKPGWFTCEPKKPGQIKPVFQGVLIGSALLLFAFGIFGLYKFIKKQR 378

Query: 274 EIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTV 333
                + FF+RNGG+LL+Q+L+  E N+E +K+F+S +LEKATDN+N NR+LGQGGQGTV
Sbjct: 379 RSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTV 438

Query: 334 YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 393
           YKGML DGRIVAVK+SK +DE  VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYE
Sbjct: 439 YKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 498

Query: 394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 453
           F+PNG L + + ++ +++ +TWE+ L IA+E++GAL YLHSAAS PIYHRDIK+ NILLD
Sbjct: 499 FVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLD 558

Query: 454 DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 513
           +KY+ KVSDFGTSRSV +DQTHLTT+V GTFGYVDPEYFQSS+FT+KSDVYSFGVVLVE+
Sbjct: 559 EKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVEL 618

Query: 514 LTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLN 573
           +TG+ P   + ++E++    +F+ A+ ENR  + +D R+  E   +++M VA LAKRCLN
Sbjct: 619 ITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLN 678

Query: 574 LNGKMRPTMKEVTNELGGIRTS 595
             GK RP M+EV+ EL  IR+S
Sbjct: 679 RKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 220/344 (63%), Positives = 287/344 (83%)

Query: 252 GLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKD 311
           G  LL    GI+ LYKFV++R+++   +KFF+RNGG+LL+Q+L+  E N+E +++F+S +
Sbjct: 349 GSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHE 408

Query: 312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK+SK VDE  VE+FINEVV+L+QIN
Sbjct: 409 LEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQIN 468

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           HRNIVKLLGCCLETEVP+LVYEF+PNG L + +H++ +++ +TWE+ L IA+E++GAL Y
Sbjct: 469 HRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSY 528

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LHSAAS PIYHRDIK+ NILLD++ RAKVSDFGTSRSV +DQTHLTT+V GTFGYVDPEY
Sbjct: 529 LHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEY 588

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           FQSS+FTEKSDVYSFGVVLVE+LTG+KP   + ++E++ L  +F++A+ ENR+ + +D R
Sbjct: 589 FQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDR 648

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           +  E   +++M+VA LA+RCLN  GK RP M+EV+ EL  IR+S
Sbjct: 649 IKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  473 bits (1218), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 219/344 (63%), Positives = 290/344 (84%)

Query: 252 GLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKD 311
           GL  L   VG++WL+K +K+R+ I   +KFFKRNGGLLL+Q+L++ + N+E +K+F+SK+
Sbjct: 362 GLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKE 421

Query: 312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           L KATDN++ +R+LGQGGQGTVYKGML DG IVAVK+SK+VDE  +E+FINE+V+LSQIN
Sbjct: 422 LRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQIN 481

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           HRNIVKLLGCCLETEVP+LVYE+IPNG L++ +H++ +++ +TWE+ LRIA+E++GAL Y
Sbjct: 482 HRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTY 541

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           +HSAAS PI+HRDIK+ NILLD+KYRAKVSDFGTSRSV +DQTHLTT V GTFGY+DPEY
Sbjct: 542 MHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEY 601

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           F SSQ+T KSDVYSFGVVLVE++TG+KP+  + ++E + L  +FL+A+ ENR+ + +D R
Sbjct: 602 FLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIR 661

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           +  E+K E++M VA LA++CLN  GK RP MKEV+NEL  IR+S
Sbjct: 662 IKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  473 bits (1218), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 290/693 (41%), Positives = 401/693 (57%), Gaps = 111/693 (16%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGIN-NLELLDGDSYYEST 61
           C   CG I I YPFGIG  C+L+K +E+IC  +   P  +L  IN  +  +     Y   
Sbjct: 27  CPKTCGGIDIPYPFGIGTGCYLEKWYEIIC-VNNSVP--FLSIINREVVSISFSDMYRRF 83

Query: 62  IRVNFPIISLKNPSNARG-----------VNLSGSPFTFSNISNRFAAIGCDDYHTVDIN 110
             V +  I ++NP  ++G           +N++G PF   + +N   A+GC++  ++  N
Sbjct: 84  FNVGYGSIRIRNPIASKGCSSGGQEFGSLLNMTGYPFYLGD-NNMLIAVGCNNTASL-TN 141

Query: 111 SSTVFGGCLAISTCDPASRRGCYDFLCAL---------------------SSNITQVFNA 149
                 GC   STC         D+L  L                     S N      A
Sbjct: 142 VEPSIVGCE--STCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKA 199

Query: 150 NLSYIYSQNI----------SRGCRSVSVVEENW-------------------------- 173
           +L   Y Q I          S+GC+   + +E +                          
Sbjct: 200 SLPARYQQIIGVEIDDSNTESKGCKVAFITDEEYFLSNGSDPERLHANGYDTVDLRWFIH 259

Query: 174 ---------VGSKYLENPLVLKQQARD--IPALLDW-----GEDIGHCAEDF--SLYSTT 215
                    +G K ++   +L++  R+  I  L D+     G     CA  F  + Y   
Sbjct: 260 TANHSFIGSLGCKSIDEYTILRRDNREYGIGCLCDYNSTTTGYATCSCASGFEGNPYIPG 319

Query: 216 ICGD---------GEYRCS----ITFGSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGI 262
            C D         G   C+    +    GY C   T +R      G       L  + GI
Sbjct: 320 ECKDINECVRGIDGNPVCTAGKCVNLLGGYTCE-YTNHRP--LVIGLSTSFSTLVFIGGI 376

Query: 263 WWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNAN 322
           +WLYKF++R++ +  K+KFFKRNGGLLLQQ+L++ E N++ T++F S++LEKAT+N++  
Sbjct: 377 YWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLT 436

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           RILG+GGQGTVYKGML DGRIVAVKKSK+VDE  +E+FINEVVILSQINHRNIVKLLGCC
Sbjct: 437 RILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCC 496

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPI-TWELLLRIAVEVSGALFYLHSAASIPIY 441
           LET+VP+LVYEFIPNG L++++H+  +++ + TWE+ LRIAV+++GAL YLHSAAS PIY
Sbjct: 497 LETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIY 556

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HRDIKS NI+LD+K+RAKVSDFGTSR+V VD THLTT V GT GY+DPEYFQSSQFT+KS
Sbjct: 557 HRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKS 616

Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           DVYSFGVVL E++TG+K +  + + E ++L  YF  A+ ENRL + +DAR+    K  ++
Sbjct: 617 DVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQV 676

Query: 562 MTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
              A +A++CLN+ G+ RP+M++V+ EL  IR+
Sbjct: 677 TAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  471 bits (1212), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/406 (57%), Positives = 306/406 (75%), Gaps = 10/406 (2%)

Query: 193 PALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGG 252
           P  L   +DI  C E+  +   T CG    +C +     + C     +R      G G  
Sbjct: 330 PYRLGGCKDINECKEEEGM---TYCGTN--KC-VNLQGHFKC-VYNNHRP--LAIGLGAS 380

Query: 253 LGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDL 312
            G L  +VGI+ LYKF+K+++++  K+KFFKRNGGLLLQQ+L S    +EKT +F+S++L
Sbjct: 381 FGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSREL 440

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
           EKAT+N+++NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE  +E+FINEVVILSQINH
Sbjct: 441 EKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINH 500

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFY 431
           RNIVKLLGCCLET+VP+LVYEFIPNG L++++H++ +E    TW + LRIA++++GAL Y
Sbjct: 501 RNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSY 560

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LHS+AS PIYHRD+KS NI+LD+KYRAKVSDFGTSR+V VD THLTT V GT GY+DPEY
Sbjct: 561 LHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEY 620

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           FQSSQFT+KSDVYSFGVVLVE++TG+K I  + + E+++L  YF+ A+ EN+LF+ +DAR
Sbjct: 621 FQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDAR 680

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           +       ++   A +A++CLNL G+ RP+M+EV+ EL  IR   G
Sbjct: 681 IRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCG 726

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  470 bits (1209), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 228/349 (65%), Positives = 285/349 (81%), Gaps = 1/349 (0%)

Query: 248 GCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLF 307
           G G   G+L L+VGIWWL KF+K+R+  K K+KFFKRNGGLLLQQ+L++N+ N+EKT++F
Sbjct: 380 GVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIF 439

Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           +S++LEKATDN++ +RILGQGGQGTVYKGML DGR VAVKKSK+VDE  +E+FINEVVIL
Sbjct: 440 SSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVIL 499

Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           SQINHR++VKLLGCCLETEVP LVYEFIPNG L+Q+IH + +++  TW + LRIAV+++G
Sbjct: 500 SQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAG 559

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           AL YLHSAAS PIYHRDIKS NILLD+KYR KVSDFGTSRSV +D TH TT + GT GYV
Sbjct: 560 ALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYV 619

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFE 546
           DPEY+ SSQ+T+KSDVYSFGVVLVE++TG+KP+  + N+ E + L  +F  A+ ENR FE
Sbjct: 620 DPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFE 679

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
            +DAR+    K E++M VA LA+RCLN  GK RP M++V  +L  I  S
Sbjct: 680 IMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  461 bits (1187), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 230/401 (57%), Positives = 291/401 (72%), Gaps = 12/401 (2%)

Query: 193 PALLDWGEDIGHCAEDFSLYSTTICGDGE--YRCS-ITFGSGYICRCRTTYRTDGFCAGC 249
           P + D  +DI  C E         CGD    YR + I    G+ C     Y       G 
Sbjct: 333 PYVSDDCQDINECTE-----YKNPCGDTRILYRNTCINTSGGHRC---IDYHIPEVMLGL 384

Query: 250 GGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTS 309
           G G  +L +  GIWW  K +++R+    K+KFFKRNGGLLLQQ+L++ +  +EKTKLF+S
Sbjct: 385 GAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSS 444

Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           ++LEKATDN+N NR++GQGGQGTVYKGML DGR VAVKKS +VDE  +++FINEV+ILSQ
Sbjct: 445 RELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQ 504

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           INHR++VKLLGCCLETEVP+LVYEFIPNG L+Q++H + +++   W + +RIAV++SGA 
Sbjct: 505 INHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAF 564

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH+AA  PIYHRDIKS NILLD+KYRAKVSDFGTSRSV +D TH TT + GT GYVDP
Sbjct: 565 SYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDP 624

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN-TDEDKSLVGYFLQAINENRLFEAL 548
           EY+ SS FTEKSDVYSFGVVLVE++TG+KP+  ++ T E   L  YF  A+ ENRLFE +
Sbjct: 625 EYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEII 684

Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           DAR+  + K E+++ VA LA RCL   GK RP M+EV+  L
Sbjct: 685 DARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTAL 725

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2

 Score =  450 bits (1158), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 212/339 (62%), Positives = 282/339 (83%), Gaps = 2/339 (0%)

Query: 257 FLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKAT 316
           F ++GI+ LYKF+++R+ I    KFFKRNGGLLL+Q+L++ + ++E +K+F+S++LEKAT
Sbjct: 366 FFVIGIFGLYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKAT 425

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           DN++ +R+LGQGGQGTVYK ML DG IVAVK+SK+VDE  +E+FINE+V+LSQINHRNIV
Sbjct: 426 DNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIV 485

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           KLLGCCLETEVP+LVYE+IPNG L++ +H++ +++ +TWE+ LRIAVE++GAL Y+HSAA
Sbjct: 486 KLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAA 545

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
           S PI+HRDIK+ NILLD+KYRAK+SDFGTSRSV  DQTHLTT V GTFGY+DPEYF SSQ
Sbjct: 546 SFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQ 605

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           +T KSDVYSFGVVLVE++TG+KP+  + ++E   L  YFL+A+ ENR  + +D R+  E+
Sbjct: 606 YTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDES 665

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           K  ++M VA LA+RCLN  G  RP M+EV+ +L  IR+S
Sbjct: 666 K--QVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSS 702

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	597
255545828	694	kinase, putative [Ricinus communis] gi|2	0.984	0.847	0.539	0.0
255545824	727	kinase, putative [Ricinus communis] gi|2	0.976	0.801	0.532	1e-178
359475622	867	PREDICTED: wall-associated receptor kina	0.978	0.673	0.546	1e-176
147765961	679	hypothetical protein VITISV_007744 [Viti	0.978	0.860	0.546	1e-175
255541802	743	kinase, putative [Ricinus communis] gi|2	0.981	0.788	0.535	1e-172
224118592	642	predicted protein [Populus trichocarpa]	0.966	0.898	0.524	1e-170
359475620	822	PREDICTED: wall-associated receptor kina	0.981	0.712	0.519	1e-169
224075946	729	predicted protein [Populus trichocarpa]	0.958	0.784	0.503	1e-160
224143699	635	predicted protein [Populus trichocarpa]	0.969	0.911	0.517	1e-159
225455808	718	PREDICTED: wall-associated receptor kina	0.968	0.805	0.514	1e-159

>gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis]

 Score =  666 bits (1718), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/654 (53%), Positives = 442/654 (67%), Gaps = 66/654 (10%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTI 62
           C+S CGN+ I +PFGIG  C++D+SFEV CN S + PK +L  IN +ELL+  S   + +
Sbjct: 32  CESYCGNVPIEFPFGIGKGCYMDESFEVTCNSSSEPPKPFLTSIN-MELLEVLS--PNQV 88

Query: 63  RVNFPII---SLKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCL 119
           +VN P+I        S A  V+LSG+PFTFSN SNRF A GC++Y  +  +     GGCL
Sbjct: 89  QVNNPVIYSNCSHKTSTASRVSLSGTPFTFSNASNRFTAKGCNNYAILMQDIGDTVGGCL 148

Query: 120 AISTCDPASRRGCYDFLCALSS--NITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSK 177
           +I   D A+  GCY   C  ++     + F AN++  +S N +  C+S  +V+++W   +
Sbjct: 149 SICR-DEANSSGCYGINCWQTTIPPYMKSFEANMTNPFSDN-TNNCKSAFMVDQSWFAFQ 206

Query: 178 YLENPLVLKQQARD-IPALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITF-------- 228
              +  +     +D +PA+LDW    G+C  D S Y    C      C            
Sbjct: 207 SSSSRSLDDLNYKDHVPAVLDWANYQGYC--DISEYYNITCTTDSSYCWKELNRSQVCIC 264

Query: 229 -----------GSGYICRCRTTYRTDGFCAGCGGGLG----------------------- 254
                       S Y CR    YR  G+   C  G G                       
Sbjct: 265 QCEDPNKCPDQSSNYNCRLFCMYRPGGYNCPCPRGHGKYENSNRCYPNSVFWGKSRTKTK 324

Query: 255 -----------LLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEK 303
                       L LL+GIW LYK +KRR+ +KLKQ FFKRNGGLLL+Q+LSS E+ +E+
Sbjct: 325 SIIIGCGSGIGFLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQ 384

Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE 363
           TK+FTSK+LEKATD+Y+ NRILGQGGQGTVYKGML DGR+VA+KKSK+VDE  ++QFINE
Sbjct: 385 TKVFTSKELEKATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINE 444

Query: 364 VVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
           VVILSQINHRN+VKL+GCCLETEVPLLVYEFIPNGTLYQYIHN  EEFP+TWE+ LRIA 
Sbjct: 445 VVILSQINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIAT 504

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           EV+GAL YLH+AAS+PIYHRDIKS+NILLD+KYRAKV+DFGTS+S+ +DQTH+TT+VQGT
Sbjct: 505 EVAGALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGT 564

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 543
           FGY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI +  + E++SL  YFL  + E+R
Sbjct: 565 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESR 624

Query: 544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           LFE LDARVLKE  +EEI+ +A LA++CLNLNGK RP MK V  EL GIR+S G
Sbjct: 625 LFEILDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQG 678

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 349/656 (53%), Positives = 434/656 (66%), Gaps = 73/656 (11%)

Query: 2   ICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYEST 61
           +CQ  CG+I+  +PFGIG  C++ + FE++CN S   PK +L  IN +ELL   S     
Sbjct: 31  VCQESCGDITFPFPFGIGKGCYMSEMFEIVCNDSFTPPKPFLTSIN-MELLHDPSIGSER 89

Query: 62  IRVNFPIISLK---NPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGC 118
           I VN P+IS       S +  V+L G+ F FSN SNRF  IGCD Y  +  + +TV GGC
Sbjct: 90  ITVNSPVISSNCSNKSSTSTEVSLLGTSFLFSNESNRFTTIGCDSYAMLTQSGNTV-GGC 148

Query: 119 LAISTCDPASRRGCYDFLCALSS--NITQVFNANLSYIYSQNIS--RGCRSVSVVEENWV 174
           L+I  C   S  GCY   C  ++     Q F  N++  ++ +      C+S  +V +NW+
Sbjct: 149 LSI--CRDNSSSGCYGLNCCQTTIPPYVQSFEVNITNPFNSDGDGRDRCKSAFMVSQNWL 206

Query: 175 GSKYLENPLVLKQQARDIPALLDWG----------------------------------- 199
            SK     L   +Q   +PA+LDW                                    
Sbjct: 207 ASK--STNLDEVRQMDHVPAVLDWANDQGYCDISKNPNITCTSRYCWAQLTENQFCICRQ 264

Query: 200 -EDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTD-GFCAGCGGGLG--- 254
            ED+G C    + Y   +      +C    G GY C C   +  +   C       G   
Sbjct: 265 CEDVGKCTNPKNYYYCQL------KCMYNRG-GYNCPCPVEHHKEYSICYPDSAFAGKSR 317

Query: 255 -------------LLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNI 301
                        LL L++GIW  YK +KRR+  KLKQKFFKRNGGLLL+Q+LSS ES++
Sbjct: 318 IKTILIGCGSGLGLLLLIIGIWLSYKIIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHV 377

Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFI 361
           E+TK+FTSK+LEKATDNY+ +RILGQGGQGTVYKGMLTDGR+VA+KKSKLVDE  ++QFI
Sbjct: 378 EQTKVFTSKELEKATDNYHTSRILGQGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFI 437

Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           NEVVILSQINHRN+VKL GCCLETEVPLLVYEFIPNGTL+QYI N  +EFPITWE+ LRI
Sbjct: 438 NEVVILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRI 497

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
           A EV+GAL YLHSAAS+PIYHRDIKS+NILLD+KYRAKV+DFGTS+S+ ++QTH+TT VQ
Sbjct: 498 ATEVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQ 557

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
           GTFGY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI ++ + E++SL  YFL  + E
Sbjct: 558 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSLRSVEERSLATYFLMTMEE 617

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           NRLFE LDARVLKE  +EEI+ +A +A++CLNLNGK RP MK V  EL GIR+S G
Sbjct: 618 NRLFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSSQG 673

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera]

 Score =  623 bits (1607), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 342/626 (54%), Positives = 422/626 (67%), Gaps = 42/626 (6%)

Query: 3   CQSECGNISISYPFGIGHE-CFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYEST 61
           CQ  CG++ I YPFGIG   C+ D+ FEV CN S   PK +L G+N LE+L+     + T
Sbjct: 37  CQERCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVN-LEVLNVS--LDGT 93

Query: 62  IRVNFPIISLKN----PSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGG 117
           IRVN P++  +N    PSN       G PF+FSN   RF A+GC     + +   TV GG
Sbjct: 94  IRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSALVYI-MQDDTVIGG 151

Query: 118 CLAI--STCDPASRRGCYDFLCALSSNITQV------FNANLSYIY--SQNISRGCRSVS 167
           C+         A +  CY   C      TQV      F ANL      S +    C+   
Sbjct: 152 CMTFCKKDATAAKKASCYGLECCQ----TQVPPGLLSFTANLGTFSDGSADEQEQCKFAF 207

Query: 168 VVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLY--STTICGDGEYRCS 225
           +V++ W  S  + +P  +K     +PA+LDW      CA   S    ST+ CG+     +
Sbjct: 208 MVDQEWFISN-VPDPHTVKDMEY-VPAVLDWRIYNATCAASTSNLNTSTSFCGENTLCST 265

Query: 226 ITFGSGYICRCRTTYRTDGF----CAG------CG----GGLGLLFLLVGIWWLYKFVKR 271
            T  S  IC C   Y  + +    C G      C     G LG L L++  WWLY  +KR
Sbjct: 266 DTQTSSLICSCFPVYEGNPYLPQGCQGTQSIEDCAVITIGALGTLLLVLCAWWLYIVLKR 325

Query: 272 RKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQG 331
           RK+IK K+K F RNGGLLL+Q+LSS E NI+KTKLFTSK+LEKATD YN NR++GQGG+G
Sbjct: 326 RKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKELEKATDRYNENRVIGQGGEG 385

Query: 332 TVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 391
           TVYKGML DGRIVAVKK K++ ++ +EQFINEVVIL QINHRN+VKLLGCCLETEVPLLV
Sbjct: 386 TVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLV 445

Query: 392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL 451
           YEFIPNGTL ++IH Q EEFPITWE+ LRIA EV+GAL YLHSAAS+PIYHRDIKS NIL
Sbjct: 446 YEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRDIKSTNIL 505

Query: 452 LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 511
           LDDKYRAKV+DFG S+ V +DQTHLTT+VQGTFGY+DPEYFQSSQFTEKSDVYSFG+VL+
Sbjct: 506 LDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLI 565

Query: 512 EILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRC 571
           E+LTG+KPI +  ++E KSL  YF+ ++NE+RL + LDA+V+KE++KEEI  +A LA+RC
Sbjct: 566 ELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRC 625

Query: 572 LNLNGKMRPTMKEVTNELGGIRTSIG 597
           +NLNGK RPTM EV  EL  IR   G
Sbjct: 626 INLNGKKRPTMMEVAMELERIRKCQG 651

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera]

 Score =  620 bits (1600), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 338/618 (54%), Positives = 418/618 (67%), Gaps = 34/618 (5%)

Query: 3   CQSECGNISISYPFGIGHE-CFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYEST 61
           CQ  CG++ I YPFGIG   C+ D+ FEV CN S   PK +L G+N LE+L+   +   T
Sbjct: 30  CQEWCGDVDIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVN-LEVLNVSLH--GT 86

Query: 62  IRVNFPIISLKN----PSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGG 117
           +RVN P++  +N    PSN       G PF+FSN   RF A+GC       +   TV GG
Sbjct: 87  VRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSAMAYF-MQDDTVIGG 144

Query: 118 CLAISTCD---PASRRGCYDFLCALSSNITQV------FNANLSYIY--SQNISRGCRSV 166
           C+ +   D    A    CY   C      TQV      F ANL      S +    C+  
Sbjct: 145 CMTLCKKDVATAAKNASCYGLECCQ----TQVPPGLLSFTANLDTFPEGSADEQEPCKYA 200

Query: 167 SVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLY--STTICGDGEYRC 224
            +V++ W  S  + +P  +K     +PA+LDW      C    S    ST+ CG+  +  
Sbjct: 201 FMVDQEWFISN-VPDPHTVKDMEY-VPAVLDWRIYNATCDASTSNLNTSTSFCGENTFCS 258

Query: 225 SITFGSGYICRCRTTYRTDGFCA-GCG----GGLGLLFLLVGIWWLYKFVKRRKEIKLKQ 279
           + T  S   C C   Y  + +   GC     G LG L L++  WWLY  +KRRK+IK K+
Sbjct: 259 TDTQTSSLTCSCPLLYEGNPYLPQGCQVITIGSLGTLLLVLCAWWLYIXLKRRKKIKYKE 318

Query: 280 KFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT 339
           K F RNGGLLL+Q+LSS+E NI+KTKLFTSK+LEKATD YN NR++GQG QGT YKGML 
Sbjct: 319 KCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENRVIGQGXQGTXYKGMLM 378

Query: 340 DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 399
           DGRIVAVKK K++ ++ +EQFINEVVIL QINHRN+VKLLGCCLETEVPLLVYEFIPNGT
Sbjct: 379 DGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 438

Query: 400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
           L ++IH Q EEFPITWE+ LRIA EV GAL YLHS ASIPIYHRDIKS NILLBDKYRAK
Sbjct: 439 LSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAK 498

Query: 460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           V+DFG S+ V +DQTHLTT+VQGTFGY+DPEYFQSSQFTEKSDVYSFG+VL+E+LTG+KP
Sbjct: 499 VADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKP 558

Query: 520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR 579
           I +I ++E KSL  YF+ ++NE+RL + LDA+V+KE++KEEI  +A LA+RC+NLNGK R
Sbjct: 559 ILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKR 618

Query: 580 PTMKEVTNELGGIRTSIG 597
           PTM EV  EL  IR   G
Sbjct: 619 PTMMEVAMELERIRKCQG 636

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 350/654 (53%), Positives = 422/654 (64%), Gaps = 68/654 (10%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTI 62
           C   CGN++I YPFGIG  C++D  F V CN +    + YL  IN LELL   S   + +
Sbjct: 32  CSDRCGNVTIPYPFGIGEGCYMDSGFAVTCNKTSLPYRPYLTSIN-LELLRV-SLESTLV 89

Query: 63  RVNFPIISLKNPSNARGVNLSGSPFTFSNI-SNRFAAIGCDDYHTVDINSSTVFGGCLAI 121
           RVN P+++          +LS S   FS   +NRF A+GC++   +      V GGCL+I
Sbjct: 90  RVNNPVLNSNCQDRPPVSDLSFSGSPFSFSDNNRFTALGCNNLALI-YRQDMVIGGCLSI 148

Query: 122 STCDPASRRGCYDFLCALSS--NITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYL 179
                 +   CY   C  +S     +  NA+L  I        CR   +V+  W  S   
Sbjct: 149 CNVT-VTESSCYGINCCQTSIPPYLKFINASLRSI-DPVPDEQCRVAFMVDREWFSSNAS 206

Query: 180 ENPLVLKQQARDIPALLDWGEDIGHCAEDFSLY-STTICGDGEYRCSITFGSGYICRCR- 237
           +N   L   A+ +PA+L+WG   G CA+      ST ICG     CS+  G  Y C C  
Sbjct: 207 DNISAL-LGAKQVPAVLEWGISNGTCADSPGAENSTDICGSNA-SCSVKVGINYQCSCNQ 264

Query: 238 ------------------------------------------------TTYRTDGFCAG- 248
                                                             Y TDG+    
Sbjct: 265 GYEGNPYLSCQDINECEDSQKNKCSMICVNTPGSYKCSCPDGYISMGNNCYLTDGYTERF 324

Query: 249 -------CGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNI 301
                     GLG+ FLL+G WWLYK  KRRK+ KL+Q+FFKRNGGLLLQQ+LSS+ES+I
Sbjct: 325 RPVIAIVLSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSI 384

Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFI 361
           EKT +FT+K+LEKATD+YN NRILGQGGQGTVYKGMLTDG++VA+KKSK+ DE+  EQFI
Sbjct: 385 EKTNMFTAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFI 444

Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           NEVVILSQINHRN+VKLLGCCLETEVPLLVYEFIPNGTLYQ++H+  EEFPITWE+ LRI
Sbjct: 445 NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRI 504

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
           A+E   AL YLHSAAS+PIYHRDIKS NILLDDKYRAKVSDFGTS+S+ VDQTH+TT+VQ
Sbjct: 505 AIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQ 564

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
           GTFGY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI +    E++SL  YFL ++ +
Sbjct: 565 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQ 624

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           NRLFE LDARVLKE  KEEI+ VA LA+RCLNLNGK RPTM+ V  E+  IR S
Sbjct: 625 NRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa]

 Score =  605 bits (1559), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 327/623 (52%), Positives = 422/623 (67%), Gaps = 46/623 (7%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPG----INNLELLDGDSYY 58
           C+S CG+ISI YPFG+   C+LD+ F+++CN S   PK  + G    +NN+ + D     
Sbjct: 6   CESYCGDISIPYPFGMKEGCYLDERFKILCNSSSGVPKLTVNGTDLEVNNISVDD----- 60

Query: 59  ESTIRVNFPIISLKNPSNARG---VNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVF 115
            STI V FPI+   N S   G   V+L GSPF FS+  N F A GC +   ++ N S + 
Sbjct: 61  -STIAVMFPIV-FANCSGKDGNTVVDLEGSPFVFSS-ENYFIARGCGNLALMNQNQSAI- 116

Query: 116 GGCLAISTCDP---ASRRGCYDFLCALS--SNITQVFNANLSYIYSQNISRG---CRSVS 167
           GGC  +S CD    +    C    C  +   +  +VFN  +  +     SRG   CR   
Sbjct: 117 GGC--VSLCDKNRDSMMASCSGIDCCQTRIPSFLKVFNVTMKGLEDGKGSRGENECRYAF 174

Query: 168 VVEENWVGSKYLENPLVL---------KQQARDIPALLDWGED---IGHCAEDFSLYS-- 213
           +++E W                     K++   +P +LDWG D        ++ S Y+  
Sbjct: 175 LIDERWTNYGGYYYDYYFGGNFDFYYDKRERDHVPVVLDWGIDRRVFESLVKNGSFYNSS 234

Query: 214 -TTICGDGE-YRCSITFGSGYICRCRTTY---RTDGFCAGCGGGLGLLFLLVGIWWLYKF 268
            T+ C +G  Y   I  G   I   + +      + F   C GG G LFLL+G+WWLYK 
Sbjct: 235 YTSTCFEGNPYLSGICQGKLLIVVSQFSSFPSMNNAFLKKCVGGFGALFLLIGLWWLYKV 294

Query: 269 VKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQG 328
            KR++  KLK+K+FKRNGGLLLQ++LSS E N+EK K+F SK+L+KATD+YN NR LGQG
Sbjct: 295 FKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVEKIKMFPSKELDKATDHYNVNRTLGQG 354

Query: 329 GQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 388
           GQGTVYKGML DG+IVAVKKSK +DE N+ QFINEVV+LSQINHRN+VKLLGCCLETE+P
Sbjct: 355 GQGTVYKGMLADGKIVAVKKSKEIDEGNLRQFINEVVLLSQINHRNVVKLLGCCLETELP 414

Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           LL+YEFIPNGTL+Q++H+  EEFP+TWE+ LRIA EV+GALFYLHSAAS+PI+HRDIKS 
Sbjct: 415 LLIYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEVAGALFYLHSAASLPIFHRDIKST 474

Query: 449 NILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGV 508
           NILLD++YRAKV+DFGTSRSV +DQTH+TT+VQGTFGY+DPEYFQSSQFT+KSDVYSFGV
Sbjct: 475 NILLDEEYRAKVADFGTSRSVSIDQTHVTTRVQGTFGYLDPEYFQSSQFTDKSDVYSFGV 534

Query: 509 VLVEILTGQKPIRAINTDED-KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATL 567
           VLVE+LTGQKPI    ++E  +SL  YF+ A+  N LF+ LD +V+K+ ++E+++ VA+L
Sbjct: 535 VLVELLTGQKPISFTRSEEQGRSLATYFIMAMESNCLFDILDPQVVKQGEREDVLMVASL 594

Query: 568 AKRCLNLNGKMRPTMKEVTNELG 590
           A+ CL LNGK RPTMK VT   G
Sbjct: 595 ARSCLRLNGKERPTMKGVTMRSG 617

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera]

 Score =  603 bits (1554), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 342/658 (51%), Positives = 424/658 (64%), Gaps = 72/658 (10%)

Query: 3   CQSECGNISISYPFGIGHE-CFLDKSFEVICNYS--GKYPKAYLPGINNLELLDGDSYYE 59
           C   CG++ I YPFGIG   C+ D+ FEV CN S     PK +L  I NLE+L+  S   
Sbjct: 153 CLETCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPKPFL-KILNLEVLNV-SLNR 210

Query: 60  STIRVNFPIISLKN----PSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVF 115
           STIRVN P++   N    PSN    +  G PF+FS+   RF A+GC     +  N S V 
Sbjct: 211 STIRVNNPVLGYMNCSGKPSN-DAQSWEGGPFSFSDTYTRFTAVGCSTLAYITQNDS-VI 268

Query: 116 GGCLA-ISTCDPASRRG-CYDFLCALSSNIT--QVFNANLSYIYSQNISRG-CRSVSVVE 170
           GGC++       A++ G CY   C  +      Q F   L    S +  +  C+   +V+
Sbjct: 269 GGCMSYCKQGTTAAKNGSCYGLKCCQTQFPPGLQYFTTMLGDFPSNSDDQDECKYAFMVD 328

Query: 171 ENWVGSKYLENPLVLKQQARDIPALLDWG------EDIGHCAEDFSLYSTTICGDGEYRC 224
           + W  S   ++P  +K      PA+LDW       + +G      S  ST+ CG      
Sbjct: 329 QEWFISME-QDPDKVKDVGH-APAVLDWRIYNATCKSVGWNNTSTSNTSTSFCGANAICS 386

Query: 225 SITFGSGYICRCRTTYRTD----------------------------------------- 243
           + T      CRC   Y  +                                         
Sbjct: 387 ADTQTPSLTCRCPRGYEGNPYLTEGCEGTNYKLYENGTVCINRNANFSCYPVDKLIVDPR 446

Query: 244 -------GFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSS 296
                  G C G   G+G L L++  WWLYK +KRR++IK K+K FKRNGGLLL+Q+LSS
Sbjct: 447 PRRMVLPGICVGILAGVGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSS 506

Query: 297 NESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN 356
           +E N++KTKLFTSK+LEKATD YN NR++GQGGQGTVYKGML DGRIVAVKK K+V +  
Sbjct: 507 SEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGK 566

Query: 357 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE 416
           VEQFINEVVILSQINHRN+VKLLGCCLET VPLLVYEFIPNGTL ++IH+Q EEFPITWE
Sbjct: 567 VEQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWE 626

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
           + LRIA+EV+GAL YLHSAASIPIYHRDIKS NILLDDKYRAKV+DFGTS+SV +DQTHL
Sbjct: 627 MRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHL 686

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
           TT+VQGTFGY+DPEYFQSSQFTEKSDVYSFG+VL+E+LTG+KPI +  ++E KSL  YF+
Sbjct: 687 TTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFI 746

Query: 537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
            ++NE+RL + LDA+V+KE KKEEI  +A LA+RC+NLNGK RPTM EV  EL  ++T
Sbjct: 747 LSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILKT 804

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa]

 Score =  572 bits (1474), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 330/656 (50%), Positives = 413/656 (62%), Gaps = 84/656 (12%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGK--YPKAYLPGINN--LELLDGDSYY 58
           CQ+ CGNISI YPFG   +C+ ++ F+++C  +     P+A++  IN   L + DG +  
Sbjct: 32  CQNRCGNISIPYPFGTAQDCYANEMFKIVCRETTNESAPRAFISMINMEVLNITDGAAI- 90

Query: 59  ESTIRVNFPIISLK---NPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVF 115
                VN PI+S       SN   +NL+GSPF FS   N F A+GC+    +      V 
Sbjct: 91  -----VNGPIMSSNCSDRQSNLPALNLTGSPFFFS-FGNVFTAVGCNVRALLTGIGRQVV 144

Query: 116 GGCLAISTCDPASRRG-----------CYDFLC--ALSSNITQVFNANLSYIYSQNISRG 162
           G     STC   S +            C D  C  A +    QVF  +L        S G
Sbjct: 145 G---CDSTCSADSNQKTLLYGQEINSLCADGNCCVARAPYRMQVFQPSLDTKNGSEDSSG 201

Query: 163 CRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHCAEDFSLY----STTICG 218
           C+   + +E       + NP  L Q  R +P +L W         D+S++    ST  C 
Sbjct: 202 CKLAFLTDETNFSFLNITNPQAL-QGWRSVPLVLAW-------MMDYSIWRYDKSTMDCK 253

Query: 219 DGEYRCSITFGSGYICRCRTTYRTDGF----------------CAG---CGGGLG----- 254
              Y  S++  SGY C C   Y  + +                C G   C   LG     
Sbjct: 254 YFLYESSVSNVSGYECSCSNGYEGNPYLGCTDINECKDPNRHSCLGITKCVNTLGSYKCE 313

Query: 255 ----------------LLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNE 298
                           +L LL GI WLYK  K+RK I+LK+KFFKRNGGLLLQQ+LSSN 
Sbjct: 314 VNKYWIVPILVVVIAGILSLLAGISWLYKLAKKRKNIELKRKFFKRNGGLLLQQQLSSNH 373

Query: 299 SNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE 358
            +++KTK+FTSK+LE ATD +N NRILGQGGQGTVYKGML DGRIVAVK+S +V E  +E
Sbjct: 374 GSVQKTKIFTSKELETATDRFNENRILGQGGQGTVYKGMLEDGRIVAVKRSTIVGEEKLE 433

Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN--QIEEFPITWE 416
           +FINEVVILSQINHRN+VKL GCCLETEVPLLVYEFI NG L+QY+HN  Q E+F ++WE
Sbjct: 434 EFINEVVILSQINHRNVVKLFGCCLETEVPLLVYEFISNGNLFQYLHNFYQNEDFILSWE 493

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
           + L+IA+EV+GAL YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG+SRS+ +DQTHL
Sbjct: 494 MRLQIAIEVAGALSYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGSSRSMAIDQTHL 553

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
           TT VQGTFGY+DPEYFQSSQFT+KSDVYSFGVVLVE+L+G+KPI +  + E +SL  +F+
Sbjct: 554 TTNVQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLSGKKPIISSTSQETRSLATHFI 613

Query: 537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
             + ENRLF+ LD +V ++  +EEIM VA LAKRCLN++ K RPTMKEV+ EL  I
Sbjct: 614 VLMEENRLFDILDVQVKEDCLEEEIMAVANLAKRCLNVSRKHRPTMKEVSAELERI 669

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143699|ref|XP_002336072.1| predicted protein [Populus trichocarpa] gi|222869913|gb|EEF07044.1| predicted protein [Populus trichocarpa]

 Score =  568 bits (1465), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 321/620 (51%), Positives = 413/620 (66%), Gaps = 41/620 (6%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTI 62
           C   CG+ISI YPFGI  +C++++ F + CN S    +A++  IN +E+L+  S   +T 
Sbjct: 27  CPDRCGDISIPYPFGIRKDCYMNEWFAIECNASVNPARAFISRIN-MEVLN-ISAERATA 84

Query: 63  RVNFPIISLKNPSNARGV--NLSGSPFTFSNISNRFAAIGCDDYHTVDINSSTVFGGCLA 120
            V  PIIS        GV  NL+G+PF FS   N F A+GC+    +   +  + G    
Sbjct: 85  TVKSPIISSNCTGREDGVPLNLTGTPFVFSRYDNVFIAVGCNTQALMTGITPNLIG---C 141

Query: 121 ISTCDPASRRGCYDFLCALSSNITQVFNANLSYIYSQNISRGCRSVSVVEENWVGSKYLE 180
           +STC     +   +F  AL  +  QVFN  +          GC+   +V   W  S  + 
Sbjct: 142 VSTCSDVKSK---NFCEALLPSSLQVFNPRIEATDDNQDREGCKLAFLVNHTWFESN-VS 197

Query: 181 NPLVLKQQARD-IPALLDWG-----EDIGHCAEDFSLYSTTICG-DGEYRCSITFGSGYI 233
           +P  L  Q+RD +PA L W      +D  +C   ++    + C  DG Y      G   +
Sbjct: 198 DPFSL--QSRDYVPAELGWAMSVNDDDPVYCRGYYNRSFGSECECDGGYEGIPYLGCIDV 255

Query: 234 CRCRTTYRTDGFCAGC---------------------GGGLGLLFLLVGIWWLYKFVKRR 272
             C+ +  +      C                     G  +  L LL+GIWWLYK VK+ 
Sbjct: 256 DECKESKHSCRGLLKCVNTRGYFNCEINKLYIALIVIGAVVLALSLLMGIWWLYKLVKKW 315

Query: 273 KEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGT 332
           K+I+LK+KFFKRNGGLLLQQEL + E  ++KTK+++SK+LE ATD +N NRILGQGGQGT
Sbjct: 316 KKIELKKKFFKRNGGLLLQQELRAAEGWVQKTKIYSSKELEVATDRFNVNRILGQGGQGT 375

Query: 333 VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 392
           VYKGML DGRIVAVKKS +VDE  +E+FINEVV+LSQINHRN+VKLLGCCLETEVPLLVY
Sbjct: 376 VYKGMLADGRIVAVKKSMVVDEGKLEEFINEVVVLSQINHRNVVKLLGCCLETEVPLLVY 435

Query: 393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
           EFIPNG LY+YIH+  E+F ++WE+ LRIA+EV+GAL YLHSA SIPIYHRDIKS NILL
Sbjct: 436 EFIPNGNLYKYIHDPNEDFLLSWEMRLRIAIEVAGALSYLHSATSIPIYHRDIKSTNILL 495

Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 512
           D+KYRAKVSDFG+SRS+ +DQTHLTT VQGTFGY+DPEYFQSSQFTEKSDVYSFGVVLVE
Sbjct: 496 DEKYRAKVSDFGSSRSISIDQTHLTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 555

Query: 513 ILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCL 572
           +++GQKPI +++  E +SL  +F+  + +NRL + LDARV +  + EE+++VA LAKRCL
Sbjct: 556 LISGQKPIFSVSQTETRSLATHFIMLMEDNRLSDVLDARVKEGCQNEEVISVANLAKRCL 615

Query: 573 NLNGKMRPTMKEVTNELGGI 592
           NLNGK RPTM+EVT+EL  I
Sbjct: 616 NLNGKNRPTMREVTSELERI 635

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 331/643 (51%), Positives = 425/643 (66%), Gaps = 65/643 (10%)

Query: 4   QSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGD-SYYESTI 62
           Q  CG+I I YPFG+G  C+ D+ F + C++S   PK  L  +N LE+L  +   ++ ++
Sbjct: 35  QDHCGDILIPYPFGMGKSCYKDEWFSISCSHSFDPPKPILSKLN-LEVLSIEMDRFQKSV 93

Query: 63  RVNFPIIS---------LKNPSNARGVNLSGSPFTFSNISNRFAAIGCDDYHTVDINSST 113
            VN PI S           +P  +R  +L GSPF +S + N    +GC +    D N   
Sbjct: 94  MVNSPIYSNCENGEVEVTSSPWQSR--DLWGSPFLYS-LHNDLVGVGCHNVLLRDRNEE- 149

Query: 114 VFGGCLAISTCDPA-SRRGC-YDFLCALSSNITQVFNANLS-YIYSQNISRGCRSVSVVE 170
           +  GC   STCD + + +GC Y   C L+         +L  Y  S   S   R      
Sbjct: 150 IMAGC--ASTCDKSITTKGCLYGINCCLTR-----LQEDLDFYSLSTTASSSERGDPDCT 202

Query: 171 ENWVGSKY--LENPLVLKQQARDIPALLDW----GEDIGHCAEDFSLYSTTICGDGEYRC 224
             ++   Y  + N   + + A+  P L+ W      D  +C +D ++Y T+      YRC
Sbjct: 203 YAFLAYNYNNVSNVTTIVRDAKYAPLLISWLIPEQVDPQNCVDD-TVY-TSRGNYPNYRC 260

Query: 225 SITF---GSGYICR----------CR---------TTYRTDGFCA----------GCGGG 252
           +  +   G+ Y+            CR         +TY+ D +C+          GC   
Sbjct: 261 ACNWAEEGNPYLAHGCQVVRECANCRWGCDGRYNSSTYKYDFYCSTKNKSKALILGCSIS 320

Query: 253 LGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDL 312
            GLL LL+  + LYK V+++ +I++K++FFKRNGGLLLQQ++SS++   EKTK+FTS +L
Sbjct: 321 GGLLLLLIFSFGLYKVVRKQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKTKIFTSDEL 380

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
           EKATDN+N NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE  +E FINE+VILSQINH
Sbjct: 381 EKATDNFNKNRILGQGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINH 440

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           RN+V +LGCCLETEVPLLVYEFI NGTL+Q IH+Q  EFP++WE+ LRIA+EVSGAL YL
Sbjct: 441 RNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYL 500

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HSA SIPIYHRDIKS NILLDDKY+AKVSDFGTSRS+ +DQTHLTT VQGTFGY+DPEYF
Sbjct: 501 HSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYF 560

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
           QSSQFTEKSDVYSFGVVLVE+LTGQKPI +  + E+KSL  +F+ ++ E+RLF+ LDARV
Sbjct: 561 QSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARV 620

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           +KE +KE+IMT A LA RCLNLNG+ RPTMKEVT E+  IR S
Sbjct: 621 VKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 663

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	597
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.559	0.444	0.613	2.1e-128
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.559	0.423	0.626	4.9e-127
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.562	0.424	0.608	8e-127
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.559	0.457	0.613	2.7e-126
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.609	0.505	0.564	1.5e-125
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.557	0.445	0.629	5e-125
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.648	0.503	0.535	1e-124
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.651	0.494	0.533	2.4e-123
TAIR|locus:2030988	764	AT1G17910 [Arabidopsis thalian	0.649	0.507	0.547	5.1e-123
TAIR|locus:2126271	793	AT4G31110 [Arabidopsis thalian	0.658	0.495	0.535	9.5e-120

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 2.1e-128, Sum P(2) = 2.1e-128
 Identities = 205/334 (61%), Positives = 270/334 (80%)

Query:   262 IWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNA 321
             IW L KFVK+R++I  K+ FFKR                ++ +K+F+SK+LEKATDN+N 
Sbjct:   364 IWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNM 423

Query:   322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             NR+LGQGGQGTVYKGML DGRIVAVK+SK++DE  VE+FINEV +LSQINHRNIVKL+GC
Sbjct:   424 NRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGC 483

Query:   382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             CLETEVP+LVYE IPNG L++ +H+  +++ +TW++ LRI+VE++GAL YLHSAAS P+Y
Sbjct:   484 CLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVY 543

Query:   442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
             HRD+K+ NILLD+KYRAKVSDFGTSRS+ VDQTHLTT V GTFGY+DPEYFQ+SQFT+KS
Sbjct:   544 HRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKS 603

Query:   502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
             DVYSFGVVLVE++TG+KP   +  +E++ LV +F +A+ +NR+ + +D+R+ +    E++
Sbjct:   604 DVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQV 663

Query:   562 MTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             + VA LA+RCL+L GK RP M+EV+ EL  IR+S
Sbjct:   664 LAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1107 (394.7 bits), Expect = 4.9e-127, Sum P(2) = 4.9e-127
 Identities = 210/335 (62%), Positives = 261/335 (77%)

Query:   262 IWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNA 321
             IWWL KF+K+R+  K K+KFFKR                +EKT++F+S++LEKATDN++ 
Sbjct:   394 IWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSE 453

Query:   322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             +RILGQGGQGTVYKGML DGR VAVKKSK+VDE  +E+FINEVVILSQINHR++VKLLGC
Sbjct:   454 SRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGC 513

Query:   382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             CLETEVP LVYEFIPNG L+Q+IH + +++  TW + LRIAV+++GAL YLHSAAS PIY
Sbjct:   514 CLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIY 573

Query:   442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
             HRDIKS NILLD+KYR KVSDFGTSRSV +D TH TT + GT GYVDPEY+ SSQ+T+KS
Sbjct:   574 HRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKS 633

Query:   502 DVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
             DVYSFGVVLVE++TG+KP+  + N+ E + L  +F  A+ ENR FE +DAR+    K E+
Sbjct:   634 DVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQ 693

Query:   561 IMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             +M VA LA+RCLN  GK RP M++V  +L  I  S
Sbjct:   694 VMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1104 (393.7 bits), Expect = 8.0e-127, Sum P(2) = 8.0e-127
 Identities = 205/337 (60%), Positives = 269/337 (79%)

Query:   262 IWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNA 321
             I+ LYKF+K+++++  K+KFFKR                +EKT +F+S++LEKAT+N+++
Sbjct:   390 IYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSS 449

Query:   322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE  +E+FINEVVILSQINHRNIVKLLGC
Sbjct:   450 NRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGC 509

Query:   382 CLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPI 440
             CLET+VP+LVYEFIPNG L++++H++ +E    TW + LRIA++++GAL YLHS+AS PI
Sbjct:   510 CLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPI 569

Query:   441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
             YHRD+KS NI+LD+KYRAKVSDFGTSR+V VD THLTT V GT GY+DPEYFQSSQFT+K
Sbjct:   570 YHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDK 629

Query:   501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
             SDVYSFGVVLVE++TG+K I  + + E+++L  YF+ A+ EN+LF+ +DAR+       +
Sbjct:   630 SDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQ 689

Query:   561 IMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             +   A +A++CLNL G+ RP+M+EV+ EL  IR   G
Sbjct:   690 VTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCG 726

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1130 (402.8 bits), Expect = 2.7e-126, Sum P(2) = 2.7e-126
 Identities = 205/334 (61%), Positives = 271/334 (81%)

Query:   262 IWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNA 321
             ++WL+K +K+R+ I   +KFFKR                +E +K+F+SK+L KATDN++ 
Sbjct:   372 LFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSI 431

Query:   322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             +R+LGQGGQGTVYKGML DG IVAVK+SK+VDE  +E+FINE+V+LSQINHRNIVKLLGC
Sbjct:   432 DRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGC 491

Query:   382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             CLETEVP+LVYE+IPNG L++ +H++ +++ +TWE+ LRIA+E++GAL Y+HSAAS PI+
Sbjct:   492 CLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIF 551

Query:   442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
             HRDIK+ NILLD+KYRAKVSDFGTSRSV +DQTHLTT V GTFGY+DPEYF SSQ+T KS
Sbjct:   552 HRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKS 611

Query:   502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
             DVYSFGVVLVE++TG+KP+  + ++E + L  +FL+A+ ENR+ + +D R+  E+K E++
Sbjct:   612 DVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQV 671

Query:   562 MTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             M VA LA++CLN  GK RP MKEV+NEL  IR+S
Sbjct:   672 MAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1067 (380.7 bits), Expect = 1.5e-125, Sum P(2) = 1.5e-125
 Identities = 209/370 (56%), Positives = 265/370 (71%)

Query:   220 GEYRCSITFGSGYICRCRTTYRTDXXXXXXXXXXXXXXXXXXIWWLYKFVKRRKEIKLKQ 279
             G+ +C    GS Y  RC  T+                     +W L K  ++RK  K K+
Sbjct:   297 GKRKCVNVLGS-Y--RCEKTWPA---ILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKR 350

Query:   280 KFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT 339
             KFF+R                + +TK+F+S DLE ATD +NA+RILGQGGQGTVYKGML 
Sbjct:   351 KFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLE 410

Query:   340 DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 399
             DG IVAVKKSK + E N+E+FINE+++LSQINHRN+VK+LGCCLETEVP+LVYEFIPN  
Sbjct:   411 DGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRN 470

Query:   400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
             L+ ++HN  E+FP++WE+ L IA EV+ AL YLHSA SIPIYHRD+KS NILLD+K+RAK
Sbjct:   471 LFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAK 530

Query:   460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             VSDFG SRSV +D THLTT VQGT GYVDPEY QS+ FT KSDVYSFGV+L+E+LTG+KP
Sbjct:   531 VSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKP 590

Query:   520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR 579
             +  +   E + L  YFL+A+  +RL E LDAR+ +E  +EE++ VA LA+RCL+LN + R
Sbjct:   591 VSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHR 650

Query:   580 PTMKEVTNEL 589
             PTM++V  EL
Sbjct:   651 PTMRDVFIEL 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1118 (398.6 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
 Identities = 211/335 (62%), Positives = 271/335 (80%)

Query:   262 IWWLYKFV-KRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYN 320
             I+ LYKFV KRRK I+++ KFF+R                +E +++F+S +LEKATDN+N
Sbjct:   359 IFGLYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFN 417

Query:   321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
              NR+LGQGGQGTVYKGML DGRIVAVK+SK VDE  VE+FINEVV+L+QINHRNIVKLLG
Sbjct:   418 KNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLG 477

Query:   381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             CCLETEVP+LVYEF+PNG L + +H++ +++ +TWE+ L IA+E++GAL YLHSAAS PI
Sbjct:   478 CCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPI 537

Query:   441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
             YHRDIK+ NILLD++ RAKVSDFGTSRSV +DQTHLTT+V GTFGYVDPEYFQSS+FTEK
Sbjct:   538 YHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEK 597

Query:   501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
             SDVYSFGVVLVE+LTG+KP   + ++E++ L  +F++A+ ENR+ + +D R+  E   ++
Sbjct:   598 SDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQ 657

Query:   561 IMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             +M+VA LA+RCLN  GK RP M+EV+ EL  IR+S
Sbjct:   658 VMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1097 (391.2 bits), Expect = 1.0e-124, Sum P(2) = 1.0e-124
 Identities = 212/396 (53%), Positives = 281/396 (70%)

Query:   200 EDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDXXXXXXXXXXXXXXXX 259
             +DI  C          +C  G  +C    G GY C   T +R                  
Sbjct:   322 KDINECVRGID--GNPVCTAG--KCVNLLG-GYTCEY-TNHRP--LVIGLSTSFSTLVFI 373

Query:   260 XXIWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNY 319
               I+WLYKF++R++ +  K+KFFKR                ++ T++F S++LEKAT+N+
Sbjct:   374 GGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENF 433

Query:   320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
             +  RILG+GGQGTVYKGML DGRIVAVKKSK+VDE  +E+FINEVVILSQINHRNIVKLL
Sbjct:   434 SLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLL 493

Query:   380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT-WELLLRIAVEVSGALFYLHSAASI 438
             GCCLET+VP+LVYEFIPNG L++++H+  +++ +T WE+ LRIAV+++GAL YLHSAAS 
Sbjct:   494 GCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASS 553

Query:   439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
             PIYHRDIKS NI+LD+K+RAKVSDFGTSR+V VD THLTT V GT GY+DPEYFQSSQFT
Sbjct:   554 PIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFT 613

Query:   499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
             +KSDVYSFGVVL E++TG+K +  + + E ++L  YF  A+ ENRL + +DAR+    K 
Sbjct:   614 DKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKL 673

Query:   559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
              ++   A +A++CLN+ G+ RP+M++V+ EL  IR+
Sbjct:   674 NQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1067 (380.7 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
 Identities = 214/401 (53%), Positives = 278/401 (69%)

Query:   197 DWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDXXXXXXXXXXXXX 256
             D   DI  C E+        C + +  C + F  GY  RC    +T              
Sbjct:   332 DGCRDIDECKEN-----PKYCKETD-TC-VNFEGGY--RC-VGDKTKAIMIGAGTGFGVL 381

Query:   257 XXXXXIWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKAT 316
                  +WWL KF+ +R+  K K+KFFKR                +EK ++FTSK+LEKAT
Sbjct:   382 VLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKAT 441

Query:   317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
             +N++ NR+LG GGQGTVYKGML DGR VAVKKSK++DE  +++FINEVVILSQINHR++V
Sbjct:   442 ENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVV 501

Query:   377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSA 435
             KLLGCCLETEVP+LVYEFI NG L+++IH +  +++ + W + LRIAV+++GAL YLHSA
Sbjct:   502 KLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSA 561

Query:   436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
             AS PIYHRDIKS NILLD+KYRAKV+DFGTSRSV +DQTH TT + GT GYVDPEY++SS
Sbjct:   562 ASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSS 621

Query:   496 QFTEKSDVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFEALDARVLK 554
             Q+TEKSDVYSFGV+L E++TG KP+  + NT E  +L  +F  A+ E RL + +DAR+  
Sbjct:   622 QYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRD 681

Query:   555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             ++K E++M VA LA +CL+  G+ RP M+EV  EL  I TS
Sbjct:   682 DSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTS 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1090 (388.8 bits), Expect = 5.1e-123, Sum P(2) = 5.1e-123
 Identities = 220/402 (54%), Positives = 274/402 (68%)

Query:   193 PALLDWGEDIGHCAEDFSLYSTTICGDGE--YR--CSITFGSGYICRCRTTYRTDXXXXX 248
             P + D  +DI  C E    Y    CGD    YR  C  T G G+  RC   Y        
Sbjct:   333 PYVSDDCQDINECTE----YKNP-CGDTRILYRNTCINTSG-GH--RC-IDYHIPEVMLG 383

Query:   249 XXXXXXXXXXXXXIWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFT 308
                          IWW  K +++R+    K+KFFKR                +EKTKLF+
Sbjct:   384 LGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFS 443

Query:   309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILS 368
             S++LEKATDN+N NR++GQGGQGTVYKGML DGR VAVKKS +VDE  +++FINEV+ILS
Sbjct:   444 SRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILS 503

Query:   369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
             QINHR++VKLLGCCLETEVP+LVYEFIPNG L+Q++H + +++   W + +RIAV++SGA
Sbjct:   504 QINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGA 563

Query:   429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
               YLH+AA  PIYHRDIKS NILLD+KYRAKVSDFGTSRSV +D TH TT + GT GYVD
Sbjct:   564 FSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVD 623

Query:   489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN-TDEDKSLVGYFLQAINENRLFEA 547
             PEY+ SS FTEKSDVYSFGVVLVE++TG+KP+  ++ T E   L  YF  A+ ENRLFE 
Sbjct:   624 PEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEI 683

Query:   548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             +DAR+  + K E+++ VA LA RCL   GK RP M+EV+  L
Sbjct:   684 IDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTAL 725

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1076 (383.8 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
 Identities = 217/405 (53%), Positives = 281/405 (69%)

Query:   193 PALLDWGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDXXXXXXXXX 252
             P +L+  +DI  C   F  Y    CG  E  C + F  GY  RC    +T          
Sbjct:   337 PYVLNGCKDIDECKVKFE-Y----CGKTE-TC-VNFEGGY--RC-VRDKTKAIMIGAGTG 386

Query:   253 XXXXXXXXXIWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDL 312
                      +WWL KF+ +R+  K K+KFFKR                +EKT++F S++L
Sbjct:   387 FGVLVLVGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSREL 446

Query:   313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
             EKAT+N++ NR+LG GGQGTVYKGML DGR VAVKKSK++DE  +++FINEVVILSQINH
Sbjct:   447 EKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINH 506

Query:   373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFY 431
             R++VKLLGCCLETEVP+LVYEFI NG L+++IH +  +++ + W + LRIAV+++GAL Y
Sbjct:   507 RHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSY 566

Query:   432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
             LHS+AS PIYHRDIKS NILLD+KYRAKV+DFGTSRSV +DQTH TT + GT GYVDPEY
Sbjct:   567 LHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEY 626

Query:   492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFEALDA 550
             +QSSQ+TEKSDVYSFGV+L E++TG KP+  + NT E  +L  +F  A+ E RL + +DA
Sbjct:   627 YQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDA 686

Query:   551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             R+  + K E++M VA +A +CL+  GK RP M+EV  EL  I TS
Sbjct:   687 RIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTS 731

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_scaffold_164000018 hypothetical protein (642 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	597
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-42
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-34
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-32
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-29
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-27
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	5e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-27
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-23
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-23
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-23
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-22
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-19
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.004
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  180 bits (459), Expect = 1e-52
 Identities = 82/277 (29%), Positives = 130/277 (46%), Gaps = 32/277 (11%)

Query: 322 NRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNI 375
            + LG+G  G VYKG L          VAVK  K    E  +E+F+ E  I+ +++H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           VKLLG C E E   +V E++  G L  Y+     +  ++   LL  A++++  + YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
            S    HRD+ + N L+ +    K+SDFG SR +  D  +     +    ++ PE  +  
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           +FT KSDV+SFGV+L EI T G++P   ++ +E    +       N  RL          
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------KNGYRL---------- 222

Query: 555 EAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
              +       +  L  +C   + + RPT  E+   L
Sbjct: 223 --PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  180 bits (458), Expect = 2e-52
 Identities = 92/271 (33%), Positives = 137/271 (50%), Gaps = 21/271 (7%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNI 375
           Y   R LG G  GTVYK      G+IVAVK  K   E + +      E+ IL +++H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V+L+    + +   LV E+   G L+ Y+       P++ +   +IA+++   L YLHS 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 494
               I HRD+K  NILLD+    K++DFG ++ ++   + LTT V GT  Y+ PE     
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           + +  K DV+S GV+L E+LTG+ P    N  +   L+   L    E    E   +   +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE--FDEPKWSSGSE 231

Query: 555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           EAK         L K+CLN +   RPT +E+
Sbjct: 232 EAKD--------LIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  180 bits (458), Expect = 2e-52
 Identities = 84/277 (30%), Positives = 130/277 (46%), Gaps = 31/277 (11%)

Query: 322 NRILGQGGQGTVYKGMLTDG-----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNI 375
            + LG+G  G VYKG L          VAVK  K    E  +E+F+ E  I+ +++H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           VKLLG C E E  ++V E++P G L  Y+     +  ++   LL  A++++  + YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
            S    HRD+ + N L+ +    K+SDFG SR +  D  +     +    ++ PE  +  
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           +FT KSDV+SFGV+L EI T G++P   ++  E    +          RL          
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------KKGYRL---------- 223

Query: 555 EAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
              K       +  L  +C   + + RPT  E+   L
Sbjct: 224 --PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 3e-52
 Identities = 70/193 (36%), Positives = 105/193 (54%), Gaps = 10/193 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG+GG GTVY       G+ VA+K   K    + +E+ + E+ IL ++NH NIVKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     LV E+   G+L   +     E  ++ + +LRI +++   L YLH   S  I H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 443 RDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 500
           RD+K  NILLD D  + K++DFG S+  +     L   + GT  Y+ PE       ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 501 SDVYSFGVVLVEI 513
           SD++S GV+L E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  178 bits (454), Expect = 7e-52
 Identities = 88/284 (30%), Positives = 130/284 (45%), Gaps = 40/284 (14%)

Query: 323 RILGQGGQGTVYKGMLTDG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           + LG+G  G VYKG L         VAVK  K    E   + F+ E  ++ ++ H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGALFY 431
           LLG C E E   LV E++  G L  Y+      FP      ++ + LL  A++++  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDP 489
           L    S    HRD+ + N L+ +    K+SDFG SR V  D  +   K  G     ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAP 176

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE-NRLFEA 547
           E  +   FT KSDV+SFGV+L EI T G  P   ++ +E        L+ + +  RL   
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL--- 226

Query: 548 LDARVLKEAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
                     K E     +  L   C  L+ + RPT  E+   L
Sbjct: 227 ---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  177 bits (451), Expect = 1e-51
 Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLG 380
             LG+G  G VY       G++VA+K  K        E+ + E+ IL ++ H NIV+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
              + +   LV E+   G L+  +  +     ++ +       ++  AL YLHS     I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSK---GI 118

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRD+K  NILLD+    K++DFG +R   +D     T   GT  Y+ PE      + + 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
            D++S GV+L E+LTG+ P    +   +      F +       F   +  +  EAK   
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLE-----LFKKIGKPKPPFPPPEWDISPEAKD-- 229

Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                 L ++ L  + + R T +E 
Sbjct: 230 ------LIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (449), Expect = 4e-51
 Identities = 84/281 (29%), Positives = 136/281 (48%), Gaps = 39/281 (13%)

Query: 322 NRILGQGGQGTVYKGMLTD-----GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNI 375
            + LG+G  G VYKG L          VAVK  K    E   E+F+ E  I+ +++H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V+LLG C + E   +V E++P G L  ++    E+  +    LL++A++++  + YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---YVDPEYF 492
            S    HRD+ + N L+ +    K+SDFG SR +  D  +      G      ++ PE  
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176

Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDA 550
           +  +FT KSDV+SFGV+L EI T G++P   ++ +E        L+ + +  RL      
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRL------ 223

Query: 551 RVLKEAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
                  + E     +  L  +C   + + RPT  E+  +L
Sbjct: 224 ------PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  152 bits (387), Expect = 3e-42
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 22/208 (10%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLL 379
            +LG+G  G+VY  +  D G ++AVK  +L    E  +E    E+ ILS + H NIV+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 380 GCCL-ETEVPLLVY-EFIPNGTLYQYIHN--QIEEFPI---TWELLLRIAVEVSGALFYL 432
           G    E +  L ++ E++  G+L   +    ++ E  I   T ++L          L YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE--------GLAYL 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVDQTHLTTKVQGTFGYVDPEY 491
           HS     I HRDIK ANIL+D     K++DFG ++ +  ++    T  V+GT  ++ PE 
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            +  ++   +D++S G  ++E+ TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  148 bits (376), Expect = 9e-41
 Identities = 79/267 (29%), Positives = 124/267 (46%), Gaps = 24/267 (8%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLL 379
           + +G+G  G VY     +DG++  +K+  L  + E   E  +NEV IL ++NH NI+K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASI 438
               E     +V E+   G L Q I  Q +E  P   E +L   V++  AL YLHS    
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            I HRDIK  NI L      K+ DFG S+ +        T V GT  Y+ PE  Q+  + 
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            KSD++S G VL E+ T + P         ++L+   L+ +     +  + ++   E   
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEG------ENLLELALKILKGQ--YPPIPSQYSSE--- 230

Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEV 585
                +  L    L  + + RP++ ++
Sbjct: 231 -----LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  143 bits (364), Expect = 4e-39
 Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+GG G VYK      G+ VA+K  KL  +   E+ INE+ IL +  H NIVK  G  L
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV---EVSGALFYLHSAASIPI 440
           + +   +V EF   G+L   + +  +    +      IA    E+   L YLHS     I
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---I 119

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+ANILL      K+ DFG   S  +  T     + GT  ++ PE      +  K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 501 SDVYSFGVVLVEILTGQKPIR 521
           +D++S G+  +E+  G+ P  
Sbjct: 178 ADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  135 bits (339), Expect = 1e-34
 Identities = 81/280 (28%), Positives = 121/280 (43%), Gaps = 22/280 (7%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH-R 373
           +Y   R LG+G  G VY     D ++VA+K   K        VE+F+ E+ IL+ +NH  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NIVKL     +     LV E++  G+L   +     + P++    L I  ++  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 434 SAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH-----LTTKVQGTFGYV 487
           S   I   HRDIK  NILLD D    K+ DFG ++ +    +      L +   GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 488 DPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            PE          +  SD++S G+ L E+LTG  P          S        I     
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231

Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
             +L + +     +      + L K+ L  + K R +   
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 8e-34
 Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 12/206 (5%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 374
           NY    ++G+G  G VYKG+ L  G  VA+K+  L  + E  ++  + E+ +L  + H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYLH 433
           IVK +G    ++   ++ E+  NG+L Q I      FP   E L+ + V +V   L YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFP---ESLVAVYVYQVLQGLAYLH 116

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
               I   HRDIK+ANIL       K++DFG + + + D +     V GT  ++ PE  +
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKP 519
            S  +  SD++S G  ++E+LTG  P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  124 bits (314), Expect = 2e-32
 Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 24/259 (9%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  G V+K +   D R+ A+K+  L  ++    E+ I+E  +L++++   I++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
            L+     +V E+  NG L++ +  Q    P+  + + R  +++   L +LHS     I 
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---IL 123

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HRDIKS N+ LD     K+ D G ++ ++ D T+    + GT  Y+ PE  +   + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           DV++ GVVL E  TG+ P  A N        G  +  I     F  +     ++      
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGV-FPPVSQMYSQQ------ 228

Query: 562 MTVATLAKRCLNLNGKMRP 580
             +A L  +CL  + + RP
Sbjct: 229 --LAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 3e-32
 Identities = 74/208 (35%), Positives = 106/208 (50%), Gaps = 13/208 (6%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+G  G V      D G++ A+K   K K++    VE  + E  ILS+INH  IVKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
              +TE  L LV E+ P G L+ ++     E   + E     A E+  AL YLHS     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG--- 113

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
           I +RD+K  NILLD     K++DFG ++ +  + +   T   GT  Y+ PE      + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172

Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDE 527
             D +S GV+L E+LTG+ P  A +  E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  124 bits (313), Expect = 7e-32
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 45/290 (15%)

Query: 323 RILGQGGQGTVYKGMLT------DGRIVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 375
           R LG+G  G V+ G         D  +VAVK  K        + F  E  +L+   H NI
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQY-----------IHNQIEEFPITWELLLRIAVE 424
           VK  G C E + P++V+E++ +G L ++                    +T   LL+IAV+
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT- 483
           ++  + YL   AS    HRD+ + N L+      K+ DFG SR V     +   +V G  
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHT 184

Query: 484 ---FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI 539
                ++ PE     +FT +SDV+SFGVVL EI T G++P              ++   +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY--GL 228

Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           +   + E +    L +  +     V  +   C   + + R  +K++   L
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  121 bits (306), Expect = 4e-31
 Identities = 75/225 (33%), Positives = 122/225 (54%), Gaps = 18/225 (8%)

Query: 323 RILGQGGQGTVYKGMLTDG----RIVAVKK-SKLVDETNVEQFINEVVILSQINHRNIVK 377
           R++G+G  G VY G L D        AVK  +++ D   VEQF+ E +I+   +H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 378 LLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           LLG CL +E  PL+V  ++ +G L  +I +  E    T + L+   ++V+  + YL   A
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYFQ 493
           S    HRD+ + N +LD+ +  KV+DFG +R +        H  T  +    ++  E  Q
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ 537
           + +FT KSDV+SFGV+L E++T G  P   +++ +   +  Y LQ
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQ 217

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 1e-30
 Identities = 79/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G+G  G V  G    G+ VAVK  K  D T  + F+ E  +++ + H N+V+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                +V E++  G+L  Y+ ++     IT    L  A++V   + YL         HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127

Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N+L+ +   AKVSDFG ++     Q      V+ T     PE  +  +F+ KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183

Query: 505 SFGVVLVEILT-GQKPIRAINTDE--DKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           SFG++L EI + G+ P   I   +       GY ++A                E    E+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA---------------PEGCPPEV 228

Query: 562 MTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             V    K C  L+   RPT K++  +L
Sbjct: 229 YKV---MKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 66/222 (29%), Positives = 116/222 (52%), Gaps = 12/222 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
             +G+G  G VYKG+L     VAVK  +S L  +    +F+ E  IL Q +H NIVKL+G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C++ +   +V E +P G+L  ++  +     +  + LL+++++ +  + YL S   I  
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEYFQSSQFTE 499
            HRD+ + N L+ +    K+SDFG SR        ++  + Q    +  PE     ++T 
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 500 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQA 538
           +SDV+S+G++L E  + G  P   ++  + +  +  GY + A
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 3e-29
 Identities = 76/291 (26%), Positives = 136/291 (46%), Gaps = 44/291 (15%)

Query: 323 RILGQGGQGTVYKGMLT--DGRI--VAVKKSKL--VDETNVEQFINEVVILSQINHRNIV 376
           +ILG+G  G+V +G L+  DG    VAVK  KL     + +E+F++E   +   +H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 377 KLLGCCLETE------VPLLVYEFIPNGTLYQYI-HNQIEEFP--ITWELLLRIAVEVSG 427
           KL+G C E         P+++  F+ +G L+ ++ ++++   P  +  + LL+  V+++ 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD----QTHLTTKVQGT 483
            + YL +   I   HRD+ + N +L +     V+DFG S+ +       Q  +    +  
Sbjct: 125 GMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMP 178

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 542
             ++  E      +T KSDV++FGV + EI T GQ P   +   E    +       + N
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL------RHGN 232

Query: 543 RLFEALDARVLKEAKKEEIMT-VATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           RL            + E+ +  +  L   C   + K RPT  ++   L  I
Sbjct: 233 RL-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 5e-29
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 42/281 (14%)

Query: 323 RILGQGGQGTVYKGMLT-DGR----IVAVKKSKLVDET---NVEQFINEVVILSQINHRN 374
           ++LG G  GTVYKG+   +G      VA+K   L +ET     ++ ++E  +++ ++H +
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPH 70

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           +V+LLG CL +    L+ + +P G L  Y+ N  +   I  + LL   V+++  + YL  
Sbjct: 71  VVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEE 127

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
                + HRD+ + N+L+      K++DFG ++ + VD+       +G      ++  E 
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALES 182

Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
                +T KSDV+S+GV + E++T G KP   I   E   L+          RL      
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------EKGERL------ 230

Query: 551 RVLKEAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
                  +  I T  V  +  +C  ++ + RPT KE+ NE 
Sbjct: 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 5e-29
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 22/219 (10%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
            + Y     +G+G  G VYK      G+ VA+KK +L  + N E  INE++I+    H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTL----YQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           IV      L  +   +V E++  G+L     Q          +    +  +  EV   L 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLE 130

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   I   HRDIKS NILL      K++DFG +  +  +++   + V GT  ++ PE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 523
             +   +  K D++S G++ +E+  G+       P+RA+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 8e-29
 Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 16/199 (8%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V+ G       VA+K   ++ E   + + FI E  ++ +++H N+V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     +V E++ NG L  Y+  +  +     E LL +  +V  A+ YL S   I   H
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQSSQFTE 499
           RD+ + N L+ +    KVSDFG +R V+ DQ    T  QGT     +  PE F  S+F+ 
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 500 KSDVYSFGVVLVEILTGQK 518
           KSDV+SFGV++ E+ +  K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 8e-29
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 325 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNV---EQFINEVVILSQINHRNIVKLL 379
           LG G  G+V KG  ++  G+ V V    L  E      ++F+ E  +++Q++H  IV+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
           G C   E  +LV E  P G L +Y+  + E   I    L  +A +V+  + YL S   + 
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKHFV- 117

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQF 497
             HRD+ + N+LL ++++AK+SDFG SR++     +      G +   +  PE     +F
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 498 TEKSDVYSFGVVLVEILT-GQKPIRAI 523
           + KSDV+S+GV L E  + G KP   +
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  114 bits (289), Expect = 1e-28
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 30/235 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN- 371
           D++   +I+G+G   TV         +  A+K   K +L+ E  V+    E  +L+++N 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H  I+KL     + E    V E+ PNG L QYI                 A E+  AL Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRF--YAAEILLALEY 117

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ---------- 481
           LHS     I HRD+K  NILLD     K++DFGT++ +  + +  + K            
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 482 ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
                    GT  YV PE        + SD+++ G ++ ++LTG+ P R  N   
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  113 bits (285), Expect = 3e-28
 Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 25/269 (9%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 380
            +G+G  GTV K    +DG+I+  K+     + E   +Q ++EV IL ++ H NIV+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 381 CCL--ETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLH--SA 435
             +    +   +V E+   G L Q I    +E   I  E + RI  ++  AL+  H  S 
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               + HRD+K ANI LD     K+ DFG ++ +  D +   T V GT  Y+ PE     
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
            + EKSD++S G ++ E+     P  A N  +   L     +       F  +  R   E
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKEGK-----FRRIPYRYSSE 237

Query: 556 AKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
             +        + K  LN++   RP+ +E
Sbjct: 238 LNE--------VIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 69/212 (32%), Positives = 118/212 (55%), Gaps = 23/212 (10%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETN-------VEQFINEVVILSQINHR 373
           ++G G  G+VY GM  + G ++AVK+ +L  V  ++       ++    E+ +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL 432
           NIV+ LG  L+ +   +  E++P G++   + N    F    E L+R  V ++   L YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-----VQGTFGYV 487
           H+     I HRDIK ANIL+D+K   K+SDFG S+ +  +     T      +QG+  ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  112 bits (282), Expect = 6e-28
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 20/207 (9%)

Query: 325 LGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQF--INEVVILSQINHRNIVK---- 377
           LG+G  G+VYK   L+D +  A+K+  L   +  E+   +NE+ IL+ +NH NI+     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 378 -LLGCCLETEVPLLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLHSA 435
            L G  L      +V E+ P G L + I   + +   I  + + RI +++   L  LH  
Sbjct: 68  FLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I HRD+KSANILL      K+ D G S+   V + ++     GT  Y+ PE ++  
Sbjct: 123 K---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQIGTPHYMAPEVWKGR 176

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRA 522
            ++ KSD++S G +L E+ T   P  A
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  112 bits (281), Expect = 8e-28
 Identities = 68/198 (34%), Positives = 110/198 (55%), Gaps = 11/198 (5%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G G  G V+ G   + R VA+K  +   + E   E FI E  ++ +++H  +V+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            E     LV+EF+ +G L  Y+  Q  +F  + E LL + ++V   + YL S+  I   H
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---H 123

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFGV++ E+ + G+ P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (281), Expect = 9e-28
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 6/206 (2%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           R LG G  G V++G+  +   VA+K  K  D    + F  EV  L ++ H++++ L   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
              E   ++ E +  G+L  ++ +  E   +    L+ +A +V+  + YL    SI   H
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI---H 127

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + NIL+ +    KV+DFG +R ++ +  +L++  +  + +  PE      F+ KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186

Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           V+SFG++L E+ T GQ P   +N  E
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  111 bits (280), Expect = 1e-27
 Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 40/279 (14%)

Query: 325 LGQGGQGTVYKGMLTD--GRI--VAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           LG G  G V +G  +   G++  VAVK  KS  + +  ++ F+ E  I+  ++H N+++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRL 61

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
            G  L T   ++V E  P G+L   +  + +  F I+   L   AV+++  + YL S   
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT----KVQGTFGYVDPEYFQ 493
           I   HRD+ + NILL    + K+ DFG  R++  ++ H       KV   F +  PE  +
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN--RLFEALDA 550
           +  F+  SDV+ FGV L E+ T G++P   ++  +        L+ I++   RL      
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDKEGERL------ 220

Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
               EA  ++I  V     +C   N   RPT   +   L
Sbjct: 221 -ERPEACPQDIYNV---MLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  112 bits (281), Expect = 1e-27
 Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 14/205 (6%)

Query: 322 NRILGQGGQGTVYKGMLT---DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
            R +G+G  G VY+G+     + +I VAVK  K     +  E+F+ E  I+ Q +H +IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 377 KLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           KL+G    TE P+ +V E  P G L  Y+  Q+ ++ +    L+  + ++S AL YL S 
Sbjct: 71  KLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
                 HRDI + N+L+      K+ DFG SR +  +  +  +K +    ++ PE     
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKP 519
           +FT  SDV+ FGV + EIL  G KP
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  111 bits (279), Expect = 1e-27
 Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 18/215 (8%)

Query: 318 NYNANRILGQG--GQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
           +Y   R+LG+G  G+ T+Y+    D  +V  K+  L  + E      +NE+VILS + H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGAL 429
           NI+      ++    L+  E+   GTLY  I  Q     EE  + W L      ++  A+
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF-----QIVSAV 114

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y+H A    I HRDIK+ NI L      K+ DFG S+ ++  +  +   V GT  Y+ P
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYMSP 170

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           E  Q  ++  KSD+++ G VL E+LT ++   A N
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  111 bits (280), Expect = 2e-27
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGC 381
           +G G  G VY  + L  G ++AVK+ ++ D     +++  +E+ +L  + H N+VK  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRI-AVEVSGALFYLHSAASIP 439
            +  E   +  E+   GTL + + + +I +     E ++R+  +++   L YLHS     
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---YVDPEYFQSSQ 496
           I HRDIK ANI LD     K+ DFG +  +  + T +  +VQ   G   Y+ PE     +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 497 FTEK---SDVYSFGVVLVEILTGQKP 519
                  +D++S G V++E+ TG++P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (280), Expect = 2e-27
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 30/267 (11%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFI-NEVVILSQINHRNIVKLLGCC 382
           LGQG  G VYK      G+I A+KK  +  +    + +  E+  L       +VK  G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGALFYLHSAASIPIY 441
            +     +V E++  G+L   +  ++ + P   E +L  IA ++   L YLH+   I   
Sbjct: 69  YKEGEISIVLEYMDGGSLAD-LLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHI--I 122

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSV--MVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
           HRDIK +N+L++ K   K++DFG S+ +   +DQ +  T V GT  Y+ PE  Q   ++ 
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSY 179

Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--LQAINENRLFEALDARVLKEAK 557
            +D++S G+ L+E   G+ P              +F  +QAI +             E +
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQ------PSFFELMQAICDGPPPSLPAEEFSPEFR 233

Query: 558 KEEIMTVATLAKRCLNLNGKMRPTMKE 584
             + ++       CL  + K RP+  E
Sbjct: 234 --DFIS------ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)

Query: 323 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 376
           + LG+G  G V            G  VAVK      E      F  E+ IL  ++H NIV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 377 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  G C +       L+ E++P+G+L  Y+    ++  I  + LL  + ++   + YL S
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
              I   HRD+ + NIL++ +   K+SDFG ++ +  D+ +   K  G    F Y  PE 
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PEC 183

Query: 492 FQSSQFTEKSDVYSFGVVLVEILT 515
            ++S+F+  SDV+SFGV L E+ T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKL 378
            LG+G  G VYK      G IVA+KK +L +E   E      + E+ +L ++ H NIVKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGALFYL 432
           L          LV+E+     L +Y+  +           I ++LL          L Y 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR--------GLAYC 114

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     I HRD+K  NIL++     K++DFG +R+  +     T +V  T  Y  PE  
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170

Query: 493 QSSQFTEKS-DVYSFGVVLVEILTGQKPI 520
             S+    + D++S G +  E++TG KP+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-27
 Identities = 66/238 (27%), Positives = 117/238 (49%), Gaps = 38/238 (15%)

Query: 322 NRILGQGGQGTVYKGMLT----DGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 375
            +++G G  G V +G L         VA+K  K+   D+  ++ F+ E  I+ Q +H NI
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           ++L G   ++   +++ E++ NG+L +++     +F  T   L+ +   ++  + YL   
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEM 125

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-----VQGTFGYVDPE 490
             +   HRD+ + NIL++     KVSDFG SR +   +   TTK     ++ T     PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP---------IRAINTDEDKSLVGYFLQA 538
                +FT  SDV+SFG+V+ E+++ G++P         I+A+         GY L  
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GYRLPP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score =  105 bits (263), Expect = 5e-27
 Identities = 44/104 (42%), Positives = 54/104 (51%), Gaps = 6/104 (5%)

Query: 3   CQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTI 62
           C   CGN+SI YPFGIG  C  D  FE+ CN +   P+  L    N E+L   S    T+
Sbjct: 4   CPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLLGNG-NYEVLS-ISLANGTV 61

Query: 63  RVNFPIISL-KNPSNARGVNLSGS---PFTFSNISNRFAAIGCD 102
           RV  PI S   N S  R  N S S   PF FS+  N+F  +GC+
Sbjct: 62  RVLDPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCN 105

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (275), Expect = 6e-27
 Identities = 83/270 (30%), Positives = 127/270 (47%), Gaps = 29/270 (10%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG G  G VY+G+       VAVK  K  D   VE+F+ E  ++ +I H N+V+LLG C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 384 ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             E P  ++ EF+  G L  Y+     +  +   +LL +A ++S A+ YL     I   H
Sbjct: 73  R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEK 500
           RD+ + N L+ + +  KV+DFG SR +M   T+ T      F   +  PE    ++F+ K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 501 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE 559
           SDV++FGV+L EI T G  P   I+  +                ++E L+     E  + 
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEG 229

Query: 560 EIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
               V  L + C   N   RP+  E+    
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  108 bits (271), Expect = 3e-26
 Identities = 70/219 (31%), Positives = 122/219 (55%), Gaps = 16/219 (7%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDET-----NVEQFINEVVILSQINHRNI 375
           ++LG G  GTVYKG+ + +G  V +  + K+++ET     NVE F++E +I++ ++H ++
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V+LLG CL   +  LV + +P+G L  Y+H   +   I  +LLL   V+++  + YL   
Sbjct: 72  VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 128

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQS 494
               + HRD+ + N+L+      K++DFG +R +  D+        +    ++  E    
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +FT +SDV+S+GV + E++T G KP   I T E   L+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  106 bits (266), Expect = 6e-26
 Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 29/271 (10%)

Query: 324 ILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           +LG+G  G V+KG L D   VAVK  K  L  E  + +F++E  IL Q +H NIVKL+G 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           C + +   +V E +P G    ++  + +E     + L++ A++ +  + YL S   I   
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HRD+ + N L+ +    K+SDFG SR         +   Q    +  PE     +++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINENRLFEALDARVLKEAKK 558
           DV+S+G++L E  + G  P   +   + +  V  GY +                  +   
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---------------PQKCP 220

Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           +++  V    +RC +   + RP   E+  EL
Sbjct: 221 DDVYKV---MQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 6e-26
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
            R LG G  G V+ G       VAVK  K     + E F+ E  I+ ++ H  +V+L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           C E E   +V E++  G+L  ++ +  E   +    L+ +A +++  + YL S   I   
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI--- 125

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTE 499
           HRD+ + NIL+ +    K++DFG +R +  D    T +    F   +  PE     +FT 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 500 KSDVYSFGVVLVEILT-GQKP 519
           KSDV+SFG++L EI+T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  106 bits (266), Expect = 1e-25
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 19/213 (8%)

Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKK------SKLVDETNVEQFINEVVILSQINHRNIVK 377
           +LG+G  GTVY G+   G+++AVK+      + L  E   E+   EV +L  + H NIV+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGALFYLHSAA 436
            LG CL+     +  EF+P G++   + N+    P   E +  +   ++   + YLH+  
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLP---EPVFCKYTKQILDGVAYLHNNC 122

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSR-----SVMVDQTHLTTKVQGTFGYVDPEY 491
            +   HRDIK  N++L      K+ DFG +R      +    +++   + GT  ++ PE 
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
              S +  KSD++S G  + E+ TG+ P+ +++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-25
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 6/198 (3%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           R LG G  G V++G+  +   VAVK  K     + + F+ E  I+ ++ H  +++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
              E   +V E +  G+L +Y+        +    L+ +A +V+  + YL +   I   H
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N+L+ +    KV+DFG +R +  D        +    +  PE    ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  106 bits (266), Expect = 2e-25
 Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 23/189 (12%)

Query: 342 RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 400
            +VAVK  +    +   E F+ EV ILS+++  NI +LLG C       ++ E++ NG L
Sbjct: 47  VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 401 YQYIHNQIEE--------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
            Q++   + E          +++  LL +A +++  + YL    S+   HRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163

Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP------EYFQSSQFTEKSDVYSF 506
              Y  K++DFG SR++     +   +VQG      P      E     +FT KSDV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYY---RVQGR--APLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 507 GVVLVEILT 515
           GV L EILT
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (262), Expect = 2e-25
 Identities = 76/269 (28%), Positives = 133/269 (49%), Gaps = 33/269 (12%)

Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           I+G+G  G V +G  T G+ VAVK  K   +   + F+ E  ++++++H+N+V+LLG  L
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
              +  +V E +  G L  ++  +     ++   LL+ +++V+  + YL S     + HR
Sbjct: 70  HNGL-YIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124

Query: 444 DIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           D+ + NIL+ +   AKVSDFG +R  S+ VD + L  K      +  PE  +  +F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178

Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           DV+S+GV+L E+ + G+ P   ++  E K                E ++     E  +  
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVK----------------ECVEKGYRMEPPEGC 222

Query: 561 IMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
              V  L   C     K RP+  ++  +L
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 3e-25
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 21/207 (10%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-----VEQFINEVVILSQINHRNIV 376
            +LG G  G+VY+G+ L DG   AVK+  L D+       V+Q   E+ +LS++ H NIV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 377 KLLGCCLETEVPLLVY-EFIPNGTLYQYIHNQIEEFPITWELLLRIAVE--VSGALFYLH 433
           + LG   E +  L ++ E +P G+    +   ++++    E ++R+     + G L YLH
Sbjct: 66  QYLGTEREED-NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLH 119

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF- 492
              ++   HRDIK ANIL+D     K++DFG ++ V+      + K  G+  ++ PE   
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIA 174

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
           Q   +   +D++S G  ++E+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 3e-25
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 47/291 (16%)

Query: 325 LGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVK 377
           LG+G  G VYKG LT          VA+K  K   E  V+Q F  E  ++S + H NIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWEL-----------LLRIAVE 424
           LLG C + +   +++E++ +G L++++  ++   +                   L IA++
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT- 483
           ++  + YL   +S    HRD+ + N L+ +    K+SDFG SR +    +    +VQ   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY---SADYYRVQSKS 186

Query: 484 ---FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI 539
                ++ PE     +FT +SD++SFGVVL EI + G +P              Y+    
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------------YY--GF 230

Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
           +   + E + +R L    ++    V  L   C N     RP  K++   L 
Sbjct: 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 39/285 (13%)

Query: 323 RILGQGGQGTVYKGML-------TDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHR 373
           R LGQG  G VY+G+         + R VA+K +   + +  E  +F+NE  ++ + N  
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETR-VAIK-TVNENASMRERIEFLNEASVMKEFNCH 69

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-------FPITWELLLRIAVEVS 426
           ++V+LLG     +  L+V E +  G L  Y+ ++  E        P T +  +++A E++
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   A+    HRD+ + N ++ +    K+ DFG +R +   D      K      
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL 544
           ++ PE  +   FT KSDV+SFGVVL E+ T  ++P + ++ +E    V  F+       L
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFVIDGGHLDL 242

Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            E    ++L+            L + C   N KMRPT  E+ + L
Sbjct: 243 PENCPDKLLE------------LMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 7e-25
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHRNI 375
           Y     +G+G  G VYK      G IVA+KK KL  E+         E+ +L ++NH NI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGAL 429
           +KLL          LV+EF+ +  LY+ I ++    P        ++LL  +A       
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA------- 112

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     I HRD+K  N+L++ +   K++DFG +RS        T  V  T  Y  P
Sbjct: 113 -FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167

Query: 490 E-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
           E       ++   D++S G +  E+L+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  103 bits (258), Expect = 1e-24
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 9/209 (4%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQIN 371
             N+   + +G+G    VYK + L DGR+VA+KK +   ++D    +  + E+ +L Q++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALF 430
           H N++K L   +E     +V E    G L + I H + ++  I    + +  V++  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           ++HS     I HRDIK AN+ +      K+ D G  R      T   + V GT  Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
               + +  KSD++S G +L E+   Q P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  102 bits (256), Expect = 2e-24
 Identities = 81/228 (35%), Positives = 118/228 (51%), Gaps = 30/228 (13%)

Query: 323 RILGQGGQGTVYKGMLTD------GRI-VAVK--KSKLVDETNVEQFINEVVILSQINHR 373
             LG G  G VY+G  TD      G I VAVK  +    D+   E F+ E  ++S  NH 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN-QIEEFP---ITWELLLRIAVEVSGAL 429
           NIVKLLG CL  E   ++ E +  G L  Y+ + ++E F    +T + LL I ++V+   
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 430 FYLHSAASIPIYHRDIKSANILLDDK-YRA----KVSDFGTSRSVMVDQTHLTTKVQG-- 482
            YL     I   HRD+ + N L+ +K Y A    K+ DFG +R +     +   + +G  
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173

Query: 483 --TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
                ++ PE     +FT +SDV+SFGV++ EILT GQ+P  A+N  E
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 19/211 (9%)

Query: 325 LGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGC 381
           LG G  G V K +L    G+I+AVK  +L ++E   +Q + E+ IL + N   IV   G 
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 382 CL-ETEVPLLVYEFIPNGTL---YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
                ++ + + E++  G+L    + +  +I E       L +IAV V   L YLH    
Sbjct: 68  FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERI-----LGKIAVAVLKGLTYLHEKHK 121

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           I   HRD+K +NIL++ + + K+ DFG S   +V+    T    GT  Y+ PE  Q + +
Sbjct: 122 I--IHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKTFV--GTSSYMAPERIQGNDY 176

Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           + KSD++S G+ L+E+ TG+ P    N   D
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPD 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  101 bits (254), Expect = 6e-24
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  + +  G+ VA+K+  L  +   E  INE++++ +  H NIV  L   L
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 138

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (253), Expect = 7e-24
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 323 RILGQGGQGTV----YKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           R+LG+G  G V    Y       G +VAVK  K    + N   +  E+ IL  + H NIV
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 377 KLLGCCLET--EVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALFYL 432
           K  GCC E   +   L+ E++P G+L  Y+  H       +    LL  A ++   + YL
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYL 123

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDP 489
           HS   I   HRD+ + N+LLD+    K+ DFG +++V     +   +  G    F Y   
Sbjct: 124 HSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-V 179

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E  + ++F+  SDV+SFGV L E+LT     ++     ++ ++G     +   RL E L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLE 238

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
             +     K     V  L K C     K RPT +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 7e-24
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 36/289 (12%)

Query: 325 LGQGGQGTVYK---GMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V       L D  G +VAVKK +     ++  F  E+ IL  + H NIVK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 380 GCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         LV E++P G+L  Y+    E   +    LL  A ++   + YL S   
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRY 129

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEYFQS 494
           +   HRD+ + NIL++ + R K+ DFG ++ +  D+ +   +  G    F Y  PE    
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-----LFEALD 549
           S+F+  SDV+SFGVVL E+ T         +D+  S    F++ +  ++     ++  ++
Sbjct: 186 SKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237

Query: 550 ARVLKEAKKEEI-----MTVATLAKRCLNLNGKMRPTMKEVTNELGGIR 593
             +LK   +          +  + K C N +   RP+  E+  ++  IR
Sbjct: 238 --LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  100 bits (251), Expect = 7e-24
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 15/208 (7%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++ +++H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     +V E++ NG L  Y+    + F      LL +  +V   + YL S   I   H
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---H 123

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEK 500
           RD+ + N L+DD+   KVSDFG SR V+ D+   T+ V   F   +  PE    S+F+ K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 501 SDVYSFGVVLVEILT-GQKPIRAINTDE 527
           SDV++FGV++ E+ + G+ P    N  E
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSE 209

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (251), Expect = 9e-24
 Identities = 68/228 (29%), Positives = 121/228 (53%), Gaps = 22/228 (9%)

Query: 323 RILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +++G G  G V++G+L   GR    VA+K  K    E   + F++E  I+ Q +H NI++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAA 436
           L G   + +  +++ E++ NG L +Y+ +   EF       +LR    ++  + YL   +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD--QTHLTTKVQGTFGYVDPEYFQS 494
            +   HRD+ + NIL++     KVSDFG SR +  D   T+ T+  +    +  PE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 541
            +FT  SDV+SFG+V+ E+++ G++P   ++  E        ++AIN+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAIND 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 15/207 (7%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
            LG+G  G+VYK +    G++VA+K   +  E ++++ I E+ IL Q +   IVK  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     +V E+   G++   +  +I    +T E +  I  +    L YLHS   I   H
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNKKI---H 122

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIK+ NILL+++ +AK++DFG S   + D       V GT  ++ PE  Q   +  K+D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181

Query: 503 VYSFGVVLVEILTGQ------KPIRAI 523
           ++S G+  +E+  G+       P+RAI
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAI 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  100 bits (251), Expect = 1e-23
 Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 47/301 (15%)

Query: 318 NYNANRILGQGGQGTVYKGMLTD--GR----IVAVKKSKL-VDETNVEQFINEVVILSQI 370
           N    + LG+G  G V K       GR     VAVK  K     + +   ++E  +L Q+
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH--NQIE------------------- 409
           NH +++KL G C +    LL+ E+   G+L  ++    ++                    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           E  +T   L+  A ++S  + YL   A + + HRD+ + N+L+ +  + K+SDFG SR V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 470 MVDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
             + +++  +K +    ++  E      +T +SDV+SFGV+L EI+T             
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------- 224

Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
             L G     I   RLF  L      E  +     +  L   C       RPT  +++ E
Sbjct: 225 --LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282

Query: 589 L 589
           L
Sbjct: 283 L 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (250), Expect = 2e-23
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 19/214 (8%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 374
           D+Y    ++G G    VY  + L +   VA+K+  L   +T+V++   EV  +SQ NH N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQ--IEEFPITWELLLRIAVEVSGAL 429
           +VK     +  +   LV  ++  G+L    +  + +  ++E  I    +L+   EV   L
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA--TVLK---EVLKGL 115

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTK-VQGTFGY 486
            YLHS   I   HRDIK+ NILL +    K++DFG S S+    D+T    K   GT  +
Sbjct: 116 EYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 487 VDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKP 519
           + PE  +    +  K+D++SFG+  +E+ TG  P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFINEVVILSQINHR 373
           DN+     +G+G  G V   + TD   GR VAVKK  L  +   E   NEVVI+    H 
Sbjct: 22  DNFVK---IGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 432
           NIV++    L  +   +V EF+  G L   + H ++ E     E +  + + V  AL +L
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLAVLKALSFL 131

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H+   I   HRDIKS +ILL    R K+SDFG    V  +     + V GT  ++ PE  
Sbjct: 132 HAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVI 187

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
               +  + D++S G++++E++ G+ P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  100 bits (249), Expect = 2e-23
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 325 LGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           LG+G  G V+           D  +VAVK  K   E+  + F  E  +L+ + H++IV+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ------IEEF------PITWELLLRIAVEVS 426
            G C E    L+V+E++ +G L +++ +       +          +T   +L IA +++
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   AS+   HRD+ + N L+      K+ DFG SR +   D   +  +      
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           ++ PE     +FT +SD++SFGVVL EI T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 78/278 (28%), Positives = 136/278 (48%), Gaps = 41/278 (14%)

Query: 323 RILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           + +G+G  G V   ML D  G  VAVK  K  ++   + F+ E  +++Q+ H N+V+LLG
Sbjct: 12  QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
             +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL +   + 
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
             HRD+ + N+L+ +   AKVSDFG ++     Q      V+ T     PE  +  +F+ 
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178

Query: 500 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
           KSDV+SFG++L EI + G+ P   I   +                    +  RV K  K 
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------------VVPRVEKGYKM 218

Query: 559 EE----IMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +        V  + K+C +L+   RP+  ++  +L  I
Sbjct: 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 70/285 (24%), Positives = 132/285 (46%), Gaps = 40/285 (14%)

Query: 324 ILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 376
            LG+G  G V+              +V VK  +   + N++  F  E+ +  +++H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYI------HNQIEEFPITWELLLRIAVEVSGALF 430
           +LLG C E E   ++ E+   G L Q++        +++  P++ +  + +  +++  + 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           +L +A  +   HRD+ + N L+  +   KVS    S+ V   + +          ++ PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL----F 545
             Q   F+ KSDV+SFGV++ E+ T G+ P   ++ +E        L  +   +L     
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKLELPVP 241

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
           E   +R+ K      +MT      RC  +N K RP+  E+ + LG
Sbjct: 242 EGCPSRLYK------LMT------RCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 77/283 (27%), Positives = 144/283 (50%), Gaps = 35/283 (12%)

Query: 323 RILGQGGQGTVYKGMLT-DGRI--VAVKKSKLV--DETNVEQFINEVVILSQINHRNIVK 377
           + LG+G  G+V +G L  D  I  VAVK  K+     + +E F++E V + + +H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 378 LLGCCLETE------VPLLVYEFIPNGTLYQY-IHNQIEEFP--ITWELLLRIAVEVSGA 428
           L+G CL+T        P+++  F+ +G L+ + +++++ + P  +  ++L++   +++  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYV 487
           + YL S + I   HRD+ + N +L++     V+DFG S+ +     +   ++ +    ++
Sbjct: 125 MEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
             E      +T KSDV+SFGV + EI T GQ P   +   E+  +  Y  Q    NRL +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQG---NRLKQ 235

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             D           +  + +L   C  LN K RP+ + +  EL
Sbjct: 236 PPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 3e-23
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLL 379
             +G+G  G VYK      G +VA+KK ++ +E        I E+ +L ++ H NIV+L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 380 GCCLETEVP--LLVYEFIP---NGTL----YQYIHNQIEEFPITWELLLRIAVEVSGALF 430
                       +V+E++     G L     ++  +QI+      +LL          L 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC--YMKQLLE--------GLQ 114

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDP 489
           YLHS     I HRDIK +NIL+++    K++DFG +R      +   T +V  T  Y  P
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 490 E-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           E    ++++  + D++S G +L E+  G KPI
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 64/210 (30%), Positives = 117/210 (55%), Gaps = 13/210 (6%)

Query: 325 LGQGGQGTVYKGM--LTDGRI-VAVKKSKLVDETNV-EQFINEVVILSQINHRNIVKLLG 380
           LG G  G V KG+  +   +I VA+K  K  +E +V ++ + E  I+ Q+++  IV+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C E E  +LV E    G L +++  + +E  IT   ++ +  +VS  + YL     +  
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV-- 117

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 498
            HRD+ + N+LL +++ AK+SDFG S+++  D ++   +  G +   +  PE     +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 499 EKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
            +SDV+S+G+ + E  + GQKP + +   E
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.4 bits (245), Expect = 4e-23
 Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 20/216 (9%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFI--------NEVVILSQ 369
            Y   R++G+G  G V+   L   +  A +K  ++ +  VEQ          NE  +L  
Sbjct: 1   KYEKIRVVGRGAFGIVH---LCRRK--ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL 55

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           ++H NI++     LE +  ++V E+ P GTL +YI  +     +  + +L   V++  AL
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114

Query: 430 FYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
            ++H+     I HRD+K+ NILLD  K   K+ DFG S+ ++  ++   T V GT  Y+ 
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYIS 169

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           PE  +   + +KSD+++ G VL E+ + ++   A N
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 97.7 bits (243), Expect = 8e-23
 Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 15/211 (7%)

Query: 325 LGQGGQGTVYKG---MLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG G  GTV KG   M    + VAVK  K+   D    ++ + E  ++ Q+++  IV+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
           G C E E  +LV E    G L +++        +T + +  +  +VS  + YL     + 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFV- 117

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQF 497
             HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   K  G +   +  PE     +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 498 TEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           + KSDV+SFGV++ E  + GQKP + +  +E
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 97.6 bits (243), Expect = 9e-23
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLG 380
           + LG G  G V+ G       VA+K    ++E  +  E FI E  ++ +++H  +V+L G
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C + +   +V EF+ NG L  Y+  +  +   + ++LL +  +V   + YL   + I  
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRD+ + N L+      KVSDFG +R V+ D+   ++  +    +  PE F  S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 501 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE 559
           SDV+SFGV++ E+ T G+ P       E KS            RL+            K 
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPF------EKKSNYEVVEMISRGFRLYRP----------KL 225

Query: 560 EIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
             MTV  +   C +   + RPT  E+   + 
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 12/228 (5%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVVILSQINHR 373
           ++   R++G+G  G V      D + + A+K   K K V++ +V   +NE  IL ++NH 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
            +V L     + E   LV + +  G L  ++  ++     + E +     E+  AL YLH
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLH 117

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           S     I HRDIK  NILLD++    ++DF  +    V    LTT   GT GY+ PE   
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLC 172

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
              ++   D +S GV   E L G++P R  +      +      A   
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 30/224 (13%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQ----FINEVV 365
           E   D+    R LG G  G VY+G+       AV+     K + E+  EQ    F+ E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITWELLLRI 421
           I+S+ NH+NIV+L+G   E     ++ E +  G L  ++            +T + LL  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMV------- 471
           A +V+    YL     I   HRDI + N LL  K     AK++DFG +R +         
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
            +  L  K      ++ PE F    FT K+DV+SFGV+L EI +
Sbjct: 179 GRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 16/211 (7%)

Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 371
           N+   ++LGQG  G VY     D GR +AVK+     ++      V     E+ +L  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALF 430
           H  IV+  GC  + E   +  E++P G+    + +Q++ +  +T  +  +   ++   + 
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 488
           YLHS     I HRDIK ANIL D     K+ DFG S+ +    +  T    V GT  ++ 
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           PE      +  K+DV+S G  +VE+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 79/303 (26%), Positives = 117/303 (38%), Gaps = 61/303 (20%)

Query: 318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFIN-----EVVILSQIN 371
            Y   + LG+G    VYK      GRIVA+KK KL +    +  IN     E+ +L ++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------PITWELLLRIAVEV 425
           H NI+ LL          LV+EF+    L + I ++                L       
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR------ 113

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L YLHS     I HRD+K  N+L+      K++DFG +RS       +T +V  T  
Sbjct: 114 --GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167

Query: 486 YVDPE-YFQSSQFTEKSDVYSFGVVLVE------ILTGQKPIRAIN---------TDED- 528
           Y  PE  F +  +    D++S G +  E       L G   I  +          T+E+ 
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 529 ---KSLVGY----FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT 581
               SL  Y            ++F A        A  + +     L +R L LN   R T
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPA--------ASDDAL----DLLQRLLTLNPNKRIT 275

Query: 582 MKE 584
            ++
Sbjct: 276 ARQ 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 25/227 (11%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--ETNVEQFINEVVILS 368
           DLE  +D       LG G  G+V K        V  KK   +    +  +Q + E+ I+ 
Sbjct: 6   DLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH 58

Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVS 426
           +     IV   G  L      +  EF+  G+L     ++I  +  PI  E+L +IAV V 
Sbjct: 59  ECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVV 113

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTKVQGTF 484
             L YL++   I   HRDIK +NIL++ + + K+ DFG S  ++  +  T +     GT 
Sbjct: 114 EGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTS 166

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
            Y+ PE  Q  ++T KSDV+S G+ ++E+  G+ P    N D+D   
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 96.3 bits (239), Expect = 4e-22
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 32/266 (12%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
             L+     ++ E++  G+    +     +EF I   L      E+   L YLHS   I 
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML-----KEILKGLDYLHSEKKI- 123

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
             HRDIK+AN+LL ++   K++DFG +  +   Q    T V GT  ++ PE  Q S +  
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180

Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE 559
           K+D++S G+  +E+  G+ P    N+D     V + +   N   L     ++  KE    
Sbjct: 181 KADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLTGEF-SKPFKE---- 231

Query: 560 EIMTVATLAKRCLNLNGKMRPTMKEV 585
                      CLN +   RPT KE+
Sbjct: 232 -------FIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 16/203 (7%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINH---RNIVKL 378
           ++G+G  G VY+G  +  GR+VA+K   L   + +V     EV +LSQ+      NI K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAAS 437
            G  L+     ++ E+   G++   +    I E  I+  +++R   EV  AL Y+H    
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS--VIIR---EVLVALKYIHKV-- 120

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ- 496
             + HRDIK+ANIL+ +    K+ DFG +  +  + +  +T V GT  ++ PE     + 
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178

Query: 497 FTEKSDVYSFGVVLVEILTGQKP 519
           +  K+D++S G+ + E+ TG  P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 325 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G G  G VYK   +  G +VA+K  KL    + E    E+ +L +  H NIV   G  L
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
             +   +V E+   G+L Q I+      P++   +  +  E    L YLH    I   HR
Sbjct: 71  RRDKLWIVMEYCGGGSL-QDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKI---HR 125

Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ------GTFGYVDPEYFQ---S 494
           DIK ANILL +    K++DFG S         LT  +       GT  ++ PE       
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
             +  K D+++ G+  +E+   Q P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 26/213 (12%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN----------VEQFINEVVILSQINH 372
           ++G+G  G VY  + +T G ++AVK+ +L               V+   +E+  L  ++H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 373 RNIVKLLGCCLETEVPLLVY-EFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
            NIV+ LG    TE  L ++ E++P G++   +  + + EE     +L+     +V   L
Sbjct: 68  LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYVD 488
            YLHS     I HRD+K+ N+L+D     K+SDFG S+ S  +        +QG+  ++ 
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 489 PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
           PE   S    ++ K D++S G V++E+  G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 76/288 (26%), Positives = 141/288 (48%), Gaps = 36/288 (12%)

Query: 323 RILGQGGQGTVYKGMLT----DGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           R+LG+G  G+V +  L       + VAVK  K+ +   +++E+F+ E   + + +H N++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 377 KLLGCCLETE------VPLLVYEFIPNGTLYQY-IHNQIEEFPITWEL--LLRIAVEVSG 427
           KL+G  L +       +P+++  F+ +G L+ + + ++I E P T  L  L+R  ++++ 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGY 486
            + YL S   I   HRD+ + N +L++     V+DFG S+ +   D        +    +
Sbjct: 125 GMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLF 545
           +  E    + +T  SDV++FGV + EI+T GQ P   +   E+  +  Y    I  NRL 
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYL---IKGNRLK 235

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR 593
           +  D           +  V  L  +C +   K RP+ + + ++L  I 
Sbjct: 236 QPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 30/265 (11%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G VYKG+  D R   V   K++D    E  +E    E+ +LSQ +   I +  G
Sbjct: 12  IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + ++  P+    +  I  E+   L YLHS   I  
Sbjct: 70  SYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI-- 123

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL ++   K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P    N+D     V  FL   N     E   ++  KE     
Sbjct: 182 ADIWSLGITAIELAKGEPP----NSDLHPMRV-LFLIPKNSPPTLEGQYSKPFKE----- 231

Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN + + RPT KE+
Sbjct: 232 ------FVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 37/294 (12%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDET-----NVEQFINEV 364
           E + +     R LGQG  G VY+G   D   G        K V+E+      +E F+NE 
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60

Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIEEFPITWEL 417
            ++      ++V+LLG   + +  L+V E + +G L  Y+        N     P T + 
Sbjct: 61  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHL 476
           ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +   D    
Sbjct: 121 MIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 535
             K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++           
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS----------- 226

Query: 536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
               NE  L   +D   L +        V  L + C   N KMRPT  E+ N L
Sbjct: 227 ----NEQVLKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 30/265 (11%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + +E  P+    +  I  E+   L YLHS   I  
Sbjct: 70  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 123

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P       E   +   FL   N     E   ++ LKE     
Sbjct: 182 ADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 231

Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN     RPT KE+
Sbjct: 232 ------FVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 75/296 (25%), Positives = 141/296 (47%), Gaps = 41/296 (13%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE--------QFINEV 364
           E A +    +R LGQG  G VY+G +  G +    ++++  +T  E        +F+NE 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIEEFPITWEL 417
            ++ + N  ++V+LLG   + +  L++ E +  G L  Y+        N   + P + + 
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHL 476
           ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D    
Sbjct: 121 MIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 535
             K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++        
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------V 230

Query: 536 LQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           L+ + E  L +  D    +L E           L + C   N KMRP+  E+ + +
Sbjct: 231 LRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 10/214 (4%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           + E   D      +LG+G  G VY    L+    +A+K+    D   V+    E+ + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           + HRNIV+ LG   E     +  E +P G+L   + ++        + ++    ++   L
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            YLH      I HRDIK  N+L+ + Y    K+SDFGTS+  +      T    GT  Y+
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQYM 176

Query: 488 DPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
            PE        +   +D++S G  +VE+ TG+ P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 31/260 (11%)

Query: 341 GRIVAVKKSKLVDETNVEQFIN---EVVILSQINHRNIVKLLGCCLET--EVPLLVYEFI 395
           G  VAVK  K   E+      +   E+ IL  + H NIVK  G C E       L+ EF+
Sbjct: 33  GEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK 455
           P+G+L +Y+     +  I  +  L+ AV++   + YL S   +   HRD+ + N+L++ +
Sbjct: 91  PSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESE 145

Query: 456 YRAKVSDFGTSRSVMVDQTHLTTK---VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 512
           ++ K+ DFG ++++  D+ + T K       F Y  PE    S+F   SDV+SFGV L E
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVTLYE 204

Query: 513 ILTGQKPIRAINTDEDKSLVGYFLQAI--NENRLFEALDARVLKEAKKEEI-----MTVA 565
           +LT          D + S +  FL+ I     ++      RVL+E K+          V 
Sbjct: 205 LLT--------YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVY 256

Query: 566 TLAKRCLNLNGKMRPTMKEV 585
            L ++C       R T + +
Sbjct: 257 QLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.0 bits (231), Expect = 4e-21
 Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 29/279 (10%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQ------FINEVVILSQI 370
            +   + LG G   + Y+   +  G ++AVK+   V  T+ EQ         E+ +++++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH +I+++LG   E     L  E++  G++   +            +++    ++   L 
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLS 117

Query: 431 YLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQT---HLTTKVQGTFGY 486
           YLH      I HRD+K AN+L+D    R +++DFG +  +    T       ++ GT  +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           + PE  +  Q+    DV+S G V++E+ T + P  A       +L+     A     + E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            L               +  +  RCL L  + RP  +E+
Sbjct: 235 HLSP------------GLRDVTLRCLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 20/218 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D++   + LG G  G V   ML      G+  A+K   K+K+V    VE  +NE  IL  
Sbjct: 1   DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           I H  +V L G   +     LV E++P G L+ +   +   FP         A +V  AL
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFY--AAQVVLAL 114

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLHS     I +RD+K  N+LLD     K++DFG ++ V   +T+      GT  Y+ P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAP 167

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E   S  + +  D ++ G+++ E+L G  P    N  +
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 21/223 (9%)

Query: 323 RILGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G V+           D  +VAVK  K   +   + F  E  +L+ + H +IV
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFP---ITWELLLRIAVEVS 426
           K  G C+E +  ++V+E++ +G L +++           E      +T   +L IA +++
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   AS    HRD+ + N L+ +    K+ DFG SR V   D   +         
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           ++ PE     +FT +SDV+S GVVL EI T G++P   ++ +E
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQGVI---H 139

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +     + V GT  ++ PE      +  + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198

Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 35/287 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGML-----TDGRI-VAVKKSK-LVDETNVEQFINEVVILSQ 369
           +N +  + LG G  G V +        +D  + VAVK  K     +  E  ++E+ I+S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 370 I-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           + NH NIV LLG C      L++ E+   G L  ++  + E F    + LL  + +V+  
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED-LLSFSYQVAKG 153

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT----F 484
           + +L S   I   HRD+ + N+LL      K+ DFG +R +M D  ++   V+G      
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 543
            ++ PE   +  +T +SDV+S+G++L EI + G  P   +  D        F + I E  
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG- 260

Query: 544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
                  R+ +         +  + K C + +   RPT K++   +G
Sbjct: 261 ------YRMAQPEHAPA--EIYDIMKTCWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 93.2 bits (232), Expect = 6e-21
 Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 57/303 (18%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNV--EQFINEVVILSQINHR 373
           + Y    ++G+G  G V K      G IVA+KK K  ++     +  + EV +L Q+ H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP----------ITWELLLRIAV 423
           NIV L           LV+E++        +   +E  P            W+LL     
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRSYIWQLL----- 110

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQG 482
               A+ Y HS     I HRDIK  NIL+ +    K+ DFG +R++     + LT  V  
Sbjct: 111 ---QAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163

Query: 483 TFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK---------SLV 532
           T  Y  PE     + + +  DV++ G ++ E+L G+ P+   ++D D+          L 
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLP 222

Query: 533 GYFLQAINENRLF-----------EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT 581
               +  + N  F           E+L+ R   +     +       K CL ++ K R T
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL----DFLKACLRMDPKERLT 278

Query: 582 MKE 584
             E
Sbjct: 279 CDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 92.6 bits (230), Expect = 7e-21
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 37/285 (12%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDG--RIVAVK----------KSKLVDETNVEQFINEVV 365
            Y     LG G  G VYK    +    ++A+K          K K   + ++   ++EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 366 IL-SQINHRNIVKLLGCCLETEVPLLVYEFI---PNGTLYQYIHNQIEEFPITWELLLRI 421
           I+  Q+ H NIV+     LE +   +V + I   P G  +  +  + + F    E +  I
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
            V++  AL YLH    I   HRD+   NI+L +  +  ++DFG ++     ++ LT+ V 
Sbjct: 119 FVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV- 174

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
           GT  Y  PE  ++  + EK+DV++FG +L ++ T Q P  + N     SL    ++A   
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEA--- 228

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
             ++E L   +  E        V  +   CL  + + RP + +V+
Sbjct: 229 --VYEPLPEGMYSE-------DVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G VYK +     ++VA+K   L   E  +E    E+  LSQ     I K  G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           L+     ++ E+   G+      + ++   +    +  I  EV   L YLH    I   H
Sbjct: 69  LKGSKLWIIMEYCGGGSCL----DLLKPGKLDETYIAFILREVLLGLEYLHEEGKI---H 121

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIK+ANILL ++   K++DFG S  +    +   T V GT  ++ PE  + S + EK+D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180

Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G+  +E+  G+ P
Sbjct: 181 IWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.5 bits (240), Expect = 1e-20
 Identities = 88/364 (24%), Positives = 154/364 (42%), Gaps = 44/364 (12%)

Query: 236 CRTTYRTDG--FCAGCGGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQE 293
           C+   +T    F   C  G  L+  LV   + + F++ R  ++LK+              
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVA--FGFVFIRGRNNLELKR-------------- 662

Query: 294 LSSNESNIEKTKLFTSKDLEKATDN-----YNANRILGQGGQGTVYKG-MLTDGRIVAVK 347
              NE    + + F SK  +  T N          ++ +G +G  YKG  + +G    VK
Sbjct: 663 -VENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK 721

Query: 348 KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ 407
           +   V+       I +   + ++ H NIVKL+G C   +   L++E+I    L + + N 
Sbjct: 722 EINDVNSIP-SSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776

Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
                ++WE   +IA+ ++ AL +LH   S  +   ++    I++D K    +       
Sbjct: 777 -----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +  D     +       YV PE  ++   TEKSD+Y FG++L+E+LTG+ P  A     
Sbjct: 831 LLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGV 884

Query: 528 DKSLVGYFLQAINENRLFEALDARVLKEA--KKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             S+V +     ++  L   +D  +  +    + EI+ V  LA  C   +   RP   +V
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944

Query: 586 TNEL 589
              L
Sbjct: 945 LKTL 948

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 13/199 (6%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VA+K  K     + E F+ E  ++ Q+ H  +V+L      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70

Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++    E   +T   L+ +A +++  + ++     I   HR
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYI---HR 126

Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKS 501
           D+++ANIL+ +    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 502 DVYSFGVVLVEILT-GQKP 519
           DV+SFG++L EI+T G+ P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 27/270 (10%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V+ G L  D   VAVK  +     +++ +F+ E  IL Q +H NIV+L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            + +   +V E +  G    ++  +     +  + L+++    +  + YL S   I   H
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKHCI---H 117

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEK 500
           RD+ + N L+ +K   K+SDFG SR    D  + +T    Q    +  PE     +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 501 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE 559
           SDV+SFG++L E  + G  P   ++  + +                EA++  V     + 
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------EAIEQGVRLPCPEL 220

Query: 560 EIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
               V  L +RC   +   RP+   V  EL
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 90.3 bits (224), Expect = 5e-20
 Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 19/220 (8%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE---QFINEVVILSQINHRNIVKLL 379
           ILG G  GTVYK   L   RI+AVK   L  +  VE   Q ++E+ IL + +   I+   
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
           G         +  EF+  G+L  Y   +I E      +L RIAV V   L YL S   + 
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY--RKIPE-----HVLGRIAVAVVKGLTYLWS---LK 115

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
           I HRD+K +N+L++ + + K+ DFG S  ++     +     GT  Y+ PE     Q+  
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
            SDV+S G+  +E+  G+ P   I  ++   +    LQ I
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 52/294 (17%)

Query: 324 ILGQGGQGTVYKGML-----TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNI 375
            LG+G  G V K         +    VAVK  K    E ++   ++E+ ++  I  H+NI
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 376 VKLLGCCLETEVPLLVYEFI-------------PNGTLYQYIHNQIEEFPITWELLLRIA 422
           + LLG C +     +V E+              P G        +  E  +T + L+  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQ 481
            +V+  + +L S   I   HRD+ + N+L+ + +  K++DFG +R +  +D    TT  +
Sbjct: 139 YQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAIN 540
               ++ PE      +T +SDV+SFGV+L EI T G  P   I  +E             
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------------- 242

Query: 541 ENRLFEALDARVLKEAKKEE-----IMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
              LF+     +LKE  + E        +  L + C +     RPT K++  +L
Sbjct: 243 ---LFK-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 9/196 (4%)

Query: 325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V        GR VAVK   L  +   E   NEVVI+    H+N+V++    L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
             E   ++ EF+  G L     + + +  +  E +  +   V  AL YLHS   I   HR
Sbjct: 89  VGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HR 141

Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           DIKS +ILL    R K+SDFG    +  D     + V GT  ++ PE    + +  + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200

Query: 504 YSFGVVLVEILTGQKP 519
           +S G++++E++ G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.4 bits (224), Expect = 6e-20
 Identities = 58/187 (31%), Positives = 103/187 (55%), Gaps = 20/187 (10%)

Query: 343 IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           +VAVK  +  V +T    F+ E+ I+S++ + NI++LLG C+  +   ++ E++ NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 402 QYI-HNQIEE-------FP-ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
           Q++   +IE         P ++   LL +AV+++  + YL   AS+   HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGV 508
            + Y  K++DFG SR++     +   ++QG       ++  E     +FT  SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219

Query: 509 VLVEILT 515
            L E+ T
Sbjct: 220 TLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 323 RILGQGGQGTV----YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNI 375
           ++LG+G  G V     KG  TD  + AVK   K  ++ + +VE  + E  +L+       
Sbjct: 1   KVLGKGSFGKVLLAELKG--TD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLH 433
           +  L  C +T+  L  V E++  G L  +I  +   F    E   R  A E+   L +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLH 113

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYVDPEYF 492
                 I +RD+K  N+LLD +   K++DFG  +  ++   T  T+   GT  Y+ PE  
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
               +    D ++ GV+L E+L GQ P    + DE
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 29/232 (12%)

Query: 325 LGQGGQGTVYKGML-----TDGRIVAVKKSKLVDETNVEQ---FINEVVILSQINHRNIV 376
           LG+   G +YKG L        ++VA+K  K  D  N +Q   F  E  ++++++H NIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI-----EEFPITWEL----LLRIA 422
            LLG   + +   +++E++  G L++++     H+ +     E+  +   L     L IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQ 481
           ++++  + YL S   +   H+D+ + NIL+ ++   K+SD G SR +   D   +  K  
Sbjct: 131 IQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
               ++ PE     +F+  SD++SFGVVL EI + G +P    +  E   +V
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 23/209 (11%)

Query: 325 LGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           + +G  G V+  K   T G I A+K   K+ ++ +  V+Q + E  ILSQ     +VKL 
Sbjct: 1   ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 380 GCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAAS 437
               + +  L LV E++P G L   + N +       E + RI   E+  AL YLHS   
Sbjct: 60  -YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLD---EDVARIYIAEIVLALEYLHS--- 111

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-------THLTTKVQGTFGYVDPE 490
             I HRD+K  NIL+D     K++DFG S+  +V +            ++ GT  Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
                  ++  D +S G +L E L G  P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.4 bits (221), Expect = 1e-19
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  + +  G+ VA+K+  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
             +   +V E++  G+L     + + E  +    +  +  E   AL +LHS   I   HR
Sbjct: 87  VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVI---HR 139

Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           DIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198

Query: 504 YSFGVVLVEILTGQKP 519
           +S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + E F+ E  I+ ++ H  +V+L     E
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++ +  E   +    L+ +A +V+  + Y+     I   HRD
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 127

Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 502
           ++SANIL+ D    K++DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           V+SFG++L E++T G+ P   +N  E
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNRE 211

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 6/198 (3%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + LG G  G V+ G   +   VAVK  K     +V+ F+ E  ++  + H  +V+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            + E   ++ E++  G+L  ++ +  E   +    L+  + +++  + Y+     I   H
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+++AN+L+ +    K++DFG +R +  ++       +    +  PE      FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 13/218 (5%)

Query: 305 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFI 361
           KL T   +      Y     +GQG  GTV+     D   G+ VA+K+  L  +   E  I
Sbjct: 7   KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELII 64

Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           NE++++ ++ + NIV  L   L  +   +V E++  G+L     + + E  +    +  +
Sbjct: 65  NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAV 120

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
             E   AL +LH+   I   HRDIKS N+LL      K++DFG    +  +Q+  +T V 
Sbjct: 121 CRECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 176

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  ++ PE      +  K D++S G++ +E++ G+ P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 21/278 (7%)

Query: 296 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 354
           S+E  +EK +   S  +      Y     +GQG  GTVY  M +  G+ VA+++  L  +
Sbjct: 1   SDEEILEKLRSIVS--VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
              E  INE++++ +  + NIV  L   L  +   +V E++  G+L     + + E  + 
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD 114

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
              +  +  E   AL +LHS   I   HRDIKS NILL      K++DFG    +  +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG------QKPIRA---INT 525
             +T V GT  ++ PE      +  K D++S G++ +E++ G      + P+RA   I T
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 526 DEDKSLVG-YFLQAINENRLFEALDARVLKEAKKEEIM 562
           +    L     L AI  + L   LD  V K    +E++
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 37/273 (13%)

Query: 325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V        G+ VAVKK  L  +   E   NEVVI+   +H N+V +    L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL YLH+   I   H
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQGVI---H 141

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +     + V GT  ++ PE      +  + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200

Query: 503 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF----LQAINENRLFEALDARVLKEAKK 558
           ++S G++++E++ G+ P              YF    LQA+   R+ + L  R +K++ K
Sbjct: 201 IWSLGIMVIEMIDGEPP--------------YFNEPPLQAM--RRIRDNLPPR-VKDSHK 243

Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG 591
                V+++ +  L+L     P+ +    EL  
Sbjct: 244 -----VSSVLRGFLDLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 20/214 (9%)

Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 371
           N+   ++LGQG  G VY     D GR +AVK+ +   E+      V     E+ +L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 372 HRNIVKLLGCCLET-EVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGA 428
           H  IV+  GC  +  E  L ++ E +P G+    I +Q++ +  +T  +  +   ++   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR---SVMVDQTHLTTKVQGTFG 485
           + YLHS     I HRDIK ANIL D     K+ DFG S+   ++ +  T + + V GT  
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE      +  K+D++S G  +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 56/198 (28%), Positives = 104/198 (52%), Gaps = 11/198 (5%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 127

Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L E+ T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)

Query: 323 RILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           R+LG+G  G V    +   GR+ AVK   K  ++ + +VE  + E  ILS   +   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 379 LGCCLET-EVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSA 435
           L CC +T +    V EF+  G L  +I    + +E    +      A E++ AL +LH  
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-----YAAEITSALMFLHDK 115

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I +RD+K  N+LLD +   K++DFG  +  + +    T+   GT  Y+ PE  Q  
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEILQEM 171

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +    D ++ GV+L E+L G  P  A N D+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 325 LGQGGQGTVYK-GMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  G V+K      G  VA+KK   + ++     Q + E+  L    H  +VKLL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                  +LV E++P   L + + +  EE P+    +      +   + Y+H+     I 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 500
           HRD+K AN+L+      K++DFG +R    ++  L +    T  Y  PE  + + ++   
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181

Query: 501 SDVYSFGVVLVEILTGQ 517
            D+++ G +  E+L G 
Sbjct: 182 VDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 65/277 (23%), Positives = 132/277 (47%), Gaps = 34/277 (12%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDETNVEQFINEV----VILSQINHRNIV 376
           ++LG G  GTV+KG+ + +G  + +  + K + + +  Q   E+    + +  ++H  IV
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG C    + L V +  P G+L  ++    +   +  + LL   V+++  ++YL    
Sbjct: 73  RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSS 495
            +   HR++ + NILL      +++DFG +  +   D+ +  ++ +    ++  E     
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           ++T +SDV+S+GV + E+++ G +P   +   E   L+          RL          
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE------KGERL---------- 230

Query: 555 EAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNEL 589
              + +I T  V  +  +C  ++  +RPT KE+ NE 
Sbjct: 231 --AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 18/215 (8%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNV-----EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + DG  V +  +  V   N      ++ ++E  +++ +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L V + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT---KVQGTFGYVDPEYFQ 493
            + + HRD+ + N+L+      K++DFG +R + +D+T       KV     ++  E   
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
             +FT +SDV+S+GV + E++T G KP   I   E
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 73/229 (31%), Positives = 111/229 (48%), Gaps = 24/229 (10%)

Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINE 363
           FT++DL+   +       +G+G  GTV K ML    G I+AVK+ +  VDE   ++ + +
Sbjct: 1   FTAEDLKDLGE-------IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52

Query: 364 V-VILSQINHRNIVKLLGCCLETEVPLLVYEF--IPNGTLYQYIHNQIE-EFPITWELLL 419
           + V++   +   IVK  G         +  E   I     Y+Y++  ++   P   E+L 
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILG 110

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
           +IAV    AL YL     + I HRD+K +NILLD     K+ DFG S   +VD    T  
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSIAKTRD 167

Query: 480 VQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINT 525
             G   Y+ PE    S    +  +SDV+S G+ L E+ TG+ P    N+
Sbjct: 168 A-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLG 380
             LG+G  G+V K  L +  ++   K+   D      +Q + E+ I        IVK  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 381 CCL---ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE-LLLRIAVEVSGALFYLHSAA 436
             L    + + + + E+   G+L        +      E +L +IA  V   L YLHS  
Sbjct: 67  AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG----YVDPEYF 492
            I   HRDIK +NILL  K + K+ DFG S         L   + GTF     Y+ PE  
Sbjct: 126 II---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPERI 175

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           Q   ++  SDV+S G+ L+E+   + P 
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 60/220 (27%), Positives = 113/220 (51%), Gaps = 18/220 (8%)

Query: 323 RILGQGGQGTVYKGM-LTDG---RI-VAVKKSKLVDETNVEQFI-NEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G   +I VA+K+ +        + I +E  +++ +++ ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L + + +P G L  Y+    +     +  LL   V+++  + YL    
Sbjct: 73  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEERR 129

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT---KVQGTFGYVDPEYFQ 493
              + HRD+ + N+L+      K++DFG ++ +  D+        KV     ++  E   
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESIL 184

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
              +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 324 ILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL 378
           ++G G  G V +G L   G+    VA+K  K    E     F++E  I+ Q +H NI+ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G   ++   +++ EF+ NG L  ++     +F +    L+ +   ++  + YL   + +
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL---SEM 125

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQG---TFGYVDPEYFQS 494
              HRD+ + NIL++     KVSDFG SR +  D +  T T   G      +  PE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)

Query: 323 RILGQGGQGTVYKGM------LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G V+           D  +VAVK  K       + F  E  +L+ + H +IV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFPI--TWEL----LLRIAV 423
           K  G C + +  ++V+E++ +G L +++          ++  P     EL    +L IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQG 482
           +++  + YL   AS    HRD+ + N L+      K+ DFG SR V   D   +      
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
              ++ PE     +FT +SDV+SFGV+L EI T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 30/209 (14%)

Query: 343 IVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           +VAVK  +     N    F+ EV ILS++   NI++LLG C++ +   ++ E++ NG L 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 402 QYI-HNQIEE---------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI 445
           Q++  + +++                 I++  LL +A++++  + YL   +S+   HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 446 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKS 501
            + N L+ +    K++DFG SR++     +   ++QG       ++  E     +FT  S
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221

Query: 502 DVYSFGVVLVEILT--GQKPIRAINTDED 528
           DV++FGV L EIL    ++P   + TDE 
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGEL-TDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 32/210 (15%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFIN--EVVILSQIN-HRNIVKL 378
           LG G  G+VY       G +VA+K  K K     + E+ +N  EV  L ++N H NIVKL
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFP------ITWELLLRIAVEVSGALFY 431
                E +    V+E++  G LYQ +   + + F       I +++L          L +
Sbjct: 64  KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--------GLAH 114

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           +H       +HRD+K  N+L+      K++DFG +R +   +   T  V  T  Y  PE 
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPEI 169

Query: 492 F-QSSQFTEKSDVYSFGVVLVEILTGQKPI 520
             +S+ ++   D+++ G ++ E+ T  +P+
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 22/215 (10%)

Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFIN----EVVILSQ 369
           N+   ++LG+G  G VY     D GR +AVK+        ET+ E  +N    E+ +L  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE--VNALECEIQLLKN 60

Query: 370 INHRNIVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVS 426
           + H  IV+  GC  +  E  L ++ E++P G+    I +Q++ +  +T  +  R   ++ 
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQIL 116

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
             + YLHS     I HRDIK ANIL D     K+ DFG S+ +       T    V GT 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            ++ PE      +  K+DV+S    +VE+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 54/312 (17%)

Query: 313 EKATDNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSK-LVDETNVEQFINE 363
           E + D     + LG+G  G V         K    +   VAVK  K    E ++   ++E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 409
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+               ++ 
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           +  +T++ L+    +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
             +D    TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Query: 528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTM 582
                           LF     ++LKE  + +     T     + + C +     RPT 
Sbjct: 248 ----------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF 286

Query: 583 KEVTNELGGIRT 594
           K++  +L  I T
Sbjct: 287 KQLVEDLDRILT 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 33/236 (13%)

Query: 313 EKATDNYNANRILGQGGQGTVYK----GMLT--DGRIVAVK--KSKLVDETNVEQFINEV 364
           E   +N    R +GQG  G V++    G+L      +VAVK  K +   +   + F  E 
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREA 59

Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQ------------ 407
            ++++ +H NIVKLLG C   +   L++E++  G L +++       Q            
Sbjct: 60  ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 408 --IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
             +   P++    L IA +V+  + YL     +   HRD+ + N L+ +    K++DFG 
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGL 176

Query: 466 SRSV-MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           SR++   D    +        ++ PE    +++T +SDV+++GVVL EI + G +P
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 323 RILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +++G G  G V  G L   G+    VA+K  K    E     F++E  I+ Q +H NI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL     
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDMGY 127

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSS 495
           +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE     
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKP 519
           +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.0 bits (207), Expect = 6e-18
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 20/214 (9%)

Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 371
           N+   ++LGQG  G VY     D GR +A K+ +   E+      V     E+ +L  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 372 HRNIVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGA 428
           H  IV+  GC  +  E  L ++ E++P G+    + +Q++ +  +T  +  +   ++   
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYTRQILEG 118

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR---SVMVDQTHLTTKVQGTFG 485
           + YLHS     I HRDIK ANIL D     K+ DFG S+   ++ +  T + + V GT  
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE      +  K+DV+S G  +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 9/207 (4%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQINHR 373
           N+   + +G+G    VY+   L DG  VA+KK +   L+D       I E+ +L Q+NH 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 432
           N++K     +E     +V E    G L + I H + ++  I  + + +  V++  AL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + HRDIK AN+ +      K+ D G  R     +T     + GT  Y+ PE  
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
             + +  KSD++S G +L E+   Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 36/210 (17%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQF-INEVVILSQI---NHRNIVK 377
            +G+G  GTVYK   L  GR VA+KK ++ + E  +    + E+ +L Q+    H NIV+
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 378 LLGCC----LETEVPL-LVYEFIPNGTLYQYIHN---------QIEEFPITWELLLRIAV 423
           LL  C     + E+ L LV+E + +  L  Y+            I++  +  +LL     
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD--LMRQLL----- 117

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
                + +LHS     I HRD+K  NIL+    + K++DFG +R +   +  LT+ V  T
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-T 169

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 513
             Y  PE    S +    D++S G +  E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.5 bits (210), Expect = 8e-18
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNI 375
           Y   + +G G  G V   +    GR VA+KK   V  D  + ++ + E+ +L  + H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 376 VKLLGCCLETEVPL-----------LVYEFIPNGT-LYQYIHNQIEEFPITWELLLRIAV 423
           + LL      ++             +V E +   T L++ I +     P+T + +     
Sbjct: 62  IGLL------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQ---PLTDDHIQYFLY 110

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG- 482
           ++   L YLHSA    + HRD+K +NIL++     K+ DFG +R V  D+       +  
Sbjct: 111 QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 483 -TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            T  Y  PE    SS++T+  D++S G +  E+LT  KP+
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 15/214 (7%)

Query: 318 NYNANRILGQGGQGTVY--KGMLTDGRIVAVKKSKL----VDETNVEQFINEVVILSQIN 371
            Y   + +G+G  G +Y  K   +D     +K+  L    V E    +   EV++L+++ 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMK 57

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NIV       E     +V E+   G L + I+ Q      + + +L   V++S  L +
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKH 116

Query: 432 LHSAASIPIYHRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           +H      I HRDIKS NI L      AK+ DFG +R  + D   L     GT  Y+ PE
Sbjct: 117 IHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPE 172

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
             Q+  +  K+D++S G VL E+ T + P    N
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 31/237 (13%)

Query: 300 NIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVE 358
           + E  +LF+  D EK    +   R +G G  G VY         +VA+KK     + + E
Sbjct: 1   DPEIAELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 57

Query: 359 QF---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPI 413
           ++   I EV  L Q+ H N ++  GC L      LV E+ + + +    +H + ++E   
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--- 114

Query: 414 TWELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
                + IA    GAL    YLHS   I   HRDIK+ NILL +    K++DFG++  V 
Sbjct: 115 -----VEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVS 166

Query: 471 VDQTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
              + +     GT  ++ PE        Q+  K DV+S G+  +E+   + P+  +N
Sbjct: 167 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)

Query: 318 NYNANRILGQG--GQGTVYKGMLTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRN 374
            YN  R++G+G  G+  + + + +D +  A+K+ +L    + VE    E V+L+++ H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 375 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           IV       E +  L +V E+   G L Q I  Q  +     + +L+  V++   + ++H
Sbjct: 60  IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIH 117

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 + HRDIKS NI L    + K+ DFG++R +     +  T V GT  YV PE ++
Sbjct: 118 EKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           +  +  KSD++S G +L E+ T + P +A
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 54/307 (17%)

Query: 313 EKATDNYNANRILGQG--GQGTVYKGMLTD----GRI--VAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  GQ  + + +  D     R+  VAVK  K    E ++   I+E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 409
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+               Q+ 
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           E  ++++ L+  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
             +D    TT  +    ++ PE      +T +SDV+SFGV+L EI T G  P   +  +E
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250

Query: 528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTM 582
                           LF     ++LKE  + +  +  T     + + C +     RPT 
Sbjct: 251 ----------------LF-----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289

Query: 583 KEVTNEL 589
           K++  +L
Sbjct: 290 KQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG G  G VYK      G   A K  ++  E  +E F+ E+ ILS+  H NIV L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASIPIY 441
                 ++ EF   G L     + + E    +T   +  +  ++  AL +LHS   I   
Sbjct: 73  YENKLWILIEFCDGGAL----DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI--- 125

Query: 442 HRDIKSANILLDDKYRAKVSDFGTS-RSVMVDQTHLTTKVQGTFGYVDPEY-----FQSS 495
           HRD+K+ NILL      K++DFG S ++    Q   T    GT  ++ PE      F+ +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            +  K+D++S G+ L+E+   + P   +N
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 9/207 (4%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQINHR 373
           N+   + +G+G    VY+   L D + VA+KK +   ++D    +  + E+ +L Q+NH 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 432
           N++K L   +E     +V E    G L Q I + + ++  I    + +  V++  A+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + HRDIK AN+ +      K+ D G  R     +T     + GT  Y+ PE  
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
             + +  KSD++S G +L E+   Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 44/288 (15%)

Query: 324 ILGQGGQGTVYKGMLT-DGRIV--AVKKSK-LVDETNVEQFINEVVILSQI-NHRNIVKL 378
           ++G+G  G V + M+  DG  +  A+K  K    E +   F  E+ +L ++ +H NI+ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 425
           LG C       +  E+ P G L  ++     +E  P           +T + LL+ A +V
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 483
           +  + YL     I   HRD+ + N+L+ +   +K++DFG SR   V V +T     V+  
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 542
             ++  E    S +T KSDV+SFGV+L EI++ G  P   +   E               
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------------- 226

Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
            L+E L      E  +     V  L ++C       RP   +++ +L 
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.9 bits (210), Expect = 5e-17
 Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 22/188 (11%)

Query: 353 DETNVEQFINEVVILSQINHRNIVKLL--GCCLETEVPLL--VYEFIPNGTLYQYIHNQI 408
           +E    +F  E  + +++ H NIV LL  G   E    LL  V+E++P  TL + +    
Sbjct: 18  EEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVLAAD- 73

Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGT 465
               +      R+ ++V  AL   H+     I HRD+K  NI++     +  AKV DFG 
Sbjct: 74  --GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

Query: 466 S------RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
                  R   V     TT+V GT  Y  PE  +    T  SD+Y++G++ +E LTGQ+ 
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

Query: 520 IRAINTDE 527
           ++  +  E
Sbjct: 189 VQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 50/277 (18%)

Query: 344 VAVK--KSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV-YEFIPNGT 399
           VAVK  K    D+ ++   I+E+ ++  I  H+NI+ LLG C + E PL V  E+   G 
Sbjct: 47  VAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104

Query: 400 LYQYIH-------------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           L +++               ++ E  ++++ L+  A +V+  + YL S   I   HRD+ 
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161

Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R V  +D    T+  +    ++ PE      +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FG+++ EI T G  P   I  +E                LF     ++L+E  + +  + 
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE----------------LF-----KLLREGHRMDKPSN 260

Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
            T     L + C +     RPT K++   L  +  ++
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K       E F+ E  I+ ++ H  +V L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V EF+  G+L  ++     ++ +    L+ +A +++  + Y+     I   HRD
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127

Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 502
           +++ANIL+ D    K++DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L E++T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGC 381
           +G G  G VYK      G ++AVK+ +     E N    ++  V+L   +   IVK  G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 382 CL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL---HSAAS 437
            + +++V  +  E +   T    +  +I+  PI  ++L ++ V +  AL YL   H    
Sbjct: 83  FITDSDV-FICMELM--STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG--- 135

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
             + HRD+K +NILLD     K+ DFG S  ++  +    T+  G   Y+ PE       
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP 191

Query: 498 TEK----SDVYSFGVVLVEILTGQKPIRAINTD 526
             K    +DV+S G+ LVE+ TGQ P +   T+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 16/223 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKK---SKLVDETNVEQFINEVVILSQINH 372
           D+    + +G G  G V+           A+K     +++     +   NE  +L +++H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             I++L     +     ++ E++P G L+ Y+ N    F  +  L    A E+  AL YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFY--ASEIVCALEYL 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     I +RD+K  NILLD +   K++DFG ++ +  D+T     + GT  Y+ PE  
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVI 170

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVG 533
           QS    +  D ++ G+++ E+L G  P    N     +K L G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 71/218 (32%), Positives = 113/218 (51%), Gaps = 17/218 (7%)

Query: 323 RILGQGGQGTVY---KGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNI 375
           ++LGQG  G V+   K    D G++ A+K   K+ L     V     E  IL+++NH  I
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60

Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           VKL     +TE  L L+ +F+  G L+  +    +E   T E +     E++ AL +LHS
Sbjct: 61  VKL-HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHS 116

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              + I +RD+K  NILLD++   K++DFG S+   +D         GT  Y+ PE    
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
              T+ +D +SFGV++ E+LTG  P +  +  E  +++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 322 NRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF--INEVVILSQINHRNIVKL 378
           NRI G+G  G VY+    T G IVA+KK ++ +E +      + E+ +L  + H NIV+L
Sbjct: 13  NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 379 L----GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
                G  L++    LV E+     L   + N    F  +   +  + +++   L YLH 
Sbjct: 72  KEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES--QVKCLMLQLLRGLQYLHE 126

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQ 493
                I HRD+K +N+LL DK   K++DFG +R+  +    +T KV  T  Y  PE    
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLG 182

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPI 520
            + +T   D+++ G +L E+L   KP+
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 31/221 (14%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG+G   TVYKG   T G IVA+K+  L  +E      I E+ ++ ++ H NIV+L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66

Query: 383 LETEVPL-LVYEFIPNGTLYQYIH----------NQIEEFPITWELLLRIAVEVSGALFY 431
           + TE  L LV+E++ +  L +Y+           N ++ F  T++LL  IA        +
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF--TYQLLKGIA--------F 115

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
            H      + HRD+K  N+L++ +   K++DFG +R+  +     + +V  T  Y  P+ 
Sbjct: 116 CHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 492 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
              S+ ++   D++S G ++ E++TG +P+     +ED+ L
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLL 211

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 54/186 (29%), Positives = 100/186 (53%), Gaps = 19/186 (10%)

Query: 343 IVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           +VAVK  +     N    F+ E+ I+S++   NI++LL  C+ ++   ++ E++ NG L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 402 QYI-HNQIEEFP-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 453
           Q++  ++ +E         I++  L+ +A +++  + YL   +S+   HRD+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 454 DKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGVV 509
             Y  K++DFG SR++     +   ++QG       ++  E     +FT  SDV++FGV 
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221

Query: 510 LVEILT 515
           L EILT
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 48/274 (17%)

Query: 344 VAVK--KSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTL 400
           VAVK  K    D+ ++   ++E+ ++  I  H+NI+ LLG C +     ++ E+   G L
Sbjct: 47  VAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105

Query: 401 YQYIHN-------------QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 447
            +Y+               ++ E  +T++ L+  A +V+  + YL S   I   HRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162

Query: 448 ANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 506
            N+L+ +    K++DFG +R V  +D    TT  +    ++ PE      +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222

Query: 507 GVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVA 565
           GV+L EI T G  P   I  +E                LF     ++LKE  + +     
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEE----------------LF-----KLLKEGHRMDKPANC 261

Query: 566 T-----LAKRCLNLNGKMRPTMKEVTNELGGIRT 594
           T     + + C +     RPT K++  +L  + T
Sbjct: 262 THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 39/231 (16%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQF----INEVVIL 367
           ++  D ++    +G+G  G VYK    D G +VA+KK +L +E   E F    I E+ IL
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 368 SQINHRNIVKLLGCCLETEVPL----------LVYEFIPN-------GTLYQYIHNQIEE 410
            Q+NHRNIV L     + +  L          LV+E++ +         L  +  + I+ 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
           F    + LL         L Y H    +   HRDIK +NILL++K + K++DFG +R   
Sbjct: 121 F---MKQLLE-------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 471 VDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 520
            +++   T    T  Y  PE     + +    DV+S G +L E+ T +KPI
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           ++LG+G  G V    L  G+     + A+KK  ++ + +VE  + E  +L+       + 
Sbjct: 1   KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 378 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQ--IEEFPITWELLLRIAVEVSGALFYLHS 434
            L C  +T+  L  V EF+  G L  +I ++   + +  T+      A E+   L +LHS
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              I   +RD+K  N++LD     K++DFG  +  +      +T   GT  Y+ PE  Q 
Sbjct: 115 KGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            ++T   D +SFGV+L E+L GQ P    + DE
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 11/209 (5%)

Query: 322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
            + LG G  G V+         VAVK  K     +VE F+ E  ++  + H  +VKL   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
            +  E   ++ EF+  G+L  ++ +  E        L+  + +++  + ++     I   
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTE 499
           HRD+++ANIL+      K++DFG +R  +++    T +    F   +  PE      FT 
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 500 KSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           KSDV+SFG++L+EI+T G+ P   ++  E
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 45/286 (15%)

Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVKK------SKLVDETNVEQFINEVVILSQINHRNIV 376
           ++G+G  G V K    + G+IVA+KK       K+V +  +     E+ +L Q+ H N+V
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP--ITWELLLRIAVEVSGALFYLHS 434
            L+      +   LV+EF+ +  L     + +E++P  +    + +   ++   + + HS
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF-Q 493
                I HRDIK  NIL+      K+ DFG +R++       T  V  T  Y  PE    
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVG 174

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK-----SLVGYFLQAINE----NRL 544
            +++    D+++ G ++ E+LTG+ P+   ++D D+       +G  +    E    N L
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 545 FEALDARVLKEAKKEEIM---------TVATLAKRCLNLNGKMRPT 581
           F  +    L E K+ E +          V  LAK+CL ++   RP+
Sbjct: 234 FAGM---RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 10/211 (4%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V K       ++  +K     +      Q I E+ +L + N   IV   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                  +  E +  G+L Q +    E   I  E+L ++++ V   L YL     I   H
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQI--MH 127

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+K +NIL++ +   K+ DFG S   ++D   +     GT  Y+ PE  Q + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 503 VYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           ++S G+ LVE+  G+ PI   +  E +++ G
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 21/220 (9%)

Query: 324 ILGQGGQGTVYKGMLTDG-----RIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNI 375
           +L +G  G ++ G+L D        V VK   + D   E  V   + E  +L  ++H+NI
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 376 VKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGAL 429
           + +L  C+E  E P ++Y ++  G L  ++             ++ + L+ +A++++  +
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVD 488
            YLH      + H+DI + N ++D++ + K++D   SR +     H L         ++ 
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
            E   + +++  SDV+SFGV+L E++T GQ P   I+  E
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 65/251 (25%), Positives = 99/251 (39%), Gaps = 59/251 (23%)

Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQ 369
              +Y     LG+G  G VYK   +  GR+VA+KK  + +E   + F    + E+ IL +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63

Query: 370 INHRNIVKLLGCCLE-----TEVPLLVYEFIP------NGTLYQYIHNQIEEFPITWELL 418
           + H N+V L+   +E           VY   P      +G L     N            
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL----ENP----------- 108

Query: 419 LRIAVEVSGA----------LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
             + +  S            + YLH      I HRDIK+ANIL+D++   K++DFG +R 
Sbjct: 109 -SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 469 VMVDQTHLTTKVQG----------TFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
                 +      G          T  Y  PE      ++T   D++  G V  E+ T  
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223

Query: 518 KPIRAINTDED 528
           +PI    +D D
Sbjct: 224 RPILQGKSDID 234

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 14/210 (6%)

Query: 329 GQGTVYKGML----TDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGCC 382
           G+G+  K +L     DG+   +K+  +   +  E  +   EV +LS + H NIV+     
Sbjct: 9   GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            E     +V ++   G LY+ I+ Q        + +L   V++  AL ++H      I H
Sbjct: 69  EENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILH 124

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NI L      K+ DFG +R V+     L     GT  Y+ PE  ++  +  KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183

Query: 503 VYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
           +++ G VL E+ T +    A N    K+LV
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNM---KNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 26/203 (12%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  G VYK      G +VA+KK +L  ET       I E+ +L ++NH NIVKLL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 382 CLETEVPL-LVYEFIPNGTLYQYIH-NQIEEFPI------TWELLLRIAVEVSGALFYLH 433
            + TE  L LV+EF+ +  L +++  + +   P+       ++LL  +A        + H
Sbjct: 68  -IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--------FCH 117

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           S   +   HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 118 SHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173

Query: 494 SSQF-TEKSDVYSFGVVLVEILT 515
             ++ +   D++S G +  E++T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQI 370
           ++N   +LG+G  G V   ML + +       I  +KK  ++ + +VE  + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 371 NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSG 427
                +  L  C +T   L  V E++  G L  +I  Q+ +F  P      +  A E++ 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHA----VFYAAEIAI 112

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGY 486
            LF+LHS     I +RD+K  N++LD +   K++DFG  +  +      TT+   GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDY 167

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           + PE      + +  D ++FGV+L E+L GQ P    + DE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)

Query: 323 RILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           ++LG+G  G V   ML + +       I  +KK  ++ + +V+  + E  IL+       
Sbjct: 1   KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57

Query: 376 VKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLH 433
           +  L CC +T+  L  V E++  G L      QI+      E   R  A EV+ AL +LH
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLM----FQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
               I   +RD+K  NILLD +   K++DFG  +  +++    TT   GT  Y+ PE  Q
Sbjct: 114 RHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQ 169

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             ++    D ++ GV++ E++ GQ P  A N D+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 44/219 (20%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQI-NHRNIVKLLG 380
           LG+G  G V+K +      +VA+KK      + T+ ++   E++ L ++ +H NIVKLL 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 381 C--------------CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
                           +ET++    +  I    L + +H +     I ++LL        
Sbjct: 75  VIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKRY----IMYQLL-------- 117

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ----G 482
            AL Y+HS   I   HRD+K +NILL+   R K++DFG +RS+   + +    V      
Sbjct: 118 KALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 483 TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           T  Y  PE    S+++T+  D++S G +L E+L G KP+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 10/200 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNV-EQFINEVVILSQINHRNIVKLLGC 381
           +G+G  G VYKG     G+IVA+KK +L  +E  V    I E+ +L ++ H NIV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
            ++     L++EF+ +  L +Y+ +  +   +  EL+     ++   + + HS     + 
Sbjct: 68  LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEK 500
           HRD+K  N+L+D+K   K++DFG +R+  +     T +V  T  Y  PE    S  ++  
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182

Query: 501 SDVYSFGVVLVEILTGQKPI 520
            D++S G +  E+ T +KP+
Sbjct: 183 VDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 14/211 (6%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKLLG 380
           LG+GG G V    +   G++ A KK   K + +   EQ  +NE  IL +++ R IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASI 438
              ET+  L LV   +  G L  +I+N  E  FP    +    A ++   L +LH     
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQRR-- 115

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            I +RD+K  N+LLDD    ++SD G +  +   +        GT GY+ PE  Q   + 
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172

Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
              D ++ G  L E++ G+ P R      +K
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 78.5 bits (193), Expect = 9e-16
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 318 NYNANRILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR 373
           ++N   +LG+G  G V     KG      I  +KK  ++ + +VE  + E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 374 NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L  C +T   L  V E++  G L   I  Q+  F     +    A E++  LF+L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFY--AAEIAIGLFFL 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEY 491
           HS     I +RD+K  N++LD +   K++DFG  +  M D   +TTK   GT  Y+ PE 
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEI 172

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
                + +  D ++FGV+L E+L GQ P    + DE
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 35/230 (15%)

Query: 312 LEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           L   T  +    ++G+G  G VYK      G++VA+K   ++ E   E+   E  IL + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 371 -NHRNIVKLLGCCLETEVPL------LVYEFIPNGT---LYQYIHNQIEEFPITWELLLR 420
            NH NI    G  ++   P       LV E    G+   L + +  + +   +  E +  
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           I  E    L YLH    I   HRDIK  NILL      K+ DFG S         L + +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTL 167

Query: 481 Q------GTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKP 519
                  GT  ++ PE     +     +  +SDV+S G+  +E+  G+ P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 18/218 (8%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQI 370
           ++N   +LG+G  G V   ML + +       I  +KK  ++ + +VE  + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 371 NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +    +  L  C +T   L  V E++  G L  +I  Q+ +F     +    A E+S  L
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGL 114

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           F+LH      I +RD+K  N++LD +   K++DFG  +  MVD    T    GT  Y+ P
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAP 170

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E      + +  D +++GV+L E+L GQ P    + DE
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  G VYK      G IVA+KK +L  E        I E+ +L ++NH NIV+LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                   LV+EF+ +  L +Y+ +      +   L+     ++   + Y HS     + 
Sbjct: 67  VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 500
           HRD+K  N+L+D +   K++DFG +R+  V     T +V  T  Y  PE    S Q++  
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180

Query: 501 SDVYSFGVVLVEILTGQKPI 520
            D++S G +  E++  ++P+
Sbjct: 181 VDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 49/234 (20%)

Query: 322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV----DETNVEQFIN----------EVVI 366
              LG+G  G V K   T  G+IVA+KK K++    D T   Q +           E+ I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI-----EEFPITWELLLRI 421
           +++I H NI+ L+   +E +   LV + I    L + +  +I     +   I  ++L  +
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS----VMVDQT--- 474
            V        LH        HRD+  ANI ++ K   K++DFG +R        D     
Sbjct: 133 NV--------LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 475 -------HLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
                   +T+KV  T  Y  PE    + ++    D++S G +  E+LTG KP+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVK--KSKLVDETNVEQFI-NEVVILSQINHRNIVKLLG 380
           LG GG G V    + +  R  A+K  K + + ET  ++ I +E  IL + NH  IVKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
              + +   ++ E+   G L+  +      +E    +     IA  V  A  YLH+    
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIACVVL-AFEYLHN---R 112

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            I +RD+K  N+LLD     K+ DFG ++ +   Q   T    GT  YV PE   +  + 
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYD 170

Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTD 526
              D +S G++L E+LTG+ P    + D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 44/303 (14%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILS 368
           D EK  +       LG G  G V K +    G I+A K   L +      Q I E+ +L 
Sbjct: 2   DFEKLGE-------LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH 54

Query: 369 QINHRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEV 425
           + N   IV   G    + E+ + + E +  G+L Q +    +I E      +L +I++ V
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE-----NILGKISIAV 108

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L YL     I   HRD+K +NIL++ +   K+ DFG S   ++D   +     GT  
Sbjct: 109 LRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANSFVGTRS 163

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-- 543
           Y+ PE  Q + +T +SD++S G+ LVE+  G+ PI   +  E +++ G  +         
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223

Query: 544 ---------------LFEALDARVLKEAKK--EEIMT--VATLAKRCLNLNGKMRPTMKE 584
                          +FE LD  V +   K      +        +CL  N K R  +KE
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283

Query: 585 VTN 587
           +T 
Sbjct: 284 LTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 72/237 (30%), Positives = 116/237 (48%), Gaps = 30/237 (12%)

Query: 324 ILGQGGQGTVYKGML-TDG-RI-VAVKKSK-LVDETNVEQFINEVVILSQIN-HRNIVKL 378
           ++G+G  G V K  +  DG R+  A+K+ K    + +   F  E+ +L ++  H NI+ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 425
           LG C       L  E+ P+G L  ++     +E  P           ++ + LL  A +V
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 483
           +  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V V +T     V+  
Sbjct: 134 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 188

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE--DKSLVGYFLQ 537
             ++  E    S +T  SDV+S+GV+L EI++ G  P   +   E  +K   GY L+
Sbjct: 189 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 16/212 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           ++LG+G  G V    L        I A+KK  ++++ +VE  + E  +L+       +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 379 LGCCLETEVPLL-VYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSA 435
           L C  +T+  L  V E++  G L  +I +  + +E    +      A E+   L +LH  
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKK 115

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
             I   +RD+K  N+LLD     K++DFG  +  M  +   +T   GT  Y+ PE  +  
Sbjct: 116 GII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           ++ E  D +SFGV+L E+L GQ P    + DE
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 36/264 (13%)

Query: 310 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           + L+   ++Y+  +++G+G  G V    +K   +  ++ A+K   K +++  ++   F  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           E  I++  N   +V+L  C  + +  L +V E++P G L   + N   + P  W      
Sbjct: 93  ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFY-- 147

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTT 478
             EV  AL  +HS   I   HRD+K  N+LLD     K++DFGT   + +D+T      T
Sbjct: 148 TAEVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDT 202

Query: 479 KVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
            V GT  Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG 
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGT 255

Query: 535 FLQAIN-ENRLFEALDARVLKEAK 557
           + + ++ +N L    D  + K AK
Sbjct: 256 YSKIMDHKNSLNFPEDVEISKHAK 279

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 25/271 (9%)

Query: 323 RILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           ++LG+G  G V+    KG      I A+KK  ++ + +VE  + E  +LS       +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 379 LGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L C  +T+  L  V E++  G L  +I +   +F +        A E+   L +LHS   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFY--AAEIICGLQFLHSKG- 116

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
             I +RD+K  NILLD     K++DFG  +  M+     T    GT  Y+ PE     ++
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173

Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL-KEA 556
               D +SFGV+L E+L GQ P    + +E         Q+I   R+      R L +EA
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSI---RMDNPCYPRWLTREA 223

Query: 557 KKEEIMTVATLAKRCLNLNGKMR--PTMKEV 585
           K   +       +R L + G +R  P  +E+
Sbjct: 224 KDILVKLFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 18/220 (8%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 378
           R+LG+GG G V    +   G++ A KK   K + +   E   +NE  IL ++N R +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAA 436
                ET+  L LV   +  G L  +I++  E  F     +    A E+   L  LH   
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEICCGLEDLHQER 122

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I +RD+K  NILLDD    ++SD G +  V   QT +  +V GT GY+ PE  ++ +
Sbjct: 123 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 177

Query: 497 FTEKSDVYSFGVVLVEILTGQKPI----RAINTDEDKSLV 532
           +T   D ++ G +L E++ GQ P     + I  +E + LV
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 378
           R+LG+GG G V    +   G++ A K+   K + +   E   +NE  IL ++N + +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLHS 434
                  +   LV   +  G L  +I+N      EE     E  L  A E+   L  LH 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-----ERALFYAAEILCGLEDLHR 120

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
             ++   +RD+K  NILLDD    ++SD G +  V + +        GT GY+ PE   +
Sbjct: 121 ENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            ++T   D +  G ++ E++ GQ P R 
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 74/243 (30%), Positives = 115/243 (47%), Gaps = 49/243 (20%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV- 352
           S++ S     K  +  +LE+       NRI G G  GTVYK +    GR+ A+K    V 
Sbjct: 61  SASGSAPSAAKSLS--ELERV------NRI-GSGAGGTVYKVIHRPTGRLYALK----VI 107

Query: 353 ----DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EVPLLVYEFIPNGTLYQY 403
               ++T   Q   E+ IL  +NH N+VK    C +      E+ +L+ EF+  G+L + 
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL-EG 161

Query: 404 IHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 463
            H   E+F      L  +A ++   + YLH      I HRDIK +N+L++     K++DF
Sbjct: 162 THIADEQF------LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADF 212

Query: 464 GTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEK-----SDVYSFGVVLVEILTG 516
           G SR  ++ QT     + V GT  Y+ PE   +            D++S GV ++E   G
Sbjct: 213 GVSR--ILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Query: 517 QKP 519
           + P
Sbjct: 270 RFP 272

Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 81/244 (33%), Positives = 117/244 (47%), Gaps = 42/244 (17%)

Query: 319 YNANRILGQGGQGTV-YKGMLTDGRIVAVKKSKLVD-ETNVEQFIN----EVVILSQINH 372
           Y  +R+LG G  GTV     ++DG   AVK   +VD E   E   N    EV  L   + 
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDF 90

Query: 373 RNIVKLLGCCLE------------TEVPLLVYEFIPNGTLYQYIHNQIEE---FPITWEL 417
            +IVK    C E              +  LV ++   G L Q I ++ +    F      
Sbjct: 91  FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 477
           LL I V +  A+ ++HS   I   HRDIKSANILL      K+ DFG S+  M   T ++
Sbjct: 147 LLFIQVLL--AVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSK--MYAAT-VS 198

Query: 478 TKVQGTFG----YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSL 531
             V  TF     YV PE ++   +++K+D++S GV+L E+LT ++P    N +E   K+L
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258

Query: 532 VGYF 535
            G +
Sbjct: 259 AGRY 262

Length = 496

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 22/257 (8%)

Query: 310 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 365
           +DL    ++Y   +++G+G  G V    +K       +  + K +++  ++   F  E  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I++  N   +V+L     +     +V E++P G L   + N   + P  W        EV
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFY--TAEV 151

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  +HS   I   HRD+K  N+LLD     K++DFGT   +  +         GT  
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 486 YVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN- 540
           Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + +N 
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 262

Query: 541 ENRLFEALDARVLKEAK 557
           +N L    D  + KEAK
Sbjct: 263 KNSLTFPDDNDISKEAK 279

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 76.4 bits (188), Expect = 5e-15
 Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 27/245 (11%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL--- 378
           R LG G  G V+  + +D  + VAVKK  L D  +V+  + E+ I+ +++H NIVK+   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 379 -----------LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
                      +G   E     +V E++        + N +E+ P++ E       ++  
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125

Query: 428 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQG--TF 484
            L Y+HSA  +   HRD+K AN+ ++ +    K+ DFG +R V    +H     +G  T 
Sbjct: 126 GLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 485 GYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 543
            Y  P      + +T+  D+++ G +  E+LTG+      +  E   L+   +  + E  
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 544 LFEAL 548
             E L
Sbjct: 243 RNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKK-SKLVDE-TNVEQFINEVVILSQINHR 373
             Y     +G G  G V   + T  G+ VA+KK     D  T  ++ + E+ IL    H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 374 NIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIH-NQIEEFPITWEL-------LLR 420
           NI+ +    L           +V + + +  L+  IH +Q    P+T E        LLR
Sbjct: 65  NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ----PLTEEHIRYFLYQLLR 118

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLT 477
                   L Y+HSA    + HRD+K +N+L+++    ++ DFG +R +     +  +  
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168

Query: 478 TKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           T+   T  Y  PE      ++T   D++S G +  E+L G++ +
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 37/273 (13%)

Query: 323 RILGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFI--NEVVILSQINHRNIVKLL 379
           R++G+G  G V      TDG+   +KK  L + +  E+     E  +LSQ+ H NIV   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 380 GCCLETEVPLL--VYEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYL 432
               E E  LL  V  F   G LY  +  Q      E   + W       V+++ AL YL
Sbjct: 66  ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      I HRD+K+ N+ L      KV D G +R V+ +Q  + + + GT  Y+ PE F
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELF 174

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
            +  +  KSDV++ G  + E+ T +    A N  +  SLV          R+ E     +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSLV---------YRIIEGKLPPM 222

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            K+   E    +  L    L+   + RP++K +
Sbjct: 223 PKDYSPE----LGELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)

Query: 324 ILGQGGQGTVYKGMLT-DGRIV--AVKKSK-LVDETNVEQFINEVVILSQINHR-NIVKL 378
           ++G+G  G V K  +  DG  +  A+K+ K    + +   F  E+ +L ++ H  NI+ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 425
           LG C       L  E+ P+G L  ++     +E  P           ++ + LL  A +V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 483
           +  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V V +T     V+  
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 542
             ++  E    S +T  SDV+S+GV+L EI++ G  P   +   E               
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------------- 219

Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
            L+E L      E        V  L ++C       RP+  ++   L 
Sbjct: 220 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNV-EQFINEVVILSQINHR 373
           D Y     +G+G  G VYK      G++VA+KK++L +DE  +    + E+ +L  ++  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 374 N-IVKLLGCCLETEVPL------LVYEFIPNGTLYQYI-------HNQIEEFPI---TWE 416
             IV+LL      E         LV+E++ +  L +++          +    I    ++
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH 475
           LL  +A        + H      + HRD+K  N+L+D  K   K++D G  R+  +    
Sbjct: 119 LLKGVA--------HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167

Query: 476 LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            T ++  T  Y  PE    S+ ++   D++S G +  E+   Q
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G G  G VYK   +  G + A+K  KL    +      E++++    H NIV   G  L
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
             +   +  EF   G+L    H      P++   +  ++ E    L+YLHS   +   HR
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKM---HR 130

Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF---QSSQFTEK 500
           DIK ANILL D    K++DFG S  +        + + GT  ++ PE     +   + + 
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQL 189

Query: 501 SDVYSFGVVLVEILTGQKPI 520
            D+++ G+  +E+   Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 325 LGQGGQGTVYK-GMLTDGRIVAVKK---SKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG G V    M   G++ A KK    +L      E  + E  IL++++ R IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSAAS 437
              +T+  L LV   +  G L  +I+N  EE P   E       A  +SG L +LH    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG-LEHLHQRR- 117

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
             I +RD+K  N+LLD+    ++SD G +  +   Q+  T    GT G++ PE  Q  ++
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174

Query: 498 TEKSDVYSFGVVLVEILTGQKPIRA 522
               D ++ GV L E++  + P RA
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 70/252 (27%), Positives = 109/252 (43%), Gaps = 49/252 (19%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF---INEVVILSQINHRNIVKLLG 380
           +G G  G VY         +VAVKK     +   E++   I EV  L Q+ H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 381 CCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGAL---FYLHSA 435
           C L+     LV E+ + + +    +H + ++E        + IA    GAL    YLHS 
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAITHGALQGLAYLHSH 140

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY---F 492
             I   HRDIK+ NILL +  + K++DFG++       + +     GT  ++ PE     
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN---------------------TDEDKSL 531
              Q+  K DV+S G+  +E+   + P+  +N                     TD  +  
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252

Query: 532 VGYFLQAINENR 543
           V Y LQ I + R
Sbjct: 253 VDYCLQKIPQER 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 35/237 (14%)

Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVKKSKLVDETNVE 358
           E  +LF  +D EK    +   R +G G  G VY     D R   +VA+KK     + + E
Sbjct: 13  EIAELFFKEDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNE 67

Query: 359 QF---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPI 413
           ++   I EV  L +I H N ++  GC L      LV E+ + + +    +H + ++E   
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--- 124

Query: 414 TWELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
                + IA    GAL    YLHS   I   HRDIK+ NILL +  + K++DFG++    
Sbjct: 125 -----VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIAS 176

Query: 471 VDQTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
              + +     GT  ++ PE        Q+  K DV+S G+  +E+   + P+  +N
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 10/223 (4%)

Query: 313 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 370
           E   D++     LG G  G V+K      G I+A K   L  +  +  Q I E+ +L + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YL     I   HRD+K +NIL++ +   K+ DFG S   ++D   +     GT  Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPE 172

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
             Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG 215

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 28/214 (13%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           +GQGG G V+     D G IVA+K   KS L     V   + E  IL+      +VKLL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL-------H 433
              + E   L  E++P G     ++N            L +  E   A FY+        
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNN------------LGVLSEDH-ARFYMAEMFEAVD 115

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           +   +   HRD+K  N L+D     K++DFG S+ ++         V G+  Y+ PE  +
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGSPDYMAPEVLR 171

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
              +    D +S G +L E L G  P      +E
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 26/260 (10%)

Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVV 365
             L    ++++  +++G+G  G V        + V A+K   K +++  ++   F  E  
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
           I++  N   IV+L     + +  L +V E++P G L   + N   + P  W        E
Sbjct: 96  IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFY--TAE 150

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGT 483
           V  AL  +HS   I   HRD+K  N+LLD     K++DFGT   +  +      T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206

Query: 484 FGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
             Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIM 260

Query: 540 N-ENRLFEALDARVLKEAKK 558
           + +N L    D  + K+AK 
Sbjct: 261 DHKNSLTFPDDIEISKQAKD 280

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG G  G VYK    + G + A K  +   E  +E ++ E+ IL+  NH  IVKLLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 384 ETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                 ++ EF P G    +   +   + E  I  +++ R  +E   AL YLHS   + I
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLE---ALQYLHS---MKI 131

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY-----FQSS 495
            HRD+K+ N+LL      K++DFG S +  V          GT  ++ PE       + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            +  K+D++S G+ L+E+   + P   +N
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELN 219

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 378
           R+LG+GG G V    +   G++ A KK   K + +   E   +NE  IL ++N R +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLH 433
                ET+  L LV   +  G L  +I+N      +E     E  +  A E++  L  LH
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----ERAVFYAAEITCGLEDLH 119

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I +RD+K  NILLDD    ++SD G +  +   +T +  +V GT GY+ PE  +
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           + ++T   D +  G ++ E++ G+ P R 
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 30/205 (14%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV-EQFINEVV-------ILSQINHRNIV 376
           LG+G  GTVY  ++ D + VA ++ K++ E  V E   NE V       +LS+++H  IV
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 377 KLLGCCLETEVPLLVYEFIPNGTL----YQYIHNQIEEFP----ITWELLLRIAVEVSGA 428
           K     LE +   ++ E+     L     +  H   +         W + L + V     
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVH---- 120

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             Y+H      I HRD+K+ NI L +    K+ DFG SR +M     L T   GT  Y+ 
Sbjct: 121 --YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMS 173

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEI 513
           PE  +   +  KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 330 QGTVYKGMLTDGRIVA--VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 387
            G  ++GM +  R+V   ++ S   DE     F+ EV    ++NH N+++ LG C+E+  
Sbjct: 13  LGEAHRGM-SKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIP 69

Query: 388 PLLVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSAASIPIYHRDI 445
            LLV EF P G L  Y+ +         +  +L R+A EV+  L +LH A  I   H D+
Sbjct: 70  YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126

Query: 446 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQ------- 496
              N  L      K+ D+G +      + +  TK        ++ PE  +          
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185

Query: 497 FTEKSDVYSFGVVLVEILT-GQKP 519
            T+KS+++S GV + E+ T   +P
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 26/220 (11%)

Query: 325 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN---HRNI 375
           +G+G  G V+K   +   GR VA+K+ ++  +T  E      I EV +L  +    H N+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 376 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           V+L   C       ET++ L V+E + +  L  Y+ +++ E  +  E +  +  ++   L
Sbjct: 67  VRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGL 123

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            +LHS     + HRD+K  NIL+    + K++DFG +R  +       T V  T  Y  P
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAP 178

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           E    S +    D++S G +  E+   +KP+   ++D D+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 53/186 (28%), Positives = 77/186 (41%), Gaps = 12/186 (6%)

Query: 343 IVAVKKSKLVDETNVEQFINEVVIL-SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           I  +KKS ++ +  V     E  I+  Q     + KL       +   LV E++  G   
Sbjct: 26  IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85

Query: 402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 461
             I   +   P  W    +   EV   +  LH      I HRDIK  N+L+D     K++
Sbjct: 86  SLI-KTLGGLPEDW--AKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLT 139

Query: 462 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
           DFG SR+ + ++     K  GT  Y+ PE        + SD +S G V+ E L G  P  
Sbjct: 140 DFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Query: 522 AINTDE 527
           A   D 
Sbjct: 195 AETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 7e-14
 Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 52/242 (21%)

Query: 317 DNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D++   +++G+G  G V+       G++ A+K   KS ++    +     E  IL+  + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY--IHNQIEE----FPITWELLLRIAVEV 425
             IVKL     + E  L LV E++P G L       +   E    F I  EL+L      
Sbjct: 61  PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVL------ 112

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS--------RSVMVDQTHLT 477
             AL  +H    I   HRDIK  NIL+D     K++DFG          R   ++ +H  
Sbjct: 113 --ALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 478 TK--------------------VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
                                   GT  Y+ PE  + + +  + D +S GV+L E+L G 
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Query: 518 KP 519
            P
Sbjct: 228 PP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)

Query: 317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRN 374
           D+Y     LG+G   TVYKG    +G++VA+K  +L +E       I E  +L  + H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLH 433
           IV L       E   LV+E++ +  L QY+        P   +L L    ++   L Y+H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YF 492
                 I HRD+K  N+L+ D    K++DFG +R+  V  +H  +    T  Y  P+   
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176

Query: 493 QSSQFTEKSDVYSFGVVLVEILTG 516
            S++++   D++  G + VE++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 380
           +         + K   T   +VAVKK  L    + +++    E++   Q+ H NI+  + 
Sbjct: 8   KCFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLR-IAVEVSGALFYLHSAASI 438
             +      +V   +  G+    +     E  P   EL +  I  +V  AL Y+HS   I
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKGFI 123

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRS---------VMVDQTHLTTKVQGTFGYVDP 489
              HR +K+++ILL    +  +S    S S         V+ D    + K      ++ P
Sbjct: 124 ---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSP 177

Query: 490 EYFQSS--QFTEKSDVYSFGVVLVEILTGQKP 519
           E  Q +   + EKSD+YS G+   E+  G  P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 41/287 (14%)

Query: 325 LGQGGQGTVYKGML---TDG---RIVAVKKSKLVDETNV-EQFINEVVILSQINHRNIVK 377
           LG+   G VYKG L     G   + VA+K  K   E  + E+F +E ++ S++ H NIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI----EEFPITWEL----LLRIAVE 424
           LLG   + +   +++ +  +  L++++     H+ +    ++  +   L     + I  +
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGT 483
           ++  + +L S     + H+D+ + N+L+ DK   K+SD G  R V   D   L       
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 542
             ++ PE     +F+  SD++S+GVVL E+ + G +P             GY  Q +   
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------YCGYSNQDV--- 235

Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
              E +  R +     +    V TL   C N     RP  K++ + L
Sbjct: 236 --IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 16/230 (6%)

Query: 323 RILGQGGQGTVYKGML--TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           R++G+G    V    L  T+ RI A   VKK  + D+ +++    E  +  Q ++   + 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 378 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            L  C +TE  L  V E++  G L  ++  Q  + P   E     + E+S AL YLH   
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYSAEISLALNYLHERG 116

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE  +   
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFCGTPNYIAPEILRGED 172

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 544
           +    D ++ GV++ E++ G+ P   + + +  D++   Y  Q I E ++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 31/235 (13%)

Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF 360
           +  +LF   D EK   +    R +G G  G VY    + +  +VA+KK     + + E++
Sbjct: 3   DVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 361 ---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITW 415
              I EV  L ++ H N ++  GC L      LV E+ + + +    +H + ++E     
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE----- 114

Query: 416 ELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
              + IA    GAL    YLHS   I   HRD+K+ NILL +    K+ DFG S S+M  
Sbjct: 115 ---VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG-SASIMAP 167

Query: 473 QTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                    GT  ++ PE        Q+  K DV+S G+  +E+   + P+  +N
Sbjct: 168 ANXFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)

Query: 324 ILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQIN---HR 373
           +LG+G  G V   +L + +       I A+KK  ++    VE  + E  I    N   H 
Sbjct: 6   VLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 374 NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            +V L   C +TE  +  V E+   G L  +IH  +   P      +  A  V   L YL
Sbjct: 63  FLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA----VFYAACVVLGLQYL 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEY 491
           H      I +RD+K  N+LLD +   K++DFG  +  M       T+   GT  ++ PE 
Sbjct: 118 HENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
              + +T   D +  GV++ E+L G+ P    + +E
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G G  G VYK   L  G + AVK  KL    +      E+ ++ +  H NIV   G  L
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 384 ETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             E   +  E+   G+L    H    + E  I +     +  E    L YLHS   +   
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQGLAYLHSKGKM--- 128

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF---QSSQFT 498
           HRDIK ANILL D    K++DFG +  +        + + GT  ++ PE     ++  + 
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187

Query: 499 EKSDVYSFGVVLVEILTGQKPI 520
           +  D+++ G+  +E+   Q P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGC 381
           LG G  G VYK    +  ++A   +K++D   E  +E ++ E+ IL+  +H NIVKLL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                   ++ EF   G +   +  ++E  P+T   +  +  +   AL YLH      I 
Sbjct: 71  FYYENNLWILIEFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLHENK---II 125

Query: 442 HRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           HRD+K+ NIL       K++DFG S    R++    + + T        V  E  +   +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAIN 524
             K+DV+S G+ L+E+   + P   +N
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 22/180 (12%)

Query: 346 VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 405
           +KK +++    V+    E  IL +++H  IV ++    +      + EF+  G L+ ++ 
Sbjct: 51  LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110

Query: 406 ------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
                 N + +F            E+  A  YLHS     I +RD+K  N+LLD+K   K
Sbjct: 111 KAGRFPNDVAKF---------YHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158

Query: 460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           V+DFG ++ V       T  + GT  Y+ PE  QS    +  D ++ GV+L E + G  P
Sbjct: 159 VTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 375
           Y   + +G G QG V     T  G  VAVKK      ++T+ ++   E+V+L  +NH+NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 376 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           + LL          E +   LV E + +  L Q IH +++   +++ LL ++   +    
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLCGIK--- 137

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            +LHSA    I HRD+K +NI++      K+ DFG +R+   +   + T    T  Y  P
Sbjct: 138 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAP 191

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTG 516
           E      + E  D++S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 28/219 (12%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKS----KLVDETN---VEQFINEVVILSQINHRNIV 376
           LGQG    ++KG+  + G    + K+    K++D+++    E F     ++SQ++H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
              G C+  +  ++V E++  G+L  Y+        I+W+  L +A +++ AL +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120

Query: 437 SIPIYHRDIKSANILL----DDKYRA----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
              + H ++ + N+LL    D K       K+SD G S +V+  +  L  ++     +V 
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI-LLERIP----WVP 172

Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTG-QKPIRAINT 525
           PE  ++ Q  +  +D +SFG  L EI +G  KP+ A+++
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 68/301 (22%), Positives = 129/301 (42%), Gaps = 37/301 (12%)

Query: 293 ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV--AVKKSK 350
           +     S I   K   S D+    D Y +  ++ +  Q ++YKG+  +  ++    KK  
Sbjct: 1   QNIITRSYINDIKCIESDDI----DKYTS-VLIKENDQNSIYKGIFNNKEVIIRTFKKFH 55

Query: 351 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL----LVYEFIPNGTLYQYIHN 406
              +  ++   NE+  L +I+  NI+K+ G  ++    L    L+ E+   G L + +  
Sbjct: 56  KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK 115

Query: 407 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 466
              E  ++++  L +A++    L+ L+   + P  ++++ S + L+ + Y+ K+   G  
Sbjct: 116 ---EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLE 170

Query: 467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           + +         K      Y   +      S++T K D+YS GVVL EI TG+ P   + 
Sbjct: 171 KILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226

Query: 525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
           T E   L+      IN+N     L      E K         + + C + +   RP +KE
Sbjct: 227 TKEIYDLI------INKNNS-LKLPLDCPLEIK--------CIVEACTSHDSIKRPNIKE 271

Query: 585 V 585
           +
Sbjct: 272 I 272

Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 378
           R+LG+GG G V    +   G++ A KK   K + +   E   +NE  IL ++N R +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYL 432
                ET+  L LV   +  G L  +I+N       E+  I +      A E+   L  L
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDL 118

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
                  I +RD+K  NILLDD+   ++SD G +  +   +T +  +V GT GY+ PE  
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVI 173

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
            + ++T   D +  G ++ E++ GQ P R
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 11/203 (5%)

Query: 323 RILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQ---FINEVVILSQINHRNIVK 377
           RILG G  G + +G   L   R + V    L    + +Q   F+ E + L Q +H NIV+
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G        ++V E++ NG L  ++     E  +    L+ +   ++  + YL     
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMGY 128

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           +   H+ + +  +L++     K+S F   +    +  + T   +    +  PE  Q   F
Sbjct: 129 V---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 498 TEKSDVYSFGVVLVEILT-GQKP 519
           +  SDV+SFG+V+ E+++ G++P
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.5 bits (178), Expect = 3e-13
 Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 36/234 (15%)

Query: 319 YNANRILGQGGQGTVYKGMLTD---GRIVAVKKSK--LVDETNV-EQFINEVVILSQINH 372
           Y+  R++G+GG G VY     D    R VA+KK +  L +   + ++F+ E  I + + H
Sbjct: 4   YDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL--------LLRIAVE 424
             IV +   C + +       +I   TL   + +  ++  ++ EL         L I  +
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT------ 478
           +   + Y+HS     + HRD+K  NILL       + D+G +    +++  L        
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 479 -----------KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
                      K+ GT  Y+ PE       +E +D+Y+ GV+L ++LT   P R
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Length = 932

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)

Query: 323 RILGQGGQGTVYKGMLT-DGRIVAVK--KSKLVDETNVEQFI--NEVVILSQINHRNIVK 377
           +++G+G  G V       DG+  AVK  + K+V     ++ I     V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 436
           L      TE    V +F+  G L+ ++  +   FP   E   R  A E++ AL YLHS  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFP---EPRARFYAAEIASALGYLHS-- 114

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
            I I +RD+K  NILLD +    ++DFG  +   + Q+  TT   GT  Y+ PE  +   
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           +    D +  G VL E+L G  P    +  E
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 40/213 (18%)

Query: 323 RILGQGGQGT---VYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN------- 371
           +ILG+ G+GT   V K      G+  A+K  K        + + +V  L +I        
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-----KHFKSLEQVNNLREIQALRRLSP 56

Query: 372 HRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAV 423
           H NI++L+    +  T    LV+E + +  LY+ I  +    P        ++LL     
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLK---- 111

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
               +L ++H      I+HRDIK  NIL+ D    K++DFG+ R +     +  T+   T
Sbjct: 112 ----SLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYIST 161

Query: 484 FGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILT 515
             Y  PE   +  +   K D+++ G V  EIL+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 323 RILGQGGQGTVYKGMLTDG----RIVAVK---KSKLV-DETNVEQFINEVVILSQINHRN 374
           ++LG+GG G V++     G    +I A+K   K+ +V ++ +      E  IL  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 375 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL 432
           IV L+    +T   L L+ E++  G L+      +E   I  E      + E+S AL +L
Sbjct: 62  IVDLI-YAFQTGGKLYLILEYLSGGELFM----HLEREGIFMEDTACFYLSEISLALEHL 116

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      I +RD+K  NILLD +   K++DFG  +  + + T +T    GT  Y+ PE  
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
             S   +  D +S G ++ ++LTG  P  A N
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)

Query: 318 NYNANRILGQGGQGTVY----KGMLTDGRIVAVK---KSKLVDET-NVEQFINEVVILSQ 369
           N+   R+LG G  G V+     G    G++ A+K   K+ +V +    E    E  +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 370 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSG 427
           +     +  L    +T+  L L+ +++  G L+ +++ Q E F    E  +R+ + E+  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIVL 116

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           AL +LH    + I +RDIK  NILLD +    ++DFG S+  + ++        GT  Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 488 DPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  +  S    +  D +S GV+  E+LTG  P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 15/220 (6%)

Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRI--VAVK---KSKLVDETNVEQFIN 362
             +  +   +++N  R LG G  G V      +     VA+K   KSK++ +  V+   +
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E  IL+ INH   V L G   +     LV EF+  G  + ++    + FP   ++    A
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPN--DVGCFYA 137

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++     YL    S+ I +RD+K  N+LLD     K++DFG ++ V       T  + G
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCG 190

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           T  Y+ PE   +    + +D ++ G+ + EIL G  P  A
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230

Length = 340

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 47/292 (16%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKK-SKLVDETNVEQF-INEVVILSQINHRNIVKLLGC 381
           +G+G  G V+K    + G+IVA+KK  +  D+  +++  + E+ +L Q+ H N+V L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFP----------ITWELLLRIAVEVSGALFY 431
                   LV+E+  +  L     N++E+ P          I W+ L         A+ +
Sbjct: 69  FRRKRKLHLVFEYCDHTVL-----NELEKNPRGVPEHLIKKIIWQTLQ--------AVNF 115

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
            H    I   HRD+K  NIL+  + + K+ DFG +R +       T  V  T  Y  PE 
Sbjct: 116 CHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPEL 171

Query: 492 F-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK---------SLVGYFLQAINE 541
               +Q+    DV++ G V  E+LTGQ P+    +D D+          L+    Q  + 
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230

Query: 542 NRLFEAL-----DARVLKEAKKEEIMTVA-TLAKRCLNLNGKMRPTMKEVTN 587
           N+ F+ L     + R   E+K   I + A +  K CL ++   R + +E+  
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)

Query: 318 NYNANRILGQGGQGTVY---------KGMLTDGRIVA----VKKSKLVDETNVEQFINEV 364
           N+   ++LG G  G V+          G L   +++     V+K+K V+ T  E+     
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER----- 55

Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
            +L  +     +  L    +TE  L L+ +++  G ++ +++ Q + F    E  +R   
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYS 111

Query: 424 -EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            E+  AL +LH    + I +RDIK  NILLD +    ++DFG S+  + ++   T    G
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168

Query: 483 TFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKP 519
           T  Y+ PE  +      K+ D +S G+++ E+LTG  P
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 17/242 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           R++G+G    V    L     +     VKK  + D+ +++    E  +  Q +    +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L  C +T   L LV E++  G L  ++  Q  + P   E     A E+  AL +LH    
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYAAEICIALNFLHERG- 116

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
             I +RD+K  N+LLD     K++D+G  +   +     T+   GT  Y+ PE  +  ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-----RLFEALDARV 552
               D ++ GV++ E++ G+ P   I  + D +   Y  Q I E      R      + V
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233

Query: 553 LK 554
           LK
Sbjct: 234 LK 235

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 36/233 (15%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 371
             Y     +GQG  G V+K       +IVA+KK  + +E   E F    + E+ IL  + 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69

Query: 372 HRNIVKLLGCCLETEVP--------LLVYEFIPN---GTL-YQYIHNQIEEFPITWELLL 419
           H N+V L+  C     P         LV+EF  +   G L  + +   + E     ++LL
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV----DQTH 475
                 +G L+Y+H      I HRD+K+ANIL+      K++DFG +R+  +        
Sbjct: 130 ------NG-LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 476 LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            T +V  T  Y  PE       +    D++  G ++ E+ T + PI   NT++
Sbjct: 180 YTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQ 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 31/222 (13%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVIL---SQINHRNIV 376
           +G G  GTVYK      G  VA+K  ++  +TN +      + EV +L      +H NIV
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 377 KLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFP---ITWELLLRIAVEVSG 427
           +L+  C       ET+V L V+E +      Q +   +++ P   +  E +  +  +   
Sbjct: 66  RLMDVCATSRTDRETKVTL-VFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            L +LH+     I HRD+K  NIL+    + K++DFG +R +   Q  LT  V  T  Y 
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV-TLWYR 174

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            PE    S +    D++S G +  E+   +KP+   N++ D+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 12/202 (5%)

Query: 325 LGQGGQGTVYKGML-TDGRIVAVKK---SKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG G V    +   G++ A KK    +L  ++  +  + E  IL ++N   IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
              E++  L LV   +  G L  +I+N + E  +  E ++  + +++  + +LHS   + 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
           I +RD+K  N+LLDD+   ++SD G   +V +      T+  GT GY+ PE  +   ++ 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 500 KSDVYSFGVVLVEILTGQKPIR 521
             D ++ G  + E++ G+ P +
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 29/215 (13%)

Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLG 380
           ++G G  G VYKG  +  G++ A+K   +   +E  ++Q IN +   S  +HRNI    G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70

Query: 381 CCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
             ++   P       LV EF   G++   I N  +   +  E +  I  E+   L +LH 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPE 490
              I   HRDIK  N+LL +    K+ DFG S    R+V    T +     GT  ++ PE
Sbjct: 130 HKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 181

Query: 491 YFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 520
                +     +  KSD++S G+  +E+  G  P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 44/225 (19%)

Query: 317 DNYNA-NRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQI 370
           D Y   NRI  +G  G VY+      G IVA+KK K+  E   E F    + E+ IL ++
Sbjct: 5   DEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKL 61

Query: 371 NHRNIVKLLGCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPI------TWE 416
            H NIV +       EV +        +V E++ +  L   +    + F          +
Sbjct: 62  QHPNIVTV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQ 114

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
           LL  +A        +LH      I HRD+K++N+LL+++   K+ DFG +R         
Sbjct: 115 LLSGVA--------HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 477 TTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           T  V  T  Y  PE    + +++   D++S G +  E+LT +KP+
Sbjct: 164 TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 24/203 (11%)

Query: 325 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 381
           LG+G   TV+KG   LT   +VA+K+ +L  E       I EV +L  + H NIV L   
Sbjct: 13  LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 382 CLETEVPL-LVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGALFYLHSA 435
            + TE  L LV+E++ +  L QY+ N      +    I    LLR        L Y H  
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYCHKR 122

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 494
               I HRD+K  N+L+++K   K++DFG +R+  V     + +V  T  Y  P+    S
Sbjct: 123 K---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178

Query: 495 SQFTEKSDVYSFGVVLVEILTGQ 517
           ++++   D++  G +L E+ TG+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 91/371 (24%), Positives = 150/371 (40%), Gaps = 101/371 (27%)

Query: 296 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRI--VAVKKS 349
           +N + I+ T+L  ++  E   DN    + LG G  G V +    G+  +  +  VAVK  
Sbjct: 17  NNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML 76

Query: 350 KLVDETN-VEQFINEVVILSQI-NHRNIVKLLG--------------CCL---------- 383
           K    T+  E  ++E+ ILS +  H+NIV LLG              CC           
Sbjct: 77  KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Query: 384 -ETEV-PLLVYEFIPNGTL-YQYIHNQ------------------IEEFPIT-------- 414
            ET +  ++    I   +  Y+ I  +                  +E  P++        
Sbjct: 137 AETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196

Query: 415 ----------WEL----LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
                     W L    LLR + +V+  + +L S   I   HRD+ + N+LL D   AK+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKI 253

Query: 461 SDFGTSRSVMVDQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            DFG +R +M D  ++   V+G       ++ PE      +T +SDV+S+G++L EI + 
Sbjct: 254 CDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310

Query: 516 GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLN 575
           G+ P   I  +        F + +         D      A  E    + ++ K C NL 
Sbjct: 311 GKSPYPGILVNSK------FYKMVKRGYQMSRPDF-----APPE----IYSIMKMCWNLE 355

Query: 576 GKMRPTMKEVT 586
              RPT  +++
Sbjct: 356 PTERPTFSQIS 366

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 25/215 (11%)

Query: 325 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 381
           LG+G   TVYKG   LTD  +VA+K+ +L  E       I EV +L  + H NIV L   
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 382 CLETEVPL-LVYEFIPNGTLYQYIH---NQIEEFPITWEL--LLRIAVEVSGALFYLHSA 435
            + TE  L LV+E++ +  L QY+    N I    +   L  LLR        L Y H  
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR 123

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 494
               + HRD+K  N+L++++   K++DFG +R+  +     + +V  T  Y  P+    S
Sbjct: 124 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           + ++ + D++  G +  E+ TG +P+   +T E++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)

Query: 317 DNYNANRILGQG--GQGTVYKGMLTDGRIVA---VKKSKLVDETNVEQFINEVVILSQIN 371
            +++   ++G+G  G+  V +   T G I A   +KKS L+ +  V  F  E  ILS  N
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              I +L     + +   LV E+ P G L   ++   ++F            +   A FY
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF------------DEDMAQFY 107

Query: 432 L-------HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           L       HS   +   HRDIK  N+L+D     K++DFG++  +  ++   +    GT 
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 485 GYVDPEYFQSSQFTEKS------DVYSFGVVLVEILTGQKP 519
            Y+ PE   +     K       D +S GV+  E++ G+ P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 12/154 (7%)

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELLLR 420
           E ++L  +NH +++++    +   +  +V   +P  +  LY Y+  +    PI   L+  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI-- 161

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           I  ++   L YLH+     I HRD+K+ NI ++D  +  + D G ++  +V    L   +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GL 216

Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            GT     PE     ++  K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 16/227 (7%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVK--KSKLV-DETNVEQFINEVVILSQINHRNIVKL 378
           R++G+G    V    L    RI A+K  K +LV D+ +++    E  +    ++   +  
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 436
           L  C +TE  L  V EF+  G L  ++  Q  + P   E   R  + E+S AL +LH   
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNFLHERG 116

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE  +   
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGED 172

Query: 497 FTEKSDVYSFGVVLVEILTGQKP--IRAINTDEDKSLVGYFLQAINE 541
           +    D ++ GV++ E++ G+ P  I  ++ + D++   Y  Q I E
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG+G  G+VYK +    G  +A+K+ +L +DE+   Q I E+ IL +     IV   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                  +  E++  G+L +     +    I  ++L RI   V   L +L    +I   H
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTKVQGTFGYVDPEYFQS------ 494
           RD+K  N+L++   + K+ DFG S +++  + +T++     G   Y+ PE  +S      
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
             +T +SDV+S G+ ++E+  G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 16/212 (7%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINE-VVILSQINHRNIVK 377
           +++G+G  G V       DG+  AVK   K  ++ +   +  + E  V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRI-AVEVSGALFYLHSA 435
           L       +    V +++  G L+   H Q E  FP   E   R  A E++ AL YLHS 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
             + I +RD+K  NILLD +    ++DFG  +  + + +  T+   GT  Y+ PE  +  
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +    D +  G VL E+L G  P  + +T E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 325 LGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINEV-VILSQINHRNIVKLLG 380
           LG+G  G V K M     G I+AVK+ +  V+    ++ + ++ + +  ++    V   G
Sbjct: 9   LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 381 C---------CLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALF 430
                     C+E     L  +F        Y     I E     ++L +IAV +  AL 
Sbjct: 68  ALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPE-----DILGKIAVSIVKALE 117

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS  S+   HRD+K +N+L++   + K+ DFG S   +VD    T    G   Y+ PE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDA-GCKPYMAPE 173

Query: 491 YF----QSSQFTEKSDVYSFGVVLVEILTGQKP 519
                     +  KSDV+S G+ ++E+ TG+ P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)

Query: 318 NYNANRILGQGGQGTVY---------KGMLTDGRIVA----VKKSKLVDETNVEQFINEV 364
           N+   ++LG G  G V+          G L   +++     V+K+K  + T  E+     
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER----- 55

Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
            +L  I     +  L    +T+  L L+ ++I  G L+ ++ +Q E F    E+ +    
Sbjct: 56  QVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG- 112

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           E+  AL +LH    + I +RDIK  NILLD      ++DFG S+    D+        GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 484 FGYVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 519
             Y+ P+  +       +  D +S GV++ E+LTG  P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 32/217 (14%)

Query: 316 TDNYNANRILGQGGQGTV--YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQIN 371
           T+ Y   + +G G  G V   +  LT G+ VA+KK           ++   E+ +L  + 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 372 HRNIVKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           H NI+ L    +   E    V E +  GT    +H  +   P+  + +     ++   L 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGLK 122

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y+HSA  +   HRD+K +NIL+++    K+ DFG +R   +    +T       GYV   
Sbjct: 123 YVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVSTR 169

Query: 491 YFQSSQ-------FTEKSDVYSFGVVLVEILTGQKPI 520
           Y+++ +       +  + D++S G +  E+L G KP+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 21/212 (9%)

Query: 325 LGQGGQGTVYKGMLTDG-RIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V +    D  RI A+K   K+ +V  + V   + E  +L+Q+N   IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIH-----NQIEEFPITWELLLRIAVEVSGALFYLHSA 435
                E   LV  FI  G L+ ++      +       T ELL         AL  LH  
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC--------ALENLHK- 111

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               + +RD+K  NILLD +    + DFG  +  M D    T    GT  Y+ PE     
Sbjct: 112 --FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGH 168

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +T+  D ++ GV+L E+LTG  P    N +E
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 19/187 (10%)

Query: 344 VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY 403
           V  K   L DE       +E+  L+  +H  IVK        +  LL+ E+   G L + 
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155

Query: 404 IHNQIEEFPITWELLLRIAVEVSGALFY-----LHSAASIPIYHRDIKSANILLDDKYRA 458
           I  +++E        L       G LFY     L    S  + HRD+KSANI L      
Sbjct: 156 IKQRLKEH-------LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208

Query: 459 KVSDFGTSR----SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
           K+ DFG S+    SV +D   + +   GT  Y+ PE ++  ++++K+D++S GV+L E+L
Sbjct: 209 KLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Query: 515 TGQKPIR 521
           T  +P +
Sbjct: 266 TLHRPFK 272

Length = 478

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 36/221 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINH 372
           D Y     +G+G  G VYK    +T+   +A+KK +L   DE      I E+ +L ++ H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 373 RNIVKLLGCCLETEVPLLVYEFI-----------PNGTLYQYIHNQIEEFPITWELLLRI 421
            NIV+L       +   LV+E++           P+   +      I+ +   +++L  I
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD---FAKNPRLIKTY--LYQILRGI 115

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKV 480
           A        Y HS     + HRD+K  N+L+D +  A K++DFG +R+  +     T +V
Sbjct: 116 A--------YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV 164

Query: 481 QGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
             T  Y  PE    S  ++   D++S G +  E++  QKP+
Sbjct: 165 V-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)

Query: 325 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 381
           LG+G   TV+KG   LT+  +VA+K+ +L  E       I EV +L  + H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGALFYLHSAA 436
               +   LV+E++ +  L QY+ +      +    I    +LR        L Y H   
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR-------GLAYCHRRK 124

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSS 495
              + HRD+K  N+L++++   K++DFG +R+  V     + +V  T  Y  P+    SS
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           +++ + D++  G +  E+ +G +P+   +T ED+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 68/286 (23%), Positives = 126/286 (44%), Gaps = 49/286 (17%)

Query: 325 LGQGGQGTVYKGML---TDGRIVAVKKSKLV-------DETNVEQFINEVVILSQINHRN 374
           LGQG    +YKG+L   +D  IV   +   V       D  +   F     ++SQ++H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           +VKL G C+  E  ++V E++  G L  ++H +     + W   L +A +++ AL YL  
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 435 AASIPIYHRDIKSANILL-----DDKYR--AKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
              +   H ++   NIL+     ++ Y    K+SD G   +V+  +     +      ++
Sbjct: 120 KKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERIPWI 171

Query: 488 DPEYFQ--SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL 544
            PE  +   +  T  +D +SFG  L+EI + G++P+  +++ E +               
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--------------R 217

Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
           F   D   L      E+   A L  +C   +   RP+ + +  +L 
Sbjct: 218 FYQ-DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 69/251 (27%), Positives = 127/251 (50%), Gaps = 27/251 (10%)

Query: 282 FKRNGGLLLQQELS--SNESNIEKTKLFTSKDLEKATD-NYNANRILGQGGQGTVYKGML 338
           F+ N   L ++E S  +N    E  +     D+ ++ + +Y    I+G G  G VY+ + 
Sbjct: 28  FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87

Query: 339 TD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNIVKL-----LGCCLETEVPL-- 389
            D    VA+KK  L D     Q+ N E++I+  +NH NI+ L       C  + E  +  
Sbjct: 88  IDTSEKVAIKKV-LQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142

Query: 390 -LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKS 447
            +V EFIP  T+++Y+ +           L+++ + ++  AL Y+HS     I HRD+K 
Sbjct: 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198

Query: 448 ANILLDDK-YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYS 505
            N+L+D   +  K+ DFG++++++  Q  ++  +   F Y  PE    ++ +T   D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWS 256

Query: 506 FGVVLVEILTG 516
            G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267

Length = 440

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLG 380
            ++G G  G VYKG  +  G++ A+K    V E   E+   E+ +L + +H RNI    G
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 381 CCLETEVP------LLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLH 433
             ++   P       LV EF   G++   + N +       W  +  I  E+   L +LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLH 138

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDP 489
           +   I   HRDIK  N+LL +    K+ DFG S    R+V    T +     GT  ++ P
Sbjct: 139 AHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAP 190

Query: 490 EYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPI 520
           E         + +  +SD++S G+  +E+  G  P+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRN 374
             Y     +G+G  G V        G  VA+KK    +     Q  + E+ IL +  H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 375 IVKLLGC----CLET--EVPLLVYEFIPNGTLYQYIHNQ------IEEFPITWELLLRIA 422
           I+ +L        E+  +V  +V E +    LY+ I  Q      I+ F   +++L R  
Sbjct: 65  IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--LYQIL-R-- 117

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-----LT 477
                 L Y+HSA  +   HRD+K +N+LL+     K+ DFG +R    D  H     LT
Sbjct: 118 -----GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167

Query: 478 TKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
             V  T  Y  PE    S  +T+  D++S G +L E+L+  +P+
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRI-VAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           D Y     +G G  G V     T     VA+KK         + ++   E+ +L  ++H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 374 NIVKLLGC-----CLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           N++ LL        LE   +V  LV   +    L   +  Q     ++ + +  +  ++ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDV-YLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQIL 128

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             L Y+HSA    I HRD+K +NI +++    K+ DFG +R        +T  V  T  Y
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVA-TRWY 181

Query: 487 VDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
             PE       + +  D++S G ++ E+LTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 48/239 (20%)

Query: 324 ILGQGGQGT---VYKGML---TDGRIVAVKKSKLVDETNVEQF-------INEVVILSQI 370
           I G  G+GT   VYK       DG+  A+KK K     + EQ+         E+ +L ++
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK----GDKEQYTGISQSACREIALLREL 59

Query: 371 NHRNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIH----NQIEEFP------ITWELL 418
            H N+V L+   LE  +  + L++++  +  L+Q I      +    P      + W++L
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQT 474
                  +G + YLHS     + HRD+K ANIL+     ++   K+ D G +R       
Sbjct: 119 -------NG-VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 475 HLTT--KVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 530
            L     V  T  Y  PE    ++ +T+  D+++ G +  E+LT +   +       KS
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 20/181 (11%)

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 471
           P+T E L+  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 472 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
           D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+ 
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE- 284

Query: 530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                F       RL E    R  + A  E  +    L   C + N + RPT  E+   L
Sbjct: 285 -----FC-----RRLKEGTRMRAPEYATPE--IYSIMLD--CWHNNPEDRPTFSELVEIL 330

Query: 590 G 590
           G
Sbjct: 331 G 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)

Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           I+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++  +   ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 380 GCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSA 435
                   P     + + +  G L    H  + +  +  E  +R  A E+   L ++H+ 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS- 494
               + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ PE  Q  
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           + +   +D +S G +L ++L G  P R   T +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV-VILSQINHRNIVK 377
           +++G+G  G V       + +  AVK   K  ++ +   +  ++E  V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 436
           L       +    V ++I  G L+ ++  +        E   R  A E++ AL YLHS  
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS-- 114

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
            + I +RD+K  NILLD +    ++DFG  +   ++    T+   GT  Y+ PE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           +    D +  G VL E+L G  P  + NT E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 319 YNANRILGQGGQGTVYKG--MLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRN 374
           Y   + +G G QG V      +T    VA+KK      + T+ ++   E+V++  +NH+N
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 375 IVKLLGC-----CLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           I+ LL        LE   +V  LV E + +  L Q I   ++      E +  +  ++  
Sbjct: 77  IIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDH-----ERMSYLLYQMLC 129

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+       +T  V  T  Y 
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVV-TRYYR 184

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            PE      + E  D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)

Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 382
           LG+G   TVYKG+   +G++VA+K   +  E  V    I E  +L  + H NIV L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 383 LETEVPLLVYEFIPNGTLYQYI---------HNQIEEFPITWELLLRIAVEVSGALFYLH 433
              E    V+E++ +  L QY+         +N +  F      LLR        L Y+H
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN-VRLFMFQ---LLR-------GLAYIH 120

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYF 492
                 I HRD+K  N+L+      K++DFG +R+  +  QT+ +  V  T  Y  P+  
Sbjct: 121 GQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175

Query: 493 Q-SSQFTEKSDVYSFGVVLVEILTGQ 517
             ++ ++   D++  G + +E+L GQ
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 14/229 (6%)

Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFI 361
            + +   + L   TD +     +G+G  G VYK     DG + AVK    + + + E   
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67

Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEFPITWE 416
              ++ S  NH N+VK  G   + +  +     LV E    G++ + +   +       E
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
            +  I+  + GAL  L    +  I HRD+K  NILL  +   K+ DFG S  +   +   
Sbjct: 128 AM--ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 477 TTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 520
            T V GT  ++ PE     Q     +  + DV+S G+  +E+  G  P+
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETN-VEQF-INEVVILSQINHRNIVKLLGC 381
           +G+G  GTV+K    +   IVA+K+ +L D+   V    + E+ +L ++ H+NIV+L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 382 CLETEVPLLVYEFIPNGTLYQYI--------HNQIEEFPITWELLLRIAVEVSGALFYLH 433
               +   LV+E+  +  L +Y            ++ F   ++LL  +A        + H
Sbjct: 68  LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF--MFQLLKGLA--------FCH 116

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YF 492
           S     + HRD+K  N+L++     K++DFG +R+  +     + +V  T  Y  P+  F
Sbjct: 117 SHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            +  ++   D++S G +  E+    +P+
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 20/183 (10%)

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 471
            +T E L+  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 472 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
           D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+ 
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 290

Query: 530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                F +     RL E    R       E   T+      C +     RPT  E+   L
Sbjct: 291 -----FCR-----RLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 336

Query: 590 GGI 592
           G +
Sbjct: 337 GNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.6 bits (154), Expect = 9e-11
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++   +++ LL ++   +  
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLCGIK- 133

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
              +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 134 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++   +++ LL ++   +   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK-- 140

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
           PE      + E  D++S G ++ E++ G 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 68/267 (25%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  +++G+G  G V      D G+I A+K   KS++  +  +     E  +L++ + 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTL------YQYIHNQIEEFPITWELLLRIAVEVS 426
             +V L     + +   L+ EF+P G L      Y      +  F +  E +L I     
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEA--- 116

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS-------------------- 466
                +H    I   HRDIK  NIL+D     K+SDFG S                    
Sbjct: 117 -----VHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 467 --------RSVMVDQTHLT--TKVQ----------------GTFGYVDPEYFQSSQFTEK 500
                    SV VD  +LT  +K Q                GT  Y+ PE F    + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDE 527
            D +S G ++ E L G  P  + N+ E
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHE 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 17/232 (7%)

Query: 329 GQGTVYKGML----TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      G+  A   +KK  ++ +  V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E++  G L+ ++     E   + +       E+  AL YLHS     I 
Sbjct: 64  FQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IV 117

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  + + +    
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAV 176

Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
           D +  GVV+ E++ G+ P    N D +K      ++ I   R   A DA+ L
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEDIKFPRTLSA-DAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 38/225 (16%)

Query: 305 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVE-QFI 361
           KL T K L+K          LG+G   TVYKG   LT  ++VA+K+ +L  E       I
Sbjct: 3   KLETYKKLDK----------LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAI 51

Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--------HNQIEEFPI 413
            E  +L  + H NIV L       +   LV+E++ +  L QY+         + +  F  
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLF 110

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 473
               LLR        L Y H      + HRD+K  N+L+ ++   K++DFG +R+  V  
Sbjct: 111 Q---LLR-------GLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157

Query: 474 THLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
              + +V  T  Y  P+    S++++   D++  G +  E+ TG+
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 44/254 (17%)

Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEF 411
           E    Q + EV ++ ++ H+NIV+ +   L    +   ++ EF   G L + I    + F
Sbjct: 53  EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIP----IYHRDIKSANILLDDKYR--------- 457
             I    ++ I  ++  AL Y H+    P    + HRD+K  NI L    R         
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 458 --------AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFG 507
                   AK+ DFG S+++ ++   +     GT  Y  PE    ++  + +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 508 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATL 567
            ++ E+ +G+ P    N          F Q I+E +    L    +K   KE    +  L
Sbjct: 231 CIIYELCSGKTPFHKANN---------FSQLISELKRGPDLP---IKGKSKE----LNIL 274

Query: 568 AKRCLNLNGKMRPT 581
            K  LNL+ K RP+
Sbjct: 275 IKNLLNLSAKERPS 288

Length = 1021

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 71/256 (27%)

Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D++ + +++G+G  G V        G I A+K   KS+++++  V     E  IL++ ++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR--IAVEVSGAL 429
             +VKL     + E  L L+ E++P G +                LL++     E     
Sbjct: 61  PWVVKLY-YSFQDENYLYLIMEYLPGGDMMT--------------LLMKKDTFTE-EETR 104

Query: 430 FY-------LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ- 481
           FY       + S   +   HRDIK  N+LLD K   K+SDFG      + ++H T   + 
Sbjct: 105 FYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG--LKKSHRTEFYRI 162

Query: 482 --------------------------------------GTFGYVDPEYFQSSQFTEKSDV 503
                                                 GT  Y+ PE F  + + ++ D 
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Query: 504 YSFGVVLVEILTGQKP 519
           +S GV++ E+L G  P
Sbjct: 223 WSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 20/183 (10%)

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 471
           P+T E L+  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 226

Query: 472 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
           D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  +E+ 
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE- 285

Query: 530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                F Q + +     A +       +   IM        C   + K RPT   +   L
Sbjct: 286 -----FCQRLKDGTRMRAPE---NATPEIYRIML------ACWQGDPKERPTFSALVEIL 331

Query: 590 GGI 592
           G +
Sbjct: 332 GDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 38/223 (17%)

Query: 319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNI 375
           Y    ++G+G  G V   + T  G  VA+KK   V E  ++  + + E+ +L  + H +I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 376 VKLLGCCL-----ETEVPLLVYEFIPNGTLYQYI---------HNQIEEFPITWELLLRI 421
           V++    L     E +   +V+E +    L+Q I         H+Q   +      LLR 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQ-----LLR- 114

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD--QTHLTTK 479
                 AL Y+H+A    ++HRD+K  NIL +   + K+ DFG +R    D       T 
Sbjct: 115 ------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 480 VQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPI 520
              T  Y  PE   S  S++T   D++S G +  E+LTG KP+
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 37/239 (15%)

Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
           F     ++ Q++H++IV L G C+     ++V EF+  G L  ++H + +     W+   
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--F 108

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILL-----DDKYRA--KVSDFGTSRSVMVD 472
           ++A +++ AL YL     +   H ++ + NILL     D +     K+SD G   +V+  
Sbjct: 109 KVAKQLASALSYLEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEI-LTGQKPIRAINTDEDKS 530
           Q  +         ++ PE  + S+  +  +D +SFG  L EI   G+ P++      DK+
Sbjct: 166 QECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKT 214

Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           L         + R +E     V    K+     +A L   C+N +   RP  + +  ++
Sbjct: 215 L-------AEKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 325 LGQGGQGTVYKGMLTDGRIVA--VKKSKLVDETNVEQ--FINEVVILSQINHRNIVKLLG 380
           +G G  G V  G +  G   A  V K   V  +  EQ  F+ E      + H N+++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVEVSGALFYLHSAASI 438
            C E    LLV EF P G L  Y+ +  +   +T +   L R+A E++  L +LH    I
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRS-------VMVDQT---------HLTTKVQG 482
              H D+   N LL      K+ D+G S +       V  DQ           L  +V G
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
               VD         T++S+V+S GV + E+   G +P R ++ ++
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 52/232 (22%)

Query: 318 NYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNV-------EQFINEVVI 366
            Y   + LGQG  G V         ++   VA+KK      TNV       ++ + E+ +
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKI-----TNVFSKKILAKRALRELKL 54

Query: 367 LSQI-NHRNIVKLLGCCLETEVP-------LLVYEFIPNGTLYQYIHN--QIEEFPI--- 413
           L     H+NI     C  + ++        L +YE +    L+Q I +   + +      
Sbjct: 55  LRHFRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD- 472
            +++L          L Y+HSA  +   HRD+K  N+L++     K+ DFG +R    + 
Sbjct: 111 IYQILC--------GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENP 159

Query: 473 ---QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 520
                 +T  V  T  Y  PE   S Q +T+  DV+S G +L E+L G+KP+
Sbjct: 160 GENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 20/231 (8%)

Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFI 361
           KT +F S      +D +     +G+G  G V+K +   +G   AVK    + + + E+  
Sbjct: 6   KTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIE 62

Query: 362 NEVVILSQI-NHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITW 415
            E  IL  + +H N+VK  G   + +V       LV E    G++   +   ++      
Sbjct: 63  AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122

Query: 416 ELLLR-IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
           E ++  I  E    L +LH   +I   HRD+K  NILL  +   K+ DFG S  +   + 
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 475 HLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 520
              T V GT  ++ PE     Q     +  + DV+S G+  +E+  G  P+
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 329 GQGTVYKGML----TDGRIVAVK----KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           G+G+  K +L    +DG   AVK    K+ L  +          V+L  + H  +V L  
Sbjct: 4   GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIP 439
                E    V +++  G L+   H Q E      E   R  A EV+ A+ YLHS   + 
Sbjct: 64  SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
           I +RD+K  NILLD +    ++DFG  +  + +    T+   GT  Y+ PE  +   +  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 500 KSDVYSFGVVLVEILTGQKP 519
             D +  G VL E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 20/244 (8%)

Query: 329 GQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  ++ +  V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   T E       E+  AL YLHS     + 
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VV 117

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RDIK  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  + + +    
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176

Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EALDARVLKEAK 557
           D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L A +LK+  
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Query: 558 KEEI 561
           K+ +
Sbjct: 235 KQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 13/159 (8%)

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           ++ N +KL       +  +L+ ++I +G L+  +  +     ++   + +I  ++  AL 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALN 123

Query: 431 YLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            LH    I   H DIK  N+L D  K R  + D+G  + +     +      GT  Y  P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           E  +   +    D ++ GV+  E+LTG+ P +  + DE+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEE 213

Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 11/120 (9%)

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           +HS   +   HRDIK  N+LLD     +++DFG+   +  D T  ++   GT  Y+ PE 
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 492 FQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
            Q+      ++  + D +S GV + E+L G+ P  A      +SLV  + + +N    F+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ 228

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 19/213 (8%)

Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           I+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++  +   ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 380 GCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSA 435
                   P     + + +  G L    H  + +  +  E  +R  A E+   L ++H+ 
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ PE  Q  
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170

Query: 496 -QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             +   +D +S G +L ++L G  P R   T +
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 323 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVK 377
           R +G G  G V+   +TD   G+ VA+KK   V  +  + ++   E+ +L    H N++ 
Sbjct: 6   RPIGYGAFGVVWS--VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQY-IHNQI-EEFPITWELLLRIAVEVSGALFYLHSA 435
            L   L+        E      L Q  +H  I    P++ + +     ++   L YLHSA
Sbjct: 64  ALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQS 494
               I HRDIK  N+L++     K+ DFG +R    D++ H+T +V   + Y  PE    
Sbjct: 123 G---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMG 178

Query: 495 SQ-FTEKSDVYSFGVVLVEILTG------QKPIRAIN 524
           S+ +T   D++S G +  E+L        Q PI+ ++
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 14/163 (8%)

Query: 359 QFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHN---QIEEFP 412
           Q  NE++ L ++NH NI+K+   L     T +    Y+F     LY ++++     ++ P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +  +    I  ++  A+ Y+H    I   HRDIK  NI L+   +  + DFGT+     +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
           +        GT     PE      + E +D++S G++L+++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 11/110 (10%)

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQ 496
           HRDIK  NIL+D     +++DFG+   +M D T  ++   GT  Y+ PE  Q+      +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           +  + D +S GV + E+L G+ P  A      +SLV  + + +N    F+
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ 228

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 44/241 (18%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D++ + +++G+G  G V      D G I A+K   K+ ++++  V     E  IL + + 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +VK+     +     L+ EF+P G +   +   +++  ++ E       E   A+  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAI 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFG---------------------------- 464
           H    I   HRDIK  N+LLD K   K+SDFG                            
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 465 ------TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 518
                  + +   ++  L     GT  Y+ PE F  + + +  D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 519 P 519
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 73/266 (27%), Positives = 104/266 (39%), Gaps = 49/266 (18%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G VY+    D  RI A+K   K ++V +  V   I E         RNI   L 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE---------RNI---LV 48

Query: 381 CCLETEVPLLV---YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY------ 431
             L  E P +V   + F  +  LY  + + +    + W L          A FY      
Sbjct: 49  RTLLDESPFIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107

Query: 432 -LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
            L       I +RD+K  NILLD      + DFG S++ + D    T    GT  Y+ PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPE 166

Query: 491 -YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT--------------------DEDK 529
                  +T+  D +S GV++ E+  G  P  A +T                    DE +
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGR 226

Query: 530 SLVGYFLQAINENRLFEALDARVLKE 555
             V   L    ++RL    DA  LKE
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKE 252

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 29/217 (13%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
           EKAT  Y A +IL                     KK  +V +  V   + E  +L    H
Sbjct: 16  EKATGRYYAMKIL---------------------KKEVIVAKDEVAHTLTENRVLQNSRH 54

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   + +       E+  AL YL
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYL 111

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS  ++   +RD+K  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  
Sbjct: 112 HSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 168

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           + + +    D +  GVV+ E++ G+ P    N D +K
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEK 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 329 GQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      G+  A+K   K  ++ +  V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS     + 
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VV 117

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  + + +    
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176

Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHEK 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)

Query: 323 RILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           +++  G  G VY    K       +  + K  L+    ++Q   E  IL+   +  +V +
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
             C  ET+  L +V E++  G     + N I   P+  ++      E   AL YLH+   
Sbjct: 67  F-CSFETKRHLCMVMEYVEGGDCATLLKN-IGALPV--DMARMYFAETVLALEYLHNYG- 121

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT--------------HLTTKVQGT 483
             I HRD+K  N+L+      K++DFG S+  ++  T               L  +V GT
Sbjct: 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             Y+ PE      + +  D ++ G++L E L G  P
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 16/163 (9%)

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT--LYQYIHNQIEEFPITWELLLR 420
           E+ IL  I+HR I+ L+          +V   +P     L+ Y+       P+  E  + 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS---GPLPLEQAIT 189

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           I   +  AL YLH      I HRD+K+ NI LD+   A + DFG   +  +D    T + 
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQC 244

Query: 481 QGTFGYVD---PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            G  G ++   PE      +  K+D++S G+VL E+      +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 70/274 (25%), Positives = 108/274 (39%), Gaps = 65/274 (23%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           + LG G  G V      D   + A+K   K  +++   V     E  IL++ ++  +VKL
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYLHSAAS 437
                + +    V ++IP G +   +  ++E FP   E+L R  + E++ A+  +H    
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFP---EVLARFYIAELTLAIESVHKMGF 122

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFG--------------------------------- 464
           I   HRDIK  NIL+D     K++DFG                                 
Sbjct: 123 I---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 465 -------------TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 511
                          R+    Q  L   + GT  Y+ PE      +T+  D +S GV+L 
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 512 EILTGQKPIRAINTDEDKSLVGYFLQAIN-ENRL 544
           E+L GQ P  A    E +      L+ IN EN L
Sbjct: 240 EMLVGQPPFLAPTPTETQ------LKVINWENTL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 20/144 (13%)

Query: 428 ALFYL-------HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           A FYL        S   +   HRDIK  N+LLD     +++DFG+   ++ D T  +   
Sbjct: 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 481 QGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 535
            GT  Y+ PE  Q+      ++  + D +S GV + E+L G+ P  A      +SLV  +
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETY 217

Query: 536 LQAIN-ENRL-FEALDARVLKEAK 557
            + +N +    F      V +EAK
Sbjct: 218 GKIMNHKEHFQFPPDVTDVSEEAK 241

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 44/241 (18%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++ + +++G+G  G V      D G + A+K   K+ ++++  V     E  IL + + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +VK+     +     L+ EF+P G +   +   +++  +T E       E   A+  +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSI 117

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFG----------------TSRSVMVDQT-- 474
           H    I   HRDIK  N+LLD K   K+SDFG                 + S+  D T  
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 475 ----------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 518
                            L     GT  Y+ PE F  + + +  D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 519 P 519
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGC 381
           +G+G  G V     ++    VA+KK     +  ++  + + E+ +L  ++H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 382 CLET-----EVPLLVYEFIPNGTLYQYIH-NQIEEFPITWE-------LLLRIAVEVSGA 428
                        +VYE + +  L+Q I  +Q     ++ +        LLR        
Sbjct: 73  MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ----TLSDDHCQYFLYQLLR-------G 120

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           L Y+HSA    + HRD+K +N+LL+     K+ DFG +R+       +T  V  T  Y  
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176

Query: 489 PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           PE     S++T   DV+S G +  E+L G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 375
           Y + + +G G  G+V   +    G  VA+KK       E   ++   E+ +L  + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTL---YQYIHNQ-IEEFPITWELLLRIAVEVSGALFY 431
           + LL    +     +  +   +  L   Y     Q I   P++ + +  +  ++   L Y
Sbjct: 77  IGLL----DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           +HSA    I HRD+K  N+ +++    K+ DFG +R    + T          GYV   +
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRW 179

Query: 492 FQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
           +++ +       + +  D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           N+V L    +  +   LV +    G L+ +I   +    I  E + R A E+  AL  LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALH 102

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I  RD+   NILLDD+   +++ F   R   V+ +     V+    Y  PE   
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEVGG 155

Query: 494 SSQFTEKSDVYSFGVVLVEILTG 516
            S+ TE  D +S G +L E+LTG
Sbjct: 156 ISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 66/300 (22%), Positives = 126/300 (42%), Gaps = 64/300 (21%)

Query: 325 LGQGGQGTVYKGML-----------------------TDGRIVAVKKSKLVDETNVE--- 358
           LGQG +  +Y G L                        +GR + V   K++D ++ +   
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVV-LKVLDPSHRDIAL 61

Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
            F     ++SQ++H ++  + G C+     ++V EF+ +G L   +  +    P+ W++ 
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-------KVSDFGTSRSVMV 471
             +A +++ AL YL       + H ++ + NILL     A       K+SD G S + + 
Sbjct: 122 --VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176

Query: 472 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEI-LTGQKPIRAINTDEDK 529
            +  +         ++ PE     +  +  +D +SFG  L+EI   G+ P++     E  
Sbjct: 177 REERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229

Query: 530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                      + R +E    R+ + + KE    +ATL  +CL      RP+ + +  +L
Sbjct: 230 -----------KERFYEK-KHRLPEPSCKE----LATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 9/197 (4%)

Query: 324 ILGQGGQGTVYKGMLTDGR-IVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLG 380
           ++G+G  G V K    + + IVA+KK K  +E     E  + E+ +L  +   NIV+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                    LV+E++    L       +EE P       ++   +   +  +H      I
Sbjct: 68  AFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK  N+L+      K+ DFG +R++        T+   T  Y  PE    + + + 
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 501 SDVYSFGVVLVEILTGQ 517
            D++S G +L E+  GQ
Sbjct: 182 VDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 34/112 (30%), Positives = 63/112 (56%), Gaps = 9/112 (8%)

Query: 408 IEEFP-ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 466
           I E P +++  L+  + +V+  + +L S   +   HRD+ + N+L+ +    K+ DFG +
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLA 286

Query: 467 RSVMVDQTHLTTKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
           R +M D  +++     TF    ++ PE   ++ +T  SDV+SFG++L EI T
Sbjct: 287 RDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 46/242 (19%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           ++LG+G  G V+   L   G++ A+K   K +++    V++ + E  IL+ ++H  +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLH 433
                +TE  L LV ++ P G L++ +  Q    + E    +      A EV  AL YLH
Sbjct: 67  Y-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-----YAAEVLLALEYLH 120

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDF-------------------GTSRSVMVDQT 474
                 I +RD+K  NILL +     +SDF                   G+ RS +    
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 475 HLTTKVQ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
             T   +         GT  Y+ PE           D ++ G++L E+L G  P +  N 
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237

Query: 526 DE 527
           DE
Sbjct: 238 DE 239

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 56/248 (22%)

Query: 323 RILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           + +G G  G V      D   + A+K   K+ ++          E  IL++ ++  +VKL
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR--IAVEVSGALFYLHSAA 436
                + +    V ++IP G +   +  ++  F    E L R  IA E++ A+  +H   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFE---EDLARFYIA-ELTCAIESVHKMG 121

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFG-------------------------------- 464
            I   HRDIK  NIL+D     K++DFG                                
Sbjct: 122 FI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 465 ---------TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
                      R             + GT  Y+ PE    + +T+  D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 515 TGQKPIRA 522
            GQ P  A
Sbjct: 239 VGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 26/182 (14%)

Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
           +E  +  E LL  + +V+  + +L S   I   HRD+ + NILL      K+ DFG +R 
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD 263

Query: 469 VMVDQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 523
           +  D  ++   V+G       ++ PE   +  +T +SDV+S+G++L EI + G  P   +
Sbjct: 264 IRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Query: 524 NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
             D        F + I E      + +     ++  +IM      K C + +   RPT K
Sbjct: 321 PVDSK------FYKMIKEGY---RMLSPECAPSEMYDIM------KSCWDADPLKRPTFK 365

Query: 584 EV 585
           ++
Sbjct: 366 QI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGA 428
           + H NI++ LG C+E    LLV+E+   G L  Y+  +      +  LLL R+A E++  
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGY 486
           + ++H    +   H D+   N  L      KV D+G   S    + ++ T         +
Sbjct: 112 VTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRW 167

Query: 487 VDPEY---FQ----SSQFTEKSDVYSFGVVLVEIL 514
           + PE    F     +++ T+ S+V++ GV L E+ 
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 13/160 (8%)

Query: 361 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELL 418
             E  IL  INH +I++L G     +   L+   +P     LY Y+  +     I    +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAIC--DI 184

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS-RSVMVDQTHLT 477
           L I   V  A+ YLH      I HRDIK+ NI ++      + DFG +   V ++     
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
               GT     PE      +    D++S G+VL E+ T  
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 477
           LL    +V+  + +L S   +   HRD+ + N+LL      K+ DFG +R +M D  +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295

Query: 478 TKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                TF    ++ PE    + +T  SDV+S+G++L EI +
Sbjct: 296 KG--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 9   NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 68

Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 69  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 174 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRI---VAVKK--SKLVDETNVEQFINE 363
           +K + +  D Y   + +G G  GTV   +  D R    VA+KK       E   ++   E
Sbjct: 7   NKTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRE 64

Query: 364 VVILSQINHRNIVKLLGCCLETEVP------LLVYEFIPN--GTLYQYIHNQIEEFPITW 415
           + +L  + H N++ LL                LV  F+    G L +  H ++ E  I +
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQF 122

Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 475
                +  ++   L Y+H+A    I HRD+K  N+ +++    K+ DFG +R    + T 
Sbjct: 123 -----LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTG 174

Query: 476 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPI 520
                  T  Y  PE   +   +T+  D++S G ++ E+LTG KP+
Sbjct: 175 YVV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G VYK    DG+       K ++ T +      E+ +L ++ H N++ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 384 ---ETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITW--ELLLRIAVEVSGALFYLHS 434
              + +V LL +++  +  L+  I     ++  + P+     ++  +  ++   + YLH+
Sbjct: 69  SHSDRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 435 AASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 488
                + HRD+K ANIL+     ++ R K++D G +R        L     V  TF Y  
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 520
           PE    ++ +T+  D+++ G +  E+LT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G VYK    DG+       K ++ T +      E+ +L ++ H N++ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 384 ---ETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITWE--LLLRIAVEVSGALFYLHS 434
              + +V LL +++  +  L+  I     ++  + P+     ++  +  ++   + YLH+
Sbjct: 69  SHADRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 435 AASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 488
                + HRD+K ANIL+     ++ R K++D G +R        L     V  TF Y  
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 520
           PE    ++ +T+  D+++ G +  E+LT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 59/258 (22%), Positives = 92/258 (35%), Gaps = 72/258 (27%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           + LG G  G V      D   + A+K   K  ++    V     E  IL++ ++  +V+L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL----- 432
                + +    V ++IP G +                LL+R+ +     A FY+     
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMS--------------LLIRMGIFPEDLARFYIAELTC 112

Query: 433 --HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS------------------------ 466
              S   +   HRDIK  NIL+D     K++DFG                          
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 467 ----------------------RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
                                 R+    Q  L   + GT  Y+ PE    + +T+  D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232

Query: 505 SFGVVLVEILTGQKPIRA 522
           S GV+L E+L GQ P  A
Sbjct: 233 SVGVILYEMLVGQPPFLA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 327 QGGQGTVYKGML-TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G  G VY G    + ++ AVK   K+ ++++  V Q   E   L+      IV L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 383 LETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                  LV E++  G +   +H     +E     E+ ++   EV+ AL YLH      I
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYLHRHG---I 125

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            HRD+K  N+L+ ++   K++DFG S+  +
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 9e-05
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 46/235 (19%)

Query: 307 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKK--SKLVDETNVEQ 359
           F  ++L K      + Y     +G G  G+V     T  R  VAVKK         +  +
Sbjct: 1   FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60

Query: 360 FINEVVILSQINHRNIVKLL-----GCCLE--TEVPL---LVYEFIPNGTLYQYIHNQIE 409
              E+ +L  + H N++ LL        +E   EV L   L+   + N    Q + ++  
Sbjct: 61  TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120

Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           +F I    LLR        L Y+HSA    I HRD+K +N+ +++    ++ DFG +R  
Sbjct: 121 QFLIYQ--LLR-------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168

Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
             + T          GYV   ++++ +       + +  D++S G ++ E+L G+
Sbjct: 169 DDEMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 15/157 (9%)

Query: 361 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELL 418
           ++E  +L +++H  ++ LL   +   +  LV   +P     LY Y+  ++   P+    +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR--PLGLAQV 262

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
             +A ++  A+ Y+H      I HRDIK+ N+L++      + DFG   +     +  T 
Sbjct: 263 TAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA--ACFARGSWSTP 317

Query: 479 KVQGTFGYVD---PEYFQSSQFTEKSDVYSFGVVLVE 512
              G  G VD   PE      +T   D++S G+V+ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 30/215 (13%)

Query: 322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--------------- 366
           ++++G GG G VY+        +  +    ++    E  + E ++               
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQIEEFPITWELLLRIAV 423
           +  I+H  I K  GC    +   + Y FI    L    + I  +I+      +L+  I  
Sbjct: 77  IHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK--KLIKNIMK 133

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQ- 481
           ++   L Y+H      I H DIK  NI++D   R  + D+G +   ++   H+  +K Q 
Sbjct: 134 DMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 482 ----GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 512
               GT  Y   +    +  T + D+ S G  +++
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 38/178 (21%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           D++   + LG+G  G VYK  L       +G+ V +KK+   +   VE ++NE V   + 
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185

Query: 371 NHRN-IVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRI 421
              N     +   LE      E    LV+ +    TL   + ++  EFP   E  LL ++
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSK--EFPYNVEPYLLGKV 243

Query: 422 AVEVSGA--------------LFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFG 464
                G               LF L    S  I HRD+K  NI+  +   + K+ D G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 11/109 (10%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDETNVEQ--FINEV 364
           E   D     + LG+G  G V +            R VAVK  K    T  E    + E+
Sbjct: 3   EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTEL 61

Query: 365 VILSQI-NHRNIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF 411
            IL  I +H N+V LLG C +   PL+V  E+   G L  Y+ ++ E F
Sbjct: 62  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 30/197 (15%)

Query: 341 GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKL-----LGCCLETEVPLLVYE 393
           G +V V+ + L    E +++   NEVV+     H NI+        G  L    P + Y 
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY- 83

Query: 394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 453
               G+    +     E  ++  L+  I       L YLH    I   HR+IK+++IL+ 
Sbjct: 84  ----GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILIS 135

Query: 454 DKYRAKVSDF---------GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSD 502
                 +S           G    V+ D    +T V     ++ PE  +     +  KSD
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSD 192

Query: 503 VYSFGVVLVEILTGQKP 519
           +YS G+   E+ TG+ P
Sbjct: 193 IYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 22/122 (18%)

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD----------------DK 455
           P +   L +I  +   AL Y H+   + + H D+K  NIL++                D 
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284

Query: 456 YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
            R ++ D G       D+ H  T +  T  Y  PE      +   +D++S G ++ E+ T
Sbjct: 285 CRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340

Query: 516 GQ 517
           G+
Sbjct: 341 GK 342

Length = 467

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 35/119 (29%), Positives = 54/119 (45%), Gaps = 8/119 (6%)

Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSK-LVD 353
           I+ T+L      E   +  +  + LG G  G     T Y    +D  + VAVK  K    
Sbjct: 19  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78

Query: 354 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F
Sbjct: 79  LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 323 RILGQGGQGTVYKGM---LTDGR---IVAVKKSKLVDETNVEQ-FINEVVILSQIN-HRN 374
           RILG G  G V +G    L+  +    VAVK  K    ++ +Q  ++E+ I++ +  H N
Sbjct: 43  RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF 411
           IV LLG C ++    ++ E+   G L  Y+H   + F
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 11/109 (10%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQ--FINEV 364
           E   D     ++LG G  G V +         +    VAVK  K    T  E    ++E+
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK-EGATASEHKALMSEL 61

Query: 365 VILSQI-NHRNIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF 411
            IL  I NH N+V LLG C +   PL+V  EF   G L  ++  + E F
Sbjct: 62  KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 11/105 (10%)

Query: 317 DNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKLVDETNVEQ--FINEVVILS 368
           D     + LG+G  G V +            R VAVK  K    T+ E    ++E+ IL 
Sbjct: 7   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILI 65

Query: 369 QINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF 411
            I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF
Sbjct: 66  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 32/147 (21%), Positives = 55/147 (37%), Gaps = 15/147 (10%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV--KLLG 380
           ++L  G    VY     D   V +K +             EV IL  +  + +   K+L 
Sbjct: 4   KLLKGGLTNRVYLLGTKDEDYV-LKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                    L+ E+I   TL +    + E+          IA +++  L  LH    + +
Sbjct: 61  SGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSR 467
            H D+   NIL+DD     + D+  + 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	597
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
smart00090	237	RIO RIO-like kinase.	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.37
PF08488	103	WAK: Wall-associated kinase; InterPro: IPR013695 T	99.34
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.02
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.7
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
PRK09902	216	hypothetical protein; Provisional	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.43
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.35
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.24
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.21
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.2
PF01636	239	APH: Phosphotransferase enzyme family This family	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.03
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
PRK10593	297	hypothetical protein; Provisional	97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.74
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.73
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.57
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.48
PRK05231	319	homoserine kinase; Provisional	97.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.35
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.28
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.03
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.91
PLN02236	344	choline kinase	96.89
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.82
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
PLN02756	418	S-methyl-5-thioribose kinase	96.75
PRK12396	409	5-methylribose kinase; Reviewed	96.63
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.62
KOG2270	520	consensus Serine/threonine protein kinase involved	96.4
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.02
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.95
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.78
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.73
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.57
COG2334	331	Putative homoserine kinase type II (protein kinase	95.01
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	94.98
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.95
PRK11768	325	serine/threonine protein kinase; Provisional	94.71

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=446.11  Aligned_cols=289  Identities=46%  Similarity=0.752  Sum_probs=257.7

Q ss_pred             cccccCHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEE
Q 038707          303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC  382 (597)
Q Consensus       303 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  382 (597)
                      ..+.|+..++..+|++|...++||+|+||.||+|.+.+++.||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999987764443145599999999999999999999999


Q ss_pred             EeCCc-ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          383 LETEV-PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       383 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      .+.+. .+||||||++|+|.++|+..... +++|..+++||.++|+||+|||....++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99994 99999999999999999986544 79999999999999999999999998899999999999999999999999


Q ss_pred             eccccccccC-CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          462 DFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       462 Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      |||+++..+. ........ .||.+|+|||++..+..+.|+|||||||+|+||++|++|.+.........+..|+...+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976654 22222211 799999999999999999999999999999999999999887666666779999999999


Q ss_pred             cCchhhhhhHHhh-hhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          541 ENRLFEALDARVL-KEAKK-EEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       541 ~~~~~~~l~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ++.+.+++|+.+. ..... .....+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9999999999987 44333 67888999999999999999999999999997765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=370.74  Aligned_cols=247  Identities=30%  Similarity=0.426  Sum_probs=210.2

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-ceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~  395 (597)
                      .+..+.||+|..|+|||+.++ +++.+|+|.+.. .++...+++.+|+++++..+||+||+++|.|..... ..|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            444678999999999999987 689999999854 456677899999999999999999999999999995 99999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++|+|++++.+..   .+++..+.+++.+|++||.|||+ ++   |+||||||+|||++..|.+||+|||.+..+...  
T Consensus       161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            9999999998753   39999999999999999999996 66   999999999999999999999999999887544  


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh-
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL-  553 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-  553 (597)
                       ......||..|||||.+.+..|+.++||||||++++|+.+|+.||....... .             .++++++.... 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~-------------~~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-L-------------DIFELLCAIVDE  297 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-C-------------CHHHHHHHHhcC
Confidence             4566789999999999999999999999999999999999999997641111 1             12222222221 


Q ss_pred             --hhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 --KEAKK-EEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 --~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ...+. ..++++..+|..||++||.+||+++|++++
T Consensus       298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              11223 477889999999999999999999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=388.17  Aligned_cols=259  Identities=35%  Similarity=0.563  Sum_probs=214.3

Q ss_pred             CccCCcccccCceEEEEEEecCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-cceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  395 (597)
                      ....+.||+|+||+||+|.+.....||||++....  ....++|.+|+.+|++++|||||+++|++.+.. ...|||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34445699999999999999765669999987533  223679999999999999999999999999988 789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccCCCc
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++|+|.++++.. ....+++..+++++.+||+||.|||+.+.  ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999885 34569999999999999999999999984  99999999999999997 99999999998754322 


Q ss_pred             eeeecccccccccCccccc--cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          475 HLTTKVQGTFGYVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.......      ........+.         
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~~---------  263 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGGL---------  263 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC---------
Confidence            2233467999999999999  5699999999999999999999999998655311      1111111111         


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ....+...++.+..|+.+||..||..||++.+++..|+.+...+
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            11223336777999999999999999999999999999987653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-47  Score=390.85  Aligned_cols=247  Identities=27%  Similarity=0.433  Sum_probs=215.9

Q ss_pred             cCCccCCcccccCceEEEEEEe-cCCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..|...++||+|||+.+|+++. ..|+.||+|.+..   ......+.+.+||++.++|+|||||+++++|++.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999997 6899999998653   45667889999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |++++++|.+++++   ++++++.+++.+++||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999999984   346999999999999999999999999   999999999999999999999999999987644


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . ......+|||.|+|||++.....+..+||||+|||||.||.|++||+..+..+       ....++.+..        
T Consensus       172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y--------  235 (592)
T KOG0575|consen  172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY--------  235 (592)
T ss_pred             c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc--------
Confidence            3 34556789999999999999999999999999999999999999997544332       3333333322        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+...+.+..+||.++|+.||.+|||+++|+.
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              113355667889999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=388.29  Aligned_cols=256  Identities=31%  Similarity=0.480  Sum_probs=223.5

Q ss_pred             CccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.+.+.||+|-||+||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||++++++..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3445689999999999999988889999988754 334578899999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeee
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT  478 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  478 (597)
                      +|.+||+.. .+..+...+.+.++.|||+|++||++++   +|||||.++||||+++..+||+||||++....+......
T Consensus       287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            999999973 3445999999999999999999999999   999999999999999999999999999965555555566


Q ss_pred             cccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       479 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ...-...|+|||.+..+.++.|||||||||+||||+| |+.|+..+...+                ..+.++.......+
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le~GyRlp~P  426 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLERGYRLPRP  426 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHhccCcCCCC
Confidence            6667789999999999999999999999999999999 999987765444                23334444445556


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..++.++.+|+..||+.+|++|||++.+.+.|+.+...
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            77889999999999999999999999999999988753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=368.25  Aligned_cols=204  Identities=32%  Similarity=0.524  Sum_probs=184.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..+|.+.+.||+|+|++||+|+++ ++..||||.+...  ..+..+.+..|+.+|+.++|||||+|+++++..+..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457889999999999999999976 5899999987654  6777888999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC------CcEEEeecccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK------YRAKVSDFGTS  466 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~------~~~kl~Dfgl~  466 (597)
                      |||.+|+|.+||+++.   .+++..+..++.|||.||++||+++   |+||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999999764   3999999999999999999999999   9999999999999764      46899999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE  527 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~  527 (597)
                      +.+.  ........+|++-|||||+++..+|+.|+|+||+|++||++++|+.||+..+..|
T Consensus       163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            9875  3344667889999999999999999999999999999999999999998655443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-46  Score=363.74  Aligned_cols=253  Identities=28%  Similarity=0.380  Sum_probs=209.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-------ETNVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++....       ........+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567889999999999999999965 79999999865421       112234579999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC---CcEEEeec
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDF  463 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Df  463 (597)
                      ..|+||||++||.|.+++-.+..   +.+..-..++.|++.|+.|||+.|   |+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999987543   788888999999999999999999   9999999999999765   78999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCC---CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      |+|+...  ....+...+|||.|.|||++.+..   +..+.|+||+||+||-+|+|.+||.....+.  +    ..+.+.
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQIL  395 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHh
Confidence            9998764  556788899999999999997654   3458899999999999999999997544332  1    233344


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+++...      .....+.+++..+||.+||..||++|||+.|+|+
T Consensus       396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            4443211      1123566778899999999999999999999886

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-47  Score=353.12  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=211.1

Q ss_pred             cCCccCCcccccCceEEEEEEe-cCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeee-EEEeCC-cceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG-CCLETE-VPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lv  391 (597)
                      .+|++.+.||+|.||+||++.. .+|..+|.|.++.  .+....+....|+.+|++|+|||||++++ .+.++. .++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4588889999999999999995 5899999998763  56677888999999999999999999998 455544 48999


Q ss_pred             EeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          392 YEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAA-SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~-~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ||++..|+|...++..+ .+..++++.+|+++.|++.||..+|+.- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999998643 3345999999999999999999999921 113999999999999999999999999999987


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .... .......|||.||+||.+.+..|+.||||||+||++|||..-++||.+.+..+       ....+..+....+. 
T Consensus       179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~p-  249 (375)
T KOG0591|consen  179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPLP-  249 (375)
T ss_pred             cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCCc-
Confidence            5433 34556789999999999999999999999999999999999999998753211       33444444332221 


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                             ....+..+.+||..|+..||+.||+...++..+
T Consensus       250 -------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  250 -------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             -------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                   255677899999999999999999954444443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5e-45  Score=388.56  Aligned_cols=260  Identities=30%  Similarity=0.494  Sum_probs=226.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      ..+.+..+.||+|+||+||+|...      +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345666789999999999999853      2467999999976665 788999999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE-----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      ++|+|||..|+|.+||.....           ..+|+..+.+.||.|||.|+.||-++.   ++||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            999999999999999986321           234899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccccccccCCCceeee-cccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  535 (597)
                      |||+||||++.....+.+... ...-..+|||||.+..+++|.+||||||||+|||+++ |+.|+.+...+|       +
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence            999999999987765554433 4445779999999999999999999999999999999 999998877666       5


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+.++.+++         -..+..++.++.+|+..||+.+|.+||+++||-..|+.+-.
T Consensus       715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            556666655         23467788899999999999999999999999999987653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=352.24  Aligned_cols=243  Identities=29%  Similarity=0.407  Sum_probs=206.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .+.|++.++||+|+||+||.++.+ +++.+|+|.++.   ....+.+..+.|..+|.+++||.||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999965 589999997664   4445678899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      +||+.||.|..+|.+..   .++++.+.-++.+|+.||.|||+++   |+||||||+|||||++|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998654   3899999999999999999999999   99999999999999999999999999986544


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. ......+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+..+       ....+..++        
T Consensus       178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k--------  241 (357)
T KOG0598|consen  178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGK--------  241 (357)
T ss_pred             CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCc--------
Confidence            32 23445789999999999999999999999999999999999999997644322       122222222        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                       ....+.-.+.+..+|+.+.|+.||++|..
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence             12223335567889999999999999963

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=350.67  Aligned_cols=255  Identities=31%  Similarity=0.467  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--cceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  392 (597)
                      ..++...+.||+|+||.||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+  ...+.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3457788999999999999999764 9999999987654444778999999999999999999999855554  688999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~~~  471 (597)
                      ||+++|+|.+++.+...  .+++..+..+++||++||.|||+++   |+|+||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999998653  5999999999999999999999999   999999999999999 79999999999987653


Q ss_pred             --CCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          472 --DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       472 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                        ..........||+.|||||++..+ ....++|||||||++.||+||+.||...     ..............      
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------  239 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------  239 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence              222234457799999999999853 3345999999999999999999999753     11111111111111      


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                         .....+...+.+..+++.+|++.+|++|||++++|+..
T Consensus       240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               11133445667789999999999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=343.23  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=212.2

Q ss_pred             hcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .+.|++.+.||.|.-++||+|.. ..++.||||++.+.... +.+.+.+|+..|+.++||||++++..|..++.+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999995 46899999998864433 36889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      ||.+|++.++++.....+ +++..+..|++++++||.|||.+|   .||||||+.||||+++|.|||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999865544 999999999999999999999999   9999999999999999999999999987765433


Q ss_pred             cee---eecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          474 THL---TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       474 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...   .....||+.|||||++..  ..|+.|+||||||++..||.+|..||....+-.      .....+....- -.+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp-~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPP-TLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCC-Ccc
Confidence            221   145679999999999543  579999999999999999999999998655432      11111111111 000


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ......+........+.++|..||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            001111122333447899999999999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=358.86  Aligned_cols=250  Identities=27%  Similarity=0.435  Sum_probs=215.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ..|...+.||+|+-|.||.+... +++.||||++........+-+++|+.+|+..+|+|||.+++.+...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45777789999999999999954 68899999999888888889999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.|.+....    +++.++..|.+++++||+|||.++   |+|||||.+|||++.++.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999997653    999999999999999999999999   99999999999999999999999999988765444 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|||||++....|++|.||||||+|++||+-|.+||-..++     +.  +...+..+.-.++       .
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lr--AlyLIa~ng~P~l-------k  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LR--ALYLIATNGTPKL-------K  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HH--HHHHHhhcCCCCc-------C
Confidence            45566799999999999999999999999999999999999999975221     11  2222222221111       1


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .....+..|.+|+.+||+.|+++|++++|+|+.
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            235566779999999999999999999999873

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=352.85  Aligned_cols=266  Identities=26%  Similarity=0.345  Sum_probs=211.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  390 (597)
                      .+.|+..++||+|.||.||+|++. +|+.||+|++....  +....-..+||.||++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            345777789999999999999964 79999999987654  44456678999999999999999999999887  68999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+|||++ +|.-++...  ...+++.++.-+++||+.||+|+|+.+   |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 888888753  334999999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch-----
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-----  544 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  544 (597)
                      .......+..+-|+.|.|||++.+ ..|+.+.|+||.||||.||+.|++.|++.++-++-..+-.......+.-+     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            666666777788999999999877 57999999999999999999999999886654432222111000001001     


Q ss_pred             --hhhhh-----HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 --FEALD-----ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 --~~~l~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ...+.     ++...+.....+....+|+..+|..||.+|.|+.++|+
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              01110     11112223344566789999999999999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-43  Score=331.86  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|+.+.++|+|+||+||+.+++ +|+.||||++....+  .-.+-.++||++|++++|||+|.|+++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788889999999999999987 599999999775433  334567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |++. ++.+-|.+...+  ++.+.+.+++.|+++|+.|+|+++   ++||||||+||||+.++.+||+|||+|+.+.. .
T Consensus        82 ~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P  154 (396)
T ss_pred             ecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence            9976 555556665544  889999999999999999999999   99999999999999999999999999998764 3


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH--------HHHHHHHhcCch
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--------GYFLQAINENRL  544 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~  544 (597)
                      ....+.+..|..|.|||++.+ .+|+...|||++||++.||++|.+.|.+...-+.--++        -...+....+..
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            445667788999999999887 78999999999999999999999988765432211111        111222223332


Q ss_pred             hhhh------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEAL------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +.-+      +++.++..-.....-+.+|+++||+.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2111      122222223444557899999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.6e-42  Score=355.33  Aligned_cols=261  Identities=28%  Similarity=0.468  Sum_probs=208.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC-
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE-  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  386 (597)
                      .++|++.++||+|+||.||+|.+.      +++.||||+++... ......+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999742      35689999886432 34456799999999999 8999999999887644 


Q ss_pred             cceEEEeccCCCChhhHHhhcCC---------------------------------------------------------
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIE---------------------------------------------------------  409 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  409 (597)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999975321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce-eeecccccccc
Q 038707          410 --EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGY  486 (597)
Q Consensus       410 --~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y  486 (597)
                        ..++++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124788999999999999999999999   999999999999999999999999999865432221 12223456789


Q ss_pred             cCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHH
Q 038707          487 VDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVA  565 (597)
Q Consensus       487 ~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~  565 (597)
                      +|||++.+..++.++||||||++||||++ |..||......+      .+...+..+...         ..+...++.+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRM---------RAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCC---------CCCCCCCHHHH
Confidence            99999998999999999999999999997 999997643322      112222222111         11223455688


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          566 TLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       566 ~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      +|+.+||+.||++|||+.|++++|+++..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=350.55  Aligned_cols=263  Identities=25%  Similarity=0.359  Sum_probs=210.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhH-HHHHHHHHHHhhcC-CCccceeeeEEEeCC-cceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNV-EQFINEVVILSQIN-HRNIVKLLGCCLETE-VPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  390 (597)
                      ..++|.+.++||.|.||.||+|+.. +++.||||+++..-.... -.=++|++.|++|+ |||||+|.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4567999999999999999999965 689999999875333322 22358999999999 999999999999988 9999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||||+ .+|.++++++  +.++++..+..|+.||++||+|+|.+|   ++|||+||+|||+..+..+||+|||+|+...
T Consensus        88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 5999999986  557999999999999999999999999   9999999999999999899999999999875


Q ss_pred             CCCceeeecccccccccCcccc-ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC---ch--
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---RL--  544 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--  544 (597)
                      .  ....+.+..|..|.|||++ ....|+.+.|+|++|||++|+.+-++.|.+.++-++...   +.+.+...   .+  
T Consensus       162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSWPE  236 (538)
T ss_pred             c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccchh
Confidence            3  3446677889999999986 457799999999999999999999999987654322111   11111111   00  


Q ss_pred             -----------hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          545 -----------FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       545 -----------~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                 +....+.-....-...+.+..+||.+|+++||.+|||++|.+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                       11111111122223467789999999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=350.75  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc----Ch-hhHHHHHHHHHHHhhcC-CCccceeeeEEEeCC
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV----DE-TNVEQFINEVVILSQIN-HRNIVKLLGCCLETE  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  386 (597)
                      ...++|.+.+.||+|+||+|+.|... +++.||+|.+...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44578999999999999999999865 6899999965432    11 33556778999999999 999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeeccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGT  465 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl  465 (597)
                      ..++||||+.+|+|.+++.+.   ..+.+.++..+++|++.|++|+|+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999999873   34899999999999999999999999   9999999999999999 9999999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCC-CC-cccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-FT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...      +....+.. +..+.
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~k-i~~~~  239 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRK-IRKGE  239 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHH-HhcCC
Confidence            98764 2334456678999999999999877 75 7999999999999999999999752      22222222 33322


Q ss_pred             hhhhhhHHhhhhhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 038707          544 LFEALDARVLKEAKKEE-IMTVATLAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl  586 (597)
                      ..          .+... +.++..|+.+||..||.+|+|+.+++
T Consensus       240 ~~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 FK----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cc----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            21          11222 66788999999999999999999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=346.50  Aligned_cols=252  Identities=30%  Similarity=0.399  Sum_probs=209.4

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      +...+|.++++||+|+|++|++|+.. .++.+|||++..   ..+....-+..|-.+|.+| .||.|++|+--|.|+..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34567999999999999999999965 689999998653   2333445567889999999 799999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      |+|+||+++|+|.++|++..   .+++.....++.||+.||+|||++|   ||||||||+|||||+++++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999764   4999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce------------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          469 VMVDQTH------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       469 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      +......            .....+||..|.+||++..+..+..+|+|+||||||+|+.|++||.+.++--      .|.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFq  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQ  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHH
Confidence            7532211            1144779999999999999999999999999999999999999998643211      111


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ..+         +  +.-+.+...++.+.+||++.|..||.+|+|.++|-++
T Consensus       298 kI~---------~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 KIQ---------A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHH---------H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            111         1  1112334455778899999999999999999887653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.5e-42  Score=317.70  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=208.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhh--HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .+|...++||+|.||.||+|.+. +|+.||||+++..+..+  .....+||+.|+.++|+||+.|+++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46778889999999999999965 79999999988754332  4567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      ||+ .+|...++..  ...++..++..++.++++||+|||++.   |+||||||+|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 5999999874  346999999999999999999999999   9999999999999999999999999999886544


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc---Cchhh---
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NRLFE---  546 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---  546 (597)
                      .... ...-|..|.|||++.+ ..|+...|+||.|||+.||+-|.+-|.+.+.-+   ...........   ..+.+   
T Consensus       156 ~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  156 RIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             cccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHHHcCCCCcccCccccc
Confidence            4332 2367889999999876 579999999999999999999987776644322   22222222211   11111   


Q ss_pred             hhhH--------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 ALDA--------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 ~l~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +.|-        ......-...+..+.+|+.+|+..||.+|++++|++++
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111        11111223345667999999999999999999999874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=379.81  Aligned_cols=261  Identities=30%  Similarity=0.531  Sum_probs=220.6

Q ss_pred             hcCCccCCcccccCceEEEEEEecC--Cc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD--GR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      ..+..+.+.||+|+||.||.|...+  +.    .||||.+.. .+.++..+|++|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456677899999999999999653  43    489998765 5677889999999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQI----EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      +|++|||++|+|..||++..    ....++..+++.++.+||+|+.||++++   +|||||..+|+||++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999999752    1345999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecc-cccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          465 TSRSVMVDQTHLTTKV-QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      +|+.+...+.+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+      .+....+.+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC
Confidence            9997665444433332 34568999999999999999999999999999999 999997655443      122233344


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ++          +.+..+++.+.+|+..||+.+|++||++..+++++..+...
T Consensus       922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            22          33577888899999999999999999999999999887653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-42  Score=332.98  Aligned_cols=247  Identities=25%  Similarity=0.435  Sum_probs=214.3

Q ss_pred             hcCCccCCcccccCceEEEEEEe-cCCcEEEEEEcc---ccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSK---LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..+|++.+.||+|.||+|-+|.. ..|+.||||.++   +.++++.-.+++||+||+.|+||||++++.+|+..+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35688889999999999999995 579999999654   45677788899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||..+|.|.||+.+..   .|++.+...+++||.+|+.|+|.++   ++|||||.+|||||+++++||+|||++..+. 
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~-  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA-  204 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc-
Confidence            99999999999998764   3999999999999999999999999   9999999999999999999999999997764 


Q ss_pred             CCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                       .......++|.+-|.+||++.+.+| .+..|-||||++||-|+.|..||++.+..       .....+..|.+++-   
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP---  273 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREP---  273 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCC---
Confidence             3344567889999999999999888 57899999999999999999999875422       24445556655542   


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                              +.+....-||++||..||++|.|+.+|...
T Consensus       274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 --------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             --------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                    223345679999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=317.75  Aligned_cols=236  Identities=29%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|.+..   ....+.+...+|..+|+.+.||.++++++.+.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999976 689999998764   33445677889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|.|.+++++..+   +++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999997543   999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .-..+|||.|+|||+++...+..++|.|+|||++|||+.|.+||...++..       ..+.+-++.+        
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v--------  258 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV--------  258 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc--------
Confidence                556789999999999999999999999999999999999999998655421       2233333222        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCC
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMR  579 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~R  579 (597)
                        ..+.....++.+|+.+.|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1234455668899999999999888

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=352.90  Aligned_cols=263  Identities=29%  Similarity=0.452  Sum_probs=216.0

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecC--C--cE-EEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTD--G--RI-VAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCL  383 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~-vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  383 (597)
                      .+...++..+.++||+|+||.||+|.+..  +  .. ||||..+.   .......+|++|+++|++++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33344555666899999999999999753  2  23 89998875   45778899999999999999999999999999


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                      .+..++||||++.+|+|.+||++...  .++..+++.++.+.|.||+|||+++   ++||||.++|+|++.++.+||+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            99999999999999999999998654  4999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      |+++..... ........-...|+|||.+....|+.++|||||||++||+++ |..||.+....+       +...+..+
T Consensus       307 GLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~  378 (474)
T KOG0194|consen  307 GLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKN  378 (474)
T ss_pred             ccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhc
Confidence            999765311 111112235678999999999999999999999999999999 899998755442       22222111


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .        .....+...+.++..++.+||..+|++||+|.++.+.|+.+...
T Consensus       379 ~--------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  379 G--------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             C--------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            1        11222335566788899999999999999999999999988754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=360.29  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=221.1

Q ss_pred             CccCCcccccCceEEEEEEecC----CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          319 YNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..+.++||.|.||+|++|.++.    ...||||.++... +....+|+.|+.||-+++||||++|.|+.......+||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4566899999999999999863    3579999999744 5567889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      ||++|+|+.||+++.  ..+++.++..+++.||.|+.||-+.+   ++||||.++|||++.+..+||+||||++.+.++.
T Consensus       711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999999865  34999999999999999999999999   9999999999999999999999999999776544


Q ss_pred             ceee--ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          474 THLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       474 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ....  ..-.-..+|.|||.+...+++.+|||||||++|||.++ |..||-.+..++                ....++.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaIe~  849 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAIEQ  849 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHHHh
Confidence            2222  22234578999999999999999999999999999998 999998766544                2233444


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+.-..+.+++..|.+|++.||++|-.+||.+.+|+..|++|-.
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            45556678999999999999999999999999999999998753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-41  Score=342.59  Aligned_cols=246  Identities=28%  Similarity=0.450  Sum_probs=210.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+..  ..+.+...+.+|+++++.++||||+.++++|+....+++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999976 588999997654  345567889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+.+ +|..+|....   .++++.+..++.+++.||.|||+.+   |+|||+||.|||++.++.+|++|||+++.... .
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N  153 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence            9976 9999998654   3999999999999999999999999   99999999999999999999999999997754 4


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      ....+...|||-|||||++.+..|+..+|.||||||||||++|++||.....      . .....+.....         
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~-~Lv~~I~~d~v---------  217 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------T-QLVKSILKDPV---------  217 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------H-HHHHHHhcCCC---------
Confidence            5567778899999999999999999999999999999999999999964221      1 11111111111         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ..+...+..+..++...|.+||.+|.|..+++.
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             113456677999999999999999999998875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-40  Score=336.61  Aligned_cols=246  Identities=22%  Similarity=0.394  Sum_probs=201.1

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhh---HHHHHHHHHHHhhcCCCccceeeeEEEe----CCcceEEEecc
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN---VEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLVYEFI  395 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  395 (597)
                      ..|++|+++.||+|.+ +|+.||||+++......   .+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 68899999887543322   5778899999999999999999999977    34678999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++|+|.+++.+..   .+++...+.++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999998642   488999999999999999999985 6   7899999999999999999999999987653221 


Q ss_pred             eeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          475 HLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                         ....++..|+|||++.+  ..++.++||||||+++|||++|+.||......+      ........+..        
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~~--------  240 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNNS--------  240 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCC--------
Confidence               22347889999999976  689999999999999999999999997543221      11111111111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                       ...+...++.+.+|+.+||+.||++|||++|+++.|+.+..
T Consensus       241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence             01122346679999999999999999999999999998864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-40  Score=333.48  Aligned_cols=256  Identities=21%  Similarity=0.390  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|..+.. .......+.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356889999999999999999863    3568999988754 23445679999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999998642  35899999999999999999999999   9999999999999999999999999876543


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+...    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~----  227 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL----  227 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC----
Confidence            222111222335678999999999999999999999999999875 999997543221       12222222111    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                           ..+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus       228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 11233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=345.28  Aligned_cols=240  Identities=32%  Similarity=0.516  Sum_probs=204.6

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      ++.||.|+.|.||+|++. ++.||||+++...+.       +|+.|++|+||||+.+.|+|....-++|||||++.|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkET-------dIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKET-------DIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhhhh-------hHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            568999999999999985 789999988754443       578899999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeeccc
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ  481 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  481 (597)
                      ..|+..   .+++......|..+||.|+.|||.+.   |||||||+-||||..+..+||+|||-++.....  .....+.
T Consensus       201 ~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  201 EVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             HHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            999864   35899999999999999999999999   999999999999999999999999999876433  2334567


Q ss_pred             ccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHH
Q 038707          482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI  561 (597)
Q Consensus       482 gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  561 (597)
                      ||..|||||++.+.+.++|.|||||||+|||||||..||...+....               ++..-...+....+..++
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCcccccCcccCc
Confidence            99999999999999999999999999999999999999976553321               111111122223456677


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          562 MTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       562 ~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      +-+.-|+++||+-.|..||++++++..|+-.
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            7899999999999999999999999998743

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=339.80  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=212.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..|...+.||+|.||.||+|.+. .++.||+|.+.+. .+.+.+++.+|+.+|++++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34666789999999999999975 6899999998864 445678899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +.+|++.+.|+...   .+.+..+.-++++++.||.|||+++   .+|||||+.|||+..+|.+||+|||++-.......
T Consensus        93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999997543   3588899999999999999999999   99999999999999999999999999987765444


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .. ....||+.|||||+++...|+.|+||||||++.+||.+|.+|+....+.-                +.-++.+....
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP  229 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPP  229 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCC
Confidence            43 67789999999999998899999999999999999999999997665422                11112211222


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......+..+.+|+..||..||+.||++.++++.
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2234566779999999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4e-41  Score=340.72  Aligned_cols=247  Identities=25%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..+.|+++++||+|+||.||+++-+ +|+.+|+|+++.   ....+++.++.|-.+|...++|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3578999999999999999999965 699999998774   345567788999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||++||++..+|.+.   ..|+++.+..++.+++-|++.||+.|   ++||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999864   35999999999999999999999999   9999999999999999999999999985332


Q ss_pred             CC----------------------Cce-----ee-------------------ecccccccccCccccccCCCCccccee
Q 038707          471 VD----------------------QTH-----LT-------------------TKVQGTFGYVDPEYFQSSQFTEKSDVY  504 (597)
Q Consensus       471 ~~----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDv~  504 (597)
                      ..                      ...     ..                   ....|||.|||||++.+..|+...|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      000     00                   113499999999999999999999999


Q ss_pred             ehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          505 SFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       505 SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                      ||||||||||.|.+||...++.+.       ...+...+.  .    +..........+..+||.++|. ||++|..
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~--~----l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRE--T----LKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhh--h----ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999988766552       111111110  0    1111123334678899999998 9999976

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=310.78  Aligned_cols=265  Identities=25%  Similarity=0.378  Sum_probs=216.1

Q ss_pred             HhcCCccCCcccccCceEEEEEE-ecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VP  388 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  388 (597)
                      ..++|.+.+.||+|||+.||+++ ..+++.+|+|++...+.++.+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45689999999999999999999 4578999999999888889999999999999999999999999876544     48


Q ss_pred             eEEEeccCCCChhhHHhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ||+++|...|+|.+.+.....++ .+++.++++|+.+|.+||++||+... |++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999998755443 69999999999999999999999874 69999999999999999999999999987


Q ss_pred             cccCCCceee--------ecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          468 SVMVDQTHLT--------TKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       468 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      .....-....        .....|..|.|||++.   +...++++|||||||+||+|+.|..||...-...+. +.    
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-la----  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LA----  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EE----
Confidence            6542211111        1123688999999975   356789999999999999999999999754432211 10    


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                              .......+........++.+.+||++||+.||.+||++.+++..++.|-
T Consensus       253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    1111112222222336778999999999999999999999999998764

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.9e-40  Score=329.45  Aligned_cols=256  Identities=23%  Similarity=0.426  Sum_probs=210.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.++||+|++|.||+|...++..||+|..... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3578999999999999999999888888999987643 334678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.++++... ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999997642 335889999999999999999999998   999999999999999999999999999876433322


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||++....++.++||||||+++|+|++ |+.||......+       ....+......         
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM---------  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence            2233345678999999988889999999999999999998 999986533221       11122111110         


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ......+.++.+++.+||..+|++||+++++++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11122345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=344.26  Aligned_cols=267  Identities=25%  Similarity=0.471  Sum_probs=215.1

Q ss_pred             CHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       308 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      +.++.+...+...+.+.||+|.||+||+|.+..  .||||.+...  .++..+.|++|+..+++-+|.||+-+.|++...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            345666667778888999999999999999864  4899987754  445788999999999999999999999999988


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      .. .||..++++-+|+.+||....  .+.....++|++||++|+.|||.++   |||||||..||+|.++++|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            88 999999999999999997543  4888999999999999999999999   99999999999999999999999999


Q ss_pred             cccccC-CCceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          466 SRSVMV-DQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       466 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      +..-.. ..........|...|||||++..   .+|++.+||||||+++|||++|..||. ....+.      ..-++..
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq------IifmVGr  607 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ------IIFMVGR  607 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh------eEEEecc
Confidence            854321 11122233347789999999754   579999999999999999999999998 332221      1112222


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      |-+.    ++.. ......++++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus       608 G~l~----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GYLM----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccC----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            2111    1111 1235567789999999999999999999999998887765

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-40  Score=347.25  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             hcCCccCCcccccCceEEEEEEe------cCCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||.||+|..      .++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999974      23568999988643 234456789999999999 89999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC----------------------------------------------------------
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE----------------------------------------------------------  409 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  409 (597)
                      .++||||+++|+|.+++++...                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999975321                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          410 --------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       410 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                                    ...+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788999999999999999999999   999999999999999999999999999765433221


Q ss_pred             e-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          476 L-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       476 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......      .+...+..+..         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCcc---------
Confidence            1 122334667999999999999999999999999999998 888986543221      12222222211         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ...+...+.++.+|+.+||+.||++||++.||+++|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.8e-40  Score=336.41  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=205.2

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-----------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVK  377 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  377 (597)
                      .++|.+.+.||+|+||.||++.+.+                 +..||+|.+... ......++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578899999999999999998532                 347999987753 3445678999999999999999999


Q ss_pred             eeeEEEeCCcceEEEeccCCCChhhHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 038707          378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE----------------EFPITWELLLRIAVEVSGALFYLHSAASIPIY  441 (597)
Q Consensus       378 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~  441 (597)
                      +++++.+.+..++||||+++++|.+++.....                ...+++..++.++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999999999999999999999999965321                124788999999999999999999999   99


Q ss_pred             eccCCCCCeEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh--CCC
Q 038707          442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQK  518 (597)
Q Consensus       442 H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~--g~~  518 (597)
                      ||||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999765433222 2223345788999999988899999999999999999987  556


Q ss_pred             CCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          519 PIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       519 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ||......+   ...............      .....+...+..+.+|+.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            776543222   111111111110000      0001112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.6e-40  Score=346.93  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=207.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||.||++...      ++..||+|++... .....+.+.+|+.+++.+ +|+||+++++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457899999999999999999842      2357999998753 344466789999999999 89999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC----------------------------------------------------------
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE----------------------------------------------------------  409 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  409 (597)
                      .++||||+++|+|.++++....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999999865321                                                          


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce-eeec
Q 038707          410 ---------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTK  479 (597)
Q Consensus       410 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~  479 (597)
                               ..++++.++++++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788999999999999999999999   999999999999999999999999999765433222 1122


Q ss_pred             ccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       480 ~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ..++..|||||++....++.++||||||+++|||++ |+.||.......      .+...+..+.         ....+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~---------~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY---------QMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc---------CccCCC
Confidence            335668999999988899999999999999999997 999997543221      1111111110         001111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ..+.++.+++.+||+.||.+|||+.+|+++|+++-
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23467899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.9e-40  Score=328.32  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=209.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ..|.+.+.||+|++|.||+|... .++.||+|..... .....++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999976 5889999987643 344678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.... ...+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999997643 335899999999999999999999999   999999999999999999999999999776443322


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |..||.....++       ....+...         ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG---------YRM  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------CCC
Confidence            2222334668999999998999999999999999999998 999986543221       11111111         111


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ..+...+.++.+++.+||+.+|++||++.+++++|+++
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            12233456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=333.25  Aligned_cols=260  Identities=25%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             cCHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--------------ChhhHHHHHHHHHHHhhcC
Q 038707          307 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--------------DETNVEQFINEVVILSQIN  371 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--------------~~~~~~~~~~E~~~l~~l~  371 (597)
                      +...+-.+..++|++.+.||+|.||.|-+|... +++.||||++...              .....++..+||.+|++++
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            344444556689999999999999999999976 6999999975431              1123568999999999999


Q ss_pred             CCccceeeeEEEe--CCcceEEEeccCCCChhhHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 038707          372 HRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFP-ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA  448 (597)
Q Consensus       372 h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~  448 (597)
                      |||||+|+++..+  .+.+|||+||+..|.+.+.-    ...+ +++.+++++++.++.||+|||.++   |+||||||+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs  239 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS  239 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence            9999999999976  56889999999988775542    2234 999999999999999999999999   999999999


Q ss_pred             CeEeCCCCcEEEeeccccccccCCC----ceeeecccccccccCccccccCC----CCcccceeehHHHHHHHHhCCCCC
Q 038707          449 NILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPI  520 (597)
Q Consensus       449 NIll~~~~~~kl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlG~il~ell~g~~p~  520 (597)
                      |+||+++|++||+|||.+.......    ........|||.|||||...++.    .+.+.||||+||+||.|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999999999999999997663221    11123366999999999987632    367899999999999999999999


Q ss_pred             CCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          521 RAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .+...-+       ....+.+.        .+......+..+++.+||++||++||++|.++.+|...
T Consensus       320 ~~~~~~~-------l~~KIvn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  320 FDDFELE-------LFDKIVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ccchHHH-------HHHHHhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            7532211       11222221        12222233556778999999999999999999998654

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-40  Score=329.94  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=214.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ...+|++.+.||+|+||.||+|...+++.+++|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568899999999999999999888999999998876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999998643 345899999999999999999999999   99999999999999999999999999976543221


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                       ......++..|+|||.+....++.++||||||+++++|++ |+.||......+       ....+..+         ..
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~~  222 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITAG---------YR  222 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHhC---------Cc
Confidence             1223345678999999988899999999999999999998 899996543211       11111111         11


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ...+...++.+.++|.+||+.+|.+|||++++++.|+++
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            111234456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-40  Score=327.80  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=209.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|++|.||+|.+.+++.||+|..+... ...+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688999999999999999998778889999887533 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999997643 335899999999999999999999999   999999999999999999999999999876532222


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .......+..|+|||++.+..++.++||||||++++||++ |+.||.......       ....+.....         .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR---------M  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence            2222223457999999998899999999999999999999 999986543211       1111111110         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ......+..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            11223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=342.83  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=212.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +-|++++-||.|+-|.|-+|++. +|+.+|||.+...   .......+-+||.+|+.+.|||+++|++++.+...+|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888999999999999999975 7999999987653   3334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|-|++++.++.   ++++.++.++++||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|....  
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            9999999999998653   5999999999999999999999999   9999999999999999999999999997643  


Q ss_pred             CceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ....-...+|.+.|.+||++.+.+| +.++||||.|||||.||+|+.||++.+       +......+..|..       
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f-------  229 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVF-------  229 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcc-------
Confidence            3345667789999999999999887 579999999999999999999997432       1123334444432       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         +.+...+.+..+|+.+||..||++|.|++||+++
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence               2345566778999999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-40  Score=326.38  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=205.3

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      +.|++.+.||+|+||.||++.+.++..+|+|..... ....+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457888999999999999999888888999987632 3335678999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +|+|.++++...  ..+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999997643  24899999999999999999999999   9999999999999999999999999987654333222


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+...         .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~---------~  221 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGFRL---------Y  221 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCC---------C
Confidence            223345668999999988889999999999999999999 899986543211       11222221110         0


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      .+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            01123456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.8e-40  Score=331.37  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=203.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .|+..+.||+|+||+||++... +++.||+|.+....   ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778889999999999999975 68999999875322   2234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999998886542 235899999999999999999999999   9999999999999999999999999997653222


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||.........   ......+...          .
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED----------Q  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc----------c
Confidence              223446899999999999999999999999999999999999999765432211   1111111110          0


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  588 (597)
                      .......+..+.+|+.+||+.||.+||+     ++++++.
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            1112334567889999999999999997     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.7e-40  Score=330.04  Aligned_cols=257  Identities=29%  Similarity=0.478  Sum_probs=210.1

Q ss_pred             cCCccCCcccccCceEEEEEEecC-C-----cEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-G-----RIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.+.... .....++.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643 2     579999876433 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          390 LVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999976421             135889999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~  534 (597)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976543222 12233346788999999988899999999999999999998 999997644322       


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ....+..+..         ...+...+.++.+|+.+||+.||.+||+++||++.|+++
T Consensus       235 ~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            2222222221         112345567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=333.90  Aligned_cols=245  Identities=27%  Similarity=0.360  Sum_probs=202.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999976 6899999987642   2234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997643   4899999999999999999999999   999999999999999999999999999765322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+..+..        
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~--------  215 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL--------  215 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc--------
Confidence                123458999999999998889999999999999999999999997543211       1111211111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  588 (597)
                        ..+......+.+|+.+||+.||.+||+     ++++++.
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              112223456889999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4e-40  Score=333.28  Aligned_cols=262  Identities=24%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||++..+ +++.+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999986 5889999987643  23345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |++++.+..+...   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9998776655432   234899999999999999999999999   9999999999999999999999999998764333


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh-----------cC
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-----------EN  542 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~  542 (597)
                      ........|++.|+|||++.+..++.++||||||+++|||++|+.||......+.  +. .......           ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ--LF-TIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHhhCCCCHHHHHhhhcc
Confidence            3333345689999999999988899999999999999999999999976432211  00 0000000           00


Q ss_pred             chhhhhh-HH------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          543 RLFEALD-AR------VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       543 ~~~~~l~-~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ....... +.      .........+..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000 00      000011124567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=339.39  Aligned_cols=263  Identities=29%  Similarity=0.463  Sum_probs=229.9

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      +++-.........+||-|.||.||.|.|+. .-.||||.++. +.-..++|+.|+.+|+.++|||+|+|+|+|..+..+|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333333445667899999999999999975 67899999884 4557899999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ||.|||..|+|.+||++.. +..++...++.++.||+.|++||..++   +|||||..+|.|+.++..+||+||||++++
T Consensus       340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999999999874 445888899999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..+.............|.|||-+..+.++.|+|||+|||+|||+.| |-.||.+.+..+                +.+++
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~LL  479 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGLL  479 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHHH
Confidence            7665555555566789999999999999999999999999999999 889988765333                34556


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ...+..+.+..+++.+.+|++.||+++|.+||++.|+-+.|+.+-.
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            6667777788899999999999999999999999999999987753

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=343.26  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCc
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV  387 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  387 (597)
                      ....++|.+.++||+|.||+|+++..+ +++.+|||.++.   ....+++..+.|..|+.... ||.++.|+.+|...+.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            334578999999999999999999987 588999998774   45667888999999998885 9999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      +++||||+.||++..+.+..    .+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999965555432    3999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ...... ..+...+|||.|||||++.+..|+.+.|.|||||+|||||.|..||.+.++++.      |...+.+...   
T Consensus       517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~~~---  586 (694)
T KOG0694|consen  517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDEVR---  586 (694)
T ss_pred             ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCCC---
Confidence            765333 356778999999999999999999999999999999999999999998765551      2121111111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                              .+...+.+...|++++|.++|++|..+
T Consensus       587 --------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 --------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --------CCCcccHHHHHHHHHHhccCcccccCC
Confidence                    234456678899999999999999876

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-40  Score=339.26  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=205.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+...   .......+.+|+.++.+++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 5899999987642   2234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997542   4899999999999999999999999   99999999999999999999999999976533 


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                         ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      + ..+....  ..+....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~-~~i~~~~--~~~~~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------W-ENLKYWK--ETLQRPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------H-HHHHhcc--ccccCCC
Confidence               23345689999999999989999999999999999999999999975443221      1 1111100  0000000


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ........+.++.+|+.+||+.+|.+||+++++++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            011112345678899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-39  Score=328.97  Aligned_cols=260  Identities=28%  Similarity=0.486  Sum_probs=212.7

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|.+.+.||+|+||+||++...      ++..+|+|.+..........+.+|+.++++++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57889999999999999999842      345789998877666677889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          391 VYEFIPNGTLYQYIHNQI----------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999997542          1234899999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHH
Q 038707          461 SDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      +|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||......+       ....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            999999765432221 1222335678999999998899999999999999999998 899986543221       1222


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      +..+....         .....+.++.+|+.+||+.+|.+|||+.+|++.|+++.+.
T Consensus       235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            22222111         1122345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-40  Score=329.33  Aligned_cols=249  Identities=35%  Similarity=0.602  Sum_probs=197.4

Q ss_pred             cCCcccccCceEEEEEEec-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          321 ANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. .....+++.+|++.+++++||||++++|++.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999986     2578999998653 344588999999999999999999999999988889999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++|+|.++|+.. ....+++..++.|+.||++||.|||+.+   ++|+||+++|||+++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999986 2335899999999999999999999998   99999999999999999999999999987632222


Q ss_pred             -eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          475 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       475 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                       ...........|+|||.+....++.++||||||+++|||++ |+.||......+       +...+.++...       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~-------  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRL-------  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEET-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccc-------
Confidence             22333446789999999999899999999999999999999 788886542211       22222222221       


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                        ..+...+..+.++|.+||+.+|++|||+++++++|
T Consensus       225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              11233456688999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-39  Score=328.07  Aligned_cols=256  Identities=30%  Similarity=0.513  Sum_probs=208.9

Q ss_pred             cCCccCCcccccCceEEEEEEecC------CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|.+.+.||+|+||.||+|...+      ++.||||..+..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999998643      478999988754444 4678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          390 LVYEFIPNGTLYQYIHNQIE-----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      +||||+++++|.+++.....           ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999976421           235889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+       ..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence            9999999976533221 11223345778999999999999999999999999999998 999986543222       11


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ..+..+...         ..+...+..+.+++.+||+.||++||++.||+++|++
T Consensus       235 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         235 ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            222222211         1122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-39  Score=335.38  Aligned_cols=241  Identities=23%  Similarity=0.331  Sum_probs=198.4

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||.||++... +|+.||||.++..   .......+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999975 6899999987642   3344567889999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeee
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT  478 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  478 (597)
                      +|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~  153 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence            999999754   34899999999999999999999999   9999999999999999999999999987543221 2233


Q ss_pred             cccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       479 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...+...       ....+..+..          ..+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~----------~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCCC
Confidence            4569999999999999999999999999999999999999996532211       1111111111          1123


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          559 EEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                      ..+.++.+|+.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3456788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1e-39  Score=336.90  Aligned_cols=245  Identities=26%  Similarity=0.335  Sum_probs=202.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||++.+. +++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56899999999999999999976 5899999987642   2234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999998643   4889999999999999999999999   999999999999999999999999999765332


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+..+..        
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~--------  232 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL--------  232 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence            2    23468999999999999999999999999999999999999996432111       1122222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  588 (597)
                        ..+...+..+.+||.+||+.||.+||+     ++++++.
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              011123456789999999999999997     6777643

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-39  Score=334.64  Aligned_cols=262  Identities=28%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||.||++... ++..+|+|..... .....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999976 5889999987753 33456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+.  |+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999997643   48999999999999999999998532  999999999999999999999999998765322 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh-------------
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-------------  540 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  540 (597)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+   +...+.....             
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence              2233468999999999999899999999999999999999999996533211   0000000000             


Q ss_pred             -----------------cCchhhhhhHHhhh----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 -----------------ENRLFEALDARVLK----EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 -----------------~~~~~~~l~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                       .....+..+.....    ......+.++.+||.+||+.||++|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                             00000111110000    0011245679999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=322.97  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=208.2

Q ss_pred             cCCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||+||+|.+..    ...||||..... ......++.+|+.++++++||||+++++.+.+.+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568899999999999999999752    457999987653 344566899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999976432  5899999999999999999999999   99999999999999999999999999987652


Q ss_pred             CCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          472 DQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       472 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+       ....+......    
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~----  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL----  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence            2222 2222335678999999998899999999999999999998 999986432211       11222211110    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                           ......+..+.+|+.+||+.+|++||++++|+++|+++
T Consensus       228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 11223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-39  Score=322.98  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=205.2

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|.+.+.||+|++|+||+|.+.++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999998777789999877432 334679999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++.....  .+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999976432  4899999999999999999999999   9999999999999999999999999987654333222


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+...         .
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL---------Y  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC---------C
Confidence            222335678999999988889999999999999999998 999986543221       11111111110         0


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      .....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11123467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-39  Score=327.46  Aligned_cols=260  Identities=27%  Similarity=0.451  Sum_probs=212.8

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .+|.+.+.||+|+||.||++...      ++..+++|............+.+|+.++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999842      345789999877666666789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          391 VYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      ||||+++++|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999976421             234899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  535 (597)
                      +||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976543222 12223446788999999998899999999999999999999 999986543221       1


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ...+..+...+         .....+..+.+++.+||+.+|++|||+++|+++|+++.+.
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            22222222211         1223456789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-40  Score=302.88  Aligned_cols=249  Identities=27%  Similarity=0.370  Sum_probs=210.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|-||.||.|..+ ++-.||+|.+...   ......++.+|++|.+.|+||||++++++|.++...||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            356899999999999999999975 6789999987632   233356799999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      +||.++|.|...|.+.. ...+++...+.++.|+|.||.|+|..+   |+||||||+|+|++..+.+||+|||.+-..+ 
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999998643 334889999999999999999999999   9999999999999999999999999986543 


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        .......+||..|+|||...+..++...|+|++|++.||++.|.+||.....++       ..+.++.-++       
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~~~-------  239 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKVDL-------  239 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHccc-------
Confidence              334556789999999999999999999999999999999999999997544222       2222222111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ..+...+....+||.+|+..+|.+|.+..|+++.
T Consensus       240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               1234556678899999999999999999999864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-39  Score=330.62  Aligned_cols=261  Identities=24%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46899999999999999999976 68899999876432 23345778999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ ++|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            97 49999987543  24789999999999999999999999   99999999999999999999999999876432221


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc------------
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE------------  541 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  541 (597)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....   .......            
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccc
Confidence             1233457899999998865 5689999999999999999999999976543221111   1111000            


Q ss_pred             CchhhhhhHHhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRLFEALDARVL----KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~~~~l~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ......+.+...    .......+.++.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000000    0011123456889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3e-39  Score=340.55  Aligned_cols=263  Identities=26%  Similarity=0.408  Sum_probs=210.2

Q ss_pred             HHhcCCccCCcccccCceEEEEEEecC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeC
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQIN-HRNIVKLLGCCLET  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  385 (597)
                      ...++|.+.++||+|+||.||+|.+..      +..||||++... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            345678999999999999999998531      347999988753 3344578999999999996 99999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC--------------------------------------------------------
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE--------------------------------------------------------  409 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  409 (597)
                      +..+|||||+++|+|.++++....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999999875321                                                        


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          410 -------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       410 -------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                                                           ...+++..++.++.||++||.|||+.+   |+|+||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                 124788899999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCc
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS  530 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~  530 (597)
                      ++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---  347 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---  347 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence            99999999999999765432221 1222346778999999988899999999999999999997 999987543221   


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                         .+...+..+..         .......+..+.+++.+||+.+|++||++.+|.++|+++..
T Consensus       348 ---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 ---TFYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence               11122222111         11123445678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=334.27  Aligned_cols=251  Identities=30%  Similarity=0.416  Sum_probs=216.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-ceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  392 (597)
                      ++|..++++|+|+||.++..+.+ ++..+++|++....  ........+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999876 57899999877643  3344578899999999999999999999999998 99999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      +|++||+|.+.+.+.. +..++++.+..|+.|++.|+.|||+..   |+|||||+.|||++.+..+||.|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999865 456999999999999999999999888   999999999999999999999999999987654


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.||.||++.+.+|..|+|||||||++|||++-+++|...+..+   +.    ..+..         ..
T Consensus       160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li----~ki~~---------~~  222 (426)
T KOG0589|consen  160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI----LKINR---------GL  222 (426)
T ss_pred             h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH----HHHhh---------cc
Confidence            4 34556779999999999999999999999999999999999999998655433   11    11111         11


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ....+...+.++..||..||+.+|..||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233456777889999999999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=341.51  Aligned_cols=252  Identities=27%  Similarity=0.490  Sum_probs=213.0

Q ss_pred             cCCcccccCceEEEEEEec-CC----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          321 ANRILGQGGQGTVYKGMLT-DG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~-~~----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..++||+|+||+||+|.+- +|    -+||||.+.. ...+...++++|+.+|.+++|||+++|++++..+. +.||.+|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            3578999999999999963 44    3688887654 44556789999999999999999999999999877 8899999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++.|+|.+|++.+..  .+..+..+.|..|||+||.|||.+.   ++||||..+|||+.+-..+||+|||+++.+..+..
T Consensus       779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999998644  4899999999999999999999998   99999999999999999999999999998875544


Q ss_pred             ee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          475 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       475 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .. .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++...++..++                +....
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----------------le~ge  917 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----------------LEKGE  917 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----------------Hhccc
Confidence            32 333344678999999999999999999999999999999 9999998877663222                22222


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .-..+...+.++..++.+||..|+..||+++++.+++.++-.
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            223356677789999999999999999999999999987654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-39  Score=320.73  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|++|.||+|...++..+|+|....... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            356888999999999999999988888899998775332 3467999999999999999999999875 45689999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.++++... ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999997642 234899999999999999999999999   999999999999999999999999999765433222


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+       ....+..+.         ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY---------RM  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence            2222335668999999988889999999999999999999 889986533211       111111110         11


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ..+...+..+.+|+.+||+.+|++|||+.++.+.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1123345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-39  Score=337.09  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..+|++.+.||+|+||.||++.+. +++.||||...      ...+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999975 68999999643      24578899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +. ++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 78988887542   4899999999999999999999999   99999999999999999999999999975432222


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC----cHHHHHHHHHhcCc------h
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK----SLVGYFLQAINENR------L  544 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~------~  544 (597)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........    ..............      .
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            2334456999999999999889999999999999999999999887543221110    01111111000000      0


Q ss_pred             hhhhhHHh---------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARV---------------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~---------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...++...               ........+.++.+||.+||+.||.+|||++|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000               00011234567899999999999999999999985

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=318.56  Aligned_cols=269  Identities=25%  Similarity=0.338  Sum_probs=212.4

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcc--ccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe-----
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSK--LVDETNVEQFINEVVILSQINHRNIVKLLGCCLE-----  384 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  384 (597)
                      ..+...|...+.||+|+||.|..+..+ +|+.||||++.  ..+....++..+|+++|+.++|+||+.+++.+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344556777889999999999999976 68999999987  5667778899999999999999999999999875     


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      -+..|+|+|+| ..+|...++...   .|+.+.+..++.||++||.|+|+.+   |+||||||+|+|++.+-.+||+|||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence            34679999999 668999988643   3999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC-CceeeecccccccccCccccc-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH-------
Q 038707          465 TSRSVMVD-QTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF-------  535 (597)
Q Consensus       465 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~-------  535 (597)
                      +|+..... .....+.+..|..|.|||++. ...|+.+.||||.||||.||++|++-|.+.+.-+.-.++...       
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            99987532 223356677899999999875 478999999999999999999999999886654433222211       


Q ss_pred             -HHHHhcCchhhhhhH------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          536 -LQAINENRLFEALDA------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       536 -~~~~~~~~~~~~l~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       ...+........+..      ......-....+...+|+.+||..||.+|+|++|.++.
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             122221111111110      00011112334567899999999999999999999863

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.3e-39  Score=321.37  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=211.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||+|... +++.||||....   ........+.+|+.++++++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999975 689999997653   23445567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|.+++..... ...+++..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999999865322 345889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......    ... ....+......      
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~~------  226 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDYP------  226 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCCC------
Confidence            221 122345788999999998888999999999999999999999998643221    111 11222211111      


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                        .......+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence              1112334567899999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-39  Score=324.55  Aligned_cols=258  Identities=27%  Similarity=0.481  Sum_probs=206.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ..++|++.+.||+|+||.||+|.+.      .++.||||+.... ......++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999999753      2567999987543 23445678999999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      .++||||+++++|.+++.+...       ...+++..++.++.|+++||.|||+.+   ++|+||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999976322       234678899999999999999999998   999999999999999999999


Q ss_pred             eeccccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHH
Q 038707          461 SDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      +|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+       ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            9999987654322211 122335778999999998889999999999999999999 788886543221       1122


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      +..+...         ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2122111         1122334568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-39  Score=330.50  Aligned_cols=256  Identities=24%  Similarity=0.490  Sum_probs=205.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|.++.. .....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45889999999999999999864 333    4899988643 344567899999999999999999999998764 5689


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ++||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999986532  4889999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +......+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---  230 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL---  230 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence            433221 222334678999999999999999999999999999998 999986533221       11222211110   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ..+...+..+.+++.+||+.+|.+||++.+++..|..+..
T Consensus       231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                  0112233468899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.3e-39  Score=323.32  Aligned_cols=262  Identities=24%  Similarity=0.434  Sum_probs=212.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe-CCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  388 (597)
                      .++|++.++||+|+||.||+|.+.+     +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678999999999999999999765     688999987643 44556778999999999999999999998776 5678


Q ss_pred             eEEEeccCCCChhhHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEE-----FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                      ++++||+++++|.+++......     ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999764322     45899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          464 GTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       464 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      |+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+       ....+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHc
Confidence            999865433322 1222345678999999988889999999999999999999 999996533211       1112211


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      +..         .......++++.+++.+||+.+|++|||+.++++.|+.+.+.+
T Consensus       235 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~  280 (280)
T cd05043         235 GYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL  280 (280)
T ss_pred             CCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence            110         0011223457899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=319.80  Aligned_cols=267  Identities=28%  Similarity=0.427  Sum_probs=205.4

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc--CCCccceeeeEEEeCC----cceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI--NHRNIVKLLGCCLETE----VPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l  390 (597)
                      ...++.++||+|.||.||||.++ ++.||||++.   ..+.+.|.+|-.|.+..  +|+||+++++.-....    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556678999999999999985 5999999986   66777888888887764  7999999999877655    7899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA------ASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      |+||.+.|+|.+||..+.    ++|....+|+..+++||+|||+.      .+++|+|||||++||||..++++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999998764    99999999999999999999973      35789999999999999999999999999


Q ss_pred             ccccccCCCce-eeecccccccccCccccccCC-CC-----cccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          465 TSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQ-FT-----EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       465 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      +|..+...... ......||.+|||||++.+.. +.     .+.||||+|.+||||+++-..++.....+.+-   .|..
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql---pfe~  438 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL---PFEA  438 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC---chhH
Confidence            99887644332 233367999999999997632 22     37999999999999999876654322111111   1222


Q ss_pred             HHhcCchhhhhhHHhhhh----------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          538 AINENRLFEALDARVLKE----------AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+....-.+-+...+..+          .....+..+.+.+..||..||+.|.|+.=|.+++.+|..
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            222222222111111110          112345678999999999999999999999999988764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=330.40  Aligned_cols=239  Identities=27%  Similarity=0.339  Sum_probs=195.2

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|+||.||++... +++.||+|.+..   ........+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 588999998763   2344567788999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecc
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV  480 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  480 (597)
                      .+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  153 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF  153 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence            99997642   4899999999999999999999999   9999999999999999999999999987543222 223345


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......      ..+..... ...          ..+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~~----------~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EPL----------RFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCC----------CCCCcC
Confidence            6899999999999999999999999999999999999999753211      11111111 110          112334


Q ss_pred             HHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPT---MKEVTN  587 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt---~~evl~  587 (597)
                      +..+.+|+.+||+.||.+||+   +.|+++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            566889999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-39  Score=325.94  Aligned_cols=264  Identities=28%  Similarity=0.440  Sum_probs=205.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-----CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  389 (597)
                      +.|++.+.||+|+||.||++...     +++.||+|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     4789999998877677778899999999999999999999987543  4678


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++++|.+++.+..  ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999999997542  34899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch---
Q 038707          470 MVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL---  544 (597)
Q Consensus       470 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  544 (597)
                      .......  .....++..|+|||.+.+..++.++||||||++++||++|..|+......        +...+.....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~  230 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM  230 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence            4332221  11222345699999998888999999999999999999988765432111        1111111000   


Q ss_pred             -----hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          545 -----FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       545 -----~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                           .+.+............+..+.+|+.+||+.+|++|||+.||+++|+.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence                 0001100001112234567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-39  Score=348.74  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=207.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-C-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-D-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..|.+.+.||+|++|.||+|... + ++.||+|............+.+|+.+++.++||||+++++++.+.+..+|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34899999999999999999864 3 678999987766666667888999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++|+|.+++++. ....++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999998753 23456899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             c-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          474 T-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       474 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+..+...       
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~-------  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYD-------  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence            2 12334568999999999999999999999999999999999999996532211       11111111110       


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+...+..+.+||.+||+.+|++||++.+++.
T Consensus       290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              112234456889999999999999999999875

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.3e-39  Score=320.22  Aligned_cols=255  Identities=24%  Similarity=0.426  Sum_probs=207.7

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .+.|++.++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence            46789999999999999999998888999999876433 3456889999999999999999999986 456789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.... ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999987643 345899999999999999999999999   999999999999999999999999999766433222


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||......+       ....+..+..         .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYR---------M  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCC---------C
Confidence            2233345678999999988889999999999999999999 999997543211       1111111110         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ......+.++.+++.+||..+|++||+++++++.|+.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            11223345799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=320.49  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=203.7

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +|++.+.||+|+||.||++.+.++..+|+|..... .....++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            47888999999999999999877778999987532 22345788999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999976432  5899999999999999999999999   99999999999999999999999999876543222222


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..         ...
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGYR---------LYR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCCc---------CCC
Confidence            22234567999999998899999999999999999999 899987543221       1111111100         011


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      +...+.++.+|+.+||..+|++|||+.|+++.|.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            1234567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.4e-39  Score=319.31  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|+||.||+|.+.+...||+|+..... ...+++.+|+.++++++||||+++++.+. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            5689999999999999999998776789999887432 23467899999999999999999999874 456799999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++.+.. ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++.........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999998642 234799999999999999999999999   9999999999999999999999999997654333222


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+       ....+..+.         ...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~---------~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY---------RMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC---------CCC
Confidence            223346678999999988889999999999999999999 888886543221       111111110         001


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      .....+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=348.03  Aligned_cols=261  Identities=23%  Similarity=0.362  Sum_probs=216.8

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEecCC-cEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeE-EEeC----
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLTDG-RIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGC-CLET----  385 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~----  385 (597)
                      .....++++.+.|.+|||+.||+|.+..+ ..+|+|++...++...+.+++||.+|++|+ |+|||.+++. ....    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34456788889999999999999998765 999999998889999999999999999996 9999999993 3221    


Q ss_pred             --CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          386 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       386 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                        -+.+|.||||.+|.|.|++....... |++.++++|+.++++|+++||... +||||||||-+||||..+++.||+||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence              25679999999999999999765544 999999999999999999999987 66999999999999999999999999


Q ss_pred             cccccccCCCcee--------eecccccccccCcccc---ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH
Q 038707          464 GTSRSVMVDQTHL--------TTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV  532 (597)
Q Consensus       464 gl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~  532 (597)
                      |.+..........        .....-|+.|.|||.+   .+...++|+|||+|||+||-|.....||.....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9986543222110        0112258999999985   567899999999999999999999999964321       


Q ss_pred             HHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       533 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                                  ..+++..+.......++..|.+||+.||+.||++||++-+|++++-+|+.
T Consensus       264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                        12333333344446788889999999999999999999999999988874

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.2e-39  Score=325.55  Aligned_cols=263  Identities=28%  Similarity=0.436  Sum_probs=210.9

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCL  383 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  383 (597)
                      ++...++|++.+.||+|+||.||++....      ...+|+|..... ......++.+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34445678899999999999999998642      367999987743 334556789999999999 7999999999999


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI  450 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NI  450 (597)
                      +.+..+++|||+++++|.++++...             ....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            9999999999999999999997531             2346899999999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCC
Q 038707          451 LLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED  528 (597)
Q Consensus       451 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~  528 (597)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            9999999999999999865433221 1222335678999999988899999999999999999997 999986543222 


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                            ....+..+..         ...+...+..+.+|+.+||+.+|++|||+.|+++.|+++.
T Consensus       243 ------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 ------LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                  1122222111         1112233557889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.8e-39  Score=331.75  Aligned_cols=242  Identities=23%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      ++||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 6899999987642   3345677889999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeee
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT  478 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  478 (597)
                      +|.+++....   .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  153 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK  153 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence            9999987542   4899999999999999999999999   9999999999999999999999999987543221 2233


Q ss_pred             cccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       479 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+       ....+.....          ..+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~----------~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDI----------KFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCc----------cCCC
Confidence            4568999999999998899999999999999999999999996533211       1111111100          1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          559 EEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                      ..+.++.+|+.+||+.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3445688999999999999997     88988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.2e-39  Score=331.99  Aligned_cols=261  Identities=29%  Similarity=0.477  Sum_probs=207.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC-C
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLET-E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  386 (597)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999742      24789999876432 33456788999999999 799999999988754 4


Q ss_pred             cceEEEeccCCCChhhHHhhcCC---------------------------------------------------------
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIE---------------------------------------------------------  409 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  409 (597)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999865321                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee-eeccccccccc
Q 038707          410 -EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV  487 (597)
Q Consensus       410 -~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~  487 (597)
                       ..++++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999998   9999999999999999999999999998764332221 22334567899


Q ss_pred             CccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHH
Q 038707          488 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT  566 (597)
Q Consensus       488 aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~  566 (597)
                      |||++.+..++.++||||||++|+||++ |..||......+      .+...+..+...         ..+...++++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM---------RAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC---------CCCccCCHHHHH
Confidence            9999999999999999999999999998 999997543222      112222222111         112233467889


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          567 LAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       567 li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ++.+||+.+|++||++.||+++|+++..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7e-39  Score=323.56  Aligned_cols=256  Identities=25%  Similarity=0.464  Sum_probs=206.2

Q ss_pred             cCCccCCcccccCceEEEEEEe-----cCCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..|++.+.||+|+||+||+|.+     ..+..+++|.+.. ........+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4578889999999999999985     2457899998874 334445788999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          391 VYEFIPNGTLYQYIHNQIE--------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      ||||+++++|.+++.....              ...+++.+++.++.|++.||.|||+.+   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999964321              234789999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~  534 (597)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976543222 12223335678999999988889999999999999999998 999986533211       


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ....+......         ..+...+..+.+++.+||+.+|.+||++.+|+++|+.
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            22222222211         1122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.2e-39  Score=331.49  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=197.6

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||.||++... +|+.||+|.+...   .......+.+|+.++++++||||+++++++.+.+..+|||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999975 6899999987642   3345567889999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeee
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT  478 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~  478 (597)
                      +|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....... ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~  153 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence            9999887542   4899999999999999999999999   9999999999999999999999999987543222 2223


Q ss_pred             cccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       479 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+      .. ..+.....          ..+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~-~~~~~~~~----------~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LF-ELILMEEI----------RFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCC----------CCCC
Confidence            4568999999999998999999999999999999999999996533221      11 11111110          1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          559 EEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                      ..++++.+|+.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            3456688999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.7e-39  Score=324.95  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=205.1

Q ss_pred             cCCccCCcccccCceEEEEEEecC-C--cEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-G--RIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~--~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++. ......+.+.+|+.+++++ +||||+++++++.+....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468899999999999999999753 3  3578888774 3344567899999999999 799999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          392 YEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      +||+++++|.++++....             ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999976321             124889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||++......  ........+..|+|||++....++.++||||||+++|||++ |..||......+       ...
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE  229 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence            99999998643211  11111223457999999988889999999999999999997 999996543221       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+..+         .....+...+..+.+|+.+||+.+|.+||++.+++++|+.+..
T Consensus       230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111         1111122345678899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-39  Score=332.99  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             hcCCccCCcccccCceEEEEEEecC--CcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||.||+|.+..  +..||+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3569999999999999999998653  368999987532   33456678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999998643   4899999999999999999999999   9999999999999999999999999997653


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..    .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...       ....+..+..      
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------  245 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII------  245 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC------
Confidence            22    223468999999999998889999999999999999999999997533211       1112222111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                          ..+...+..+.+++.+||+.+|++|+     +++++++.
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                01122345578999999999999995     88888764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.7e-38  Score=369.61  Aligned_cols=265  Identities=27%  Similarity=0.443  Sum_probs=210.2

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +.....+...++||+|+||.||+|... +++.||||++......    ...|++.+++++|||||++++++.+.+..++|
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            333456778889999999999999974 7899999988643322    23468899999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.++++.      ++|..+.+++.|+++||+|||....++|+||||||+||+++.++..++. |+.......
T Consensus       762 ~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            999999999999963      8899999999999999999996655559999999999999999888875 665543221


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .     ....+++.|||||++.+..++.++|||||||++|||++|+.||.... ........+.............+++.
T Consensus       835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcc
Confidence            1     12357899999999999999999999999999999999999995432 22334444444333333334444444


Q ss_pred             hhh--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          552 VLK--EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       552 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      +..  ....+...++.+++.+||+.+|++||||+||+++|+++.+
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            322  2234556678899999999999999999999999998865

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.7e-39  Score=330.90  Aligned_cols=263  Identities=27%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+... .....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999976 5888999987653 33455779999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+. +   |+|+||||+|||+++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999997642   488999999999999999999975 5   999999999999999999999999998755322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH-------------------
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG-------------------  533 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~-------------------  533 (597)
                         ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......+......                   
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               1233468999999999998889999999999999999999999997543211000000                   


Q ss_pred             -HHHHHHh-----cCchhhhhhHHhhhhh----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          534 -YFLQAIN-----ENRLFEALDARVLKEA----KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       534 -~~~~~~~-----~~~~~~~l~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .......     ........+.......    ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence             0000000     0000011111000000    0113456899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.5e-39  Score=325.45  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             cCCccCCcccccCceEEEEEEec--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCccceeeeEEEe-----
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLE-----  384 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  384 (597)
                      ++|++.+.||+|+||+||+|...  +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999863  46889999876432  22344566777777766   69999999999853     


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      ....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346789999996 69999997643 234899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--  542 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  542 (597)
                      +++.....  .......|++.|+|||.+.+..++.++||||||+++|||++|++||......+   ............  
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE  230 (290)
T ss_pred             ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCCh
Confidence            99765432  22334558999999999988899999999999999999999999997644322   111111111000  


Q ss_pred             -chh-------hhhhH---HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          543 -RLF-------EALDA---RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       543 -~~~-------~~l~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .+.       ..+.+   ..........++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             000       00000   0000111234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-39  Score=322.80  Aligned_cols=267  Identities=29%  Similarity=0.443  Sum_probs=203.8

Q ss_pred             CccCCcccccCceEEEEEEe-----cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceE
Q 038707          319 YNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL  390 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  390 (597)
                      |++.+.||+|+||+||++..     .+++.||+|...... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     257789999876533 33567789999999999999999999988764  35789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      +|||+++++|.+++...    .+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999999754    3899999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  ......++..|+|||.+.+..++.++||||||++++||++|..|+......-. ..............+.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence            32221  11222356679999999888899999999999999999999999865332110 0000000000000111111


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      +.......+...+.++.+++.+||+.+|++|||+++|++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111112334567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=318.17  Aligned_cols=255  Identities=26%  Similarity=0.473  Sum_probs=204.3

Q ss_pred             CccCCcccccCceEEEEEEecC----CcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-----
Q 038707          319 YNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-----  387 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  387 (597)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++..  ......++.+|+..++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    368999987743  34456789999999999999999999999876554     


Q ss_pred             -ceEEEeccCCCChhhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          388 -PLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       388 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                       .++++||+++++|.+++....   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999986532   2235899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          464 GTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       464 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+       ....+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc
Confidence            9998664332221 112234678999999988899999999999999999999 889986533211       1122222


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      +...         ..+...+..+.+++.+||+.||++||++.||++.|+++
T Consensus       231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2111         11233456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-38  Score=322.83  Aligned_cols=258  Identities=28%  Similarity=0.443  Sum_probs=207.1

Q ss_pred             CCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      +|++.+.||+|+||.||+|...      ....+++|...... .....++.+|+.+++.++||||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999853      23578888876433 3456789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 038707          391 VYEFIPNGTLYQYIHNQI---------------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~N  449 (597)
                      ++||+++++|.+++....                     ...++++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999987531                     1135889999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcC
Q 038707          450 ILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE  527 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~  527 (597)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999997654332211 222335678999999988889999999999999999998 999986543221


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                             .........         ....+...+.++.+++.+||+.+|++||++.++++.|+++-.
T Consensus       238 -------~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 -------LFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -------HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                   112221111         111123344678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-38  Score=314.50  Aligned_cols=247  Identities=28%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      ++||+|+||.||+|...++..+|+|...... ......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998888999999876543 334557899999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeeccc
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ  481 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  481 (597)
                      +++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++...............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            9987543  34889999999999999999999999   999999999999999999999999998754322222222233


Q ss_pred             ccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       482 gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      ++..|+|||++....++.++||||||+++|+|++ |..||......+       ....+..+..         .......
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYR---------MSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCCCC
Confidence            4678999999998889999999999999999998 999996543221       1111111110         1112234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      +..+.+|+.+||+.+|++||++.+++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-38  Score=316.11  Aligned_cols=248  Identities=28%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      +.||+|+||.||+|.+. +++.+|+|.... ........+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999975 689999998654 3344567899999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee-ec
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TK  479 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~  479 (597)
                      .+++....  ..+++..++.++.|+++||.|||+.+   |+|+||||+|||++.++.+||+|||++........... ..
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99997532  34899999999999999999999999   99999999999999999999999999875432211111 11


Q ss_pred             ccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       480 ~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||......+       ....+...         .......
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCCCCcc
Confidence            123457999999998889999999999999999998 888886433211       11111111         0111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ..+..+.+|+.+||+.+|++|||+.+|+++|+.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=308.76  Aligned_cols=261  Identities=22%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhh--HHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  391 (597)
                      ++|+.++.|++|.||.||+|+++ +++.||+|+++...+..  .-..++||.+|.+.+|||||.+-.+....  +..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45778889999999999999986 68999999988754332  23468999999999999999999988754  478999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||++. +|..+++...  .++...++.-++.|+++||+|||.+.   |+|||||++|+|+...|.+||+|||+|+.+..
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 8999998754  45899999999999999999999999   99999999999999999999999999998865


Q ss_pred             CCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh---cCchhhh
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---ENRLFEA  547 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  547 (597)
                      +. ...+...-|..|.|||++.+ ..|+.+.|+||+|||+.||+++++-|.+...-++  +...| ..+.   +..+..+
T Consensus       230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If-~llGtPte~iwpg~  305 (419)
T KOG0663|consen  230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIF-KLLGTPSEAIWPGY  305 (419)
T ss_pred             Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHH-HHhCCCccccCCCc
Confidence            43 34566678999999999876 5799999999999999999999999887553332  21111 1111   1111000


Q ss_pred             --h------------hHHhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 --L------------DARVLKEAKKE-EIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 --l------------~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        +            ...+...+... ..+.-.+|+..+|..||.+|.|++|.|+
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              0            00111111111 3466789999999999999999999875

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-38  Score=325.18  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 689999998765332 234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |++ ++|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 68888887542  34889999999999999999999999   9999999999999999999999999987543221


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc---h---h-
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---L---F-  545 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~-  545 (597)
                       .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......  ..............   +   . 
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence             12233457899999999865 458899999999999999999999997643211  11111111000000   0   0 


Q ss_pred             -hhhhHH---------hhhh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 -EALDAR---------VLKE-AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 -~~l~~~---------~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ....+.         +... .....+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             000000         0000 00012356789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=336.66  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|.+.+.||+|+||+||++... +++.||||++...   .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 6899999987642   2245567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999865   34899999999999999999999999   999999999999999999999999999765433


Q ss_pred             C----------------------------ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          473 Q----------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       473 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                      .                            ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                            112233468999999999999999999999999999999999999997544


Q ss_pred             CcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 038707          525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-MKEVTNE  588 (597)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~  588 (597)
                      ..+      ..........       ..........++.+.+||.+||+ +|.+||+ ++++++.
T Consensus       235 ~~~------~~~~i~~~~~-------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQE------TYNKIINWKE-------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH------HHHHHhccCC-------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            211      1111111000       00000011145678899999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.5e-39  Score=331.10  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=200.6

Q ss_pred             CCccCCcccccCceEEEEEEec----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      +|++.+.||+|+||.||++...    +++.||+|.+...    .....+.+..|+.++..+ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998852    5789999987532    223456788999999999 499999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999997543   4899999999999999999999999   99999999999999999999999999976


Q ss_pred             ccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .............||+.|+|||++.+. .++.++||||||+++|||++|+.||.........   ..+...+...     
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~-----  226 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC-----  226 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC-----
Confidence            544333333445699999999998765 4789999999999999999999999754322211   1111111110     


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                       ++    ..+...+..+.+|+.+||+.||++||     +++++++
T Consensus       227 -~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 -DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             00    11223455688999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.2e-39  Score=336.18  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=203.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+..   ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467999999999999999999976 588999998753   223344567899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999999753    3888999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccccccCccccccC----CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ...........||+.|+|||++.+.    .++.++||||||++||||++|+.||......      ..+...........
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~  267 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT  267 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC
Confidence            3322223345699999999998653    4789999999999999999999999753321      11111111100000


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                             .......+.++.+||.+||+.+|.+  ||+++++++.
T Consensus       268 -------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 -------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                   0011134567889999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.7e-38  Score=315.99  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|++|.||+|... +++.+|+|..+.   ......+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999987 789999997753   33444678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|.+++.... ....+++.+++.++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999997532 2345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....    +... ....+..+....     
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~~-----  227 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEKCDYPP-----  227 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH-HHhhhhcCCCCC-----
Confidence            221 12234578899999999888899999999999999999999999864321    1111 111111111110     


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                         ......+..+.++|.+||..+|++|||+.+|+++|++++
T Consensus       228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               011244567889999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-39  Score=332.92  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=198.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cce
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL  389 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  389 (597)
                      +|++.+.||+|+||.||+|... +++.||||++...  ......++.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999975 6899999987642  2334567889999999999999999999886433     479


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||++ ++|.+++....   .+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68999887543   4899999999999999999999999   999999999999999999999999999765


Q ss_pred             cCCCc--eeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH--------HHHH
Q 038707          470 MVDQT--HLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG--------YFLQ  537 (597)
Q Consensus       470 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~--------~~~~  537 (597)
                      .....  .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||.............        ....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221  12234568999999999865  678999999999999999999999997543211000000        0000


Q ss_pred             HHhcCchhhhhhH---Hhhh---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          538 AINENRLFEALDA---RVLK---EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       538 ~~~~~~~~~~l~~---~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .+......+.+..   ....   ......++.+.+++.+||+.||++|||++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0111111111100   0000   0001234567899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-38  Score=320.70  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=207.5

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .+|...++||+|+||.||++...      ++..+++|..........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45778899999999999999742      356899998887777777899999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          391 VYEFIPNGTLYQYIHNQIE------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      +|||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999986432            124889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence            99999998765432221 1222335678999999998899999999999999999998 899986433221       11


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ..+..+..         ...+...+..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       235 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11111111         01112344568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.6e-38  Score=326.44  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||.||++... +++.||+|.++..   .......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999976 6889999987642   233456688999999998 699999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT  153 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence            9999988754   24999999999999999999999999   9999999999999999999999999987532211 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC--CCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+  ......+..+.+.....          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence            34568999999999999999999999999999999999999997543322  11112222222222211          1


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPT------MKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~  587 (597)
                      .+...+..+.+|+.+||+.||.+||+      ++++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12233456889999999999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-38  Score=319.83  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=204.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|.+.+.||+|++|.||+|.+.+      +..|++|...... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999999753      5688999876433 34456799999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEe
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVS  461 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~  461 (597)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+.+   ++|+||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999986532    125899999999999999999999999   99999999999998754   59999


Q ss_pred             eccccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          462 DFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       462 Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      |||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+       ....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            999998653222111 112223567999999998899999999999999999997 999987543221       11111


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .....         ...+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         235 TGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11110         11122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.3e-39  Score=331.93  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=204.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||+|.++..   .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999976 6899999987642   2334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999998652  34899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccccccCccccc------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQ------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .........||+.|+|||++.      ...++.++||||||+++|||++|+.||......+      .+...........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC
Confidence            333334456899999999986      4567899999999999999999999997533211      1111111111100


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .       ......+..+.+|+.+||+ +|.+|||+.++++
T Consensus       230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0       0011245568899999997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-38  Score=327.00  Aligned_cols=241  Identities=27%  Similarity=0.382  Sum_probs=196.0

Q ss_pred             CcccccCceEEEEEEec----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.||+|+||.||++...    .++.||+|.++..    .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999853    5789999987642    223445678999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++....   .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999999997543   4788999999999999999999999   9999999999999999999999999987543222 


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .......|++.|+|||++.+..++.++||||||+++|||++|+.||.......       ....+..+..          
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~----------  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL----------  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------
Confidence            22233568999999999998889999999999999999999999997533211       1111111111          


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                      ..+...+..+.+||.+||+.+|++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11223345688999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-38  Score=315.42  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=204.6

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|++|.||++.+..+..+|+|...... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688889999999999999998777789999876432 23467889999999999999999999875 456899999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.++++... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            999999997642 334899999999999999999999999   9999999999999999999999999997654332222


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..         ..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYR---------MP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------CC
Confidence            223346678999999988889999999999999999999 899987543211       1111111110         01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .....+..+.+++.+||+.+|++||++++|++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            123345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-38  Score=325.37  Aligned_cols=261  Identities=27%  Similarity=0.433  Sum_probs=209.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET  385 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  385 (597)
                      .++|.+.+.||+|+||.||++...        +...+|+|..... ......++.+|+.+++++ +||||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357999999999999999999853        1346999988753 344567789999999999 799999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      +..++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999986432             134899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCc
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS  530 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~  530 (597)
                      ++++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....++   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            99999999999998765322111 1112224568999999988889999999999999999998 888886433211   


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                          +...+..+..         .+.+...+.++.+|+.+||+.+|.+|||+.+|++.|+++.+.
T Consensus       251 ----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         251 ----LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                1222222211         111233456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-38  Score=317.22  Aligned_cols=260  Identities=25%  Similarity=0.372  Sum_probs=210.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|++|.||++... +++.++||....   .......++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 789999997654   23345578899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999987532 2345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+.    .. ....+.....       
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~-------  225 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDY-------  225 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HH-HhhhhhcCCC-------
Confidence            221 1223458889999999988889999999999999999999999986533211    11 1111111110       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                       ........+..+.+++.+||+.+|++|||+.+|++.++++-
T Consensus       226 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 -PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             00111235567899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-38  Score=317.09  Aligned_cols=255  Identities=26%  Similarity=0.485  Sum_probs=201.3

Q ss_pred             CccCCcccccCceEEEEEEecC-Cc--EEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------Cc
Q 038707          319 YNANRILGQGGQGTVYKGMLTD-GR--IVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------EV  387 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  387 (597)
                      +.+.+.||+|+||.||+|.+.. +.  .+|+|..+..  .....+.+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999764 33  6899987643  455677899999999999999999999987532      24


Q ss_pred             ceEEEeccCCCChhhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      .+++|||+++|+|.+++....   ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885321   2234899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          465 TSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       465 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      +++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcC
Confidence            998764332211 122235678999999999999999999999999999999 888986532211       12222222


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ....         .....+..+.++|.+||+.+|++|||+.++++.|+++
T Consensus       231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2111         1123445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.3e-39  Score=334.54  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+..   ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999976 588999998753   223345568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999753    3889999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCceeeecccccccccCccccccC----CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ...........||+.|+|||++...    .++.++||||||++||||++|+.||......      ..+...+.......
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~  267 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLN  267 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccC
Confidence            3333233456699999999998654    3789999999999999999999999754321      11111111111000


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                             .......+..+.+++.+||+.++.+  ||++.|+++.
T Consensus       268 -------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 -------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                   0111234566788999999755543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=315.27  Aligned_cols=251  Identities=29%  Similarity=0.470  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|++|.||++... ++.||+|....... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999875 78999999876544 5678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999986532 35899999999999999999999999   99999999999999999999999999976532211 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                         ....+..|+|||.+....++.++||||||+++++|++ |..||......+       .......+.         ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGY---------RM  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC---------CC
Confidence               2334668999999988889999999999999999997 999986443221       111111111         01


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ..+...++.+.+++.+||..+|++|||+++++++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-38  Score=314.32  Aligned_cols=245  Identities=30%  Similarity=0.445  Sum_probs=198.3

Q ss_pred             cccccCceEEEEEEec---CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          324 ILGQGGQGTVYKGMLT---DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   47889999876432  345678999999999999999999999875 45678999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee-
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-  477 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-  477 (597)
                      +|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999997542   4899999999999999999999999   99999999999999999999999999987644332211 


Q ss_pred             -ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          478 -TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       478 -~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                       ....++..|+|||.+....++.++||||||+++|||++ |+.||......+       ....+..+..         ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~---------~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGER---------ME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC---------CC
Confidence             12234578999999988889999999999999999998 999997543221       2222222211         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .+...+.++.+||.+||+.||++||++.+|.+.|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            123345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.7e-38  Score=318.66  Aligned_cols=257  Identities=23%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|...... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            45778899999999999999974 344    47788765432 334567888999999999999999999875 455789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ++||+++|+|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999998643  34899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--
Confidence            33221 2233446778999999988899999999999999999998 999987543221       112222221111  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                             .+......+.+++.+||..+|++|||+.|+++.|..+...
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                   0111234578899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-38  Score=323.68  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR--IVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||.||+|.++ ++.  .+++|..+.. .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888999999999999999975 444  4678776642 344567889999999999 899999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          392 YEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      |||+++++|.++++....             ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999976421             235889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||++.......  .......+..|+|||.+.+..++.++||||||++++||++ |..||......+       ...
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  234 (303)
T ss_pred             EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHH
Confidence            999999986432111  1111224567999999988889999999999999999998 999996543221       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+....         ....+...+..+.+|+.+||+.+|++||++.++++.|+++..
T Consensus       235 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         235 KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111110         001112234568899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-38  Score=316.44  Aligned_cols=256  Identities=28%  Similarity=0.475  Sum_probs=207.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CC---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DG---RIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|+..+.||+|+||.||+|.+. ++   ..+++|..... .....+++.+|++++++++|+||+++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356888899999999999999975 33   37999987654 34456789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++....  ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999997643  34899999999999999999999999   9999999999999999999999999987664


Q ss_pred             CCCceeee--cccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          471 VDQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       471 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ........  ....+..|+|||++....++.++||||||+++|||++ |+.||......+       ....+.....   
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~---  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFR---  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCC---
Confidence            32222111  1223457999999988889999999999999999997 999996533211       2222222110   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                            .......+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       229 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 ------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  111223456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.7e-38  Score=325.23  Aligned_cols=243  Identities=27%  Similarity=0.416  Sum_probs=194.6

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||+||++... +++.+|+|.++..   .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 5889999987642   334456788899988877 799999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~  153 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT  153 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence            9999988754   24899999999999999999999999   9999999999999999999999999987543221 122


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC--CCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+....+.....          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            34568999999999999999999999999999999999999996433221  11112222222222111          1


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                      .+...+..+.+|+.+||+.||++||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            123345568899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=334.79  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=200.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||||++...   .......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999976 6899999987642   2344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999997643   4899999999999999999999999   999999999999999999999999998754321


Q ss_pred             Cce-------------------------------------eeecccccccccCccccccCCCCcccceeehHHHHHHHHh
Q 038707          473 QTH-------------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT  515 (597)
Q Consensus       473 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~  515 (597)
                      ...                                     ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            100                                     0112358999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038707          516 GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT---MKEVTN  587 (597)
Q Consensus       516 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  587 (597)
                      |..||......+      .............       .......++.+.+||.+|+. +|.+|++   ++++++
T Consensus       235 G~~Pf~~~~~~~------~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQE------TYRKIINWKETLQ-------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHH------HHHHHHcCCCccC-------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999997543221      1111111000000       00011234567899999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-38  Score=334.92  Aligned_cols=265  Identities=26%  Similarity=0.428  Sum_probs=210.0

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCccceeeeEE
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCC  382 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  382 (597)
                      +.+...++|.+.+.||+|+||.||+|.+.      .++.||||+++... ....+.+.+|+.+|.++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            34455567888999999999999999863      24689999987532 333567899999999997 99999999999


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCC-----------------------------------------------------
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIE-----------------------------------------------------  409 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  409 (597)
                      ...+..++||||+++|+|.+++++...                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999975321                                                     


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 038707          410 ------------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS  447 (597)
Q Consensus       410 ------------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~  447 (597)
                                                                ...+++..++.++.||+.||.|||+.+   ++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence                                                      123678889999999999999999998   99999999


Q ss_pred             CCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCC
Q 038707          448 ANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINT  525 (597)
Q Consensus       448 ~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~  525 (597)
                      +|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976532221 11222346788999999998889999999999999999998 8899865432


Q ss_pred             cCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      .+      .....+..+..         ...+...+.++.+|+.+||+.+|.+||++++|++.|+++-
T Consensus       348 ~~------~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NE------QFYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hH------HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            21      11111111110         0112233567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=317.29  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=208.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..++|.+.+.||+|++|.||+|..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++.+....++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346799999999999999999998888889999877432 3457799999999999999999999999998999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999998643 235899999999999999999999999   99999999999999999999999999876543222


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      ........+..|+|||.+.+..++.++||||||+++++|++ |+.||.......       ....+..+.         .
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY---------R  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence            22222334568999999998889999999999999999998 999986533211       111111110         0


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ...+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            01112235678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.9e-38  Score=314.98  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=208.0

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||.||++.+.++..+++|..... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678999999999999999999877888999987643 3345789999999999999999999999887 7789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999997643 335889999999999999999999998   999999999999999999999999999765433222


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||++....++.++|+||||+++++|++ |+.||......+       ....+..+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM---------  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCC---------
Confidence            2223345678999999988889999999999999999998 999986533211       11222221111         


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ......+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            11223455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=332.21  Aligned_cols=248  Identities=25%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .+|+..+.||+|+||+||++.+. +++.||||.+... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999976 6899999987643 334457789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+..       ...+..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999986532       2567788899999999999999999   9999999999999999999999999997654222 


Q ss_pred             eeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .......||..|+|||++..     ...+.++||||||+++|||++|+.||......+.   .. ....+...       
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~-~~~~~~~~-------  291 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---AS-LMCAICMS-------  291 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HH-HHHHHhcc-------
Confidence            12234568999999998743     2345689999999999999999999974322221   10 00111000       


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        .........+.++.+||.+||+.||++|||+.|+++.
T Consensus       292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0011123345678999999999999999999999874

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.2e-39  Score=329.34  Aligned_cols=242  Identities=23%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||.||++... +++.||+|.+...   .......+.+|++++..++||||+++++++.+.+..+|||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999975 6899999987642   2344567889999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      +|.+++....   .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM  153 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence            9999887542   48999999999999999999997 67   99999999999999999999999999875432221 22


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....++       ....+.....          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~----------~~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RFP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence            34568999999999998999999999999999999999999996533221       1111111110          112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                      ...+.++.+|+.+||+.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            23345688999999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3e-38  Score=322.06  Aligned_cols=259  Identities=28%  Similarity=0.447  Sum_probs=208.4

Q ss_pred             HhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE  386 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  386 (597)
                      ..++|.+.+.||+|+||.||++...      .+..+|+|..+... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467999999999999999999742      24579999876543 34457799999999999 7999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+++|||+++++|.++++.... ..+++.++..++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999976432 23899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          467 RSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       467 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      +........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+      .+......+. 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~-  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGY-  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCC-
Confidence            866433221 1222345678999999998899999999999999999998 999987543221      1111111111 


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                              ........++++.+|+.+||..+|++|||+.|+++.|+++
T Consensus       262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    0011122345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.5e-39  Score=346.59  Aligned_cols=259  Identities=27%  Similarity=0.354  Sum_probs=208.3

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-  386 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  386 (597)
                      +.....++|.+.+.||+|+||+||++... +++.||||.+..  ........+.+|+..+..++|+||++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445679999999999999999999865 689999998754  34556677899999999999999999988775433 


Q ss_pred             -------cceEEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          387 -------VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       387 -------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                             ..++||||+++|+|.++++... ...++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   3579999999999999997643 2346899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||+++....... .......||+.|+|||++.+..++.++||||||++||||++|+.||......+       ...
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~  255 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMH  255 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHH
Confidence            9999999976543221 22334568999999999999999999999999999999999999996532211       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ....+..         ...+...++++.+|+.+||+.+|.+||++.++++.
T Consensus       256 ~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111         11123345678999999999999999999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-38  Score=333.72  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=198.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .|++.+.||+|+||+||+|... +++.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999975 5889999987642   33456678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.+..   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999997643   4889999999999999999999999   9999999999999999999999999975331100


Q ss_pred             c----------------------------------------------eeeecccccccccCccccccCCCCcccceeehH
Q 038707          474 T----------------------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG  507 (597)
Q Consensus       474 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG  507 (597)
                      .                                              .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                              001234699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhc--ccCCCCCCCHHHH
Q 038707          508 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCL--NLNGKMRPTMKEV  585 (597)
Q Consensus       508 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl--~~~p~~RPt~~ev  585 (597)
                      |++|||++|+.||......+.      ....+.....       .........+.++.+||.+|+  ..++..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET------QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH------HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999976432221      1111110000       000011123456788998854  5566669999999


Q ss_pred             HHH
Q 038707          586 TNE  588 (597)
Q Consensus       586 l~~  588 (597)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-38  Score=321.19  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             CCccCCcccccCceEEEEEEecC------CcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .|++.+.||+|+||.||+|...+      +..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46777899999999999998642      47899999875433 335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          391 VYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      ++||+++++|.+++....             ....+++..++.++.|++.||.|||+++   |+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999986321             1234888999999999999999999999   999999999999999999


Q ss_pred             EEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  535 (597)
                      +||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||......+       .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence            99999999876543222 12223345778999999988889999999999999999998 888886543221       2


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ...+..+...         ..+...+..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus       236 ~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2222222211         1123455678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-38  Score=315.80  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=208.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecC----CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|.+.+.||+|+||.||+|.+.+    ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3458888999999999999998643    2468999876544 5566789999999999999999999998875 55789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999976432  4899999999999999999999999   9999999999999999999999999987665


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...........++..|+|||.+....++.++||||||++++||++ |..||......+       ....+..+...    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~----  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENGERL----  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCcC----
Confidence            443222333345568999999988889999999999999999996 999997543221       11111111110    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           ..+...+..+.+++.+||..+|++|||+.++++.|++++..
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 11233456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-38  Score=322.52  Aligned_cols=262  Identities=27%  Similarity=0.442  Sum_probs=210.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLE  384 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  384 (597)
                      ..++|.+.+.||+|+||.||++...        ++..||+|..... ......++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567889999999999999999741        2457999987643 344567899999999999 89999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL  451 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIl  451 (597)
                      ....++||||+++++|.+++.....             ...+++..++.++.||++||.|||+++   |+||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999986421             235788999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK  529 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~  529 (597)
                      +++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            999999999999999866432222 1222345678999999988889999999999999999998 788886443221  


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           ....+..+...         ......+..+.+|+.+||+.+|++||++.|+++.|+++.+.
T Consensus       248 -----~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 -----LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                 12222222111         11223456788999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.4e-38  Score=314.94  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-C---CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-D---GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999864 2   3479999876432 34467899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....  ..+++.+++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999997643  34899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeee--cccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          472 DQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       472 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .......  ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+       ....+.++..    
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR----  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc----
Confidence            3322221  1223568999999998899999999999999999887 999987543221       1112221110    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                           .......+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 011123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-38  Score=326.69  Aligned_cols=244  Identities=25%  Similarity=0.372  Sum_probs=195.4

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHH---hhcCCCccceeeeEEEeCCcceEE
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVIL---SQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      |++.+.||+|+||.||++... +++.||||.++..   .....+.+.+|+.++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999976 6899999987642   233445677776655   566899999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|..+++..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999999888642    4899999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+       ....+..+..       
T Consensus       154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~-------  218 (324)
T cd05589         154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEV-------  218 (324)
T ss_pred             CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence            21 22334568999999999999999999999999999999999999997543221       1111111111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                         ..+...+..+.++|.+||+.||.+||     ++.++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               11223456688999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.4e-38  Score=313.18  Aligned_cols=247  Identities=27%  Similarity=0.439  Sum_probs=197.8

Q ss_pred             cccccCceEEEEEEec---CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCC
Q 038707          324 ILGQGGQGTVYKGMLT---DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  399 (597)
                      .||+|+||.||+|.+.   .+..||+|...... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   35679999887543 334567999999999999999999999875 457899999999999


Q ss_pred             hhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee--
Q 038707          400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--  477 (597)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--  477 (597)
                      |.+++....  ..+++..++.++.|++.||.|||+++   ++|+||||+|||++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999997532  35899999999999999999999999   99999999999999999999999999976543322211  


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||......+       +...+..+..         ...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKR---------LDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC---------CCC
Confidence            11223578999999988889999999999999999996 999997543221       1122222111         112


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      +...++++.+++.+||+.+|++||++.+|++.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            233456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=310.18  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=207.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChh--hHHHHHHHHHHHhhcCCCc-cceeeeEEEeCC------
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRN-IVKLLGCCLETE------  386 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  386 (597)
                      ..|...++||+|+||+||+|+.. +|+.||+|++....++  ......+|+.+|+.++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666778999999999999975 6899999998875443  4456789999999999999 999999999877      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      .++||+||+ ..+|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            788999999 55999999876532 23777899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc---
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---  541 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---  541 (597)
                      |+....+... .+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+....+   ........+..   
T Consensus       167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCc
Confidence            9966533322 4556689999999998875 79999999999999999999999998765422   11111111111   


Q ss_pred             Cchhhhh-------------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhh
Q 038707          542 NRLFEAL-------------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGI  592 (597)
Q Consensus       542 ~~~~~~l-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l  592 (597)
                      ..+....             .+...............+++.+||+.+|.+|.|++.++++  +..+
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            1111000             0111111111122468899999999999999999999986  5544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=327.47  Aligned_cols=256  Identities=29%  Similarity=0.493  Sum_probs=218.7

Q ss_pred             cCCccCCcccccCceEEEEEEecC---C--cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD---G--RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~---~--~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ....+.++||.|-||.||+|.+.+   |  -.||||.-+. ...++.+.|+.|..+|++++||||++|+|++.+. ..||
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            344556789999999999999643   3  3689998776 5566789999999999999999999999999765 5589


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||.++-|.|.+||+.++.  .|+......++.||..||+|||+..   ++||||..+|||+....-+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999998654  4889999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .+..+..+...-...|||||.+.-..++.++|||.|||.+||++. |..||.+....+...                .+.
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iE  606 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIE  606 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------Eec
Confidence            766666665566789999999999999999999999999999998 999999876555211                111


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ..-....++.+++.|..|+.+||..+|.+||++.|+...|..++.
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            222233467788899999999999999999999999999988764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-38  Score=325.60  Aligned_cols=236  Identities=30%  Similarity=0.431  Sum_probs=193.0

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||+||++... +++.||||.+...   .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 5889999987632   234556778899988877 699999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~  153 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT  153 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence            99999987643   4899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+       ....+..+..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence            34568999999999999999999999999999999999999997543221       1112211111          011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                      ...+.++.+|+.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2234568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=318.32  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||+|....      +..||+|...... ......+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578889999999999999998642      3689999976433 34456789999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999976322       234788999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          462 DFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       462 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      |||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence            99998765433221 2223346788999999988889999999999999999998 999986533222       11222


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ..+....         .+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            2221111         122235678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-38  Score=319.84  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             HhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24589999876433 2344568899999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999976321       234678889999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHH
Q 038707          461 SDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      +|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++       ....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            999998765432221 1122234678999999998899999999999999999998 788886533221       1111


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      +..+...         ..+...+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111         111223467999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=313.98  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|++|.||++... +++.+|+|......     ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999975 68999999865422     2234678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999997642   4889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceee--ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+      .........      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQP------  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhccC------
Confidence            3221111  23457889999999999889999999999999999999999986432111      111111110      


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         .....+...+..+.+++.+||..+|.+|||+.++++.
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               0111223345568899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-38  Score=324.78  Aligned_cols=242  Identities=26%  Similarity=0.373  Sum_probs=196.1

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||.||+|... +++.||||.+...   .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 5789999987642   234456778899999876 799999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            99999987543   4899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+..+..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~----------~~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV----------LYP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence            34568999999999998899999999999999999999999997543221       1111111111          011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRP-------TMKEVTNE  588 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~  588 (597)
                      ...+.++.+|+.+||+.||++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            12345688999999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=334.63  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|.+.+.||+|+||+||++... +++.||||.+...   .....+.+.+|++++++++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999975 6899999987532   2334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999754   24889999999999999999999999   999999999999999999999999998633210


Q ss_pred             Cce----------------------------------------------eeecccccccccCccccccCCCCcccceeeh
Q 038707          473 QTH----------------------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF  506 (597)
Q Consensus       473 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl  506 (597)
                      ...                                              ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                              0012458999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 038707          507 GVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR---PTMK  583 (597)
Q Consensus       507 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~  583 (597)
                      ||+||||++|+.||......+      .+............       ......+.++.+||.+||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999996533211      11111110000000       0011234568899999997 77765   5999


Q ss_pred             HHHHH
Q 038707          584 EVTNE  588 (597)
Q Consensus       584 evl~~  588 (597)
                      |+++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-38  Score=312.19  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|.+.+.||+|++|.||++... +++.|++|.+..  ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999976 689999998764  3455677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.++++... ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999998752 345899999999999999999999998   99999999999999999999999999876543222


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......+++.|+|||++.+..++.++|+||||+++++|++|+.||......+       ....+..+..         .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~  219 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVF---------P  219 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence             2233457889999999998889999999999999999999999997543111       1111111111         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122445678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-38  Score=330.76  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||||.+...   .......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999976 5899999987642   2334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+.   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999999864   34899999999999999999999999   999999999999999999999999998754311


Q ss_pred             Cc----------------------------------eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCC
Q 038707          473 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK  518 (597)
Q Consensus       473 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~  518 (597)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                  00123469999999999999999999999999999999999999


Q ss_pred             CCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 038707          519 PIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGK---MRPTMKEVTNE  588 (597)
Q Consensus       519 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~---~RPt~~evl~~  588 (597)
                      ||......+      .+ ..+......-.+.+      .....+++.+||.+++. +|.   .||+++||++.
T Consensus       235 Pf~~~~~~~------~~-~~i~~~~~~~~~p~------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQE------TY-KKVMNWKETLIFPP------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHH------HH-HHHHcCcCcccCCC------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            997543222      11 11111100000000      11133457778887664 344   46899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.7e-38  Score=324.46  Aligned_cols=240  Identities=25%  Similarity=0.377  Sum_probs=192.5

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||+|... +++.||+|.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 5889999987642   233445566777777654 799999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            99999997643   4899999999999999999999999   9999999999999999999999999997643322 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+       ....+....          ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~----------~~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR----------PHFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC----------CCCC
Confidence            34568999999999998899999999999999999999999997543211       111111110          0112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMK-EVT  586 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  586 (597)
                      ...+.++.+|+.+||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22345678999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7e-38  Score=322.96  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||++... +++.+|+|.++..   .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 5789999987642   234456788999999988 699999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT  153 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence            99999887542   4999999999999999999999999   9999999999999999999999999987532221 123


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||++||||++|+.||......+.........+.+.....          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence            3456899999999999999999999999999999999999999765444333333333333222211          112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                      ...+..+.+++.+||+.||++||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2334567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=318.62  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=203.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +|++.+.||+|+||+||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999975 68999999876422   2233567889999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999887542 235899999999999999999999999   9999999999999999999999999997654222


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      .  .....|++.|+|||++.+..++.++||||||+++|||++|+.||.......   ....+...+...          .
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~----------~  221 (285)
T cd05605         157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED----------Q  221 (285)
T ss_pred             c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc----------c
Confidence            1  223468999999999988889999999999999999999999997543221   111111111110          0


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                      .......+..+.+|+.+||+.||++||     +++++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            111233556788999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=325.56  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=216.0

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhh-HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +...+.++||+|-||+|.+.....+..||+|+++...... ..+|.+|+++|.+|+||||++|+|+|..++.+.+|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4456678999999999999999888999999998755544 589999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+|+.++.... +.......|+.||+.||+||.+.+   ++||||.++|+|+|.++++||+|||+++.+.....+
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999998874322 455666789999999999999999   999999999999999999999999999977655544


Q ss_pred             e-eecccccccccCccccccCCCCcccceeehHHHHHHHHh--CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          476 L-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       476 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .....-...|||||.+..++++.++|||+||++|||+++  ...||.....++.   .+..-.........      .
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~------~  764 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQ------V  764 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcc------e
Confidence            3 344556789999999999999999999999999999976  7889876554331   11111111111111      1


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ....+.-++..+.+|+.+||..+-++||+++++...|.+.
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1122455677889999999999999999999999988764

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3e-38  Score=316.00  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=204.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||.||+|... +++.||+|+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            56999999999999999999975 68899999887655556677889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.++++..   .++++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++....... .
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A  161 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence            999999999753   34899999999999999999999998   9999999999999999999999999997653221 1


Q ss_pred             eeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          476 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ......++..|+|||.+.   ...++.++||||||+++|||++|+.||......+...      . +......   .+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~~~~---~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKSNFQ---PPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecCCCC---CCCC
Confidence            123345888999999874   3457889999999999999999999986443222100      0 0000000   0000


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                        ......+..+.+++.+||+.+|++|||++++++.|
T Consensus       232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00123456788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=319.62  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=203.5

Q ss_pred             cCCccCCcccccCceEEEEEEecC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeee
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD---------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLG  380 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  380 (597)
                      ++|++.+.||+|+||.||++....               ...||+|..... .....+.+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               235899987653 3445667999999999999999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQIE---------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL  451 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIl  451 (597)
                      ++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||.|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999965321         124788999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh--CCCCCCCCCCcCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTDED  528 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~--g~~p~~~~~~~~~  528 (597)
                      +++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++++|++  +..||......+ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            999999999999999765432221 1222335678999999988889999999999999999998  566776543222 


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                        ............      ........+...++.+.+|+.+||+.+|++||++.+|++.|++
T Consensus       241 --~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              111111111000      0000011122234679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-38  Score=314.19  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=198.3

Q ss_pred             CcccccCceEEEEEEecC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTD-GR--IVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||.||+|.+.+ +.  .+++|..+.. .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999753 43  5788887643 345567899999999999 799999999999999999999999999


Q ss_pred             CChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          398 GTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       398 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      ++|.+++.....             ...+++..+..++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999976421             124789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ++.......  .......+..|+|||++....++.++||||||++++||++ |..||......+       ....+..+.
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~  228 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGY  228 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCC
Confidence            985322111  1111223567999999988889999999999999999997 999996533211       111111111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                               ..+.....+..+.+|+.+||+.+|.+|||+.+++..|+++-
T Consensus       229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     11112233456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-38  Score=324.47  Aligned_cols=241  Identities=26%  Similarity=0.378  Sum_probs=196.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCC-ccceeeeEEEeCCcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  392 (597)
                      +|++.+.||+|+||.||+|... +++.||||.+...   .....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999976 5789999987642   334567788999999999764 5888999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999997543   4899999999999999999999999   999999999999999999999999998753322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....        
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~--------  218 (324)
T cd05587         155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV--------  218 (324)
T ss_pred             C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence            2 12334568999999999999999999999999999999999999997543221       1111111111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                        ..+...+.++.+|+.+||+.||.+|++.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1122334568899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.8e-38  Score=315.67  Aligned_cols=257  Identities=26%  Similarity=0.481  Sum_probs=205.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|+||+||+|.+. +++    .||+|..+.. ......++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            46888899999999999999854 444    4899987643 34456778999999999999999999999875 45789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ++||+++|+|.++++...  ..+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999998643  24899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+       ....+..+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERL---  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC---
Confidence            332221 122235678999999988899999999999999999998 899986433211       11122221111   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                            ......+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                  11123445688999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.7e-38  Score=314.42  Aligned_cols=255  Identities=26%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             cCCccCCcccccCceEEEEEEecC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-G---RIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..|++.+.||+|+||.||+|.+.. +   ..||||..... ......+|..|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            347888999999999999999753 3   36999987754 455567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....  ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999997643  34899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCcee--eeccc--ccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          472 DQTHL--TTKVQ--GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       472 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .....  .....  .+..|+|||.+....++.++||||||+++|||++ |..||......+       ....+....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~---  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDY---  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---
Confidence            22111  11111  2457999999998999999999999999999886 999986533211       111211110   


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                            ......+.+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0111233456688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-38  Score=331.51  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cce
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL  389 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  389 (597)
                      +|++.+.||+|+||.||++... +++.||||++...  ......++.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999975 6899999987642  3344567899999999999999999999998776     789


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +|+||+. ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 5788887643   34899999999999999999999999   999999999999999999999999999865


Q ss_pred             cCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh--
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE--  546 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  546 (597)
                      ............+++.|+|||++.+. .++.++||||||+++|||++|+.||......+.   ..............+  
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence            43333333444578999999998764 579999999999999999999999976543221   111111111100000  


Q ss_pred             --------hhhH--------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 --------ALDA--------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 --------~l~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                              .+..        ..........++++.+||.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    0000        00000112235678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.6e-38  Score=321.41  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             cCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE  386 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  386 (597)
                      ++|.+.+.||+|+||.||++...        ....+|+|..+.. ......++.+|+.+++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56888999999999999999742        2457899987743 334567789999999999 6999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      ..+++|||+++|+|.+++.....             ...+++..+..++.||+.||.|||+++   ++|+||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            99999999999999999976421             235899999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcH
Q 038707          454 DKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL  531 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~  531 (597)
                      +++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            9999999999999765432211 1112224467999999988899999999999999999999 888986543222    


Q ss_pred             HHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       532 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                         +...+..+...         ..+...+.++.+|+.+||+.+|++|||+.++++.|+++..
T Consensus       245 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ---LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               22222222111         1122334568899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-38  Score=333.97  Aligned_cols=250  Identities=23%  Similarity=0.291  Sum_probs=196.9

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .|++.++||+|+||+||+|... +++.+|+|.+...   .......+.+|+.++++++||||+++++.+.+.+..+||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999975 6889999987642   23445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999997642   4889999999999999999999999   9999999999999999999999999975321000


Q ss_pred             ----------------------------------------------ceeeecccccccccCccccccCCCCcccceeehH
Q 038707          474 ----------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG  507 (597)
Q Consensus       474 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG  507 (597)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0001224589999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 038707          508 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT---MKE  584 (597)
Q Consensus       508 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e  584 (597)
                      |+||||++|+.||......+      ...........       .........++++.++|.+|+ .+|.+|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~~------~~~~i~~~~~~-------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLE------TQMKVINWQTS-------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHH------HHHHHHccCCC-------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            99999999999997543221      11111110000       000111223456778888876 59999987   777


Q ss_pred             HHH
Q 038707          585 VTN  587 (597)
Q Consensus       585 vl~  587 (597)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.3e-39  Score=297.02  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=210.4

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhc-CCCccceeeeEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------ETNVEQFINEVVILSQI-NHRNIVKLLGCC  382 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  382 (597)
                      +...++|...++||.|..++|-+...+ +|...|+|++....        ..-.+.-++|+.||+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888899999999999988865 68888988765421        12245667899999998 699999999999


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                      +.....++|+|.|+.|.|.|+|.+..   .++++...+|++|+.+|++|||..+   |+||||||+|||+|++-++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999998654   4999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCceeeecccccccccCcccccc------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||++..+...  ......+|||+|+|||.+.-      ..|+...|+|+.|||||.||.|.+||....       .....
T Consensus       167 FGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlML  237 (411)
T KOG0599|consen  167 FGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLML  237 (411)
T ss_pred             cceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHH
Confidence            9999877543  34566789999999998742      468899999999999999999999996421       12234


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .++.+|...      .......+.+....+||.+||+.||.+|.|++|+|..
T Consensus       238 R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  238 RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            444454432      1122235567788999999999999999999999863

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.4e-38  Score=317.64  Aligned_cols=264  Identities=26%  Similarity=0.420  Sum_probs=206.7

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-----------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVK  377 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  377 (597)
                      .++|++.+.||+|+||.||++.+.+                 +..||+|.+... .....+++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999988642                 246899987653 3345678999999999999999999


Q ss_pred             eeeEEEeCCcceEEEeccCCCChhhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 038707          378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       378 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~N  449 (597)
                      +++++...+..+++|||+++++|.+++.+...        ...+++..++.++.|++.||+|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999986431        125899999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh--CCCCCCCCCCc
Q 038707          450 ILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTD  526 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~--g~~p~~~~~~~  526 (597)
                      |++++++.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++  +..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999976543322 12233446778999999988889999999999999999998  66777543321


Q ss_pred             CCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      +   .........+...      ...........+.++.+|+.+||+.+|++|||+.||++.|++
T Consensus       241 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 Q---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             H---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1   1111111111100      001111122334679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.8e-38  Score=328.80  Aligned_cols=258  Identities=24%  Similarity=0.340  Sum_probs=203.6

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      ++....++|++.+.||+|+||.||++... +++.+|+|.+..   ........+.+|+.+++.++||||+++++.+.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44445678999999999999999999976 588999998753   22334556889999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||+++|+|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999753    3888999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccC----CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      ...............||+.|+|||++...    .++.++||||||++||||++|+.||...+..      ..+.......
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~  263 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHK  263 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC
Confidence            87643333333455699999999998653    3789999999999999999999999753321      1122221111


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                      .....       ......+..+.+||.+||..++.+  ||++.++++.
T Consensus       264 ~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            11110       011234566889999999844433  7899988875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.2e-38  Score=311.78  Aligned_cols=249  Identities=28%  Similarity=0.476  Sum_probs=201.9

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEE-eCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||.||++... ++.+|+|..+..  ...+.+.+|+.++++++|+|++++++++. +.+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999864 788999987642  33567899999999999999999999765 456789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++++.. ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999998643 234889999999999999999999999   9999999999999999999999999987543222  


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                        .....+..|+|||++.+..++.++||||||+++|+|++ |+.||......+       ....+..+.         ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY---------KM  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC---------CC
Confidence              22334568999999988889999999999999999998 999986432211       111111111         01


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ......+..+.+++.+||+.+|++|||+.++++.|++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            11233456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=310.88  Aligned_cols=248  Identities=24%  Similarity=0.398  Sum_probs=212.6

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |.++.+||+|+||.||++.++ .|..+|||++..  +.+.+++..|+.+|++.+.|++|+++|.+.....+|+||||+..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667789999999999999976 699999999875  56788999999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |++.+.++..  +++|+++++..+++..++||+|||...   -+|||||..|||++.+|.+||+|||.+-.+.. .....
T Consensus       113 GSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR  186 (502)
T ss_pred             CcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence            9999999864  457999999999999999999999988   78999999999999999999999999976643 23344


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|||||++..-.|+.++||||||++..||..|++||....+-..       .-++..       .+......+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT-------~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPT-------KPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccC-------CCCCCCCCh
Confidence            567799999999999999999999999999999999999999976543221       001100       111122335


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...+.++.++++.||-.+|++|.|+.++++.
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            7778889999999999999999999998874

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-38  Score=325.78  Aligned_cols=238  Identities=28%  Similarity=0.357  Sum_probs=193.7

Q ss_pred             CcccccCceEEEEEEe----cCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          323 RILGQGGQGTVYKGML----TDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      +.||+|+||.||++..    .+|+.+|+|.+....  ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    257899999876422  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++.+.   ..+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++....... ..
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~  154 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK  154 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence            99999999754   34899999999999999999999999   9999999999999999999999999987654322 22


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      .....|++.|+|||.+....++.++||||||+++|||++|+.||......+       ....+.....          ..
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~----------~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL----------GM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence            334568999999999998889999999999999999999999997533211       1111111111          11


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTMKE  584 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~~e  584 (597)
                      +...+..+.+|+.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2234456889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.1e-38  Score=322.94  Aligned_cols=241  Identities=27%  Similarity=0.379  Sum_probs=195.8

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +|++.+.||+|+||.||+|... +++.||||.+...   .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999976 5789999987642   233445677888888887 5899999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999987543   4899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+.....        
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~--------  218 (323)
T cd05616         155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV--------  218 (323)
T ss_pred             C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--------
Confidence            2 12334568999999999999999999999999999999999999997543221       1111111111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                        ..+...+.++.+|+.+||+.+|++|++.
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              1122345668899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.5e-38  Score=311.96  Aligned_cols=252  Identities=29%  Similarity=0.491  Sum_probs=203.9

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      .+|++.+.||+|+||.||++.+.+++.+|+|.+... .....++.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            457888999999999999999877889999987643 2234678999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++....  .+++++.++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999997643  34889999999999999999999999   9999999999999999999999999987654332222


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+.  ....      
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~------  222 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYK------  222 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCC------
Confidence            222335678999999998889999999999999999998 999986433211       112221110  0001      


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                       +...++.+.+|+.+||+.+|++|||+.+++++|.
T Consensus       223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             1113466899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7e-38  Score=311.11  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=205.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +|++.+.||+|+||.||++... +++.+|+|.... ......+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999976 688999998754 23445678889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.... ...+++..++.++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++....... .
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~  155 (255)
T cd08219          81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-A  155 (255)
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-c
Confidence            9999999987542 335889999999999999999999999   9999999999999999999999999987654322 2


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.......       ....+..+....         
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQGSYKP---------  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcCCCCC---------
Confidence            2234568889999999998889999999999999999999999996432111       111122221111         


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .+...+..+.+|+.+||+.||++||++.+++.+
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122334568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.7e-38  Score=314.64  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|+||+||++... +|+.+|+|.+...   .......+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999975 5899999987532   122234566799999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecc
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV  480 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  480 (597)
                      .+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.......  .....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            99887543 334899999999999999999999999   9999999999999999999999999987654322  22344


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      .|+..|+|||++.+..++.++||||||+++|||++|+.||.......  .... .........        .. ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~-~~~~~~~~~--------~~-~~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEE-LKRRTLEDE--------VK-FEHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHH-HHHHhhccc--------cc-cccccC
Confidence            68999999999998889999999999999999999999997533211  1111 111110100        00 001234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                      +.++.+|+.+||+.||++||+++|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            55688999999999999999997766544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=310.02  Aligned_cols=249  Identities=32%  Similarity=0.515  Sum_probs=205.5

Q ss_pred             CcccccCceEEEEEEecC----CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||.||++....    +..+++|........ ..+.+.+|+..++.++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999763    789999998764443 378899999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          398 GTLYQYIHNQIE------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       398 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ++|.+++.....      ...+++..++.++.|+++||+|||+++   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521      256999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          472 DQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       472 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ... .......++..|+|||.+....++.++||||||+++++|++ |..||......+       ....+..+..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            321 22333457889999999988899999999999999999999 699997652211       1222222111     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                          ...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                1112334667899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.1e-38  Score=315.79  Aligned_cols=246  Identities=24%  Similarity=0.291  Sum_probs=196.6

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|+.++++++|+||+++.+++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999975 68999999876322   22345678899999999999999999999999999999999999999


Q ss_pred             hhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeec
Q 038707          401 YQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK  479 (597)
Q Consensus       401 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  479 (597)
                      .+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            98886432 2345899999999999999999999999   99999999999999999999999999976543222 2234


Q ss_pred             ccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHH
Q 038707          480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE  559 (597)
Q Consensus       480 ~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  559 (597)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   ......+....          ...+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS----------VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC----------CCCccc
Confidence            56899999999999999999999999999999999999999754322110   00111110000          011233


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          560 EIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       560 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                      .+..+.+++.+||+.||++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            456788999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-38  Score=333.86  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +|++.+.||+|+||.||++... +++.||||.+...   .......+.+|+.+|++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999975 5899999987532   22345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999997642   4889999999999999999999999   9999999999999999999999999975321000


Q ss_pred             ------------------------------------------ceeeecccccccccCccccccCCCCcccceeehHHHHH
Q 038707          474 ------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV  511 (597)
Q Consensus       474 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~  511 (597)
                                                                ........||+.|||||++.+..++.++|||||||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00011246899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 038707          512 EILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP---TMKEVTNE  588 (597)
Q Consensus       512 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~~  588 (597)
                      ||++|+.||......+.      . ..+......      .........+.++.++|.+|+ .+|.+|+   ++.++++.
T Consensus       236 ell~G~~Pf~~~~~~~~------~-~~i~~~~~~------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAET------Q-LKVINWETT------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHH------H-HHHhccCcc------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999976442221      1 111110000      000011123456778888876 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.8e-38  Score=316.11  Aligned_cols=262  Identities=27%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             cCCccCCcccccCceEEEEEEe-----cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          317 DNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      ..|++.+.||+|+||.||++.+     .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999984     247889999987543 44457899999999999999999999998875  567


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++.+..  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999997643  24899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCc--------CCCcHHHHHHHH
Q 038707          469 VMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD--------EDKSLVGYFLQA  538 (597)
Q Consensus       469 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~~  538 (597)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||++++.|.......        ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221  122344667899999998888999999999999999999987764321100        000001111111


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ...+..         .......+..+.+|+.+||+.+|++|||++++++.|+++
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111         111223456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-37  Score=316.38  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCcccee
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-----------------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKL  378 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  378 (597)
                      ++|++.+.||+|+||.||++...                 ++..+|+|..... ......++.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 2346899988753 34456789999999999999999999


Q ss_pred             eeEEEeCCcceEEEeccCCCChhhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 038707          379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI  450 (597)
Q Consensus       379 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NI  450 (597)
                      ++++.+.+..++||||+++++|.+++.....        ...+++..++.++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999986421        124778899999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccccccccCCCcee-eecccccccccCccccccCCCCcccceeehHHHHHHHHh--CCCCCCCCCCcC
Q 038707          451 LLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTDE  527 (597)
Q Consensus       451 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~--g~~p~~~~~~~~  527 (597)
                      |+++++.+||+|||++.......... .....++..|+|||......++.++||||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999997654332211 122334678999999888889999999999999999998  778886543222


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .   .............      ......+...+..+.+|+.+||+.||++||++.+|++.|++
T Consensus       242 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V---IENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   1111111100000      00001112334678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.9e-38  Score=322.34  Aligned_cols=261  Identities=22%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999976 58899999876533 22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++ +|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 8888887543  24889999999999999999999999   99999999999999999999999999876432221


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC---chhhh---
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---RLFEA---  547 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---  547 (597)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....   ........   .+...   
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcch
Confidence             1223457899999998865 5689999999999999999999999976543321111   11110000   00000   


Q ss_pred             ---hhHHhh-------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 ---LDARVL-------KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 ---l~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .+....       .......++++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence               000000       0011223567889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-37  Score=312.17  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=200.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.++||+|+||.||+|.+. +++.+|+|..... ......++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35788899999999999999964 6889999987643 344456799999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999997652       2788899999999999999999999   999999999999999999999999999765322  


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......+...........+.....        ..
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~  219 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------PV  219 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------CC
Confidence             123346889999999999889999999999999999999999999754332211111111111111000        00


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......++++.+++.+||+.+|++||+++|+++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0112234568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=307.58  Aligned_cols=248  Identities=29%  Similarity=0.474  Sum_probs=201.5

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      ++||+|++|.||++.+.+++.|++|....... .....+.+|+.++++++|+||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987799999998775433 35678999999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee-ecc
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKV  480 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~  480 (597)
                      +++....  ..+++..+..++.+++.||.|||+.+   ++||||||+|||++.++.+||+|||++........... ...
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9997643  24889999999999999999999999   99999999999999999999999999876532221111 122


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE  559 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  559 (597)
                      ..+..|+|||.+.+..++.++||||||++++||++ |..||.......       ....+....         ....+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY---------RMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC---------CCCCCcc
Confidence            34567999999988899999999999999999999 888886543221       111111110         0111233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          560 EIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       560 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .+.++.+++.+||+.+|++|||+.||++.|+.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            45678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.4e-39  Score=310.65  Aligned_cols=265  Identities=26%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  389 (597)
                      +-.|...+++|.|+||.||+|... +++.||||+.-...+.    -.+|+++|+.++|||||+|+-+|....     ..-
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            345777889999999999999976 5799999987643332    236899999999999999999887533     234


Q ss_pred             EEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeeccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSR  467 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~  467 (597)
                      |||||||. +|.++++... .+..++...+.-+..||.+||.|||+++   |+||||||.|+|+|.+ |.+||+|||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999976 8999988531 1234888889999999999999999999   9999999999999976 899999999999


Q ss_pred             cccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch--
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL--  544 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  544 (597)
                      .+...+..  ..+..|..|.|||++.+ ..|+.+.||||.||++.||+-|++-|.+.+..+.  +.. ....+.....  
T Consensus       175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~e-Iik~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVE-IIKVLGTPTRED  249 (364)
T ss_pred             eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence            87654433  45667889999999876 6799999999999999999999999987443321  111 1111111100  


Q ss_pred             --------hhhhhHHhhhh-----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhhh
Q 038707          545 --------FEALDARVLKE-----AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN--ELGGIR  593 (597)
Q Consensus       545 --------~~~l~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~l~  593 (597)
                              .+...+.+...     .....++++.+|+.++|+.+|.+|.++.|++.  .++.+|
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                    01111111111     23445677899999999999999999999985  344444

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-38  Score=317.85  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=205.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .+|++.+.||+|++|.||+|... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+.+....++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999965 68899999887666666788999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.+.    .+++.++..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999998653    3889999999999999999999999   99999999999999999999999999876432221 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......      .......... ..       ..
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~-------~~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-------LQ  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC-CC-------CC
Confidence            1223458889999999988889999999999999999999999996533211      1111111110 00       01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ........+.+|+.+||..+|++||++.++++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            123345668899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.1e-38  Score=321.85  Aligned_cols=240  Identities=26%  Similarity=0.364  Sum_probs=193.2

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||.||++.+. +++.||+|.++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 5889999987642   123455677788888765 899999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            9999998764   24899999999999999999999999   9999999999999999999999999987532211 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+....          ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~----------~~~~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT----------PHYP  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC----------CCCC
Confidence            44568999999999999999999999999999999999999997543211       111111111          0111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMK-EVT  586 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  586 (597)
                      .....++.+|+.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22345688999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.9e-38  Score=320.54  Aligned_cols=240  Identities=27%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||+|... +++.||||.++..   .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 5789999987642   223445677788888764 899999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            9999999754   24889999999999999999999999   99999999999999999999999999875432221 22


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+.....          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDNP----------CYP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC----------CCC
Confidence            34568999999999998899999999999999999999999997543211       1111111110          011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMK-EVT  586 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  586 (597)
                      .....++.+|+.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            22345678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.2e-38  Score=322.91  Aligned_cols=237  Identities=25%  Similarity=0.377  Sum_probs=190.2

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||+|... +++.||||.+...   ......++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999976 6899999987642   2223345555555 56789999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT  153 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence            9999999754   24899999999999999999999999   999999999999999999999999998754322 1223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+      .+ ..+.....          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~-~~i~~~~~----------~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MY-DNILNKPL----------RLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HH-HHHHcCCC----------CCC
Confidence            34568999999999999999999999999999999999999997533211      11 11111111          111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMK  583 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~  583 (597)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23356688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.3e-38  Score=322.08  Aligned_cols=241  Identities=26%  Similarity=0.385  Sum_probs=196.4

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||++... +++.||||.++..   .......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 5789999987642   234456778899999888 699999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++.+..   .+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT  153 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence            99999987643   4899999999999999999999999   99999999999999999999999999875322221 22


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....          ..+
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence            33458999999999999999999999999999999999999997543211       1111111111          112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTM-----KEVTN  587 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  587 (597)
                      ...+..+.+||.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2345568899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=309.03  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=198.9

Q ss_pred             CcccccCceEEEEEEecC----CcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||.||+|.+..    +..+|+|....... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998542    26899998775433 35567999999999999999999999876 4567999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++....   .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999998653   4899999999999999999999999   99999999999999999999999999986643332211


Q ss_pred             --ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          478 --TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       478 --~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                        ....++..|+|||.+....++.++||||||+++|+|++ |..||......+       +...+.....         .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGER---------L  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCc---------C
Confidence              11223467999999998899999999999999999998 999986543211       1122222211         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ..+...+..+.++|.+||..+|++||++.+|++.|+++.
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            112234467889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-37  Score=309.43  Aligned_cols=251  Identities=29%  Similarity=0.477  Sum_probs=196.0

Q ss_pred             CcccccCceEEEEEEec----CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEE-eCCcceEEEeccC
Q 038707          323 RILGQGGQGTVYKGMLT----DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPLLVYEFIP  396 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  396 (597)
                      +.||+|+||.||+|.+.    +...+|||+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    245799998754 33455778999999999999999999999776 4556899999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++.+...  .+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999976432  3678888999999999999999998   9999999999999999999999999997654322111


Q ss_pred             ---eecccccccccCccccccCCCCcccceeehHHHHHHHHhC-CCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          477 ---TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       477 ---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                         .....++..|+|||.+....++.++||||||+++|||++| .+||......      ... ..+..+..        
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~-~~~~~~~~--------  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DIT-VYLLQGRR--------  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHhcCCC--------
Confidence               1223456789999999888999999999999999999995 5566432211      111 11111110        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                       ...+...+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus       221 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         221 -LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             00112234568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-37  Score=323.53  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             hcCCccCCcccccCceEEEEEEe------cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC-C
Q 038707          316 TDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLET-E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  386 (597)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999974      246889999987532 33456788999999999 689999999988654 4


Q ss_pred             cceEEEeccCCCChhhHHhhcCC---------------------------------------------------------
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIE---------------------------------------------------------  409 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  409 (597)
                      ..+++|||+++|+|.++++....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999975321                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce-eeeccc
Q 038707          410 -------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQ  481 (597)
Q Consensus       410 -------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~  481 (597)
                             ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123688899999999999999999999   999999999999999999999999998765322211 112233


Q ss_pred             ccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       482 gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||......+      .+...+..+....         .+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR---------APDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCC---------CCCCC
Confidence            5678999999988899999999999999999997 999986543221      1112222221110         01112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ++++.+++.+||+.+|++|||+.||++.|+.+..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3468899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-37  Score=315.47  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||++...      ++..+|+|.+.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457899999999999999999863      46789999876533 34456799999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE-------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~N  449 (597)
                      +++|||+++++|.+++.....                   ...+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999975321                   124788999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcC
Q 038707          450 ILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE  527 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~  527 (597)
                      ||+++++.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998754322211 1122234667999999988899999999999999999998 888886543221


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                             ....+..+....         .+...+.++.+|+.+||+.+|++|||+.|+++.|++
T Consensus       241 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -------VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   122222222211         122345678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=321.12  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||+|.+..   ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46899999999999999999976 589999998753   23334566889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999997632  24899999999999999999999999   999999999999999999999999998765443


Q ss_pred             CceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .........||+.|+|||++..     ..++.++||||||+++|+|++|+.||......+      ..............
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~  229 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF  229 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence            3333333468999999999863     457889999999999999999999996532211      11111111111100


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGK--MRPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~  588 (597)
                            .......++.+.+|+.+||..+++  .||+++++++.
T Consensus       230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                  000122456688899998865443  37899988865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=322.75  Aligned_cols=261  Identities=27%  Similarity=0.440  Sum_probs=208.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLE  384 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  384 (597)
                      ...+|++.+.||+|+||.||++....        ...||+|..+.. .....+++.+|+.+++++ +||||+++++++.+
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            34568999999999999999997421        236899987643 344567899999999999 79999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL  451 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIl  451 (597)
                      .+..+++|||+++|+|.+++.+..             ....+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence            999999999999999999997632             1234889999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK  529 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~  529 (597)
                      +++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....++  
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  244 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--  244 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            999999999999999765432211 1222234567999999999999999999999999999998 888886543222  


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                           +...+..+...         ......+..+.+|+.+||+.+|++||++.|+++.|+++.+
T Consensus       245 -----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         245 -----LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             -----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                 22222221111         1122334568899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=320.48  Aligned_cols=253  Identities=28%  Similarity=0.384  Sum_probs=215.7

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcc
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVP  388 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  388 (597)
                      .....|++.+.||+|.||.||+++.+ +|+.+|+|.+....   ....+.+.+|+.+|+++. |||||.+.+.+.+.+..
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34567999999999999999999987 49999999876432   235678999999999998 99999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC----CcEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfg  464 (597)
                      ++|||++.+|.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999876    2999999999999999999999999   9999999999999543    579999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ++.....  ........||+.|+|||++....|+..+||||+|+++|.|++|.+||.+....+.       ...+..+.+
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~~  255 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGDF  255 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCCC
Confidence            9988755  4556778899999999999999999999999999999999999999987554331       112223322


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                            .............+.++|+.||..||.+|+|+.++++.
T Consensus       256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                  12233345567789999999999999999999999984

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-37  Score=309.14  Aligned_cols=248  Identities=27%  Similarity=0.449  Sum_probs=201.8

Q ss_pred             CcccccCceEEEEEEecC--C--cEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTD--G--RIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999999743  3  3699999876555 567789999999999999999999999988 888999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce--
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--  475 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--  475 (597)
                      ++|.+++.+... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999987542 45899999999999999999999999   999999999999999999999999999876543221  


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||......+      ...........         .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~---------~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER---------L  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc---------C
Confidence            1122446788999999998899999999999999999998 999986443221      11111111100         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-37  Score=312.72  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|+..+.||+|+||+||+|..+      +.+.+++|........ ..+++.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999964      2467999987654443 5678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          390 LVYEFIPNGTLYQYIHNQIEE------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999865422      25899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      |++...............++..|+|||.+.+...+.++||||||+++++|++ |..||.......       .......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence            9987544332222333446778999999988888999999999999999999 788886433211       11222222


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      ...        .......+..+.+++.+||+.+|++|||+.|++++|.+
T Consensus       235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111        11112344578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-38  Score=310.88  Aligned_cols=250  Identities=34%  Similarity=0.558  Sum_probs=201.3

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHH--HHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      |++.+.||+|+||+||++... +++.+|+|...........  ...+|+.++++++||||+++++++.+.+..++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677889999999999999987 4679999998865544433  3467999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++...   ..+++..++.++.||++||.+||+.+   |+|+||||+||++++++.++|+|||.+... .....
T Consensus        81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNE  153 (260)
T ss_dssp             TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccc
Confidence            999999999832   34899999999999999999999999   999999999999999999999999999754 22223


Q ss_pred             eeecccccccccCccccc-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......++..|+|||++. +...+.++||||||+++++|++|..||......+   ........         .......
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~---------~~~~~~~  221 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKI---------LKRPLPS  221 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHH---------HHTHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhc---------ccccccc
Confidence            344566899999999998 8889999999999999999999999997541111   11111000         0000000


Q ss_pred             hh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EA--KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..  .......+.+++.+||+.||++||++.++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  0111267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-37  Score=318.23  Aligned_cols=263  Identities=29%  Similarity=0.419  Sum_probs=203.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||.||++... ++..+|+|..... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999976 5788999987653 334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.++++..   ..+++..+..++.|+++||.|||+ .+   ++|+||||+|||+++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999999764   348999999999999999999998 46   999999999999999999999999998754322 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc------------
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE------------  541 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  541 (597)
                        ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+.................            
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              123346889999999998888999999999999999999999998654322110000000000000            


Q ss_pred             -----CchhhhhhHHhhh----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 -----NRLFEALDARVLK----EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 -----~~~~~~l~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           ....+..+.....    ......+.++.+|+.+||+.+|++|||+++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000001000000    0011234568999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-37  Score=314.33  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=200.7

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999976 68999999876432  23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ ++|.+++........+++..++.++.||++||.|||+.+   ++|+||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 689999876554456999999999999999999999999   9999999999999999999999999987553222 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh--cCch---h--h
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN--ENRL---F--E  546 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~---~--~  546 (597)
                      .......+++.|+|||.+.+ ..++.++||||||+++++|++|+.||......+  .....+.....  +..+   .  .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence            12223346889999998865 457899999999999999999999997543211  01000000000  0000   0  0


Q ss_pred             hhh-------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALD-------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...       ...........++++.+||.+||+.||.+|||+++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000       00000111224567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=314.67  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-----CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLE--TEVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  388 (597)
                      +.|++.+.||+|+||.||++.+.     .++.+|||.+...... ..+.+.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777889999999999999864     3678999988754443 56789999999999999999999999887  5578


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +++|||+++++|.+++.....  .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999986532  4899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC--------cHHHHHHHH
Q 038707          469 VMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK--------SLVGYFLQA  538 (597)
Q Consensus       469 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~~~  538 (597)
                      .......  ......++..|+|||.+.+..++.++||||||++++||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532221  111233556799999998889999999999999999999999998653322111        001111111


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      +...         .........+.++.+|+.+||+.+|++|||+.||+++|++++
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1111         111112234467999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.9e-38  Score=321.68  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHH-HHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEV-VILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||++... +++.+|+|.+....   .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999976 57889999876321   22233444444 456788999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++....   .+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~  153 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence            99999997542   4788899999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      .+ ..+.....          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~~----------~~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MY-DNILNKPL----------QLK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HH-HHHHhCCc----------CCC
Confidence            34568999999999999999999999999999999999999997533221      11 11111111          111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                      ...+..+.+++.+||+.+|.+||++.+.+.++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            23456688999999999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-37  Score=345.19  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=205.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.++||+|+||.||+|.+. +++.||||++...   .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 5899999987642   2334567999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          393 EFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      ||+++++|.+++.....        ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999975211        123567888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCc-----------------eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC
Q 038707          465 TSRSVMVDQT-----------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE  527 (597)
Q Consensus       465 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~  527 (597)
                      ++........                 .......||+.|||||++.+..++.++||||||+++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                 01112458999999999999999999999999999999999999997532211


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhh
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIR  593 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~  593 (597)
                      .   .  ....+        .++.. .......+..+.+++.+||+.||++|| +++++++.|+.+.
T Consensus       239 i---~--~~~~i--------~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 I---S--YRDVI--------LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             h---h--hhhhc--------cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0   0  00000        00100 011124456788999999999999995 6777888777653

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-37  Score=308.35  Aligned_cols=240  Identities=24%  Similarity=0.407  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEecC-------------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          323 RILGQGGQGTVYKGMLTD-------------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358899877655666678899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc-------EEEee
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-------AKVSD  462 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-------~kl~D  462 (597)
                      +||||+++++|..++....  .++++..++.++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999987542  34899999999999999999999999   999999999999987654       89999


Q ss_pred             ccccccccCCCceeeecccccccccCccccc-cCCCCcccceeehHHHHHHHH-hCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL-TGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlG~il~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      ||++......     ....++..|+|||.+. ...++.++||||||+++|||+ .|..||......+.       .... 
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~-  222 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY-  222 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH-
Confidence            9998654322     2234778899999886 467899999999999999998 48888764332210       0000 


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      .+.. .         .......++.+|+.+||+.||.+||++.+|++.|+
T Consensus       223 ~~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1100 0         01112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-37  Score=309.21  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++.+++++.....||+|+||.||+|.+. +++.|++|..........+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445566666779999999999999965 578899998877666677889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSV  469 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~  469 (597)
                      |+||+++++|.+++.........++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999986432212388889999999999999999999   999999999999976 679999999998765


Q ss_pred             cCCCceeeecccccccccCccccccC--CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ..... ......+++.|+|||++...  .++.++||||||+++|+|++|+.||........   ..+.....        
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~--------  227 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF--------  227 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh--------
Confidence            32221 22234578999999998654  378999999999999999999999865322110   00000000        


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ......+....+++.+|+.+||+.+|++|||+.|+++.
T Consensus       228 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               00111123345668899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-37  Score=313.13  Aligned_cols=250  Identities=28%  Similarity=0.350  Sum_probs=200.8

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999976 68999999875422   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999986542 234899999999999999999999999   99999999999999999999999999876532221


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                        .....|+..|+|||++.+..++.++||||||+++|+|++|+.||..........   .......          ....
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~----------~~~~  222 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVK----------EVQE  222 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhh----------hhhh
Confidence              223468999999999998899999999999999999999999997543221100   0111000          0011


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                      ......+..+.+|+.+||+.||++|||     ++|+++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            112234456889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.9e-38  Score=322.41  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=192.0

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||++... +|+.+|+|.+...   ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999975 6899999987642   2233445566655 56779999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..... ....
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  153 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT  153 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence            9999988753   34899999999999999999999999   999999999999999999999999998754222 1223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+      .+ ..+.....          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~-~~~~~~~~----------~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MY-DNILHKPL----------VLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HH-HHHHcCCc----------cCC
Confidence            34568999999999999999999999999999999999999997543211      11 11111111          011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...+..+.+++.+||+.+|.+||++++.+++
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            2234567899999999999999988644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=310.53  Aligned_cols=256  Identities=27%  Similarity=0.500  Sum_probs=206.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .+|++.+.||+|+||+||+|.+. +++    .+|+|...... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45788899999999999999964 333    68999876543 4456789999999999999999999999987 78899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   ++|+||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999986433  4899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCceee-ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....... ....++..|+|||.+....++.++||||||++++||++ |+.||......+       +.+.+..+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---  230 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL---  230 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence            3322211 11223568999999988889999999999999999998 999997543222       22222222111   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ..+......+.+++.+||..+|++||++.++++.|+++.+
T Consensus       231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  1111233457899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=297.70  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=205.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++-+.||+|.|+.|++.... +|+.+|+|.+..  ......+++.+|+.|-+.|+||||++|.+...+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888889999999999998864 688888886543  33447789999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl~~~~  469 (597)
                      |+|.+++|..-+-..   ...++..+...++||++||.|+|..+   |+|||+||+|+|+..   ..-+||+|||++...
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997766543   34788899999999999999999999   999999999999943   446999999999887


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .  ....-....|||+|||||++...+|+..+|||+-||+||-||.|.+||.+.+...       ..+.+..+.+.    
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd----  230 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD----  230 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC----
Confidence            6  3344556779999999999999999999999999999999999999997533221       22222222221    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        +.........++..+|+++||..||.+|.|+.|.|+
T Consensus       231 --~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 --YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence              111112345567889999999999999999998875

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-37  Score=310.59  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |++.+.||+|+||.||+|... ++..+++|..........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677789999999999999976 4788999988776677778899999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++.+.  ..++++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~  160 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  160 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence            9999988753  235899999999999999999999999   9999999999999999999999999987653221 222


Q ss_pred             ecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          478 TKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ....++..|+|||++.     ...++.++||||||+++|||++|+.||......+      .......... ...     
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~-~~~-----  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEP-PTL-----  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCC-CCC-----
Confidence            3345889999999974     3457889999999999999999999986533211      1111111100 000     


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ..+...+.++.+||.+||+.+|.+||++.++++.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0112344678999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-37  Score=319.34  Aligned_cols=261  Identities=25%  Similarity=0.345  Sum_probs=198.9

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC----
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE----  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  386 (597)
                      ...++|++.+.||+|+||.||++... +++.||+|++..  ........+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999975 589999998753  23445677889999999999999999999986543    


Q ss_pred             --cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          387 --VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       387 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                        ..++||||+++ +|.+.++.     .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              46899999965 67666643     2788999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc-
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  543 (597)
                      +++.....  .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+   ............. 
T Consensus       169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~  243 (359)
T cd07876         169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSA  243 (359)
T ss_pred             CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcH
Confidence            99754322  22334568999999999999999999999999999999999999997643211   0000000000000 


Q ss_pred             ---------hhhhhhH--------------Hh----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          544 ---------LFEALDA--------------RV----LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       544 ---------~~~~l~~--------------~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                               .......              ..    ...........+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     0000000              00    000011124568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-37  Score=320.29  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=200.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||+|.+..   ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 588999998753   22334556889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999998642  24899999999999999999999999   999999999999999999999999999766543


Q ss_pred             CceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .........||+.|+|||++..     ..++.++||||||++||+|++|+.||......+      ............. 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-  228 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ-  228 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-
Confidence            3333334569999999999865     467899999999999999999999997533211      1111111110000 


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                      +     .......++++.+|+.+||..++.+  |++++++++.
T Consensus       229 ~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0     0001223567889999999866544  4678887754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=305.78  Aligned_cols=246  Identities=25%  Similarity=0.304  Sum_probs=202.5

Q ss_pred             cCCccCCcccccCceEEEEEEecC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +.|++.+.||+|.-|+||++.+.+ +..+|+|.+..   .......+...|-+||+.++||.++.|+..++.++..+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456677899999999999999874 68999998764   23444566778999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++||+|..+++++. ...+++..+.-++.+|+-||+|||..|   ||.|||||+||||.++|++-|+||.|+......
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999998874 446999999999999999999999999   999999999999999999999999987543210


Q ss_pred             C---------------------------------c----------------------eeeecccccccccCccccccCCC
Q 038707          473 Q---------------------------------T----------------------HLTTKVQGTFGYVDPEYFQSSQF  497 (597)
Q Consensus       473 ~---------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~  497 (597)
                      .                                 .                      ......+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            0                                 0                      00112358999999999999999


Q ss_pred             CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCC
Q 038707          498 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGK  577 (597)
Q Consensus       498 ~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~  577 (597)
                      +.+.|+|+||++|||||.|+.||.+.+.++.      +         ..++.+.+........+..+.+||++.|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l---------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------L---------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh------H---------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            9999999999999999999999998765541      1         122222222222235566789999999999999


Q ss_pred             CCCC
Q 038707          578 MRPT  581 (597)
Q Consensus       578 ~RPt  581 (597)
                      +|..
T Consensus       378 kRlg  381 (459)
T KOG0610|consen  378 KRLG  381 (459)
T ss_pred             hhhc
Confidence            9988

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-37  Score=319.44  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=200.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.++||+|+||+||++..+ +++.+|+|.+..   ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 478899998753   22333456889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999998642  24899999999999999999999999   999999999999999999999999998765433


Q ss_pred             CceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .........||+.|+|||++.     ...++.++||||||++||||++|+.||......+      ..............
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~  229 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQF  229 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccccC
Confidence            333334456999999999986     3468899999999999999999999997533211      11111111110000


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                            .......+.++.+|+.+||..++.+  |++++++++.
T Consensus       230 ------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 ------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                  0111234566889999998665444  6899998876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.1e-38  Score=318.42  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46889999999999999999976 58899999876433 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ ++|.+++....  ..+++..+..++.||++||.|||+.+   |+|+||||+|||+++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 58999887643  24889999999999999999999999   99999999999999999999999999876433221


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh---cCchhhhhh-
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---ENRLFEALD-  549 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~-  549 (597)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.   ...+.....   ...+...++ 
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence             1223346889999998765 4578999999999999999999999976543221   111111100   000000000 


Q ss_pred             --------HHh----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 --------ARV----LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 --------~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              +..    ........+..+.+||.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    000    00111223556889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=321.84  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=213.7

Q ss_pred             ccCCcccccCceEEEEEEecC--C--cEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          320 NANRILGQGGQGTVYKGMLTD--G--RIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~--~--~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .+.++||+|.||.|++|.|+.  |  ..||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            345789999999999999863  4  36899998876555 67899999999999999999999999998 777899999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++.|+|.+.|++ ..+..|....+-.++.|||.||.||.+++   +|||||..+|+||-....+||+||||.+.+...+.
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999998 34456888889999999999999999999   99999999999999999999999999998764433


Q ss_pred             e-eee-cccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          475 H-LTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       475 ~-~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . .+. ...-...|.|||.+....++.++|||+|||+||||++ |..||.+.....                +.+.+|..
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~  331 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAG  331 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccc
Confidence            3 222 2334668999999999999999999999999999999 889997754322                33445544


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ..-..+..+++++.++++.||..+|.+|||+..|.+.+-..+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            444556788999999999999999999999999986654433

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.6e-37  Score=310.63  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=203.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||.||+|... +++.+++|..........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999976 48899999988777777888999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|..++.+..  ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++....... .
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            9999999886543  34899999999999999999999998   9999999999999999999999999886543221 1


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          476 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ......+++.|+|||++.     ...++.++||||||+++|||++|+.||......      ........ .....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~----  234 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SEPPT----  234 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhc-CCCcc----
Confidence            123345788999999984     345788999999999999999999998653321      11111111 10000    


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ...+...+.++.+++.+||+.+|++||++.++++
T Consensus       235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 ---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               0112234456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.1e-37  Score=308.31  Aligned_cols=250  Identities=26%  Similarity=0.488  Sum_probs=202.4

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccC------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +|.+.+.||+|+||+||+|...+++.+|+|.+....      ......+.+|+.++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998889999999876422      22346688999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      +||+++++|.+++.+..   ++++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997642   4889999999999999999999999   99999999999999999999999999876432


Q ss_pred             CC-----ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          472 DQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       472 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ..     ........++..|+|||.+.+..++.++||||||+++++|++|+.||...+..+     . ........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~~-  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGLM-  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCCC-
Confidence            11     111223458889999999998889999999999999999999999996533211     0 11111000000 


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             .......+.++.++|++||+.+|++||++.++++
T Consensus       228 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 -------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   1112334566889999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=309.83  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=204.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||.|++|.||+|... +++.+|+|...... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999976 58899999876543 44567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++...    ++++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999999764    5899999999999999999999999   9999999999999999999999999997765332 


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....         .
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~---------~  216 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNP---------P  216 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCC---------C
Confidence            22233457889999999998889999999999999999999999996543211       1111111100         0


Q ss_pred             hhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EAKKE-EIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..... .+..+.+++.+||..+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11111 4567889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-37  Score=319.44  Aligned_cols=237  Identities=24%  Similarity=0.353  Sum_probs=188.9

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||.||++... +++.||+|.+...   ......++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 5889999987532   2223345555554 67889999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            9999988753   34889999999999999999999999   9999999999999999999999999987532222 223


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+       ....+.....          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~----------~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKPL----------QLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence            34568999999999998899999999999999999999999997532111       1111111110          112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMK  583 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~  583 (597)
                      ......+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23445688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.2e-37  Score=305.70  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=193.2

Q ss_pred             CcccccCceEEEEEEecC---CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||.||+|...+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998643   4679999876543 334457899999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          399 TLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       399 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +|.++++....  ....++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432  234677888899999999999999999   9999999999999999999999999987543322211


Q ss_pred             -eecccccccccCccccccC-------CCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          477 -TTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       477 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||......+   ..   ...+. +.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~---~~~~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VL---TYTVR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HH---HHHhh-cccCCC
Confidence             1234467889999998642       35789999999999999996 999996543222   10   01111 111111


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ..+..    .....+.+.+++..|+ .+|++|||++||+..|+
T Consensus       231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111    1123345778999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-37  Score=318.26  Aligned_cols=241  Identities=27%  Similarity=0.387  Sum_probs=195.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +|+..+.||+|+||+||++... +++.||+|.+...   .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3778899999999999999976 6899999987632   2334567888999998886 577888999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999997543   4899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+.....        
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~--------  218 (323)
T cd05615         155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV--------  218 (323)
T ss_pred             C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--------
Confidence            2 12234458999999999998899999999999999999999999997543211       1111111111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                        ..+...+.++.+++.+||+.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1122334567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-37  Score=311.92  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=200.1

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC------
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLET------  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  385 (597)
                      .+++.|++.+.||+|+||.||+|... +++.+|+|...... ....++.+|+.+++++ +|+||+++++++.+.      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999976 58899999876433 3446788999999998 699999999998763      


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ...+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            35789999999999999998642 335899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      +....... .......|+..|+|||++.     ...++.++||||||+++|||++|+.||.......     ..  ....
T Consensus       158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~--~~~~  229 (272)
T cd06637         158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL--FLIP  229 (272)
T ss_pred             ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH--HHHh
Confidence            87653222 1233456889999999985     3457889999999999999999999996432111     00  0111


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ......        ......+..+.+|+.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            110000        011223456889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-37  Score=314.58  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=194.8

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCccceeeeEEEeC-----C
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLET-----E  386 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  386 (597)
                      +|++.+.||+|+||+||+|... +++.||+|.++...  ......+.+|+.+++.+   +||||+++++++.+.     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999976 68999999876432  22234456677777665   799999999988653     3


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+++|||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            5789999997 58989887643 234899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC---c
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---R  543 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~  543 (597)
                      +......  ......++..|+|||++.+..++.++||||||+++|+|++|++||......+   ............   .
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDD  230 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhh
Confidence            7654221  2233457899999999988899999999999999999999999986543221   111111111000   0


Q ss_pred             hhhh----------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LFEA----------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~~~----------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +...          .............++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000          0000011112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-37  Score=305.52  Aligned_cols=251  Identities=30%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|+..+.||+|+||.||.+... +++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999865 5889999986643  355567889999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++.++..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999998653 345899999999999999999999999   99999999999999999999999999876643332


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......+++.|+|||.+.+..++.++||||||+++++|++|..||......+      .. ..+..+...         
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~-~~~~~~~~~---------  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LV-VKIVQGNYT---------  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHcCCCC---------
Confidence             2334558899999999988889999999999999999999999986432211      11 111111111         


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                      ......+.++.+++.+||+.+|++||+++++++.+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11133456688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-37  Score=332.13  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=193.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--------C
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET--------E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  386 (597)
                      .++|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+|++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999975 68999999875321    2345799999999999999999887532        1


Q ss_pred             cceEEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeecc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFG  464 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg  464 (597)
                      ..++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999974 7877775422 2345899999999999999999999999   99999999999998665 69999999


Q ss_pred             ccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +++.......  .....+|+.|+|||++.+ ..++.++||||||++||||++|.+||.+....+.   .....+......
T Consensus       217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            9986543222  223468999999999765 4689999999999999999999999976433211   111111111000


Q ss_pred             hh---------------hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LF---------------EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~---------------~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..               ......+....+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00               000001111112234567899999999999999999999984

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=306.44  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=206.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|++|.||++... +++.+++|..........+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999975 57889999988766667788999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||++....... .
T Consensus        83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  156 (262)
T cd06613          83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A  156 (262)
T ss_pred             CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence            9999999987642  34899999999999999999999999   9999999999999999999999999987654321 1


Q ss_pred             eeecccccccccCccccccC---CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          476 LTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ......++..|+|||.+...   .++.++||||||+++|+|++|+.||......+.      .. .......    .+..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~-~~~~~~~----~~~~  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LF-LISKSNF----PPPK  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhccC----CCcc
Confidence            22334578899999998776   889999999999999999999999975432211      00 0111100    0000


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .......+.++.+++.+||+.+|.+|||+.+|++
T Consensus       226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0112344567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-37  Score=309.08  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=202.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46888889999999999999975 58899999987665566677889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....   .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... ..
T Consensus        89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~  161 (267)
T cd06645          89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA  161 (267)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence            9999999987543   4899999999999999999999999   999999999999999999999999998765322 12


Q ss_pred             eeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          476 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ......|+..|+|||++.   ...++.++||||||+++|+|++|+.||........      ....... ...    +..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~-~~~----~~~  230 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKS-NFQ----PPK  230 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhcc-CCC----CCc
Confidence            223446899999999874   45688999999999999999999999864332211      0011111 100    000


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ... ....+..+.+++.+||+.+|++||++++|++
T Consensus       231 ~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000 1123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.7e-37  Score=314.34  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=205.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|.+.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367999999999999999999964 6899999998766666667889999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.+.    .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999998653    3889999999999999999999999   99999999999999999999999999876533221


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........      .....+ ..       ..
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~~-------~~  235 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TP-------EL  235 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-CC-------CC
Confidence             1233457889999999998889999999999999999999999996543221100      000000 00       00


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+...+..+.+|+.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            112334456789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=320.76  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |.-++.||.|+||.||-+.+. +.+.||||++....   .+..++++.|+..|++++|||++.+-|||......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            556778999999999999965 68899999987543   34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      | -|+-.|++.-+.  +++.+.++..|..+.++||+|||+++   .||||||..|||+++.|.|||+|||.+.....   
T Consensus       108 C-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             H-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9 568888887653  46999999999999999999999999   99999999999999999999999999865432   


Q ss_pred             eeeecccccccccCcccc---ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          475 HLTTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        ...+.|||.|||||++   ..+.|+-|+||||||++..||.-.++|+..++.-.       +...+..+.-     |.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNes-----Pt  244 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES-----PT  244 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCC-----CC
Confidence              3456799999999986   45789999999999999999999999987554211       1222211111     11


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +   ...+.+..+..|+..||+.-|.+|||..+++..
T Consensus       245 L---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 L---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1   146778889999999999999999999998764

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-37  Score=305.40  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=204.7

Q ss_pred             cCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|+..+.||+|++|.||+|...+ ++.+++|.+.....  .+++.+|++++++++||||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999864 78999998865322  678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999997533  35899999999999999999999999   99999999999999999999999999876543321 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||........       ...+..... .      ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~-~------~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPNKPP-P------TLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhccCCC-C------CCC
Confidence            22334478899999999988999999999999999999999999975432211       000000000 0      001


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+......+.+++.+||+.+|++|||++||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12234467899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.5e-37  Score=307.36  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=204.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..|+..+.||+|+||.||+|.+. +++.||||...... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34777889999999999999976 58899999876432 45567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++...    ++++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999998643    4889999999999999999999998   99999999999999999999999999976543221


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......++..|+|||++.+..++.++|+||||+++|||++|+.||........       ...+..+         ...
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~---------~~~  219 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKN---------NPP  219 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcC---------CCC
Confidence             22334578899999999888899999999999999999999999875432211       0011111         011


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2234456778999999999999999999999775

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-37  Score=306.68  Aligned_cols=248  Identities=29%  Similarity=0.517  Sum_probs=200.9

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh---------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---------TNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999975 588999997654322         123568899999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+++|||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999999764   24889999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCce-----eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          468 SVMVDQTH-----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       468 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      ........     ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......     .. ... +...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~~-~~~~  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA-IFK-IGEN  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH-HHH-Hhcc
Confidence            66422111     112245788999999999888999999999999999999999999753211     10 111 1110


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                               .....+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                     011122334567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=310.76  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=211.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .+-|.+.+.||+|.|+.|-+|++- +|+.||||++...  +......+.+|+.-|+.++|||||+||++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            355888899999999999999853 7999999987653  3445678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe-CCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll-~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |.=++|+|++||.++..+  +.++...+++.||+.|+.|+|+.+   ++||||||+|+.+ ..-|-+||+|||++..+..
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999987655  999999999999999999999999   9999999999877 5568899999999977653


Q ss_pred             CCceeeecccccccccCccccccCCCC-cccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      .  ...+..+|.+.|.|||++.+..|+ ++.||||||||||.|++|++||+..+..|.       ..+        ++|-
T Consensus       172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------LTm--------ImDC  234 (864)
T KOG4717|consen  172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------LTM--------IMDC  234 (864)
T ss_pred             c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------hhh--------hhcc
Confidence            3  335567899999999999998876 689999999999999999999987665552       111        2222


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+  ..+...+.+..+||..||..||.+|.+.+||..
T Consensus       235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            22  235666778899999999999999999999875

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-37  Score=310.67  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||.||++... +++.+|+|.+... ......++.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999976 6899999987643 344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++........+++..+..++.|+++||.|||+ .+   |+|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999998864333458999999999999999999997 46   9999999999999999999999999987653221


Q ss_pred             ceeeecccccccccCccccccC------CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                         .....+++.|+|||.+.+.      .++.++||||||+++|+|++|+.||.......   ..... ..+..+.    
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~~~----  226 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL-SAIVDGD----  226 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH-HHHhhcC----
Confidence               2233478899999998543      35889999999999999999999996532211   11111 1111111    


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           ....+...+.++.+|+.+||+.+|++||++.++++.
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                 111223456678899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.6e-37  Score=303.72  Aligned_cols=238  Identities=24%  Similarity=0.460  Sum_probs=191.4

Q ss_pred             CcccccCceEEEEEEecC-C----------cEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          323 RILGQGGQGTVYKGMLTD-G----------RIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-~----------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +.||+|+||.||+|.+.+ +          ..+++|........ ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999999864 3          25778876644333 6789999999999999999999999988 788999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-------cEEEeecc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-------RAKVSDFG  464 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-------~~kl~Dfg  464 (597)
                      |||+++++|.+++.....  .+++..+..++.||+.||+|||+.+   |+|+||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999986532  5899999999999999999999999   99999999999999887       79999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccC--CCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ++.....     .....++..|+|||++...  .++.++||||||+++|+|++ |..||......+...       ....
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~  221 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQD  221 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhc
Confidence            9876543     2223466789999998776  78999999999999999999 577776554222110       1111


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ....           .......+.+++.+||..+|.+|||+.+|++.|+
T Consensus       222 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1000           0111157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-37  Score=304.79  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-CcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  393 (597)
                      +|++.+.||+|++|.||++... +++.+|+|++...  .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999976 5789999987642  334556789999999999999999999987644 46789999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++.... ..++++.+++.++.|++.||++||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999998642 345899999999999999999999999   9999999999999999999999999997654322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      . ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+..      .... .+..+..         
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~~~---------  219 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEGKL---------  219 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhcCC---------
Confidence            2 223445789999999999989999999999999999999999998643211      1111 1111111         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11223455678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-37  Score=308.87  Aligned_cols=239  Identities=23%  Similarity=0.382  Sum_probs=189.7

Q ss_pred             cccccCceEEEEEEecC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcccee
Q 038707          324 ILGQGGQGTVYKGMLTD-------------------------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL  378 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  378 (597)
                      .||+|+||.||+|.+..                         ...|++|.+.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13588898876555556789999999999999999999


Q ss_pred             eeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC--
Q 038707          379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY--  456 (597)
Q Consensus       379 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~--  456 (597)
                      ++++.+....++||||+++|+|..++.+..  ..+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999987532  34889999999999999999999998   99999999999997643  


Q ss_pred             -----cEEEeeccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHH-hCCCCCCCCCCcCCC
Q 038707          457 -----RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEIL-TGQKPIRAINTDEDK  529 (597)
Q Consensus       457 -----~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell-~g~~p~~~~~~~~~~  529 (597)
                           .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+. 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                 3899999987543221     12346788999998865 56899999999999999995 69999875433221 


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                        ..    ......           ..+......+.++|.+||+.+|++|||+.+|++.|+
T Consensus       231 --~~----~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --ER----FYEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HH----HHHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              10    110000           001112245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.5e-37  Score=308.49  Aligned_cols=250  Identities=32%  Similarity=0.499  Sum_probs=199.0

Q ss_pred             CcccccCceEEEEEEecC-------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLTD-------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.||+|+||.||+|...+       ++.+|||...... .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998642       2578999765432 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-----cEEEeeccc
Q 038707          395 IPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-----RAKVSDFGT  465 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-----~~kl~Dfgl  465 (597)
                      +++++|.+++.+...    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999976321    234789999999999999999999998   99999999999999877     899999999


Q ss_pred             cccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          466 SRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       466 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHHhcCC
Confidence            8765432211 1122335678999999999999999999999999999998 999986432111       111111111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .         .......+..+.+++.+||+.+|.+||++++|++.|++
T Consensus       231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1         11123345678999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=324.05  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             cccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhh
Q 038707          324 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ  402 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  402 (597)
                      +||+|.||+||.|++. +...+|||.+...+....+-+.+||.+.++|+|.|||+++|++.+++..-|.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999976 467899999988888888899999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEEEeeccccccccCCCceeeec
Q 038707          403 YIHNQIEEFPI--TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTK  479 (597)
Q Consensus       403 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~  479 (597)
                      +|+..  -+|+  ++..+-.+.+||++||.|||...   |+|||||-+|+|++ -.|.+||+|||-++.+. .-.+.+..
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET  735 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET  735 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence            99863  4456  78889999999999999999999   99999999999995 57899999999998764 34455667


Q ss_pred             ccccccccCccccccC--CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          480 VQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       480 ~~gt~~y~aPE~~~~~--~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ..||.-|||||++..+  .|+.++|||||||++.||.||++||.......        ..+.+-|..      ......+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmy------KvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMY------KVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcce------ecCCCCc
Confidence            7899999999998764  58999999999999999999999997544322        111111111      1223345


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+.+.+...+|.+|..++|.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            777788999999999999999999999975

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-37  Score=325.71  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=197.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +++.||||.+...   .......+.+|+.++.+++||||+++++.+.+.+..+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 5899999987632   2344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999997542   4899999999999999999999999   999999999999999999999999998654211


Q ss_pred             Cc----------------------------------eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCC
Q 038707          473 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK  518 (597)
Q Consensus       473 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~  518 (597)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                  00113468999999999999999999999999999999999999


Q ss_pred             CCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038707          519 PIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT---MKEVTN  587 (597)
Q Consensus       519 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  587 (597)
                      ||......+      .. ..+......      +........++++.+||.+++ .+|.+|++   +.++++
T Consensus       235 Pf~~~~~~~------~~-~~i~~~~~~------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQE------TY-RKVMNWKET------LVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHH------HH-HHHHcCCCc------eecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            997543322      11 111110000      000001123456788898877 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.9e-37  Score=304.45  Aligned_cols=251  Identities=32%  Similarity=0.527  Sum_probs=204.2

Q ss_pred             CccCCcccccCceEEEEEEecC-----CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          319 YNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +++.+.||+|+||.||++...+     +..||+|........ ....+.+|+..+.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999763     388999998754433 6778999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999976432 12899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .........+++.|+|||.+.+..++.++||||||+++++|++ |+.||......+       ....+..+...      
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------  223 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRL------  223 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC------
Confidence            3322222336789999999988889999999999999999998 788886522111       11122221111      


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                         ......+.++.+++.+||..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               11222456789999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.6e-37  Score=310.72  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=200.2

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |+..+.||+|+||+||++.+. +++.+|+|.+....   ......+.+|+.++++++|+||+++++.+.+.+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999975 68899999876422   23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999999987542 235999999999999999999999999   9999999999999999999999999987653221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.........   ...........          .
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~----------~  222 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE----------E  222 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc----------c
Confidence             123346899999999998889999999999999999999999999754322110   01111111100          0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  588 (597)
                      ......+..+.+|+.+||+.||++||+     +.++++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            112233456789999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-37  Score=321.68  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=199.0

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC----
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE----  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  386 (597)
                      ...++|++.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35578999999999999999999975 5889999987642  3345577889999999999999999999986443    


Q ss_pred             --cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          387 --VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       387 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                        ..++||||+++ +|.+.+..     .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence              46899999965 67776653     2889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--  542 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  542 (597)
                      +++.....  .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+.   ...........  
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence            99764322  223345689999999999988999999999999999999999999975432111   00000000000  


Q ss_pred             --------chhhhhh----------HHhh--------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          543 --------RLFEALD----------ARVL--------KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       543 --------~~~~~l~----------~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                              .....++          +...        ..........+.+||.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                    0000000          0000        00011224568899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=308.94  Aligned_cols=252  Identities=27%  Similarity=0.365  Sum_probs=205.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|++|.||++.+. +++.+|+|..........+.+.+|+.++++++||||+++++.+.+....++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            56888999999999999999975 68899999988777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....... .
T Consensus        85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (280)
T cd06611          85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q  158 (280)
T ss_pred             CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence            9999999987643  34899999999999999999999999   9999999999999999999999999887653222 1


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          476 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ......+++.|+|||.+.     ...++.++||||||+++|+|++|+.||......+      .... +..+...     
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~-----  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLK-ILKSEPP-----  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHH-HhcCCCC-----
Confidence            223345889999999874     3457889999999999999999999997542211      1111 1111100     


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 --TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              001122344568899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-37  Score=310.54  Aligned_cols=246  Identities=27%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .|+..+.||+|+||.||+|.+. +++.||+|...... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566678999999999999875 57899999876432 445678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++...    .+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            999999998642    4899999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......       ....+..+.         ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~---------~~~  220 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKNS---------PPT  220 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcCC---------CCC
Confidence            1223457889999999998889999999999999999999999986433221       111111111         111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....+..+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            12234566889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.7e-37  Score=314.35  Aligned_cols=197  Identities=24%  Similarity=0.397  Sum_probs=161.7

Q ss_pred             CCcccccCceEEEEEEec---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcceEEEeccC
Q 038707          322 NRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIP  396 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  396 (597)
                      .++||+|+||+||+|...   +++.+|+|.+...  .....+.+|+.++++++||||+++++++.+  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999964   4678999987643  223457889999999999999999999865  346789999985


Q ss_pred             CCChhhHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe----CCCCcEEEeecccc
Q 038707          397 NGTLYQYIHNQI------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTS  466 (597)
Q Consensus       397 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfgl~  466 (597)
                       ++|.+++....      ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888876421      1235899999999999999999999999   9999999999999    45678999999999


Q ss_pred             ccccCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          467 RSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       467 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                      +........  ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            865432221  2234568999999999876 468999999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-37  Score=323.29  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..+|++.+.||+|+||.||++...   .++.||+|.+...     ....+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3578999987632     23568999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |++. ++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 6888888432   35999999999999999999999999   999999999999999999999999999765433


Q ss_pred             Cc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh------
Q 038707          473 QT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF------  545 (597)
Q Consensus       473 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  545 (597)
                      .. .......||+.|+|||++....++.++||||||+++|||++|+.||..................+......      
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22 22334569999999999999999999999999999999999999997755433211111111111110000      


Q ss_pred             ----hhh---hHHhhh--hh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 ----EAL---DARVLK--EA-----KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ----~~l---~~~~~~--~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                          +.+   ......  ..     ......++.++|.+||+.||++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                000   000000  00     01224567899999999999999999999864

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5e-37  Score=304.86  Aligned_cols=247  Identities=28%  Similarity=0.491  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|+||.||++.. .++.+|+|.....  ...+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 5788999987643  2346789999999999999999999998654 4799999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999998653 335899999999999999999999998   999999999999999999999999998754321    


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+       ....+..+..         ..
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYR---------ME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCC---------CC
Confidence            112234567999999988899999999999999999998 999986543222       1122222111         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                      .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-37  Score=313.10  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .+|++.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46889999999999999999964 68999999887655556678899999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++...    .+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            999999998653    3899999999999999999999999   99999999999999999999999999876543222 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......+.      ... +.......       ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~-~~~~~~~~-------~~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYL-IATNGTPE-------LQ  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCcc-------cC
Confidence            12234588899999999988899999999999999999999999965432111      111 11000000       01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....+..+.+||.+||+.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12234556889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-37  Score=319.71  Aligned_cols=259  Identities=22%  Similarity=0.359  Sum_probs=193.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..+|++.+.||+|+||.||+|... +++.||+|....      .....|+.++++++||||+++++++.+....++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999976 578899997542      2235699999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      + .++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       139 ~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        139 Y-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             c-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            9 468988887543  35899999999999999999999999   999999999999999999999999998753221  


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH----HHHHHHHHhcCch-----h
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL----VGYFLQAINENRL-----F  545 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~-----~  545 (597)
                      .......||+.|+|||++.+..++.++||||||+++|||+++..|+...........    ...+...+.....     .
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            122345689999999999999999999999999999999986655433222111110    0111111110000     0


Q ss_pred             ---------hhhhHHhhh---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 ---------EALDARVLK---------EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ---------~~l~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                               ..++.....         ......+..+.+||.+||+.||.+|||+.||++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                     000000000         0001223456679999999999999999999863

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.5e-37  Score=312.97  Aligned_cols=256  Identities=28%  Similarity=0.521  Sum_probs=202.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|+..+.||+|+||.||+|.+. +++    .+|+|...... .....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45778889999999999999864 443    57888876433 33345789999999999999999999998754 4679


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ++||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999997643  24889999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--  231 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLP--  231 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC--
Confidence            32221 1222335678999999998899999999999999999997 899986543221       112222211110  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                             .....+..+.+++.+||..+|++||++++++++|+.+..
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   111234568899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=324.61  Aligned_cols=262  Identities=21%  Similarity=0.333  Sum_probs=200.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ...+|.+.+.||+|+||.||++.+. .++.||||...      ...+.+|+++|++++|+||+++++++...+..+||||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3557999999999999999999976 47899999643      2346789999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      ++ .++|.+++....  ..+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       241 ~~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KY-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            99 478999887542  25999999999999999999999999   9999999999999999999999999997654322


Q ss_pred             c-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC-CCcHHHHHHHHHhcCchh-----h
Q 038707          474 T-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE-DKSLVGYFLQAINENRLF-----E  546 (597)
Q Consensus       474 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~-----~  546 (597)
                      . .......||+.|+|||++.+..++.++|||||||+||||++|..|+....... .......+...+......     .
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            1 12234569999999999999999999999999999999999887664433221 111111122222211110     0


Q ss_pred             h----hhHHhhh---------------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 A----LDARVLK---------------EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 ~----l~~~~~~---------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .    +......               .........+.+||.+||+.||.+|||+.|+|+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0    0000000               0000123468899999999999999999999974

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-37  Score=307.54  Aligned_cols=240  Identities=25%  Similarity=0.451  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEecC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLTD--------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.||+|+||.||+|....        ...+++|..........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        234888887655555667899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc--------EEEeecccc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--------AKVSDFGTS  466 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--------~kl~Dfgl~  466 (597)
                      +++|+|.++++....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999986432  4899999999999999999999999   999999999999987765        699999988


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCC-CCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      .....     .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......       ........  
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~--  221 (258)
T cd05078         156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYEDR--  221 (258)
T ss_pred             cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHHHcc--
Confidence            65432     122457888999999876 45899999999999999999985 5554322111       00111110  


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                               ...+.....++.+|+.+||+.+|++|||++++++.|+
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     0111222356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-36  Score=313.94  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=195.2

Q ss_pred             cCCccccc--CceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          321 ANRILGQG--GQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       321 ~~~~lg~G--~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.++||+|  +|++||++..+ +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999975 6899999988653  2334566778999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999976432 24899999999999999999999999   999999999999999999999999865443211110


Q ss_pred             ------eeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          476 ------LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       476 ------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                            ......++..|+|||++.+  ..++.++||||||+++|||++|+.||........      ..... .+.....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~-~~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM------LLEKL-NGTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH------HHHHh-cCCcccc
Confidence                  0112246778999999876  4689999999999999999999999975332110      00000 0000000


Q ss_pred             hhH------------------------------------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 LDA------------------------------------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 l~~------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ++.                                    ...........+.+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000                                    0000111234567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.5e-37  Score=305.83  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=203.0

Q ss_pred             CCccCCcccccCceEEEEEEecC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHhh-cCCCccceeeeEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLV----------DETNVEQFINEVVILSQ-INHRNIVKLLGCCLE  384 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  384 (597)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  688999976532          23345668889998875 799999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999998652 223458999999999999999999996 56   99999999999999999999999


Q ss_pred             ccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      ||++.......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......       ....+...
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEA  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhc
Confidence            99997654332  2344558889999999998889999999999999999999999986432111       11111111


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ....        ......+..+.+++.+||+.||++||++.|+.++|+
T Consensus       229 ~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1110        001123467889999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.7e-37  Score=321.09  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  385 (597)
                      ...++|++.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34578999999999999999999975 5889999987642  344556788999999999999999999987643     


Q ss_pred             -CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          386 -EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       386 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                       ...++||||+++ +|.+++..     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence             346899999964 77777753     2788999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh----
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN----  540 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----  540 (597)
                      +++.....  .......+|..|+|||++.+..++.++||||||+++|+|++|+.||...+..+.   .........    
T Consensus       172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~  246 (364)
T cd07875         172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP  246 (364)
T ss_pred             CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence            99764322  222345689999999999999999999999999999999999999976442211   000000000    


Q ss_pred             ---------------cCch-----hhhhhHHhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 ---------------ENRL-----FEALDARVL----KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 ---------------~~~~-----~~~l~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                     ....     .+.+.+...    ..........+.+||.+||+.||.+|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                           0000     000000000    00011123468899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-36  Score=303.93  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=196.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      .+|+..+.||+|+||.||+|... +++.|++|++...     .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999975 5889999987532     123456788999999999999999999998763  567


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++++||+++++|.+++....   .+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999997542   3889999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          469 VMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       469 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+      ..........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~---  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT---  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC---
Confidence            532111  11223457889999999998889999999999999999999999997432111      1111111110   


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            ....+....+.+.+++ +||..+|++||+++||++
T Consensus       227 ------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                  0111223345567777 688899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.7e-37  Score=303.04  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=202.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ......+.+|+.++++++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999986 78999999865433     33567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      +||+++++|.+++....   ++++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997642   4889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccccccCccccccCC-CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......      ............      
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~------  220 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL------  220 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC------
Confidence            32  233455888999999987766 899999999999999999999998653311      111111110111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ...+......+.+++.+||+.+|++||++.++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               1112234566889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-36  Score=303.43  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=192.1

Q ss_pred             CcccccCceEEEEEEecC---CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||.||+|...+   ...+++|.+... .......+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   457888876543 3344567899999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce-
Q 038707          399 TLYQYIHNQIEE--FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-  475 (597)
Q Consensus       399 sL~~~l~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-  475 (597)
                      +|.+++......  ...++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999875322  23567888999999999999999999   999999999999999999999999998654322211 


Q ss_pred             eeecccccccccCcccccc-------CCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......+      .......... ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence            1222345678999998643       456889999999999999999 788886432211      1111121111 111


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ..+.    .....+..+.+++..|+ .||++|||+++|++.|.
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    12234456778889998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-37  Score=308.85  Aligned_cols=255  Identities=28%  Similarity=0.418  Sum_probs=204.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||+||++... +++.+|+|..... .....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999975 5889999986643 244567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++...   .++++..+..++.+++.||.|||+ ++   ++|+||||+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            9999999998763   248999999999999999999997 46   9999999999999999999999999986543221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC-----cHHHHHHHHHhcCchhhhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK-----SLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l  548 (597)
                         .....++..|+|||++.+..++.++||||||+++|+|++|+.||......++.     .....+...+..       
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------  228 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence               12346889999999998889999999999999999999999999865432211     111111111110       


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                        ..........+..+.+|+.+||+.||++|||+.|++++.
T Consensus       229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 --PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              000001122456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-36  Score=301.88  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||.|++|+||+|... ++..+++|...... ......+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46899999999999999999965 68899999876432 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.++++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999987543345899999999999999999999999   99999999999999999999999999877654332


Q ss_pred             e---eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          475 H---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       475 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      .   ......++..|+|||++... .++.++|+||||+++++|++|+.||......+      .+........      +
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP------P  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCC------C
Confidence            2   22334588899999998776 78999999999999999999999997543321      1111111100      0


Q ss_pred             Hhhhhh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEA-KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...... ....++.+.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            010000 1244567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-37  Score=318.45  Aligned_cols=259  Identities=22%  Similarity=0.327  Sum_probs=196.7

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  385 (597)
                      ...++|++.+.||+|+||+||++... +++.||||++...  .......+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34678999999999999999999975 6889999987642  223456688999999999999999999987643     


Q ss_pred             -CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          386 -EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       386 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                       ...++++|++ +++|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 77998887542    3899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +++.....    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   ........... .
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~  235 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGT-P  235 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCC-C
Confidence            99765322    233458999999999876 578999999999999999999999996533211   11101000000 0


Q ss_pred             hhhhhh---H----Hh-----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          544 LFEALD---A----RV-----------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       544 ~~~~l~---~----~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ..+.+.   .    ..           .........+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000   0    00           000001123457899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=319.01  Aligned_cols=240  Identities=27%  Similarity=0.313  Sum_probs=188.2

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc---CCCccceeeeEEEeCCcceEEEeccCC
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ||+|+||+||+|... +++.||||.+...   .......+..|..++...   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999976 5899999987532   222344566677777665   699999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~  153 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT  153 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence            9999998754   34899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+       ....+..+...      +   .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~------~---~  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR------F---P  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCC------C---C
Confidence            345689999999998754 58999999999999999999999997533211       11112111110      0   0


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPT----MKEVTN  587 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  587 (597)
                      ....+..+.+|+.+||+.||.+||+    +.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1123456789999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.2e-37  Score=308.81  Aligned_cols=261  Identities=23%  Similarity=0.346  Sum_probs=203.4

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe--
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE--  384 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--  384 (597)
                      .+.+..+.++|++.+.||+|+||.||++... +++.+|+|...... ....++.+|+.+++++ +||||+++++++..  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4556667889999999999999999999975 58899999876432 2346688899999999 69999999998853  


Q ss_pred             ---CCcceEEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          385 ---TEVPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       385 ---~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                         .+..++||||+++++|.++++... ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence               346899999999999999887532 2345889999999999999999999998   999999999999999999999


Q ss_pred             eeccccccccCCCceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH
Q 038707          461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~  535 (597)
                      +|||++........ ......|++.|+|||++..     ..++.++||||||+++|||++|+.||.......      ..
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~  238 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------AL  238 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HH
Confidence            99999876543221 2233458999999998753     457889999999999999999999986543211      00


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .. ..........+       +......+.+|+.+||+.+|++|||+.||++.
T Consensus       239 ~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00 00110000000       11224468899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-36  Score=303.81  Aligned_cols=256  Identities=25%  Similarity=0.486  Sum_probs=201.2

Q ss_pred             CccCCcccccCceEEEEEEec----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          319 YNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      |.+.+.||+|+||.||+|.+.    +++.||||.....  .....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864    3688999987642  3455678999999999999999999999886542      


Q ss_pred             cceEEEeccCCCChhhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                      ..++++||+++|+|.+++....   ....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999999875421   2235889999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          464 GTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       464 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      |+++........ ......+++.|++||.+....++.++||||||+++|+|++ |+.||......+       ....+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHHc
Confidence            999865433221 1122335678999999988889999999999999999999 888886543211       1111111


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ....         ......+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       231 ~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         231 GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            1110         011233457899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.6e-37  Score=307.71  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=203.5

Q ss_pred             CHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe-
Q 038707          308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE-  384 (597)
Q Consensus       308 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  384 (597)
                      +..++....+.|++.+.||+|+||.||+|.+. +++.+|+|..... .....++..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34455556788999999999999999999975 5889999987643 33456788999999999 69999999999863 


Q ss_pred             -----CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEE
Q 038707          385 -----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       385 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                           .+..+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.+|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 456799999999999999997643 335889999999999999999999999   99999999999999999999


Q ss_pred             EeeccccccccCCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      |+|||++........ ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||......+.      
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------  234 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------  234 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------
Confidence            999999875432211 122345888999999875     34678899999999999999999999965332110      


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ... .....        .........+..+.+||.+||+.||.+|||+.|+++
T Consensus       235 ~~~-~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LFL-IPRNP--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhh-HhhCC--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000 00000        001111234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-36  Score=301.93  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|+||.+|++... +++.+|+|.+...  ......++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999975 6889999987642  344566899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++.+++.++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999997642 234789999999999999999999999   99999999999999999999999999976543221


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......+++.|+|||++.+...+.++|+||||+++++|++|+.||......      ....... .+..         .
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~---------~  219 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-RGSY---------P  219 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-cCCC---------C
Confidence             122334788999999999888999999999999999999999998643211      1111111 1111         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ..+...+..+.++|.+||+.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1123345678999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2e-36  Score=302.45  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=198.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      .+|++.+.||+|+||.||+|... +++.||||.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999975 5899999986532     123456889999999999999999999998764  467


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +++|||+++++|.+++....   .+++..+.+++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999997542   3789999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          469 VMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       469 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      .........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQP----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHHHhcCC----
Confidence            532111  11223458889999999988889999999999999999999999986431111      111111110    


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           .....+......+.+++.+|+ .+|++||++++|++
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         226 -----TNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence                 011123344566889999999 59999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-36  Score=302.38  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=204.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  392 (597)
                      +|++.+.||.|+||.||++... +++.+|+|.+..  ......+++.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999965 688999998763  344556788999999999999999999998764  34678999


Q ss_pred             eccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          393 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLH-----SAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ||+++++|.+++.... ...++++..++.++.||+.||.|||     +.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999997642 2346899999999999999999999     666   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......       .....+..+..  
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~--  227 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKF--  227 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCC--
Confidence            87643322 123346899999999999888999999999999999999999999754311       12222222221  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                             ...+...+..+.+++.+||+.+|++||++++|++.
T Consensus       228 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   12233455678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-36  Score=302.24  Aligned_cols=252  Identities=25%  Similarity=0.457  Sum_probs=202.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      +|+..+.||+|++|.||++... +++.+|+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999964 68999999876432      2245788999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSV  469 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~  469 (597)
                      ||||+++++|.+++.+..   ++++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999997542   4899999999999999999999999   99999999999998775 5999999998766


Q ss_pred             cCCCce---eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          470 MVDQTH---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       470 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......   ......++..|+|||.+.+..++.++||||||+++++|++|..||........   ...... ....    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~----  226 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFK-IASA----  226 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHH-Hhcc----
Confidence            433211   12234578899999999888899999999999999999999999964332211   111101 0000    


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ......+...++.+.+++.+||+.+|++||++.++++
T Consensus       227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                0111223445667889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-36  Score=307.90  Aligned_cols=262  Identities=23%  Similarity=0.315  Sum_probs=203.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||+|.+. +++.|++|++....  ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 68999999876543  34457899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      + +++|.+++....  .++++.+++.++.||++||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999997643  45999999999999999999999999   99999999999999999999999999987654332


Q ss_pred             eeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc---hh---hh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---LF---EA  547 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~  547 (597)
                      .......++..|+|||.+.+. .++.++||||||++++||++|++||......+   .............   +.   +.
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence            223344588899999998654 46899999999999999999988876433211   1111111100000   00   00


Q ss_pred             -----h-----hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 -----L-----DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 -----l-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           +     ..........+....+.+|+.+||+.+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 0     0000011112335788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.2e-37  Score=330.14  Aligned_cols=267  Identities=20%  Similarity=0.271  Sum_probs=194.9

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC------CccceeeeE
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINH------RNIVKLLGC  381 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~  381 (597)
                      .+++....++|++.++||+|+||+||+|.+. .++.||||+++... ....++..|+.+++.++|      .++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3445556788999999999999999999975 58899999986432 233455667777777654      458889888


Q ss_pred             EEeC-CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCC---
Q 038707          382 CLET-EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKY---  456 (597)
Q Consensus       382 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~---  456 (597)
                      +... ...++|||++ +++|.+++.+.   ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++   
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence            8765 4678999988 77899988754   348999999999999999999998 48   99999999999998765   


Q ss_pred             -------------cEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCC
Q 038707          457 -------------RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI  523 (597)
Q Consensus       457 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~  523 (597)
                                   .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         49999999875422    2233456899999999999999999999999999999999999999764


Q ss_pred             CCcCCCcHHHHH--------HH---------HHh-cCchhhhhhHHhhhh-------hhHHHHHHHHHHHHHhcccCCCC
Q 038707          524 NTDEDKSLVGYF--------LQ---------AIN-ENRLFEALDARVLKE-------AKKEEIMTVATLAKRCLNLNGKM  578 (597)
Q Consensus       524 ~~~~~~~~~~~~--------~~---------~~~-~~~~~~~l~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~  578 (597)
                      ...+........        ..         ... .+.+....++.....       ........+.+||.+||++||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            432211111000        00         000 000000000000000       00112356789999999999999


Q ss_pred             CCCHHHHHH
Q 038707          579 RPTMKEVTN  587 (597)
Q Consensus       579 RPt~~evl~  587 (597)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999986

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.6e-37  Score=309.44  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=201.3

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444467999999999999975 6889999998766666677899999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+||++++++.+||+|||++........ ..
T Consensus       104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~  175 (292)
T cd06658         104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR  175 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence            9999988543    3889999999999999999999999   99999999999999999999999999876532221 22


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+      .+ ..+..     .+.+.+.  ..
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~-~~~~~-----~~~~~~~--~~  241 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AM-RRIRD-----NLPPRVK--DS  241 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHh-----cCCCccc--cc
Confidence            33458899999999988889999999999999999999999986432211      11 11111     0011110  01


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...+..+.+++.+||+.+|.+|||++++++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2234568899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=311.59  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|++|.||++... +++.+|+|.......   .....+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999976 489999998764322   35567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+.+++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987542 345899999999999999999999999   999999999999999999999999998754321


Q ss_pred             Cce----------------------------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          473 QTH----------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       473 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                      ...                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            1112357889999999998889999999999999999999999997543


Q ss_pred             CcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 038707          525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT----MKEVTN  587 (597)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  587 (597)
                      ..+      .+......         ..........+..+.+++.+||+.+|++||+    +.+++.
T Consensus       237 ~~~------~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDE------TFSNILKK---------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHH------HHHHHhcC---------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            221      11111111         1111111225677999999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.9e-36  Score=301.96  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             CcccccCceEEEEEEecCC---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLTDG---RIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.||+|+||+||+|...++   ..+++|..... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985432   35667766543 2345678999999999999999999999999999999999999999


Q ss_pred             ChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC-cee
Q 038707          399 TLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-THL  476 (597)
Q Consensus       399 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~~  476 (597)
                      +|.+++++... ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999986432 234677788899999999999999998   9999999999999999999999999985432211 112


Q ss_pred             eecccccccccCcccccc-------CCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......      ......+... .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKDQ-QVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhhc-ccccC
Confidence            233457889999998743       245789999999999999997 56677543221      1122222211 11222


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ++...    ....+.+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22221    123456788999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-36  Score=306.72  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|++|.||+|... +++.||+|+.....  ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999986 58999999875432  2234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|..++...   ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99998888876543   24899999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc-----------
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-----------  541 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------  541 (597)
                      . ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||......+.   ..........           
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccc
Confidence            1 1223447788999999865 5688999999999999999999999975443221   0000000000           


Q ss_pred             Cchhh---hhhHHhh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRLFE---ALDARVL---KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~~~---~l~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +....   ..++...   .......+..+.+|+.+||+.+|++||++.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000   0000000   0001223567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=300.53  Aligned_cols=269  Identities=26%  Similarity=0.393  Sum_probs=209.2

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc--CCCccceeeeEEEeCC----
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI--NHRNIVKLLGCCLETE----  386 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----  386 (597)
                      ..+.++..+.+.||+|.||+||+|.+. |+.||||++...++   ..+.+|.+|.+..  +|+||+.+++.-..++    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            445577888999999999999999995 89999999875433   4577888888874  8999999998876543    


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-----AASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      .++||.+|.+.|+|.|||.+.    .++.+..++++..+|.||++||.     ++++.|.|||||+.|||+..++.+-|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            679999999999999999874    49999999999999999999996     577889999999999999999999999


Q ss_pred             eccccccccCCCce---eeecccccccccCccccccCC----C--CcccceeehHHHHHHHHhC----------CCCCCC
Q 038707          462 DFGTSRSVMVDQTH---LTTKVQGTFGYVDPEYFQSSQ----F--TEKSDVYSFGVVLVEILTG----------QKPIRA  522 (597)
Q Consensus       462 Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~SlG~il~ell~g----------~~p~~~  522 (597)
                      |+|||-....+...   ......||.+|||||++.+.-    +  -..+||||||.++||+..+          +.||..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999776544322   234567999999999986532    1  2469999999999999752          357765


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .-+.+...  +.....+-..++...+..+   ....+....+.+|++.||..||.-|.|+-.+-+.|.++-+
T Consensus       439 ~Vp~DPs~--eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDPSF--EEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCCH--HHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            54433211  1111222222222222222   2235667789999999999999999999999999988763

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.8e-36  Score=299.46  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=202.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|+..+.||+|++|.||++... +++.+|+|.+...  .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999975 6889999986543  344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++.... ...+++..+..++.|++++|.|||+++   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999998642 335899999999999999999999999   9999999999999865 468999999997664322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                        ......++..|+|||.+....++.++||||||+++++|++|+.||...+...      .... .......        
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~-~~~~~~~--------  219 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLK-IMSGTFA--------  219 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHH-HHhcCCC--------
Confidence              1223457889999999998889999999999999999999999986533211      1111 1111111        


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       ......+..+.+++.+||+.+|++|||++|+++.
T Consensus       220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             1122345568899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-36  Score=306.40  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             ccCHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEE
Q 038707          306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCL  383 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  383 (597)
                      ++...++..+.++|++.+.||+|+||.||++... +++.+|+|...... .....+.+|+.++.++ +|||++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            3455666677899999999999999999999975 68899999876432 2346678899999999 7999999999987


Q ss_pred             eCC-----cceEEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          384 ETE-----VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       384 ~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      ..+     ..++||||+++++|.++++... ....+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence            543     5799999999999999987532 2345899999999999999999999998   999999999999999999


Q ss_pred             EEEeeccccccccCCCceeeecccccccccCccccccC-----CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH
Q 038707          458 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV  532 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~  532 (597)
                      +||+|||++........ ......++..|+|||.+...     .++.++||||||+++|||++|+.||......+     
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----  240 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----  240 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence            99999999876543221 12234578899999997543     36899999999999999999999997543211     


Q ss_pred             HHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       533 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .... +..+......       ........+.+||.+||+.+|++||++.|+++
T Consensus       241 -~~~~-~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 -TLFK-IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHH-HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1111 1111111110       11233456899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-36  Score=300.72  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=202.9

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|+..+.||+|++|.||+|... +++.+++|.++....  ...+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888899999999999999975 688999998775444  3678899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999999764   23789999999999999999999999   99999999999999999999999999877654332


Q ss_pred             eee---ecccccccccCccccccCC---CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          475 HLT---TKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       475 ~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...   ....++..|+|||++....   ++.++||||||+++++|++|+.||.......     .... .+..+....  
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~--  226 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMF-HVGAGHKPP--  226 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHH-HHhcCCCCC--
Confidence            221   1345788999999988766   8999999999999999999999996432111     1111 111110000  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .  .......+.+.+++.+||+.+|++||++.+++.
T Consensus       227 ---~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 ---I--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---C--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               0  001123566789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8e-37  Score=341.07  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=200.5

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      ...++|.+.+.||+|+||+||++.+. .+..+|+|.+..  ........+..|+.++++++||||+++++++.+.  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999976 577899998764  3444567899999999999999999999998654  468


Q ss_pred             eEEEeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeccCCCCCeEeCC---------
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAAS----IPIYHRDIKSANILLDD---------  454 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~i~H~Dik~~NIll~~---------  454 (597)
                      +|||||+++++|.++|..... ...+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            999999999999999976322 2459999999999999999999998542    23999999999999964         


Q ss_pred             --------CCcEEEeeccccccccCCCceeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          455 --------KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       455 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                              ...+||+|||++......  .......||+.|+|||++..  ..++.++||||||||||||++|+.||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    234899999999765322  12234568999999999854  458999999999999999999999996432


Q ss_pred             CcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..     . .+...+......          .....+..+.+||..||+.+|.+||++.|++.
T Consensus       248 ~~-----~-qli~~lk~~p~l----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NF-----S-QLISELKRGPDL----------PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cH-----H-HHHHHHhcCCCC----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            11     1 111112111110          01123456889999999999999999999984

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-36  Score=302.61  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=200.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC----------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD----------ETNVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      +|.+.+.||+|++|.||+|... +++.+|+|..+...          ....+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999865 68999999765311          112356889999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||+++++|.+++++.   .++++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999999865   35899999999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCce-eeecccccccccCccccccCC--CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          467 RSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       467 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ......... ......++..|+|||.+....  ++.++|+||||+++++|++|..||......     .. ..... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~-~~~~~-~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AA-MFKLG-NKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HH-HHHhh-ccc
Confidence            765422211 123345888999999987654  889999999999999999999998532211     11 11110 011


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ....+    ........+..+.+++.+||+.+|++||++++|++.
T Consensus       229 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            01111    111122345678999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.6e-37  Score=308.22  Aligned_cols=261  Identities=24%  Similarity=0.360  Sum_probs=200.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|++|.||++.++ +++.+|+|+.....  ....+.+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 58999999865422  2235678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.++....   ..+++.+++.++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999888876543   23899999999999999999999998   9999999999999999999999999987654332


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--chhhhhh-
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEALD-  549 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~-  549 (597)
                       .......++..|+|||++.+ ..++.++||||||++++||++|++||......+   ...........-  ...+..+ 
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhcc
Confidence             22233457889999999865 457889999999999999999999986433211   000000000000  0000000 


Q ss_pred             ---------H-----HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ---------A-----RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ---------~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                               +     ..........+..+.+|+.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                     0     0000111234567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-36  Score=309.25  Aligned_cols=260  Identities=21%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             CCcccccCceEEEEEEec---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcceEEEeccC
Q 038707          322 NRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIP  396 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  396 (597)
                      .++||+|+||+||+|...   ++..+|+|.+...  .....+.+|+.++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999965   3578999987643  223467899999999999999999999864  456789999986


Q ss_pred             CCChhhHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe----CCCCcEEEeecccc
Q 038707          397 NGTLYQYIHNQI------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTS  466 (597)
Q Consensus       397 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfgl~  466 (597)
                       ++|.+++....      ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             47888775321      2235889999999999999999999999   9999999999999    56678999999999


Q ss_pred             ccccCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH---HHHHHHHHh
Q 038707          467 RSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL---VGYFLQAIN  540 (597)
Q Consensus       467 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~---~~~~~~~~~  540 (597)
                      +........  ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||.....+.....   .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            865433221  2233468999999999876 4589999999999999999999999975443211100   000000000


Q ss_pred             c--------------CchhhhhhHHh-------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 E--------------NRLFEALDARV-------------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~--------------~~~~~~l~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .              ......+....             ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0              00000000000             00000112345788999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.6e-36  Score=301.48  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|+..+.||+|++|.||++.+. +++.+++|.+.... .....++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999986 58999999876543 34567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++....  .++++..+..++.|+++||+|||+ .+   ++|+||||+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999998653  458999999999999999999999 88   9999999999999999999999999987653222


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      ..   ...++..|+|||.+.+..++.++||||||+++++|++|+.||....... ........... ....         
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~---------  221 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEPP---------  221 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCCC---------
Confidence            11   1557889999999998899999999999999999999999997543211 11111111111 1100         


Q ss_pred             hhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          554 KEAKK-EEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       554 ~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..... ..+..+.++|.+||..+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            01111 15567899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.5e-36  Score=307.29  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=201.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ......+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999976 57899999876432   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997642   4899999999999999999999998   999999999999999999999999988642111


Q ss_pred             Cc--------------eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHH
Q 038707          473 QT--------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       473 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      ..              .......++..|+|||.+....++.++|+||||+++|||++|+.||.+....+       ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence            00              01112347889999999988889999999999999999999999996433211       1111


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ...+...   .+    ......+..+.+|+.+||+.+|++||++.++++.|+
T Consensus       228 ~~~~~~~---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDDIE---WP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhcccC---CC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1111100   00    001134556889999999999999999766666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-36  Score=302.63  Aligned_cols=262  Identities=22%  Similarity=0.366  Sum_probs=202.8

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986 689999998875432 33567789999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 89998876554456999999999999999999999999   99999999999999999999999999975533221 


Q ss_pred             eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH-----------hc-C
Q 038707          476 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI-----------NE-N  542 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~-~  542 (597)
                      ......++..|++||.+.+ ..++.++||||||+++|+|++|+.||......+.   ........           .. .
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcCc
Confidence            1223346889999998865 4578999999999999999999999976543221   11110000           00 0


Q ss_pred             chhh---hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          543 RLFE---ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       543 ~~~~---~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+..   ..............+..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000   00000111112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-36  Score=306.72  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||+|... +|+.+|+|.+....  ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 68999999876432  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ ++|.+++....  ..+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            96 58888876532  34899999999999999999999999   99999999999999999999999999876533221


Q ss_pred             eeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc------hhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR------LFEA  547 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  547 (597)
                       ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+......+  ..............      +.+.
T Consensus       155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhc
Confidence             12234578899999998664 47899999999999999999998865332211  11111100000000      0000


Q ss_pred             hhHH--------h-hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 LDAR--------V-LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 l~~~--------~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+..        . ........++++.+|+.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000        0 00111224567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.1e-36  Score=305.91  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|.+.+.||+|+||.||++... +++.+++|..........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67999999999999999999865 68899999987655556678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++.+.    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            999999999753    3789999999999999999999999   99999999999999999999999998875543222 


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......+++.|+|||.+....++.++||||||+++|+|++|+.||......+...      .....+.        ....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CCCC
Confidence            2223458889999999988889999999999999999999999997543322100      0000000        0011


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .....+..+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122345568899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-36  Score=307.56  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=200.2

Q ss_pred             cCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCC
Q 038707          321 ANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  399 (597)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3447999999999999975 689999999876555566788999999999999999999999999999999999999999


Q ss_pred             hhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeec
Q 038707          400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK  479 (597)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~  479 (597)
                      |.+++...    .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... .....
T Consensus       105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  176 (297)
T cd06659         105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS  176 (297)
T ss_pred             HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence            99987542    3899999999999999999999999   9999999999999999999999999987554322 12233


Q ss_pred             ccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHH
Q 038707          480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE  559 (597)
Q Consensus       480 ~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  559 (597)
                      ..++..|+|||++.+..++.++||||||++++||++|+.||......+       ....+.......       ......
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------~~~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPK-------LKNAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCC-------ccccCC
Confidence            558899999999998889999999999999999999999997432211       111111110000       001122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          560 EIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       560 ~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ....+.+++.+||+.+|++||+++++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            34568899999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=302.39  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC------
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE------  386 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  386 (597)
                      .+++|++.+.||+|++|.||+|... +++.+++|....... ..+++.+|+.+++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999985 578999998775433 446799999999999 6999999999997655      


Q ss_pred             cceEEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4799999999999999987632 2346899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      +....... .......++..|+|||.+..     ..++.++||||||++|++|++|+.||.......      ...+ +.
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~  231 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFK-IP  231 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHH-hh
Confidence            87653222 22233458889999998753     346789999999999999999999996432111      1111 11


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ......       .......++.+.+|+.+||..||++|||+.++++
T Consensus       232 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111100       0112235567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=307.19  Aligned_cols=262  Identities=25%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.++..  .....+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 5889999987642  33445789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |++++.+..++...   ..+++.+++.++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99987776655432   34899999999999999999999999   9999999999999999999999999988765443


Q ss_pred             ceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh------------
Q 038707          474 THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------------  540 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------  540 (597)
                      ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+   ..........            
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhccc
Confidence            3233345678899999999887 88999999999999999999999997543211   0000000000            


Q ss_pred             cC-----chhhhhhHHh-hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 EN-----RLFEALDARV-LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~-----~~~~~l~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..     ...+..++.. ........+.++.+||++||..+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00     0000000000 00111223677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.7e-36  Score=298.57  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=208.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|++|.||++... +++.+++|+...... .....+.+|+..+++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999987 589999998775443 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++...   .++++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999864   358999999999999999999999 88   9999999999999999999999999987664332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......   ..... ..+.....         
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~-~~~~~~~~---------  220 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELM-QAICDGPP---------  220 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHH-HHHhcCCC---------
Confidence            22 223457889999999998899999999999999999999999997654311   11111 11111111         


Q ss_pred             hhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 KEAKKE-EIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...... .+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111222 55679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-37  Score=314.24  Aligned_cols=245  Identities=26%  Similarity=0.439  Sum_probs=197.3

Q ss_pred             ccCCcccccCceEEEEEEec-CCcEEEE---EEcc-ccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc--ceEEE
Q 038707          320 NANRILGQGGQGTVYKGMLT-DGRIVAV---KKSK-LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV--PLLVY  392 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~-~~~~vai---K~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  392 (597)
                      +...+||+|+|-+||+|.+. +|..||=   |.-. ...+...++|..|+.+|+.|+||||++++.+..+...  ..+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999986 4777763   3222 1345667999999999999999999999999987665  77899


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~~~~~  471 (597)
                      |.+..|+|..|++++.+   ++.+.+..|++||++||.|||++. +||+|||||-+||+|+.+ |.|||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999998754   889999999999999999999987 679999999999999764 7899999999987643


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ..   .....|||.|||||+.. ..|++..||||||+.|+||+|+..||..     -.+....+ ..+-.|.-...+.  
T Consensus       199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIY-KKV~SGiKP~sl~--  266 (632)
T KOG0584|consen  199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIY-KKVTSGIKPAALS--  266 (632)
T ss_pred             cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHH-HHHHcCCCHHHhh--
Confidence            22   22367999999999987 7899999999999999999999999953     33333332 2222332222221  


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            .-..+++.+||.+||.. .++|||+.|+|.
T Consensus       267 ------kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 ------KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                  11135688999999988 999999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.4e-36  Score=303.13  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=198.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|+..+.||.|++|.||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999976 68999999876432  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +. ++|.+++.... ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 68999887643 345899999999999999999999999   99999999999999999999999999876532221


Q ss_pred             eeeecccccccccCccccccCC-CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc--hhhhhh--
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR--LFEALD--  549 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~--  549 (597)
                       ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+  ..... ........  ....+.  
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRI-FRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHhCCCChhhhhhhhHH
Confidence             122234678899999886644 6889999999999999999999997533211  11110 00000000  000000  


Q ss_pred             -----------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 -----------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                 .............++.++|.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                       00000111123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-37  Score=310.90  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  391 (597)
                      ....|++.++||+||.+.||++...+.+.+|+|++..  .+.....-|.+|+..|.+|+ |.+||+|++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3466999999999999999999988888899987653  56777889999999999995 99999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||= ..+|..+|++....  ++...+..+..|++.|+.++|.++   |||.||||.|+|+-.. .+||+|||.|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence            9976 56999999876433  443478889999999999999999   9999999999999765 899999999998876


Q ss_pred             CCce-eeecccccccccCccccccCC-----------CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          472 DQTH-LTTKVQGTFGYVDPEYFQSSQ-----------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       472 ~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      +... ......||+.||+||.+....           .+.++||||||||||+|+.|+.||....     +...      
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~a------  580 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIA------  580 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHH------
Confidence            6554 345567999999999975422           4679999999999999999999996321     1111      


Q ss_pred             hcCchhhhhhHHhhhhhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          540 NENRLFEALDARVLKEAKKEE-IMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ++..+.++....+++..- ..++.++++.||++||.+||+..++|+
T Consensus       581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence               122233332222211111 112889999999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.8e-36  Score=300.79  Aligned_cols=247  Identities=27%  Similarity=0.451  Sum_probs=201.9

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      -|++.+.||+|+||.||+|... +++.+|||...... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999875 68899999876432 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++...    .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++....... .
T Consensus        85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~  156 (277)
T cd06641          85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  156 (277)
T ss_pred             CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence            999999998643    4899999999999999999999999   9999999999999999999999999987654322 1


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......++..|+|||.+.+...+.++|+||||+++++|++|..||.......       ....+....         ...
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~  220 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN---------PPT  220 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC---------CCC
Confidence            1223457889999999988889999999999999999999999986432111       111111111         011


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            123345668899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-36  Score=314.31  Aligned_cols=201  Identities=30%  Similarity=0.429  Sum_probs=174.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-C-----CccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-H-----RNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~  389 (597)
                      -+|.+.++||+|.||.|-++.+. +++.||||+++. ...-..+...|+.+|..|+ |     -|+|+++++|...++.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            37999999999999999999975 699999999985 3445567788999999997 4     48999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC--CcEEEeeccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGTSR  467 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~--~~~kl~Dfgl~~  467 (597)
                      ||+|.+ ..+|.++|+.+... .++...+..++.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.|.
T Consensus       265 iVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999 56999999987443 4999999999999999999999999   9999999999999643  379999999997


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE  527 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~  527 (597)
                      ....   ... .+..+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+
T Consensus       340 ~~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  340 FESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             ccCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            5432   112 4556788999999999999999999999999999999988887765443

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.5e-36  Score=302.21  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=195.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHH-HhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||.||++.+. +|+.||||+++... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999976 68999999876532 2334456666665 566789999999999999999999999


Q ss_pred             ccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          394 FIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |++ ++|.+++.... ....+++..++.++.||+.||+|||++ +   ++||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 68988886532 234689999999999999999999987 7   99999999999999999999999999876532


Q ss_pred             CCceeeecccccccccCcccccc----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ..  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||......     .......... .... 
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~-  227 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEE-PSPQ-  227 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhc-CCCC-
Confidence            21  1223457889999998864    45689999999999999999999998642211     1111111111 0000 


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             ......++++.++|.+||..+|++||++.++++
T Consensus       228 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 -------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   001224567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=304.41  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=197.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999976 689999998764322 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++ +|.+++.....  .+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            974 99999876432  5899999999999999999999999   99999999999999999999999999875432211


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC---ch------
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---RL------  544 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------  544 (597)
                      . .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  .........+...   .+      
T Consensus       159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence            1 122346788999999865 558899999999999999999999996543111  0000000000000   00      


Q ss_pred             -------hhhhhHHhhhhhhHHH--HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 -------FEALDARVLKEAKKEE--IMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 -------~~~l~~~~~~~~~~~~--~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             .....+..........  ...+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                   0000000000000111  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=299.78  Aligned_cols=260  Identities=28%  Similarity=0.322  Sum_probs=203.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--cceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  392 (597)
                      ++|+..+.||.|++|.||++.+. +++.+|+|...... .....++.+|++++++++||||+++++++.+..  ..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999985 58899999876433 345677999999999999999999999986543  679999


Q ss_pred             eccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|.+++.... ....+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999886532 2345899999999999999999999999   99999999999999999999999999865432


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ...   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ...+.........+. 
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~-  231 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPELKDE-  231 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchhhccC-
Confidence            221   23347888999999998899999999999999999999999997653311 111111 111111111111000 


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .  ......++.+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0  001224567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-36  Score=303.60  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|++|.||++... +++.+|+|.....   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999976 5899999987532   2344577899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999999765   34899999999999999999999999   999999999999999999999999999776433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......+       ....+..+..        
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKV--------  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence                233458899999999988889999999999999999999999996533111       1111111111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                        ..+...+..+.+++.+||+.+|.+||     +++|+++
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              11122356688999999999999998     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-36  Score=301.69  Aligned_cols=247  Identities=28%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |...+.||+|++|.||++... +++.+++|+.........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444568999999999999965 6889999988766666667799999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++...    .+++..+..++.|++.||+|||+++   |+||||+|+||++++++.+||+|||++........ ..
T Consensus       101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            9999998762    3899999999999999999999999   99999999999999999999999998875543221 22


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....|++.|+|||.+.+..++.++||||||+++++|++|+.||......+      . ...+.....     +..  ...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~-~~~~~~~~~-----~~~--~~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------A-MKRIRDNLP-----PKL--KNL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------H-HHHHHhcCC-----CCC--ccc
Confidence            33458899999999988889999999999999999999999986432111      1 111111100     000  001


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...+..+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            124467899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-35  Score=303.83  Aligned_cols=246  Identities=26%  Similarity=0.393  Sum_probs=197.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +.|+..+.||+|+||+||+|... +++.||+|.....   ......++.+|+.+++.++||||+++++++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999975 6899999987532   2344567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++ |+|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 67878776532  34899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                           ....++..|+|||++.   ...++.++||||||+++|||++|+.||.......      ... .+..+..     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~-~~~~~~~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNDS-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHH-HHhcCCC-----
Confidence                 2235788999999874   4568899999999999999999999986432111      000 1111100     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ........++.+.+++.+||+.+|++||++.+|+..
T Consensus       232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               001122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=300.77  Aligned_cols=253  Identities=27%  Similarity=0.431  Sum_probs=206.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..++|+..+.||+|++|.||+|.++ ++..+++|.+..... ..+.+.+|++++++++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999987 688999999876544 56788999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999998753  35999999999999999999999998   9999999999999999999999999886554322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      .... +.......       
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~-------  235 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPP-------  235 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCC-------
Confidence            1 2223347889999999988889999999999999999999999986432211      1111 11111100       


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .......+..+.++|.+||+.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            00112245678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=299.95  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=200.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcC---CCccceeeeEEEeCCcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .|+..+.||+|+||.||+|.+. +++.+|+|..... .....+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778889999999999999974 6899999987643 3445677889999999997   999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++...    ++++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999998653    4899999999999999999999999   999999999999999999999999999776543


Q ss_pred             CceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........       ..+.....     +.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~-----~~  221 (277)
T cd06917         155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKP-----PR  221 (277)
T ss_pred             cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCC-----CC
Confidence            32 2233458889999998865 45789999999999999999999999754322110       00001000     00


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +.   ....+.++.+++.+||+.+|++||++.++++
T Consensus       222 ~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LE---DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            10   0114557889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.8e-36  Score=304.54  Aligned_cols=261  Identities=27%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDET-----NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +|++.+.||+|++|.||+|... +++.||||.+......     ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788889999999999999975 6899999987653322     345677899999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997643  35999999999999999999999999   99999999999999999999999999976643


Q ss_pred             CCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--------
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--------  542 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  542 (597)
                      ... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+||......+   ............        
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhc
Confidence            322 1222346788999998854 567899999999999999999987776533211   111111100000        


Q ss_pred             -chhhhhh-----HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          543 -RLFEALD-----ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       543 -~~~~~l~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       .......     +..........+..+.++|.+||+.+|++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0000000     000001112335678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-36  Score=303.42  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  391 (597)
                      ++|++.+.||+|++|.||+|... +++.+++|.++....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999986 588999998764332  2234577899999999999999999999877  889999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||++ ++|.+++.....  .+++..++.++.||+.||+|||+.+   ++|+||||+|||+++++.+||+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 599999876432  5899999999999999999999999   99999999999999999999999999986654


Q ss_pred             CCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh----------
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN----------  540 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------  540 (597)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++++|++|+.||......+.   .........          
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHh
Confidence            321 12334478899999998654 468999999999999999999999975432211   110000000          


Q ss_pred             -------cCchhhhhhHHhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 -------ENRLFEALDARVLKEAKKE-EIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 -------~~~~~~~l~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             ...........+....... .++.+.+||.+||+.+|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                   0000000001111111111 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-35  Score=292.37  Aligned_cols=249  Identities=30%  Similarity=0.446  Sum_probs=205.7

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      .|...+.||+|++|.||++... +++.+++|+...........+.+|+.++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3778889999999999999986 688999999876655567889999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++....  ..+++..+..++.|++.||.+||+.+   ++|+||+|+||++++++.+||+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999998653  35899999999999999999999988   99999999999999999999999999877654332  


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      .....++..|+|||.+....++.++||||||+++++|++|+.||...+..+   .    .............       .
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~~~~-------~  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---A----LFKIATNGPPGLR-------N  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---H----HHHHHhcCCCCcC-------c
Confidence            334558889999999988889999999999999999999999986543111   0    0011111000000       0


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ....+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112567899999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-36  Score=299.41  Aligned_cols=247  Identities=26%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +|++.+.||+|+||.||++... +++.+|+|.....   .....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999976 5899999987642   23456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++...   .++++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999764   35899999999999999999999999   9999999999999999999999999987654332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......    ...+......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence              2234558889999999988889999999999999999999999997654321    1112111111          00


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTM--KEVT  586 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl  586 (597)
                      ...+...+..+.++|.+||+.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11123345678899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-35  Score=300.17  Aligned_cols=264  Identities=23%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999975 68899999876433 223346788999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+. ++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9995 67877776532  24788899999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc----------
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE----------  541 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  541 (597)
                      ... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ............          
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence            211 223346889999999875 457889999999999999999999997543211  000000000000          


Q ss_pred             --Cchh-hhhh---HHhhhhh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 --NRLF-EALD---ARVLKEA--KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 --~~~~-~~l~---~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        .... +...   +......  .......+.+++.+|++.||++|||++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              0000 0000   0000000  0112456889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=314.06  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=206.2

Q ss_pred             CccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |++...||.|+||.||+|..++ +...|-|.+...+.+..++|+-||.||+..+||+||+|++.|...+.+++..|||+|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4555679999999999999875 445667888888888999999999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |.++.++-+-.  .+|++.++..+.+|++.||.|||+..   |||||||+.|||++-+|.++|+|||.+..... .....
T Consensus       114 GAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR  187 (1187)
T KOG0579|consen  114 GAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR  187 (1187)
T ss_pred             chHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence            99999988753  35999999999999999999999999   99999999999999999999999999865432 22345


Q ss_pred             ecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          478 TKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ..+.|||.|||||++.     ..+|+.++||||||++|.||..+.+|-...++.-       +.-.+...      ++..
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKS------ePPT  254 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKS------EPPT  254 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhc------CCCc
Confidence            5677999999999863     4689999999999999999999999975433211       11111110      1111


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +. .+......+.+++.+||..||..||++.++++.
T Consensus       255 Ll-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11 145667789999999999999999999999863

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=303.89  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             CCccCCcccccCceEEEEEEec---CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccce
Q 038707          318 NYNANRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL  389 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  389 (597)
                      +|++.+.||+|++|.||+|...   +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999975   47899999877532   34456788999999999999999999999988  7899


Q ss_pred             EEEeccCCCChhhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC----CCcEEEeec
Q 038707          390 LVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDF  463 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~----~~~~kl~Df  463 (597)
                      +||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 77777754322  236899999999999999999999999   999999999999999    999999999


Q ss_pred             cccccccCCCc--eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH------HH
Q 038707          464 GTSRSVMVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV------GY  534 (597)
Q Consensus       464 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~------~~  534 (597)
                      |++........  .......++..|+|||.+.+ ..++.++||||||++|++|++|+.||............      ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543222  12233457889999998766 45899999999999999999999999865543311100      00


Q ss_pred             HHHHHhc------------Cchhhhh--------h-HHhhhhhhH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          535 FLQAINE------------NRLFEAL--------D-ARVLKEAKK--EEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       535 ~~~~~~~------------~~~~~~l--------~-~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +...+..            .......        . ..+......  ....++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000            0000000        0 000000011  33456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.1e-36  Score=297.21  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|+||.||++... ++..+|+|.....  .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 5889999987542  223456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++.... ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999997643 235899999999999999999999999   99999999999999885 46999999987654322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                       .......|++.|+|||.+....++.++|+||||+++++|++|+.||......      ....... .+..         
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~---------  219 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYF---------  219 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccC---------
Confidence             1222345888999999998888999999999999999999999998643211      1111111 1111         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            01112334568899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-36  Score=323.72  Aligned_cols=268  Identities=20%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC--CcEEEEE------------------EccccChhhHHHHHHHHHHHhhcCCCc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD--GRIVAVK------------------KSKLVDETNVEQFINEVVILSQINHRN  374 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n  374 (597)
                      ..++|++.+.||+|+||+||++..+.  ++..++|                  +.. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            35789999999999999999987542  2222222                  111 12233556889999999999999


Q ss_pred             cceeeeEEEeCCcceEEEeccCCCChhhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       375 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      |+++++++.+.+..++|+|++. ++|.+++.....  ........+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999984 578887754321  112346678889999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCC-CCCCCCcCCCcH
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP-IRAINTDEDKSL  531 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p-~~~~~~~~~~~~  531 (597)
                      +.++.+||+|||+++..............||..|+|||++.+..++.++||||||++||||++|..+ +..........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987654433334446799999999999999999999999999999999998754 433222211111


Q ss_pred             HHHHHHHHh--cC-------chhhhhhHHhhhh----h-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          532 VGYFLQAIN--EN-------RLFEALDARVLKE----A-----KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       532 ~~~~~~~~~--~~-------~~~~~l~~~~~~~----~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .... ..+.  ..       .+++.++......    .     ....+..+.++|.+||+.||.+|||+.|+++.
T Consensus       381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111 0000  00       0011111000000    0     01123457788999999999999999999863

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=299.79  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=200.1

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceEEEe
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYE  393 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  393 (597)
                      |++.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|+.++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 58899999987642  34456788999999999999999999999988  88999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++ +|.+++....  ..+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9974 8988887542  35899999999999999999999999   9999999999999999999999999998765443


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc---Cc------
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NR------  543 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~------  543 (597)
                      ........++..|+|||.+.+ ..++.++||||||++++||++|+.||........   ..........   ..      
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence            222333456788999998764 4679999999999999999999999975442211   1111110000   00      


Q ss_pred             --------hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 --------LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 --------~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              ........+........+..+.+++++||+.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    00000000111111112667899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-35  Score=301.17  Aligned_cols=263  Identities=22%  Similarity=0.326  Sum_probs=198.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCc-----
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV-----  387 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  387 (597)
                      ++|++.+.||+|+||.||+|.+. +++.||||......  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999976 68999999866432  223467889999999995 6999999999987665     


Q ss_pred             ceEEEeccCCCChhhHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeecc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFG  464 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg  464 (597)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 89998875432  246899999999999999999999999   999999999999998 8899999999


Q ss_pred             ccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+  .+.. +........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPT  232 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCC
Confidence            98765332211 122346788999998765 567999999999999999999999997543211  1110 111110000


Q ss_pred             --hh------------hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 --LF------------EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 --~~------------~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..            ....+..........++++.+||.+||+.||.+||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              00            000000111111235667899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-35  Score=298.01  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=194.4

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeC--CcceEEEe
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVYE  393 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  393 (597)
                      |++.+.||+|+||.||+|... +++.+|+|+.+... ........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999975 68899999876432 222334567899999885 99999999999987  88999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |++ ++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            996 58888887543  35899999999999999999999999   999999999999999 999999999997654322


Q ss_pred             ceeeecccccccccCccccc-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH-----------hc
Q 038707          474 THLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI-----------NE  541 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~  541 (597)
                      .  .....++..|+|||.+. +..++.++||||||+++|||++|+.||...+..+   .........           ..
T Consensus       154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence            2  22345788999999764 4567899999999999999999999997643221   111111100           00


Q ss_pred             CchhhhhhHH----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRLFEALDAR----VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~~~~l~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ........+.    .........+..+.+||.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    001112244678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.9e-35  Score=301.31  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=196.7

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |...+.||+|+||.||++... ++..+|+|.+...   .......+.+|+.++++++|||++++++++.+.+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677789999999999999975 6889999987632   233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ |+|.+++...  ..++++.++..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....   
T Consensus       107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            96 5888877653  234899999999999999999999999   99999999999999999999999998865432   


Q ss_pred             eeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          475 HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        .....+++.|+|||.+.   ...++.++||||||+++|||++|+.||......+      ..........        
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~--------  241 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES--------  241 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC--------
Confidence              12345788999999973   4568999999999999999999999986432111      1111111110        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                       ........++.+.+|+.+||+.+|.+||++.++++.+
T Consensus       242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence             0111223455688999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-35  Score=293.49  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||++... +++.+++|.....  ......++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 6889999987643  345567888999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++.+.. ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999987632 2345899999999999999999999999   999999999999999999999999999776543 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                        ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+       +......+..         
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY---------  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence              2223457889999999998899999999999999999999999996543221       1122222211         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .......+.++.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1122345567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=298.91  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      |++.+.||.|++|.||+|... +|+.||+|++....  ......+.+|+.++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999975 68999999876432  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      + ++|.+++..... ..+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 689999876532 35899999999999999999999998   999999999999999999999999999765322211


Q ss_pred             eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--c----hhhh-
Q 038707          476 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--R----LFEA-  547 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~-  547 (597)
                       .....++..|+|||++.+. .++.++||||||+++|+|++|+.||.......  .+...+ ......  .    .... 
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIF-RTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCChHHhhhhhhch
Confidence             1223467889999987654 57899999999999999999999996543211  011100 000000  0    0000 


Q ss_pred             --------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 --------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 --------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              .............+..+.++|.+||+.+|.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    0000001111223467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.7e-35  Score=298.13  Aligned_cols=259  Identities=19%  Similarity=0.286  Sum_probs=187.9

Q ss_pred             hcCCccCCcccccCceEEEEEEecC----CcEEEEEEccccChhhH-----------HHHHHHHHHHhhcCCCccceeee
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-----------EQFINEVVILSQINHRNIVKLLG  380 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  380 (597)
                      .++|++.++||+|+||+||+|...+    +..+|+|..........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4679999999999999999999754    45667775443222111           11233445566778999999999


Q ss_pred             EEEeCC----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          381 CCLETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       381 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      +.....    ..++++|++. .++.+.+....   ..++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876544    3367788764 36666665432   2578889999999999999999999   99999999999999999


Q ss_pred             cEEEeeccccccccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCc
Q 038707          457 RAKVSDFGTSRSVMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS  530 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~  530 (597)
                      .+||+|||+++........      ......||+.|+|||++.+..++.++||||||++|+||++|+.||........  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence            9999999999866432211      12234589999999999999999999999999999999999999986532221  


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      ..    .......+..+......   ....+..+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LI----HAAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HH----HHhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11    00000000111111110   1223567899999999999999999999998874

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-35  Score=291.66  Aligned_cols=250  Identities=32%  Similarity=0.444  Sum_probs=206.7

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||++... +++.+++|+.....  .....++.+|++++++++|+|++++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999976 58899999877543  35677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +++++|.+++.+.. ....+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998742 1346999999999999999999999998   9999999999999999999999999997654432


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                       .......+++.|+|||.+....++.++|+||||+++++|++|+.||......      ....... ....         
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~---------  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKIL-KGQY---------  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHh-cCCC---------
Confidence             2333446888999999998888999999999999999999999998643311      1111111 1111         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1112234566889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=308.60  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  388 (597)
                      .++|++.+.||+|++|.||+|... +++.||||.+... .......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999965 6899999988643 2334567889999999999999999999876543     47


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++++||++ ++|.+++...    .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            89999996 4888877543    4899999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch-
Q 038707          469 VMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-  544 (597)
Q Consensus       469 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  544 (597)
                      .......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...   .............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence            5432211  1223457889999998654 568999999999999999999999996533211   11111111110000 


Q ss_pred             --hhhhhHHh--------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          545 --FEALDARV--------------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       545 --~~~l~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ..+.+...              ........+.++.+|+.+||+.+|++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00000000              000111235668899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=292.87  Aligned_cols=249  Identities=26%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      .+|++.+.||+|++|.||+|.+. +++.+|+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999975 5899999986432     234456889999999999999999999998764  457


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++++||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999997542   4889999999999999999999999   99999999999999999999999999976


Q ss_pred             ccCCC--ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          469 VMVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       469 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .....  ........++..|+|||.+.+..++.++|+||||+++++|++|+.||......+      .+.+....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-----  224 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQ-----  224 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcC-----
Confidence            53211  111223458889999999988889999999999999999999999996432111      11111110     


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ......+....+.+.+++.+||+ +|..||+..++++
T Consensus       225 ----~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 ----PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                01112234455678999999998 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-35  Score=305.91  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=199.7

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC----
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE----  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  386 (597)
                      ...++|++.+.||+|+||.||++... +++.||||.+..  .......++.+|+.++++++||||+++++++....    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999975 689999998753  23445567889999999999999999999986443    


Q ss_pred             --cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          387 --VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       387 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                        ..++||||+. ++|.+.+...     +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence              4689999995 5888887642     889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh----
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN----  540 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----  540 (597)
                      +++......  ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+....   .........    
T Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  238 (353)
T cd07850         164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSD  238 (353)
T ss_pred             cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence            997653322  12334578899999999999999999999999999999999999975432110   000000000    


Q ss_pred             ---------------cCc------hhhhhhHHhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 ---------------ENR------LFEALDARVL----KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 ---------------~~~------~~~~l~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                     ...      +.+.......    .......+..+.++|.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                           000      0000000000    00011235568899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-35  Score=303.73  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  390 (597)
                      .++|++.+.||+|+||.||+|... +|+.||+|.......  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999976 589999998764322  2234567899999999999999999998765  46799


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+. ++|.+++....  ..+++.+++.++.||++||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999996 58888887642  35899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc--Cchhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE--NRLFEA  547 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  547 (597)
                      ... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+   ...........  ......
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchh
Confidence            332 11222345788999999865 568999999999999999999999997543222   11111111100  000000


Q ss_pred             h-----------hHHh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 L-----------DARV---LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 l-----------~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +           ....   ........++.+.+||.+||+.||++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0           0000   000011135667899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.1e-35  Score=290.84  Aligned_cols=250  Identities=27%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY  392 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  392 (597)
                      +|...+.||+|++|.||+|... +++.|++|......  ....+.+.+|+.++++++|+||+++++.+.+.  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999986 68999999876543  35678899999999999999999999999988  8899999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999998653   5999999999999999999999998   999999999999999999999999998876543


Q ss_pred             Cce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......++..|+|||.+.....+.++||||||+++++|++|..||....     ......... ..        ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~--------~~  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKI-GS--------SG  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhc-cc--------cC
Confidence            321 1233458889999999988889999999999999999999999997544     111111111 10        00


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....+...+..+.++|.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111122334677999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-35  Score=308.16  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=202.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----c
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----V  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  387 (597)
                      .++|.+.+.||+|+||+||++... +++.||||.+...  .......+.+|+.+++.++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999975 6899999987642  2334567788999999999999999999886543     4


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++|+||+. ++|.+++...   .++++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999995 6898888753   34999999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh------
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------  540 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------  540 (597)
                      ...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+..+   ..........      
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  232 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED  232 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence            654322 22233457889999998765 568999999999999999999999997543211   1111111110      


Q ss_pred             -----cCchhhhhh-------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhhh
Q 038707          541 -----ENRLFEALD-------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGIR  593 (597)
Q Consensus       541 -----~~~~~~~l~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l~  593 (597)
                           .......+.       ... .......++++.+||++||+.+|++|||++++++.  |+.++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                 000000000       000 01112345678999999999999999999999987  65544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.5e-35  Score=292.17  Aligned_cols=242  Identities=27%  Similarity=0.326  Sum_probs=196.3

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||.|++|.||++... +++.+|+|.....   .....+.+.+|+.++++++||||+++++.+.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999976 4889999987542   223456799999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecc
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV  480 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  480 (597)
                      .+++.+..   .+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            99997642   3899999999999999999999999   9999999999999999999999999998764332  22334


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      .++..|++||.+....++.++|+||||+++|+|++|+.||.....+.    ......... +.        .....+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~--------~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK-GN--------GKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc-cC--------CCCCCCccc
Confidence            57889999999988889999999999999999999999997644211    111111110 00        001112223


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                      ++.+.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            567899999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.7e-35  Score=301.63  Aligned_cols=266  Identities=27%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC---
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE---  386 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  386 (597)
                      +...++|++.+.||+|++|.||+|..+ +++.||+|.+....  ......+.+|++++++++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999986 58899999876532  233456788999999999999999999987655   


Q ss_pred             -------cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEE
Q 038707          387 -------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       387 -------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                             ..++|+||+++ +|.+++...  ...+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   78999999976 777777654  235899999999999999999999999   99999999999999999999


Q ss_pred             EeeccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHH
Q 038707          460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      |+|||++...............++..|+|||.+.+ ..++.++||||||+++++|++|++||......   .....+...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL  233 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence            99999998664433222222345778999998764 45789999999999999999999999743321   111111111


Q ss_pred             HhcCc-----------hhhhhhHH-----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          539 INENR-----------LFEALDAR-----VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       539 ~~~~~-----------~~~~l~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....           .....+..     .........+..+.+++.+||+.+|.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10000           00000000     000001123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.4e-35  Score=295.26  Aligned_cols=242  Identities=24%  Similarity=0.310  Sum_probs=188.2

Q ss_pred             cccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhh---cCCCccceeeeEEEeCCcceEEEeccC
Q 038707          324 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQ---INHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..+++.   .+||||+++++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 58999999765321   2222334455444433   479999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++....   .+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||++.......   
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999999987543   4999999999999999999999999   9999999999999999999999999986543221   


Q ss_pred             eecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....|+..|+|||.+.+ ..++.++||||||+++++|++|+.||.........    .......          .....
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~----------~~~~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL----------TVNVE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh----------cCCcC
Confidence            123458999999999864 56899999999999999999999999754332211    1111100          00111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                      .+...+.++.+++.+||+.||++||     +++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2234556788999999999999999     69988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4e-35  Score=297.52  Aligned_cols=243  Identities=27%  Similarity=0.421  Sum_probs=198.5

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      ..||+|+||.||++... +++.||||+...........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999975 68999999987656666778999999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeeccc
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ  481 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  481 (597)
                      +++...    .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....... .......
T Consensus       106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  177 (292)
T cd06657         106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV  177 (292)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence            987543    3899999999999999999999999   9999999999999999999999999987654322 1223345


Q ss_pred             ccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHH
Q 038707          482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI  561 (597)
Q Consensus       482 gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  561 (597)
                      +++.|+|||.+.+..++.++|+||||+++|+|++|+.||......+       ....+...     +.....  .....+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~-----~~~~~~--~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPKLK--NLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhh-----CCcccC--CcccCC
Confidence            7889999999988889999999999999999999999986432211       11111110     000000  012234


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          562 MTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       562 ~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            56789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=289.29  Aligned_cols=247  Identities=29%  Similarity=0.476  Sum_probs=204.0

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|++.+.||+|++|.||++... +++.+++|.......  ...+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999876 578999998776443  5667899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++...   .++++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999999764   35899999999999999999999999   99999999999999999999999999987654332


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      . .....++..|+|||.+.+..++.++||||||+++++|++|+.||......     .... . ......         .
T Consensus       155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~-~-~~~~~~---------~  217 (254)
T cd06627         155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALF-R-IVQDDH---------P  217 (254)
T ss_pred             c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHH-H-HhccCC---------C
Confidence            1 23345788999999998888899999999999999999999998643311     1111 1 111100         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+...++.+.+++.+||..+|++|||+.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            112233567889999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.7e-35  Score=297.06  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=195.4

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|...+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++.++. |+||+++++++.+....+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3555678999999999999976 5899999987643 2345667899999999996 99999999999999999999999


Q ss_pred             cCCCChhhHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          395 IPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       395 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ++ ++|.++...  ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            86 455554321  11224589999999999999999999975 7   99999999999999999999999999976543


Q ss_pred             CCceeeecccccccccCccccccC---CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...  .....++..|+|||.+...   .++.++||||||+++|+|++|+.||....     ............ .     
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~-----  227 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-D-----  227 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-C-----
Confidence            221  1233578899999998766   68999999999999999999999996432     111111111110 0     


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .+.+........+.++.+|+.+||+.+|++|||+++|++.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111111123356678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.1e-35  Score=294.43  Aligned_cols=244  Identities=26%  Similarity=0.312  Sum_probs=193.8

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|+||+||++... +++.+|+|.+...   .......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 6899999987532   222345678899999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecc
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV  480 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  480 (597)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......  ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence            999986532 35899999999999999999999999   999999999999999999999999998765432  112234


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      .++..|+|||.+.+..++.++||||||+++++|++|+.||..........   ........          .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE----------MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc----------ccccCCccC
Confidence            57889999999988889999999999999999999999997544321110   01010000          001112234


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                      ++.+.+++.+||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            56788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=296.78  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=201.5

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      |++.+.||+|++|.||++... +++.+++|+......  .....+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999975 688999998764322  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||.+....... .
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R  153 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence            75 8888887643  35899999999999999999999999   9999999999999999999999999997765433 1


Q ss_pred             eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--chhhhh----
Q 038707          476 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEAL----  548 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l----  548 (597)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.   ...........  .....+    
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhh
Confidence            22234577889999998776 789999999999999999999999965442211   11111100000  000000    


Q ss_pred             ----------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 ----------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                ............+.++.++|.+||+.||.+||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      000001122345678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-35  Score=293.37  Aligned_cols=245  Identities=29%  Similarity=0.386  Sum_probs=197.3

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|+||.||++... +++.+++|.......   ...+.+.+|+.++++++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 489999998764333   4567889999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc------
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT------  474 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~------  474 (597)
                      .+++.+..   .+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99998643   4899999999999999999999999   99999999999999999999999999876543321      


Q ss_pred             -eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          475 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       475 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                       .......++..|+|||.+.....+.++||||||+++++|++|+.||......+      .+ ..+..+...        
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~--------  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IF-QNILNGKIE--------  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCcC--------
Confidence             12233457889999999988889999999999999999999999996543211      11 111111110        


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      .......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0000112567889999999999999999955555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.2e-35  Score=304.64  Aligned_cols=266  Identities=27%  Similarity=0.365  Sum_probs=199.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC--cc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE--VP  388 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~  388 (597)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++..  ........+.+|+.+++++ +||||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567899999999999999999976 588999998753  2334556788899999999 9999999999986543  67


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||++ ++|.+++...    .+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5999988753    4889999999999999999999999   99999999999999999999999999986


Q ss_pred             ccCCCc----eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH--------
Q 038707          469 VMVDQT----HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--------  535 (597)
Q Consensus       469 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~--------  535 (597)
                      ......    .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            643322    12233458899999998755 56789999999999999999999999654322110000000        


Q ss_pred             HHHHhcCchhhhhhH------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          536 LQAINENRLFEALDA------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...+.......+++.      ..........+.++.++|.+||+.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000000000      00001111235678999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.2e-35  Score=299.66  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=194.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc------
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV------  387 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  387 (597)
                      ++|++.+.||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||+++++++...+.      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56999999999999999999976 68999999875432  2223456789999999999999999999876544      


Q ss_pred             --ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          388 --PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       388 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                        .++||||+. ++|.+++....  ..+++.+++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence              499999996 48888876532  34899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCce---eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          466 SRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       466 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      +.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........   ..........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~~  242 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCGS  242 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCC
Confidence            9765432221   12233467889999988664 478899999999999999999999975432211   1111111000


Q ss_pred             --------CchhhhhhH---------Hhhhhh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 --------NRLFEALDA---------RVLKEA-KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 --------~~~~~~l~~---------~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              ....+..+.         ...... .......+.+||.+||+.||.+|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                    000000000         000000 0011345679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.7e-35  Score=304.74  Aligned_cols=265  Identities=23%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  388 (597)
                      .++|++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468999999999999999999975 68999999876432  2345678889999999999999999998763    3467


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+. ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999995 6899988653   24899999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCce---eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH--------HHH
Q 038707          469 VMVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG--------YFL  536 (597)
Q Consensus       469 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~--------~~~  536 (597)
                      .......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.........        .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211   1233468889999999765 568999999999999999999999997543221100000        000


Q ss_pred             HHHhcCchhhhhhHHh------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          537 QAINENRLFEALDARV------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .......+.+..+...      ........+.++.++|.+||+.+|.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0001111111111000      00111234677999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=303.11  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ....|.+.+.||+|.|++|.+|.+. ++..||||.+..  .+....+.+.+|+++|..++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467999999999999999999975 699999998664  3344556799999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||..+|.+++|+.++..   +.+..+..++.|+.+|++|||++.   |+|||||++||||+.+-++||+|||++..+. 
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence            999999999999998654   667889999999999999999999   9999999999999999999999999998764 


Q ss_pred             CCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                       .........|++.|.|||++.+.+| ++++|+||+|++||.|+.|..||++-...+.....       ..+++      
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------l~gk~------  272 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------LRGKY------  272 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh-------eeeee------
Confidence             4445667789999999999998766 68999999999999999999999875544421110       00110      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ..+.....+..+||+++|-.+|.+|++++++.+
T Consensus       273 ----rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 ----RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                112333445778999999999999999999875

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-35  Score=296.53  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=197.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|++|+||+|..+ +++.||+|......  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999976 68999999876432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccccccccCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~~~~  472 (597)
                      |++ ++|.+++.... ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 58888876542 234688899999999999999999998   999999999999985 557999999999765332


Q ss_pred             CceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh---
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL---  548 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---  548 (597)
                      . .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+   ............ ..+..   
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~-~~~~~~~~  231 (294)
T PLN00009        157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTP-NEETWPGV  231 (294)
T ss_pred             c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC-Chhhcccc
Confidence            1 11223356889999998865 457899999999999999999999997543211   110000000000 00000   


Q ss_pred             -------------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 -------------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 -------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                   ............++++.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                         000000111233566889999999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=288.99  Aligned_cols=243  Identities=26%  Similarity=0.305  Sum_probs=189.6

Q ss_pred             CcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHH-HhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|++|.||+|... +++.||+|......   ......+..|..+ ....+|+|++++++++.+.+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999975 58999999876432   2222334455544 4455899999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      ++|.+++....   ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....     .
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            99999997542   4899999999999999999999999   99999999999999999999999999875432     2


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||......+       ....+..+...      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCccc
Confidence            23457889999999988889999999999999999999999996533211       11111111110      000111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          558 KEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       558 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                      ...+..+.+++.+||+.+|++||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            23456789999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.7e-35  Score=295.24  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             CCccCCcccccCceEEEEEEec----CCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVD----ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      +|++.+.||+|++|.||++...    +++.+|||.++...    ......+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999853    47889999876422    22345688999999999 599999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++...   ..+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999998753   24889999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCceeeecccccccccCccccccCC--CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .............++..|+|||.+.+..  .+.++||||||+++++|++|..||.......  ............     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-----  227 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-----  227 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-----
Confidence            5543333333445889999999987654  7889999999999999999999986432111  111111111100     


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                            ....+...+..+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                  001122234568899999999999999999888777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.6e-34  Score=294.71  Aligned_cols=255  Identities=20%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCC
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  399 (597)
                      .+.+|.|+++.|+++.. +++.||||++...  .......+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555544 6899999987653  45566789999999999999999999999999999999999999999


Q ss_pred             hhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce----
Q 038707          400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH----  475 (597)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~----  475 (597)
                      |.+++..... ..+++..+..++.|+++||.|||+++   |+||||||+||+++.++.+||+|||.+.........    
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999986532 34889999999999999999999999   999999999999999999999999988655322111    


Q ss_pred             --eeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh----
Q 038707          476 --LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA----  547 (597)
Q Consensus       476 --~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  547 (597)
                        ......++..|+|||++..  ..++.++||||||++++||++|+.||.......  ..    ...... .....    
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~----~~~~~~-~~~~~~~~~  234 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--ML----LEKVRG-TVPCLLDKS  234 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHhc-cCccccccC
Confidence              1122346778999999866  458899999999999999999999997543211  11    111100 00000    


Q ss_pred             ----------------hh----HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 ----------------LD----ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 ----------------l~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                      .+    .............++.+|+.+||+.||++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                            00    001111123345678899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-34  Score=297.09  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             Cccccc--CceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQG--GQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G--~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ..||+|  +|++||++.+. +++.||+|.....  .....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999975 6999999987643  334467889999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee-
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-  476 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-  476 (597)
                      ++|.+++.+... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999986532 24899999999999999999999999   9999999999999999999999998654332111110 


Q ss_pred             -----eecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc------
Q 038707          477 -----TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR------  543 (597)
Q Consensus       477 -----~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------  543 (597)
                           .....++..|+|||++.+  ..++.++||||||++++||++|+.||......+.      .........      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~  233 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccc
Confidence                 011224567999999876  3478999999999999999999999975432110      001000000      


Q ss_pred             ------------------------------hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 ------------------------------LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ------------------------------~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                                    .....+..............+.+|+++||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                          00001111111223345678899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-35  Score=303.80  Aligned_cols=266  Identities=26%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cce
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL  389 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  389 (597)
                      +|++.+.||+|++|.||++... +++.+|||++....  ....+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999976 48999999876533  445678999999999999999999999988775     789


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ++|||++ ++|.+++....   ++++..++.++.||+.||.|||+.+   |+|+||||+|||+++++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 58988887543   5999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCc--eeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH-------
Q 038707          470 MVDQT--HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI-------  539 (597)
Q Consensus       470 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------  539 (597)
                      .....  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+....   .....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhH
Confidence            54321  122334578899999999887 889999999999999999999999976543221000   00000       


Q ss_pred             ----hcCchhhhhhH------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhhh
Q 038707          540 ----NENRLFEALDA------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGIR  593 (597)
Q Consensus       540 ----~~~~~~~~l~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l~  593 (597)
                          ........+..      ..........+..+.+++.+||+.+|++||+++++++.  |++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                00000000000      00001112245678999999999999999999999985  55544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-34  Score=295.84  Aligned_cols=246  Identities=25%  Similarity=0.377  Sum_probs=196.1

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .|...+.||+|++|.||+|... +++.+|+|....   .......++.+|+++++.++|+|++++++++.+....++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999975 578999998753   233445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+. ++|.+++....  .++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 68888776532  34899999999999999999999998   999999999999999999999999998754322 


Q ss_pred             ceeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          474 THLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                          ....+++.|+|||.+.   ...++.++||||||+++|+|++|+.||......+       .......+...     
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~-----  232 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESP-----  232 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCCC-----
Confidence                2345788999999874   3568889999999999999999999986532211       00111111110     


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                         .......+..+.+||.+||+.+|++||++.++++.-
T Consensus       233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence               011223456688999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-34  Score=286.98  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=191.3

Q ss_pred             HHHhcCCccCCcc--cccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          313 EKATDNYNANRIL--GQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       313 ~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      ....++|++.+.+  |+|+||.||++... +++.+|+|..........     |+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3344667777766  99999999999975 688899998764221111     22222222 699999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSR  467 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~  467 (597)
                      ++||||+++++|.+++....   +++++++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++.
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            99999999999999998653   5999999999999999999999999   99999999999999998 99999999987


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .....     ....++..|+|||++.+..++.++||||||+++++|++|+.||.....++ ..... ..... ..     
T Consensus       159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~-~~-----  225 (267)
T PHA03390        159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES-LLKRQ-QK-----  225 (267)
T ss_pred             ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH-HHHhh-cc-----
Confidence            65322     12357899999999998899999999999999999999999997443222 11111 11111 00     


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-MKEVTN  587 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  587 (597)
                           ........++.+.++|.+||+.+|.+||+ ++++++
T Consensus       226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                 00112245567899999999999999996 688874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=288.99  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCccceeeeEEEeCCc-----
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEV-----  387 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  387 (597)
                      |++.+.||+|+||.||+|.++ +++.+|+|.+....  ......+.+|+.+++++   +|+||+++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999987 48999999886432  22234566788777666   59999999999998776     


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+++|||++ ++|.+++..... ..+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 489998876432 35899999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch---
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL---  544 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  544 (597)
                      .......  .....++..|+|||.+.+..++.++||||||+++|+|++|++||......+   ....+.........   
T Consensus       156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhc
Confidence            7543221  122347888999999998899999999999999999999999987543221   11111111100000   


Q ss_pred             ----------hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 ----------FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ----------~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                ...................+.+++.+||+.||++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                      0000000011112344567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-34  Score=293.43  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=194.4

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |...+.||+|+||+||+|... +++.|++|.+...   .......+.+|+.++++++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999975 6889999987642   233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +. ++|.+++....  .++++.+++.++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            95 57888876532  35899999999999999999999999   99999999999999999999999998864321   


Q ss_pred             eeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          475 HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        .....++..|+|||++.   ...++.++||||||+++|+|++|..||.......      ....... ....      
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~~------  238 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDSP------  238 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh-cCCC------
Confidence              22345788999999974   4568899999999999999999999986543211      1111111 1110      


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        .......+..+.+|+.+||+.+|.+||++.+++..
T Consensus       239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              01112234568899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-34  Score=290.53  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             CCccCCcccccCceEEEEEEe----cCCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          318 NYNANRILGQGGQGTVYKGML----TDGRIVAVKKSKLVD----ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      +|++.+.||+|+||.||++..    .+|+.||+|.+....    ....+.+.+|+.+++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    368899999876422    22346788999999999 599999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++...   .++++..+..++.|+++||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999999764   24889999999999999999999999   99999999999999999999999999976


Q ss_pred             ccCCCceeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .............++..|+|||.+..  ..++.++||||||+++|+|++|+.||.......  ..............   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~---  229 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP---  229 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCC---
Confidence            54332222333458889999999865  347889999999999999999999986432211  11111111111100   


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                              ..+......+.+++.+||+.+|++||     ++.++++
T Consensus       230 --------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 --------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                    01223445688999999999999997     6677665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=318.62  Aligned_cols=264  Identities=29%  Similarity=0.448  Sum_probs=217.8

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec----C----CcEEEEEEccc-cChhhHHHHHHHHHHHhhcC-CCccceeee
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT----D----GRIVAVKKSKL-VDETNVEQFINEVVILSQIN-HRNIVKLLG  380 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  380 (597)
                      .++...++..+.+.||+|+||.|++|...    .    ...||||.++. ....+.+.+..|+++|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            44555566677779999999999999843    1    35799998874 44467789999999999995 999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQI-------E----E--FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS  447 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~  447 (597)
                      ++.+.+..++|+||+..|+|.++++...       .    .  ..++..+++.++.|||.|++||++..   ++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999999865       0    0  13899999999999999999999999   99999999


Q ss_pred             CCeEeCCCCcEEEeeccccccccCCCceeeecccc--cccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCC
Q 038707          448 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG--TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN  524 (597)
Q Consensus       448 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~  524 (597)
                      +|||+.++..+||+|||+++..............+  ...|||||.+....|+.|+||||||++||||++ |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999776555554333332  456999999999999999999999999999999 999997633


Q ss_pred             CcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ..+      .+.+.+++|..         .+.+..+.+++.++++.||+.+|++||++.++.+.|+.+
T Consensus       527 ~~~------~l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTE------ELLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHH------HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            121      12233444332         334556678899999999999999999999999999885

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=272.70  Aligned_cols=248  Identities=25%  Similarity=0.421  Sum_probs=196.1

Q ss_pred             cCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccCC
Q 038707          321 ANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      .+..||.|.-|.|++.... .|...|||.+.. .+.++.++++..+.++..-+ .|.||+.+|+|..+...++.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            3456999999999999976 589999998764 45666778888888777665 8999999999999999999999983 


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      .-++.++++-  ..++++..+-++...+++||.||..++.  |+|||+||+|||+|+.|++||+|||.+-.+....  ..
T Consensus       175 ~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah  248 (391)
T KOG0983|consen  175 TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH  248 (391)
T ss_pred             HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence            4566666653  3469999999999999999999998764  9999999999999999999999999997765433  34


Q ss_pred             ecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          478 TKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      +...|-+.|||||.+.-   ..|+.++||||||++|+||.||+.||.+-+.+-  .    ....+.+. ....++.    
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e----~ltkvln~-ePP~L~~----  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--E----VLTKVLNE-EPPLLPG----  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--H----HHHHHHhc-CCCCCCc----
Confidence            45568999999999853   578999999999999999999999998644321  0    11111110 0011111    


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ....++.+.+++..||++|+.+||...+++++
T Consensus       318 --~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  318 --HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence              12256779999999999999999999998864

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=289.34  Aligned_cols=262  Identities=24%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      |++.+.||+|++|+||+|... +++.|+||+...... .......+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999986 578999998764322 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                       +++|.+++.... ...+++..++.++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889999987653 235899999999999999999999999   99999999999999999999999999976543221 


Q ss_pred             eeecccccccccCccccc-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH----------HHHHHHhcCch
Q 038707          476 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG----------YFLQAINENRL  544 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~  544 (597)
                       .....++..|+|||.+. ...++.++|+||||+++++|++|+.||......+......          +.........+
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             22345788999999874 4568999999999999999999999986543221100000          00000000000


Q ss_pred             hhhhh---HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALD---ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...+.   ..............+.++|++||+.+|++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000   00001111112467899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.3e-34  Score=291.37  Aligned_cols=248  Identities=29%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|.+.+.||+|++|.||++... +++.||+|....   ........+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999976 689999998753   23344567889999999998 99999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++.+..   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999998643   4999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCc-------------------eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH
Q 038707          472 DQT-------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV  532 (597)
Q Consensus       472 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~  532 (597)
                      ...                   .......++..|+|||.+....++.++||||||+++++|++|+.||......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence            221                   1122334788999999998888999999999999999999999999754311      


Q ss_pred             HHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 038707          533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM----KEVTN  587 (597)
Q Consensus       533 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~  587 (597)
                      ..+.... .          .....+...++.+.+|+.+||+.+|++||++    +++++
T Consensus       229 ~~~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTFQKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1111111 1          0111223335678899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.8e-35  Score=297.44  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=194.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|++.+.||+|++|.||+|... +++.+|||++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999976 588999998754322  22346788999999999999999999876544      


Q ss_pred             --cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          387 --VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       387 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                        ..++|+||+.. +|...+...  ...+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999964 677777643  235999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCce----------eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH
Q 038707          465 TSRSVMVDQTH----------LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG  533 (597)
Q Consensus       465 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~  533 (597)
                      ++.........          ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||........   ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            99765432211          1123356888999998765 4589999999999999999999999975433211   11


Q ss_pred             HHHHHHhcC-----------------chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          534 YFLQAINEN-----------------RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       534 ~~~~~~~~~-----------------~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .........                 .......+.. ........+.+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111100000                 0000000000 0011122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.7e-35  Score=320.69  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=193.7

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET------  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  385 (597)
                      +....|+..++||+||||.||+++++ ||+.+|||++... .......+.+|+..|++|+|||||+++....+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45567888999999999999999987 8999999998764 344556789999999999999999987643210      


Q ss_pred             --------------------------------------------------------------------------------
Q 038707          386 --------------------------------------------------------------------------------  385 (597)
Q Consensus       386 --------------------------------------------------------------------------------  385 (597)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038707          386 ---------------------------------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL  432 (597)
Q Consensus       386 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L  432 (597)
                                                       ..+||-||||+..+|.++++++...  -.....|+++++|+.||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                             0026778999988888888765321  14778899999999999999


Q ss_pred             HhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc------C-----------CCceeeecccccccccCccccccC
Q 038707          433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM------V-----------DQTHLTTKVQGTFGYVDPEYFQSS  495 (597)
Q Consensus       433 H~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~  495 (597)
                      |+.+   ||||||||.||+||++..|||+|||++....      .           ......+...||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998721      0           011123446699999999998764


Q ss_pred             ---CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhc
Q 038707          496 ---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCL  572 (597)
Q Consensus       496 ---~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl  572 (597)
                         .|+.|+|+||||+||+||+.   ||...  .|   . ......++.+.+...      ........+.-+.+|++|+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME---R-a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--ME---R-ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch--HH---H-HHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               59999999999999999996   56421  11   1 112333344443322      1112223334468999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 038707          573 NLNGKMRPTMKEVTN  587 (597)
Q Consensus       573 ~~~p~~RPt~~evl~  587 (597)
                      +.||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999985

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=299.38  Aligned_cols=261  Identities=26%  Similarity=0.359  Sum_probs=196.1

Q ss_pred             cCCc-cCCcccccCceEEEEEEec-CCcEEEEEEccccChhh--------------HHHHHHHHHHHhhcCCCccceeee
Q 038707          317 DNYN-ANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN--------------VEQFINEVVILSQINHRNIVKLLG  380 (597)
Q Consensus       317 ~~y~-~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  380 (597)
                      ++|. +.+.||+|+||+||+|.+. +++.||||.........              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4578999999999999976 68999999876432211              124779999999999999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      ++...+..++||||++ ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999996 6899998753   24899999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCC-------------ceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCc
Q 038707          461 SDFGTSRSVMVDQ-------------THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTD  526 (597)
Q Consensus       461 ~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~  526 (597)
                      +|||++.......             ........+++.|+|||.+.+. .++.++||||||+++++|++|+.||...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999987654111             1111223467889999998764 4789999999999999999999999755432


Q ss_pred             CCCcHHHHHHHHHhcCchh---hh--------h---hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          527 EDKSLVGYFLQAINENRLF---EA--------L---DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~---~~--------l---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +   ...............   +.        .   .+..........+..+.++|.+||+.+|++||+++|++.
T Consensus       241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1   111111111100000   00        0   000001111223567889999999999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=300.62  Aligned_cols=262  Identities=22%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|...+.||+|+||.||+|... +++.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999975 6899999987532  2233456889999999999999999999987543      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++|+||+.. +|.+++.     ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            35899999964 6766542     23899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH--------
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ--------  537 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------  537 (597)
                      +.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   .......        
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  237 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPE  237 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence            764321    223457888999999866 568999999999999999999999997543211   0000000        


Q ss_pred             ---HHhcCchhhhhhH--Hh-hh---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhhh
Q 038707          538 ---AINENRLFEALDA--RV-LK---EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGIR  593 (597)
Q Consensus       538 ---~~~~~~~~~~l~~--~~-~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l~  593 (597)
                         .............  .. ..   .........+.+||.+||+.||++||++++++..  ++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence               0000000000000  00 00   0001234568899999999999999999999954  65554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.2e-34  Score=287.28  Aligned_cols=242  Identities=23%  Similarity=0.303  Sum_probs=187.5

Q ss_pred             cccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHH---HHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          324 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVV---ILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      +||+|+||.||++... +++.||+|.+....   ......+.+|..   .++...||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999975 58899999865321   111222344433   4445579999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++...   ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++.......   
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            99999998753   35999999999999999999999999   9999999999999999999999999987543221   


Q ss_pred             eecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..........    ........          ...
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~----------~~~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM----------AVE  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc----------CCC
Confidence            1234589999999998754 68999999999999999999999997643222111    11111000          011


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                      .+...+..+.+++.+||..+|.+||     ++.++++.
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1222356788999999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=275.62  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=203.6

Q ss_pred             HhcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe----CCc
Q 038707          315 ATDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE----TEV  387 (597)
Q Consensus       315 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  387 (597)
                      ++++|.+. ++||-|-.|.|-....+ +++.+|+|.+..     ..+.++|+++.-.. .|||||.+++++..    ..-
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45566654 58999999999998875 689999998763     35667899988777 59999999999864    346


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeecc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFG  464 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg  464 (597)
                      +.+|||.|+||.|++.+.++. ...+++.++..|++||..|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            789999999999999998864 346999999999999999999999999   999999999999964   4569999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      +|+....  .......+-|+.|.|||++....|+...|+||+||++|-||+|.+||.......   ..--....++.+.+
T Consensus       210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy  284 (400)
T KOG0604|consen  210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQY  284 (400)
T ss_pred             cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCc
Confidence            9987543  233455678999999999999999999999999999999999999997654321   11123334444433


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      . +-     .......++...++|+.+|+.+|.+|.|+.++++
T Consensus       285 ~-FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 E-FP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c-CC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1 11     1223556778999999999999999999999875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=274.06  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=203.1

Q ss_pred             CcccccCceEEEEEE-ecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      +.||+|+|+.|-..+ +.+|..+|||++.....-...+..+|++++.+.+ |+||++|+++|++++..|||||.|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            589999999999887 5689999999988776677889999999999995 99999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEeeccccccccC--C---
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMV--D---  472 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfgl~~~~~~--~---  472 (597)
                      ..+|+++.   .+++.++.++.+.|+.||.|||.++   |.||||||+|||-.+...   +||+||.+..-...  +   
T Consensus       164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99998754   4999999999999999999999999   999999999999976544   79999988754321  1   


Q ss_pred             -CceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC-----C---CcHHHHHHHH
Q 038707          473 -QTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE-----D---KSLVGYFLQA  538 (597)
Q Consensus       473 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~-----~---~~~~~~~~~~  538 (597)
                       .++......|+..|||||+..     ...|+.+.|.||||||||-||+|.+||.+.-..+     .   ..-.......
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence             122233456888999999863     3468999999999999999999999998754321     1   1122233444


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +.+|.+. +.|     .-....+.+..+||...|..++.+|.++.+++.
T Consensus       318 IQEGkYe-FPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKYE-FPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCCc-CCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            4444431 111     112445667889999999999999999988876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=289.01  Aligned_cols=259  Identities=27%  Similarity=0.384  Sum_probs=200.2

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      |+..+.||+|++|.||+|... +++.+|+|......  ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 58999999877543  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      + ++|.+++.+..  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 59999998753  34999999999999999999999999   99999999999999999999999999876543222 


Q ss_pred             eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc-------------
Q 038707          476 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-------------  541 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  541 (597)
                      ......++..|+|||.+.+. .++.++||||||++++||++|+.||......+.   ..........             
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence            22233457789999998766 789999999999999999999999965432211   1111110000             


Q ss_pred             --CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 --NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 --~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ....+..............+..+.+++.+||+.+|++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000000001111223567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-34  Score=298.50  Aligned_cols=266  Identities=22%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             CHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       308 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      ...++..++++|.+.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566777899999999999999999999864 6899999987642  23345678899999999999999999998864


Q ss_pred             C------CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          385 T------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       385 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      .      ...+++++++ +++|.+++...    .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence            3      3357788876 78998887643    3899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||.......   .......
T Consensus       160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~  232 (345)
T cd07877         160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR  232 (345)
T ss_pred             EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence            99999998754321    223457889999999866 568899999999999999999999996533211   1111100


Q ss_pred             HHhc--CchhhhhhH----Hhh-----------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          538 AINE--NRLFEALDA----RVL-----------KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       538 ~~~~--~~~~~~l~~----~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ....  ..+...+..    ...           .......+..+.+||.+||+.+|.+||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000  000000000    000           00001124568899999999999999999998863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.9e-34  Score=291.87  Aligned_cols=252  Identities=24%  Similarity=0.421  Sum_probs=194.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|++|.||+|.+.+ ++.||||.++... .....++..|+.++.+.. ||||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568889999999999999999874 8999999976432 334556777887777775 999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      ||++ ++|.+++....  .++++..+..++.|++.||+|||+ .+   |+||||+|+||++++++.+||+|||++.....
T Consensus        94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 47777766532  258999999999999999999997 47   99999999999999999999999999876533


Q ss_pred             CCceeeecccccccccCccccccCC----CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ...  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     ............ .. 
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~-  238 (296)
T cd06618         168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-PS-  238 (296)
T ss_pred             CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC-CC-
Confidence            222  22334778999999987543    789999999999999999999998642211     111111111110 00 


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                            .......+.++.+|+.+||+.+|.+||++.++++.
T Consensus       239 ------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 ------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  00011235568999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-34  Score=301.13  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=195.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC---------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET---------  385 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  385 (597)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999975 5899999998776666677899999999999999999999876654         


Q ss_pred             -----CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEE
Q 038707          386 -----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAK  459 (597)
Q Consensus       386 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~k  459 (597)
                           ...++||||++ ++|.+++...    .+++..+..++.||++||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 5898888643    4899999999999999999999999   99999999999997 456789


Q ss_pred             EeeccccccccCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          460 VSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      |+|||++.........  ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+...   ...
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~  232 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LIL  232 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence            9999998765322111  1122347889999998654 568899999999999999999999997543221100   000


Q ss_pred             HHHhc------CchhhhhhHHhh----------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          537 QAINE------NRLFEALDARVL----------KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       537 ~~~~~------~~~~~~l~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....      ......+.....          .........++.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000      000000000000          0011123456889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-34  Score=285.94  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=195.7

Q ss_pred             CCccCCcccccCceEEEEEEecC-CcEEEEEEccc-----cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL-----VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +|.+.+.||+|+||.||++.... +..+++|..+.     .......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998753 44455554332     1233445677899999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++++|.+++.... ....+++..++.++.|+++||.|||+.+   ++|+||+|+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999987532 2346999999999999999999999999   999999999999976 469999999987654


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ... .......+++.|+|||.+.+..++.++|+||||+++++|++|..||....      ........ ..+.       
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~-~~~~-------  221 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI-VEGP-------  221 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-HcCC-------
Confidence            322 22333457889999999988888999999999999999999999985321      11111111 1111       


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ....+...+.++.++|.+||+.+|++||++.++++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence              11122345567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=292.59  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE--  386 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  386 (597)
                      +....++|++.+.||+|++|.||++... +++.||||+....  .......+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            4445778999999999999999999965 6899999987532  2334567889999999999999999999987654  


Q ss_pred             ----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          387 ----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       387 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                          ..++||||+ +++|.+++...    .+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                348999999 77998888642    4899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH-------
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY-------  534 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~-------  534 (597)
                      ||++......    .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||........  ....       
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~  235 (343)
T cd07880         162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTP  235 (343)
T ss_pred             cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            9999765322    223457889999999876 4588999999999999999999999975432110  0000       


Q ss_pred             ---HHHHHhcCchhhhhh------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          535 ---FLQAINENRLFEALD------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       535 ---~~~~~~~~~~~~~l~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         +...+........+.      +.............+.++|.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000000000000      00000111223456889999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=281.56  Aligned_cols=268  Identities=24%  Similarity=0.374  Sum_probs=221.9

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEecC------CcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEE
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCL  383 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  383 (597)
                      ++.....+++...++-+|.||.||.|.+.+      .+.|.+|.++. .++.+...++.|...+..+.|||+.++.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            344445678888899999999999997643      35677787653 56667888999999999999999999999886


Q ss_pred             e-CCcceEEEeccCCCChhhHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          384 E-TEVPLLVYEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       384 ~-~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      + .+.++++|.++.-|+|..||...     .....++-.+...++.|++.|++|||+++   |+|.||..+|.+||+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            5 56889999999999999999842     22345788889999999999999999999   999999999999999999


Q ss_pred             EEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  535 (597)
                      +||+|=.+++.+...+.+ ..........||+||.+.+..|+.++|||||||+||||+| |+.|+...++.|       .
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m  507 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------M  507 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------H
Confidence            999999999977644433 3333345678999999999999999999999999999999 999998766655       2


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhcC
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG  597 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~  597 (597)
                      ...+++|         +....+..++.+|..++.-||+..|++||+++|+..-|.+...+++
T Consensus       508 ~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  508 EHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             HHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            2223332         3333467788899999999999999999999999999998887764

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=277.16  Aligned_cols=241  Identities=24%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|..+++||+|.||+|-+.+-+ +++.+|||+++.   ..+.+...-+.|-++|+..+||.+..|--.|+..+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999999976 699999998764   4455667778899999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||..+|.|.-+|.+..   .++++...-+-.+|+.||.|||+.+   |+.||||.+|.|+|.+|++||+|||+.+....
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999997643   3888888999999999999999999   99999999999999999999999999987543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . ...+...+|||.|+|||++....|..+.|.|.+||+||||++|+.||...+.+.                +++++--.
T Consensus       321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~e  383 (516)
T KOG0690|consen  321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILME  383 (516)
T ss_pred             c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHhh
Confidence            3 334667889999999999999999999999999999999999999997644322                22222111


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRP  580 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP  580 (597)
                      - ...+....++...|+...|.+||.+|.
T Consensus       384 d-~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 D-LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             h-ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            1 123455566788999999999999995

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-35  Score=303.69  Aligned_cols=268  Identities=26%  Similarity=0.409  Sum_probs=201.5

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------Ccce
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------EVPL  389 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  389 (597)
                      .+...+.||+||||.||+|+++ +|+.||||.... ......+...+|+++|++++|+|||++++.-.+.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3555678999999999999965 799999998764 3445677889999999999999999999986654      4678


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC--C--CCcEEEeeccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--D--KYRAKVSDFGT  465 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~--~--~~~~kl~Dfgl  465 (597)
                      +||||+.+|+|...|.+-....-|++.+++.++..+..||.|||+++   |+||||||.||++-  +  ....||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999987555556999999999999999999999999   99999999999993  3  33479999999


Q ss_pred             cccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc---
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---  541 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---  541 (597)
                      |+.+..+.  ......||..|++||++.. ..|+...|.|||||++|++.||..||.......  +........+..   
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPS  246 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCC
Confidence            99875443  6777889999999999985 889999999999999999999999996543221  111111111111   


Q ss_pred             -----------CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhh
Q 038707          542 -----------NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP--TMKEVTNELGGI  592 (597)
Q Consensus       542 -----------~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~evl~~L~~l  592 (597)
                                 +++.....-...-.........+-..+..+|..+|.+|-  ...+....+..|
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence                       111000000001112233334455667777888888887  555555555544

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=319.30  Aligned_cols=258  Identities=25%  Similarity=0.355  Sum_probs=214.8

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      .++....+.|.++++||+|+||.|..++.+ +++.+|+|++..   ....+..-|..|-.+|..-+.+.|++|+-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344444577999999999999999999976 588999998765   4566778899999999999999999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ..+|+||||++||+|..++.+..   +++++.+.-++.+|..||.-||+.|   +|||||||+|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998764   4999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      +-.+..+..-.....+|||.|++||++..     +.|+...|.||+||++|||+.|..||....      +..-+...++
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~  295 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN  295 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc
Confidence            98887666667777889999999999853     568999999999999999999999998533      3333333333


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT---MKEVTN  587 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  587 (597)
                      ....+.+.+       ..+.+++..+||.+.+ -+|+.|..   ++++-.
T Consensus       296 hk~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  296 HKESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            322221111       1336677889999988 67888877   666543

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=288.49  Aligned_cols=244  Identities=27%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +.|...++||+||||.||-.+.. +|+.+|.|++..   .......-.++|-.+|.+++.+.||.+--.|+..+.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            55788899999999999999865 699999987542   12223345678999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ..|.||+|.-+|.+... .-+++..++-++.+|+-||++||+..   |+.||+||+|||||+.|+++|+|+|||..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999987653 34999999999999999999999999   999999999999999999999999999887644


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ..  .....||.+|||||++++..|+...|.|||||+||||+.|+.||........                .+-+|.++
T Consensus       341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr~  402 (591)
T KOG0986|consen  341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRRT  402 (591)
T ss_pred             Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHHH
Confidence            33  3444799999999999999999999999999999999999999975432221                22233333


Q ss_pred             hh---hhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          553 LK---EAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       553 ~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                      ..   +.+...+++..+|.+..|+.||++|..-
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            22   2335556778899999999999999754

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8e-35  Score=275.52  Aligned_cols=271  Identities=21%  Similarity=0.327  Sum_probs=203.0

Q ss_pred             HHhcCCccCCcccccCceEEEEEEecC-----CcEEEEEEccccChh--hHHHHHHHHHHHhhcCCCccceeeeEEEe-C
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGCCLE-T  385 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  385 (597)
                      .....|+....||+|.||.||+|..++     .+.+|||+++.....  -.....+|+.+++.++||||+.|..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345679999999999999999997432     237899988754322  23567899999999999999999999988 6


Q ss_pred             CcceEEEeccCCCChhhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC----CcEE
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAK  459 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~k  459 (597)
                      ...+|++||.+. +|.+.|+-+.  ....++...+..|+.||+.|+.|||+.=   |+||||||.|||+..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            688999999966 8988887532  3356999999999999999999999999   9999999999999877    8999


Q ss_pred             EeeccccccccCCCcee--eecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH----
Q 038707          460 VSDFGTSRSVMVDQTHL--TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV----  532 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~----  532 (597)
                      |+|||+++.+...-...  ...+.-|..|.|||++.+ ..||.+.|||+.|||+.||++-++-|.+...+-.....    
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999887654443  345667999999999877 57999999999999999999999888775443222110    


Q ss_pred             --HHHHHHHh---cCch--------h-hhhh-HH--hhhh--------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          533 --GYFLQAIN---ENRL--------F-EALD-AR--VLKE--------AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       533 --~~~~~~~~---~~~~--------~-~~l~-~~--~~~~--------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+...+.   +..+        . ..+. .+  ....        .....++...+|+.++|..||-+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence              01111110   0000        0 0000 00  0000        00111233678999999999999999999987


Q ss_pred             H
Q 038707          588 E  588 (597)
Q Consensus       588 ~  588 (597)
                      .
T Consensus       337 h  337 (438)
T KOG0666|consen  337 H  337 (438)
T ss_pred             c
Confidence            5

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.9e-34  Score=295.17  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe-CCc
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEV  387 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  387 (597)
                      +..++++|++.+.||+|+||.||++... +++.||+|++..  ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999966 689999998653  223345678899999999999999999999876 557


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++++||+ +++|.++++..    ++++..+..++.|+++||.|||+.+   |+|+||+|+|||+++++.+||+|||++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999998 56898888643    3788889999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh------
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------  540 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------  540 (597)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||.......   ..........      
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~  229 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            54221    123456888999998765 578999999999999999999999996543211   0000000000      


Q ss_pred             -----cCchhhhhhHHh------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 -----ENRLFEALDARV------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 -----~~~~~~~l~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           .....+.+....      ..+.....++.+.++|.+||+.+|++||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000000000      000011234678999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=325.71  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEe-cCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ...+-+++-...||.|.||.||-+.. .+|+..|+|.++..  .........+|..++..++|||+|+++|+-.+.+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34456788888999999999999995 46999999976643  3344567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |.|||+++|+|.+.+.....   .++.....+..|++.|+.|||++|   ||||||||.||||+.+|.+|++|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999976432   566667778899999999999999   999999999999999999999999999887


Q ss_pred             cCCCce---eeecccccccccCccccccC---CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          470 MVDQTH---LTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       470 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ......   ......||+.|||||++.+.   ...-++|||||||+++||+||+.||...+.+=   .+++.   +.-|.
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~---V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYH---VAAGH 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhH---HhccC
Confidence            654211   12345699999999998653   45679999999999999999999997543211   11111   11111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .         ...+...+.+-.+++.+||+.||++|-++.|+++.
T Consensus      1459 ~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 K---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         12233456667899999999999999999888764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-34  Score=298.93  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc---
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV---  387 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  387 (597)
                      ...++|++.+.||+|++|.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999986 5889999987642  23345678889999999999999999998876554   


Q ss_pred             ---ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          388 ---PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       388 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                         .++|+||+ +++|.+++...    .+++..++.++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               79999998 66999988752    4899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh---
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---  540 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  540 (597)
                      ++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+   ..........   
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCC
Confidence            99765332    233457888999999865 467899999999999999999999996543211   0110001000   


Q ss_pred             --------cCchhhhhhHHh------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 --------ENRLFEALDARV------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 --------~~~~~~~l~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              .......+....      ........++.+.+++.+||+.+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                    000000000000      00001123567899999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=283.13  Aligned_cols=241  Identities=27%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..|..+.+||+|+||+|.+|..+ +.+.+|||+++.   ....+.+--+.|-++|+... -|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            45899999999999999999976 467899998764   23445566677888888774 68899999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+.+|+|--++++..+   +.+..+.-+|.+||-||-+||+++   |+.||||.+|||||.+|++||+|||+++.-..
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999999987543   778889999999999999999999   99999999999999999999999999987554


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      +. ..+....|||.|+|||++...+|+..+|.|||||+|||||.|++||++.+.++       ..+.+.+..        
T Consensus       503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~ehn--------  566 (683)
T KOG0696|consen  503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIMEHN--------  566 (683)
T ss_pred             CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHHcc--------
Confidence            33 33556789999999999999999999999999999999999999998765544       222222211        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                        ...+...+.+...+.+..|...|.+|..
T Consensus       567 --vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 --VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              1224455666788999999999999953

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.7e-34  Score=292.88  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=192.2

Q ss_pred             CCccCCcccccCceEEEEEEec-C--CcEEEEEEcccc--ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC----Cc
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-D--GRIVAVKKSKLV--DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET----EV  387 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  387 (597)
                      +|++.+.||+|+||.||++... .  +..+|+|++...  .....+.+.+|+.+++++ +||||+++++.....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999975 3  778999987642  223356788999999999 599999999875432    35


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++++||+. ++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678889885 6899988653   34899999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCce---eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh---
Q 038707          468 SVMVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---  540 (597)
Q Consensus       468 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  540 (597)
                      ........   ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||.......   ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence            65432211   1223468899999998765 568999999999999999999999987543211   1110110000   


Q ss_pred             --------cCchhhhhh---H---HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 --------ENRLFEALD---A---RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 --------~~~~~~~l~---~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              .........   .   .............+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    000000000   0   0000001112457889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=277.01  Aligned_cols=236  Identities=31%  Similarity=0.371  Sum_probs=193.3

Q ss_pred             ccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          325 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      ||+|++|.||++... +++.+++|.+....   ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 58999999866422   23566889999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecc
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV  480 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  480 (597)
                      .+++....   .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            99997643   4899999999999999999999998   9999999999999999999999999987654322 123344


Q ss_pred             cccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       481 ~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      .++..|++||.+.+...+.++|+||||+++|+|++|+.||......+       ....+....          ...+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~----------~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------IYEKILKDP----------LRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcCC----------CCCCCCC
Confidence            57889999999988889999999999999999999999996433211       111111111          1112223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKE  584 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~e  584 (597)
                      +..+.+++.+||..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=282.04  Aligned_cols=258  Identities=30%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccC-------hhhHHHHHHHHHHHhhcCCCccceeeeEEE-eC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVD-------ETNVEQFINEVVILSQINHRNIVKLLGCCL-ET  385 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~  385 (597)
                      ..++|-++.+||+|||++||++.+ ...+.||+|+.....       +...+...+|..|.+.|.||.||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346788889999999999999995 468899999865421       112345678999999999999999999986 66


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC---CCCcEEEee
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSD  462 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~D  462 (597)
                      +.++-|+||+++.+|+-||+.+.   .++++++..|+.||+.||.||.... +||+|-||||.||||-   .-|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            78889999999999999998764   3999999999999999999999876 6799999999999994   347899999


Q ss_pred             ccccccccCCCc------eeeecccccccccCcccccc----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH
Q 038707          463 FGTSRSVMVDQT------HLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV  532 (597)
Q Consensus       463 fgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~  532 (597)
                      |||++.+..+..      .......||..|++||.+.-    ...+.|.||||+|||+|+.+.|++||.......+    
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd----  692 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD----  692 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH----
Confidence            999998764322      23445669999999998743    3578899999999999999999999976443321    


Q ss_pred             HHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       533 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           .+.++.+...-  ++.....+....+...+|++||++.-++|.+..++..
T Consensus       693 -----ILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  693 -----ILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -----HHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                 11122221111  1111223444566789999999999999998887753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=247.72  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=199.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +|...++||+|.||+||+|+.. +++.||+|++...+.  .......+|+-+|+.++|+|||++++....+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666788999999999999965 589999999876433  3456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +. -+|..|.....  ..++.+....++.|+++||.++|+++   +.|||+||.|.||+.+|.+||+|||+++.+..+..
T Consensus        83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            94 58888887643  34899999999999999999999999   99999999999999999999999999987754432


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHH--HhcCchhh---h
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA--INENRLFE---A  547 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~  547 (597)
                       ......-|..|.+|.++.+ .-|+...|+||-|||+.|+.. |++.|.+.+.++  ++...|+..  ..+..+..   +
T Consensus       157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCccccC
Confidence             2344457899999999877 458999999999999999998 666666544333  222222211  11221111   1


Q ss_pred             hhHHhh---------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 LDARVL---------KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 l~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .|-...         ....+.....=.+|+++.|.-+|.+|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            110000         0011111222368899999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.7e-32  Score=307.07  Aligned_cols=145  Identities=28%  Similarity=0.377  Sum_probs=131.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++...   .......+..|+.+++.++||||+++++.+...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999976 6899999987642   3344577899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997542   4889999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=267.47  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=198.8

Q ss_pred             ccccCHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeee
Q 038707          304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLG  380 (597)
Q Consensus       304 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  380 (597)
                      ...|+.++++.       +..||.|+||+|+|-.++ .|+..|||++.... +.+..+++.|.+...+- +.||||+++|
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            33455555544       346999999999998876 69999999988644 46677888888866555 6899999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      ....++..|+.||.| ..+|+.+.+.  ..++..+++..+-.|......||.||...-.  |+|||+||+||||+..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCE
Confidence            999999999999999 4577665543  1123458999999999999999999988653  9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||+|||.+-.+...  ...+...|-..|||||.+..  ..|+.+|||||||++|+|+.||+.|+...+.     ..+...
T Consensus       208 KLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  208 KLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            99999998665422  22344457888999999854  4589999999999999999999999975432     222222


Q ss_pred             HHHhcCchhhhhhHHhh-h-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          537 QAINENRLFEALDARVL-K-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~-~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +....       |+..+ . ....+....+..+|.-||.+|-++||...++++
T Consensus       281 ~Vv~g-------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  281 QVVIG-------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHcC-------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            22211       11111 1 112345667899999999999999999998865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=282.17  Aligned_cols=244  Identities=26%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             CCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCC
Q 038707          322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      .++||.|.||+||-|+.+ +|+.||||.+..  .......++++|+.||+++.||.||.|.-.|+..+..++|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            478999999999999975 799999997653  33445578999999999999999999999999999999999999 56


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC---CcEEEeeccccccccCCCce
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      +..+.|-... +..|++..-.-++.||+.||.|||.++   |+|.||||+|||+.+.   -++||+|||+++.+.  +..
T Consensus       648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--Eks  721 (888)
T KOG4236|consen  648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKS  721 (888)
T ss_pred             hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhh
Confidence            6666665432 334899988999999999999999999   9999999999999654   479999999999874  344


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|+|||++.+..|...-|+||.|||+|.-|+|..||.....-.         ..+.+...   +   +...
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaF---M---yPp~  786 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAF---M---YPPN  786 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhcccc---c---cCCC
Confidence            4566789999999999999999999999999999999999999996432111         11111111   1   1122


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...+......+||...|+..-.+|-+...-+.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            33556667889999999999999988876543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=269.37  Aligned_cols=220  Identities=24%  Similarity=0.227  Sum_probs=177.0

Q ss_pred             cCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhhHHhh
Q 038707          328 GGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN  406 (597)
Q Consensus       328 G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  406 (597)
                      |.+|.||++.+. +++.+|+|++....     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999976 68999999886432     233455556666799999999999999999999999999999999976


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccc
Q 038707          407 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY  486 (597)
Q Consensus       407 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y  486 (597)
                      ..   .+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+|||.+......    .....++..|
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y  148 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY  148 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence            43   4899999999999999999999999   999999999999999999999999987654321    1223456789


Q ss_pred             cCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHH
Q 038707          487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT  566 (597)
Q Consensus       487 ~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~  566 (597)
                      +|||.+....++.++||||+|+++|||++|+.|+........            ...         ....+...+..+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THT---------TLNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccc---------ccCCcccCCHHHHH
Confidence            999999888899999999999999999999988753211100            000         00112234456889


Q ss_pred             HHHHhcccCCCCCCCHH
Q 038707          567 LAKRCLNLNGKMRPTMK  583 (597)
Q Consensus       567 li~~cl~~~p~~RPt~~  583 (597)
                      ++.+||+.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-33  Score=286.06  Aligned_cols=239  Identities=25%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++.|.+...+|.|+|+.|-.+... +++..++|++...    ..+-.+|+.++... +||||+++.+.+.+....++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888889999999999998865 5788899987643    12234566565555 69999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe-CCCCcEEEeeccccccccCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll-~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      .+.++-|.+.+....    ....++..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++....+
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998888877543    223788889999999999999999   9999999999999 68899999999999876544


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          ....+-|..|.|||++....|++++|+||||++||+||+|+.||.....+      ......+..+..        
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~--------  531 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKF--------  531 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcc--------
Confidence                22334678899999999999999999999999999999999999765444      112233333222        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ....+....+|+.+||+.||.+||+|.++..
T Consensus       532 ----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 ----SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                2445667889999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=6.3e-32  Score=295.23  Aligned_cols=260  Identities=20%  Similarity=0.274  Sum_probs=171.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-C----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeE------EE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-D----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC------CL  383 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  383 (597)
                      ..++|++.+.||+|+||.||+|.+. +    +..||||++.....  .+...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999975 4    68999998764222  1222222  1222223333322222      23


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQIEE-----------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK  446 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik  446 (597)
                      +....+|||||+++++|.+++......                 .......+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999999999754211                 01123456789999999999999999   9999999


Q ss_pred             CCCeEeCC-CCcEEEeeccccccccCCCceeeecccccccccCccccccC----------------------CCCcccce
Q 038707          447 SANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS----------------------QFTEKSDV  503 (597)
Q Consensus       447 ~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv  503 (597)
                      |+|||+++ ++.+||+|||+++..............+++.|||||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 57999999999986654433444456789999999965322                      23456799


Q ss_pred             eehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc----hhhhhhHHhhhh------hhHHHHHHHHHHHHHhcc
Q 038707          504 YSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR----LFEALDARVLKE------AKKEEIMTVATLAKRCLN  573 (597)
Q Consensus       504 ~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~~~~~~------~~~~~~~~l~~li~~cl~  573 (597)
                      |||||+||||+++..|+..       .+..........+.    +...+.+....+      ..........+||.+||+
T Consensus       363 wSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999997665321       11111111111110    001111110000      000112234589999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 038707          574 LNGKMRPTMKEVTNE  588 (597)
Q Consensus       574 ~~p~~RPt~~evl~~  588 (597)
                      .||++|||++++++.
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.7e-34  Score=264.49  Aligned_cols=266  Identities=23%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEe--------C
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLE--------T  385 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  385 (597)
                      ..|+...+||+|.||+||+|... +|+.||+|+....+  +.-....++|+.+|..|+|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999965 57889998755432  2334567899999999999999999988753        2


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ...+|||++++. +|.-+|.....  .++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999965 88888876433  3889999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCc---eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          466 SRSVMVDQT---HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       466 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ++.+.....   ...+...-|..|.+||.+.+ ..|+++.|||.-||+|.||++|.+-+++......-.++......+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            987654322   22344556999999998766 67999999999999999999999988876544433332222111111


Q ss_pred             C--------chhhhhhHH-hhhh---hhHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 N--------RLFEALDAR-VLKE---AKKE------EIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 ~--------~~~~~l~~~-~~~~---~~~~------~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .        ++.+.+..+ +...   ...+      ..++..+|+.++|..||.+|+++++++..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            1        111111101 0000   0011      12367899999999999999999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=7.1e-32  Score=264.55  Aligned_cols=238  Identities=29%  Similarity=0.402  Sum_probs=194.4

Q ss_pred             CceEEEEEEec-CCcEEEEEEccccChhh-HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhhHHhh
Q 038707          329 GQGTVYKGMLT-DGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN  406 (597)
Q Consensus       329 ~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  406 (597)
                      +||.||+|... +++.+++|......... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999987654444 78899999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccc
Q 038707          407 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY  486 (597)
Q Consensus       407 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y  486 (597)
                      ...   +++..++.++.+++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            432   889999999999999999999998   9999999999999999999999999998765432  23345578899


Q ss_pred             cCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHH
Q 038707          487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT  566 (597)
Q Consensus       487 ~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~  566 (597)
                      ++||.+....++.++||||||+++++|++|..||......+      .............       .......+.++.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHHHH
Confidence            99999988889999999999999999999999986531111      1111111111100       0000004567889


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 038707          567 LAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       567 li~~cl~~~p~~RPt~~evl~  587 (597)
                      ++.+||..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.9e-32  Score=288.65  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=207.2

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe-----CC
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE-----TE  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~  386 (597)
                      ..++.|++.+.||+|.+|.||+++.. +++.+|+|++... .+..+++..|..+|+.+ .|||++.++|++..     .+
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34567889999999999999999964 6888999987754 33346677788899888 59999999999874     56


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      .+|||||||.+|+..|+++... ...+.|..+..|++.++.||.+||...   ++|||||-.|||++.++.|||.|||++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence            8999999999999999999865 566999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ...... ........||+.|||||++..     ..|+.++|+||||++..||--|.+|+-.+.+.-       +.-.+..
T Consensus       171 aQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aLF~IpR  242 (953)
T KOG0587|consen  171 AQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPR  242 (953)
T ss_pred             eeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hhccCCC
Confidence            876433 233455669999999999854     347889999999999999999999986543221       1111111


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +       |......+....+++.++|..||..|-++||++.++++
T Consensus       243 N-------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 N-------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             C-------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1       11112224667888999999999999999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=9.6e-32  Score=286.63  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=182.8

Q ss_pred             hcCCccCCcccccCceEEEEEEe-----------------cCCcEEEEEEccccChhhHHHHH--------------HHH
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-----------------TDGRIVAVKKSKLVDETNVEQFI--------------NEV  364 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~~--------------~E~  364 (597)
                      .++|++.++||+|+||+||+|.+                 ..++.||||++........++|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 23568999998764443333343              466


Q ss_pred             HHHhhcCCCcc-----ceeeeEEEe--------CCcceEEEeccCCCChhhHHhhcCC---------------------C
Q 038707          365 VILSQINHRNI-----VKLLGCCLE--------TEVPLLVYEFIPNGTLYQYIHNQIE---------------------E  410 (597)
Q Consensus       365 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~  410 (597)
                      .++.+++|.++     +++++++..        .+..+|||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     677777653        3567999999999999999975321                     1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCcc
Q 038707          411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE  490 (597)
Q Consensus       411 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE  490 (597)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            13567889999999999999999999   999999999999999999999999999765432221112223578999999


Q ss_pred             ccccCC----------------------CCcccceeehHHHHHHHHhCCC-CCCCCCCcCCC--c--HHHHHHHHHhcCc
Q 038707          491 YFQSSQ----------------------FTEKSDVYSFGVVLVEILTGQK-PIRAINTDEDK--S--LVGYFLQAINENR  543 (597)
Q Consensus       491 ~~~~~~----------------------~~~~sDv~SlG~il~ell~g~~-p~~~~~~~~~~--~--~~~~~~~~~~~~~  543 (597)
                      .+....                      ...+.||||+||++++|++|.. |+.........  .  .....+.......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875432                      1235799999999999999875 66432211100  0  0000000111110


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNG---KMRPTMKEVTNE  588 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~  588 (597)
                              ..........+...+|+.++|..+|   .+|+|++|++++
T Consensus       461 --------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 --------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             --------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                    0011122345668899999999766   689999999863

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=267.78  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--C----ccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINH--R----NIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~  388 (597)
                      +++|.+.+.+|+|.||.|-...+. .+..||||+++.... -.+..+-|+++|.++.+  |    -+|++.++|...+..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            788999999999999999999875 478999999885433 34566779999999942  2    378888999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC--------------
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--------------  454 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~--------------  454 (597)
                      +||+|.+ |-++.++|.++ ...+++...+..++.|+++++++||+.+   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 66999999876 3457999999999999999999999999   999999999999931              


Q ss_pred             ------CCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC
Q 038707          455 ------KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED  528 (597)
Q Consensus       455 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~  528 (597)
                            +..+||+|||.|+......    .....|..|.|||++.+-.++.++||||+||||+||.+|...|+.-+..| 
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E-  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE-  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH-
Confidence                  3468999999997654333    44567899999999999999999999999999999999999998755332 


Q ss_pred             CcHHH----------HHHHHH------hcCchh-----------hhhh---H-HhhhhhhHHHHHHHHHHHHHhcccCCC
Q 038707          529 KSLVG----------YFLQAI------NENRLF-----------EALD---A-RVLKEAKKEEIMTVATLAKRCLNLNGK  577 (597)
Q Consensus       529 ~~~~~----------~~~~~~------~~~~~~-----------~~l~---~-~~~~~~~~~~~~~l~~li~~cl~~~p~  577 (597)
                       .+..          ......      ..+++.           ...+   + .............|.+|+++||..||.
T Consensus       317 -HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  317 -HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             -HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence             1111          000000      001000           0000   0 000111234455799999999999999


Q ss_pred             CCCCHHHHHHH
Q 038707          578 MRPTMKEVTNE  588 (597)
Q Consensus       578 ~RPt~~evl~~  588 (597)
                      +|+|+.|++..
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999863

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=259.82  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=206.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  390 (597)
                      .+.|.++++||+|+|++|..+.+. +.+.+|+|.++.   .+.+++.....|-.+..+. +||.+|.|+.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999976 578899997663   3444555666677777666 69999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |.||+++|+|--++.++.+   |+++.+.-+..+|..||.|||+.+   |+.||||.+|+|+|..|++||+|+|+.+...
T Consensus       329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            9999999999998887643   999999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC-CCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE-DKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .+ ...+....|||.|+|||++.+..|....|.|+|||+|+||+.|+.||+....+. +.+...+..+.+-+..+.    
T Consensus       403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----  477 (593)
T KOG0695|consen  403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----  477 (593)
T ss_pred             CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence            33 334667889999999999999999999999999999999999999998765443 344445555555443331    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRP  580 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  580 (597)
                            .+...+.....+++.-|.+||.+|.
T Consensus       478 ------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                  2334444566789999999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.3e-31  Score=268.64  Aligned_cols=206  Identities=26%  Similarity=0.372  Sum_probs=175.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .-|...+.||-|+||+|.++.-. +...+|+|.+...   ........+.|-.||...+.+.||+|+-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34777889999999999999843 4677899977643   3445667888999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc--
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--  470 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~--  470 (597)
                      ||++||++-.+|-+..   -+.++.+.-++.++.-|+++.|..|   +|||||||+|||||.+|++||+||||..-+.  
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999998643   3788888899999999999999999   9999999999999999999999999965331  


Q ss_pred             -------CCCce--------------------------------eeecccccccccCccccccCCCCcccceeehHHHHH
Q 038707          471 -------VDQTH--------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV  511 (597)
Q Consensus       471 -------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~  511 (597)
                             .....                                ......||+.|+|||++....++...|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   00000                                001135999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcCC
Q 038707          512 EILTGQKPIRAINTDED  528 (597)
Q Consensus       512 ell~g~~p~~~~~~~~~  528 (597)
                      ||+.|+.||......+.
T Consensus       863 em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHhhCCCCccCCCCCcc
Confidence            99999999988776664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3e-31  Score=241.31  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=195.9

Q ss_pred             hcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeC--CcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  391 (597)
                      .++|++.+.+|+|.+++||.|.. .+++.++||.++   +...+.+.+|+.+|..|. ||||++|++...+.  ..+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46799999999999999999994 578899999988   445677899999999997 99999999999864  477899


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~~~~  470 (597)
                      +||+.+.+...+..      .++...+...+.|++.||.|+|+.|   |+|||+||.|++||.. -.++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999887766654      2788899999999999999999999   9999999999999864 569999999998876


Q ss_pred             CCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh--
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA--  547 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  547 (597)
                      ......  ....+..|--||++.. ..|+..-|+|||||+|..|+..+.||....... .+++.. ...+....+...  
T Consensus       185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkI-akVLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKI-AKVLGTDELYAYLN  260 (338)
T ss_pred             CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHH-HHHhChHHHHHHHH
Confidence            544332  2234556889999865 568899999999999999999999997544322 222211 111111111111  


Q ss_pred             -----hhHHhhh----------------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 -----LDARVLK----------------EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 -----l~~~~~~----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           +|++...                +...-..++..+|+.+.|..|..+|||++|.+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 2221111                000112367889999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=283.99  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=188.9

Q ss_pred             CccCCcccccCceE-EEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEeccC
Q 038707          319 YNANRILGQGGQGT-VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       319 y~~~~~lg~G~~g~-Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      |.-.+++|.|+.|+ ||+|.. +|+.||||++-   .+-..-..+|+..|+.- .|||||++++.-.++...||..|.+ 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456899999987 899998 58899999875   33344567899999988 5999999999999999999999999 


Q ss_pred             CCChhhHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-----CCcEEEeecccccccc
Q 038707          397 NGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRSVM  470 (597)
Q Consensus       397 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfgl~~~~~  470 (597)
                      .-+|.+++...... ........+.+..|+++||++||+.+   |+||||||.||||+.     ...++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            45999999874111 11222456788999999999999999   999999999999965     3579999999999987


Q ss_pred             CCCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          471 VDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       471 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .+....  .....||-+|+|||++....-+.++|||||||++|+.++ |.+||...-..+.        ..+..+.-...
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee
Confidence            655443  345679999999999998888889999999999999999 5899965332220        00111000000


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +      +...+.  +..+||.+|+.++|..||++.+|+.
T Consensus       735 L------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 L------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             e------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0      001111  6789999999999999999999974

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-32  Score=269.34  Aligned_cols=242  Identities=24%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             cCCccCCcccccCceEEEEEEecCCc-EEEEEEcc---ccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKKSK---LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vaiK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .+++....||-||||.|=++..+..+ .+|+|.++   ..+..+.+.+..|-.+|...+.|.||+++.-|.++...|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555667999999999999876443 46766544   466677788999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |-+-+|.|...|+...   .+......-++..+++|++|||+++   |+.|||||+|.+||.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999998643   4888889999999999999999999   999999999999999999999999999987543


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                        ..+-..+|||.|.|||++.+...+.++|.||||+++||||+|.+||.+.++-...+       .+-.|        .-
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-------~ILkG--------id  636 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-------LILKG--------ID  636 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-------HHHhh--------hh
Confidence              34566789999999999999999999999999999999999999998765433211       11111        11


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                      ..+.+........+||++..+.+|.+|..
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            12334555666789999999999999975

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=249.60  Aligned_cols=263  Identities=23%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             ccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-----cceEE
Q 038707          320 NANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPLLV  391 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  391 (597)
                      +-.+.||-|+||.||.+.+. +|+.||+|++...-  -...+.+.+|+++|..++|.|++..++...-..     ++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            33568999999999999975 79999999877532  334578999999999999999999998876433     45677


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      .|.|. .+|..++-.   ..+++.+.+.-++.||++||.|||+.+   |.||||||.|.|++.|-.+||+|||+++....
T Consensus       136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88773 466666643   345899999999999999999999999   99999999999999999999999999998777


Q ss_pred             CCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH--------HHHHhcC
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--------LQAINEN  542 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  542 (597)
                      ++...++...-|-.|.|||++++ ..|+.+.||||.|||+.||+.++..|+.-.+-+.-+++...        ....-+|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            76666777778999999999887 57999999999999999999999998876554432222111        1111112


Q ss_pred             chhhhhhHH-------hhh--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          543 RLFEALDAR-------VLK--EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       543 ~~~~~l~~~-------~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                      .-..++...       .+-  ........+...+..+++..||+.|.+..+.+..+
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111111110       000  11122233466788999999999999998887654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=232.53  Aligned_cols=207  Identities=27%  Similarity=0.403  Sum_probs=169.7

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcc
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  388 (597)
                      ++...+.......||+|++|.|-+-++. +|...|+|++.. .+.+...+.++|+.+..+- ..|.+|.++|...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3444444555678999999999888864 799999998775 3455667788888877665 689999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ++.||.| ..+|+.+-++. ..+..+++..+-+|+..+..||.|||++-+  ++|||+||+||||+..|++|++|||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 56888877652 334569999999999999999999999763  9999999999999999999999999997


Q ss_pred             cccCCCceeeecccccccccCcccccc----CCCCcccceeehHHHHHHHHhCCCCCCCC
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAI  523 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlG~il~ell~g~~p~~~~  523 (597)
                      .+.+.-.  .+...|-..|||||.+..    ..|+.|+||||||+++.||.+++.||...
T Consensus       198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            6643221  222347778999998743    47999999999999999999999998653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.7e-28  Score=234.51  Aligned_cols=211  Identities=36%  Similarity=0.590  Sum_probs=184.4

Q ss_pred             ccccCceEEEEEEecC-CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhh
Q 038707          325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ  402 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  402 (597)
                      ||+|.+|.||++...+ ++.+++|........ ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999998754433 45789999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccccccccCCCceeeeccc
Q 038707          403 YIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQ  481 (597)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~  481 (597)
                      ++....  ..+++..++.++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            998642  34899999999999999999999998   999999999999999 89999999999976543321 123345


Q ss_pred             ccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHH
Q 038707          482 GTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE  560 (597)
Q Consensus       482 gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  560 (597)
                      +...|++||.+... ..+.++|+|+||+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            78889999998877 889999999999999999                                               


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                       ..+.+++.+|++.+|++||++.++++.|
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             4577899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=256.25  Aligned_cols=196  Identities=25%  Similarity=0.368  Sum_probs=168.0

Q ss_pred             CCccCCcccccCceEEEEEEecC-CcEEEEEEccccC---hh-----hHHHHHHHHHHHhhcC---CCccceeeeEEEeC
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ET-----NVEQFINEVVILSQIN---HRNIVKLLGCCLET  385 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~---~~-----~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  385 (597)
                      .|...+.+|+|+||.|+.+.++. ...|+||.+....   ..     ..-..-.||+||+.++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            37888999999999999999874 5678888765311   11     1223567999999997   99999999999999


Q ss_pred             CcceEEEeccC-CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          386 EVPLLVYEFIP-NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       386 ~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      +..||++|-.. +-+|.++|..+.+   +++.++..|++||+.|+++||+.+   |+|||||-+|+.++.+|-+||+|||
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            99999999865 5589999986543   999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCC
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRA  522 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~  522 (597)
                      .+.....   .......||.+|.|||++.+..| ...-|||++|++||.++....||..
T Consensus       716 saa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9876533   33556779999999999999876 5779999999999999999888863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=264.57  Aligned_cols=253  Identities=27%  Similarity=0.386  Sum_probs=208.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++...+|.|.+|.|||+++. .++..|+|.+++....+..-+.+|+.+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357889999999999999999976 6999999999998888888889999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +.+|+|.+.-+.   ..++++.++..+.++.+++|+|||+.+   -+|||||-.|||+++.+.+|++|||.+..+...- 
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            999999998774   346999999999999999999999999   7899999999999999999999999987764322 


Q ss_pred             eeeecccccccccCcccc---ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          475 HLTTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .......||+.|||||+.   ..+.|..++|||++|+...|+---++|.....+..       +...+... .   .++.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS-~---~qpp  235 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKS-G---FQPP  235 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhcc-C---CCCC
Confidence            234456799999999985   45779999999999999999988888754322111       11111111 0   1111


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+.+ .....+.+.+|++.+|..+|++||+++.++.
T Consensus       236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1122 3455677899999999999999999987654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=238.45  Aligned_cols=131  Identities=28%  Similarity=0.398  Sum_probs=111.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----C---CccceeeeEEEeC--
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----H---RNIVKLLGCCLET--  385 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~--  385 (597)
                      .+|.+.++||.|-|++||++.+. ..+.||+|+.+.. +.-.+..+.||++|++++     |   .+||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67889999999999999999975 6789999998743 344577889999999983     3   4699999999854  


Q ss_pred             --CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          386 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       386 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                        ...++|+|++ |.+|..+|....-+. ++...+.+|++||+.||.|||....  |||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence              4789999999 668999888754333 8999999999999999999999863  9999999999999

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=5.4e-29  Score=250.19  Aligned_cols=269  Identities=20%  Similarity=0.236  Sum_probs=209.0

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC------CCccceeeeEEEe
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN------HRNIVKLLGCCLE  384 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~  384 (597)
                      .+....+|.+....|+|-|++|-+|.++ .|..||||++.. ++.-...=+.|+++|++|+      .-|.++|+-.|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3455678888899999999999999976 478999999874 3444456678999999995      3589999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeec
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDF  463 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Df  463 (597)
                      .++++||+|-+ ..+|.++|+......-|....+..++.|+.-||..|...+   |+|.||||+|||+++. ..+||+||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence            99999999988 5699999998777767899999999999999999999999   9999999999999876 45899999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH-----HHH
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF-----LQA  538 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~  538 (597)
                      |.|.......   .+.+.-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+......-.+.+..     ..+
T Consensus       582 GSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  582 GSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            9997654332   33444566799999999999999999999999999999999999876544321111111     011


Q ss_pred             HhcCchh---------------------------hhhhH------Hh-----hhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 038707          539 INENRLF---------------------------EALDA------RV-----LKEAKKEEIMTVATLAKRCLNLNGKMRP  580 (597)
Q Consensus       539 ~~~~~~~---------------------------~~l~~------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP  580 (597)
                      ++.+...                           ..+.|      .+     +.+-.....+.|.+|+.+||..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            1111110                           00000      11     1112244567889999999999999999


Q ss_pred             CHHHHHHH
Q 038707          581 TMKEVTNE  588 (597)
Q Consensus       581 t~~evl~~  588 (597)
                      |..++|..
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99998863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=7.2e-29  Score=236.72  Aligned_cols=260  Identities=25%  Similarity=0.362  Sum_probs=195.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------C
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  386 (597)
                      ..+|.-++.+|.|+- .|-.+.+. .++.||+|++..  .+.....+..+|...+..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777888999988 66666554 589999998653  3344566788999999999999999999999743      3


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..|+|||+| ..+|...++..     ++.+.+..|+.|++.|+.|||+.+   |+||||||+||++..+..+||.|||++
T Consensus        95 e~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            568999999 56898888732     788899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC----------------Cc
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED----------------KS  530 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~----------------~~  530 (597)
                      +....+  ..++.+..|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+.-+.                ..
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            865433  467778899999999999988899999999999999999999998875332110                00


Q ss_pred             HHHHHHHHHhcCchhhhh-------hH--HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          531 LVGYFLQAINENRLFEAL-------DA--RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l-------~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +....+...+...-....       |.  ....+.+......+.+|+.+||..||++|.+++++|+
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            000001111100000000       00  0000111122345779999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.9e-27  Score=230.65  Aligned_cols=199  Identities=36%  Similarity=0.536  Sum_probs=174.1

Q ss_pred             CccCCcccccCceEEEEEEecC-CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      |.+.+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999875 899999998765544 67889999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +++|.+++......  +++..+..++.+++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||.+..........
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999999864321  789999999999999999999998   9999999999999999999999999998765443112


Q ss_pred             eecccccccccCcccc-ccCCCCcccceeehHHHHHHHHhCCCCCCC
Q 038707          477 TTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRA  522 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlG~il~ell~g~~p~~~  522 (597)
                      .....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334577889999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2.6e-27  Score=234.34  Aligned_cols=265  Identities=25%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec----CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCC
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETE  386 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  386 (597)
                      +....+.|...++||+|.|++||++.+.    ..+.||+|.+...+  ....+.+|++.|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999854    36789999877533  3456889999999995 999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGT  465 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl  465 (597)
                      ...+|+||++.....++...      ++..++..+++.++.||.++|..|   |+||||||+|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999998864      778999999999999999999999   999999999999975 46789999999


Q ss_pred             cccccCCC-------------------------------------------ceeeecccccccccCcccccc-CCCCccc
Q 038707          466 SRSVMVDQ-------------------------------------------THLTTKVQGTFGYVDPEYFQS-SQFTEKS  501 (597)
Q Consensus       466 ~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~s  501 (597)
                      +.......                                           ........||++|.|||++.. ...+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87211000                                           000112359999999999765 5678999


Q ss_pred             ceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH---HHH------HHHhcCc--hhh---------------hhh-HHhhh
Q 038707          502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVG---YFL------QAINENR--LFE---------------ALD-ARVLK  554 (597)
Q Consensus       502 Dv~SlG~il~ell~g~~p~~~~~~~~~~~~~~---~~~------~~~~~~~--~~~---------------~l~-~~~~~  554 (597)
                      ||||.|||++.+++++.||.....+-+ .+.+   .+-      -+...+.  +.+               -++ .....
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             ceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            999999999999999999975443321 1111   110      0001111  111               010 00000


Q ss_pred             ---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 ---------EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                               ......+..+.+|+.+||..||.+|.|+++.|+.
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                     0011123368899999999999999999999863

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-27  Score=218.78  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=186.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeE-EEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGC-CLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv  391 (597)
                      ..+.|.+.+.||+|.||.+-++.++ ..+.+++|.+. .......+|.+|...--.|. |.||+.-++. |+..+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3477999999999999999999986 56788888765 34556788999988777774 8999988765 5566677899


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC--CCCcEEEeeccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSV  469 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfgl~~~~  469 (597)
                      +||+|.|+|.+-+....    +.+....+++.|+++||.|||+++   ++|||||.+||||-  +..++||+|||+.+..
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999998886533    788888999999999999999999   99999999999993  3448999999998754


Q ss_pred             cCCCceeeecccccccccCcccccc---C--CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQS---S--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ..    ......-+..|.+||....   +  ...+.+|||.||++++.+|+|+.||+... ..+.....|.....+.+. 
T Consensus       174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~-  247 (378)
T KOG1345|consen  174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNP-  247 (378)
T ss_pred             Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCc-
Confidence            32    1222334667999998643   2  34688999999999999999999998433 333333333222221111 


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            .+.. .-...++.+..+.++-|..++++|=-..++.+
T Consensus       248 ------~~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  248 ------ALPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             ------cCch-hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence                  1111 11223445678888999999999844444443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1e-26  Score=266.65  Aligned_cols=195  Identities=18%  Similarity=0.234  Sum_probs=139.7

Q ss_pred             hcCC-CccceeeeEE-------EeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 038707          369 QINH-RNIVKLLGCC-------LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI  440 (597)
Q Consensus       369 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  440 (597)
                      .++| +||+++++++       .+.+.+++++|++ +++|.++|...  ...+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 6888888877       3334667889987 66999999753  235999999999999999999999999   9


Q ss_pred             EeccCCCCCeEeCC-------------------CCcEEEeeccccccccCCC---------------ceeeecccccccc
Q 038707          441 YHRDIKSANILLDD-------------------KYRAKVSDFGTSRSVMVDQ---------------THLTTKVQGTFGY  486 (597)
Q Consensus       441 ~H~Dik~~NIll~~-------------------~~~~kl~Dfgl~~~~~~~~---------------~~~~~~~~gt~~y  486 (597)
                      +||||||+||||+.                   ++.+|++|||+++......               ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456666667665321100               0001123578889


Q ss_pred             cCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHH
Q 038707          487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT  566 (597)
Q Consensus       487 ~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~  566 (597)
                      ||||++.+..++.++|||||||+||||++|..|+....     ...    ..+..    ..+.+..     .........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~----~~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRH----RVLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHH----hhcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999888764211     000    00000    0111111     111234568


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 038707          567 LAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       567 li~~cl~~~p~~RPt~~evl~  587 (597)
                      ++.+||+.+|.+||++.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999975

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.93  E-value=3e-26  Score=194.49  Aligned_cols=100  Identities=46%  Similarity=0.772  Sum_probs=86.3

Q ss_pred             CCCCCCcCCeeeecCCCCCCCCCCCCCCceeecCCCCCCcccCCCCcceeeecccccccceeeeecccccccCCCCC---
Q 038707            1 RICQSECGNISISYPFGIGHECFLDKSFEVICNYSGKYPKAYLPGINNLELLDGDSYYESTIRVNFPIISLKNPSNA---   77 (597)
Q Consensus         1 ~~C~~~CG~v~IpyPFgi~~~C~~~~~F~l~C~~~~~~~~~~~~~~~~~~v~~i~~~~~~~~~v~~~~~~~~~~~~~---   77 (597)
                      |+||++||||+|||||||+++|++.++|+|+|++++++|++++.+. +++|++| +|++++++|..++.+.|.....   
T Consensus         2 ~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~-~~~V~~I-~~~~~~i~v~~~~~~~~~~~~~~~~   79 (106)
T PF13947_consen    2 PGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSG-NYEVLSI-SYENGTIRVSDPISSNCYSSSSSNS   79 (106)
T ss_pred             CCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCC-cEEEEEE-ecCCCEEEEEeccccceecCCCCcc
Confidence            7999999999999999999999995599999999988888988555 5999999 9999999999999888743322   


Q ss_pred             --CceeecCCCeEeccCCceEEEEcccc
Q 038707           78 --RGVNLSGSPFTFSNISNRFAAIGCDD  103 (597)
Q Consensus        78 --~~~~~~~~pf~~s~~~n~~~~~gC~~  103 (597)
                        ..+++.+ ||++|+++|.|+++||++
T Consensus        80 ~~~~~~~~~-~~~~s~~~N~~~~~GC~t  106 (106)
T PF13947_consen   80 SNSNLSLNG-PFFFSSSSNKFTVVGCNT  106 (106)
T ss_pred             cccEEeecC-CceEccCCcEEEEECCCC
Confidence              2345555 899999999999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.9e-25  Score=208.75  Aligned_cols=169  Identities=22%  Similarity=0.261  Sum_probs=127.4

Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|.++++..  +.++++.+++.++.||+.||.|||+.+         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6899999864  235999999999999999999999876         999999999999999  99987653321    


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAK  557 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  557 (597)
                        ..||+.|||||++.+..++.++||||||+++|||++|+.||......  ..............      ++.. ....
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~~-~~~~  132 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPRD-RSNL  132 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Cccc-cccH
Confidence              25889999999999999999999999999999999999998643211  11111111111100      0000 0011


Q ss_pred             HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          558 KEEIM--TVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       558 ~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .....  ++.+++.+||+.+|.+||++.|+++.+..+..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22222  68999999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-24  Score=208.33  Aligned_cols=265  Identities=18%  Similarity=0.247  Sum_probs=212.4

Q ss_pred             hcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .-+|++.++||+|.||+++.|+. -++++||||.-..  ..+..++..|....+.|. .++|..++-+..+.-.-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            45799999999999999999994 4799999997654  334467888999888885 6999999988888889999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-----CCcEEEeecccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRS  468 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfgl~~~  468 (597)
                      .+ +-+|+|++.=+.++  ++.+.+..+|.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+++.
T Consensus       105 LL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99 77999988766554  899999999999999999999999   999999999999964     34689999999998


Q ss_pred             ccCCCcee------eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          469 VMVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       469 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      +..+.+..      .....||..||+=..+.+.+.+.+.|+-|||-+++++|-|..||++......+...+.    +.+.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~  254 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGET  254 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hccc
Confidence            87655443      2335699999999999999999999999999999999999999998776653332221    1111


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhcC
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG  597 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~  597 (597)
                      +-     .-...+.....+.++..-++-.=..+-.+-|+.+-+.+.+..+.+.+|
T Consensus       255 Kr-----~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  255 KR-----STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             cc-----cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            10     011123344556677777777777888999999999888888877654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=8.3e-24  Score=217.10  Aligned_cols=261  Identities=22%  Similarity=0.259  Sum_probs=198.9

Q ss_pred             CCccCCcccccCceEEEEEEecC--CcEEEEEEccccChhhHHHHHHHHHHHhhcCC----CccceeeeEE-EeCCcceE
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINH----RNIVKLLGCC-LETEVPLL  390 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  390 (597)
                      +|.+.+.||+|+||.||++....  .+.+|+|............+..|+.++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999999765  35788887665433333378889999999873    6899999999 47778899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-----CcEEEeeccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-----YRAKVSDFGT  465 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-----~~~kl~Dfgl  465 (597)
                      ||+.+ +.+|.++..... ...++...++.|+.|++.+|.+||+.|   ++||||||+|+++...     ..++|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 779999887665 445999999999999999999999999   9999999999999754     4699999999


Q ss_pred             cc--cccCCCc----ee---eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          466 SR--SVMVDQT----HL---TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       466 ~~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ++  .......    ..   .....||..|.+++.+.+...+.+.|+||++.++.||+.|..||...........   +.
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence            98  4322221    11   2345599999999999999999999999999999999999999976543332111   11


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ........    ..     .....+..+.++...+-..+..++|....+.+.|+.+...
T Consensus       251 ~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  251 KDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            11111000    00     1122234455666666668999999999999998776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-24  Score=197.88  Aligned_cols=264  Identities=19%  Similarity=0.240  Sum_probs=208.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..++|.+.+.||.|+||.+|.|.. .+|+.||||.-..  .....++..|..+...|++ ..|+.+..+..+.+.-.|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            357899999999999999999994 5799999997553  2333567789999999975 78888888899999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl~~~~  469 (597)
                      |.+ +-+|.+++.-..+.  ++.+.++-++-|++.-++|+|.++   ++||||||+|+|..-   ...+.|+|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 77999998876554  889999999999999999999999   999999999999953   357999999999887


Q ss_pred             cCCCcee------eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          470 MVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       470 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ....+..      .....||..|.+-..+.+.+.+.+.|+-|+|.+|.++.-|..||++.......+..+......    
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK----  240 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK----  240 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh----
Confidence            6433221      334569999998888877888999999999999999999999999877655433322221111    


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           -...........+.++.-.+.-|=..--++-|+..-+-+.+.-|...
T Consensus       241 -----~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  241 -----MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             -----cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence                 11112223445567788888889888889999988887777766543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=7e-24  Score=217.24  Aligned_cols=169  Identities=19%  Similarity=0.143  Sum_probs=131.8

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccce-eee
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVK-LLG  380 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~  380 (597)
                      .+......++|.+.+.||+|+||+||+|.+.  +++.+|||+....     .....+.+.+|+++|++++|+|+++ ++.
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            3344456678999999999999999999875  5777899985432     2334567999999999999999985 443


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeEeCCCCcEE
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI-KSANILLDDKYRAK  459 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Di-k~~NIll~~~~~~k  459 (597)
                          .+..+|||||+++++|... ..      ..   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.+|
T Consensus        90 ----~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         90 ----TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             ----cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence                2467999999999999632 11      11   1467899999999999999   999999 99999999999999


Q ss_pred             EeeccccccccCCCcee-------eecccccccccCcccccc
Q 038707          460 VSDFGTSRSVMVDQTHL-------TTKVQGTFGYVDPEYFQS  494 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  494 (597)
                      |+|||+++.........       .....+++.|+|||++..
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999998765322111       134567888999999854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=195.49  Aligned_cols=250  Identities=19%  Similarity=0.312  Sum_probs=191.0

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      .+..+|.+...|+.|+|+++.+ .++.|++...  ......+|..|.-.|+-+.||||+.+++.|.....+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3445688899999999999754 4455554432  222345788899999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      |+|...|++.. ....+..++.+++..||+|++|||+.... |.---|.+..+++|++.+++|+-=. .+.     +...
T Consensus       272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad-~kf-----sfqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMAD-TKF-----SFQE  343 (448)
T ss_pred             hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheeccc-cee-----eeec
Confidence            99999999864 34577889999999999999999998853 4445689999999999888774211 111     0011


Q ss_pred             ecccccccccCccccccCCC---CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          478 TKVQGTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~---~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ....-.|.||+||.++..+-   -.++|+|||.++||||.|+..||....+-|-.               +.+--..+..
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv  408 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRV  408 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccc
Confidence            11224678999999987654   35899999999999999999999876654421               1111122333


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ..++..+..+..|+.-|+..||.+||.+..|+-.|++++
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            445666777899999999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.5e-21  Score=197.89  Aligned_cols=261  Identities=31%  Similarity=0.403  Sum_probs=197.8

Q ss_pred             CccCCcccccCceEEEEEEecCCcEEEEEEccccChh---hHHHHHHHHHHHhhcCCC-ccceeeeEEEeCCcceEEEec
Q 038707          319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET---NVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  394 (597)
                      |.+.+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999987  78888887653332   477899999999999988 799999999777778999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~  473 (597)
                      +.+++|.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++... .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765421124899999999999999999999999   99999999999999998 79999999997554333


Q ss_pred             ce-----eeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          474 TH-----LTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       474 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ..     ......++..|+|||.+..   ...+...|+||+|++++++++|..||......   .........+......
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            22     2456679999999999987   57899999999999999999999996654331   0011111111111100


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       .................+.+++.+++..+|..|.++.+....
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000000000001223467899999999999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=6.5e-23  Score=223.70  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=191.4

Q ss_pred             ccCCcccccCceEEEEEEec-CCcEEEEEEc-----cccChhh-HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          320 NANRILGQGGQGTVYKGMLT-DGRIVAVKKS-----KLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~-----~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ...+++|.|++|.|+..... ..+..+.|..     ....+.. ...+..|+.+-..+.|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999987777643 3333343322     1112222 223677888888999999998888877777666669


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++. +|..++...   ..++..++-.+++|++.|+.|||+.+   |.|||+|++|++++.++.+||+|||.+.....+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999999864   23888999999999999999999999   999999999999999999999999999876644


Q ss_pred             Cc---eeeecccccccccCccccccCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          473 QT---HLTTKVQGTFGYVDPEYFQSSQFTE-KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       473 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..   .......|...|+|||++....|++ ..||||.|+++..|++|+.||.....++...     ......+.. .. 
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~-~~-  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQR-NI-  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccc-cc-
Confidence            33   4556677999999999999988876 6899999999999999999998765554321     001001100 00 


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ..-........+.+-..++.+||+.+|.+|.|+++|++
T Consensus       547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             00112233555667789999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=3.1e-22  Score=217.68  Aligned_cols=248  Identities=20%  Similarity=0.278  Sum_probs=182.2

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEcccc-ChhhHHHHH---HHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV-DETNVEQFI---NEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~-~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++...+.||.+.|=+|.++++++|. |+||..-.. +......|.   .|++ ...++|||.+++.-........|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6788899999999999999998887 788865432 233344444   4444 555689999999888777778889999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+.+ +|.|.|..+.   -+..-+...|+.|++.||.-+|..+   |+|||||.+||||+.-.-+.|+||..-+....++
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9854 8999887543   3778888999999999999999999   9999999999999999999999998665433222


Q ss_pred             c------eeeecccccccccCcccccc----------CC-CCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHH
Q 038707          474 T------HLTTKVQGTFGYVDPEYFQS----------SQ-FTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       474 ~------~~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~  535 (597)
                      .      ........-.+|+|||.+..          .. ++++.||||+||++.||++ |++||.-      .++..| 
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY-  247 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY-  247 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH-
Confidence            1      12223334568999998643          12 6789999999999999999 7888742      111111 


Q ss_pred             HHHHhcCchhhhhhH-HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          536 LQAINENRLFEALDA-RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                          +.+.   ..++ ..++.   -....+.+||..|++.||++|.++++.|+.-.+
T Consensus       248 ----r~~~---~~~~e~~Le~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 ----RSGN---ADDPEQLLEK---IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ----hccC---ccCHHHHHHh---CcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                1110   0011 11111   112257899999999999999999999987544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=1.4e-21  Score=186.42  Aligned_cols=172  Identities=12%  Similarity=0.124  Sum_probs=134.4

Q ss_pred             HHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChh---hHHH------HHHHHHHHhhcCCCccceeeeEEEe
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET---NVEQ------FINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~---~~~~------~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      ...++|+..++||+|+||.||+... ++..+|||.+......   ..+.      +.+|+..+.++.|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4468899999999999999999655 5778999987643222   2223      5789999999999999999988664


Q ss_pred             C--------CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          385 T--------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       385 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      .        ...+|+|||++|.+|.++..       ++.    ....+++.+|..||+.+   ++|||+||+||++++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            4        35789999999999988732       332    24569999999999999   99999999999999988


Q ss_pred             cEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL  514 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell  514 (597)
                       ++|+|||.......+...             ..++....+..++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988654321111             01334456778999999999988765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=8.1e-21  Score=179.05  Aligned_cols=139  Identities=19%  Similarity=0.175  Sum_probs=108.6

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChh--h-------H-----------------HHHHHHHHHHhhcCCCcc
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--N-------V-----------------EQFINEVVILSQINHRNI  375 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  375 (597)
                      ...||+|++|.||+|...+|+.||||.++.....  .       .                 ....+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999987643211  1       1                 122359999999988877


Q ss_pred             ceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCeEeCC
Q 038707          376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL-HSAASIPIYHRDIKSANILLDD  454 (597)
Q Consensus       376 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~i~H~Dik~~NIll~~  454 (597)
                      ........  ...+|||||++++++...+...   ..+++..+..++.|++.+|.+| |+.+   |+||||||+|||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence            44333222  2348999999988776553322   3488999999999999999999 6888   999999999999984


Q ss_pred             CCcEEEeeccccccc
Q 038707          455 KYRAKVSDFGTSRSV  469 (597)
Q Consensus       455 ~~~~kl~Dfgl~~~~  469 (597)
                       +.++|+|||++...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             78999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.2e-20  Score=194.80  Aligned_cols=217  Identities=24%  Similarity=0.470  Sum_probs=166.4

Q ss_pred             HhhcCCCccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeccC
Q 038707          367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI-YHRDI  445 (597)
Q Consensus       367 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-~H~Di  445 (597)
                      |+.+.|.|+.+++|.+.+....++|.+|+..|+|.|.+...  ...+++.....+++.|+.||.|||+..   | .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence            45789999999999999999999999999999999999873  345899999999999999999999876   4 99999


Q ss_pred             CCCCeEeCCCCcEEEeeccccccccC-CCceeeecccccccccCccccccC-------CCCcccceeehHHHHHHHHhCC
Q 038707          446 KSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQ  517 (597)
Q Consensus       446 k~~NIll~~~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlG~il~ell~g~  517 (597)
                      ++.|.++|..+.+||+|||+...... ..........-..-|.|||.+...       ..+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876642 111111222245579999998653       2477899999999999999999


Q ss_pred             CCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          518 KPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       518 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .||......++.  .+.+.. ++.+ ....+.|.+...  .+..+++..++.+||..+|.+||++++|-..++.+..
T Consensus       156 ~~~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCCh--HHHHHH-HHhc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999876555443  111111 2220 111111211111  1444578999999999999999999999999887765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.4e-19  Score=171.18  Aligned_cols=139  Identities=21%  Similarity=0.197  Sum_probs=110.7

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHhhcCCCcc
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--------------------------NVEQFINEVVILSQINHRNI  375 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  375 (597)
                      .+.||+|++|.||+|.+.+|+.||||........                          ....+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999987643211                          01234678999999999987


Q ss_pred             ceeeeEEEeCCcceEEEeccCCCChhhH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeC
Q 038707          376 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLD  453 (597)
Q Consensus       376 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~  453 (597)
                      .....+...  ..+|||||++++++... +..    ..++......++.|++.+|.+||+ .+   |+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            544443332  34899999998865443 332    247888999999999999999999 88   99999999999999


Q ss_pred             CCCcEEEeecccccccc
Q 038707          454 DKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~~  470 (597)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=6.3e-20  Score=180.25  Aligned_cols=233  Identities=21%  Similarity=0.269  Sum_probs=152.3

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCC----------CccceeeeEEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINH----------RNIVKLLGCCL  383 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  383 (597)
                      .....+.||.|+++.||.+++. +++.+|+|.....   .....+++++|......+.+          -.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455679999999999999987 5899999975432   23346777777766655432          12222222222


Q ss_pred             e---------C---C-----cceEEEeccCCCChhhHHhh---cC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 038707          384 E---------T---E-----VPLLVYEFIPNGTLYQYIHN---QI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYH  442 (597)
Q Consensus       384 ~---------~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H  442 (597)
                      -         .   +     ..+++|+-+ .++|.+++..   .. ....+....++.+..|+++.+++||+.+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            1         1   1     125677777 5688888653   11 1223556667788899999999999999   999


Q ss_pred             ccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCcccccc--------CCCCcccceeehHHHHHHHH
Q 038707          443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--------SQFTEKSDVYSFGVVLVEIL  514 (597)
Q Consensus       443 ~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlG~il~ell  514 (597)
                      +||+|+|++++.+|.++|+||+.......   . ......+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE---E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc---e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999987654321   1 111345678999997643        24788999999999999999


Q ss_pred             hCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCC
Q 038707          515 TGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR  579 (597)
Q Consensus       515 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  579 (597)
                      ++..||...........                    ...... +.++.+..||..+|++||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986544332211                    122333 788889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.1e-19  Score=202.12  Aligned_cols=204  Identities=22%  Similarity=0.315  Sum_probs=166.8

Q ss_pred             ccCHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCccceeeeEE
Q 038707          306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCC  382 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~  382 (597)
                      +-...+++.....|.+.+.||+|+||+||+|...+|+.||||.-+....-   +|.--.+++.+|+   -+-|+.+..++
T Consensus       687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHH
Confidence            33445666677889999999999999999999888999999987653322   2222234444444   35566677777


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-------CC
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-------DK  455 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-------~~  455 (597)
                      .-.+.-+||+||.+.|||.+++..   ...++|.....++.|++..++.||..+   |||+||||+|+||.       ++
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence            778888999999999999999983   334999999999999999999999999   99999999999994       34


Q ss_pred             CcEEEeeccccccccC-CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCC
Q 038707          456 YRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK  518 (597)
Q Consensus       456 ~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~  518 (597)
                      ..++|+|||.+-.+.. .........++|-.+--+|...+..++..+|.|.|+.+++-||.|+.
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            5689999999876653 23345667778999999999999999999999999999999999985

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.5e-19  Score=167.26  Aligned_cols=188  Identities=16%  Similarity=0.049  Sum_probs=139.4

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccChh----hHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEec
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET----NVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++|++|. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997765 6778887766643321    1225789999999995 5889999886    446999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI-KSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Di-k~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      +.+.+|...+..         . ...++.|++++|.++|+++   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999888654321         1 1357889999999999999   999999 7999999999999999999997543222


Q ss_pred             ce----e--------eecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Q 038707          474 TH----L--------TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINT  525 (597)
Q Consensus       474 ~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~  525 (597)
                      ..    .        ......++.|++|+...-  ..--...+.++-|..+|.++|+..|.....+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0        011225677788775322  2223567889999999999999988765443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=8.5e-21  Score=197.54  Aligned_cols=225  Identities=25%  Similarity=0.323  Sum_probs=178.1

Q ss_pred             cccccCceEEEEEEe----cCCcEEEEEEccccCh--hhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccC
Q 038707          324 ILGQGGQGTVYKGML----TDGRIVAVKKSKLVDE--TNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      .+|+|.||.|+++.-    +.+..+|+|..+....  ........|..++...+ ||.++++.-.++.....++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998652    3466777776543211  11125667888888887 9999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +|.|...+....   ...+.....+...++-+++++|+.+   |+|||+|++||+++.+|++|+.|||+++........ 
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999988886543   3667777778889999999999999   999999999999999999999999999876543332 


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                          +||..|||||++.  .....+|.||||++++||++|..||..    +      ......+.           .-..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il~~-----------~~~~  206 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRILKA-----------ELEM  206 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHhhh-----------ccCC
Confidence                7899999999998  678899999999999999999999975    1      01111110           1123


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                      +.+....+.+++..++..+|..|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            45666778889999999999999765

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.2e-18  Score=165.73  Aligned_cols=136  Identities=16%  Similarity=0.168  Sum_probs=106.3

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc-----CCCccceeeeEEEeCC---c-ceE
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-----NHRNIVKLLGCCLETE---V-PLL  390 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  390 (597)
                      .-.+.||+|++|.||.  +......+||+.........+++.+|+.+++.+     .||||+++++++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456899999999996  433233379987765455667899999999999     5799999999998874   3 337


Q ss_pred             EEec--cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCeEeCC----CCcEEEeec
Q 038707          391 VYEF--IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL-FYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDF  463 (597)
Q Consensus       391 v~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~i~H~Dik~~NIll~~----~~~~kl~Df  463 (597)
                      |+||  .++++|.+++.+.    .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5579999999653    25555  35677888777 9999999   999999999999974    347999995


Q ss_pred             ccc
Q 038707          464 GTS  466 (597)
Q Consensus       464 gl~  466 (597)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.1e-17  Score=161.14  Aligned_cols=134  Identities=22%  Similarity=0.285  Sum_probs=113.8

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccCh--------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.||+|++|.||+|.. .+..+++|+......        .....+.+|+.++..+.|++++....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677888997543211        1234678899999999999998887777788889999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998643      12 78899999999999999999   99999999999999 78999999998854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=8e-19  Score=179.55  Aligned_cols=242  Identities=21%  Similarity=0.300  Sum_probs=163.6

Q ss_pred             CccCCcccccCceEEEEEEecC----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeee-------EEE----
Q 038707          319 YNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG-------CCL----  383 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~~----  383 (597)
                      ..+.+..+..+++.++......    .+-++-+.....+-.......+++..+....|.+..-+.+       ...    
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            4455566666777666655332    2334444444333233334444555555544433332222       111    


Q ss_pred             -eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          384 -ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       384 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                       ....+++.|+++...+|.++|.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence             123478999999999999999866555568889999999999999999   67   89999999999999999999999


Q ss_pred             ccccccccCCC-----ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHH
Q 038707          463 FGTSRSVMVDQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       463 fgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||+........     ....+...||..||+||.+.+..|+.|+||||||++|+||+. =..++.          -..+.
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~  469 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATL  469 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhh
Confidence            99987765444     224455679999999999999999999999999999999997 111211          11122


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV  585 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  585 (597)
                      .-++++.+.+    ....+.+.     -..|+.+++.+.|.+||++.++
T Consensus       470 ~d~r~g~ip~----~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGIIPP----EFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCCCh----HHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence            3334444331    11122121     2479999999999999954443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=9.6e-18  Score=164.83  Aligned_cols=196  Identities=23%  Similarity=0.240  Sum_probs=139.9

Q ss_pred             CCCccceeeeEEEeC---------------------------CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHH
Q 038707          371 NHRNIVKLLGCCLET---------------------------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV  423 (597)
Q Consensus       371 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  423 (597)
                      +|||||++++.|.++                           ..+||||...+ -+|.+|+..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            699999999887542                           23578998874 48999997653    66677778999


Q ss_pred             HHHHHHHHHHhCCCCCeEeccCCCCCeEe--CCC--CcEEEeeccccccccC-----CCceeeecccccccccCcccccc
Q 038707          424 EVSGALFYLHSAASIPIYHRDIKSANILL--DDK--YRAKVSDFGTSRSVMV-----DQTHLTTKVQGTFGYVDPEYFQS  494 (597)
Q Consensus       424 qi~~~L~~LH~~~~~~i~H~Dik~~NIll--~~~--~~~kl~Dfgl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~  494 (597)
                      |+++|+.|||.++   |.|||+|++|||+  |++  -.+.|+|||.+-....     +.....-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   9999999999999  333  3589999998743221     11111112236778999999754


Q ss_pred             CC------CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHH
Q 038707          495 SQ------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLA  568 (597)
Q Consensus       495 ~~------~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li  568 (597)
                      .+      .-.|+|.|+.|.+.||+++...||......-   +...        .+.+    .-+...+...+..+.+|+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~~r--------~Yqe----~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LDTR--------TYQE----SQLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---echh--------hhhh----hhCCCCcccCChHHHHHH
Confidence            32      2369999999999999999999998622111   1000        0000    111223455667789999


Q ss_pred             HHhcccCCCCCCCHHHHHHHH
Q 038707          569 KRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       569 ~~cl~~~p~~RPt~~evl~~L  589 (597)
                      ...|++||++|++..-....|
T Consensus       491 ~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHhcCCccccCCccHHHhHH
Confidence            999999999999876665554

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.9e-17  Score=159.31  Aligned_cols=143  Identities=17%  Similarity=0.121  Sum_probs=111.8

Q ss_pred             cCCccCCcccccCceEEEEEE--ecCCcEEEEEEccccChh------------------------hHHHHHHHHHHHhhc
Q 038707          317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDET------------------------NVEQFINEVVILSQI  370 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l  370 (597)
                      .-|.+.+.||+|++|.||+|.  ..+|+.||||........                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            348888999999999999998  457999999987643210                        112356899999999


Q ss_pred             CCC--ccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 038707          371 NHR--NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA  448 (597)
Q Consensus       371 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~  448 (597)
                      .+.  .++++++.    ...+|||||+++.+|.......   ..+.......++.||+.+|.+||+.+.  |+|+||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence            753  34455543    2358999999998887765322   235666778999999999999999873  999999999


Q ss_pred             CeEeCCCCcEEEeeccccccc
Q 038707          449 NILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       449 NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 789999999998654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=8.6e-17  Score=153.29  Aligned_cols=143  Identities=22%  Similarity=0.208  Sum_probs=111.7

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHhh
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE----------------------TNVEQFINEVVILSQ  369 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~~l~~  369 (597)
                      +......|.+.+.||+|+||.||++...+|+.||||+......                      .....+..|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333345888899999999999999988899999997543210                      011236778999999


Q ss_pred             cCCCc--cceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 038707          370 INHRN--IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS  447 (597)
Q Consensus       370 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~  447 (597)
                      +.|++  +++.++    ....++||||+++++|.+....         .....++.+++.++.++|+.+   |+|+||||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            98874  444443    3456899999999998765421         235678899999999999998   99999999


Q ss_pred             CCeEeCCCCcEEEeecccccccc
Q 038707          448 ANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       448 ~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      +||++++++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.3e-16  Score=152.14  Aligned_cols=130  Identities=21%  Similarity=0.303  Sum_probs=107.1

Q ss_pred             cccccCceEEEEEEecCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .||+|++|.||+|.+ ++..+++|......        .....++.+|++++..+.|+++....-+..+.+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 56789999744311        112366789999999999887666555666777789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++++|.+++....    .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999876421    1      78999999999999999   99999999999999 78999999998854

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.5e-16  Score=174.38  Aligned_cols=137  Identities=20%  Similarity=0.281  Sum_probs=112.2

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEE-c-ccc------ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK-S-KLV------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~-~-~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ...|...++||+|+||+||+|.+.... +++|+ . +..      .....+.+.+|+++++.++|++++....+..+.+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345567889999999999999876443 33332 2 111      11224568899999999999999988888878788


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999999885           34678999999999999999   9999999999999 67799999999996


Q ss_pred             c
Q 038707          468 S  468 (597)
Q Consensus       468 ~  468 (597)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=1.8e-17  Score=180.98  Aligned_cols=209  Identities=26%  Similarity=0.367  Sum_probs=146.0

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ...|+..+.|..|++|.||...++. .+.+|+|.-+.   ..  -+++   ++.....|.+               |   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~l--ilRn---ilt~a~npfv---------------v---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NL--ILRN---ILTFAGNPFV---------------V---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc---ch--hhhc---cccccCCcce---------------e---
Confidence            4678889999999999999998874 56677754331   00  0001   2222223332               2   


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                         |+=...++.-   .+++.+.        +.+++|||+.+   |+|||+||+|.||+.-|++|++|||+++.......
T Consensus       136 ---gDc~tllk~~---g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNI---GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccC---CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               3333333321   2243333        78999999999   99999999999999999999999999876432111


Q ss_pred             e--------------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          475 H--------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       475 ~--------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      .              ......||+.|+|||++....|....|+|++|+|+||++-|..||.+..+++.      |.+.+.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~vis  272 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVIS  272 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhh
Confidence            1              12335699999999999999999999999999999999999999998776662      333332


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                      +...+        .+.....+.+++++|.+.|+.+|..|.-
T Consensus       273 d~i~w--------pE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  273 DDIEW--------PEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhccc--------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            22111        1112344567889999999999999953

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=3.9e-15  Score=140.46  Aligned_cols=136  Identities=21%  Similarity=0.221  Sum_probs=98.9

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChh--hHHH----------------------HHHHHHHHhhcCCC--cc
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQ----------------------FINEVVILSQINHR--NI  375 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  375 (597)
                      .+.||+|+||+||+|...+++.||||........  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5689999999999999888999999976542211  1111                      13556666666443  34


Q ss_pred             ceeeeEEEeCCcceEEEeccCCCChhhH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeC
Q 038707          376 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLD  453 (597)
Q Consensus       376 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~  453 (597)
                      .+.+++    ...++||||++++++... +....    .. .....++.+++.++.++|. .+   |+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            445543    346899999998554322 21110    11 5678899999999999999 88   99999999999999


Q ss_pred             CCCcEEEeecccccccc
Q 038707          454 DKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~~  470 (597)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999996553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=6.6e-15  Score=133.10  Aligned_cols=135  Identities=23%  Similarity=0.211  Sum_probs=114.5

Q ss_pred             cCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--CccceeeeEEEeCCcceEEEeccCCC
Q 038707          321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..++.++|  .++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35689999999999999854 7899998765433  5678899999999976  58999999888888899999999887


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      .+..+          +......++.+++++|.+||......++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4566778899999999999997544599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=6.6e-17  Score=176.73  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=193.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecC--CcEEEEEEccccC--hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVD--ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  390 (597)
                      ...|.+.+.||+|+|+.|-......  ...+|+|......  ....+....|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3468888889999999998887643  4556667655432  334555666888888887 9999999999999999999


Q ss_pred             EEeccCCCChhhHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccc
Q 038707          391 VYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLH-SAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSR  467 (597)
Q Consensus       391 v~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~  467 (597)
                      +.||..++++.+.+ +....  ..+.......+.|+..++.|+| ..+   +.|+||||+|.+++..+ ..|++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999999988 43321  3666777889999999999999 888   99999999999999999 99999999998


Q ss_pred             cccC--CCceeeecccc-cccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          468 SVMV--DQTHLTTKVQG-TFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       468 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      .+..  ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........     +..++....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----~~~~~~~~~  248 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----YSSWKSNKG  248 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----ceeeccccc
Confidence            8765  33344555668 9999999998874 5678999999999999999999998765443311     111111100


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  586 (597)
                      .       ..............+++.+++..+|..|.+.+++-
T Consensus       249 ~-------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 R-------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c-------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence            0       00111233344567889999999999999988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.8e-14  Score=140.78  Aligned_cols=135  Identities=19%  Similarity=0.274  Sum_probs=105.0

Q ss_pred             Cccc-ccCceEEEEEEecCCcEEEEEEcccc-------------ChhhHHHHHHHHHHHhhcCCCcc--ceeeeEEEeCC
Q 038707          323 RILG-QGGQGTVYKGMLTDGRIVAVKKSKLV-------------DETNVEQFINEVVILSQINHRNI--VKLLGCCLETE  386 (597)
Q Consensus       323 ~~lg-~G~~g~Vy~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  386 (597)
                      .+|| .||.|+||++... +..++||+....             .......+.+|+.++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8889999998874 678888865321             11234568899999999998775  67777654432


Q ss_pred             c----ceEEEeccCC-CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          387 V----PLLVYEFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       387 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      .    .++|||++++ .+|.+++...    +++..    .+.+|+++|.+||+.+   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    3599999997 6899888642    24543    3568999999999999   9999999999999998899999


Q ss_pred             eccccccc
Q 038707          462 DFGTSRSV  469 (597)
Q Consensus       462 Dfgl~~~~  469 (597)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=7.5e-13  Score=140.62  Aligned_cols=141  Identities=19%  Similarity=0.178  Sum_probs=101.2

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhH----------------------------------------HHHH
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV----------------------------------------EQFI  361 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~  361 (597)
                      .+.||.|++|.||+|++.+|+.||||..........                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999998654211110                                        1255


Q ss_pred             HHHHHHhhcC----CCccceeeeEEE-eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 038707          362 NEVVILSQIN----HRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG-ALFYLHSA  435 (597)
Q Consensus       362 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~  435 (597)
                      +|+..+.++.    |.+-+.+-..+. ..+..+|||||+++++|.++.......  .   ....++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            5666666652    332233322332 245679999999999999887542111  2   23456666665 47888998


Q ss_pred             CCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       436 ~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      +   ++|+|+||.||+++++++++|+|||++....
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=1.6e-13  Score=132.40  Aligned_cols=202  Identities=19%  Similarity=0.268  Sum_probs=139.6

Q ss_pred             HHHhhcCCCccceeeeEEEeC-----CcceEEEeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038707          365 VILSQINHRNIVKLLGCCLET-----EVPLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASI  438 (597)
Q Consensus       365 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  438 (597)
                      .-|-++-|.|||+++.+..+.     ....++.|||..|+|..+|++..+ ...+..+...+|+.||+.||.|||+.. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            345566799999999987654     346789999999999999987432 345888899999999999999999987 6


Q ss_pred             CeEeccCCCCCeEeCCCCcEEEeeccccccccC----CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHH
Q 038707          439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV----DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL  514 (597)
Q Consensus       439 ~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell  514 (597)
                      ||+|+++..+-|++..++-+|+.--- ......    ..........+.++|.+||.=.....+.++|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            69999999999999999888874321 111100    0001112233678999999877777888999999999999998


Q ss_pred             hCCCCCCCCC-CcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          515 TGQKPIRAIN-TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       515 ~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .+..--.... ..+.+.....        .++ .+...           .=..++.+|++..|..||+|++++..
T Consensus       277 ilEiq~tnseS~~~~ee~ia~--------~i~-~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIAN--------VII-GLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhhh--------hee-eccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence            7664211100 0000000000        000 00000           11358899999999999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=3.7e-13  Score=140.90  Aligned_cols=247  Identities=22%  Similarity=0.289  Sum_probs=182.3

Q ss_pred             CCccCCcccc--cCceEEEEEEe--c-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcce
Q 038707          318 NYNANRILGQ--GGQGTVYKGML--T-DGRIVAVKKSKL--VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       318 ~y~~~~~lg~--G~~g~Vy~~~~--~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  389 (597)
                      .+...+.+|.  |.+|.||.+..  . ++..+|+|+.+.  ........=++|+.....++ |+|.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556677888  99999999986  3 588899998443  33344444456777777774 999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeecc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG----ALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFG  464 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg  464 (597)
                      +-.|++. .+|.++.+.-..  .++...++....+..+    ||.++|+..   ++|-|+||.||++.++ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999884 788888876432  3778888888888888    999999999   9999999999999999 889999999


Q ss_pred             ccccccCCCce----eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          465 TSRSVMVDQTH----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       465 l~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      +...+....-.    ......+...|++||..+ ..++.++|+|++|.+..+..++..+........-        ...+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--------~~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSW--------SQLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCc--------cccc
Confidence            99877644311    122235788999999876 5678999999999999999998776543211110        0000


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .  ..      +..+.......++...+..|++.+|-.|++.+.+..
T Consensus       340 ~--~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 Q--GY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c--cc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0  00      111222223334556889999999999998887654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=1e-11  Score=131.27  Aligned_cols=165  Identities=19%  Similarity=0.210  Sum_probs=129.8

Q ss_pred             cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHH
Q 038707          339 TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL  418 (597)
Q Consensus       339 ~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~  418 (597)
                      .++.+|.|...+..+....+...+.++.|+.++||||++++.........|||.|.+.  .|..++++      +.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            3678888887776666666778899999999999999999999999999999999883  67778875      446677


Q ss_pred             HHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCC
Q 038707          419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT  498 (597)
Q Consensus       419 ~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  498 (597)
                      ..-+.||+.||.|||+.+.  ++|++|..+.|++++.|..||.+|.+......... ......--..|..|+.+....  
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence            7889999999999987653  99999999999999999999999988754432111 111112223466776554322  


Q ss_pred             cccceeehHHHHHHHHhC
Q 038707          499 EKSDVYSFGVVLVEILTG  516 (597)
Q Consensus       499 ~~sDv~SlG~il~ell~g  516 (597)
                      -..|.|.||++++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            456999999999999999

>PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins

Probab=99.34  E-value=4e-12  Score=105.50  Aligned_cols=97  Identities=24%  Similarity=0.465  Sum_probs=67.6

Q ss_pred             CCcccccccccc--CC-cceeEeeeeeccc-cccCCcceEEEEeccceeecccCCChhhhhccCCCcceeEeeeeecCCc
Q 038707          130 RGCYDFLCALSS--NI-TQVFNANLSYIYS-QNISRGCRSVSVVEENWVGSKYLENPLVLKQQARDIPALLDWGEDIGHC  205 (597)
Q Consensus       130 ~~c~g~~cc~~~--~~-~~~~~~~~~~~~~-~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~vLdW~i~~~~C  205 (597)
                      ..|+|.+|||+.  .+ ++++++++..... ..+..+|.+|||||+.||.++..+...  .+..+.+||+|+|+|...+.
T Consensus         2 ~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~--~~~~~y~pv~L~W~i~t~~~   79 (103)
T PF08488_consen    2 SSCSGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPED--FHAMGYVPVVLDWFIDTSDS   79 (103)
T ss_pred             CccCCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHH--hccCCeeEEEEEEEEecCCc
Confidence            579999999998  33 5678887776543 233479999999999999776544433  24567799999999975433


Q ss_pred             cccCCCccccccCCCCceeccCCCCceeeecC
Q 038707          206 AEDFSLYSTTICGDGEYRCSITFGSGYICRCR  237 (597)
Q Consensus       206 ~~~~~~~~~~~C~s~~~c~~~~~~~gy~C~C~  237 (597)
                      .    ...+++|....+ .+.    ..+|.|.
T Consensus        80 ~----~~~s~~C~~~~~-y~~----~~~C~C~  102 (103)
T PF08488_consen   80 S----FSNSLACKNNTE-YSS----SNRCSCS  102 (103)
T ss_pred             C----cCcCccCCCcee-ccC----CCcEeCC
Confidence            2    223578888744 222    1289986

WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1.2e-11  Score=114.67  Aligned_cols=129  Identities=22%  Similarity=0.141  Sum_probs=96.3

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEeccCCCChh
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      +.|+.|..+.||++... ++.+++|....... ....+..|+.+++.+.+.++ ++++...  .+..++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56889999999999875 77899998754322 23356789999999865554 4455443  33468999999998876


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      +..        .   ....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+.
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            530        1   11245678999999999987  22359999999999999 5689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=3.4e-11  Score=129.52  Aligned_cols=144  Identities=17%  Similarity=0.161  Sum_probs=96.9

Q ss_pred             cCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChh------------------------------h----H----
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET------------------------------N----V----  357 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~------------------------------~----~----  357 (597)
                      ..|+. +.||.|++|.||+|++++ |+.||||.....-..                              .    .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999987 999999987532110                              0    1    


Q ss_pred             --HHHHHHHHHHhhcC----CCccceeeeEEEe-CCcceEEEeccCCCChhhHH--hhcC-CCCCCCHHHHHHHHHHHHH
Q 038707          358 --EQFINEVVILSQIN----HRNIVKLLGCCLE-TEVPLLVYEFIPNGTLYQYI--HNQI-EEFPITWELLLRIAVEVSG  427 (597)
Q Consensus       358 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qi~~  427 (597)
                        -+|.+|+..+.+++    +.+.+.+=..+.+ ....+|||||++|+.|.++-  .... ....+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              12445555555552    3333444344433 45678999999999998753  2211 11124444444445554  


Q ss_pred             HHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeeccccccccC
Q 038707          428 ALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMV  471 (597)
Q Consensus       428 ~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfgl~~~~~~  471 (597)
                           +..+   ++|+|+||.||+++.++    ++++.|||+...+..
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3467   99999999999999888    999999999877643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=1.4e-10  Score=108.49  Aligned_cols=136  Identities=17%  Similarity=0.144  Sum_probs=100.0

Q ss_pred             CCcccccCceEEEEEEecC-------CcEEEEEEcccc-------------C---------hhhHHHHH----HHHHHHh
Q 038707          322 NRILGQGGQGTVYKGMLTD-------GRIVAVKKSKLV-------------D---------ETNVEQFI----NEVVILS  368 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~-------------~---------~~~~~~~~----~E~~~l~  368 (597)
                      ...||.|--+.||.|...+       +..+|||..+..             +         ......+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543       478999953320             0         11122333    8999999


Q ss_pred             hcCC--CccceeeeEEEeCCcceEEEeccCCCChhh-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecc
Q 038707          369 QINH--RNIVKLLGCCLETEVPLLVYEFIPNGTLYQ-YIHNQIEEFPITWELLLRIAVEVSGALFYL-HSAASIPIYHRD  444 (597)
Q Consensus       369 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~i~H~D  444 (597)
                      ++..  -++++++++    ..-+|||||+.+..+.. .+++    ..++.++...+..+++.+|..| |..+   |+|+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9953  567777764    56789999997654422 2222    1255566778889999999999 8888   99999


Q ss_pred             CCCCCeEeCCCCcEEEeeccccccc
Q 038707          445 IKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       445 ik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |++.|||+++ +.++|+|||.+-..
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999974 58999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=2.4e-10  Score=103.28  Aligned_cols=131  Identities=22%  Similarity=0.274  Sum_probs=101.5

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccc--------cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--------VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..+.+|+-+.+|.+.+. |.++++|.-..        ...-..+.-.+|+.++++++--.|.-.+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999764 44577774221        1112345677899999999765655555566677788899999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +++..|.+++...          ...++..+-.-+.-||..+   |+|+||.++||++.... +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999898754          2456777777888899999   99999999999998774 99999999964

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=6.2e-10  Score=100.00  Aligned_cols=143  Identities=22%  Similarity=0.260  Sum_probs=108.6

Q ss_pred             cCCcccccCceEEEEEEecCCcEEEEEEccc--------cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--------VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       321 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ...+|-||+-+.|+++.+ .|+..+||.-..        ...-...+.++|++.|.++.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456889999999999988 477878874321        11223556789999999987655555555566777778999


Q ss_pred             eccCC-CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEeecccccc
Q 038707          393 EFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRS  468 (597)
Q Consensus       393 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfgl~~~  468 (597)
                      ||+++ .++.+++....... ........+++.|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 48889988754432 233333789999999999999999   99999999999996544   458999999854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.15  E-value=7.1e-10  Score=113.91  Aligned_cols=169  Identities=23%  Similarity=0.355  Sum_probs=130.2

Q ss_pred             CceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEE----eCCcceEEEeccCC-CChhh
Q 038707          329 GQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL----ETEVPLLVYEFIPN-GTLYQ  402 (597)
Q Consensus       329 ~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~  402 (597)
                      --.+.|++... +|..+++|++.............-++..+++.|.|||++.+++.    .+..++|||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34678999865 89999999985433344444556678899999999999999887    34467899999985 57777


Q ss_pred             HHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          403 YIHNQIE------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       403 ~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      +.-....            ...+++..+|.++.|+..||.++|+.|   +.-+-|.+.+||++.+-+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6543211            124678999999999999999999999   8899999999999999999999998876654


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCC
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK  518 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~  518 (597)
                      .+..               |.+..   -.+-|.-.||.+++.|.+|..
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            4331               11111   126788899999999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=4e-10  Score=109.08  Aligned_cols=142  Identities=19%  Similarity=0.225  Sum_probs=110.9

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCC--CccceeeeEEEeCC---cceEEEeccC
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE-TNVEQFINEVVILSQINH--RNIVKLLGCCLETE---VPLLVYEFIP  396 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  396 (597)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+.+  .++++++.+..+..   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999998764322 235678899999999976  44677777766543   5689999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA----------------------------------------  436 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------  436 (597)
                      +.++.+.+..    ..++..+...++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776532    23677788888889999999888631                                        


Q ss_pred             -------------CCCeEeccCCCCCeEeCC--CCcEEEeecccccc
Q 038707          437 -------------SIPIYHRDIKSANILLDD--KYRAKVSDFGTSRS  468 (597)
Q Consensus       437 -------------~~~i~H~Dik~~NIll~~--~~~~kl~Dfgl~~~  468 (597)
                                   ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         134799999999999998  66789999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=2.9e-11  Score=126.84  Aligned_cols=261  Identities=19%  Similarity=0.200  Sum_probs=184.2

Q ss_pred             ccccCHHH-HHHHhcCCccCCcccccCceEEEEEEec--CCcEEEEEEccccChhhH--HHHHHHHHHHhhc-CCCccce
Q 038707          304 TKLFTSKD-LEKATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLVDETNV--EQFINEVVILSQI-NHRNIVK  377 (597)
Q Consensus       304 ~~~~~~~~-~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~  377 (597)
                      .+++..++ ......+|..+..||.|.|+.|++...+  ++..+++|.+........  ..-..|+.+...+ .|.+++.
T Consensus       251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence            34555555 4445677999999999999999988754  577889987654333222  2335677777777 4899999


Q ss_pred             eeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-C
Q 038707          378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-Y  456 (597)
Q Consensus       378 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~  456 (597)
                      ....+...+..++-.||++++++...+.-   ...+.+..++++..|++.++.++|+..   ++|+|+||+||++..+ +
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~  404 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGF  404 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchh
Confidence            88888888888899999999988776632   223788889999999999999999988   9999999999999876 7


Q ss_pred             cEEEeeccccccccCCCceeeeccccccccc--CccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV--DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      ..++.|||.+..+....   .. ....-+++  +|+......+-.+.|++|||.-+.+.+++..--..     ...    
T Consensus       405 ~~~~~~~~~~t~~~~~~---~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~~----  471 (524)
T KOG0601|consen  405 FSKLGDFGCWTRLAFSS---GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GVQ----  471 (524)
T ss_pred             hhhccccccccccceec---cc-ccccccccccchhhccccccccccccccccccccccccCcccCcc-----ccc----
Confidence            88999999886422111   11 11222344  55556667889999999999999999987743111     000    


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                       ...++.+..         ...+. ....+..+.+.++..++..||.+.++....+-.++
T Consensus       472 -~~~i~~~~~---------p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  472 -SLTIRSGDT---------PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             -ceeeecccc---------cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence             001111111         11111 12557788899999999999999988877665554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.02  E-value=5.8e-11  Score=130.82  Aligned_cols=250  Identities=23%  Similarity=0.271  Sum_probs=171.9

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ...+.+.+.+-+-.|.++.++.+.-. .|...++|......   ..+.+..+.+-.++-..+||-++...--+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34566777888999999999987743 34444444333221   222233333333333344565555544455667889


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |+++|..+++|...|+...   ..+.+........+.++++|||+..   +.|+|++|.|+|+..++..+++||+.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999999998643   3566666677788899999999987   899999999999999999999999832221


Q ss_pred             c-C----CC-------------------------ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCC
Q 038707          470 M-V----DQ-------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP  519 (597)
Q Consensus       470 ~-~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p  519 (597)
                      . .    +.                         ........+|+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            1 0    00                         0011224589999999999999999999999999999999999999


Q ss_pred             CCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038707          520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK  583 (597)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  583 (597)
                      |.....+..      | +.+-.+.+.       ..........+..+++...+..+|.+|..+.
T Consensus      1035 ~na~tpq~~------f-~ni~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI------F-ENILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhh------h-hccccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            986554431      1 111111110       1112334455677899999999999997665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=4.1e-09  Score=105.76  Aligned_cols=266  Identities=18%  Similarity=0.183  Sum_probs=161.8

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEE-------EeCCcceEEE
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC-------LETEVPLLVY  392 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-------~~~~~~~lv~  392 (597)
                      ...+.||+|+.+.+|-.-.- +..| -|+...-......+...  ++.+.-.||-+-.-+.+=       ......-+.|
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk~a--~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQKVA--ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecchh-hchh-heeecCCCchHHHHHHH--HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34578999999999954311 1122 23322211222222111  122222455433211110       1122356778


Q ss_pred             eccCCC-ChhhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          393 EFIPNG-TLYQYIHNQIE---EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       393 e~~~~g-sL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ..+++. .+..++.-..+   -....|+..++++++++.+.+.||.+|   .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            877654 23333332211   234789999999999999999999999   88999999999999999999999654333


Q ss_pred             ccCCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhC-CCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      .  ..........|...|++||.-.     +..-+...|.|.||+++++||.| ++||.+.....+....  ....+..+
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--~E~~Ia~g  242 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--LETDIAHG  242 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--chhhhhcc
Confidence            2  2333344456889999999754     34567899999999999999995 9999886543221110  00111111


Q ss_pred             chhhhhhHH------hhhhhhHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhhhhhhc
Q 038707          543 RLFEALDAR------VLKEAKKEEIMTVATLAKRCLNL--NGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       543 ~~~~~l~~~------~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .....-+.+      .......-.+..+.-|..+|+..  ++.-|||++.++..|..+++++
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            111111110      01111233445677777788743  3568999999999999999876

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=4.5e-09  Score=98.08  Aligned_cols=126  Identities=25%  Similarity=0.265  Sum_probs=84.2

Q ss_pred             EEEEEEecCCcEEEEEEcccc--------------C------------hhhHHHHHHHHHHHhhcCCC--ccceeeeEEE
Q 038707          332 TVYKGMLTDGRIVAVKKSKLV--------------D------------ETNVEQFINEVVILSQINHR--NIVKLLGCCL  383 (597)
Q Consensus       332 ~Vy~~~~~~~~~vaiK~~~~~--------------~------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  383 (597)
                      .||.|...+|..+|||..+..              .            ........+|.+.|.++..-  ++++++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            389999888999999954321              0            01134567899999999765  56777754  


Q ss_pred             eCCcceEEEeccC--CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          384 ETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY-LHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       384 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                        ..-.|||||++  +..+..+....     ++.+....++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24579999998  55554433321     2234456677788885555 57888   9999999999999988 9999


Q ss_pred             eecccccccc
Q 038707          461 SDFGTSRSVM  470 (597)
Q Consensus       461 ~Dfgl~~~~~  470 (597)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=5.1e-08  Score=96.51  Aligned_cols=134  Identities=16%  Similarity=0.102  Sum_probs=97.6

Q ss_pred             ceEEEEEEecCCcEEEEEEccccChh-----------hHHHHHHHHHHHhhcCCC--ccceeeeEEEeC-----CcceEE
Q 038707          330 QGTVYKGMLTDGRIVAVKKSKLVDET-----------NVEQFINEVVILSQINHR--NIVKLLGCCLET-----EVPLLV  391 (597)
Q Consensus       330 ~g~Vy~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~-----~~~~lv  391 (597)
                      ...|.+..+ +|+.+.||+.....-.           ....+.+|...+.++...  ..++++++....     ..-+||
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            344666655 5778999965432211           112477899999888533  344556665432     346799


Q ss_pred             EeccCCC-ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-------CCcEEEeec
Q 038707          392 YEFIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-------KYRAKVSDF  463 (597)
Q Consensus       392 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-------~~~~kl~Df  463 (597)
                      +|++++. +|.+++.... ..+.+......++.+++..+.-||..+   |+|+|++++|||++.       +..+.|+||
T Consensus       114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999886 8999986432 123566778899999999999999999   999999999999975       468999999


Q ss_pred             ccccc
Q 038707          464 GTSRS  468 (597)
Q Consensus       464 gl~~~  468 (597)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=8.9e-08  Score=91.92  Aligned_cols=135  Identities=21%  Similarity=0.207  Sum_probs=98.7

Q ss_pred             CccCCcccccCceEEEEEEecCCcEEEEEEccccC----------------------hhhHHHHHHHHHHHhhcCCC--c
Q 038707          319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD----------------------ETNVEQFINEVVILSQINHR--N  374 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  374 (597)
                      ..+..+||-|--+.||.|....|.++|||..+...                      ........+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45668999999999999999999999999543210                      11234567899999999755  6


Q ss_pred             cceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC
Q 038707          375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD  454 (597)
Q Consensus       375 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~  454 (597)
                      +++.+++    +.-.+|||++++-.|...-        ++.+....++..|++-+..+-..|   ++|+|+++-|||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7776643    5557999999886654432        223334445555555555555677   999999999999999


Q ss_pred             CCcEEEeecccccc
Q 038707          455 KYRAKVSDFGTSRS  468 (597)
Q Consensus       455 ~~~~kl~Dfgl~~~  468 (597)
                      +|.+.++||-.+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999965543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=5.1e-09  Score=111.60  Aligned_cols=151  Identities=23%  Similarity=0.280  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee--------eecccccccccCccccc
Q 038707          422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL--------TTKVQGTFGYVDPEYFQ  493 (597)
Q Consensus       422 ~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~  493 (597)
                      +.+++.||.|+|...+  +||++|.|++|.++.++..||..|+.+..........        ....+....|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3456699999998764  9999999999999999999999999876544321111        11123566899999999


Q ss_pred             cCCCCcccceeehHHHHHHHHhCCCCC-CCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhc
Q 038707          494 SSQFTEKSDVYSFGVVLVEILTGQKPI-RAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCL  572 (597)
Q Consensus       494 ~~~~~~~sDv~SlG~il~ell~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl  572 (597)
                      ....+.++|+||||+++|-+..|..+. ..........    + .        ...+..-........++++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~-~--------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----F-S--------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh----h-h--------hcccccccccccccCcHHHHHHHHHHh
Confidence            988999999999999999999655443 3221111100    0 0        001111111223556677888899999


Q ss_pred             ccCCCCCCCHHHHHH
Q 038707          573 NLNGKMRPTMKEVTN  587 (597)
Q Consensus       573 ~~~p~~RPt~~evl~  587 (597)
                      ..++.-||++.+++.
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=4e-07  Score=87.10  Aligned_cols=108  Identities=19%  Similarity=0.202  Sum_probs=86.4

Q ss_pred             hHHHHHHHHHHHhhcCC--CccceeeeEEEeCC----cceEEEeccCCC-ChhhHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 038707          356 NVEQFINEVVILSQINH--RNIVKLLGCCLETE----VPLLVYEFIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGA  428 (597)
Q Consensus       356 ~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~  428 (597)
                      ......+|...+..|..  -..++.+++.....    ..+||+|++++. +|.+++.....   ++......++.++++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL  130 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence            34567888888888853  44566777766543    347999999874 79999876322   5667788999999999


Q ss_pred             HHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEeeccccccc
Q 038707          429 LFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRSV  469 (597)
Q Consensus       429 L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfgl~~~~  469 (597)
                      +.-||..+   |+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999   99999999999998887   8999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=3.9e-06  Score=78.96  Aligned_cols=139  Identities=17%  Similarity=0.114  Sum_probs=103.3

Q ss_pred             ccccCceEEEEEEecCCcEEEEEEccc------cChhhHHHHHHHHHHHhhcCC--CccceeeeEEEeCC----cceEEE
Q 038707          325 LGQGGQGTVYKGMLTDGRIVAVKKSKL------VDETNVEQFINEVVILSQINH--RNIVKLLGCCLETE----VPLLVY  392 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~~~~~vaiK~~~~------~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~  392 (597)
                      -|+||.+.|++..+. |..+-+|+...      ..+.....|.+|+..|.+|..  -.+++++..-....    .-+||.
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            366899999997764 44688887541      113356789999999999953  33555552222221    357999


Q ss_pred             eccCC-CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc--EEEeecccccc
Q 038707          393 EFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGTSRS  468 (597)
Q Consensus       393 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--~kl~Dfgl~~~  468 (597)
                      |-+++ -+|.+++.+.. ..+.+......+..++++.+.-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 58888886542 224677888899999999999999999   999999999999986667  99999986654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2.5e-06  Score=82.76  Aligned_cols=132  Identities=17%  Similarity=0.119  Sum_probs=85.2

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--cceeeeEEEeCCcceEEEeccCCCC-
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFIPNGT-  399 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-  399 (597)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+.+..+.+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47899999999983   25567888876422  3455788999999986433  4677888877778889999998863 


Q ss_pred             hhhHHhhcCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCC
Q 038707          400 LYQYIHNQIEEFPITWELLLRIAVEVSGA---------------------------------------LFYLHSA-ASIP  439 (597)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~---------------------------------------L~~LH~~-~~~~  439 (597)
                      +...+.       .+......++.++++.                                       ..+|... ....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            221111       0001111111111111                                       1222211 2234


Q ss_pred             eEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          440 IYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       440 i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            78999999999999888 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=1.5e-06  Score=93.28  Aligned_cols=185  Identities=19%  Similarity=0.222  Sum_probs=113.2

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChh------------------------------hH----------HHHHH
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET------------------------------NV----------EQFIN  362 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~------------------------------~~----------~~~~~  362 (597)
                      +.|+.++-|.||+|++++|+.||||.....-..                              ..          -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            678999999999999999999999964431110                              01          12455


Q ss_pred             HHHHHhhcC-----CCccceeeeEEE-eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038707          363 EVVILSQIN-----HRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA  436 (597)
Q Consensus       363 E~~~l~~l~-----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  436 (597)
                      |...+.+++     .+++ ++=.++. -.....|+|||++|..+.+...-....  ++.+.+.....++.  +..+-..+
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f--~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAF--LRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHH--HHHHHhcC
Confidence            666666652     2332 2222333 356778999999999998885332221  44333333222221  22222346


Q ss_pred             CCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee---------------ecccccccccCcccc---------
Q 038707          437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT---------------TKVQGTFGYVDPEYF---------  492 (597)
Q Consensus       437 ~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~---------------~~~~gt~~y~aPE~~---------  492 (597)
                         ++|.|.+|.||+++.++++.+.|||+...+........               ....-..+|.+|+.-         
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~r~~l~~~~~a~~~rD~~~v~~~~~~~G~~~~~~~~~~~~~~i~  362 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFRRYLAELLLAFLNRDYDRVAELHVELGYVPPDTDRDPLAAAIR  362 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCHHHHHHHHHHHHHHHhhCHHHHHHHHHHhCCCCCccchHHHHHHHH
Confidence               99999999999999999999999999877643221110               001123467776431         


Q ss_pred             --ccCCCCcccceeehHHHHHHHHh
Q 038707          493 --QSSQFTEKSDVYSFGVVLVEILT  515 (597)
Q Consensus       493 --~~~~~~~~sDv~SlG~il~ell~  515 (597)
                        ....+.....-.|+|-++.++..
T Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~  387 (517)
T COG0661         363 AVLEPIYGKPLEEISFGEILDKLFE  387 (517)
T ss_pred             HHHHhhhCCChhhccHHHHHHHHHH
Confidence              11224455566677777777765

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.35  E-value=4.1e-06  Score=79.05  Aligned_cols=138  Identities=17%  Similarity=0.210  Sum_probs=89.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHH---------HHHHHHHHhhcC---CCccceeeeEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQ---------FINEVVILSQIN---HRNIVKLLGCC  382 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~  382 (597)
                      ..++|...+++-......|.+-.. +|..+++|............         ..+++..+.+++   -..+..++-+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            356777777777776666666554 57889999766533222222         223344444443   23333333332


Q ss_pred             E-----eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          383 L-----ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       383 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                      .     -....+|+|||++|..|.++..       +++    .++..+++++.-||..|   ++|+|.+|.|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            2     2234568999999988876542       222    34566778899999999   9999999999999966 5


Q ss_pred             EEEeecccccc
Q 038707          458 AKVSDFGTSRS  468 (597)
Q Consensus       458 ~kl~Dfgl~~~  468 (597)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999986643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.24  E-value=1.4e-05  Score=78.62  Aligned_cols=139  Identities=14%  Similarity=0.092  Sum_probs=85.7

Q ss_pred             ccccCc-eEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccCCCChhh
Q 038707          325 LGQGGQ-GTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ  402 (597)
Q Consensus       325 lg~G~~-g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  402 (597)
                      |-.|.. ..||+.... +..+.||+.....   ..++.+|+++++.+. +--+++++++....+..++|||+++|.+|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444544 789998764 4788888876433   345678999888884 4456678888777777899999999987764


Q ss_pred             HHh-------------------hcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 038707          403 YIH-------------------NQIE-EFPITW--ELLLRIAV--------------------EVSGALFYLHS----AA  436 (597)
Q Consensus       403 ~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qi~~~L~~LH~----~~  436 (597)
                      ...                   .... ..+...  ........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            421                   1000 001110  00000000                    01111222211    12


Q ss_pred             CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 ~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            2448999999999999998778999998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.21  E-value=1.6e-05  Score=76.00  Aligned_cols=150  Identities=21%  Similarity=0.232  Sum_probs=100.6

Q ss_pred             HHHHHHHhcCCccCC---cccccCceEEEEEEecCCcEEEEEEccccChh-------------------h-----HHHHH
Q 038707          309 SKDLEKATDNYNANR---ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET-------------------N-----VEQFI  361 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~---~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-------------------~-----~~~~~  361 (597)
                      .+.+.....+..+..   .|..|--+.||+|...++..+|+|+.+.....                   .     .....
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            344455555554444   46678888999999888999999975432110                   0     11235


Q ss_pred             HHHHHHhhcC--CCccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCC
Q 038707          362 NEVVILSQIN--HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASI  438 (597)
Q Consensus       362 ~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~  438 (597)
                      .|+..|+++.  +-.+++-+.+.    .-.|||||+...-+   -.-..+..++..++...+..++++.+.-|-. .+  
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence            6777787774  45555555443    34699999975311   0001112234455677788888889988887 56  


Q ss_pred             CeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       439 ~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                       ++|+||+.=|||+. ++.+.|+||+.|...
T Consensus       188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             -cccccchhhheEEE-CCeEEEEECcccccc
Confidence             99999999999999 779999999988554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.20  E-value=2.2e-07  Score=98.27  Aligned_cols=186  Identities=18%  Similarity=0.128  Sum_probs=134.9

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-cceeeeEEEeCCcceEEEeccC
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      -+...+-++++++++++|.+....+....+.+...     ....-++++|.+++||| .+..++-+..++..++++++..
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            34444567889999999987544343345544322     55667899999999999 7777777777788899999998


Q ss_pred             CC-ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          397 NG-TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       397 ~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      .+ +...-...  ....+...+...+.+.-+++|++||+..   -+|+|    ||+..+ +..|..||+....+....  
T Consensus       318 ~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  318 TGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence            76 22221111  1112445566677778889999999875   57888    777766 588999999887664332  


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCC
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI  520 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~  520 (597)
                      ......+++.++|||+...+.+..+.|+|++++-..++--|-+|-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            344566899999999999999999999999998777777777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.18  E-value=8.7e-06  Score=79.16  Aligned_cols=142  Identities=23%  Similarity=0.253  Sum_probs=83.9

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ccceeeeEEEeC---CcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLLGCCLET---EVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~  397 (597)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+++++......   ...+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578899999999999876 69999986643  4567788899999888533  356777654333   346899999999


Q ss_pred             CChhh----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 038707          398 GTLYQ----------------YIH---NQ-IEEFPITWEL---------LLRI------------AVEVSG-ALFYLHS-  434 (597)
Q Consensus       398 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~-  434 (597)
                      .++..                .+.   .. ....+.....         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                111   11 0000011000         0000            111222 2333332 


Q ss_pred             ---CCCCCeEeccCCCCCeEeC-CCCcEEEeeccccc
Q 038707          435 ---AASIPIYHRDIKSANILLD-DKYRAKVSDFGTSR  467 (597)
Q Consensus       435 ---~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~  467 (597)
                         .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1334499999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.14  E-value=1e-05  Score=75.78  Aligned_cols=104  Identities=25%  Similarity=0.330  Sum_probs=82.3

Q ss_pred             HHHHHHHhhcCC-CccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 038707          361 INEVVILSQINH-RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP  439 (597)
Q Consensus       361 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  439 (597)
                      .+|..+++.+.+ +++++++|.|-    .++|.||.+.+++......-..-...+|..+.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 79999999993    3789999987766432100001123789999999999999999999865555


Q ss_pred             eEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          440 IYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       440 i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +.-.|++++|+-+++++++|++|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99999999999999999999999986643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=4.8e-05  Score=88.02  Aligned_cols=79  Identities=13%  Similarity=0.283  Sum_probs=57.8

Q ss_pred             CCcccccCceEEEEEEecCC---cEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCcc--ceeeeEEEeC---CcceEE
Q 038707          322 NRILGQGGQGTVYKGMLTDG---RIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNI--VKLLGCCLET---EVPLLV  391 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  391 (597)
                      .+.|+.|....+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  ++++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45788899999999876553   467788764322 123457889999999995 6664  7888887664   467999


Q ss_pred             EeccCCCCh
Q 038707          392 YEFIPNGTL  400 (597)
Q Consensus       392 ~e~~~~gsL  400 (597)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.03  E-value=0.00012  Score=69.12  Aligned_cols=128  Identities=23%  Similarity=0.271  Sum_probs=89.9

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccC----------------hhhHHHHHHHHHHHhhcC------CCccceee
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD----------------ETNVEQFINEVVILSQIN------HRNIVKLL  379 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  379 (597)
                      ...||+|+.-.||.  +.+.....||+.....                .....+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999995  4445556777765443                223455666666665555      88999999


Q ss_pred             eEEEeCCcceEEEeccCC------CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          380 GCCLETEVPLLVYEFIPN------GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       380 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      |...++..+-+|+|.+.+      -||.+++.+..    ++. ...+.   +-+-..||-.++   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998763      36888885432    554 33333   344456677777   99999999999995


Q ss_pred             CCC----cEEEee
Q 038707          454 DKY----RAKVSD  462 (597)
Q Consensus       454 ~~~----~~kl~D  462 (597)
                      .+.    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332    567777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=4.1e-05  Score=82.09  Aligned_cols=140  Identities=17%  Similarity=0.125  Sum_probs=89.4

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhh-------------------------------------HHHHHHHHH
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN-------------------------------------VEQFINEVV  365 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~-------------------------------------~~~~~~E~~  365 (597)
                      +.|+..+.|.||+|++++|+.||||.-+..-+..                                     .-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999644321110                                     012445555


Q ss_pred             HHhhc----CCCc------cceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038707          366 ILSQI----NHRN------IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA  435 (597)
Q Consensus       366 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  435 (597)
                      ...+.    .|-+      |++++-.  -.....|+|||++|..+.|.-.-...  .++...+..-+.+...-+  |-..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--If~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--IFKT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--HHhc
Confidence            44443    3444      3333321  24467899999999877765332111  255554444443332222  2223


Q ss_pred             CCCCeEeccCCCCCeEeCC----CCcEEEeeccccccccC
Q 038707          436 ASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       436 ~~~~i~H~Dik~~NIll~~----~~~~kl~Dfgl~~~~~~  471 (597)
                      |   ++|.|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            5   999999999999984    67899999999876643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00013  Score=66.05  Aligned_cols=128  Identities=17%  Similarity=0.226  Sum_probs=87.8

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccc-eeeeEEEeCCcceEEEeccCCC
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      ++.+.|++|.+|.||++.+. |..+|+|.-..  +.....+..|+++|..+.-.++- +++.+-    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            34578999999999999986 55888887653  44456788999999999866654 344442    234559999887


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCCeEeCCCCcEEEeeccccc
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK-SANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik-~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .|.+.-...      +.    +-...++++---|...+   |-|+.|. |..++|..+..+.|+||..|+
T Consensus        98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            887765421      12    22334455544555667   8899887 444444444499999999886

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00032  Score=71.10  Aligned_cols=76  Identities=9%  Similarity=0.043  Sum_probs=56.7

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC---CccceeeeEEEeC---CcceEEEecc
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH---RNIVKLLGCCLET---EVPLLVYEFI  395 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~  395 (597)
                      .+.||.|..+.||+....+++ +.+|..+.  ......+..|...|+.|.-   ..++++++.+.+.   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            457999999999998765554 66676432  1133578899999998853   4688899887643   5689999999


Q ss_pred             CCCCh
Q 038707          396 PNGTL  400 (597)
Q Consensus       396 ~~gsL  400 (597)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.82  E-value=0.00015  Score=70.91  Aligned_cols=73  Identities=18%  Similarity=0.225  Sum_probs=46.3

Q ss_pred             CcccccCce-EEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC---ccceeeeEEEeC---CcceEEEecc
Q 038707          323 RILGQGGQG-TVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR---NIVKLLGCCLET---EVPLLVYEFI  395 (597)
Q Consensus       323 ~~lg~G~~g-~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  395 (597)
                      +.|+.|+.. .||+.    +..+++|....  ......+.+|.+++..+...   -+.++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766665 48875    23467776543  22345788999999888532   345555443332   2458899999


Q ss_pred             CCCChh
Q 038707          396 PNGTLY  401 (597)
Q Consensus       396 ~~gsL~  401 (597)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.74  E-value=0.0002  Score=71.02  Aligned_cols=138  Identities=14%  Similarity=0.132  Sum_probs=77.9

Q ss_pred             cccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEeccCCCChhh
Q 038707          324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNGTLYQ  402 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  402 (597)
                      .+..|-...+|+.. .+++.+++|..............+|..+++.+....+ .+++...    ..++||||++|.++..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            34567778899887 3567788887543222211235678888888864333 4444443    2479999999876542


Q ss_pred             H-----------------HhhcC-CCCCCCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCCeEeccCCCCC
Q 038707          403 Y-----------------IHNQI-EEFPITWEL-LLRIAVE---------VSGALFYLHSA-----ASIPIYHRDIKSAN  449 (597)
Q Consensus       403 ~-----------------l~~~~-~~~~l~~~~-~~~i~~q---------i~~~L~~LH~~-----~~~~i~H~Dik~~N  449 (597)
                      .                 ||... ...+++... +..+..+         +...+..+...     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 011122221 1111111         11222222221     12348999999999


Q ss_pred             eEeCCCCcEEEeeccccc
Q 038707          450 ILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~  467 (597)
                      |++++++ +.|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.73  E-value=0.00034  Score=68.28  Aligned_cols=74  Identities=23%  Similarity=0.196  Sum_probs=47.9

Q ss_pred             CcccccCceEEEEEEecC--CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-cceeeeEEEeCCcceEEEeccCCCC
Q 038707          323 RILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gs  399 (597)
                      +.|..|-...+|+....+  ++.+++|........ .....+|+.+++.+...+ .++++....    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999988654  678889976532221 123346888888885433 444544332    248999999877


Q ss_pred             hh
Q 038707          400 LY  401 (597)
Q Consensus       400 L~  401 (597)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.00051  Score=71.78  Aligned_cols=75  Identities=20%  Similarity=0.244  Sum_probs=55.6

Q ss_pred             CcccccCceEEEEEEecCC-cEEEEEEcccc-----C--hhhHHHHHHHHHHHhhcC---CCccceeeeEEEeCCcceEE
Q 038707          323 RILGQGGQGTVYKGMLTDG-RIVAVKKSKLV-----D--ETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  391 (597)
                      +.||.|.+..||++...+| +.++||.....     .  +...+++..|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4789999999999998876 58999974421     1  234567788888888863   3467778776  44667899


Q ss_pred             EeccCCCC
Q 038707          392 YEFIPNGT  399 (597)
Q Consensus       392 ~e~~~~gs  399 (597)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.57  E-value=0.0008  Score=62.98  Aligned_cols=125  Identities=30%  Similarity=0.473  Sum_probs=89.3

Q ss_pred             cCCccCCcccccCc-eEEEEEEecCCcEEEEEEccc---cCh------------------hhHHHHHHHHHHHhhcC---
Q 038707          317 DNYNANRILGQGGQ-GTVYKGMLTDGRIVAVKKSKL---VDE------------------TNVEQFINEVVILSQIN---  371 (597)
Q Consensus       317 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  371 (597)
                      ..++..+.||.|.. |.||++.. +|+.+|||..+.   ...                  .....|..|-+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77899999999999 99999998 477999998221   000                  11235777888777774   


Q ss_pred             CCcc--ceeeeEEEeC-C-----------------cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038707          372 HRNI--VKLLGCCLET-E-----------------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY  431 (597)
Q Consensus       372 h~ni--v~l~~~~~~~-~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~  431 (597)
                      +.++  |+.+|+..=. +                 ...||.||++...            .++.    .-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            5566  8999987422 0                 1247888776532            1222    345567777888


Q ss_pred             HHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       432 LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99999   999999999986     3489999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.48  E-value=0.00039  Score=79.12  Aligned_cols=197  Identities=18%  Similarity=0.192  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHhhcCCCccceeeeEEEeCCcc----eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 038707          358 EQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH  433 (597)
Q Consensus       358 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  433 (597)
                      ....-|+..+.++.|+|++.++.+-.+....    .+.-|++..-++...+...   ..++....+.+..++..||.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHH
Confidence            3344577778888999999999988765432    3445777777887777653   34888999999999999999999


Q ss_pred             hCCCCCeEeccCCCC---CeEeCCCCcEEEe--eccccccccCCCceeeecccccccccCccccccCCCCc--ccceeeh
Q 038707          434 SAASIPIYHRDIKSA---NILLDDKYRAKVS--DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE--KSDVYSF  506 (597)
Q Consensus       434 ~~~~~~i~H~Dik~~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDv~Sl  506 (597)
                      +..   ..|.-+..+   +.-.+..+.+.++  ||+.+.........  ....-+..+.+||......++.  ..|+|.+
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence            986   656555555   5555677777777  99888766533222  1222355678888877665544  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038707          507 GVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       507 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  586 (597)
                      |.++..+..|..+-....      .            ...+++     ....   ..+.+...+|+..++++|++..+++
T Consensus       379 gll~~~~~~~~~i~~~~~------~------------~~~~l~-----~~~~---~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA------V------------PVSLLD-----VLST---SELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCccccccc------c------------hhhhhc-----cccc---hhhhhhhhhhcchhhhhccchhhhh
Confidence            999999998775421100      0            001111     0011   1456788899999999999999988


Q ss_pred             HH
Q 038707          587 NE  588 (597)
Q Consensus       587 ~~  588 (597)
                      ..
T Consensus       433 ~~  434 (1351)
T KOG1035|consen  433 TH  434 (1351)
T ss_pred             hc
Confidence            65

>PRK05231 homoserine kinase; Provisional

Probab=97.40  E-value=0.0043  Score=63.62  Aligned_cols=156  Identities=15%  Similarity=0.200  Sum_probs=82.1

Q ss_pred             CHHHHHHHhcCCcc-----CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ccceeee
Q 038707          308 TSKDLEKATDNYNA-----NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLLG  380 (597)
Q Consensus       308 ~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~  380 (597)
                      +.+++......|.+     .+.|..|....+|+....+| .+++|+.....   .+.+..|+.++..|...  .+++.+.
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~   83 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVA   83 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCccee
Confidence            34444444445544     34566777788999876555 68888765222   23334455555555321  2334332


Q ss_pred             ------EEEeCCcceEEEeccCCCChhh-----------H---HhhcCCCC--------CCCH-HHHHH-----------
Q 038707          381 ------CCLETEVPLLVYEFIPNGTLYQ-----------Y---IHNQIEEF--------PITW-ELLLR-----------  420 (597)
Q Consensus       381 ------~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~~--------~l~~-~~~~~-----------  420 (597)
                            +....+..++++||++|..+..           .   +|......        .+.+ .....           
T Consensus        84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (319)
T PRK05231         84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA  163 (319)
T ss_pred             CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence                  1223556789999998875421           1   11111110        0111 11111           


Q ss_pred             -HH-HHHHHHHHHHHhC----CCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          421 -IA-VEVSGALFYLHSA----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       421 -i~-~qi~~~L~~LH~~----~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                       .. ..+...+..+...    -...++|+|+++.|||++++...-|+||+.+.
T Consensus       164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             11 1111222333211    12349999999999999977556899998774

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.35  E-value=0.0023  Score=65.25  Aligned_cols=156  Identities=18%  Similarity=0.259  Sum_probs=86.6

Q ss_pred             HHHHHHHhcCCcc-----CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ccceeeeE
Q 038707          309 SKDLEKATDNYNA-----NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLLGC  381 (597)
Q Consensus       309 ~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~  381 (597)
                      .+++....++|.+     .+.++.|....+|+....++ .+++|+.....  ..++...|++++..|...  .+++++..
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t   85 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS   85 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence            3445444445544     34567777788998876544 57788754321  123455667777766422  23444432


Q ss_pred             ------EEeCCcceEEEeccCCCChhh--------------HHhhcCCCCC---------CCHHHHH------------H
Q 038707          382 ------CLETEVPLLVYEFIPNGTLYQ--------------YIHNQIEEFP---------ITWELLL------------R  420 (597)
Q Consensus       382 ------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~~---------l~~~~~~------------~  420 (597)
                            ....+..++++||++|..+..              .+|......+         -.|....            .
T Consensus        86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~  165 (307)
T TIGR00938        86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH  165 (307)
T ss_pred             CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence                  122456789999998855421              1121111100         0111100            0


Q ss_pred             HHHHHHHHHHHHHh----CCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          421 IAVEVSGALFYLHS----AASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       421 i~~qi~~~L~~LH~----~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ....+.+.++++..    .-...++|+|+++.||++++++.+.|+||+.+.
T Consensus       166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            11223345555543    122349999999999999988777899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.34  E-value=0.0045  Score=62.68  Aligned_cols=142  Identities=15%  Similarity=0.129  Sum_probs=84.0

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ccceeeeE------EEeCCcceEEEe
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLLGC------CLETEVPLLVYE  393 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  393 (597)
                      .+.|..|....+|+.... +..+++|....   ....++..|+.++..+.+.  .+++++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            345777877899998754 44688888764   2345566788888877432  24454432      123456689999


Q ss_pred             ccCCCChhh----HH----------hhcCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 038707          394 FIPNGTLYQ----YI----------HNQIEE--------FPITWELLL----------RIAVEVSGALFYLHSA----AS  437 (597)
Q Consensus       394 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~qi~~~L~~LH~~----~~  437 (597)
                      |++|..+..    .+          |.....        ....|....          .....+..++.++...    ..
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    11          111100        001111110          1112233445555531    12


Q ss_pred             CCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          438 IPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       438 ~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ..++|+|+.|.|||++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.28  E-value=0.0016  Score=66.33  Aligned_cols=139  Identities=26%  Similarity=0.349  Sum_probs=81.8

Q ss_pred             cccccCceEEEEEEecC-------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-cceeeeEEEeCCcceEEEecc
Q 038707          324 ILGQGGQGTVYKGMLTD-------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .|..|-...+|+....+       ++.+++|...... ....+..+|++++..+.... ..++++.+.    -.+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence            45556667889887654       5788999865432 22345677888888885333 345555543    23689999


Q ss_pred             CCCChhhH-----------------HhhcCCCC--------CCCHHHHHH--------------------------HHHH
Q 038707          396 PNGTLYQY-----------------IHNQIEEF--------PITWELLLR--------------------------IAVE  424 (597)
Q Consensus       396 ~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~q  424 (597)
                      +|.++...                 +|+.....        +.-+..+..                          +..+
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88776431                 11111100        000111111                          1122


Q ss_pred             HHHHHHHHHh------CCCCCeEeccCCCCCeEeCCC----CcEEEeeccccc
Q 038707          425 VSGALFYLHS------AASIPIYHRDIKSANILLDDK----YRAKVSDFGTSR  467 (597)
Q Consensus       425 i~~~L~~LH~------~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfgl~~  467 (597)
                      +...+..|..      .....++|+|+.+.|||++++    +.++|+||..+.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            2233334432      133458999999999999985    789999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.03  E-value=0.004  Score=62.41  Aligned_cols=73  Identities=22%  Similarity=0.251  Sum_probs=48.1

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCccceeeeEEEeCCcceEEEeccCCC
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      .+.|+.|....+|+.. .+++.+.||...   ......|..|+.-|+.|.   --.+++++++....+..+|+|||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            3568888999999877 567889999866   333456777888887773   456889999988888889999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.00  E-value=0.0075  Score=60.37  Aligned_cols=31  Identities=23%  Similarity=0.486  Sum_probs=25.4

Q ss_pred             CCeEeccCCCCCeEeCCCCc-EEEeecccccc
Q 038707          438 IPIYHRDIKSANILLDDKYR-AKVSDFGTSRS  468 (597)
Q Consensus       438 ~~i~H~Dik~~NIll~~~~~-~kl~Dfgl~~~  468 (597)
                      ..++|+|+++.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 56999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.91  E-value=0.01  Score=59.97  Aligned_cols=128  Identities=16%  Similarity=0.218  Sum_probs=81.2

Q ss_pred             EEEEEecCCcEEEEEEcc-ccChhhHHHHHHHHHHHhhcCC--CccceeeeEEEeCC--cceEEEeccCCCChhhHHhhc
Q 038707          333 VYKGMLTDGRIVAVKKSK-LVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETE--VPLLVYEFIPNGTLYQYIHNQ  407 (597)
Q Consensus       333 Vy~~~~~~~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~  407 (597)
                      +|..... ++.+++.+.. ...........+|..+++.+.-  .-+...++++.+..  .++.||+|+++..+.+.+...
T Consensus        41 t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~  119 (321)
T COG3173          41 TFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE  119 (321)
T ss_pred             eEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc
Confidence            4443333 6777777332 2334455667788888888753  34455677777666  779999999885433322211


Q ss_pred             CCCCCCCHHHHHHHH-HHHHHHHHHHHhCC--------------------------------------------------
Q 038707          408 IEEFPITWELLLRIA-VEVSGALFYLHSAA--------------------------------------------------  436 (597)
Q Consensus       408 ~~~~~l~~~~~~~i~-~qi~~~L~~LH~~~--------------------------------------------------  436 (597)
                      .    ..    .+++ ..+++.|.-||+..                                                  
T Consensus       120 ~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~  191 (321)
T COG3173         120 S----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR  191 (321)
T ss_pred             c----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence            0    01    1222 25555555555421                                                  


Q ss_pred             -----CCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          437 -----SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       437 -----~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                           ...++|+|+++.||+++.+.-+=|.||+++...
T Consensus       192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                 246999999999999999888999999998653

>PLN02236 choline kinase

Probab=96.89  E-value=0.0086  Score=62.02  Aligned_cols=139  Identities=21%  Similarity=0.227  Sum_probs=79.0

Q ss_pred             cccccCceEEEEEEecC-----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEeccCC
Q 038707          324 ILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      .|-.|-.-.+|+....+     ++.+++|........... -.+|+.+++.+...++ .++++.+...    .|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            34446667788877532     367888977654332222 3678888888864443 3456655332    58999987


Q ss_pred             CChhhH-----------------HhhcC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 038707          398 GTLYQY-----------------IHNQI-E--EFPITWELLLRIAVEV-----------------SGALFYL----HS-A  435 (597)
Q Consensus       398 gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi-----------------~~~L~~L----H~-~  435 (597)
                      .+|...                 +|+.. .  ..+..+..+.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 11111 0  0012233333333221                 1112222    21 2


Q ss_pred             CCCCeEeccCCCCCeEeCC-CCcEEEeeccccc
Q 038707          436 ASIPIYHRDIKSANILLDD-KYRAKVSDFGTSR  467 (597)
Q Consensus       436 ~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~  467 (597)
                      ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            2335899999999999986 4689999998774

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.82  E-value=0.0019  Score=64.05  Aligned_cols=134  Identities=17%  Similarity=0.190  Sum_probs=93.2

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHhhcCC--C
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE----------------------TNVEQFINEVVILSQINH--R  373 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h--~  373 (597)
                      -+.+.++||-|.-+-||.+...+|++.++|...+...                      -..-...+|+..|+.|.-  =
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3677889999999999999999999999995332100                      012234578888888842  2


Q ss_pred             ccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       374 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      -+++.++    .+.-++|||++.+-.|...-+-      .+...   +...+..-+--|-.+|   +||+|..-=||+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            2444443    3455789999988777654321      22222   3333444455677788   99999999999999


Q ss_pred             CCCcEEEeeccccc
Q 038707          454 DKYRAKVSDFGTSR  467 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~  467 (597)
                      ++..++++||-..-
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999996543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.014  Score=59.92  Aligned_cols=79  Identities=16%  Similarity=0.162  Sum_probs=52.2

Q ss_pred             cccccCceEEEEEEecCC-cEEEEEEccc-------cChhhHHHHHHHHHHHhhcC--CC-ccceeeeEEEeCCcceEEE
Q 038707          324 ILGQGGQGTVYKGMLTDG-RIVAVKKSKL-------VDETNVEQFINEVVILSQIN--HR-NIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  392 (597)
                      .||.|....||++...+| +.|+||....       .-+...++..-|...|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578899999999998654 6899996332       12344566677888887763  24 45555543  555667999


Q ss_pred             eccCCC-ChhhHH
Q 038707          393 EFIPNG-TLYQYI  404 (597)
Q Consensus       393 e~~~~g-sL~~~l  404 (597)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999653 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.75  E-value=0.019  Score=59.97  Aligned_cols=80  Identities=14%  Similarity=0.151  Sum_probs=53.3

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccc----cCh---hhHHHHHHHHHHHhhcC---CCccceeeeEEEeCCcceEE
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKL----VDE---TNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  391 (597)
                      .+.||.|....||+.... +..++||+...    ...   -...+-..|...|+.+.   ..++++++.++.  +.-+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998864 55699997552    111   23444555667676653   357888888776  556789


Q ss_pred             EeccCC--CChhhHH
Q 038707          392 YEFIPN--GTLYQYI  404 (597)
Q Consensus       392 ~e~~~~--gsL~~~l  404 (597)
                      ||++++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  3454444

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.63  E-value=0.023  Score=59.10  Aligned_cols=81  Identities=15%  Similarity=0.085  Sum_probs=54.2

Q ss_pred             CCcccccCceEEEEEEecC-CcEEEEEEccc------cChhhHHHHHHHHHHHhhcC--CC-ccceeeeEEEeCCcceEE
Q 038707          322 NRILGQGGQGTVYKGMLTD-GRIVAVKKSKL------VDETNVEQFINEVVILSQIN--HR-NIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv  391 (597)
                      .+.||-|.-..||++.+.+ ++.|+||....      .-+-..++..-|.+.|+...  -| .+++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999999853 67899996332      12345677777888888774  24 45556643  55566789


Q ss_pred             EeccCCC-ChhhHH
Q 038707          392 YEFIPNG-TLYQYI  404 (597)
Q Consensus       392 ~e~~~~g-sL~~~l  404 (597)
                      ||+++.. .|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998643 244443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.62  E-value=0.00014  Score=84.24  Aligned_cols=161  Identities=14%  Similarity=0.015  Sum_probs=117.1

Q ss_pred             HHHHHHHHHhhcCCCccceeeeEEE--eCCcceEEEeccCCCChhhHHhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 038707          359 QFINEVVILSQINHRNIVKLLGCCL--ETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSA  435 (597)
Q Consensus       359 ~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~  435 (597)
                      -...|..-++...|+++.....-..  ++...+..++|+..|.+.+.|-+..++. ++....+...-.+...+..-+|+.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            3445555666678988776554443  3346688999999999999998765443 344444444444435666665554


Q ss_pred             C--CCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHH
Q 038707          436 A--SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI  513 (597)
Q Consensus       436 ~--~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~el  513 (597)
                      .  ....+|+++|+.|.+|..+.++|+.++|+.+.. ...........+++.|+.|++...-.++.++|+|..|+.+|++
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            3  234789999999999999999999999999832 2233334445578889999999888899999999999999999


Q ss_pred             HhCCCCC
Q 038707          514 LTGQKPI  520 (597)
Q Consensus       514 l~g~~p~  520 (597)
                      -.|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8888775

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.40  E-value=0.029  Score=56.93  Aligned_cols=142  Identities=19%  Similarity=0.211  Sum_probs=94.8

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEcccc-----Chh--------------------h-HHHHHHHHHHHhhcCCC
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV-----DET--------------------N-VEQFINEVVILSQINHR  373 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~-----~~~--------------------~-~~~~~~E~~~l~~l~h~  373 (597)
                      ++...|..|--+.||.+.-.+|..+|||+.+..     +.+                    - ....-.|+.-|.+|+..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            344578899999999999999999999964421     000                    0 11234577777777654


Q ss_pred             ccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       374 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      .|.-.--....  .-.|||+|+....   +-.-..+..+++...+..+-.|++.-+.-|.+...  +||.||.-=|+|+.
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence            43322111111  2258999996321   11111223457777888888899999988887763  99999999999996


Q ss_pred             CCCcEEEeeccccccc
Q 038707          454 DKYRAKVSDFGTSRSV  469 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~  469 (597)
                      +. .+.|+|-+.+-..
T Consensus       300 dG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DG-KLYIIDVSQSVEH  314 (520)
T ss_pred             CC-EEEEEEccccccC
Confidence            65 8999998876543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.09  E-value=0.0075  Score=63.42  Aligned_cols=50  Identities=16%  Similarity=0.226  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHHhhcCCCccceeeeEEEeCC-cceEEEeccCCCChhhHHhhc
Q 038707          357 VEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQ  407 (597)
Q Consensus       357 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~  407 (597)
                      ..++.....+++.+.|+|+.+.+.+..... ...+|+|++ +.+|.+++..+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            456777889999999999999998876543 467889998 67999998764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.02  E-value=0.16  Score=51.68  Aligned_cols=28  Identities=36%  Similarity=0.438  Sum_probs=24.5

Q ss_pred             CeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          439 PIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       439 ~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4899999999999988 578999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.95  E-value=0.013  Score=56.16  Aligned_cols=30  Identities=27%  Similarity=0.433  Sum_probs=21.2

Q ss_pred             CeEeccCCCCCeEe-CCCCcEEEeecccccc
Q 038707          439 PIYHRDIKSANILL-DDKYRAKVSDFGTSRS  468 (597)
Q Consensus       439 ~i~H~Dik~~NIll-~~~~~~kl~Dfgl~~~  468 (597)
                      .+.|+|+.+.|||+ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999987743

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.78  E-value=0.12  Score=52.56  Aligned_cols=30  Identities=13%  Similarity=0.241  Sum_probs=27.1

Q ss_pred             CeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          439 PIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       439 ~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      .++|+|+.++|||+++++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999999999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.73  E-value=0.083  Score=54.40  Aligned_cols=139  Identities=18%  Similarity=0.222  Sum_probs=76.1

Q ss_pred             cccccCceEEEEEEecC----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEeccCCC
Q 038707          324 ILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      .|..|=.-.+|+....+    +..+++|....... ..-.-.+|..+++.+..-++ +++++++. ..   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            34446666788876543    23788887654322 22233578888888865554 35565552 22   589999776


Q ss_pred             Chhh-------HH----------hhcC-C--CCCCCHHHHHHHHHHH----------------------HHHHHH----H
Q 038707          399 TLYQ-------YI----------HNQI-E--EFPITWELLLRIAVEV----------------------SGALFY----L  432 (597)
Q Consensus       399 sL~~-------~l----------~~~~-~--~~~l~~~~~~~i~~qi----------------------~~~L~~----L  432 (597)
                      +|..       .+          |... .  ..+-.+..+.++..++                      .+-+..    +
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            6532       11          1110 0  0011223332222221                      111111    1


Q ss_pred             HhCC-CCCeEeccCCCCCeEeCC-CCcEEEeeccccc
Q 038707          433 HSAA-SIPIYHRDIKSANILLDD-KYRAKVSDFGTSR  467 (597)
Q Consensus       433 H~~~-~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~  467 (597)
                      ...+ ...++|+|+.+.|||+++ ++.++++||..+.
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            1111 223799999999999975 5689999998774

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.61  E-value=0.044  Score=51.71  Aligned_cols=149  Identities=17%  Similarity=0.157  Sum_probs=87.3

Q ss_pred             CceEEEEEEecCCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCChhhHHhhc
Q 038707          329 GQGTVYKGMLTDGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ  407 (597)
Q Consensus       329 ~~g~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  407 (597)
                      +..+.-++.-+-| +..+|++...+-. ...-|.++..+++++.  .|++|..-  +.-..-++.|++-.-..       
T Consensus        74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence            3444444443222 3455665544444 4566788999998874  46666522  23345688898732110       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeeccccccccc
Q 038707          408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV  487 (597)
Q Consensus       408 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~  487 (597)
                           +    -..++..=+.+|.-.|+... ..+|+|-.|+||+-|..|.+||.|-+..-.-   .          ..|.
T Consensus       142 -----~----~~N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~---~----------V~~v  198 (308)
T PF07387_consen  142 -----N----FSNFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN---Q----------VNMV  198 (308)
T ss_pred             -----c----hhHHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh---e----------eeEE
Confidence                 1    01122222467788886543 3999999999999999999999997644211   1          1111


Q ss_pred             CccccccCCCCcccceeehHHHHHHHHh
Q 038707          488 DPEYFQSSQFTEKSDVYSFGVVLVEILT  515 (597)
Q Consensus       488 aPE~~~~~~~~~~sDv~SlG~il~ell~  515 (597)
                      --   .....+.++.+-+|=.-++++..
T Consensus       199 N~---~Y~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  199 NI---EYESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             ee---eccccChHHHHHHHHHHHHHHHH
Confidence            11   12345667777777666666665

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.57  E-value=0.035  Score=56.23  Aligned_cols=74  Identities=24%  Similarity=0.187  Sum_probs=57.5

Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      ....|++|++. +++|. .+.      ...++++..++.+-+..++-+...-  ++=|||+...||||+ +|++.|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is-~ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-IIK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceee-eee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            34556777765 44442 222      2568899999999988888887765  588999999999999 9999999999


Q ss_pred             ccccc
Q 038707          465 TSRSV  469 (597)
Q Consensus       465 l~~~~  469 (597)
                      +++.-
T Consensus       367 lsRl~  371 (488)
T COG5072         367 LSRLS  371 (488)
T ss_pred             eeecc
Confidence            99854

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.01  E-value=0.6  Score=47.78  Aligned_cols=140  Identities=21%  Similarity=0.316  Sum_probs=81.2

Q ss_pred             cccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCc---cceeeeEEE--eC--CcceEEEe
Q 038707          324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRN---IVKLLGCCL--ET--EVPLLVYE  393 (597)
Q Consensus       324 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~~~~--~~--~~~~lv~e  393 (597)
                      .|.+ .-..+|+....+|+. ++|.....  ....++..|+..|..|.   .+=   +..+=|-..  -.  ...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556689888877777 88887654  34456667777777773   111   222222111  12  36778999


Q ss_pred             ccCCCChhh---------------HHhhcCCCC---------CCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 038707          394 FIPNGTLYQ---------------YIHNQIEEF---------PITWEL-------------LLRIAVEVSGALFYLHSAA  436 (597)
Q Consensus       394 ~~~~gsL~~---------------~l~~~~~~~---------~l~~~~-------------~~~i~~qi~~~L~~LH~~~  436 (597)
                      |++|..+..               .||...++.         ...|..             -.....++...+..+.+.-
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999887772               111111111         122320             1112334444444444321


Q ss_pred             ----C---CCeEeccCCCCCeEeCCCCc-EEEeeccccc
Q 038707          437 ----S---IPIYHRDIKSANILLDDKYR-AKVSDFGTSR  467 (597)
Q Consensus       437 ----~---~~i~H~Dik~~NIll~~~~~-~kl~Dfgl~~  467 (597)
                          .   ..++|+|+.|.|||++++.. +.++||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                1   22899999999999999985 8999998764

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=94.98  E-value=0.036  Score=45.48  Aligned_cols=69  Identities=16%  Similarity=0.274  Sum_probs=45.6

Q ss_pred             CcceEEEEeccceeecccCC-ChhhhhccCCCcceeEeeeeecCCccccCCCccccccCCC-CceeccCCCCceeeecCC
Q 038707          161 RGCRSVSVVEENWVGSKYLE-NPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDG-EYRCSITFGSGYICRCRT  238 (597)
Q Consensus       161 ~~c~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~vLdW~i~~~~C~~~~~~~~~~~C~s~-~~c~~~~~~~gy~C~C~~  238 (597)
                      ..|...+.|+.......... ...-+.+ ....+++|+|.+..+.|.         +|..+ +.|....+..-+.|.|++
T Consensus        23 ~~C~~~v~vPV~~~~~~~~~~~~~~~~~-~L~~GF~L~w~~~~~~C~---------~C~~SgG~Cgy~~~~~~f~C~C~d   92 (94)
T PF14380_consen   23 GSCQKSVVVPVLGSAVDSIDGSSGNYEE-VLKKGFELEWNADSGDCR---------ECEASGGRCGYDSNSEQFTCFCSD   92 (94)
T ss_pred             CcCCEEEEEEECchhhhccccchhHHHH-HHhcCcEEEEeCCCCcCc---------ChhcCCCEeCCCCCCceEEEECCC
Confidence            56988776665543211111 1111122 234699999998778998         88876 889877777789999997


Q ss_pred             C
Q 038707          239 T  239 (597)
Q Consensus       239 g  239 (597)
                      |
T Consensus        93 g   93 (94)
T PF14380_consen   93 G   93 (94)
T ss_pred             C
Confidence            5

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.95  E-value=0.36  Score=46.06  Aligned_cols=73  Identities=19%  Similarity=0.262  Sum_probs=50.7

Q ss_pred             ccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc---CCCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       325 lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      +.-|.--..|...+ +..++-||.-.   ......|..|+.-|..|   +.-++.+++.+-.+.+..||||||++-+.+.
T Consensus        24 v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          24 VSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            44344444444332 45678888654   34456677777766666   4567889999999999999999999987666

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.71  E-value=0.64  Score=47.71  Aligned_cols=94  Identities=16%  Similarity=0.106  Sum_probs=52.6

Q ss_pred             ccCHHHHHHHhcCCccC---C-cccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ccceee
Q 038707          306 LFTSKDLEKATDNYNAN---R-ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLL  379 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~---~-~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~  379 (597)
                      .++.+.+..+...+-+.   + ..=.+.-..||+....++..+++|..... .-...++..|+..+..|...  .++...
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~   88 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL   88 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence            34455555554444331   1 11234456799988877888999986532 22345666777777766321  122211


Q ss_pred             ---e--EEEeCCcceEEEeccCCCCh
Q 038707          380 ---G--CCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       380 ---~--~~~~~~~~~lv~e~~~~gsL  400 (597)
                         |  ....++..+.++++++|...
T Consensus        89 ~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         89 AFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence               1  12234567789999987643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	597
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-47
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-46
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-31
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-27
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-27
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-27
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-27
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-27
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-27
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-27
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-27
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-27
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-27
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-27
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-27
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-27
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-27
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-27
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-27
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-27
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-27
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-26
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-26
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-25
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-25
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-23
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-23
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-23
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-23
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-23
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-23
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-23
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-23
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-23
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-23
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-23
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-23
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-23
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-23
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-23
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-23
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-23
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-23
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-23
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-23
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-23
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-22
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-22
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-22
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-22
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-22
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-21
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-21
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-20
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-20
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-20
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-20
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-20
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-19
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-19
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-19
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-19
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-19
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-19
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-19
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-19
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-19
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-18
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-18
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-18
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-18
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-18
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-18
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-18
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-18
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-18
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-18
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-18
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-18
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-17
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-17
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  186 bits (472), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 168/293 (57%), Gaps = 4/293 (1%)
Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFI 361
           + K F+ ++L+ A+DN++   ILG+GG G VYKG L DG +VAVK+ K       E QF 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLR 420
            EV ++S   HRN+++L G C+     LLVY ++ NG++   +  + E + P+ W    R
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           IA+  +  L YLH      I HRD+K+ANILLD+++ A V DFG ++ +     H+   V
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP--IRAINTDEDKSLVGYFLQA 538
           +GT G++ PEY  + + +EK+DV+ +GV+L+E++TGQ+   +  +  D+D  L+ +    
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG 591
           + E +L   +D  +    K EE+  +  +A  C   +   RP M EV   L G
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 104/293 (35%), Positives = 166/293 (56%), Gaps = 4/293 (1%)
Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFI 361
           + K F+ ++L+ A+DN+    ILG+GG G VYKG L DG +VAVK+ K       E QF 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLR 420
            EV ++S   HRN+++L G C+     LLVY ++ NG++   +  + E + P+ W    R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           IA+  +  L YLH      I HRD+K+ANILLD+++ A V DFG ++ +     H+   V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP--IRAINTDEDKSLVGYFLQA 538
           +G  G++ PEY  + + +EK+DV+ +GV+L+E++TGQ+   +  +  D+D  L+ +    
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG 591
           + E +L   +D  +    K EE+  +  +A  C   +   RP M EV   L G
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  182 bits (462), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 167/281 (59%), Gaps = 5/281 (1%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           DLE+AT+N++   ++G G  G VYKG+L DG  VA+K+        +E+F  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
            H ++V L+G C E    +L+Y+++ NG L ++++ + +    ++WE  L I +  +  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS-VMVDQTHLTTKVQGTFGYVD 488
            YLH+ A   I HRD+KS NILLD+ +  K++DFG S+    +DQTHL   V+GT GY+D
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           PEYF   + TEKSDVYSFGVVL E+L  +  I      E  +L  + +++ N  +L + +
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           D  +  + + E +      A +CL L+ + RP+M +V  +L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  179 bits (455), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 166/281 (59%), Gaps = 5/281 (1%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           DLE+AT+N++   ++G G  G VYKG+L DG  VA+K+        +E+F  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
            H ++V L+G C E    +L+Y+++ NG L ++++ + +    ++WE  L I +  +  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS-VMVDQTHLTTKVQGTFGYVD 488
            YLH+ A   I HRD+KS NILLD+ +  K++DFG S+    + QTHL   V+GT GY+D
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           PEYF   + TEKSDVYSFGVVL E+L  +  I      E  +L  + +++ N  +L + +
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           D  +  + + E +      A +CL L+ + RP+M +V  +L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/301 (32%), Positives = 164/301 (54%), Gaps = 20/301 (6%)
Query: 307 FTSKDLEKATDNYNANRI------LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           F+  +L+  T+N++   I      +G+GG G VYKG + +  +   K + +VD T  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            QF  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +       P++W +
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHL 476
             +IA   +  + +LH    I   HRDIKSANILLD+ + AK+SDFG +R S    QT +
Sbjct: 135 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--GY 534
            +++ GT  Y+ PE  +  + T KSD+YSFGVVL+EI+TG   + A++   +  L+    
Sbjct: 192 XSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG---LPAVDEHREPQLLLDIK 247
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                 E  + + +D + + +A    +  + ++A +CL+     RP +K+V   L  +  
Sbjct: 248 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
Query: 595 S 595
           S
Sbjct: 307 S 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/301 (32%), Positives = 163/301 (54%), Gaps = 20/301 (6%)
Query: 307 FTSKDLEKATDNYNANRI------LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           F+  +L+  T+N++   I      +G+GG G VYKG + +  +   K + +VD T  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            QF  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +       P++W +
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHL 476
             +IA   +  + +LH    I   HRDIKSANILLD+ + AK+SDFG +R S    QT +
Sbjct: 135 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--GY 534
             ++ GT  Y+ PE  +  + T KSD+YSFGVVL+EI+TG   + A++   +  L+    
Sbjct: 192 XXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG---LPAVDEHREPQLLLDIK 247
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                 E  + + +D + + +A    +  + ++A +CL+     RP +K+V   L  +  
Sbjct: 248 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
Query: 595 S 595
           S
Sbjct: 307 S 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 96/301 (31%), Positives = 162/301 (53%), Gaps = 20/301 (6%)
Query: 307 FTSKDLEKATDNYNANRI------LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           F+  +L+  T+N++   I      +G+GG G VYKG + +  +   K + +VD T  E  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            QF  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +       P++W +
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHL 476
             +IA   +  + +LH    I   HRDIKSANILLD+ + AK+SDFG +R S    Q  +
Sbjct: 129 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--GY 534
             ++ GT  Y+ PE  +  + T KSD+YSFGVVL+EI+TG   + A++   +  L+    
Sbjct: 186 XXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG---LPAVDEHREPQLLLDIK 241
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                 E  + + +D + + +A    +  + ++A +CL+     RP +K+V   L  +  
Sbjct: 242 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 300
Query: 595 S 595
           S
Sbjct: 301 S 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 153/295 (51%), Gaps = 20/295 (6%)
Query: 307 FTSKDLEKATDNYNANRI------LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           F+  +L+  T+N++   I       G+GG G VYKG + +  +   K + +VD T  E  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            QF  E+ + ++  H N+V+LLG   + +   LVY + PNG+L   +       P++W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHL 476
             +IA   +  + +LH    I   HRDIKSANILLD+ + AK+SDFG +R S    Q   
Sbjct: 126 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--GY 534
            +++ GT  Y  PE  +  + T KSD+YSFGVVL+EI+TG   + A++   +  L+    
Sbjct: 183 XSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG---LPAVDEHREPQLLLDIK 238
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                 E  + + +D +   +A    +    ++A +CL+     RP +K+V   L
Sbjct: 239 EEIEDEEKTIEDYIDKKX-NDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 147/281 (52%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 150
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R ++    D  H  T  +    ++  E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 256
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 257 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 208
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 314
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 315 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 353

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 142/283 (50%), Gaps = 39/283 (13%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFI----NEVVILSQINHRNIVKLL 379
           I+G GG G VY+     G  VAVK ++   + ++ Q I     E  + + + H NI+ L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
           G CL+     LV EF   G L + +  +     I  ++L+  AV+++  + YLH  A +P
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 440 IYHRDIKSANILLDDKYR--------AKVSDFGTSRSVMVDQTHLTTKVQ--GTFGYVDP 489
           I HRD+KS+NIL+  K           K++DFG +R     + H TTK+   G + ++ P
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAP 183
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E  ++S F++ SDV+S+GV+L E+LTG+ P R I    D   V Y    +  N+L   + 
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI----DGLAVAY---GVAMNKLALPIP 236
Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +   +          A L + C N +   RP+   + ++L  I
Sbjct: 237 STCPE--------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 154
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 260
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 261 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 149
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 255
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 256 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 294

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/229 (36%), Positives = 123/229 (53%), Gaps = 25/229 (10%)
Query: 307 FTSKDLEKATDN-YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNV---- 357
           F    L    DN     + +G+GG G V+KG L  D  +VA+K   L D   ET +    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 358 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
           ++F  EV I+S +NH NIVKL G  L    P +V EF+P G LY  + ++    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRSVMVD 472
            LR+ ++++  + Y+ +    PI HRD++S NI L          AKV+DFGTS+     
Sbjct: 124 KLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---- 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
             H  + + G F ++ PE   + +  +TEK+D YSF ++L  ILTG+ P
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 149
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 255
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 256 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 147
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 253
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 254 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 292

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 150
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYF 492
           AS    HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             R
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------RR 256
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           +L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 257 LLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 295

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 141
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 246
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 247 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 286

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 147
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 252
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 253 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 144
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 249
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 250 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 289

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 168
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 273
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 274 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 313

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 146
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 251
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 252 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 167
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 272
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 273 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 312

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 148
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 253
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 254 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 293

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 149
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 254
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 255 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 294

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 149
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 254
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 255 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 147/282 (52%), Gaps = 33/282 (11%)
Query: 322 NRILGQGGQGTVYKGML--TDGRIV--AVKK-SKLVDETNVEQFINEVVILSQINHRNIV 376
           N ++G+G  G VY G L   DG+ +  AVK  +++ D   V QF+ E +I+   +H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 377 KLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
            LLG CL +E  PL+V  ++ +G L  +I N+      T + L+   ++V+  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 148
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ----THLTTKVQGTFGYVDPEY 491
           AS    HRD+ + N +LD+K+  KV+DFG +R  M D+     H  T  +    ++  E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 492 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
            Q+ +FT KSDV+SFGV+L E++T G  P   +NT +   +  Y LQ             
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-----------R 253
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           R+L+     + +    L  +C +   +MRP+  E+ + +  I
Sbjct: 254 RLLQPEYCPDPLYEVML--KCWHPKAEMRPSFSELVSRISAI 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 121/227 (53%), Gaps = 7/227 (3%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILS 368
           D++    + N    +G G  GTV++     G  VAVK    +      V +F+ EV I+ 
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           ++ H NIV  +G   +     +V E++  G+LY+ +H       +     L +A +V+  
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYV 487
           + YLH+  + PI HR++KS N+L+D KY  KV DFG SR  +   T L++K   GT  ++
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWM 206
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
            PE  +     EKSDVYSFGV+L E+ T Q+P   +N  +  + VG+
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/229 (35%), Positives = 122/229 (53%), Gaps = 25/229 (10%)
Query: 307 FTSKDLEKATDN-YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNV---- 357
           F    L    DN     + +G+GG G V+KG L  D  +VA+K   L D   ET +    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 358 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
           ++F  EV I+S +NH NIVKL G  L    P +V EF+P G LY  + ++    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRSVMVD 472
            LR+ ++++  + Y+ +    PI HRD++S NI L          AKV+DFG S+     
Sbjct: 124 KLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
             H  + + G F ++ PE   + +  +TEK+D YSF ++L  ILTG+ P
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 119/227 (52%), Gaps = 7/227 (3%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILS 368
           D++    + N    +G G  GTV++     G  VAVK    +      V +F+ EV I+ 
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           ++ H NIV  +G   +     +V E++  G+LY+ +H       +     L +A +V+  
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYV 487
           + YLH+  + PI HRD+KS N+L+D KY  KV DFG SR  +     L +K   GT  ++
Sbjct: 150 MNYLHN-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWM 206
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
            PE  +     EKSDVYSFGV+L E+ T Q+P   +N  +  + VG+
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 121/229 (52%), Gaps = 25/229 (10%)
Query: 307 FTSKDLEKATDN-YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNV---- 357
           F    L    DN     + +G+GG G V+KG L  D  +VA+K   L D   ET +    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 358 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
           ++F  EV I+S +NH NIVKL G  L    P +V EF+P G LY  + ++    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRSVMVD 472
            LR+ ++++  + Y+ +  + PI HRD++S NI L          AKV+DF  S+     
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---- 178
Query: 473 QTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFGVVLVEILTGQKP 519
             H  + + G F ++ PE    +   +TEK+D YSF ++L  ILTG+ P
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 135/266 (50%), Gaps = 26/266 (9%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           ++G+G  G V K      + VA+K+  +  E+  + FI E+  LS++NH NIVKL G CL
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPI-TWELLLRIAVEVSGALFYLHSAASIPIYH 442
                 LV E+   G+LY  +H   E  P  T    +   ++ S  + YLHS     + H
Sbjct: 72  NPVC--LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 443 RDIKSANILL-DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           RD+K  N+LL       K+ DFGT+  +   QTH+T   +G+  ++ PE F+ S ++EK 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKC 184
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           DV+S+G++L E++T +KP      DE        + A++           ++K   K   
Sbjct: 185 DVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVH-----NGTRPPLIKNLPK--- 231
Query: 562 MTVATLAKRCLNLNGKMRPTMKEVTN 587
             + +L  RC + +   RP+M+E+  
Sbjct: 232 -PIESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 135/266 (50%), Gaps = 26/266 (9%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           ++G+G  G V K      + VA+K+  +  E+  + FI E+  LS++NH NIVKL G CL
Sbjct: 16  VVGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPI-TWELLLRIAVEVSGALFYLHSAASIPIYH 442
                 LV E+   G+LY  +H   E  P  T    +   ++ S  + YLHS     + H
Sbjct: 73  NPVC--LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 443 RDIKSANILL-DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           RD+K  N+LL       K+ DFGT+  +   QTH+T   +G+  ++ PE F+ S ++EK 
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKC 185
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           DV+S+G++L E++T +KP      DE        + A++           ++K   K   
Sbjct: 186 DVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVH-----NGTRPPLIKNLPK--- 232
Query: 562 MTVATLAKRCLNLNGKMRPTMKEVTN 587
             + +L  RC + +   RP+M+E+  
Sbjct: 233 -PIESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 123/219 (56%), Gaps = 16/219 (7%)
Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDET-----NVEQFINEVVILSQINHRNI 375
           ++LG G  GTVYKG+ + +G  V +  + K+++ET     NVE F++E +I++ ++H ++
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 102
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V+LLG CL   +  LV + +P+G L +Y+H   +   I  +LLL   V+++  + YL   
Sbjct: 103 VRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 159
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQS 494
               + HRD+ + N+L+      K++DFG +R +  D+        +    ++  E    
Sbjct: 160 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +FT +SDV+S+GV + E++T G KP   I T E   L+
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 132
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P                   I+ ++++E L+     E  +   
Sbjct: 193 VWAFGVLLWEIATYGMSP----------------YPGIDPSQVYELLEKDYRMERPEGCP 236
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 123/219 (56%), Gaps = 16/219 (7%)
Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDET-----NVEQFINEVVILSQINHRNI 375
           ++LG G  GTVYKG+ + +G  V +  + K+++ET     NVE F++E +I++ ++H ++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 79
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V+LLG CL   +  LV + +P+G L +Y+H   +   I  +LLL   V+++  + YL   
Sbjct: 80  VRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 136
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQS 494
               + HRD+ + N+L+      K++DFG +R +  D+        +    ++  E    
Sbjct: 137 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +FT +SDV+S+GV + E++T G KP   I T E   L+
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 243
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 243
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 135
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 239
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 6/194 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV+EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A+ I   HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEASVI---HRD 128
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 505 SFGVVLVEILTGQK 518
           SFGV++ E+ +  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 132
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDP----------------SQVYELLEKDYRMERPEGCP 236
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 132
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDP----------------SQVYELLEKDYRMERPEGCP 236
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 243
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 138
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 242
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 136
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 240
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 135
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 239
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G CLE
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV+EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A  I   HRD
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 131
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 505 SFGVVLVEILTGQK 518
           SFGV++ E+ +  K
Sbjct: 192 SFGVLMWEVFSEGK 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 243
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV+EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A  I   HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 128
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 505 SFGVVLVEILTGQK 518
           SFGV++ E+ +  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 238
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 243
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 147
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 208 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 251
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEI 275

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 106/196 (54%), Gaps = 7/196 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G CLE
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV+EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A  I   HRD
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 126
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 505 SFGVVLVEILT-GQKP 519
           SFGV++ E+ + G+ P
Sbjct: 187 SFGVLMWEVFSEGKIP 202

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 136
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 240
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 136
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 240
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 7/216 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                +V E++P G L  Y+     E  +T  +LL +A ++S A+ YL     I   HRD
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLEKKNFI---HRD 155
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ + +  KV+DFG SR +  D        +    +  PE    + F+ KSDV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 505 SFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQ 537
           +FGV+L EI T G  P   I+  +   L+  GY ++
Sbjct: 216 AFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   ++  +LL +A ++S A+ YL     I   H
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFI---H 341
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           R++ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 445
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  K     + + FI E  ++ +++H  +V+L G CLE
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV+EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A  I   HRD
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 148
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 505 SFGVVLVEILTGQK 518
           SFGV++ E+ +  K
Sbjct: 209 SFGVLMWEVFSEGK 222

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G VY+G+     +    K+   D   VE+F+ E  ++ +I H N+V+LLG C  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 385 TEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                ++ EF+  G L  Y+   N+ E   +   +LL +A ++S A+ YL     I   H
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI---H 380
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           R++ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KSD
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FGV+L EI T G  P   I+                 ++++E L+     E  +   
Sbjct: 441 VWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEGCP 484
Query: 562 MTVATLAKRCLNLNGKMRPTMKEV 585
             V  L + C   N   RP+  E+
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G CLE
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
                LV EF+ +G L  Y+  Q   F    E LL + ++V   + YL  A  I   HRD
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 129
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           + + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+++ KSDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 505 SFGVVLVEILTGQK 518
           SFGV++ E+ +  K
Sbjct: 190 SFGVLMWEVFSEGK 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 34/294 (11%)
Query: 323 RILGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           R LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 378 LLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
             G C         L+ EF+P G+L +Y+    E   I    LL+   ++   + YL + 
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYLGTK 136
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYF 492
             I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE  
Sbjct: 137 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESL 192
Query: 493 QSSQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRL 544
             S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N  
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-- 250
Query: 545 FEALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
               + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 251 ----NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 117/210 (55%), Gaps = 13/210 (6%)
Query: 325 LGQGGQGTVYKG---MLTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG G  G+V +G   M      VA+K  K   ++ + E+ + E  I+ Q+++  IV+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C + E  +LV E    G L++++  + EE P++   +  +  +VS  + YL     +  
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKNFV-- 132
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 498
            HRD+ + N+LL +++ AK+SDFG S+++  D ++ T +  G +   +  PE     +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 499 EKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
            +SDV+S+GV + E L+ GQKP + +   E
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA-PESLTE 191
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 247
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 248 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 139 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 194
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 250
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 251 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 140
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 141 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 196
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 252
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 253 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 139 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 194
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 250
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 251 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 142
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 143 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 198
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 254
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 255 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 191
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 247
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 248 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 191
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 247
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 248 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 141
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 142 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 197
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 253
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 254 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 134
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 135 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 190
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 246
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 247 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 139
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 140 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 195
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 251
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 252 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 133
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 134 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 189
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 245
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR  + 
Sbjct: 246 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDQMA 292

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 154 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 209
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 265
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 266 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 167 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 222
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 278
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR  + 
Sbjct: 279 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 121/233 (51%), Gaps = 15/233 (6%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H    +F +  + L+ IA + 
Sbjct: 73  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQT 129
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-TSRSVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG  +       +H   ++ G+ 
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINT-DEDKSLVG 533
            ++ PE  +   S+ ++ +SDVY+FG+VL E++TGQ P   IN  D+   +VG
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 130/239 (54%), Gaps = 24/239 (10%)
Query: 322 NRILGQGGQGTVYKGML--TDGR---IVAVK--KSKLVDETNVEQFINEVVILSQINHRN 374
            +++G G  G VYKGML  + G+    VA+K  K+   ++  V+ F+ E  I+ Q +H N
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHN 107
Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           I++L G   + +  +++ E++ NG L +++  +  EF +    L+ +   ++  + YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYL-- 163
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD--QTHLTTKVQGTFGYVDPEYF 492
            A++   HRD+ + NIL++     KVSDFG SR +  D   T+ T+  +    +  PE  
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALD 549
              +FT  SDV+SFG+V+ E++T G++P   ++  E        ++AIN+  RL   +D
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPTPMD 274

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 142/292 (48%), Gaps = 34/292 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 136
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HR++ + NIL++++ R K+ DFG ++ +  D+ +   K  G    F Y  PE    
Sbjct: 137 I---HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA-PESLTE 192
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 248
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++ 
Sbjct: 249 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMA 295

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 34/291 (11%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVKK +   E ++  F  E+ IL  + H NIVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G C         L+ E++P G+L  Y+    E   I    LL+   ++   + YL +   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G    F Y  PE    
Sbjct: 154 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 209
Query: 495 SQFTEKSDVYSFGVVLVEILT----GQKP----IRAINTDEDKSLVGYFLQAINENRLFE 546
           S+F+  SDV+SFGVVL E+ T     + P    +R I  D+   ++ + L  + +N    
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---- 265
Query: 547 ALDARVLK-EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
             + R+ + +   +EI  + T    C N N   RP+ +++   +  IR ++
Sbjct: 266 --NGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 32/286 (11%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDET--NVEQFINEVVILS 368
           A ++   NRILG+G  G VY+G+ T+ +     VAVK  K  D T  N E+F++E VI+ 
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK 64
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
            ++H +IVKL+G  +E E   ++ E  P G L  Y+        +    L+  ++++  A
Sbjct: 65  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKA 121
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +  +    ++ 
Sbjct: 122 MAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
           PE     +FT  SDV+ F V + EIL+ G++P   +   E+K ++G   +    +RL + 
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL---ENKDVIGVLEKG---DRLPKP 232
Query: 548 -LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            L   VL            TL  RC + +   RP   E+   L  +
Sbjct: 233 DLCPPVL-----------YTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 32/286 (11%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDET--NVEQFINEVVILS 368
           A ++   NRILG+G  G VY+G+ T+ +     VAVK  K  D T  N E+F++E VI+ 
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK 68
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
            ++H +IVKL+G  +E E   ++ E  P G L  Y+        +    L+  ++++  A
Sbjct: 69  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKA 125
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +  +    ++ 
Sbjct: 126 MAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
           PE     +FT  SDV+ F V + EIL+ G++P   +   E+K ++G   +    +RL + 
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL---ENKDVIGVLEKG---DRLPKP 236
Query: 548 -LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            L   VL            TL  RC + +   RP   E+   L  +
Sbjct: 237 DLCPPVL-----------YTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 32/286 (11%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDET--NVEQFINEVVILS 368
           A ++   NRILG+G  G VY+G+ T+ +     VAVK  K  D T  N E+F++E VI+ 
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK 80
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
            ++H +IVKL+G  +E E   ++ E  P G L  Y+        +    L+  ++++  A
Sbjct: 81  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKA 137
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +  +    ++ 
Sbjct: 138 MAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 194
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
           PE     +FT  SDV+ F V + EIL+ G++P   +   E+K ++G   +    +RL + 
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL---ENKDVIGVLEKG---DRLPKP 248
Query: 548 -LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            L   VL            TL  RC + +   RP   E+   L  +
Sbjct: 249 DLCPPVL-----------YTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 122/217 (56%), Gaps = 19/217 (8%)
Query: 320 NANRILGQGGQGTVYKGMLTD---GRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRN 374
           +++R++G+G  G VY G   D    RI  A+K  S++ +   VE F+ E +++  +NH N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 375 IVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           ++ L+G  L  E +P ++  ++ +G L Q+I +  +  P T + L+   ++V+  + YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNP-TVKDLISFGLQVARGMEYL- 140
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-----QTHLTTKVQGTFGYVD 488
             A     HRD+ + N +LD+ +  KV+DFG +R ++       Q H   ++   +  + 
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL- 197
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            E  Q+ +FT KSDV+SFGV+L E+LT G  P R I+
Sbjct: 198 -ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 121/233 (51%), Gaps = 15/233 (6%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H    +F +  + L+ IA + 
Sbjct: 61  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQT 117
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 118 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINT-DEDKSLVG 533
            ++ PE  +   S+ ++ +SDVY+FG+VL E++TGQ P   IN  D+   +VG
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 227

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 127/234 (54%), Gaps = 18/234 (7%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG---MLTDGRIVAVKKSKL-VDETN 356
           ++  KLF  +D     +   A+  LG G  G+V +G   M      VA+K  K   ++ +
Sbjct: 325 LKDKKLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD 379
Query: 357 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE 416
            E+ + E  I+ Q+++  IV+L+G C + E  +LV E    G L++++  + EE P++  
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS-- 436
Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
            +  +  +VS  + YL     +   HR++ + N+LL +++ AK+SDFG S+++  D ++ 
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 477 TTKVQGTFG--YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           T +  G +   +  PE     +F+ +SDV+S+GV + E L+ GQKP + +   E
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 325 LGQGGQGTVY----KGMLT--DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           LG+G  G V+      +L   D  +VAVK  K   E+  + F  E  +L+ + H++IV+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ------------IEEFPITWELLLRIAVEVS 426
            G C E    L+V+E++ +G L +++ +             +   P+    LL +A +V+
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   A +   HRD+ + N L+      K+ DFG SR +   D   +  +      
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           ++ PE     +FT +SDV+SFGVVL EI T G++P   ++  E
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 325 LGQGGQGTVY----KGMLT--DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           LG+G  G V+      +L   D  +VAVK  K   E+  + F  E  +L+ + H++IV+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ------------IEEFPITWELLLRIAVEVS 426
            G C E    L+V+E++ +G L +++ +             +   P+    LL +A +V+
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   A +   HRD+ + N L+      K+ DFG SR +   D   +  +      
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           ++ PE     +FT +SDV+SFGVVL EI T G++P   ++  E
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 325 LGQGGQGTVY----KGMLT--DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           LG+G  G V+      +L   D  +VAVK  K   E+  + F  E  +L+ + H++IV+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ------------IEEFPITWELLLRIAVEVS 426
            G C E    L+V+E++ +G L +++ +             +   P+    LL +A +V+
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 485
             + YL   A +   HRD+ + N L+      K+ DFG SR +   D   +  +      
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           ++ PE     +FT +SDV+SFGVVL EI T G++P   ++  E
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 119/233 (51%), Gaps = 15/233 (6%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
            + D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G     ++ + V ++    +LY ++H    +F +  + L+ IA + 
Sbjct: 73  VLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQT 129
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-TSRSVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG  +       +H   ++ G+ 
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINT-DEDKSLVG 533
            ++ PE  +   S+ ++ +SDVY+FG+VL E++TGQ P   IN  D+   +VG
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + +F   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N KMRPT  E
Sbjct: 241 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPKMRPTFLE 281
Query: 585 VTNEL 589
           + N L
Sbjct: 282 IVNLL 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 143/303 (47%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 184 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 242
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 243 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 285
Query: 587 NEL 589
           + +
Sbjct: 286 SSI 288

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + +F   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 237
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N KMRPT  E
Sbjct: 238 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPKMRPTFLE 278
Query: 585 VTNEL 589
           + N L
Sbjct: 279 IVNLL 283

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 143/303 (47%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           +F   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 239
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 240 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 282
Query: 587 NEL 589
           + +
Sbjct: 283 SSI 285

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGCC 382
           +G G  GTVYKG       VAVK  K+VD T    + F NEV +L +  H NI+  +G  
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +  + + V ++    +LY+++H Q  +F +    L+ IA + +  + YLH+     I H
Sbjct: 102 TKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---IIH 155
Query: 443 RDIKSANILLDDKYRAKVSDFG----TSRSVMVDQTHLTTKVQGTFGYVDPEYFQ---SS 495
           RD+KS NI L +    K+ DFG     SR     Q    T   G+  ++ PE  +   ++
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPEVIRMQDNN 212
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            F+ +SDVYS+G+VL E++TG+ P   IN
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 85  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 141
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-TSRSVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG  +       +H   ++ G+ 
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 258
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 259 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 293

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 77  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 133
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-TSRSVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG  +       +H   ++ G+ 
Sbjct: 134 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 250
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 251 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 285

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDET----N 356
           + +F   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 357 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N KMRPT  E
Sbjct: 241 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPKMRPTFLE 281
Query: 585 VTNEL 589
           + N L
Sbjct: 282 IVNLL 286

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 41/298 (13%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE--------QFIN 362
           + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E        +F+N
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-------PITW 415
           E  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E        P + 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQT 474
             ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D  
Sbjct: 123 SKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVG 533
               K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++      
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------ 233
Query: 534 YFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             L+ + E  L +  D    +L E           L + C   N KMRP+  E+ + +
Sbjct: 234 -VLRFVMEGGLLDKPDNCPDMLLE-----------LMRMCWQYNPKMRPSFLEIISSI 279

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 143/303 (47%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 242
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 243 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 285
Query: 587 NEL 589
           + +
Sbjct: 286 SSI 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 144/308 (46%), Gaps = 41/308 (13%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           +    ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E  
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAA 60
Query: 359 ------QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
                 +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E  
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 412 ------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
                 P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG 
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGM 177
Query: 466 SRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 523
           +R +   D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + +
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 524 NTDEDKSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT 581
           + ++        L+ + E  L +  D    +L E           L + C   N KMRP+
Sbjct: 238 SNEQ-------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPS 279
Query: 582 MKEVTNEL 589
             E+ + +
Sbjct: 280 FLEIISSI 287

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 143
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 136/306 (44%), Gaps = 43/306 (14%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + +F   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 470 MVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 526
             +  +     +G     ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ +
Sbjct: 181 -YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 527 EDKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
           +    V   GY  Q  N                       V  L + C   N KMRPT  
Sbjct: 240 QVLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPKMRPTFL 280
Query: 584 EVTNEL 589
           E+ N L
Sbjct: 281 EIVNLL 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 144/308 (46%), Gaps = 41/308 (13%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-- 358
           +    ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E  
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAA 60
Query: 359 ------QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
                 +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E  
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 412 ------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
                 P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG 
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGM 177
Query: 466 SRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 523
           +R +   D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + +
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 524 NTDEDKSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT 581
           + ++        L+ + E  L +  D    +L E           L + C   N KMRP+
Sbjct: 238 SNEQ-------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPS 279
Query: 582 MKEVTNEL 589
             E+ + +
Sbjct: 280 FLEIISSI 287

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 143/303 (47%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 94
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 212 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 270
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 271 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 313
Query: 587 NEL 589
           + +
Sbjct: 314 SSI 316

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 143/303 (47%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 249 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 291
Query: 587 NEL 589
           + +
Sbjct: 292 SSI 294

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 61
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 62  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 118
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 235
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 236 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 270

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 58
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 59  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 115
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 116 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 232
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 233 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 267

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ +F +    L+  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 117
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 61
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 62  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 118
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 235
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 236 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 143
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 84  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 140
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 141 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 257
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 258 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVV 365
           +S D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV 
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + 
Sbjct: 85  VLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 141
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTF 484
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+ 
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 485 GYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF--- 535
            ++ PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 258
Query: 536 LQAINEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           L  +  N  +  + L A  LK+ + E  +    LA
Sbjct: 259 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 293

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ +F +    L+  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 117
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +        +K + 
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL 174
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 195 IWAFGVLMWEIYSLGKMPYERFTNSE 220

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 128
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 127
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 188 IWAFGVLMWEIYSLGKMPYERFTNSE 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 128
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VA+K   ++ E ++  ++FI E  ++  ++H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S   +   H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---H 123
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+F+ KSD
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           +++FGV++ EI + G+ P       E
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSE 209

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 41/298 (13%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE--------QFIN 362
           + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E        +F+N
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-------PITW 415
           E  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E        P + 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQT 474
             ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D  
Sbjct: 125 SKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVG 533
               K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++      
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------ 235
Query: 534 YFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             L+ + E  L +  D    +L E           L + C   N KMRP+  E+ + +
Sbjct: 236 -VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 142/303 (46%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 59
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------ 411
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+ +   E       
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 412 -PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N  + + +  K+ DFG +R + 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 235
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 236 ------VLRFVMEGGLLDKPDNCPDMLLE-----------LMRMCWQYNPKMRPSFLEII 278
Query: 587 NEL 589
           + +
Sbjct: 279 SSI 281

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 117
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILS 368
           D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + +  
Sbjct: 60  KTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-TSRSVMVDQTHLTTKVQGTFGYV 487
           + YLH+ +   I HRD+KS NI L +    K+ DFG  +       +H   ++ G+  ++
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 488 DPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF---LQA 538
            PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    L  
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 539 INEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           +  N  +  + L A  LK+ + E  +    LA
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 122
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 123 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 145
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 146 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 202
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 142/303 (46%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 62
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------NQIEE 410
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+        N    
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 238
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 239 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 281
Query: 587 NEL 589
           + +
Sbjct: 282 SSI 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 323 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE----QFINEVVILSQINHRNI 375
           R LGQG  G VY+G   D   G        K V+E+       +F+NE  ++      ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIEEFPITWELLLRIAVEVSGA 428
           V+LLG   + +  L+V E + +G L  Y+        N     P T + ++++A E++  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYV 487
           + YL++   +   HRD+ + N ++   +  K+ DFG +R +   D      K      ++
Sbjct: 142 MAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV---GYFLQAINENR 543
            PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++    V   GY  Q  N   
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 258
Query: 544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                               V  L + C   N KMRPT  E+ N L
Sbjct: 259 -------------------RVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 117
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 121 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 120 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 176
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ +F +    L+  A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + ++   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N  MRPT  E
Sbjct: 241 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPNMRPTFLE 281
Query: 585 VTNEL 589
           + N L
Sbjct: 282 IVNLL 286

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 142/303 (46%), Gaps = 41/303 (13%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE------- 358
           ++   + E A +    +R LGQG  G VY+G +  G +    ++++  +T  E       
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 359 -QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------NQIEE 410
            +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+        N    
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
            P +   ++++A E++  + YL++   +   HRD+ + N ++ + +  K+ DFG +R + 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 471 -VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
             D      K      ++ PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++ 
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248
Query: 529 KSLVGYFLQAINENRLFEALD--ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                  L+ + E  L +  D    +L E           L + C   N KMRP+  E+ 
Sbjct: 249 ------VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEII 291
Query: 587 NEL 589
           + +
Sbjct: 292 SSI 294

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILS 368
           D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +  H NI+  +G   + ++ + V ++    +LY ++H  I E       L+ IA + +  
Sbjct: 60  KTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYV 487
           + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+  ++
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 488 DPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF---LQA 538
            PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    L  
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 539 INEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           +  N  +  + L A  LK+ + E  +    LA
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 30/281 (10%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           N    ++L   G+G     ML D  G  VAVK  K  ++   + F+ E  +++Q+ H N+
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 248
Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           V+LLG  +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL  
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG 307
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              +   HRD+ + N+L+ +   AKVSDFG ++     Q      V+    +  PE  + 
Sbjct: 308 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALRE 360
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
            +F+ KSDV+SFG++L EI + G+ P   I   +        +  + +    +A D    
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCP- 412
Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                     V  + K C +L+   RPT  ++  +L  IRT
Sbjct: 413 --------PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNV-EQFIN 362
           +++D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E + + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ +F +    L+  A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K + 
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 38/285 (13%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           N    ++L   G+G     ML D  G  VAVK  K  ++   + F+ E  +++Q+ H N+
Sbjct: 10  NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 67
Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           V+LLG  +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL  
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG 126
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              +   HRD+ + N+L+ +   AKVSDFG ++     Q      V+    +  PE  + 
Sbjct: 127 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALRE 179
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAIN--ENRLFEALD 549
           + F+ KSDV+SFG++L EI + G+ P   I   +    V  GY + A +     ++E + 
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM- 238
Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                              K C +L+  MRP+  ++  +L  I+T
Sbjct: 239 -------------------KNCWHLDAAMRPSFLQLREQLEHIKT 264

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 137/281 (48%), Gaps = 30/281 (10%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           N    ++L   G+G     ML D  G  VAVK  K  ++   + F+ E  +++Q+ H N+
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 76
Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           V+LLG  +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL  
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG 135
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              +   HRD+ + N+L+ +   AKVSDFG ++     Q      V+    +  PE  + 
Sbjct: 136 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALRE 188
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
            +F+ KSDV+SFG++L EI + G+ P   I   +        +  + +    +A D    
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCP- 240
Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                     V  + K C +L+  MRP+  ++  +L  I+T
Sbjct: 241 --------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVE 358
           K K   SK  + A +++   R LG+G  G VY       + I+A+K   K++L       
Sbjct: 20  KQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 79
Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
           Q   EV I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRT 136
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
                E++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT
Sbjct: 137 ATYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 191
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            + GT  Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 192 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVE 358
           K K   SK  + A +++   R LG+G  G VY       + I+A+K   K++L       
Sbjct: 11  KQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 70
Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
           Q   EV I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +  
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRT 127
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
                E++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT
Sbjct: 128 ATYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 182
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            + GT  Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 183 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 21/228 (9%)
Query: 318 NYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           N    R LG+G  G V+           D  +VAVK  K   +   + F  E  +L+ + 
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFP---ITWELLLRI 421
           H +IVK  G C+E +  ++V+E++ +G L +++           E  P   +T   +L I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKV 480
           A +++  + YL   AS    HRD+ + N L+ +    K+ DFG SR V   D   +    
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
                ++ PE     +FT +SDV+S GVVL EI T G++P   ++ +E
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 131/306 (42%), Gaps = 38/306 (12%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D  N  + LG+G  G V +            R VAVK  K     +    
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF-P---- 412
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF P    
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 413 ----ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
               +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARD 193
Query: 469 VMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 526
           +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  D
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
           E+              RL E    R       E   T+      C +     RPT  E+ 
Sbjct: 254 EEFX-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELV 298
Query: 587 NELGGI 592
             LG +
Sbjct: 299 EHLGNL 304

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 121
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT 
Sbjct: 122 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 175
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 139/285 (48%), Gaps = 38/285 (13%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           N    ++L   G+G     ML D  G  VAVK  K  ++   + F+ E  +++Q+ H N+
Sbjct: 4   NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 61
Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           V+LLG  +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL  
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG 120
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              +   HRD+ + N+L+ +   AKVSDFG ++     Q      V+ T     PE  + 
Sbjct: 121 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALRE 173
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAIN--ENRLFEALD 549
            +F+ KSDV+SFG++L EI + G+ P   I   +    V  GY + A +     ++E + 
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM- 232
Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                              K C +L+  MRP+  ++  +L  I+T
Sbjct: 233 -------------------KNCWHLDAAMRPSFLQLREQLEHIKT 258

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 22/272 (8%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILS 368
           D E         + +G G  GTVYKG       VAVK   +   T   ++ F NEV +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +  H NI+  +G     ++ + V ++    +LY ++H  I E       L+ IA + +  
Sbjct: 60  KTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYV 487
           + YLH+ +   I HRD+KS NI L +    K+ DFG +        +H   ++ G+  ++
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 488 DPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYF---LQA 538
            PE  +    + ++ +SDVY+FG+VL E++TGQ P   IN  +    +   GY    L  
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 539 INEN--RLFEALDARVLKEAKKEEIMTVATLA 568
           +  N  +  + L A  LK+ + E  +    LA
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 119
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT 
Sbjct: 120 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 173
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 121
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT 
Sbjct: 122 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 175
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 125
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 126 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 221

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 145
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 146 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 127
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 128 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 131
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 132 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 141/300 (47%), Gaps = 36/300 (12%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVK----KSKLVDETNVEQFINE 363
           +D+      +   R+LG+G  G+V +  L   DG  V V     K+ ++  +++E+F+ E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 364 VVILSQINHRNIVKLLGCCLETE------VPLLVYEFIPNGTLYQY-IHNQIEEFPITWE 416
              + + +H ++ KL+G  L +       +P+++  F+ +G L+ + + ++I E P    
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 417 L--LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQ 473
           L  L+R  V+++  + YL S   I   HRD+ + N +L +     V+DFG SR +   D 
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
                  +    ++  E    + +T  SDV++FGV + EI+T GQ P   I   E+  + 
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI---ENAEIY 249
Query: 533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            Y    I  NRL          +   E +  V  L  +C + + K RP+   +  EL  I
Sbjct: 250 NYL---IGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 147
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 148 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 147
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 148 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L D R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL--TTKVQGTF 484
            AL + H      I HRD+K ANIL+      KV DFG +R++      +  T  V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 120/263 (45%), Gaps = 33/263 (12%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L D R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
            AL + H      I HRD+K ANI++      KV DFG +R++      +T    V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            Y+ PE  +      +SDVYS G VL E+LTG+ P    + D     V Y  Q + E+ +
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS----VAY--QHVREDPI 237
Query: 545 FEA---------LDARVLKEAKK 558
             +         LDA VLK   K
Sbjct: 238 PPSARHEGLSADLDAVVLKALAK 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 119
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT 
Sbjct: 120 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 173
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 489
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 490 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 131/306 (42%), Gaps = 38/306 (12%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D  N  + LG+G  G V +            R VAVK  K     +    
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF-P---- 412
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF P    
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 413 ----ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
               +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARD 193
Query: 469 VMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 526
           +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  D
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
           E+              RL E    R       E   T+      C +     RPT  E+ 
Sbjct: 254 EEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELV 298
Query: 587 NELGGI 592
             LG +
Sbjct: 299 EHLGNL 304

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P G +Y+ +  ++ +F    +       E
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKF--DEQRTATYITE 121
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT 
Sbjct: 122 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 175
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 490
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 491 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 12/223 (5%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNV-EQFINEVV 365
           D E   +     R +G+G  G V++G+          VA+K  K     +V E+F+ E +
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
            + Q +H +IVKL+G   E  V  ++ E    G L  ++  Q+ ++ +    L+  A ++
Sbjct: 61  TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 117
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
           S AL YL S   +   HRDI + N+L+      K+ DFG SR +     +  +K +    
Sbjct: 118 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
           ++ PE     +FT  SDV+ FGV + EIL  G KP + +  ++
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 121
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT 
Sbjct: 122 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTL 175
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 117
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT 
Sbjct: 118 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTL 171
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L D R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
            AL + H      I HRD+K ANI++      KV DFG +R++      +T    V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 114/219 (52%), Gaps = 15/219 (6%)
Query: 322 NRILGQGGQGTVYKG-----MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG      +     V + K++  D    ++ + E  ++ Q+++  IV
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 131
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+     +  G +   +  PE    
Sbjct: 132 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +F+ KSDV+SFGV++ E  + GQKP R +   E  +++
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLV----DETNVEQFINEVVILSQINHRNIVKLLG 380
           LG GG  TVY    T   I    K+  +     E  +++F  EV   SQ++H+NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
              E +   LV E+I   TL +YI +     P++ +  +    ++   + + H    + I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK  NIL+D     K+ DFG ++++       T  V GT  Y  PE  +     E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 501 SDVYSFGVVLVEILTGQKP 519
           +D+YS G+VL E+L G+ P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  M +  G+ VA+++  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 23/246 (9%)
Query: 323 RILGQGGQGTVYKGMLT--DGRI--VAVKKSKLVDETN--VEQFINEVVILSQINHRNIV 376
           +ILG+G  G+V +G L   DG    VAVK  KL + +   +E+F++E   +   +H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 377 KLLGCCLETEV-----PLLVYEFIPNGTLYQY-IHNQIEEFP--ITWELLLRIAVEVSGA 428
           +LLG C+E        P+++  F+  G L+ Y +++++E  P  I  + LL+  V+++  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYV 487
           + YL +   +   HRD+ + N +L D     V+DFG S+ +     +   ++ +    ++
Sbjct: 160 MEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE--DKSLVGYFLQAINE--N 542
             E      +T KSDV++FGV + EI T G  P   +   E  D  L G+ L+   +  +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD 276
Query: 543 RLFEAL 548
            L+E +
Sbjct: 277 ELYEIM 282

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 118
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K+++FG S  V    +  TT + GT 
Sbjct: 119 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTL 172
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 322 NRILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
            +I+G G  G V  G L   G+    VA+K  K    E     F++E  I+ Q +H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L G      + ++V E++ NG+L  ++     +F I    L+ +   V   + YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLSDLG 171
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + N+L+D     KVSDFG SR +  D     T   G     +  PE    
Sbjct: 172 YV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
             F+  SDV+SFGVV+ E+L  G++P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + ++   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 5   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 64
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HR++ + N ++   +  K+ DFG +R +
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 241
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N  MRPT  E
Sbjct: 242 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPNMRPTFLE 282
Query: 585 VTNEL 589
           + N L
Sbjct: 283 IVNLL 287

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 322 NRILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
            R++G G  G V  G L   G+    VA+K  K+   E     F+ E  I+ Q +H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            L G     +  ++V EF+ NG L  ++     +F +    L+ +   ++  + YL   A
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI--QLVGMLRGIAAGMRYL---A 162
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + NIL++     KVSDFG SR +  D   + T   G     +  PE  Q 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 41/305 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVE-- 358
           + ++   + E + +     R LGQG  G VY+G   D   G        K V+E+     
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 359 --QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIE 409
             +F+NE  ++      ++V+LLG   + +  L+V E + +G L  Y+        N   
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
             P T + ++++A E++  + YL++   +   HR++ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
              D      K      ++ PE  +   FT  SD++SFGVVL EI +  ++P + ++ ++
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 528 DKSLV---GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
               V   GY  Q  N                       V  L + C   N  MRPT  E
Sbjct: 241 VLKFVMDGGYLDQPDNCPE-------------------RVTDLMRMCWQFNPNMRPTFLE 281
Query: 585 VTNEL 589
           + N L
Sbjct: 282 IVNLL 286

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 322 NRILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
            +I+G G  G V  G L   G+    VA+K  K    E     F++E  I+ Q +H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L G      + ++V E++ NG+L  ++     +F I    L+ +   V   + YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLSDLG 171
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTKVQGTFGYVDPEYFQS 494
            +   HRD+ + N+L+D     KVSDFG SR +    D  + TT  +    +  PE    
Sbjct: 172 YV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
             F+  SDV+SFGVV+ E+L  G++P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +    T++ GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 117
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S  V    +   T + GT 
Sbjct: 118 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT-LCGTL 171
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVV 365
           K  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E+
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITEL 118
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
           + AL Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  
Sbjct: 119 ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSGTLD 172
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 126
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT  Y+ PE
Sbjct: 127 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPE 180
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 121
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT  Y+ PE
Sbjct: 122 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPE 175
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 14/218 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY     + + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   ++    L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE
Sbjct: 123 YCHSKKVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
             +     EK D++S GV+  E L G+ P  A NT +D
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQD 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 119
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K+++FG S  V    +  TT + GT 
Sbjct: 120 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTL 173
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 151
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 152 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 134
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 135 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVV 365
           K  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E+
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITEL 117
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
           + AL Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  
Sbjct: 118 ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLD 171
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P G +Y+ +  ++ +F    +       E
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKF--DEQRTATYITE 121
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT 
Sbjct: 122 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTL 175
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E + NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
               ++   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGAV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 136
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 137 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 161
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 162 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVE 358
           K K   SK  + A +++   R LG+G  G VY       + I+A+K   K++L       
Sbjct: 20  KQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 79
Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
           Q   EV I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRT 136
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
                E++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +     
Sbjct: 137 ATYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---D 190
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            + GT  Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 191 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 341 GRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYEFIPN 397
           G  VAVK  K     N +     E+ IL  + H NIVK  G C E       L+ EF+P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
           G+L +Y+     +  I  +  L+ AV++   + YL S   +   HRD+ + N+L++ +++
Sbjct: 110 GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 164
Query: 458 AKVSDFGTSRSVMVDQTHLTTKVQ---GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            K+ DFG ++++  D+   T K       F Y  PE    S+F   SDV+SFGV L E+L
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELL 223
Query: 515 TGQKPIRAINTDEDKSLVGYFLQAI 539
           T          D D S +  FL+ I
Sbjct: 224 T--------YCDSDSSPMALFLKMI 240

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
              + +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 142
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 143 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 142
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 143 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 132
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 133 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 132
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 133 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 118
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT 
Sbjct: 119 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTL 172
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 122/265 (46%), Gaps = 30/265 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + +E  P+    +  I  E+   L YLHS   I  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 126
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 127 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 184
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P   ++      +   FL   N     E   ++ LKE     
Sbjct: 185 ADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNPPTLEGNYSKPLKE----- 234
Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN     RPT KE+
Sbjct: 235 ------FVEACLNKEPSFRPTAKEL 253

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 132
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 133 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT  Y+ PE
Sbjct: 120 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPE 173
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 341 GRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYEFIPN 397
           G  VAVK  K     N +     E+ IL  + H NIVK  G C E       L+ EF+P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
           G+L +Y+     +  I  +  L+ AV++   + YL S   +   HRD+ + N+L++ +++
Sbjct: 98  GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 152
Query: 458 AKVSDFGTSRSVMVDQTHLTTKVQ---GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            K+ DFG ++++  D+   T K       F Y  PE    S+F   SDV+SFGV L E+L
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELL 211
Query: 515 TGQKPIRAINTDEDKSLVGYFLQAI 539
           T          D D S +  FL+ I
Sbjct: 212 T--------YCDSDSSPMALFLKMI 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 130/309 (42%), Gaps = 41/309 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D  N  + LG+G  G V +            R VAVK  K     +    
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF-----P 412
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF     P
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 413 -------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
                  +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGL 194
Query: 466 SRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 523
           +R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 524 NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
             DE+              RL E    R       E   T+      C +     RPT  
Sbjct: 255 KIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFS 299
Query: 584 EVTNELGGI 592
           E+   LG +
Sbjct: 300 ELVEHLGNL 308

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGML--TDGRIVAV-----KKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           LG G  G V +G      G+ V+V     K   L     ++ FI EV  +  ++HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G  L   + + V E  P G+L   +      F +    L R AV+V+  + YL S   
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKRF 136
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSS 495
           I   HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F +  PE  ++ 
Sbjct: 137 I---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
            F+  SD + FGV L E+ T GQ+P   +N
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 122/265 (46%), Gaps = 30/265 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + +E  P+    +  I  E+   L YLHS   I  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 146
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 147 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 204
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P   ++      +   FL   N     E   ++ LKE     
Sbjct: 205 ADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNPPTLEGNYSKPLKE----- 254
Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN     RPT KE+
Sbjct: 255 ------FVEACLNKEPSFRPTAKEL 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 13/218 (5%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEV 364
           SK  + A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I S + H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITE 119
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           ++ AL Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT 
Sbjct: 120 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTL 173
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
            Y+ PE  +     EK D++S GV+  E L G+ P  A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG +R +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  M +  G+ VA+++  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  M +  G+ VA+++  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  M +  G+ VA+++  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 140
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 200 IWSLGIMAIEMIEGEPP 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  R LG+G  G VY       + I+A+K   K++L       Q   EV I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQIEEFPITWELLLRIAVEVSGAL 429
            NI++L G   +     L+ E+ P GT+Y   Q +    E+   T+        E++ AL
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANAL 125
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y HS   I   HRDIK  N+LL      K++DFG S  V    +  TT + GT  Y+ P
Sbjct: 126 SYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPP 179
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E  +     EK D++S GV+  E L G  P  A    E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 26/263 (9%)
Query: 325 LGQGGQGTVYKGMLTDGR-IVAVKKSKLVDETNVEQFIN-EVVILSQINHRNIVKLLGCC 382
           +G+G  G VYKG+    + +VA+K   L +  +  + I  E+ +LSQ +   I +  G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           L++    ++ E++  G+      + ++  P+    +  I  E+   L YLHS   I   H
Sbjct: 87  LKSTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIK+AN+LL ++   K++DFG +  +   Q      V GT  ++ PE  + S +  K+D
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDFKAD 198
Query: 503 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           ++S G+  +E+  G+ P    N+D     V  FL   N     E   ++  KE       
Sbjct: 199 IWSLGITAIELAKGEPP----NSDLHPMRV-LFLIPKNSPPTLEGQHSKPFKE------- 246
Query: 563 TVATLAKRCLNLNGKMRPTMKEV 585
                 + CLN + + RPT KE+
Sbjct: 247 ----FVEACLNKDPRFRPTAKEL 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 133
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR--LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +GQG  GTVY  M +  G+ VA+++  L  +   E  INE++++ +  + NIV  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V E++  G+L   +    ++E  I       +  E   AL +LHS   I   H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 140
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           R+IKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++ +E++ G+ P
Sbjct: 200 IWSLGIMAIEMIEGEPP 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E + NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 134
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 135 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 129/308 (41%), Gaps = 40/308 (12%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF----P- 412
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF    P 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 413 ------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 466
                 +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLA 195
Query: 467 RSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 524
           R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   + 
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 525 TDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
            DE+              RL E    R       E   T+      C +     RPT  E
Sbjct: 256 IDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSE 300
Query: 585 VTNELGGI 592
           +   LG +
Sbjct: 301 LVEHLGNL 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E++ NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG  R +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 125
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE
Sbjct: 126 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPE 179
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML---TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQINH 372
           N + ++++G G  G V  G L   +   I VA+K  K+   E     F+ E  I+ Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +++  ++V E + NG+L  ++     +F +    L+ +   ++  + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASGMKYL 163
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPE 490
                +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 164 SDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                +FT  SDV+S+G+VL E+++ G++P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLVY-EFIPNGTLYQYIHNQIEEFP----- 412
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 413 --------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
                   +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 245 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 289
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 290 SELVEHLGNL 299

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L   R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 71  HPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
            AL + H      I HRD+K ANI++      KV DFG +R++      +T    V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 38/281 (13%)
Query: 318 NYNANRI-LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
            Y AN I +G+G  G V        G+ VAVKK  L  +   E   NEVVI+   +H N+
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV 104
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           V +    L  +   +V EF+  G L   + H ++ E     E +  + + V  AL YLH+
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHN 159
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              I   HRDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE    
Sbjct: 160 QGVI---HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISR 215
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF----LQAINENRLFEALDA 550
             +  + D++S G++++E++ G+ P              YF    LQA+   R+ ++L  
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPP--------------YFNEPPLQAM--RRIRDSLPP 259
Query: 551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG 591
           RV      +++  V+++ +  L+L     P+ +    EL G
Sbjct: 260 RV------KDLHKVSSVLRGFLDLMLVREPSQRATAQELLG 294

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 130/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLVY-EFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 245 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 289
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 290 SELVEHLGNL 299

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 142/295 (48%), Gaps = 31/295 (10%)
Query: 314 KATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFI--NEVVILSQI 370
           ++ + Y    ++G+G  G V K    D GRIVA+KK    D+  + + I   E+ +L Q+
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP--ITWELLLRIAVEVSGA 428
            H N+V LL  C + +   LV+EF+ +  L     + +E FP  + ++++ +   ++   
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTIL-----DDLELFPNGLDYQVVQKYLFQIING 136
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + + HS     I HRDIK  NIL+      K+ DFG +R++         +V  T  Y  
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRA 192
Query: 489 PEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK---------SLVGYFLQA 538
           PE      ++ +  DV++ G ++ E+  G+ P+   ++D D+         +L+    + 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 539 INENRLFEALDARVLKEAKKEEIM------TVATLAKRCLNLNGKMRPTMKEVTN 587
            N+N +F  +    +KE +  E         V  LAK+CL+++   RP   E+ +
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 270
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 329
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL---- 378
           LG GG G V + +  D G  VA+K+ +  +   N E++  E+ I+ ++NH N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 379 --LGCCLETEVPLLVYEFIPNGTLYQYIHNQIE------EFPITWELLLRIAVEVSGALF 430
             L      ++PLL  E+   G L +Y+ NQ E      E PI       +  ++S AL 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-----TLLSDISSALR 136
Query: 431 YLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           YLH      I HRD+K  NI+L     +   K+ D G ++ +  DQ  L T+  GT  Y+
Sbjct: 137 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 191
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  +  ++T   D +SFG +  E +TG +P
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 79
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 135
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 32/266 (12%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
             L+     ++ E++  G+    +     +EF I   L      E+   L YLHS   I 
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATML-----KEILKGLDYLHSEKKI- 142
Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 499
             HRDIK+AN+LL ++   K++DFG +  +   Q    T V GT  ++ PE  Q S +  
Sbjct: 143 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 199
Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKE 559
           K+D++S G+  +E+  G+ P    N+D     V + +   N   L      +  KE    
Sbjct: 200 KADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLVGDF-TKSFKE---- 250
Query: 560 EIMTVATLAKRCLNLNGKMRPTMKEV 585
                      CLN +   RPT KE+
Sbjct: 251 -------FIDACLNKDPSFRPTAKEL 269

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 130/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 254 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 298
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 299 SELVEHLGNL 308

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 133
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 130/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 195
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 196 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 256 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 300
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 301 SELVEHLGNL 310

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + +E  P+    +  I  E+   L YLHS   I  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 141
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL +    K++DFG +  +   Q      V GT  ++ PE  + S +  K
Sbjct: 142 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSK 199
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P   ++      +   FL   N     E   ++ LKE     
Sbjct: 200 ADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNPPTLEGNYSKPLKE----- 249
Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN     RPT KE+
Sbjct: 250 ------FVEACLNKEPSFRPTAKEL 268

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 78
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 134
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL---- 378
           LG GG G V + +  D G  VA+K+ +  +   N E++  E+ I+ ++NH N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 379 --LGCCLETEVPLLVYEFIPNGTLYQYIHNQIE------EFPITWELLLRIAVEVSGALF 430
             L      ++PLL  E+   G L +Y+ NQ E      E PI       +  ++S AL 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-----TLLSDISSALR 135
Query: 431 YLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           YLH      I HRD+K  NI+L     +   K+ D G ++ +  DQ  L T+  GT  Y+
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 190
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  +  ++T   D +SFG +  E +TG +P
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 122
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE
Sbjct: 123 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 139
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 198
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 150
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 209
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 148
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 207
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 11/213 (5%)
Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V+ G L  D  +VAVK  +     +++ +F+ E  IL Q +H NIV+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            + +   +V E +  G    ++  +     +  + LL++  + +  + YL S   I   H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI---H 236
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEK 500
           RD+ + N L+ +K   K+SDFG SR    D  +  +    Q    +  PE     +++ +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 501 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
           SDV+SFG++L E  + G  P   ++  + +  V
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 133
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 133
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G  G V+KG+  D R   V   K++D    E  +E    E+ +LSQ +   + K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
             L+     ++ E++  G+      + +E  P+    +  I  E+   L YLHS   I  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 126
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HRDIK+AN+LL +    K++DFG +  +   Q      V GT  ++ PE  + S +  K
Sbjct: 127 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSK 184
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           +D++S G+  +E+  G+ P   ++      +   FL   N     E   ++ LKE     
Sbjct: 185 ADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNPPTLEGNYSKPLKE----- 234
Query: 561 IMTVATLAKRCLNLNGKMRPTMKEV 585
                   + CLN     RPT KE+
Sbjct: 235 ------FVEACLNKEPSFRPTAKEL 253

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 130/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 230
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D  ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 231 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 291 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 335
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 336 SELVEHLGNL 345

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L   R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
            AL + H      I HRD+K ANI++      KV DFG +R++      +T    V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 143
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 202
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 86
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 142
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 72
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 128
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 129 DLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V    + + G++VAVKK  L  +   E   NEVVI+    H N+V++    L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 384 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +   +V EF+  G L   + H ++ E     E +  + + V  AL  LH+   I   H
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLQALSVLHAQGVI---H 193
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RDIKS +ILL    R K+SDFG    V  +       V GT  ++ PE      +  + D
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVD 252
Query: 503 VYSFGVVLVEILTGQKP 519
           ++S G++++E++ G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQI 370
           A +++   R LG+G  G VY       + I+A+K   K++L       Q   EV I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI++L G   +     L+ E+ P GT+Y+ +  ++ +F    +       E++ AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKF--DEQRTATYITELANALS 125
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS   I   HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE
Sbjct: 126 YCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPPE 179
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +     EK D++S GV+  E L G+ P  A
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 82
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 138
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 139 DLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 83
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 139
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 85
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 141
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           D+++ANIL+ D    K++DFG +R +  ++       +    +  PE      FT KSDV
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 504 YSFGVVLVEILT-GQKPIRAINTDE 527
           +SFG++L EI+T G+ P   +   E
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 83
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 139
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 140 DLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 9/212 (4%)
Query: 325 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V+ G L  D  +VAVK  +     +++ +F+ E  IL Q +H NIV+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            + +   +V E +  G    ++  +     +  + LL++  + +  + YL S   I   H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI---H 236
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEYFQSSQFTEKS 501
           RD+ + N L+ +K   K+SDFG SR         +  + Q    +  PE     +++ +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
           DV+SFG++L E  + G  P   ++  + +  V
Sbjct: 297 DVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 323 RILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           R++G G  G V  G L   G+    VA+K  K+   E     F+ E  I+ Q +H NI+ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G   +++  ++V E++ NG+L  ++     +F +    L+ +   +S  + YL     
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI--QLVGMLRGISAGMKYLSDMGY 145
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSS 495
           +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE     
Sbjct: 146 V---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVL 553
           +FT  SDV+S+G+V+ E+++ G++P   + T++D       ++A+ E  RL   +D    
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEM-TNQD------VIKAVEEGYRLPSPMDCPA- 254
Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                     +  L   C       RP   E+ N L
Sbjct: 255 ---------ALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 254 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 298
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 299 SELVEHLGNL 308

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 87
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 143
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           D+++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 144 DLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLV-DETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L   R VAVK  ++ L  D +   +F  E    + +N
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 372 HRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           H  IV +     E E     +P +V E++   TL   +H    E P+T +  + +  +  
Sbjct: 88  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADAC 143
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 484
            AL + H      I HRD+K ANI++      KV DFG +R++      +T    V GT 
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            Y+ PE  +      +SDVYS G VL E+LTG+ P     T +    V Y  Q + E+ +
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF----TGDSPVSVAY--QHVREDPI 254
Query: 545 FEA---------LDARVLKEAKK 558
             +         LDA VLK   K
Sbjct: 255 PPSARHEGLSADLDAVVLKALAK 277

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLVY-EFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 245 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 289
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 290 SELVEHLGNL 299

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 245 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 289
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 290 SELVEHLGNL 299

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKG------MLTDGRIVAVKKSKL-VDETNVEQ 359
           + +   E   D     + LG+G  G V +            R VAVK  K     +    
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 360 FINEVVILSQINHR-NIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF------ 411
            ++E+ IL  I H  N+V LLG C +   PL+V  EF   G L  Y+ ++  EF      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 412 P-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
           P       +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +  D   +     +    ++ PE      +T +SDV+SFGV+L EI + G  P   
Sbjct: 194 LARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           +  DE+              RL E    R       E   T+      C +     RPT 
Sbjct: 254 VKIDEEFC-----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTF 298
Query: 583 KEVTNELGGI 592
            E+   LG +
Sbjct: 299 SELVEHLGNL 308

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  R LG+G  G VY       + I+A+K   K++L       Q   EV I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQIEEFPITWELLLRIAVEVSGAL 429
            NI++L G   +     L+ E+ P GT+Y   Q +    E+   T+        E++ AL
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANAL 125
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y HS   I   HRDIK  N+LL      K++DFG S  V    +   T + GT  Y+ P
Sbjct: 126 SYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT-LCGTLDYLPP 179
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E  +     EK D++S GV+  E L G  P  A    E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ +I H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VA+K  K     + E F+ E  I+ ++ H  +V+L     E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++ +  E   +    L+ +A +V+  + Y+     I   HRD
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 130
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           ++SANIL+ +    K++DFG +R +  ++       +    +  PE     +FT KSDV+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 505 SFGVVLVEILT-GQKPIRAINTDE 527
           SFG++L E++T G+ P   +N  E
Sbjct: 191 SFGILLTELVTKGRVPYPGMNNRE 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D+++  R LG+G  G VY       + I+A+K   KS+L  E    Q   E+ I S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALF 430
            NI+++     + +   L+ EF P G LY+ +  H + +E     +       E++ AL 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATFMEELADALH 129
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDP 489
           Y H    I   HRDIK  N+L+  K   K++DFG S    V    L  +   GT  Y+ P
Sbjct: 130 YCHERKVI---HRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPP 182
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E  +     EK D++  GV+  E L G  P  + +  E
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +LG+G  G   K    + G ++ +K+    DE     F+ EV ++  + H N++K +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            + +    + E+I  GTL   I +   ++P  W   +  A +++  + YLHS     I H
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--------------KVQGTFGYVD 488
           RD+ S N L+ +     V+DFG +R +MVD+                    V G   ++ 
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLAR-LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           PE      + EK DV+SFG+VL EI      I  +N D D
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEI------IGRVNADPD 224

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           +++ANIL+ +    KV+DFG +R +  ++       +    +  PE     +FT KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 505 SFGVVLVEILT 515
           SFG++L E+ T
Sbjct: 200 SFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 130
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 131 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 189 VWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 128
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 129 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 187 VWSFGILLTELTT 199

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           DN+   R+LG+G  G V    + + G + AVK   K  ++ + +VE  + E  ILS   +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGAL 429
              +  L CC +T   L  V EF+  G L  +I    + +E    +      A E+  AL
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-----YAAEIISAL 137
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            +LH      I +RD+K  N+LLD +   K++DFG  +  + +    T    GT  Y+ P
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTATFCGTPDYIAP 193
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E  Q   +    D ++ GV+L E+L G  P  A N D+
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L      
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 73
Query: 385 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           T+ P+ ++ E++ NG+L  ++        +T   LL +A +++  + ++     I   HR
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI---HR 129
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKS 501
           ++++ANIL+ D    K++DFG +R  +++    T +    F   +  PE      FT KS
Sbjct: 130 NLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDE 527
           DV+SFG++L EI+T G+ P   +   E
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPE 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 129/278 (46%), Gaps = 25/278 (8%)
Query: 316 TDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQ--FINEVVILSQINH 372
            ++Y     +G G  G   K    +DG+I+  K+      T  E+   ++EV +L ++ H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 373 RNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHNQIEEFP-ITWELLLRIAVEVSGAL 429
            NIV+     ++ T   L +V E+   G L   I    +E   +  E +LR+  +++ AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 430 FYLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
              H  S     + HRD+K AN+ LD K   K+ DFG +R +  D +   T V GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE      + EKSD++S G +L E+     P  A +    K L G     I E + F  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG----KIREGK-FRR 235
Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +  R   E    EI+T      R LNL    RP+++E+
Sbjct: 236 IPYRYSDELN--EIIT------RMLNLKDYHRPSVEEI 265

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 388
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 389 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 447 VWSFGILLTELTT 459

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 306
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG  R  +++    T +    F   +  PE     +FT KSD
Sbjct: 307 LRAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 365 VWSFGILLTELTT 377

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 111/258 (43%), Gaps = 29/258 (11%)
Query: 341 GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP--LLVYEFIPN 397
           G +VAVK  K      +   +  E+ IL  + H +I+K  GCC +       LV E++P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
           G+L  Y+        I    LL  A ++   + YLH+   I   HRD+ + N+LLD+   
Sbjct: 120 GSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRL 172
Query: 458 AKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            K+ DFG +++V         +  G    F Y  PE  +  +F   SDV+SFGV L E+L
Sbjct: 173 VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYELL 231
Query: 515 TGQKPIRAINTDEDKSLVGYFLQAINEN-------RLFEALDARVLKEAKKEEIMTVATL 567
           T        + D  +S    FL+ I          RL E L+         +    V  L
Sbjct: 232 T--------HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHL 283
Query: 568 AKRCLNLNGKMRPTMKEV 585
            K C       RPT + +
Sbjct: 284 MKNCWETEASFRPTFENL 301

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 113/246 (45%), Gaps = 31/246 (12%)
Query: 322 NRILGQGGQGTVYKG------MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
            R LG+G  G V+           D  +VAVK  K       + F  E  +L+ + H +I
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFP------ITWELLLRIA 422
           VK  G C + +  ++V+E++ +G L +++          ++  P      +    +L IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQ 481
            +++  + YL   AS    HRD+ + N L+      K+ DFG SR V   D   +     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAIN 540
               ++ PE     +FT +SDV+SFGV+L EI T G++P   ++  E        ++ I 
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECIT 249
Query: 541 ENRLFE 546
           + R+ E
Sbjct: 250 QGRVLE 255

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 24/242 (9%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 22  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 81
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE 410
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+   G L  ++  + E 
Sbjct: 82  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEA 139
Query: 411 -------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 463
                   P+    LL  + +V+  + +L S   I   HRD+ + N+LL + + AK+ DF
Sbjct: 140 DLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDF 196
Query: 464 GTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIR 521
           G +R +M D  ++     +    ++ PE      +T +SDV+S+G++L EI + G  P  
Sbjct: 197 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 256
Query: 522 AI 523
            I
Sbjct: 257 GI 258

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 323 RILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +++G G  G V  G L   G+    VA+K  K    E     F++E  I+ Q +H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G   ++   +++ EF+ NG+L  ++     +F +    L+ +   ++  + YL   A 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYL---AD 153
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQG---TFGYVDPEYFQ 493
           +   HRD+ + NIL++     KVSDFG SR +  D +  T T   G      +  PE  Q
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
             +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 129
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           +++ANIL+ +    KV+DFG +R +  ++       +    +  PE     +FT KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 505 SFGVVLVEILT 515
           SFG++L E+ T
Sbjct: 190 SFGILLTELTT 200

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 323 RILGQG--GQGTVYKGMLTD---GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G+ ++Y    T+   G +VAVK  K      +   +  E+ IL  + H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 377 KLLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  GCC +  E  L LV E++P G+L  Y+        I    LL  A ++   + YLHS
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHS 135
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
              I   HR++ + N+LLD+    K+ DFG +++V     +   +  G    F Y  PE 
Sbjct: 136 QHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PEC 191
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-------RL 544
            +  +F   SDV+SFGV L E+LT        + D  +S    FL+ I          RL
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT--------HCDSSQSPPTKFLELIGIAQGQMTVLRL 243
Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            E L+         +    V  L K C       RPT + +
Sbjct: 244 TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENL 284

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D+++  R LG+G  G VY       + I+A+K   KS+L  E    Q   E+ I S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALF 430
            NI+++     + +   L+ EF P G LY+ +  H + +E     +       E++ AL 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATFMEELADALH 128
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDP 489
           Y H    I   HRDIK  N+L+  K   K++DFG S    V    L  +   GT  Y+ P
Sbjct: 129 YCHERKVI---HRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPP 181
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E  +     EK D++  GV+  E L G  P  + +  E
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 24/242 (9%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE 410
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+   G L  ++  + E 
Sbjct: 90  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEA 147
Query: 411 -------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 463
                   P+    LL  + +V+  + +L S   I   HRD+ + N+LL + + AK+ DF
Sbjct: 148 DLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDF 204
Query: 464 GTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIR 521
           G +R +M D  ++     +    ++ PE      +T +SDV+S+G++L EI + G  P  
Sbjct: 205 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 264
Query: 522 AI 523
            I
Sbjct: 265 GI 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I + +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 127/278 (45%), Gaps = 25/278 (8%)
Query: 316 TDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQ--FINEVVILSQINH 372
            ++Y     +G G  G   K    +DG+I+  K+      T  E+   ++EV +L ++ H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 373 RNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHNQIEEFP-ITWELLLRIAVEVSGAL 429
            NIV+     ++ T   L +V E+   G L   I    +E   +  E +LR+  +++ AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 430 FYLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
              H  S     + HRD+K AN+ LD K   K+ DFG +R ++   T       GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYM 183
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE      + EKSD++S G +L E+     P  A +    K L G     I E + F  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG----KIREGK-FRR 235
Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +  R   E    EI+T      R LNL    RP+++E+
Sbjct: 236 IPYRYSDELN--EIIT------RMLNLKDYHRPSVEEI 265

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 132
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 133 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 191 VWSFGILLTELTT 203

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 305
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 137/276 (49%), Gaps = 34/276 (12%)
Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDETNVEQ----FINEVVILSQINHRNIV 376
           ++LG G  GTV+KG+ + +G  + +    K++++ +  Q      + ++ +  ++H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG C  + + L V +++P G+L  ++        +  +LLL   V+++  ++YL    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQGTFGYVDPEYFQSS 495
            +   HR++ + N+LL    + +V+DFG +  +  D   L  ++ +    ++  E     
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           ++T +SDV+S+GV + E++T G +P   +   E   L+          RL +        
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------KGERLAQP------- 239
Query: 555 EAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNE 588
                +I T  V  +  +C  ++  +RPT KE+ NE
Sbjct: 240 -----QICTIDVYMVMVKCWMIDENIRPTFKELANE 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           LG G  G V  G       VAVK   ++ E ++  ++F  E   + +++H  +VK  G C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     +V E+I NG L  Y+ +  +    +   LL +  +V   + +L S   I   H
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFLESHQFI---H 127
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+ + N L+D     KVSDFG +R V+ DQ   +   +    +  PE F   +++ KSD
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
           V++FG+++ E+ + G+ P       E        L+    +RL+    A           
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHRLYRPHLASD--------- 232
Query: 562 MTVATLAKRCLNLNGKMRPTMKEVTNELGGIR 593
            T+  +   C +   + RPT +++ + +  +R
Sbjct: 233 -TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 137/276 (49%), Gaps = 34/276 (12%)
Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDETNVEQ----FINEVVILSQINHRNIV 376
           ++LG G  GTV+KG+ + +G  + +    K++++ +  Q      + ++ +  ++H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG C  + +  LV +++P G+L  ++        +  +LLL   V+++  ++YL    
Sbjct: 97  RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQGTFGYVDPEYFQSS 495
            +   HR++ + N+LL    + +V+DFG +  +  D   L  ++ +    ++  E     
Sbjct: 154 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           ++T +SDV+S+GV + E++T G +P   +   E   L+          RL +        
Sbjct: 211 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------KGERLAQP------- 257
Query: 555 EAKKEEIMT--VATLAKRCLNLNGKMRPTMKEVTNE 588
                +I T  V  +  +C  ++  +RPT KE+ NE
Sbjct: 258 -----QICTIDVYMVMVKCWMIDENIRPTFKELANE 288

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 305
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 117
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 19/225 (8%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINE 363
           D  K TD +N   +LG+G  G V   ML D +       I  +KK  ++ + +VE  + E
Sbjct: 14  DRVKLTD-FNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVE 69
Query: 364 VVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
             +L+ ++    +  L  C +T   L  V E++  G L  +I  Q+ +F     +    A
Sbjct: 70  KRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--A 126
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            E+S  LF+LH      I +RD+K  N++LD +   K++DFG  +  M+D    T +  G
Sbjct: 127 AEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCG 182
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           T  Y+ PE      + +  D +++GV+L E+L GQ P    + DE
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 305
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 503 VYSFGVVLVEILT-GQKP 519
           V+SFG++L E+ T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL  C  + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 153
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 243

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  ++ ++ +    L+ +A +++  + Y+     +   HRD
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 139
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           + +ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 140 LAAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 119
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 118/234 (50%), Gaps = 22/234 (9%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           ++ D +    NY   + +G+G    V   + +LT GR VAVK   K++L + T++++   
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQL-NPTSLQKLFR 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 64  EVRIMKILNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 121
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S    V     T  
Sbjct: 122 ----QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-- 172
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
             G+  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E +  V
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 25/278 (8%)
Query: 316 TDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQ--FINEVVILSQINH 372
            ++Y     +G G  G   K    +DG+I+  K+      T  E+   ++EV +L ++ H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 373 RNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHNQIEEFP-ITWELLLRIAVEVSGAL 429
            NIV+     ++ T   L +V E+   G L   I    +E   +  E +LR+  +++ AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 430 FYLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
              H  S     + HRD+K AN+ LD K   K+ DFG +R +  D+     +  GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYM 183
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE      + EKSD++S G +L E+     P  A +    K L G     I E + F  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG----KIREGK-FRR 235
Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +  R   E    EI+T      R LNL    RP+++E+
Sbjct: 236 IPYRYSDELN--EIIT------RMLNLKDYHRPSVEEI 265

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 323 RILGQG--GQGTVYKGMLTD---GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G+ ++Y    T+   G +VAVK  K      +   +  E+ IL  + H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 377 KLLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  GCC +  E  L LV E++P G+L  Y+        I    LL  A ++   + YLH+
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 135
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
              I   HR++ + N+LLD+    K+ DFG +++V     +   +  G    F Y  PE 
Sbjct: 136 QHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PEC 191
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-------RL 544
            +  +F   SDV+SFGV L E+LT        + D  +S    FL+ I          RL
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT--------HCDSSQSPPTKFLELIGIAQGQMTVLRL 243
Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            E L+         +    V  L K C       RPT + +
Sbjct: 244 TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENL 284

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRI----VAVKKSKLVDETNVEQFIN-EVVILSQI 370
            ++++  + LG+G  G V    L   R+    VAVK   +    +  + I  E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           NH N+VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVV 118
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDP 489
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  L  K+ GT  YV P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 490 EYFQSSQF-TEKSDVYSFGVVLVEILTGQKP 519
           E  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 44/224 (19%)
Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH---------- 372
           +LGQG  G V K     D R  A+KK +  +E  +   ++EV++L+ +NH          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 373 ---RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVE 424
              RN VK +    +     +  E+  NGTLY  IH+     Q +E+   W L  +I   
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---WRLFRQIL-- 126
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-------VDQTHLT 477
              AL Y+HS     I HRD+K  NI +D+    K+ DFG +++V        +D  +L 
Sbjct: 127 --EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 478 ------TKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL 514
                 T   GT  YV  E    +  + EK D+YS G++  E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 323 RILGQG--GQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 376
           R LG+G  G+ ++Y    T+   G +VAVK  K      +   +  E+ IL  + H +IV
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 377 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  GCC +   +   LV E++P G+L  Y+        +    LL  A ++   + YLH+
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHA 130
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
              I   HR + + N+LLD+    K+ DFG +++V     +   +  G    F Y  PE 
Sbjct: 131 QHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PEC 186
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
            +  +F   SDV+SFGV L E+LT     ++ +T +   L+G+    +   RL E L+  
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGHTQGQMTVLRLTELLERG 245
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                       +  L K C       RPT + + 
Sbjct: 246 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG+G  G+VYK +  + G+IVA+K+  +  E+++++ I E+ I+ Q +  ++VK  G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
           +     +V E+   G++   I  ++    +T + +  I       L YLH    I   HR
Sbjct: 95  KNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFMRKI---HR 149
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           DIK+ NILL+ +  AK++DFG +   + D       V GT  ++ PE  Q   +   +D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVA-GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADI 208
Query: 504 YSFGVVLVEILTGQKPIRAIN 524
           +S G+  +E+  G+ P   I+
Sbjct: 209 WSLGITAIEMAEGKPPYADIH 229

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 323 RILGQG--GQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 376
           R LG+G  G+ ++Y    T+   G +VAVK  K      +   +  E+ IL  + H +IV
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 377 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  GCC +   +   LV E++P G+L  Y+        +    LL  A ++   + YLH+
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHA 129
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 491
              I   HR + + N+LLD+    K+ DFG +++V     +   +  G    F Y  PE 
Sbjct: 130 QHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PEC 185
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
            +  +F   SDV+SFGV L E+LT     ++ +T +   L+G+    +   RL E L+  
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGHTQGQMTVLRLTELLERG 244
Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                       +  L K C       RPT + + 
Sbjct: 245 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ ++ +++  + Y+     +   HRD
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMNYV---HRD 136
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 195 VWSFGILLTELTT 207

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++    ++G GG G V+K     DG+   +K+ K     N E+   EV  L++++H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIV 67
Query: 377 KLLGCC----------------LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
              GC                  +T+   +  EF   GTL Q+I  +  E  +   L L 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALE 126
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           +  +++  + Y+HS   I   +RD+K +NI L D  + K+ DFG   S+  D     +K 
Sbjct: 127 LFEQITKGVDYIHSKKLI---NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            GT  Y+ PE   S  + ++ D+Y+ G++L E+L
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
             +  +V E++  G+L  ++  +  ++ +    L+ ++ +++  + Y+     +   HRD
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMNYV---HRD 136
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSD 502
           +++ANIL+ +    KV+DFG +R  +++    T +    F   +  PE     +FT KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 503 VYSFGVVLVEILT 515
           V+SFG++L E+ T
Sbjct: 195 VWSFGILLTELTT 207

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 30/248 (12%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFI-------------PN 397
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+              P 
Sbjct: 90  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPP 147
Query: 398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
           G  Y Y  +   E  ++   LL  + +V+  + +L S   I   HRD+ + N+LL + + 
Sbjct: 148 GLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHV 204
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
           AK+ DFG +R +M D  ++     +    ++ PE      +T +SDV+S+G++L EI + 
Sbjct: 205 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 264
Query: 516 GQKPIRAI 523
           G  P   I
Sbjct: 265 GLNPYPGI 272

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 137/308 (44%), Gaps = 48/308 (15%)
Query: 313 EKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAVKKSKL---VDETNVEQFINEVV 365
           E   +N    ++LG G  G V      G+   G  + V    L    D +  E  ++E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 366 ILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------------ 412
           +++Q+ +H NIV LLG C  +    L++E+   G L  Y+ ++ E+F             
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 413 --------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
                   +T+E LL  A +V+  + +L   + +   HRD+ + N+L+      K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFG 217
Query: 465 TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            +R +M D  ++     +    ++ PE      +T KSDV+S+G++L EI + G  P   
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM 582
           I  D +     ++    N  ++ +   A        EEI  +    + C   + + RP+ 
Sbjct: 278 IPVDAN-----FYKLIQNGFKMDQPFYA-------TEEIYII---MQSCWAFDSRKRPSF 322
Query: 583 KEVTNELG 590
             +T+ LG
Sbjct: 323 PNLTSFLG 330

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 15/242 (6%)
Query: 317 DNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++    +LG+G    VY+   +  G  VA+K   K  +     V++  NEV I  Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            +I++L     ++    LV E   NG + +Y+ N+++  P +         ++   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYL 128
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVDQTHLTTKVQGTFGYVDPEY 491
           HS     I HRD+  +N+LL      K++DFG +  + M  + H T  + GT  Y+ PE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
              S    +SDV+S G +   +L G+ P    +TD  K+ +   + A  E   F +++A+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP---FDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 552 VL 553
            L
Sbjct: 241 DL 242

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 18/229 (7%)
Query: 313 EKA-TDNYNANRILGQGGQGTVY---KGMLTDGR----IVAVKKSKLVDETNVEQFINEV 364
           EKA    +   ++LGQG  G V+   K   +D R    +  +KK+ L     V   + E 
Sbjct: 19  EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ER 77
Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
            IL ++NH  IVKL     +TE  L L+ +F+  G L+  +  ++     T E +     
Sbjct: 78  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLA 133
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           E++ AL +LHS     I +RD+K  NILLD++   K++DFG S+   +D         GT
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGT 189
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
             Y+ PE       T+ +D +SFGV++ E+LTG  P +  +  E  +++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 18/229 (7%)
Query: 313 EKA-TDNYNANRILGQGGQGTVY---KGMLTDGR----IVAVKKSKLVDETNVEQFINEV 364
           EKA    +   ++LGQG  G V+   K   +D R    +  +KK+ L     V   + E 
Sbjct: 20  EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ER 78
Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
            IL ++NH  IVKL     +TE  L L+ +F+  G L+  +  ++     T E +     
Sbjct: 79  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLA 134
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           E++ AL +LHS   + I +RD+K  NILLD++   K++DFG S+   +D         GT
Sbjct: 135 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGT 190
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
             Y+ PE       T+ +D +SFGV++ E+LTG  P +  +  E  +++
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 6/196 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G   +   VAVK  K     +V+ F+ E  ++  + H  +V+L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
            E   ++ E++  G+L  ++ +  E   +    L+  + +++  + Y+     I   HRD
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---HRD 135
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           +++AN+L+ +    K++DFG +R +  ++       +    +  PE      FT KSDV+
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 505 SFGVVLVEILT-GQKP 519
           SFG++L EI+T G+ P
Sbjct: 196 SFGILLYEIVTYGKIP 211

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 323 RILGQGGQGTVYK-GMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           R LG G  G V+      +GR  A+K   K  +V    VE   +E ++LS + H  I+++
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G   + +   ++ ++I  G L+  +    + FP    +    A EV  AL YLHS    
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNP--VAKFYAAEVCLALEYLHSKD-- 126
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            I +RD+K  NILLD     K++DFG ++ V      +T  + GT  Y+ PE   +  + 
Sbjct: 127 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINT 525
           +  D +SFG+++ E+L G  P    NT
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 18/229 (7%)
Query: 313 EKA-TDNYNANRILGQGGQGTVY---KGMLTDGR----IVAVKKSKLVDETNVEQFINEV 364
           EKA    +   ++LGQG  G V+   K   +D R    +  +KK+ L     V   + E 
Sbjct: 19  EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ER 77
Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
            IL ++NH  IVKL     +TE  L L+ +F+  G L+  +  ++     T E +     
Sbjct: 78  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLA 133
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           E++ AL +LHS   + I +RD+K  NILLD++   K++DFG S+   +D         GT
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGT 189
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
             Y+ PE       T+ +D +SFGV++ E+LTG  P +  +  E  +++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 325 LGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           +G+G  G V        GR VAVK   L  +   E   NEVVI+    H N+V++    L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
             E   ++ EF+  G L     + + +  +  E +  +   V  AL YLH+   I   HR
Sbjct: 113 VGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI---HR 165
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 503
           DIKS +ILL    R K+SDFG    +  D       V GT  ++ PE    S +  + D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEVDI 224
Query: 504 YSFGVVLVEILTGQKP 519
           +S G++++E++ G+ P
Sbjct: 225 WSLGIMVIEMVDGEPP 240

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNV-----EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + DG  V +  +  V   N      ++ ++E  +++ +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L V + +P G L  ++        +  + LL   ++++  + YL    
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGR--LGSQDLLNWCMQIAKGMSYLED-- 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
            + + HRD+ + N+L+      K++DFG +R + +D+T       +    ++  E     
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
           +FT +SDV+S+GV + E++T G KP   I   E   L+
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 323 RILGQGGQGTVYKGML-TDGR---IVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           +++G G  G V  G L   G+    VA+K  K+   D+     F++E  I+ Q +H NI+
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 93
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            L G   + +  +++ E++ NG+L  ++      F +    L+ +   +   + YL   +
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSDMS 151
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
           ++   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE    
Sbjct: 152 AV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+ G   +   VAVK  K     +V+ F+ E  ++  + H  +V+L     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
            E   ++ EF+  G+L  ++ +  E   +    L+  + +++  + Y+     I   HRD
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---HRD 134
Query: 445 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
           +++AN+L+ +    K++DFG +R +  ++       +    +  PE      FT KS+V+
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 505 SFGVVLVEILT-GQKP 519
           SFG++L EI+T G+ P
Sbjct: 195 SFGILLYEIVTYGKIP 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 323 RILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +++G G  G V  G L   G+    VA+K  K    E     F++E  I+ Q +H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G   ++   +++ EF+ NG+L  ++     +F +    L+ +   ++  + YL   A 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYL---AD 127
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQG---TFGYVDPEYFQ 493
           +   HR + + NIL++     KVSDFG SR +  D +  T T   G      +  PE  Q
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
             +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE---QFINEVVILSQINHR 373
           N+   + +G+G    VY+   L DG  VA+KK ++ D  + +     I E+ +L Q+NH 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 432
           N++K     +E     +V E    G L + I H + ++  I    + +  V++  AL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + HRDIK AN+ +      K+ D G  R     +T     + GT  Y+ PE  
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 208
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
             + +  KSD++S G +L E+   Q P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 137/309 (44%), Gaps = 56/309 (18%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVY----------EFI----PNGTLYQYIHNQIEEFP 412
             I  H+NI+ LLG C + + PL V           E++    P G  Y Y  N++ E  
Sbjct: 95  KMIGKHKNIINLLGACTQ-DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-V 471
           +T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 530
           D    TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEV 585
                        LF     ++LKE  + +     T     + + C +     RPT K++
Sbjct: 268 -------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 586 TNELGGIRT 594
             +L  I T
Sbjct: 310 VEDLDRILT 318

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 54/312 (17%)
Query: 313 EKATDNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  G V         K    +   VAVK  K    E ++   ++E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 409
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ 
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 139
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           E  +T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
             +D    TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E
Sbjct: 197 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 256
Query: 528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTM 582
                           LF     ++LKE  + +     T     + + C +     RPT 
Sbjct: 257 ----------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 295
Query: 583 KEVTNELGGIRT 594
           K++  +L  I T
Sbjct: 296 KQLVEDLDRILT 307

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    +++DFG +R +  +D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 268 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 311 EDLDRILT 318

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 29/268 (10%)
Query: 311 DLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVV 365
           D +    NY   + +G+G    V   + +LT GR VA+K   K++L + T++++   EV 
Sbjct: 6   DEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQL-NPTSLQKLFREVR 63
Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIA 422
           I+  +NH NIVKL    +ETE  L L+ E+   G ++ Y+  H +++E     +      
Sbjct: 64  IMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---- 118
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S    V     T    G
Sbjct: 119 -QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCG 172
Query: 483 TFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSLVGY 534
           +  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  + +
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 232
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIM 562
           ++    EN L   L    +K    E+IM
Sbjct: 233 YMSTDCENLLKRFLVLNPIKRGTLEQIM 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 138/313 (44%), Gaps = 56/313 (17%)
Query: 313 EKATDNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  G V         K    +   VAVK  K    E ++   ++E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVY----------EFI----PNGTLYQYIHNQI 408
           + ++  I  H+NI+ LLG C + + PL V           E++    P G  Y Y  N++
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
            E  +T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD 206
Query: 469 VM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 526
           +  +D    TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPT 581
           E                LF     ++LKE  + +     T     + + C +     RPT
Sbjct: 267 E----------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 582 MKEVTNELGGIRT 594
            K++  +L  I T
Sbjct: 306 FKQLVEDLDRILT 318

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 259
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 260 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 302
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 303 EDLDRILT 310

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 54/312 (17%)
Query: 313 EKATDNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  G V         K    +   VAVK  K    E ++   ++E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 409
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ 
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 137
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           E  +T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 470 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 527
             +D    TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E
Sbjct: 195 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 254
Query: 528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTM 582
                           LF     ++LKE  + +     T     + + C +     RPT 
Sbjct: 255 ----------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 293
Query: 583 KEVTNELGGIRT 594
           K++  +L  I T
Sbjct: 294 KQLVEDLDRILT 305

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 40/227 (17%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++    ++G GG G V+K     DG+   +++ K     N E+   EV  L++++H NIV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKY----NNEKAEREVKALAKLDHVNIV 68
Query: 377 KLLGC-------------CLE----------------TEVPLLVYEFIPNGTLYQYIHNQ 407
              GC              LE                T+   +  EF   GTL Q+I  +
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
             E  +   L L +  +++  + Y+HS   I   HRD+K +NI L D  + K+ DFG   
Sbjct: 129 RGE-KLDKVLALELFEQITKGVDYIHSKKLI---HRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
           S+  D     T+ +GT  Y+ PE   S  + ++ D+Y+ G++L E+L
Sbjct: 185 SLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 37/255 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 15  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 74
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE 410
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+   G L  ++  + E 
Sbjct: 75  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEA 132
Query: 411 F--------------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI 450
                                P+    LL  + +V+  + +L S   I   HRD+ + N+
Sbjct: 133 MLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNV 189
Query: 451 LLDDKYRAKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVV 509
           LL + + AK+ DFG +R +M D  ++     +    ++ PE      +T +SDV+S+G++
Sbjct: 190 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 249
Query: 510 LVEILT-GQKPIRAI 523
           L EI + G  P   I
Sbjct: 250 LWEIFSLGLNPYPGI 264

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 127/268 (47%), Gaps = 29/268 (10%)
Query: 311 DLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVV 365
           D +    NY   + +G+G    V   + +LT GR VA+K   K++L + T++++   EV 
Sbjct: 9   DEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQL-NPTSLQKLFREVR 66
Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIA 422
           I+  +NH NIVKL    +ETE  L L+ E+   G ++ Y+  H +++E     +      
Sbjct: 67  IMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---- 121
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S    V          G
Sbjct: 122 -QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCG 175
Query: 483 TFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSLVGY 534
              Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  + +
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235
Query: 535 FLQAINENRLFEALDARVLKEAKKEEIM 562
           ++    EN L   L    +K    E+IM
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
           +K  +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +++H   VKL     + E       +  NG L +YI  +I  F  T         E+  A
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSA 119
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV 487
           L YLH      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE        + SD+++ G ++ +++ G  P RA N
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 323 RILGQGGQGTVYKGML-TDGR---IVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           +++G G  G V  G L   G+    VA+K  K+   D+     F++E  I+ Q +H NI+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 72
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            L G   + +  +++ E++ NG+L  ++      F +    L+ +   +   + YL   +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSDMS 130
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE    
Sbjct: 131 YV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
           +K  +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +++H   VKL     + E       +  NG L +YI  +I  F  T         E+  A
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSA 121
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV 487
           L YLH      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE        + SD+++ G ++ +++ G  P RA N
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
           +K  +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +++H   VKL     + E       +  NG L +YI  +I  F  T         E+  A
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSA 122
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV 487
           L YLH      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE        + SD+++ G ++ +++ G  P RA N
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D++   R LG+G  G VY         IVA+K   KS++  E    Q   E+ I + ++H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L     +     L+ E+ P G LY+ +           +    I  E++ AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELADALMYC 139
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEY 491
           H    I   HRDIK  N+LL  K   K++DFG S    V    L  K   GT  Y+ PE 
Sbjct: 140 HGKKVI---HRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEM 192
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +     EK D++  GV+  E+L G  P  + + +E
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 140 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
           +K  +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +++H   VKL     + E       +  NG L +YI  +I  F  T         E+  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSA 120
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV 487
           L YLH      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE        + SD+++ G ++ +++ G  P RA N
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAVK   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T  
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-- 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSL 531
             G+  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           + +++    EN L + L     K    E+IM
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 323 RILGQGGQGTVYKGML-TDGR---IVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           +++G G  G V  G L   G+    VA+K  K+   D+     F++E  I+ Q +H NI+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 78
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            L G   + +  +++ E++ NG+L  ++      F +    L+ +   +   + YL   +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSDMS 136
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQS 494
            +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE    
Sbjct: 137 YV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 140 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                 ++ SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)
Query: 317 DNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V         K    +   VAVK  K    E ++   ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+              N++ E  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VD 472
           T++ L+    +++  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  +D
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSL 531
               TT  +    ++ PE      +T +SDV+SFGV++ EI T G  P   I  +E    
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEVT 586
                       LF     ++LKE  + +     T     + + C +     RPT K++ 
Sbjct: 314 ------------LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 587 NELGGIRT 594
            +L  I T
Sbjct: 357 EDLDRILT 364

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 140 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 142 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 35/257 (13%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML--TDGR----IVAVKKSKL-VD 353
           ++  K+      E    N    + LG+G  G V K       GR     VAVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------- 405
            + +   ++E  +L Q+NH +++KL G C +    LL+ E+   G+L  ++         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 406 -------------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
                        +  +E  +T   L+  A ++S  + YL   A + + HRD+ + NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSDVYSFGVVL 510
            +  + K+SDFG SR V  + +++  + QG     ++  E      +T +SDV+SFGV+L
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 511 VEILT-GQKPIRAINTD 526
            EI+T G  P   I  +
Sbjct: 243 WEIVTLGGNPYPGIPPE 259

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAVK   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T  
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-- 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSL 531
             G+  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           + +++    EN L + L     K    E+IM
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 84  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 141 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 139 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 142 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 114/218 (52%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 139 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 10/219 (4%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  ED
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 313 EKATDNYNANRILGQGGQGTVYK----GMLTD--GRI--VAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  G V      G+  D   R+  VAVK  K    E ++   I+E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI---------------HNQ 407
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+               HN 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
            E+  ++ + L+  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R
Sbjct: 144 EEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 468 SVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINT 525
            +  +D    TT  +    ++ PE      +T +SDV+SFGV+L EI T G  P   +  
Sbjct: 199 DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRP 580
           +E                LF     ++LKE  + +  +  T     + + C +     RP
Sbjct: 259 EE----------------LF-----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 581 TMKEVTNELGGI 592
           T K++  +L  I
Sbjct: 298 TFKQLVEDLDRI 309

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 140 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 35/257 (13%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML--TDGR----IVAVKKSKL-VD 353
           ++  K+      E    N    + LG+G  G V K       GR     VAVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------- 405
            + +   ++E  +L Q+NH +++KL G C +    LL+ E+   G+L  ++         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 406 -------------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
                        +  +E  +T   L+  A ++S  + YL   A + + HRD+ + NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILV 183
Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSDVYSFGVVL 510
            +  + K+SDFG SR V  ++     + QG     ++  E      +T +SDV+SFGV+L
Sbjct: 184 AEGRKMKISDFGLSRDV-YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 511 VEILT-GQKPIRAINTD 526
            EI+T G  P   I  +
Sbjct: 243 WEIVTLGGNPYPGIPPE 259

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 145 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 44/224 (19%)
Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH---------- 372
           +LGQG  G V K     D R  A+KK +  +E  +   ++EV++L+ +NH          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 373 ---RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVE 424
              RN VK +    +     +  E+  N TLY  IH+     Q +E+   W L  +I   
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY---WRLFRQIL-- 126
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-------VDQTHLT 477
              AL Y+HS     I HRD+K  NI +D+    K+ DFG +++V        +D  +L 
Sbjct: 127 --EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 478 ------TKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL 514
                 T   GT  YV  E    +  + EK D+YS G++  E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 35/257 (13%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML--TDGR----IVAVKKSKL-VD 353
           ++  K+      E    N    + LG+G  G V K       GR     VAVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------- 405
            + +   ++E  +L Q+NH +++KL G C +    LL+ E+   G+L  ++         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 406 -------------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 452
                        +  +E  +T   L+  A ++S  + YL   A + + HRD+ + NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQFTEKSDVYSFGVVL 510
            +  + K+SDFG SR V  ++     + QG     ++  E      +T +SDV+SFGV+L
Sbjct: 184 AEGRKMKISDFGLSRDV-YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 511 VEILT-GQKPIRAINTD 526
            EI+T G  P   I  +
Sbjct: 243 WEIVTLGGNPYPGIPPE 259

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 106 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
            +   HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 163 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 220 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 145 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 140 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 87  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 144 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 201 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 141 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 141 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 75  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
            +   HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 132 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 91  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 148 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 205 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 141 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGG-QGTVYKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G    TV    L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 146
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 128/271 (47%), Gaps = 29/271 (10%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAVK   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S             
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDA 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSL 531
             G   Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  
Sbjct: 172 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           + +++    EN L + L     K    E+IM
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAV+   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S            +
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDE 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSL 531
             G+  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           + +++    EN L + L     K    E+IM
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 28/246 (11%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ--- 407
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+   G L  ++  +   
Sbjct: 90  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 408 IEEFP--------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
           +E  P        ++   LL  + +V+  + +L S   I   HRD+ + N+LL + + AK
Sbjct: 148 LETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAK 204
Query: 460 VSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 517
           + DFG +R +M D  ++     +    ++ PE      +T +SDV+S+G++L EI + G 
Sbjct: 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 518 KPIRAI 523
            P   I
Sbjct: 265 NPYPGI 270

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 151
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 152 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 241

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 146
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 149
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 22/257 (8%)
Query: 310 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 365
           +DL    ++Y   +++G+G  G V    +K       +  + K +++  ++   F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I++  N   +V+L     +     +V E++P G L   + N   + P  W        EV
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFY--TAEV 177
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  +HS   I   HRD+K  N+LLD     K++DFGT   +  +         GT  
Sbjct: 178 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 486 YVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN- 540
           Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + +N 
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 288
Query: 541 ENRLFEALDARVLKEAK 557
           +N L    D  + KEAK
Sbjct: 289 KNSLTFPDDNDISKEAK 305

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 146
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAV+   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L LV E+   G ++ Y+  H +++E     +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T  
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-- 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSL 531
             G+  Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E        K  
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIM 562
           + +++    EN L + L     K    E+IM
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 149
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 146
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 78  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 135 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 192 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 22/257 (8%)
Query: 310 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 365
           +DL    ++Y   +++G+G  G V    +K       +  + K +++  ++   F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I++  N   +V+L     +     +V E++P G L   + N   + P  W        EV
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFY--TAEV 182
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  +HS   I   HRD+K  N+LLD     K++DFGT   +  +         GT  
Sbjct: 183 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 486 YVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN- 540
           Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + +N 
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 293
Query: 541 ENRLFEALDARVLKEAK 557
           +N L    D  + KEAK
Sbjct: 294 KNSLTFPDDNDISKEAK 310

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 148
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 312 LEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           L+   ++Y+  +++G+G  G V    +K       +  + K +++  ++   F  E  I+
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           +  N   +V+L     + +   +V E++P G L   + N   + P  W        EV  
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFY--TAEVVL 185
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKVQGTF 484
           AL  +HS   I   HRD+K  N+LLD     K++DFGT   + +D+T   H  T V GT 
Sbjct: 186 ALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVHCDTAV-GTP 239
Query: 485 GYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 540
            Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + ++
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGTYSKIMD 293
Query: 541 -ENRLFEALDARVLKEAK 557
            +N L    DA + K AK
Sbjct: 294 HKNSLCFPEDAEISKHAK 311

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 313 EKATDNYNANRILGQGGQGTVYK----GMLTD--GRI--VAVKKSKL-VDETNVEQFINE 363
           E   D     + LG+G  G V      G+  D   R+  VAVK  K    E ++   I+E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 364 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI---------------HNQ 407
           + ++  I  H+NI+ LLG C +     ++ E+   G L +Y+               HN 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
            E+  ++ + L+  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R
Sbjct: 129 EEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 468 SVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINT 525
            +  +D    TT  +    ++ PE      +T +SDV+SFGV+L EI T G  P   +  
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRP 580
           +E                LF     ++LKE  + +  +  T     + + C +     RP
Sbjct: 244 EE----------------LF-----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 581 TMKEVTNELGGI 592
           T K++  +L  I
Sbjct: 283 TFKQLVEDLDRI 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 177
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 276
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 22/257 (8%)
Query: 310 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 365
           +DL    ++Y   +++G+G  G V    +K       +  + K +++  ++   F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           I++  N   +V+L     +     +V E++P G L   + N   + P  W        EV
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFY--TAEV 182
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  +HS   I   HRD+K  N+LLD     K++DFGT   +  +         GT  
Sbjct: 183 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 486 YVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN- 540
           Y+ PE  +S      +  + D +S GV L E+L G  P  A       SLVG + + +N 
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 293
Query: 541 ENRLFEALDARVLKEAK 557
           +N L    D  + KEAK
Sbjct: 294 KNSLTFPDDNDISKEAK 310

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 118/260 (45%), Gaps = 19/260 (7%)
Query: 276 KLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK 335
           +L+QKF +                 I K     ++D  K TD +N   +LG+G  G V  
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKV-- 357
Query: 336 GMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 388
            ML++ +       +  +KK  ++ + +VE  + E  +L+       +  L  C +T   
Sbjct: 358 -MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416
Query: 389 L-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 447
           L  V E++  G L  +I  Q+  F     +    A E++  LF+L S     I +RD+K 
Sbjct: 417 LYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFY--AAEIAIGLFFLQSKG---IIYRDLKL 470
Query: 448 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 507
            N++LD +   K++DFG  +  + D    T    GT  Y+ PE      + +  D ++FG
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 508 VVLVEILTGQKPIRAINTDE 527
           V+L E+L GQ P    + DE
Sbjct: 530 VLLYEMLAGQAPFEGEDEDE 549

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 169
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 170 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 230 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 268
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 269 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 130
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 131 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 116/223 (52%), Gaps = 14/223 (6%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKS--KLVDETNVE---QFINEVVILSQIN 371
            +   ++LG G  GTVYKG+ + +G  V +  +  +L + T+ +   + ++E  +++ ++
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           + ++ +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + Y
Sbjct: 110 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 166
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPE 490
           L       + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E
Sbjct: 167 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
                 +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 218
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 317
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 318 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 166
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 167 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 227 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 265
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 266 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 145
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+         VAVK  K     +VE F+ E  ++  + H  +VKL      
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 79
Query: 385 TEVPL-LVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           T+ P+ ++ EF+  G+L  ++  ++  + P+    L+  + +++  + ++     I   H
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRNYI---H 134
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+++ANIL+      K++DFG +R +  ++       +    +  PE      FT KSD
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 194
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           V+SFG++L+EI+T G+ P   ++  E
Sbjct: 195 VWSFGILLMEIVTYGRIPYPGMSNPE 220

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 177
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 276
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 177
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 276
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              VKL     + E       +  NG L +YI  +I  F  T         E+  AL YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFY--TAEIVSALEYL 145
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEY 491
           H      I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE 
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
                  + SD+++ G ++ +++ G  P RA N
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 50/273 (18%)
Query: 344 VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           VAVK  K    E ++   I+E+ ++  I  H+NI+ LLG C +     ++ E+   G L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 402 QYI---------------HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 446
           +Y+               HN  E+  ++ + L+  A +V+  + YL S   I   HRD+ 
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQ--LSSKDLVSCAYQVARGMEYLASKKCI---HRDLA 170
Query: 447 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           + N+L+ +    K++DFG +R +  +D    TT  +    ++ PE      +T +SDV+S
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 506 FGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTV 564
           FGV+L EI T G  P   +  +E                LF     ++LKE  + +  + 
Sbjct: 231 FGVLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSN 269
Query: 565 AT-----LAKRCLNLNGKMRPTMKEVTNELGGI 592
            T     + + C +     RPT K++  +L  I
Sbjct: 270 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 28/246 (11%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAV-----KKSKL 351
           I+ T+L  ++  E   +N    + LG G  G V +    G+  +  ++ V     K +  
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 352 VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ--- 407
            DE   E  ++E+ I+S +  H NIV LLG C      L++ E+   G L  ++  +   
Sbjct: 90  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 408 IEEFPI--------TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
           +E  P         +   LL  + +V+  + +L S   I   HRD+ + N+LL + + AK
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAK 204
Query: 460 VSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 517
           + DFG +R +M D  ++     +    ++ PE      +T +SDV+S+G++L EI + G 
Sbjct: 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 518 KPIRAI 523
            P   I
Sbjct: 265 NPYPGI 270

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 313 EKA-TDNYNANRILGQGGQGTVY---------KGMLTDGRIVAVKKSKLVDETNVEQFIN 362
           EKA   ++   ++LGQG  G V+          G L   +++     K+ D    +    
Sbjct: 23  EKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM--- 79
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           E  IL+ +NH  +VKL     +TE  L L+ +F+  G L+  +  ++     T E +   
Sbjct: 80  ERDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFY 135
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
             E++  L +LHS   + I +RD+K  NILLD++   K++DFG S+   +D         
Sbjct: 136 LAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEA-IDHEKKAYSFC 191
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
           GT  Y+ PE       +  +D +S+GV++ E+LTG  P +  +  E  +L+
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+         VAVK  K     +VE F+ E  ++  + H  +VKL      
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 252
Query: 385 TEVPL-LVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           T+ P+ ++ EF+  G+L  ++  ++  + P+    L+  + +++  + ++     I   H
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRNYI---H 307
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+++ANIL+      K++DFG +R +  ++       +    +  PE      FT KSD
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           V+SFG++L+EI+T G+ P   ++  E
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPE 393

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 324 ILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL 378
           ++G G  G V +G L   G+    VA+K  K    E    +F++E  I+ Q  H NI++L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G    +   +++ EF+ NG L  ++     +F +    L+ +   ++  + YL   A +
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYL---AEM 135
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGTFG--YVDPEYFQ 493
              HRD+ + NIL++     KVSDFG SR +     D T+ T+ + G     +  PE   
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY-TSSLGGKIPIRWTAPEAIA 194
Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
             +FT  SD +S+G+V+ E+++ G++P
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 10/224 (4%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 15/234 (6%)
Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-Q 359
           +K K+   KD     D++     LG G  G V K      G I+A K   L  +  +  Q
Sbjct: 6   QKAKVGELKD-----DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ 60
Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
            I E+ +L + N   IV   G         +  E +  G+L Q +    E   I  E+L 
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILG 117
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
           ++++ V   L YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +   
Sbjct: 118 KVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS 172
Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
             GT  Y+ PE  Q + ++ +SD++S G+ LVE+  G+ PI   +  E +++ G
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFG 226

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 324 ILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL 378
           ++G G  G V +G L   G+    VA+K  K    E    +F++E  I+ Q  H NI++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G    +   +++ EF+ NG L  ++     +F +    L+ +   ++  + YL   A +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYL---AEM 137
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSR------SVMVDQTHLTTKVQGTFGYVDPEYF 492
              HRD+ + NIL++     KVSDFG SR      S   + + L  K+     +  PE  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI--PIRWTAPEAI 195
Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKP 519
              +FT  SD +S+G+V+ E+++ G++P
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGC 381
           +G G  G V+K      G ++AVK+ +     E N    ++  V+L   +   IV+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
            +      +  E +  GT  + +  +++  PI   +L ++ V +  AL+YL     +   
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKHGV--I 147
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE-- 499
           HRD+K +NILLD++ + K+ DFG S  ++ D+     +  G   Y+ PE       T+  
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 500 ---KSDVYSFGVVLVEILTGQKPIRAINTD 526
              ++DV+S G+ LVE+ TGQ P +   TD
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNVEQFINEVVILSQINH 372
           +++  +++LG+G  G V+            I A+KK  ++ + +VE  + E  +LS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  + C  +T+  L  V E++  G L  +I +   +F ++       A E+   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATF--YAAEIILGLQF 134
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LHS     I +RD+K  NILLD     K++DFG  +  M+     T +  GT  Y+ PE 
Sbjct: 135 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYIAPEI 190
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
               ++    D +SFGV+L E+L GQ P    + +E
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 226

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 11/224 (4%)
Query: 325 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG G   TVYKG+  T G  VA+K+ KL  +E      I E+ ++ ++ H NIV+L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLL--RIAVEVSGALFYLHSAASIP 439
                  LV+EF+ N  L +Y+ ++ +   P   EL L      ++   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-FT 498
           I HRD+K  N+L++ + + K+ DFG +R+  +     +++V  T  Y  P+    S+ ++
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYS 187
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
              D++S G +L E++TG+      N +E   L+   +   NE+
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 324 ILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR-NIV 376
           ++G+G  G V K      G+  D  I  +K+    D+     F  E+ +L ++ H  NI+
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 89
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAV 423
            LLG C       L  E+ P+G L  ++     +E  P           ++ + LL  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQ 481
           +V+  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V V +T     V+
Sbjct: 150 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
               ++  E    S +T  SDV+S+GV+L EI++
Sbjct: 207 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 324 ILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR-NIV 376
           ++G+G  G V K      G+  D  I  +K+    D+     F  E+ +L ++ H  NI+
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 79
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAV 423
            LLG C       L  E+ P+G L  ++     +E  P           ++ + LL  A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQ 481
           +V+  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V V +T     V+
Sbjct: 140 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 196
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
               ++  E    S +T  SDV+S+GV+L EI++
Sbjct: 197 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 113/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++L  G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L++ + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 88  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 145 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 19/227 (8%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFI 361
           ++D  K TD +N   +LG+G  G V   ML++ +       +  +KK  ++ + +VE  +
Sbjct: 13  NRDRMKLTD-FNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTM 68
Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
            E  +L+       +  L  C +T   L  V E++  G L  +I  Q+  F     +   
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFY- 126
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
            A E++  LF+L S     I +RD+K  N++LD +   K++DFG  +  + D    T   
Sbjct: 127 -AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXF 181
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            GT  Y+ PE      + +  D ++FGV+L E+L GQ P    + DE
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++L  G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 145 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVY----KGMLTDGRIVAVKKSKLV------DET 355
           ++  K   K  ++Y   R LG G  G V     K   ++  I  +KKS+        D  
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 356 NVEQF----INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN--QIE 409
           N+E+F     NE+ +L  ++H NI+KL     + +   LV EF   G L++ I N  + +
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTS 466
           E          I  ++   + YLH      I HRDIK  NILL++K      K+ DFG S
Sbjct: 145 ECDAA-----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
            S       L  ++ GT  Y+ PE  +  ++ EK DV+S GV++  +L G  P    N D
Sbjct: 197 -SFFSKDYKLRDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-D 252
Query: 527 ED 528
           +D
Sbjct: 253 QD 254

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 10/223 (4%)
Query: 313 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 370
           E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L + 
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 180
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ PE
Sbjct: 181 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 235
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
             Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 323 RILGQGGQGTVYKGM-LTDGR----IVAVKKSKLVDETNV-EQFINEVVILSQINHRNIV 376
           ++L  G  GTVYKG+ + +G      VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V L+  + +P G L  Y+    +   I  + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              + HRD+ + N+L+      K++DFG ++ +  ++     +  +    ++  E     
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
            +T +SDV+S+GV + E++T G KP   I   E  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 10/223 (4%)
Query: 313 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 370
           E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L + 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 145
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ PE
Sbjct: 146 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 200
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
             Q + ++ +SD++S G+ LVE+  G+ PI   +  E + + G
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 374
           + Y     +G+G  G VYK   + GRIVA+K+ +L   DE      I E+ +L +++H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEVSGALF 430
           IV L+          LV+EF+          N    Q  +  I    LLR        + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR-------GVA 133
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           + H      I HRD+K  N+L++     K++DFG +R+  +     T +V  T  Y  P+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
Query: 491 YFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
               S +++   D++S G +  E++TG KP+    TD+D+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQ 228

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y   R+LG+G  G V   K  +T G+  AVK   K ++  +T+ E  + EV +L Q+
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +H NI+KL     +     LV E    G L+  I   I     +     RI  +V   + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGIT 146
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  +  K+ GT  Y+
Sbjct: 147 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYI 201
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE    + + EK DV+S GV+L  +L+G  P    N
Sbjct: 202 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y   R+LG+G  G V   K  +T G+  AVK   K ++  +T+ E  + EV +L Q+
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +H NI+KL     +     LV E    G L+  I   I     +     RI  +V   + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGIT 164
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  +  K+ GT  Y+
Sbjct: 165 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYI 219
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE    + + EK DV+S GV+L  +L+G  P    N
Sbjct: 220 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 320 NANRI-LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           N +R+ LG+G  G VY G  L++   +A+K+    D    +    E+ +   + H+NIV+
Sbjct: 24  NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
            LG   E     +  E +P G+L   + ++        + +     ++   L YLH    
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 142
Query: 438 IPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
             I HRDIK  N+L+ + Y    K+SDFGTS+  +      T    GT  Y+ PE     
Sbjct: 143 --IVHRDIKGDNVLI-NTYSGVLKISDFGTSKR-LAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 496 Q--FTEKSDVYSFGVVLVEILTGQKP 519
              + + +D++S G  ++E+ TG+ P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 374
           + Y     +G+G  G VYK   + GRIVA+K+ +L   DE      I E+ +L +++H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEVSGALF 430
           IV L+          LV+EF+          N    Q  +  I    LLR        + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR-------GVA 133
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           + H      I HRD+K  N+L++     K++DFG +R+  +     T +V  T  Y  P+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
Query: 491 YFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
               S +++   D++S G +  E++TG KP+    TD+D+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQ 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y   R+LG+G  G V   K  +T G+  AVK   K ++  +T+ E  + EV +L Q+
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +H NI+KL     +     LV E    G L+  I   I     +     RI  +V   + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGIT 163
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  +  K+ GT  Y+
Sbjct: 164 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYI 218
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE    + + EK DV+S GV+L  +L+G  P    N
Sbjct: 219 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 22/234 (9%)
Query: 308 TSKDLEKATDNYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFIN 362
           TS D +    NY   + +G+G    V   + +LT G+ VAVK   K++L + +++++   
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQL-NSSSLQKLFR 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I   +NH NIVKL    +ETE  L LV E+   G ++ Y+  H + +E     +   
Sbjct: 63  EVRIXKVLNHPNIVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR- 120
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S             
Sbjct: 121 ----QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDA 171
Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
             G   Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E +  V
Sbjct: 172 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 12/216 (5%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNVEQFINEVVILSQINH 372
           +++  +++LG+G  G V+            I A+KK  ++ + +VE  + E  +LS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  + C  +T+  L  V E++  G L  +I +   +F ++       A E+   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATF--YAAEIILGLQF 133
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LHS     I +RD+K  NILLD     K++DFG  +  M+     T    GT  Y+ PE 
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAPEI 189
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
               ++    D +SFGV+L E+L GQ P    + +E
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y   R+LG+G  G V   K  +T G+  AVK   K ++  +T+ E  + EV +L Q+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +H NI+KL     +     LV E    G L+  I   I     +     RI  +V   + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGIT 140
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  +  K+ GT  Y+
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYI 195
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
            PE    + + EK DV+S GV+L  +L+G  P    N
Sbjct: 196 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S++NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 161 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 320 NANRI-LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           N +R+ LG+G  G VY G  L++   +A+K+    D    +    E+ +   + H+NIV+
Sbjct: 10  NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
            LG   E     +  E +P G+L   + ++        + +     ++   L YLH    
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 128
Query: 438 IPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
             I HRDIK  N+L+ + Y    K+SDFGTS+  +      T    GT  Y+ PE     
Sbjct: 129 --IVHRDIKGDNVLI-NTYSGVLKISDFGTSKR-LAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 496 Q--FTEKSDVYSFGVVLVEILTGQKP 519
              + + +D++S G  ++E+ TG+ P
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S++NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 147 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 138 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 194
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 29/261 (11%)
Query: 318 NYNANRILGQGGQGTV--YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           NY   + +G+G    V   + +LT G+ VAVK   K++L + +++++   EV I+  +NH
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLNH 65
Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
            NIVKL    +ETE  L LV E+   G ++ Y+  H  ++E     +       ++  A+
Sbjct: 66  PNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----QIVSAV 119
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y H      I HRD+K+ N+LLD     K++DFG S          T    G+  Y  P
Sbjct: 120 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAP 174
Query: 490 EYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE-------DKSLVGYFLQAINE 541
           E FQ  ++   + DV+S GV+L  +++G  P    N  E        K  + +++    E
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 234
Query: 542 NRLFEALDARVLKEAKKEEIM 562
           N L + L     K    E+IM
Sbjct: 235 NLLKKFLILNPSKRGTLEQIM 255

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 324 ILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR-NIV 376
           ++G+G  G V K      G+  D  I  +K+    D+     F  E+ +L ++ H  NI+
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 86
Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAV 423
            LLG C       L  E+ P+G L  ++     +E  P           ++ + LL  A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQ 481
           +V+  + YL     I   HR++ + NIL+ + Y AK++DFG SR   V V +T     V+
Sbjct: 147 DVARGMDYLSQKQFI---HRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 203
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
               ++  E    S +T  SDV+S+GV+L EI++
Sbjct: 204 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVK+ +         F  E+ IL  ++   IVK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G       +   LV E++P+G L  ++         +   LL  + ++   + YL S   
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRRC 135
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           +   HRD+ + NIL++ +   K++DFG ++ + +D+ +   +  G    F Y  PE    
Sbjct: 136 V---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSD 191
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           + F+ +SDV+SFGVVL E+ T          D+  S    FL+ +   R   AL   +  
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT--------YCDKSCSPSAEFLRMMGSERDVPALSRLLEL 243
Query: 555 EAKKEEIMT-------VATLAKRCLNLNGKMRPTMKEVTNEL 589
             + + +         V  L K C   + + RP+   +  +L
Sbjct: 244 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 146 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 161 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 146 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVK+ +         F  E+ IL  ++   IVK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 380 GCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G       P   LV E++P+G L  ++         +   LL  + ++   + YL S   
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRRC 132
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           +   HRD+ + NIL++ +   K++DFG ++ + +D+     +  G    F Y  PE    
Sbjct: 133 V---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA-PESLSD 188
Query: 495 SQFTEKSDVYSFGVVLVEILT 515
           + F+ +SDV+SFGVVL E+ T
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 147 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 33  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 153 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 209
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 43  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 163 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 219
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 10/209 (4%)
Query: 313 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 370
           E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L + 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 121
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YL     I   HRD+K +NIL++ +   K+ DFG S   ++D+  +  +  GT  Y+ PE
Sbjct: 122 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDE--MANEFVGTRSYMSPE 176
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             Q + ++ +SD++S G+ LVE+  G+ P
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 313 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 370
           E   D++     LG G  G V+K      G ++A K   L  +  +  Q I E+ +L + 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 137
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ PE
Sbjct: 138 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 192
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
             Q + ++ +SD++S G+ LVE+  G+ PI
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 53  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 173 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 229
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 161 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 44  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 164 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 220
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +   
Sbjct: 187 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 44/224 (19%)
Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +LGQG  G V K     D R  A+KK +  +E  +   ++EV +L+ +NH+ +V+     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 383 LE--------TEVP-----LLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVE 424
           LE        T V       +  E+  N TLY  IH+     Q +E+   W L  +I   
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY---WRLFRQIL-- 126
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-------VDQTHLT 477
              AL Y+HS     I HR++K  NI +D+    K+ DFG +++V        +D  +L 
Sbjct: 127 --EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 478 ------TKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL 514
                 T   GT  YV  E    +  + EK D YS G++  E +
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVK+ +         F  E+ IL  ++   IVK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G       +   LV E++P+G L  ++         +   LL  + ++   + YL S   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRRC 148
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           +   HRD+ + NIL++ +   K++DFG ++ + +D+ +   +  G    F Y  PE    
Sbjct: 149 V---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSD 204
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
           + F+ +SDV+SFGVVL E+ T          D+  S    FL+ +   R   AL   +  
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT--------YCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 555 EAKKEEIMT-------VATLAKRCLNLNGKMRPTMKEVTNEL 589
             + + +         V  L K C   + + RP+   +  +L
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y   R+LG+G  G V   K  +T G+  AVK   K ++  +T+ E  + EV +L Q+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +H NI KL     +     LV E    G L+  I   I     +     RI  +V   + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGIT 140
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ-----G 482
           Y H      I HRD+K  N+LL+ K +    ++ DFG S       TH     +     G
Sbjct: 141 YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKXKDKIG 190
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           T  Y+ PE    + + EK DV+S GV+L  +L+G  P    N
Sbjct: 191 TAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 137
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG S ++
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGAL 193
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 246
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 247 EEIIGGQVFFRQ-------------RVSSECQH--------LIRWCLALRPSDRPTFEEI 285
Query: 586 TNE 588
            N 
Sbjct: 286 QNH 288

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 325 LGQGGQGTV----YKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           LG+G  G+V    Y  +  + G +VAVK+ +         F  E+ IL  ++   IVK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 380 GCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           G       +   LV E++P+G L  ++         +   LL  + ++   + YL S   
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRRC 136
Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           +   HRD+ + NIL++ +   K++DFG ++ + +D+ +   +  G    F Y  PE    
Sbjct: 137 V---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSD 192
Query: 495 SQFTEKSDVYSFGVVLVEILT 515
           + F+ +SDV+SFGVVL E+ T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG G  G V+         VAVK  K     +VE F+ E  ++  + H  +VKL      
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 246
Query: 385 TEVPL-LVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           T+ P+ ++ EF+  G+L  ++  ++  + P+    L+  + +++  + ++     I   H
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRNYI---H 301
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 502
           RD+++ANIL+      K++DFG +R             +    +  PE      FT KSD
Sbjct: 302 RDLRAANILVSASLVCKIADFGLAR----------VGAKFPIKWTAPEAINFGSFTIKSD 351
Query: 503 VYSFGVVLVEILT-GQKPIRAINTDE 527
           V+SFG++L+EI+T G+ P   ++  E
Sbjct: 352 VWSFGILLMEIVTYGRIPYPGMSNPE 377

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 137
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG S ++
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGAL 193
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 246
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 247 EEIIGGQVFFRQ-------------RVSSECQH--------LIRWCLALRPSDRPTFEEI 285
Query: 586 TNE 588
            N 
Sbjct: 286 QNH 288

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 136
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 192
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 245
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 246 EEIIGGQVFFRQ-------------RVSSECQH--------LIRWCLALRPSDRPTFEEI 284
Query: 586 TNE 588
            N 
Sbjct: 285 QNH 287

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFINEVV 365
           E    N    R LG G  G VY+G ++          VAVK   ++  E +   F+ E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL----LLRI 421
           I+S+ NH+NIV+ +G  L++    ++ E +  G L  ++            L    LL +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTT 478
           A +++    YL     I   HRDI + N LL        AK+ DFG ++ +     +   
Sbjct: 147 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKG 203
Query: 479 K-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 515
                   ++ PE F    FT K+D +SFGV+L EI +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 136
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG S ++
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGAL 192
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 245
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 246 EEIIGGQVFFRQ-------------RVSSECQH--------LIRWCLALRPSDRPTFEEI 284
Query: 586 TNE 588
            N 
Sbjct: 285 QNH 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGR--IVAVKKSKLVDETNVEQFINEVVILSQIN 371
           +D Y   + LG G  G V   K  LT     I  +KKS +   +N    ++EV +L Q++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NI+KL     +     LV E    G L+  I  + +   +   ++++   +V     Y
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTY 136
Query: 432 LHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           LH      I HRD+K  N+LL+ K R    K+ DFG S    V       +  GT  Y+ 
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIA 191
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           PE  +  ++ EK DV+S GV+L  +L G  P     TD++
Sbjct: 192 PEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGG-QTDQE 229

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 137
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 193
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 246
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 247 EEIIGGQVFFRQ-------------RVSXECQH--------LIRWCLALRPSDRPTFEEI 285
Query: 586 TNE 588
            N 
Sbjct: 286 QNH 288

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 137
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG S ++
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGAL 193
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 246
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 247 EEIIGGQVFFRQ-------------RVSXECQH--------LIRWCLALRPSDRPTFEEI 285
Query: 586 TNE 588
            N 
Sbjct: 286 QNH 288

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 136
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG S ++
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGAL 192
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      + D
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHD 245
Query: 529 KSLVG---YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++G   +F Q             RV  E +         L + CL L    RPT +E+
Sbjct: 246 EEIIGGQVFFRQ-------------RVSXECQH--------LIRWCLALRPSDRPTFEEI 284
Query: 586 TNE 588
            N 
Sbjct: 285 QNH 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 374
           D+Y    ++G G    V        +  VA+K+  L   +T++++ + E+  +SQ +H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-----ITWELLLRIAVEVSGAL 429
           IV      +  +   LV + +  G++   I + + +       +    +  I  EV   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---- 485
            YLH    I   HRD+K+ NILL +    +++DFG S  +         KV+ TF     
Sbjct: 130 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 486 YVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE   Q   +  K+D++SFG+  +E+ TG  P
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 374
           D+Y    ++G G    V        +  VA+K+  L   +T++++ + E+  +SQ +H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-----ITWELLLRIAVEVSGAL 429
           IV      +  +   LV + +  G++   I + + +       +    +  I  EV   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---- 485
            YLH    I   HRD+K+ NILL +    +++DFG S  +         KV+ TF     
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 486 YVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE  +  + +  K+D++SFG+  +E+ TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 313 EKATDNYNANRILGQGGQGTVYK----GMLTDGRIVAVKKSKLVDETNVEQ---FINEVV 365
           E   +N    R +G+G  G V++    G+L       V    L +E + +    F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI------------HNQIE---- 409
           ++++ ++ NIVKLLG C   +   L++E++  G L +++            H+ +     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 410 -----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 464
                  P++    L IA +V+  + YL     +   HRD+ + N L+ +    K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFG 219
Query: 465 TSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 522
            SR++   D             ++ PE    +++T +SDV+++GVVL EI + G +P   
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 523 INTDE 527
           +  +E
Sbjct: 280 MAHEE 284

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF-- 360
            +LF   D EK    ++  R +G G  G VY    + +  +VA+KK     + + E++  
Sbjct: 44  AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 361 -INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITWEL 417
            I EV  L ++ H N ++  GC L      LV E+ + + +    +H + ++E       
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------- 153
Query: 418 LLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            + IA    GAL    YLHS   I   HRD+K+ NILL +    K+ DFG++ S+M    
Sbjct: 154 -VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSA-SIMAPAN 208
Query: 475 HLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
                  GT  ++ PE        Q+  K DV+S G+  +E+   + P+  +N 
Sbjct: 209 XFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK-KSKLVDETNVEQFINEVV 365
           K  E   D Y+   +LG G    V   +  D R   +VA+K  +K   E       NE+ 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +I H NIV L           L+ + +  G L+  I   +E+   T     R+  +V
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQV 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
             A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+  M D   + +   G
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACG 180
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           T GYV PE      +++  D +S GV+   +L G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 304 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF-- 360
            +LF   D EK    ++  R +G G  G VY    + +  +VA+KK     + + E++  
Sbjct: 5   AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 361 -INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITWEL 417
            I EV  L ++ H N ++  GC L      LV E+ + + +    +H + ++E       
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------- 114
Query: 418 LLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            + IA    GAL    YLHS   I   HRD+K+ NILL +    K+ DFG++ S+M    
Sbjct: 115 -VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSA-SIMAPAN 169
Query: 475 HLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
                  GT  ++ PE        Q+  K DV+S G+  +E+   + P+  +N 
Sbjct: 170 XFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 323 RILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVV---ILSQINHRNIVKL 378
           R+LG+GG G V+   M   G++ A KK         + +   +V   IL++++ R IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSA 435
                ET+  L LV   +  G +  +I+N  E+ P   E   +   A  VSG L +LH  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLHQR 308
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRA 522
           ++    D ++ GV L E++  + P RA
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 323 RILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVV---ILSQINHRNIVKL 378
           R+LG+GG G V+   M   G++ A KK         + +   +V   IL++++ R IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSA 435
                ET+  L LV   +  G +  +I+N  E+ P   E   +   A  VSG L +LH  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLHQR 308
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRA 522
           ++    D ++ GV L E++  + P RA
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 120 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 323 RILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVV---ILSQINHRNIVKL 378
           R+LG+GG G V+   M   G++ A KK         + +   +V   IL++++ R IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSA 435
                ET+  L LV   +  G +  +I+N  E+ P   E   +   A  VSG L +LH  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLHQR 308
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRA 522
           ++    D ++ GV L E++  + P RA
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-T 167
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 323 RILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVV---ILSQINHRNIVKL 378
           R+LG+GG G V+   M   G++ A KK         + +   +V   IL++++ R IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSA 435
                ET+  L LV   +  G +  +I+N  E+ P   E   +   A  VSG L +LH  
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLHQR 308
Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
               I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRA 522
           ++    D ++ GV L E++  + P RA
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK-KSKLVDETNVEQFINEVV 365
           K  E   D Y+   +LG G    V   +  D R   +VA+K  +K   E       NE+ 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +I H NIV L           L+ + +  G L+  I   +E+   T     R+  +V
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQV 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
             A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+  M D   + +   G
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACG 180
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           T GYV PE      +++  D +S GV+   +L G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 120 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK-KSKLVDETNVEQFINEVV 365
           K  E   D Y+   +LG G    V   +  D R   +VA+K  +K   E       NE+ 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +I H NIV L           L+ + +  G L+  I   +E+   T     R+  +V
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQV 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
             A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+  M D   + +   G
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACG 180
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           T GYV PE      +++  D +S GV+   +L G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 117 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 172
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK-KSKLVDETNVEQFINEVV 365
           K  E   D Y+   +LG G    V   +  D R   +VA+K  +K   E       NE+ 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L +I H NIV L           L+ + +  G L+  I   +E+   T     R+  +V
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQV 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
             A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+  M D   + +   G
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACG 180
Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           T GYV PE      +++  D +S GV+   +L G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK-LVDETNVEQFINEV 364
           FT++DL+   +       +G+G  G+V K +    G+I+AVK+ +  VDE   +Q + ++
Sbjct: 19  FTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 365 -VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRI 421
            V++   +   IV+  G         +  E +       Y+Y+++ +++  I  E+L +I
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKI 130
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
            +    AL +L    ++ I HRDIK +NILLD     K+ DFG S   +VD     T+  
Sbjct: 131 TLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIA-KTRDA 186
Query: 482 GTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINT 525
           G   Y+ PE    S     +  +SDV+S G+ L E+ TG+ P    N+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 314 KATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           K +DNY+    LG+G    V +      G+    +I+  KK    D   +E+   E  I 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 59
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIA 422
            ++ H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  IA
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 479
                   Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +     
Sbjct: 120 --------YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 166
Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             GT GY+ PE  +   +++  D+++ GV+L  +L G  P      DED+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF----WDEDQ 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 314 KATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           K +DNY+    LG+G    V +      G+    +I+  KK    D   +E+   E  I 
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 82
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIA 422
            ++ H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  IA
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 142
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 479
                   Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +     
Sbjct: 143 --------YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 189
Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             GT GY+ PE  +   +++  D+++ GV+L  +L G  P      DED+
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF----WDEDQ 235

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 314 KATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           K +DNY+    LG+G    V +      G+    +I+  KK    D   +E+   E  I 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 59
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIA 422
            ++ H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  IA
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 479
                   Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +     
Sbjct: 120 --------YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 166
Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             GT GY+ PE  +   +++  D+++ GV+L  +L G  P      DED+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF----WDEDQ 212

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           ILGQG    V++G     G + A+K       +   +V+  + E  +L ++NH+NIVKL 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 380 GCCLETEV--PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
               ET     +L+ EF P G+LY  +      + +     L +  +V G + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 438 IPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
             I HR+IK  NI+     D +   K++DFG +R +  D+  +   + GT  Y+ P+ ++
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMYE 188
Query: 494 SS--------QFTEKSDVYSFGVVLVEILTGQKPIR 521
            +        ++    D++S GV      TG  P R
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 16/235 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML--TDGRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 372
           +++  R++G+G    V    L  TD RI A+K  K +LV D+ +++    E  +  Q ++
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNY 136
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE 
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXFCGTPNYIAPEI 192
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 544
            +   +    D ++ GV++ E++ G+ P   + + +  D++   Y  Q I E ++
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 247

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 314 KATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 367
           K +DNY+    LG+G    V +      G+    +I+  KK    D   +E+   E  I 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 58
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIA 422
            ++ H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  IA
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 118
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 479
                   Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +     
Sbjct: 119 --------YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 165
Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             GT GY+ PE  +   +++  D+++ GV+L  +L G  P      DED+
Sbjct: 166 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF----WDEDQ 211

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 324 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 379
           ILGQG    V++G     G + A+K       +   +V+  + E  +L ++NH+NIVKL 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 380 GCCLETEV--PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
               ET     +L+ EF P G+LY  +      + +     L +  +V G + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 438 IPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
             I HR+IK  NI+     D +   K++DFG +R +  D+  ++  + GT  Y+ P+ ++
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 494 SS--------QFTEKSDVYSFGVVLVEILTGQKPIR 521
            +        ++    D++S GV      TG  P R
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 113 LQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 316 TDNYNANRILGQGGQGTVY--KGMLTDGR--IVAVKKSKLVDETNVEQFINEVVILSQIN 371
           +D Y   + LG G  G V   K  LT     I  +KKS +   +N    ++EV +L Q++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NI+KL     +     LV E    G L+  I  + +   +   ++++   +V     Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTY 119
Query: 432 LHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           LH      I HRD+K  N+LL+ K R    K+ DFG S    V       +  GT  Y+ 
Sbjct: 120 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIA 174
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           PE  +  ++ EK DV+S GV+L  +L G  P
Sbjct: 175 PEVLR-KKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 16/235 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML--TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINH 372
           +++  R++G+G    V    L  TD RI A   VKK  + D+ +++    E  +  Q ++
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNY 168
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE 
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEI 224
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 544
            +   +    D ++ GV++ E++ G+ P   + + +  D++   Y  Q I E ++
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 16/235 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML--TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINH 372
           +++  R++G+G    V    L  TD RI A   VKK  + D+ +++    E  +  Q ++
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNY 125
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE 
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXFCGTPNYIAPEI 181
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 544
            +   +    D ++ GV++ E++ G+ P   + + +  D++   Y  Q I E ++
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKS-KLVDETNVE-----QFINEVVILSQ 369
           ++ Y   + LG G  G V   +L   ++  V+++ K++ +T+V      + + EV +L  
Sbjct: 36  SEMYQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           ++H NI+KL     +     LV E    G L+  I ++++   +   ++++   +V   +
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGV 149
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            YLH      I HRD+K  N+LL+ K +    K+ DFG S +V  +Q  +  ++ GT  Y
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMKERL-GTAYY 204
Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           + PE  +  ++ EK DV+S GV+L  +L G  P
Sbjct: 205 IAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 16/235 (6%)
Query: 318 NYNANRILGQGGQGTVYKGML--TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINH 372
           +++  R++G+G    V    L  TD RI A   VKK  + D+ +++    E  +  Q ++
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 373 RNIVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
              +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNY 121
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y+ PE 
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXFCGTPNYIAPEI 177
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 544
            +   +    D ++ GV++ E++ G+ P   + + +  D++   Y  Q I E ++
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 117/231 (50%), Gaps = 40/231 (17%)
Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQIN-HRN 374
           Y   + LG+G  G V+K +    G +VAVKK      + T+ ++   E++IL++++ H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 375 IVKLLGCCL---ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           IV LL       + +V  LV++++    L+  I   I E P+  + ++   ++V   + Y
Sbjct: 71  IVNLLNVLRADNDRDV-YLVFDYMETD-LHAVIRANILE-PVHKQYVVYQLIKV---IKY 124
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--------------------- 470
           LHS     + HRD+K +NILL+ +   KV+DFG SRS +                     
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 471 VDQTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            DQ  LT  V  T  Y  PE    S+++T+  D++S G +L EIL G KPI
Sbjct: 182 DDQPILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 45/313 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSKLVDE 354
           I+ T+L      E   +  +  + LG G  G     T Y  + +D  + VAVK  K    
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 355 -TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S   I   HRD+ + NILL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 183
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            K+ DFG +R +  D  ++     +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 516 GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVLKEAKKEEIMTVATLAKRCLNL 574
           G  P   +  D        F + I E  R+     A     A+  +IM      K C + 
Sbjct: 244 GSSPYPGMPVDSK------FYKMIKEGFRMLSPEHA----PAEMYDIM------KTCWDA 287
Query: 575 NGKMRPTMKEVTN 587
           +   RPT K++  
Sbjct: 288 DPLKRPTFKQIVQ 300

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE---QFINEVVILSQINH 372
           + +   R+LG+GG G V    +   G++ A KK +       +     +NE  IL ++N 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFY 431
           R +V L       +   LV   +  G L  +I++  +  FP    +    A E+   L  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF--YAAEICCGLED 301
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  NILLDD    ++SD G +  V   QT +  +V GT GY+ PE 
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPI----RAINTDEDKSLV 532
            ++ ++T   D ++ G +L E++ GQ P     + I  +E + LV
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 27  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 87  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 143
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 144 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 199
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 200 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 254
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     I   ++F     RV  E +         L + CL L    RPT +E+ N 
Sbjct: 255 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQNH 294

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 7   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 66
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 67  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 123
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 179
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 180 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 234
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 235 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 273

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKDFMDASALTGIPLPLIKSYLF 110
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 317 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE---QFINEVVILSQINH 372
           + +   R+LG+GG G V    +   G++ A KK +       +     +NE  IL ++N 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFY 431
           R +V L       +   LV   +  G L  +I++  +  FP    +    A E+   L  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF--YAAEICCGLED 301
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH      I +RD+K  NILLDD    ++SD G +  V   QT +  +V GT GY+ PE 
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPI----RAINTDEDKSLV 532
            ++ ++T   D ++ G +L E++ GQ P     + I  +E + LV
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 124
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 180
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 235
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 236 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 274

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 45/313 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSKLVDE 354
           I+ T+L      E   +  +  + LG G  G     T Y  + +D  + VAVK  K    
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 355 -TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S   I   HRD+ + NILL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 206
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            K+ DFG +R +  D  ++     +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 207 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 516 GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVLKEAKKEEIMTVATLAKRCLNL 574
           G  P   +  D        F + I E  R+     A     A+  +IM      K C + 
Sbjct: 267 GSSPYPGMPVDSK------FYKMIKEGFRMLSPEHA----PAEMYDIM------KTCWDA 310
Query: 575 NGKMRPTMKEVTN 587
           +   RPT K++  
Sbjct: 311 DPLKRPTFKQIVQ 323

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 323 RILGQGGQGTVYK-----GMLTDGRIVAVK---KSKLV-DETNVEQFINEVVILSQINHR 373
           R+LG+GG G V++     G  T G+I A+K   K+ +V +  +      E  IL ++ H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANT-GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE-LLLRIAVEVSGALFYL 432
            IV L+          L+ E++  G L+     Q+E   I  E        E+S AL +L
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFM----QLEREGIFMEDTACFYLAEISMALGHL 137
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      I +RD+K  NI+L+ +   K++DFG  +  + D T +T    GT  Y+ PE  
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEIL 193
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
             S      D +S G ++ ++LTG  P    N
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 45/313 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSKLVDE 354
           I+ T+L      E   +  +  + LG G  G     T Y  + +D  + VAVK  K    
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 355 -TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S   I   HRD+ + NILL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 206
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            K+ DFG +R +  D  ++     +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 207 TKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 516 GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVLKEAKKEEIMTVATLAKRCLNL 574
           G  P   +  D        F + I E  R+     A     A+  +IM      K C + 
Sbjct: 267 GSSPYPGMPVDSK------FYKMIKEGFRMLSPEHA----PAEMYDIM------KTCWDA 310
Query: 575 NGKMRPTMKEVTN 587
           +   RPT K++  
Sbjct: 311 DPLKRPTFKQIVQ 323

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL   + TE  L +        +++++H  ++ F        I   L+     ++
Sbjct: 61  PNIVKLLDV-IHTENKLYL--------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 124
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 180
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 235
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 236 ----------IIRGQVF--FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQN 274

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 151
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 207
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 262
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     I   ++F     RV  E +         L + CL L    RPT +E+ N 
Sbjct: 263 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQNH 302

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 323 RILGQGGQGTVYK-----GMLTDGRIVAVK---KSKLV-DETNVEQFINEVVILSQINHR 373
           R+LG+GG G V++     G  T G+I A+K   K+ +V +  +      E  IL ++ H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANT-GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE-LLLRIAVEVSGALFYL 432
            IV L+          L+ E++  G L+     Q+E   I  E        E+S AL +L
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFM----QLEREGIFMEDTACFYLAEISMALGHL 137
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      I +RD+K  NI+L+ +   K++DFG  +  + D T +T    GT  Y+ PE  
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEIL 193
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
             S      D +S G ++ ++LTG  P    N
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 124
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 180
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 235
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 236 ----------IIRGQVF--FRQRVSXECQH--------LIRWCLALRPXDRPTFEEIQN 274

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 7   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 66
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 67  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 123
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 179
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 180 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 234
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 235 ----------IIRGQVF--FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQN 273

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 40  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 99
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 100 LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 156
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 157 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 212
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 213 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 267
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     I   ++F     RV  E +         L + CL L    RPT +E+ N 
Sbjct: 268 ----------IIRGQVF--FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQNH 307

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 167
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 323 RILGQGGQGTVY--KGMLTDGRIVA---VKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
            +LG G    V+  K  LT G++ A   +KKS    ++++E   NE+ +L +I H NIV 
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVT 70
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L      T    LV + +  G L+  I   +E    T +    +  +V  A+ YLH    
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 438 IPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
             I HRD+K  N+L    ++  +  ++DFG S+   ++Q  + +   GT GYV PE    
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
             +++  D +S GV+   +L G  P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 15/226 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D++   R +G+G  G V      D  ++ A+K   K K V+   V     E+ I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +V L     + E   +V + +  G L  ++   +     T +L +    E+  AL YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI---CELVMALDYL 131
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
            +     I HRD+K  NILLD+     ++DF  + +++  +T +TT + GT  Y+ PE F
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITT-MAGTKPYMAPEMF 186
Query: 493 QSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 535
            S +   ++   D +S GV   E+L G++P    ++   K +V  F
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 45/313 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSKLVDE 354
           I+ T+L      E   +  +  + LG G  G     T Y  + +D  + VAVK  K    
Sbjct: 25  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 84
Query: 355 -TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 85  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 144
Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S   I   HRD+ + NILL     
Sbjct: 145 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 201
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            K+ DFG +R +  D  ++     +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 202 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 261
Query: 516 GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVLKEAKKEEIMTVATLAKRCLNL 574
           G  P   +  D        F + I E  R+     A     A+  +IM      K C + 
Sbjct: 262 GSSPYPGMPVDSK------FYKMIKEGFRMLSPEHA----PAEMYDIM------KTCWDA 305
Query: 575 NGKMRPTMKEVTN 587
           +   RPT K++  
Sbjct: 306 DPLKRPTFKQIVQ 318

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGC 381
           LG G  G VYK    +  ++A   +K++D   E  +E ++ E+ IL+  +H NIVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                   ++ EF   G +   +     E P+T   +  +  +   AL YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 442 HRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           HRD+K+ NIL       K++DFG S    R++    + + T        V  E  +   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAIN 524
             K+DV+S G+ L+E+   + P   +N
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 115 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 170
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  +++F        I   L+     
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 167
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 136
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 192
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 247
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     I   ++F     RV  E +         L + CL L    RPT +E+ N 
Sbjct: 248 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQNH 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 325 LGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNV-EQFINEVVILSQINHRNIVK 377
           LG+   G VYKG L         + VA+K  K   E  + E+F +E ++ +++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI----EEFPITWEL----LLRIAVE 424
           LLG   + +   +++ +  +G L++++     H+ +    ++  +   L     + +  +
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVDQTHLTTKVQGT 483
           ++  + YL S     + H+D+ + N+L+ DK   K+SD G  R V   D   L       
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
             ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 135/313 (43%), Gaps = 45/313 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSKLVDE 354
           I+ T+L      E   +  +  + LG G  G     T Y  + +D  + VAVK  K    
Sbjct: 23  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 82
Query: 355 -TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 83  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 142
Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S   I   HRD+ + NILL     
Sbjct: 143 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 199
Query: 458 AKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 515
            K+ DFG +R +  D  ++     +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 200 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 259
Query: 516 GQKPIRAINTDEDKSLVGYFLQAINEN-RLFEALDARVLKEAKKEEIMTVATLAKRCLNL 574
           G  P   +  D        F + I E  R+     A     A+  +IM      K C + 
Sbjct: 260 GSSPYPGMPVDSK------FYKMIKEGFRMLSPEHA----PAEMYDIM------KTCWDA 303
Query: 575 NGKMRPTMKEVTN 587
           +   RPT K++  
Sbjct: 304 DPLKRPTFKQIVQ 316

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 325 LGQGGQGTVYKGMLT----DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKL 378
           L + G+G+  K +L     DGR   +K+  +  +     E+   EV +L+ + H NIV+ 
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
                E     +V ++   G L++ I+ Q +      + +L   V++  AL ++H     
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK-- 145
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            I HRDIKS NI L      ++ DFG +R V+     L     GT  Y+ PE  ++  + 
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 499 EKSDVYSFGVVLVEILT 515
            KSD+++ G VL E+ T
Sbjct: 204 NKSDIWALGCVLYELCT 220

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 151
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 207
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 262
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     I   ++F     RV  E +         L + CL L    RPT +E+ N 
Sbjct: 263 ----------IIRGQVF--FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQNH 302

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 317 DNYNANRILGQGGQGTVY-----KGMLTDGRIVAVK---KSKLVDETNV-EQFINEVVIL 367
           +N+   ++LG G  G V+      G  T G++ A+K   K+ +V +    E    E  +L
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDT-GKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 368 SQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EV 425
             I     +  L    +TE  L L+ ++I  G L+ ++ +Q E F    E  ++I V E+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFT---EHEVQIYVGEI 168
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL +LH    + I +RDIK  NILLD      ++DFG S+  + D+T       GT  
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 486 YVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 519
           Y+ P+  +   S   +  D +S GV++ E+LTG  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+ K +L  ET       I E+ +L ++NH
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+ K +L  ET       I E+ +L ++NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 317 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINH 372
           +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++NH
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAVEV 425
            NIVKLL          LV+EF         +H  +++F        I   L+     ++
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 486 YVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
           Y  PE     ++   + D++S G +  E++T
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 92/186 (49%), Gaps = 18/186 (9%)
Query: 341 GRIVAVK----KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 396
           G++ AVK    K+    E+++E   NE+ +L +I H NIV L           LV + + 
Sbjct: 47  GKLFAVKCIPKKALKGKESSIE---NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVS 103
Query: 397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---D 453
            G L+  I   +E+   T +    +  +V  A++YLH    + I HRD+K  N+L    D
Sbjct: 104 GGELFDRI---VEKGFYTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQD 157
Query: 454 DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 513
           ++ +  +SDFG S+  M  +  + +   GT GYV PE      +++  D +S GV+   +
Sbjct: 158 EESKIMISDFGLSK--MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 215
Query: 514 LTGQKP 519
           L G  P
Sbjct: 216 LCGYPP 221

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 325 LGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNV-EQFINEVVILSQINHRNIVK 377
           LG+   G VYKG L         + VA+K  K   E  + E+F +E ++ +++ H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI----EEFPITWEL----LLRIAVE 424
           LLG   + +   +++ +  +G L++++     H+ +    ++  +   L     + +  +
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVDQTHLTTKVQGT 483
           ++  + YL S     + H+D+ + N+L+ DK   K+SD G  R V   D   L       
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
             ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGC 381
           LG G  G VYK    +  ++A   +K++D   E  +E ++ E+ IL+  +H NIVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                   ++ EF   G +   +     E P+T   +  +  +   AL YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 442 HRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           HRD+K+ NIL       K++DFG S    R +    + + T        V  E  +   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAIN 524
             K+DV+S G+ L+E+   + P   +N
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP-------ITWELLLRIAV 423
           NH NIVKLL          LV+EF         +H  ++ F        I   L+     
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSYLF 113
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 484 FGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILT 515
             Y  PE     ++   + D++S G +  E++T
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 316 TDNYNANRILGQGGQGTVYK---GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
            + YN   +LG+G  G V K    +      V V         +    + EV +L +++H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI+KL     ++    +V E    G L+  I   I+    +     RI  +V   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYM 137
Query: 433 HSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           H      I HRD+K  NILL+ K +    K+ DFG S +     T +  ++ GT  Y+ P
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI-GTAYYIAP 192
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           E  + + + EK DV+S GV+L  +L+G  P    N
Sbjct: 193 EVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 109
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 166
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 221
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN--- 362
           KD E     Y    +LG+GG GTV+ G  LTD   VA+K   +++++  + +   +    
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 363 EVVILSQI----NHRNIVKLLGCCLETEVPLLVYE-FIPNGTLYQYIHNQIEEFPITWEL 417
           EV +L ++     H  +++LL      E  +LV E  +P   L+ YI    E+ P+    
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGP 140
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTHL 476
                 +V  A+ + HS     + HRDIK  NIL+D +   AK+ DFG S +++ D+ + 
Sbjct: 141 SRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPY- 195
Query: 477 TTKVQGTFGYVDPEYFQSSQFTE-KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 535
            T   GT  Y  PE+    Q+    + V+S G++L +++ G  P                
Sbjct: 196 -TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--------------- 239
Query: 536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                  R  E L+A +   A          L +RCL      RP+++E+
Sbjct: 240 ------ERDQEILEAELHFPAHVSP--DCCALIRRCLAPKPSSRPSLEEI 281

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 309 SKDLEKATDNYNANRI------LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFI 361
           S++ E    + + N +      LG G  G VYK    + G + A K  +   E  +E +I
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 362 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
            E+ IL+  +H  IVKLLG         ++ EF P G +   I  +++   +T   +  +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVV 122
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
             ++  AL +LHS     I HRD+K+ N+L+  +   +++DFG S   +       + + 
Sbjct: 123 CRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI- 178
Query: 482 GTFGYVDPEY-----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           GT  ++ PE       + + +  K+D++S G+ L+E+   + P   +N
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 24/239 (10%)
Query: 314 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQ 369
           +A   Y     +G+G  G V+K   +   GR VA+K+ ++   +E      I EV +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 370 IN---HRNIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
           +    H N+V+L   C       ET++  LV+E + +  L  Y+ +++ E  +  E +  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           +  ++   L +LHS     + HRD+K  NIL+    + K++DFG +R +   Q  LT+ V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVV 180
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
             T  Y  PE    S +    D++S G +  E+   +KP+   ++D D+  +G  L  I
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ--LGKILDVI 235

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 316 TDNYNANRILGQGGQGTVYK---GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
            + YN   +LG+G  G V K    +      V V         +    + EV +L +++H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI+KL     ++    +V E    G L+  I   I+    +     RI  +V   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYM 137
Query: 433 HSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           H      I HRD+K  NILL+ K +    K+ DFG S +     T +  ++ GT  Y+ P
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI-GTAYYIAP 192
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           E  + + + EK DV+S GV+L  +L+G  P    N
Sbjct: 193 EVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 87
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 144
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDG------RIVAVKKSKLVDETNVEQF----INEVVI 366
           +NY    ILG+G    V + +          +I+ V          V++     + EV I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 367 LSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           L +++ H NI++L           LV++ +  G L+ Y+  ++         ++R  +EV
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D      +V GT  
Sbjct: 124 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPS 175
Query: 486 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKP 519
           Y+ PE  + S       + ++ D++S GV++  +L G  P
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGC 381
           LG G  G VYK    +  ++A   +K++D   E  +E ++ E+ IL+  +H NIVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
                   ++ EF   G +   +     E P+T   +  +  +   AL YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 442 HRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           HRD+K+ NIL       K++DFG S    R +      + T        V  E  +   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 498 TEKSDVYSFGVVLVEILTGQKPIRAIN 524
             K+DV+S G+ L+E+   + P   +N
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELN 244

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 79
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 136
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 191
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 87
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 144
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           NH NIVKLL          LV+EF+ +  L +++  + +   P+   L+     ++   L
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLP--LIKSYLFQLLQGL 117
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  P
Sbjct: 118 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 490 EYFQSSQFTEKS-DVYSFGVVLVEILT 515
           E     ++   + D++S G +  E++T
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           NH NIVKLL          LV+EF+ +  L +++  + +   P+   L+     ++   L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLP--LIKSYLFQLLQGL 119
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  P
Sbjct: 120 AFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 490 EYFQSSQFTEKS-DVYSFGVVLVEILT 515
           E     ++   + D++S G +  E++T
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 83
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 140
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 195
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 24/240 (10%)
Query: 314 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQ 369
           +A   Y     +G+G  G V+K   +   GR VA+K+ ++   +E      I EV +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 370 IN---HRNIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
           +    H N+V+L   C       ET++  LV+E + +  L  Y+ +++ E  +  E +  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           +  ++   L +LHS     + HRD+K  NIL+    + K++DFG +R +   Q  LT+ V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVV 180
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 540
             T  Y  PE    S +    D++S G +  E+   +KP+   ++D D+  +G  L  I 
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ--LGKILDVIG 236

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 94
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 151
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 206
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 76
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 133
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 188
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDG------RIVAVKKSKLVDETNVEQF----INEVVI 366
           +NY    ILG+G    V + +          +I+ V          V++     + EV I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 367 LSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           L +++ H NI++L           LV++ +  G L+ Y+  ++         ++R  +EV
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D      +V GT  
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPS 188
Query: 486 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKP 519
           Y+ PE  + S       + ++ D++S GV++  +L G  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 131/293 (44%), Gaps = 46/293 (15%)
Query: 319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           Y   + LG GG G V+  +  D  + VA+KK  L D  +V+  + E+ I+ +++H NIVK
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 378 L--------------LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
           +              +G   E     +V E++        + N +E+ P+  E       
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMY 127
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
           ++   L Y+HSA    + HRD+K AN+ ++ +    K+ DFG +R +    +H     +G
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 483 --TFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
             T  Y  P    S + +T+  D+++ G +  E+LTG+      +  E   L+   L++I
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LESI 241
Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
                       V+ E  ++E+++V  +  R       M    K +T  L GI
Sbjct: 242 P-----------VVHEEDRQELLSVIPVYIR-----NDMTEPHKPLTQLLPGI 278

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 24/240 (10%)
Query: 314 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQ 369
           +A   Y     +G+G  G V+K   +   GR VA+K+ ++   +E      I EV +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 370 IN---HRNIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
           +    H N+V+L   C       ET++  LV+E + +  L  Y+ +++ E  +  E +  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           +  ++   L +LHS     + HRD+K  NIL+    + K++DFG +R +   Q  LT+ V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVV 180
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 540
             T  Y  PE    S +    D++S G +  E+   +KP+   ++D D+  +G  L  I 
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ--LGKILDVIG 236

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG G  G VYK    + G + A K  +   E  +E +I E+ IL+  +H  IVKLLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
                 ++ EF P G +   I  +++   +T   +  +  ++  AL +LHS     I HR
Sbjct: 79  HDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKR---IIHR 133
Query: 444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY-----FQSSQFT 498
           D+K+ N+L+  +   +++DFG S   +       + + GT  ++ PE       + + + 
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 192
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAIN 524
            K+D++S G+ L+E+   + P   +N
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELN 218

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 109
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 166
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 113
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 170
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 111
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 168
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 103
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 160
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDG------RIVAVKKSKLVDETNVEQF----INEVVI 366
           +NY    ILG+G    V + +          +I+ V          V++     + EV I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 367 LSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           L +++ H NI++L           LV++ +  G L+ Y+  ++         ++R  +EV
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D       V GT  
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLRSVCGTPS 188
Query: 486 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKP 519
           Y+ PE  + S       + ++ D++S GV++  +L G  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 88
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 145
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 80
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 137
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--LSQINHRN 374
           DN     ++G+G  G VYKG L D R VAVK     +  N   FINE  I  +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 375 IVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           I + +              LLV E+ PNG+L +Y+     +    W    R+A  V+  L
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGL 124
Query: 430 FYLHSAASIP--------IYHRDIKSANILLDDKYRAKVSDFGTSRSVM-------VDQT 474
            YLH+   +P        I HRD+ S N+L+ +     +SDFG S  +         ++ 
Sbjct: 125 AYLHT--ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 475 HLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEIL 514
           +      GT  Y+ PE  + +          ++ D+Y+ G++  EI 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           NH NIVKLL          LV+EF+ +  L  ++  + +   P+   L+     ++   L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLP--LIKSYLFQLLQGL 119
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  P
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 490 EYFQSSQFTEKS-DVYSFGVVLVEILT 515
           E     ++   + D++S G +  E++T
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           NH NIVKLL          LV+EF+ +  L  ++  + +   P+   L+     ++   L
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLP--LIKSYLFQLLQGL 118
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  P
Sbjct: 119 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 490 EYFQSSQFTEKS-DVYSFGVVLVEILT 515
           E     ++   + D++S G +  E++T
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 154
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 211
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 316 TDNYNANRILGQGGQGTVYK---GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
            + YN   +LG+G  G V K    +      V V         +    + EV +L +++H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI+KL     ++    +V E    G L+  I   I+    +     RI  +V   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYM 137
Query: 433 HSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           H      I HRD+K  NILL+ K +    K+ DFG S +     T +  ++ GT  Y+ P
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI-GTAYYIAP 192
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 524
           E  + + + EK DV+S GV+L  +L+G  P    N
Sbjct: 193 EVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++ +RI+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 373 RNIVKLLGCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
            +   ++        P     + + +  G L    H  + +  +  E  +R  A E+   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           L ++H+     + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ 
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 489 PEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           PE  Q    +   +D +S G +L ++L G  P R   T +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++ +RI+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 373 RNIVKLLGCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
            +   ++        P     + + +  G L    H  + +  +  E  +R  A E+   
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILG 303
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           L ++H+     + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ 
Sbjct: 304 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 357
Query: 489 PEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           PE  Q    +   +D +S G +L ++L G  P R   T +
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 397

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + +G G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++ +RI+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 373 RNIVKLLGCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
            +   ++        P     + + +  G L    H  + +  +  E  +R  A E+   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           L ++H+     + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ 
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 489 PEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           PE  Q    +   +D +S G +L ++L G  P R   T +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++ +RI+G+GG G VY     D G++ A+K   K ++  +      +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 373 RNIVKLLGCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
            +   ++        P     + + +  G L    H  + +  +  E  +R  A E+   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           L ++H+     + +RD+K ANILLD+    ++SD G +      + H +    GT GY+ 
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 489 PEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           PE  Q    +   +D +S G +L ++L G  P R   T +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK         + F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + +G G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++   +++ LL ++ V +   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK-- 140
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + +G G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 318 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +Y     LG G  G V  G   LT G  VAVK   + K+     V +   E+  L    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALF 430
            +I+KL           +V E++  G L+ YI  H ++EE         R+  ++  A+ 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-----RLFQQILSAVD 125
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y H      + HRD+K  N+LLD    AK++DFG S ++M D   L T   G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPE 180
Query: 491 YFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
                 +   + D++S GV+L  +L G  P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++   +++ LL ++ V +   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK-- 140
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK  L D+    +F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDK----RFKNRELQIMRKLDHCNI 75
Query: 376 VKLL------GCCLETEVPLLVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L       G   +     LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++     
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 141
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPE 194
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 324 ILGQGGQGTVYKG-MLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLG 380
           ++G G  G VYKG  +  G++ A+K   +   +E  ++Q IN +   S  +HRNI    G
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 88
Query: 381 CCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
             ++   P       LV EF   G++   I N  +   +  E +  I  E+   L +LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPE 490
              I   HRDIK  N+LL +    K+ DFG S    R+V    T +     GT  ++ PE
Sbjct: 148 HKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 199
Query: 491 YF-----QSSQFTEKSDVYSFGVVLVEILTGQKPI 520
                    + +  KSD++S G+  +E+  G  P+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK         + F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQI 370
           + +N+     +G+G  G VYK    LT G +VA+KK +L  ET       I E+ +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           NH NIVKLL          LV+E + +  L +++  + +   P+   L+     ++   L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLP--LIKSYLFQLLQGL 119
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            + HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  P
Sbjct: 120 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 490 EYFQSSQFTEKS-DVYSFGVVLVEILT 515
           E     ++   + D++S G +  E++T
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 318 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNI 375
           +Y   +++G G  G VY+  L D G +VA+KK         + F N E+ I+ +++H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 376 VKLLGCCLET-----EVPL-LVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAVEVS 426
           V+L      +     EV L LV +++P  T+Y+   +     +  P+ +  L     ++ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY--MYQLF 132
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++        
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           Y  PE  F ++ +T   DV+S G VL E+L GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E + P   L+ +I    E   +  EL  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGALQEELAR 117
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 118 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 171
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 219
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 220 -IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 258

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 62  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 174
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 227
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 146
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 375
           Y   + +G G QG V     T  G  VAVKK      ++T+ ++   E+V+L  +NH+NI
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 376 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           + LL          E +   LV E + +  L Q IH +++      E +  +  ++   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDH-----ERMSYLLYQMLCGI 137
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            +LHSA    I HRD+K +NI++      K+ DFG +R+   +   + T    T  Y  P
Sbjct: 138 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYYRAP 192
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTG 516
           E      + E  D++S G ++ E++ G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 50/286 (17%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVVILSQI 370
            Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 371 NH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           +     +++LL      +  +L+ E   P   L+ +I    E   +  EL      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 121
Query: 428 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T   GT  Y
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--TDFDGTRVY 175
Query: 487 VDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVG---YFLQAINEN 542
             PE+ +  ++  +S  V+S G++L +++ G  P      + D+ ++G   +F Q     
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQ----- 225
Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                   RV  E +         L + CL L    RPT +E+ N 
Sbjct: 226 --------RVSSECQH--------LIRWCLALRPSDRPTFEEIQNH 255

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++P G ++ ++  +I  F    E   R  A ++   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLT 146
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 233

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 317 DNYNANRILGQGGQGTV--YKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINH 372
           D Y     +G G  G V   +  LT G+ VA+KK     +  TN ++ + E+ IL    H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 373 RNIVKLLGCCLETEVPL-------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
            NI+ +    L   VP        +V + +    L+Q IH+     P+T E +     ++
Sbjct: 114 DNIIAIKDI-LRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ---PLTLEHVRYFLYQL 168
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQG 482
              L Y+HSA  I   HRD+K +N+L+++    K+ DFG +R +     +  +  T+   
Sbjct: 169 LRGLKYMHSAQVI---HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 483 TFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQK 518
           T  Y  PE   S  ++T+  D++S G +  E+L  ++
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++   +++ LL ++ V +   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK-- 140
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 318 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +Y     LG G  G V  G   LT G  VAVK   + K+     V +   E+  L    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALF 430
            +I+KL           +V E++  G L+ YI  H ++EE         R+  ++  A+ 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-----RLFQQILSAVD 125
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y H      + HRD+K  N+LLD    AK++DFG S ++M D   L     G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRDSC-GSPNYAAPE 180
Query: 491 YFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
                 +   + D++S GV+L  +L G  P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 118
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 172
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 220
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 221 -IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 259

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 471
           PIT E L+  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 472 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
           +  ++     +    ++ PE      ++ KSDV+S+GV+L EI + G  P   +  DED 
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311
Query: 530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                       +RL E +  R  + +  E    +  +   C + + K RP   E+  +L
Sbjct: 312 C-----------SRLREGMRMRAPEYSTPE----IYQIMLDCWHRDPKERPRFAELVEKL 356
Query: 590 GGI 592
           G +
Sbjct: 357 GDL 359

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              + KL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL---- 379
           I  +G  G V+K  L +   VAVK   L D+ +  Q   E+     + H N+++ +    
Sbjct: 22  IKARGRFGCVWKAQLMND-FVAVKIFPLQDKQSW-QSEREIFSTPGMKHENLLQFIAAEK 79
Query: 380 -GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G  LE E+  L+  F   G+L  Y+   I    ITW  L  +A  +S  L YLH    +
Sbjct: 80  RGSNLEVEL-WLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHE--DV 132
Query: 439 P----------IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYV 487
           P          I HRD KS N+LL     A ++DFG +      +    T  Q GT  Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 488 DPEY------FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
            PE       FQ   F  + D+Y+ G+VL E+++  K   A +   D+ ++  F + I +
Sbjct: 193 APEVLEGAINFQRDAFL-RIDMYAMGLVLWELVSRCK---AADGPVDEYMLP-FEEEIGQ 247
Query: 542 NRLFEALDARV----LKEAKKEEIMTVATLAKRCLNLN 575
           +   E L   V    ++   K+  +    LA+ C+ + 
Sbjct: 248 HPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIE 285

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              + KL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 117
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 118 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 171
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 219
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 220 -IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 258

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 32/233 (13%)
Query: 314 KATDNY-NANRILGQGGQGTVYKGML--TDGRIVAVKK-----------------SKLVD 353
           K  D Y N  RI+    QG   K +L   D +  A+KK                  K+  
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL-----YQYIHNQI 408
           ++  + F NE+ I++ I +   +   G     +   ++YE++ N ++     Y ++ ++ 
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
               I  +++  I   V  +  Y+H+  +I   HRD+K +NIL+D   R K+SDFG S  
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGES-E 200
Query: 469 VMVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFGVVLVEILTGQKP 519
            MVD+       +GT+ ++ PE+F  +SS    K D++S G+ L  +     P
Sbjct: 201 YMVDKK--IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 118
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 172
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 220
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 221 -IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 259

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 317 DNYNANRILGQGGQGTV--YKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINH 372
           D Y     +G G  G V   +  LT G+ VA+KK     +  TN ++ + E+ IL    H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 373 RNIVKLLGCCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
            NI+ +    L   VP      + V   +    L+Q IH+     P+T E +     ++ 
Sbjct: 113 DNIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ---PLTLEHVRYFLYQLL 168
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGT 483
             L Y+HSA  I   HRD+K +N+L+++    K+ DFG +R +     +  +  T+   T
Sbjct: 169 RGLKYMHSAQVI---HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 484 FGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQK 518
             Y  PE   S  ++T+  D++S G +  E+L  ++
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 322 NRILGQGGQGTVYKGMLTD----GRI----VAVKKSKLVDETNVEQFINEVVILSQINHR 373
           N  LGQG    ++KG+  +    G++    V +K          E F     ++S+++H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           ++V   G C+  +  +LV EF+  G+L  Y+        I W+  L +A +++ A+ +L 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLE 130
Query: 434 SAASIPIYHRDIKSANILL---DDKYRA-----KVSDFGTSRSVMVDQTHLTTKVQGTFG 485
               I   H ++ + NILL   +D+        K+SD G S +V+         +Q    
Sbjct: 131 ENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERIP 182
Query: 486 YVDPEYFQSSQ-FTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 543
           +V PE  ++ +     +D +SFG  L EI + G KP+ A+  D  + L  Y         
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQFY--------- 231
Query: 544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                D   L   K  E+   A L   C++     RP+ + +  +L  + T
Sbjct: 232 ----EDRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNI 375
           ++   + LG+GG G V++     D    A+K+ +L + E   E+ + EV  L+++ H  I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI--EEFPITW------------ELLLRI 421
           V+     LE      +    P   +Y YI  Q+  +E    W             + L I
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPK--VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD---QTHLT- 477
            ++++ A+ +LHS     + HRD+K +NI        KV DFG   ++  D   QT LT 
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 478 -------TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
                  T   GT  Y+ PE    + ++ K D++S G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV--------ILS 368
            Y+   ++G+G    V + +    G   AVK  ++  E    + + EV         IL 
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 369 QI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           Q+  H +I+ L+     +    LV++ +  G L+ Y+  ++         ++R  +E   
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE--- 211
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           A+ +LH+     I HRD+K  NILLDD  + ++SDFG   S  ++      ++ GT GY+
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF--SCHLEPGEKLRELCGTPGYL 266
Query: 488 DPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKP 519
            PE  + S       + ++ D+++ GV+L  +L G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 118
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 172
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 220
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 221 -IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 259

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              + KL     +     +V E+ P G ++ ++  +I  F    E   R  A ++     
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFX---EPHARFYAAQIVLTFE 156
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+++D +   KV+DFG ++ V       T  + GT  Y+ PE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPE 209
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D +   R LG G  G V   ML      G   A+K   K K+V    +E  +NE  I   
Sbjct: 42  DQFERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E+ P G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   KV+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 319 YNANRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 375
           Y   + +G G QG V     T  G  VAVKK      ++T+ ++   E+V+L  +NH+NI
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 376 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           + LL          E +   LV E + +  L Q IH +++      E +  +  ++   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDH-----ERMSYLLYQMLCGI 139
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            +LHSA    I HRD+K +NI++      K+ DFG +R+   +   + T    T  Y  P
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAP 194
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTG 516
           E      +    D++S G ++ E++ G
Sbjct: 195 EVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFIN 362
           K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 363 EVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLL 419
           EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL  
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 140
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTT 478
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T
Sbjct: 141 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--T 194
Query: 479 KVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+         
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE--------- 242
Query: 538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
            I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 243 -IIRGQVF--FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQN 281

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVK--KSKLVDETNVEQFIN-EVVILSQINHR 373
           NY   + LG+G  G V      T G+ VA+K    K++ +++++  I  E+  L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           +I+KL       +  ++V E+  N  L+ YI   ++   ++ +   R   ++  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I HRD+K  N+LLD+    K++DFG S ++M D   L T   G+  Y  PE   
Sbjct: 130 RHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVIS 184
Query: 494 SSQFT-EKSDVYSFGVVLVEILTGQKP 519
              +   + DV+S GV+L  +L  + P
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVK--KSKLVDETNVEQFIN-EVVILSQINHR 373
           NY   + LG+G  G V      T G+ VA+K    K++ +++++  I  E+  L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           +I+KL       +  ++V E+  N  L+ YI   ++   ++ +   R   ++  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I HRD+K  N+LLD+    K++DFG S ++M D   L T   G+  Y  PE   
Sbjct: 131 RHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVIS 185
Query: 494 SSQFT-EKSDVYSFGVVLVEILTGQKP 519
              +   + DV+S GV+L  +L  + P
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 46/291 (15%)
Query: 322 NRILGQGGQGTVYKGMLTD----GRI----VAVKKSKLVDETNVEQFINEVVILSQINHR 373
           N  LGQG    ++KG+  +    G++    V +K          E F     ++S+++H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           ++V   G C   +  +LV EF+  G+L  Y+        I W+  L +A +++ A+ +L 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAWAMHFLE 130
Query: 434 SAASIPIYHRDIKSANILL---DDKYRA-----KVSDFGTSRSVMVDQTHLTTKVQGTFG 485
               I   H ++ + NILL   +D+        K+SD G S +V+         +Q    
Sbjct: 131 ENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERIP 182
Query: 486 YVDPEYFQSSQ-FTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 543
           +V PE  ++ +     +D +SFG  L EI + G KP+ A+  D  + L  Y         
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQFY--------- 231
Query: 544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
                D   L   K  E+   A L   C++     RP+ + +  +L  + T
Sbjct: 232 ----EDRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRN 374
           + Y+    +G+G  G VYK     G   A+KK +L   DE      I E+ IL ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 375 IVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           IVKL       +  +LV+E +      L       +E       LL     ++   + Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL-----QLLNGIAYC 116
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      + HRD+K  N+L++ +   K++DFG +R+  +     T +V  T  Y  P+  
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVL 172
Query: 493 Q-SSQFTEKSDVYSFGVVLVEILTG 516
             S +++   D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRN 374
           + Y+    +G+G  G VYK     G   A+KK +L   DE      I E+ IL ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 375 IVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           IVKL       +  +LV+E +      L       +E       LL     ++   + Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL-----QLLNGIAYC 116
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      + HRD+K  N+L++ +   K++DFG +R+  +     T +V  T  Y  P+  
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVL 172
Query: 493 Q-SSQFTEKSDVYSFGVVLVEILTG 516
             S +++   D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 317 DNYNANRILGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           D +   + LG G  G V   K M T G   A+K   K K+V    +E  +NE  IL  +N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
              +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFS---EPHARFYAAQIVLTFE 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ PE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPE 208
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
              S  + +  D ++ GV++ E+  G  P  A
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVK--KSKLVDETNVEQFIN-EVVILSQINHR 373
           NY   + LG+G  G V      T G+ VA+K    K++ +++++  I  E+  L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           +I+KL       +  ++V E+  N  L+ YI   ++   ++ +   R   ++  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I HRD+K  N+LLD+    K++DFG S ++M D   L T   G+  Y  PE   
Sbjct: 121 RHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVIS 175
Query: 494 SSQFT-EKSDVYSFGVVLVEILTGQKP 519
              +   + DV+S GV+L  +L  + P
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 318 NYNANRILGQGGQGTVYKG-MLTDGRIVAVK--KSKLVDETNVEQFIN-EVVILSQINHR 373
           NY   + LG+G  G V      T G+ VA+K    K++ +++++  I  E+  L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           +I+KL       +  ++V E+  N  L+ YI   ++   ++ +   R   ++  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I HRD+K  N+LLD+    K++DFG S ++M D   L T   G+  Y  PE   
Sbjct: 125 RHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVIS 179
Query: 494 SSQFT-EKSDVYSFGVVLVEILTGQKP 519
              +   + DV+S GV+L  +L  + P
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 140
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D++   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 227

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRN 374
           + Y+    +G+G  G VYK     G   A+KK +L   DE      I E+ IL ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 375 IVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           IVKL       +  +LV+E +      L       +E   +T +  L   +++   + Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES--VTAKSFL---LQLLNGIAYC 116
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      + HRD+K  N+L++ +   K++DFG +R+  +     T ++  T  Y  P+  
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 493 Q-SSQFTEKSDVYSFGVVLVEILTG 516
             S +++   D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDH-----ERMSYLLYQMLX 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 174
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 62
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 174
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVV 365
           E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   EVV
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 366 ILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIA 422
           +L +++     +++LL      +  +L+ E   P   L+ +I    E   +  EL     
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFF 119
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
            +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T   
Sbjct: 120 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--TDFD 173
Query: 482 GTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 540
           GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+          I 
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE----------II 220
Query: 541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
             ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 221 RGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 257

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 325 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFI--NEVVILSQINHRNIVKLLGC 381
           +G+G  G V+K    D G+IVA+KK    ++  V + I   E+ +L Q+ H N+V LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQ--IEEF---PITWELLLRIAVEVSGALFYLHSAA 436
                   LV+E+  +  L++    Q  + E     ITW+ L         A+ + H   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QAVNFCHKHN 122
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF-QSS 495
            I   HRD+K  NIL+      K+ DFG +R +     +   +V  T  Y  PE     +
Sbjct: 123 CI---HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDT 178
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK---------SLVGYFLQAINENRLFE 546
           Q+    DV++ G V  E+L+G  P+    +D D+          L+    Q  + N+ F 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 547 ALDARVLKEAKKEEI------MTVATLAKRCLNLNGKMRPTMKEVTNE 588
            +     ++ +  E+           L K CL+++   R T +++ + 
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC-- 381
           +  +G  G V+K  L +   VAVK   + D+ +  Q   EV  L  + H NI++ +G   
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEK 88
Query: 382 -CLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
                +V L L+  F   G+L  ++   +    ++W  L  IA  ++  L YLH    IP
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE--DIP 142
Query: 440 ---------IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDP 489
                    I HRDIKS N+LL +   A ++DFG +      ++   T  Q GT  Y+ P
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 490 EY------FQSSQFTEKSDVYSFGVVLVEILT 515
           E       FQ   F  + D+Y+ G+VL E+ +
Sbjct: 203 EVLEGAINFQRDAFL-RIDMYAMGLVLWELAS 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 103/209 (49%), Gaps = 11/209 (5%)
Query: 325 LGQGGQGTVYKGMLTDGR-IVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  GTV+K    +   IVA+K+ +L D+        + E+ +L ++ H+NIV+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +   LV+EF  +  L +Y  +   +  +  E++     ++   L + HS     + 
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 500
           HRD+K  N+L++     K++DFG +R+  +     + +V  T  Y  P+  F +  ++  
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            D++S G +  E+    +P+   N  +D+
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQ 211

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDH-----ERMSYLLYQMLC 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFA---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFX---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFS---EPHARFYAAQIVLT 174
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLA 227
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 154
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 316 TDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           TD Y     +G+G    V +      G     +I+  KK    D   +E+   E  I   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIAVE 424
           + H NIV+L     E     LV++ +  G L++ I     +++ +      ++L      
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL------ 113
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ 481
              A+ + H    + + HRD+K  N+LL  K +    K++DFG +  V  DQ        
Sbjct: 114 --EAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFA 167
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           GT GY+ PE  +   + +  D+++ GV+L  +L G  P      DED+
Sbjct: 168 GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF----WDEDQ 211

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNV 357
           ++  L  S +      +++  +++G+G  G V    +K       +  ++K  ++ +   
Sbjct: 23  QQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE 82
Query: 358 EQFINEV-VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE 416
           +  ++E  V+L  + H  +V L       +    V ++I  G L+ ++  +        E
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLE 138
Query: 417 LLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 475
              R  A E++ AL YLHS   + I +RD+K  NILLD +    ++DFG  +   ++   
Sbjct: 139 PRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNS 194
Query: 476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            T+   GT  Y+ PE      +    D +  G VL E+L G  P  + NT E
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFX---EPHARFYAAQIVLT 174
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 227
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 22/257 (8%)
Query: 301 IEKTKLFTSK--DLEKATDNYNANRILGQGGQGTVYKGMLTDG-RIVAVK---KSKLVDE 354
           +E  K FTSK   +    +++   +++G+G  G V    L +  ++ A+K   K +++  
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
                F  E  +L   + + I  L     +     LV ++   G L   +    +  P  
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-- 173
Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            E + R  +  +  +  + S   +   HRDIK  NIL+D     +++DFG+   +M D T
Sbjct: 174 -EEMARFYL--AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 475 HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L G+ P  A      +
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA------E 284
Query: 530 SLVGYFLQAINENRLFE 546
           SLV  + + +N    F+
Sbjct: 285 SLVETYGKIMNHKERFQ 301

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 139
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 194
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVVILSQI 370
            Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 371 NH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           +     +++LL      +  +L+ E   P   L+ +I    E   +  EL      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 121
Query: 428 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T   GT  Y
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--TDFDGTRVY 175
Query: 487 VDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
             PE+ +  ++  +S  V+S G++L +++ G  P      DE+          I   ++F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE----------IIRGQVF 222
Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                RV  E +         L + CL L    RPT +E+ N 
Sbjct: 223 --FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQNH 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFX---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 15/226 (6%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-----EV 364
           D++     Y     LG+G   TVYK    +  +IVA+KK KL   +  +  IN     E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            +L +++H NI+ LL          LV++F+          N +   P   +  + + ++
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
               L YLH      I HRD+K  N+LLD+    K++DFG ++S          +V  T 
Sbjct: 124 ---GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TR 176
Query: 485 GYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            Y  PE  F +  +    D+++ G +L E+L  + P    ++D D+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQ 221

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFX---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKL----VDETNVEQFIN 362
           E   D Y+    LG G    V K      G+    + +  +++K     V   ++E+   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           EV IL +I H N++ L          +L+ E +  G L+ ++    E+  +T E      
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQTHLTT 478
            ++   ++YLHS   + I H D+K  NI+L D    K R K+ DFG +  +  D  +   
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDH-----ERMSYLLYQMLX 130
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDH-----ERMSYLLYQMLX 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 381
           LG+G   TVYKG   LTD  +VA+K+ +L  E       I EV +L  + H NIV L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGALFYLHSAA 436
               +   LV+E++ +  L QY+ +      +    +    LLR        L Y H   
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR-------GLAYCHRQK 120
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSS 495
              + HRD+K  N+L++++   K++DFG +R+  +       +V  T  Y  P+    S+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            ++ + D++  G +  E+ TG +P+   +T E++
Sbjct: 177 DYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEEQ 209

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFX---EPHARFYAAQIVLT 148
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 201
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 235

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           E+  L  + H +I+KL          ++V E+   G L+ YI   +E+  +T +   R  
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYI---VEKKRMTEDEGRRFF 114
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++  A+ Y H      I HRD+K  N+LLDD    K++DFG S ++M D   L T   G
Sbjct: 115 QQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-G 169
Query: 483 TFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
           +  Y  PE      +   + DV+S G+VL  +L G+ P
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 44/282 (15%)
Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVVILSQI 370
            Y    +LG GG G+VY G+ ++D   VA+K   K ++ D     N  +   EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 371 NH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           +     +++LL      +  +L+ E   P   L+ +I    E   +  EL      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 121
Query: 428 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  +++ D  +  T   GT  Y
Sbjct: 122 AVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY--TDFDGTRVY 175
Query: 487 VDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
             PE+ +  ++  +S  V+S G++L +++ G  P      DE+          I   ++F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE----------IIRGQVF 222
Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                RV  E +         L + CL L    RPT +E+ N
Sbjct: 223 --FRQRVSXECQH--------LIRWCLALRPSDRPTFEEIQN 254

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 473 QTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 530
             ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+  
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
                       RL E    R       E   T+      C +     RPT  E+   LG
Sbjct: 307 -----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 351
Query: 591 GI 592
            +
Sbjct: 352 NL 353

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 473 QTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 530
             ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+  
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
                       RL E    R       E   T+      C +     RPT  E+   LG
Sbjct: 305 -----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 349
Query: 591 GI 592
            +
Sbjct: 350 NL 351

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 473 QTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 530
             ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+  
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
                       RL E    R       E   T+      C +     RPT  E+   LG
Sbjct: 314 -----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 358
Query: 591 GI 592
            +
Sbjct: 359 NL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T E L+  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 473 QTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 530
             ++     +    ++ PE      +T +SDV+SFGV+L EI + G  P   +  DE+  
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
                       RL E    R       E   T+      C +     RPT  E+   LG
Sbjct: 312 -----------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 356
Query: 591 GI 592
            +
Sbjct: 357 NL 358

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NIVKL     +     LV E +  G L++ I  +          ++R  V    A+ +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV---SAVSH 121
Query: 432 LHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           +H    + + HRD+K  N+L    +D    K+ DFG +R    D   L T    T  Y  
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
           PE    + + E  D++S GV+L  +L+GQ P ++     D+SL 
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS----HDRSLT 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ ++  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 175
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 230
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 124
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  
Sbjct: 125 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 180
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 238
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 239 LAGLLKKDPKQRLGGGPSDAKEVME 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 121
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  
Sbjct: 122 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 177
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 121
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  
Sbjct: 122 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 177
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKK-----SKLVDETNVEQFINEVVILSQIN 371
           D +   R LG G  G V+   L + R   +++     +K   +  +EQ   E+ +L  ++
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALF 430
           H NI+K+     +     +V E    G L + I   Q     ++   +  +  ++  AL 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 431 YLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y HS     + H+D+K  NIL  D       K+ DFG +     D+   +T   GT  Y+
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYM 193
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
            PE F+    T K D++S GVV+  +LTG  P    + +E +    Y
Sbjct: 194 APEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+++D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 314 KATDNYNANRILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQ 369
           +    Y   R LG+GG    Y+    D + V     V KS L+     E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +++ ++V   G   + +   +V E     +L +    +           +R  ++    +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---GV 155
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D     T + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           E       + + D++S G +L  +L G+ P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 212 SIDIWSVGCILAEMLSN-RPI 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 103/209 (49%), Gaps = 11/209 (5%)
Query: 325 LGQGGQGTVYKGMLTDGR-IVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 381
           +G+G  GTV+K    +   IVA+K+ +L D+        + E+ +L ++ H+NIV+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +   LV+EF  +  L +Y  +   +  +  E++     ++   L + HS     + 
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 500
           HRD+K  N+L++     K+++FG +R+  +     + +V  T  Y  P+  F +  ++  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            D++S G +  E+    +P+   N  +D+
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 325 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKLL 379
           +GQG  G V+K      G+ VA+KK  ++ E   E F    + E+ IL  + H N+V L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 380 GCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
             C     P         LV++F  +  L   + N + +F  T   + R+   +   L+Y
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYY 140
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVD 488
           +H      I HRD+K+AN+L+      K++DFG +R+  + +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           PE     + +    D++  G ++ E+ T + PI   NT++ +
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 325 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKLL 379
           +GQG  G V+K      G+ VA+KK  ++ E   E F    + E+ IL  + H N+V L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 380 GCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
             C     P         LV++F  +  L   + N + +F  T   + R+   +   L+Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYY 140
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVD 488
           +H      I HRD+K+AN+L+      K++DFG +R+  + +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           PE     + +    D++  G ++ E+ T + PI   NT++ +
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 138
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 193
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 208 SIDIWSVGCILAEMLSN-RPI 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 175
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 230
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL---- 378
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
               +E    + + + +    LY+ +  Q     ++ + +     ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ 496
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 497 -FTEKSDVYSFGVVLVEILTGQKPI 520
            +T+  D++S G +L E+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 131
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 186
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 138
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 193
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 130
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 140
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + +      T  Y  
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYYRA 195
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTG 516
           PE      + E  D++S G ++ E++ G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 137
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 131
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 186
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 325 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKLL 379
           +GQG  G V+K      G+ VA+KK  ++ E   E F    + E+ IL  + H N+V L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 380 GCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
             C     P         LV++F  +  L   + N + +F  T   + R+   +   L+Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKF--TLSEIKRVMQMLLNGLYY 140
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVD 488
           +H      I HRD+K+AN+L+      K++DFG +R+  + +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           PE     + +    D++  G ++ E+ T + PI   NT++ +
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E + +  L Q I  +++      E +  +  ++  
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH-----ERMSYLLYQMLC 136
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 191
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            PE      + E  D++S G ++ E++
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 325 LGQGGQGTV--YKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           LG+GG   V   +G L DG   A+K+    ++ + E+   E  +    NH NI++L+  C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 383 LE----TEVPLLVYEFIPNGTLYQYIHNQIEEFP-----ITWELLLRIAVEVSGALFYLH 433
           L          L+  F   GTL+    N+IE        +T + +L + + +   L  +H
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLW----NEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGT----------SRSVMVDQTHLTTKVQGT 483
           +       HRD+K  NILL D+ +  + D G+          SR  +  Q     +   T
Sbjct: 152 AKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC--T 206
Query: 484 FGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKP 519
             Y  PE F         E++DV+S G VL  ++ G+ P
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 213 SIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 214 SIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 205 SIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 212 SIDIWSVGCILAEMLSN-RPI 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKL---- 378
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
               +E    + +   +    LY+ +  Q     ++ + +     ++   L Y+HSA   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ 496
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 497 -FTEKSDVYSFGVVLVEILTGQKPI 520
            +T+  D++S G +L E+L+  +PI
Sbjct: 224 GYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKL---- 378
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
               +E    + + + +    LY+ +  Q     ++ + +     ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ 496
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 497 -FTEKSDVYSFGVVLVEILTGQKPI 520
            +T+  D++S G +L E+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKL---- 378
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
               +E    + + + +    LY+ +  Q     ++ + +     ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ 496
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 497 -FTEKSDVYSFGVVLVEILTGQKPI 520
            +T+  D++S G +L E+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 325 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKLL 379
           +GQG  G V+K      G+ VA+KK  ++ E   E F    + E+ IL  + H N+V L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 380 GCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
             C     P         LV++F  +  L   + N + +F  T   + R+   +   L+Y
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKF--TLSEIKRVMQMLLNGLYY 139
Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVD 488
           +H      I HRD+K+AN+L+      K++DFG +R+  + +     +      T  Y  
Sbjct: 140 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 489 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           PE     + +    D++  G ++ E+ T + PI   NT++ +
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 212 SIDIWSVGCILAEMLSN-RPI 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 210 SIDIWSVGCILAEMLSN-RPI 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 206 SIDIWSVGCILAEMLSN-RPI 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT  Y+ 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           P    S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 208 SIDIWSVGCILAEMLSN-RPI 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 206 SIDIWSVGCILAEMLSN-RPI 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 216 SIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 208 SIDIWSVGCILAEMLSN-RPI 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF-----INEVVILS 368
           AT  Y     +G G  GTVYK      G  VA+K  ++ +            + EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 369 QIN---HRNIVKLLGCCL----ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
           ++    H N+V+L+  C     + E+ + LV+E + +  L  Y+ ++     +  E +  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           +  +    L +LH+     I HRD+K  NIL+      K++DFG +R +   Q  LT  V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVV 180
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             T  Y  PE    S +    D++S G +  E+   +KP+   N++ D+
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 228 SIDIWSVGCILAEMLSN-RPI 247

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 314 KATDNYNANRILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQ 369
           +    Y   R LG+GG    Y+    D + V     V KS L+     E+   E+ I   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +++ ++V   G   + +   +V E     +L +    +           +R  ++    +
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---GV 139
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 140 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 195
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           E       + + D++S G +L  +L G+ P
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 210 SIDIWSVGCILAEMLSN-RPI 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNIVK 377
           Y   +++G G  G V++  L +   VA+KK  L D+    +F N E+ I+  + H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDK----RFKNRELQIMRIVKHPNVVD 96
Query: 378 LLGCCL-----ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALF 430
           L          + EV L LV E++P  T+Y+   +  +       LL+++ + ++  +L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           Y+HS   I I HRDIK  N+LLD      K+ DFG+++ ++  + +++        Y  P
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAP 210
Query: 490 EY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
           E  F ++ +T   D++S G V+ E++ GQ
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGMLTDGRI-VAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V        ++ VA+KK S    +T  ++ + E+ IL    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 210 SIDIWSVGCILAEMLSN-RPI 229

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 143
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 144 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 198
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEIL 514
           PE      + E  D++S G ++ E++
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 314 KATDNYNANRILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQ 369
           +    Y   R LG+GG    Y+    D + V     V KS L+     E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +++ ++V   G   + +   +V E     +L +    +           +R  ++    +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---GV 155
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAP 211
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           E       + + D++S G +L  +L G+ P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 314 KATDNYNANRILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQ 369
           +    Y   R LG+GG    Y+    D + V     V KS L+     E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +++ ++V   G   + +   +V E     +L +    +           +R  ++    +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---GV 155
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 211
Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           E       + + D++S G +L  +L G+ P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 316 TDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           TD Y     LG+G    V +      G     +I+  KK    D   +E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRI-AV 423
           + H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  +   
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKV 480
            ++G            I HRD+K  N+LL  K +    K++DFG +  V  DQ       
Sbjct: 120 HLNG------------IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
            GT GY+ PE  +   + +  D+++ GV+L  +L G  P      DED+
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF----WDEDQ 211

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+ +T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 212 SIDIWSVGCILAEMLSN-RPI 231

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 316 TDNYNANRILGQG--GQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           +D Y+  + +G G  G   + +  LT   +VAVK   +   +DE    + IN       +
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAIDENVQREIINH----RSL 73
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEVS 426
            H NIV+     L      ++ E+   G LY+ I N      +E    ++ LL       
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL------- 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
             + Y H   S+ I HRD+K  N LLD     R K+ DFG S+S ++     +T   GT 
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTP 181
Query: 485 GYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
            Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 43/233 (18%)
Query: 316 TDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           TD Y     LG+G    V +      G     +I+  KK    D   +E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           + H NIV+L     E     LV++ +  G L++ I                +A E     
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI----------------VAREYYSEA 103
Query: 430 FYLHSAASI----------PIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHL 476
              H    I           I HRD+K  N+LL  K +    K++DFG +  V  DQ   
Sbjct: 104 DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QA 162
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
                GT GY+ PE  +   + +  D+++ GV+L  +L G  P      DED+
Sbjct: 163 WFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF----WDEDQ 211

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 132
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T  Y  
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 187
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEIL 514
           PE      + E  D++S G ++ E++
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 19/226 (8%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQIN 371
           AT  Y     +G G  GTVYK      G  VA+K  ++   +E      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 372 ---HRNIVKLLGCCL----ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
              H N+V+L+  C     + E+ + LV+E + +  L  Y+ ++     +  E +  +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           +    L +LH+     I HRD+K  NIL+      K++DFG +R +   Q  L   V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAPVVV-T 174
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             Y  PE    S +    D++S G +  E+   +KP+   N++ D+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 319 YNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           Y   + +G+G  G V      +   R+   K S    +T  ++ + E+ IL +  H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 377 K----LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
                L    LE    + + + +    LY+ + +Q     ++ + +     ++   L Y+
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQ----QLSNDHICYFLYQILRGLKYI 160
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGTFGYVDPE 490
           HSA    + HRD+K +N+L++     K+ DFG +R      D T   T+   T  Y  PE
Sbjct: 161 HSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 491 YFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 520
              +S+ +T+  D++S G +L E+L+  +PI
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 17/273 (6%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEV 364
           + D +   ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E 
Sbjct: 2   AMDPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            +L    H  +  L       +    V E+   G L+ ++     E   T E       E
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAE 118
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           +  AL YLHS   +   +RDIK  N++LD     K++DFG  +  + D   +     GT 
Sbjct: 119 IVSALEYLHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTP 174
Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            Y+ PE  + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R 
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRT 232
Query: 545 F----EALDARVLKEAKKEEIMTVATLAKRCLN 573
                ++L A +LK+  K+ +    + AK  + 
Sbjct: 233 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 265

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           D ++  + LG G  G V   ML      G   A+K   K K+V    +E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGA 428
           +N   +VKL     +     +V E++  G ++ ++  +I  F    E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFS---EPHARFYAAQIVLT 153
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ V       T  + GT   + 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEALA 206
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           PE   S  + +  D ++ GV++ E+  G  P  A
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 121
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   +     GT  Y+ PE  
Sbjct: 122 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEVL 177
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDE---TNVEQ 359
           F  +D+E   D+Y     LG G    V     KG   +     +KK +L       + E+
Sbjct: 5   FRQEDVE---DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE 61
Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
              EV IL +I H NI+ L          +L+ E +  G L+ ++    E+  +T +   
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEAT 118
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTH 475
           +   ++   + YLHS     I H D+K  NI+L DK     R K+ DFG +  +  +  +
Sbjct: 119 QFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGN 173
Query: 476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
               + GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 16/217 (7%)
Query: 317 DNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           D+Y+ +  LG G  G V++      G   A K      E++ E    E+  +S + H  +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYI---HNQIEEFPITWELLLRIAVEVSGALFYL 432
           V L     +    +++YEF+  G L++ +   HN++ E     +  +    +V   L ++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----DEAVEYMRQVCKGLCHM 271
Query: 433 HSAASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           H    +   H D+K  NI+   K     K+ DFG   +  +D         GT  +  PE
Sbjct: 272 HENNYV---HLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPKQSVKVTTGTAEFAAPE 326
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             +       +D++S GV+   +L+G  P    N DE
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 121
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   +     GT  Y+ PE  
Sbjct: 122 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEVL 177
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 28/238 (11%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV 365
           F  + +E         R+L +GG   VY+   +  GR  A+K+    +E      I EV 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 366 ILSQIN-HRNIVKLLGCCL-------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            + +++ H NIV+               +   L+   +  G L +++       P++ + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS----------- 466
           +L+I  +   A+ ++H     PI HRD+K  N+LL ++   K+ DFG++           
Sbjct: 138 VLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 467 ---RSVMVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
              R  +V++  T  TT +  T   +D   + +    EK D+++ G +L  +   Q P
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIID--LYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           +G  G+  V K  LT G  VAVK   + K+     V +   E+  L    H +I+KL   
Sbjct: 26  VGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 382 CLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
                   +V E++  G L+ YI  + +++E     +   R+  ++   + Y H      
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNGRLDE-----KESRRLFQQILSGVDYCHRHM--- 136
Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT- 498
           + HRD+K  N+LLD    AK++DFG S ++M D   L     G+  Y  PE      +  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXSC-GSPNYAAPEVISGRLYAG 194
Query: 499 EKSDVYSFGVVLVEILTGQKP 519
            + D++S GV+L  +L G  P
Sbjct: 195 PEVDIWSSGVILYALLCGTLP 215

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 380
           +G+G   TVYKG+ T+   V V   +L D    ++  ++F  E   L  + H NIV+   
Sbjct: 34  IGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 381 CCLET----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IAVEVSGALFYLHSA 435
               T    +  +LV E   +GTL  Y+      F +    +LR    ++   L +LH+ 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 436 ASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
              PI HRD+K  NI +       K+ D G +    + +      V GT  +  PE ++ 
Sbjct: 149 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXYEE 204
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
            ++ E  DVY+FG   +E  T + P
Sbjct: 205 -KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 17/265 (6%)
Query: 317 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++     E   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYL 121
Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   +   +RDIK  N++LD     K++DFG  +  + D   +     GT  Y+ PE  
Sbjct: 122 HSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEVL 177
Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF----EAL 548
           + + +    D +  GVV+ E++ G+ P    N D ++      ++ I   R      ++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 549 DARVLKEAKKEEIMTVATLAKRCLN 573
            A +LK+  K+ +    + AK  + 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVME 260

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 20/259 (7%)
Query: 310 KDLEKATDNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVV 365
           K++    D++   +++G+G    V    M   G++ A+K   K  ++    V  F  E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           +L   + R I +L     +     LV E+   G L   +    E  P   E+      E+
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--EMARFYLAEI 171
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
             A+  +H    +   HRDIK  NILLD     +++DFG+   +  D T  +    GT  
Sbjct: 172 VMAIDSVHRLGYV---HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 486 YVDPEYFQS-------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 538
           Y+ PE  Q+         +  + D ++ GV   E+  GQ P  A +T E    + ++   
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY--- 285
Query: 539 INENRLFEALDARVLKEAK 557
             E+     +D  V +EA+
Sbjct: 286 -KEHLSLPLVDEGVPEEAR 303

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 25/289 (8%)
Query: 301 IEKTKLFTS--KDLEKATDNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDE 354
           +E  K FT   K+++   +++   +++G+G  G V    M    RI A+K   K +++  
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
                F  E  +L   + + I  L     +     LV ++   G L   +    ++ P  
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP-- 189
Query: 415 WELLLRIAV-EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 473
            E + R  + E+  A+  +H    +   HRDIK  N+LLD     +++DFG+   +  D 
Sbjct: 190 -EDMARFYIGEMVLAIDSIHQLHYV---HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG 245
Query: 474 THLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           T  ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L G+ P  A      
Sbjct: 246 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ 299
Query: 529 KSLVGYFLQAINENRLFE-ALDARVLKEAKKEEIMTVATLAKRCLNLNG 576
           +SLV  + + +N    F+       + E  K+ I  +    +R L  NG
Sbjct: 300 ESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNG 348

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 25/289 (8%)
Query: 301 IEKTKLFTS--KDLEKATDNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDE 354
           +E  K FT   K+++   +++   +++G+G  G V    M    RI A+K   K +++  
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
                F  E  +L   + + I  L     +     LV ++   G L   +    ++ P  
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP-- 173
Query: 415 WELLLRIAV-EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 473
            E + R  + E+  A+  +H    +   HRDIK  N+LLD     +++DFG+   +  D 
Sbjct: 174 -EDMARFYIGEMVLAIDSIHQLHYV---HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG 229
Query: 474 THLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           T  ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L G+ P  A      
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ 283
Query: 529 KSLVGYFLQAINENRLFE-ALDARVLKEAKKEEIMTVATLAKRCLNLNG 576
           +SLV  + + +N    F+       + E  K+ I  +    +R L  NG
Sbjct: 284 ESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNG 332

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 22/226 (9%)
Query: 314 KATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 372
           K  D +   R+ GQG  GTV  G   + G  VA+KK  + D     + +  +  L+ ++H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHH 78
Query: 373 RNIVKL------LGCCLETEVPL-LVYEFIPNGTLYQ----YIHNQIEEFPITWELLLRI 421
            NIV+L      LG     ++ L +V E++P+ TL++    Y   Q+   PI  ++ L  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKV 480
            +   G L       S+ + HRDIK  N+L+++     K+ DFG+++ +   + ++    
Sbjct: 138 LIRSIGCLHL----PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 481 QGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
             +  Y  PE  F +  +T   D++S G +  E++ G+   R  N+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 139
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D     T + GT  Y+ PE       +
Sbjct: 140 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 242
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 243 ----VAASLIQKMLQTDPTARPTINELLND 268

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQIN 371
           AT  Y     +G G  GTVYK      G  VA+K  ++   +E      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 372 ---HRNIVKLLGCCL----ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
              H N+V+L+  C     + E+ + LV+E + +  L  Y+ ++     +  E +  +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           +    L +LH+     I HRD+K  NIL+      K++DFG +R            V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--T 174
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             Y  PE    S +    D++S G +  E+   +KP+   N++ D+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 19/226 (8%)
Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQIN 371
           AT  Y     +G G  GTVYK      G  VA+K  ++   +E      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 372 ---HRNIVKLLGCCL----ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
              H N+V+L+  C     + E+ + LV+E + +  L  Y+ ++     +  E +  +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           +    L +LH+     I HRD+K  NIL+      K++DFG +R +   Q  L   V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALDPVVV-T 174
Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
             Y  PE    S +    D++S G +  E+   +KP+   N++ D+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 219

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 316 TDNYNANRILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           +D +     LG+G    VY    KG      +  +KK+  VD+  V     E+ +L +++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVR---TEIGVLLRLS 106
Query: 372 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           H NI+KL     ET   + LV E +  G L+  I   +E+   +         ++  A+ 
Sbjct: 107 HPNIIKL-KEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILEAVA 162
Query: 431 YLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           YLH      I HRD+K  N+L          K++DFG S+  +V+   L   V GT GY 
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVCGTPGYC 217
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  +   +  + D++S G++   +L G +P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H     +   T  Y  PE   +S+ +T+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 212 SIDIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 325 LGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V      L   R+   K S    +T  ++ + E+ IL +  H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
               +  +   +I    +   ++  ++   ++ + +     ++   L Y+HSA    + H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQ-FTE 499
           RD+K +N+LL+     K+ DFG +R    D  H     +   T  Y  PE   +S+ +T+
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 500 KSDVYSFGVVLVEILTGQKPI 520
             D++S G +L E+L+  +PI
Sbjct: 213 SIDIWSVGCILAEMLSN-RPI 232

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 44/246 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHR 373
           D Y    ++G G  G V +     + R+VA+KK   V  D  + ++ + E+ IL+++NH 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 374 NIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVSG 427
           ++VK+L   +  +V     L V   I +    +     +   E  I   LL  + V V  
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVK- 170
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV------------------ 469
              Y+HSA    I HRD+K AN L++     KV DFG +R+V                  
Sbjct: 171 ---YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 470 --MVDQTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQKPI 520
             +V   H     +   G+V   ++++ +       +TE  DV+S G +  E+L   K  
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 521 RAINTD 526
            A + D
Sbjct: 285 VAYHAD 290

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 139
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D     T + GT  Y+ PE       +
Sbjct: 140 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 242
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 243 ----VAASLIQKMLQTDPTARPTINELLND 268

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 143
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D     T + GT  Y+ PE       +
Sbjct: 144 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 246
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 247 ----VAASLIQKMLQTDPTARPTINELLND 272

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 317 DNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDE---TNVEQFINEVVILSQ 369
           D+Y     LG G    V     KG   +     +KK +L       + E+   EV IL +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           I H NI+ L          +L+ E +  G L+ ++    E+  +T +   +   ++   +
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 142
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            YLHS     I H D+K  NI+L DK     R K+ DFG +  +  +  +    + GT  
Sbjct: 143 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPE 197
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           +V PE         ++D++S GV+   +L+G  P
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 16/217 (7%)
Query: 317 DNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           D+Y+ +  LG G  G V++      G   A K      E++ E    E+  +S + H  +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYI---HNQIEEFPITWELLLRIAVEVSGALFYL 432
           V L     +    +++YEF+  G L++ +   HN++ E     +  +    +V   L ++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----DEAVEYMRQVCKGLCHM 165
Query: 433 HSAASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           H    +   H D+K  NI+   K     K+ DFG   +  +D         GT  +  PE
Sbjct: 166 HENNYV---HLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPKQSVKVTTGTAEFAAPE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             +       +D++S GV+   +L+G  P    N DE
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 257

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 324 ILGQGGQGT-VYKGMLTDGRIVAVKKSKLVDETNVEQFIN-EVVILSQIN-HRNIVKLLG 380
           +LG G +GT VY+GM  D R VAVK  +++ E     F + EV +L + + H N+++   
Sbjct: 31  VLGHGAEGTIVYRGMF-DNRDVAVK--RILPECF--SFADREVQLLRESDEHPNVIRYFC 85
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
              + +   +  E     TL +Y+  +  +F       + +  + +  L +LH   S+ I
Sbjct: 86  TEKDRQFQYIAIELC-AATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLH---SLNI 139
Query: 441 YHRDIKSANILLD-----DKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQ 493
            HRD+K  NIL+       K +A +SDFG  + + V +   + +  V GT G++ PE   
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 494 S---SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
                  T   D++S G V   +++ G  P             G  LQ    N L  A  
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPF------------GKSLQR-QANILLGACS 246
Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              L   K E+++    L ++ + ++ + RP+ K V
Sbjct: 247 LDCLHPEKHEDVIA-RELIEKMIAMDPQKRPSAKHV 281

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 317 DNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDE---TNVEQFINEVVILSQ 369
           D+Y     LG G    V     KG   +     +KK +L       + E+   EV IL +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           I H NI+ L          +L+ E +  G L+ ++    E+  +T +   +   ++   +
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 121
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
            YLHS     I H D+K  NI+L DK     R K+ DFG +  +  +  +    + GT  
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPE 176
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           +V PE         ++D++S GV+   +L+G  P
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 120/304 (39%), Gaps = 61/304 (20%)
Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR-IVAVK-----KSKLVDETNVEQF 360
           F    L +    Y+    +GQG  G V   +    R I A+K     K + ++  +VE+ 
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 361 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY------------------- 401
             EV ++ +++H NI +L     + +   LV E    G L                    
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 402 ------------QYIHNQIEEFPITWELLLR------IAVEVSGALFYLHSAASIPIYHR 443
                       + I+  I  F  + + + R      I  ++  AL YLH+     I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHR 192
Query: 444 DIKSANILL--DDKYRAKVSDFGTSRSVMV----DQTHLTTKVQGTFGYVDPEYFQSSQ- 496
           DIK  N L   +  +  K+ DFG S+        +   +TTK  GT  +V PE   ++  
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 497 -FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
            +  K D +S GV+L  +L G  P   +N  +  S      Q +N+   FE  +  VL  
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLCFENPNYNVLSP 305
Query: 556 AKKE 559
             ++
Sbjct: 306 LARD 309

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 329 GQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  +V +  V   + E  +L    H  +  L   
Sbjct: 160 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 219
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS  ++   
Sbjct: 220 FQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNV--V 274
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  + + +    
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 333
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 334 DWWGLGVVMYEMMCGRLPF--YNQDHEK 359

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 329 GQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  +V +  V   + E  +L    H  +  L   
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS  ++   
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNV--V 271
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  + + +    
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 330
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 331 DWWGLGVVMYEMMCGRLPF--YNQDHEK 356

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 324 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           ILG G  G V+K   T  G  +A K  K     + E+  NE+ +++Q++H N+++L    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
                 +LV E++  G L+  I +  E + +T    +    ++   + ++H    + I H
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMH---QMYILH 210
Query: 443 RDIKSANILL--DDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSSQFTE 499
            D+K  NIL    D  + K+ DFG +R     +     KV  GT  ++ PE       + 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 500 KSDVYSFGVVLVEILTGQKPIRAINTDE 527
            +D++S GV+   +L+G  P    N  E
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAE 295

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + +      T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEIL 514
           PE      + E  D++S G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           TD+Y     LG+G    V + +          +I+  KK    D   +E+   E  I   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRL 86
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIAVE 424
           + H NIV+L     E     LV++ +  G L++ I     +++ +      ++L  +   
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN-- 144
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ 481
                 ++H      I HRD+K  N+LL  K +    K++DFG +  V  +Q        
Sbjct: 145 ------HIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGFA 194
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           GT GY+ PE  +   + +  D+++ GV+L  +L G  P      DED+
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF----WDEDQ 238

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK-----------SKLVDETNVEQ 359
           +L      Y   R +  G  G V  G+ ++G  VA+K+           + L D    ++
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEFPIT 414
            + E+ +L+  +H NI+ L    +  E P      LV E +    L Q IH+Q     I+
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ--RIVIS 132
Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-- 472
            + +      +   L  LH A    + HRD+   NILL D     + DF  +R    D  
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 473 QTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
           +TH  T       Y  PE   Q   FT+  D++S G V+ E+   +   R
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 137
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D       + GT  Y+ PE       +
Sbjct: 138 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 240
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 241 ----VAASLIQKMLQTDPTARPTINELLND 266

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN--VEQFINEVVILSQIN 371
           + D Y     LG+G  G VYK + T     VA+K+ +L  E        I EV +L ++ 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           HRNI++L           L++E+  N  L +Y+    +   ++  ++     ++   + +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPD---VSMRVIKSFLYQLINGVNF 147
Query: 432 LHSAASIPIYHRDIKSANILL-----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            HS   +   HRD+K  N+LL      +    K+ DFG +R+  +     T ++  T  Y
Sbjct: 148 CHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 487 VDPE-YFQSSQFTEKSDVYSFGVVLVEIL 514
             PE    S  ++   D++S   +  E+L
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 319 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G QG V   Y  +L   R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 374 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           NI+ LL        LE    + +   + +  L Q I  +++      E +  +  ++   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 138
Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
           + +LHSA    I HRD+K +NI++      K+ DFG +R+     + +      T  Y  
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRYYRA 193
Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEIL 514
           PE      + E  D++S G ++ E++
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK-----------SKLVDETNVEQ 359
           +L      Y   R +  G  G V  G+ ++G  VA+K+           + L D    ++
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEFPIT 414
            + E+ +L+  +H NI+ L    +  E P      LV E +    L Q IH+Q     I+
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ--RIVIS 132
Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-- 472
            + +      +   L  LH A    + HRD+   NILL D     + DF  +R    D  
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 473 QTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
           +TH  T       Y  PE   Q   FT+  D++S G V+ E+   +   R
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 303 KTKLFTSKDLEKAT----DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDET 355
           + K F  +D+ K        Y +   +G G  G+V   +    G  VA+KK       E 
Sbjct: 24  RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 83
Query: 356 NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITW 415
             ++   E+++L  + H N++ LL            Y+F       Q    +I     + 
Sbjct: 84  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSE 143
Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 475
           E +  +  ++   L Y+HSA    + HRD+K  N+ +++    K+ DFG +R    + T 
Sbjct: 144 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 476 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQ 517
                  T  Y  PE   S   + +  D++S G ++ E+LTG+
Sbjct: 201 YVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 163
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D       + GT  Y+ PE       +
Sbjct: 164 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 266
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 267 ----VAASLIQKMLQTDPTARPTINELLND 292

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKL-VDETNVEQFINEVVI 366
           +++ E   D+      LG+G  G V K   +  G+I+AVK+ +  V+    ++ + ++ I
Sbjct: 43  NQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 102
Query: 367 -LSQINHRNIVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRIAV 423
            +  ++    V   G         +  E +       Y+ + ++ +  P   ++L +IAV
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP--EDILGKIAV 160
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
            +  AL +LHS  S+   HRD+K +N+L++   + K+ DFG S   +VD    T    G 
Sbjct: 161 SIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTIDA-GC 216
Query: 484 FGYVDPEY----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
             Y+ PE          ++ KSD++S G+ ++E+   + P  +  T         F Q  
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--------FQQL- 267
Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              ++ E    ++  +    E +   +   +CL  N K RPT  E+
Sbjct: 268 --KQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPEL 308

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 303 KTKLFTSKDLEKAT----DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDET 355
           + K F  +D+ K        Y +   +G G  G+V   +    G  VA+KK       E 
Sbjct: 6   RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 356 NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITW 415
             ++   E+++L  + H N++ LL            Y+F       Q    +I     + 
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE 125
Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 475
           E +  +  ++   L Y+HSA    + HRD+K  N+ +++    K+ DFG +R    + T 
Sbjct: 126 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 476 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQ 517
                  T  Y  PE   S   + +  D++S G ++ E+LTG+
Sbjct: 183 YVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI--NHRNIVKLLGCC 382
           +G+G  G V++G L  G  VAVK     DE   + +  E  I + +   H NI+  +   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 383 LETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
           + +        L+  +  +G+LY ++  Q  E      L LR+AV  +  L +LH     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP----HLALRLAVSAACGLAHLHVEIFG 127
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD KS N+L+    +  ++D G   +VM  Q      +      GT  Y+ 
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGL--AVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 489 PEY---------FQSSQFTEKSDVYSFGVVLVEI 513
           PE          F+S ++T   D+++FG+VL EI
Sbjct: 186 PEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 32/270 (11%)
Query: 325 LGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG+GG    ++    D + V     V KS L+     E+   E+ I   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASI 438
              + +   +V E     +L + +H + +    P     L +I +       YLH    I
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRNRVI 161
Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
              HRD+K  N+ L++    K+ DFG +  V  D       + GT  Y+ PE       +
Sbjct: 162 ---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 217
Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK 558
            + DV+S G ++  +L G+ P       E      Y     NE  + + ++         
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINP-------- 264
Query: 559 EEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 A+L ++ L  +   RPT+ E+ N+
Sbjct: 265 ----VAASLIQKMLQTDPTARPTINELLND 290

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           ++G+G  G VY G       + +   +  +E  ++ F  EV+   Q  H N+V  +G C+
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 384 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 443
                 ++       TLY  + +   +  +      +IA E+   + YLH+     I H+
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHK 154
Query: 444 DIKSANILLDDKYRAKVSDFG---TSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSSQ--- 496
           D+KS N+  D+  +  ++DFG    S  +   +     ++Q G   ++ PE  +      
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 497 ------FTEKSDVYSFGVVLVEILTGQKPIR 521
                 F++ SDV++ G +  E+   + P +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDG------RIVAVKKSKLVDETNVEQFIN---EVVIL 367
           D Y  ++ LG G  G V              RI++ +K  +      +  +N   E+ IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
            ++NH  I+K+     + E   +V E +  G L+  +         T +L      ++  
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 250
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L   + GT 
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTP 305
Query: 485 GYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 329 GQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  +V +  V   + E  +L    H  +  L   
Sbjct: 18  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 77
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS  ++   
Sbjct: 78  FQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNV--V 132
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   +     GT  Y+ PE  + + +    
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEVLEDNDYGRAV 191
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 192 DWWGLGVVMYEMMCGRLPF--YNQDHEK 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 357 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLL--VYEFIPNGTLYQYIHNQIEEFPIT 414
           +EQ   E+ IL +++H N+VKL+    +     L  V+E +  G + +    +    P++
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLS 135
Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            +       ++   + YLH      I HRDIK +N+L+ +    K++DFG S        
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 475 HLTTKVQGTFGYVDPEYFQSSQ--FTEKS-DVYSFGVVLVEILTGQKP 519
            L+  V GT  ++ PE    ++  F+ K+ DV++ GV L   + GQ P
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 317 DNYNANRILGQGGQGTVYKGMLTDG------RIVAVKKSKLVDETNVEQFIN---EVVIL 367
           D Y  ++ LG G  G V              RI++ +K  +      +  +N   E+ IL
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
            ++NH  I+K+     + E   +V E +  G L+  +         T +L      ++  
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 264
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L   + GT 
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTP 319
Query: 485 GYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
            Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 329 GQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  +V +  V   + E  +L    H  +  L   
Sbjct: 17  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 76
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS  ++   
Sbjct: 77  FQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNV--V 131
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   +     GT  Y+ PE  + + +    
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEVLEDNDYGRAV 190
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 191 DWWGLGVVMYEMMCGRLPF--YNQDHEK 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 333 VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 392
           V  G     +I+  KK    D   +E+   E  I   + H NIV+L     E     L++
Sbjct: 44  VLAGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGHHYLIF 100
Query: 393 EFIPNGTLYQYI-----HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 447
           + +  G L++ I     +++ +      ++L         A+ + H      + HRD+K 
Sbjct: 101 DLVTGGELFEDIVAREYYSEADASHCIQQIL--------EAVLHCHQMG---VVHRDLKP 149
Query: 448 ANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
            N+LL  K +    K++DFG +  V  +Q        GT GY+ PE  +   + +  D++
Sbjct: 150 ENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 208
Query: 505 SFGVVLVEILTGQKPIRAINTDEDK 529
           + GV+L  +L G  P      DED+
Sbjct: 209 ACGVILYILLVGYPPF----WDEDQ 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-----------LTDGRIVAVKKSKLVDET-NVEQFINEV 364
           D Y  ++ LG G  G V               +   R  A+  ++  D   NVE    E+
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 65
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPIT---WELLL 419
            IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E       +++LL
Sbjct: 66  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHL 476
                   A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L
Sbjct: 125 --------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 171
Query: 477 TTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
              + GT  Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-----------LTDGRIVAVKKSKLVDET-NVEQFINEV 364
           D Y  ++ LG G  G V               +   R  A+  ++  D   NVE    E+
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 72
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPIT---WELLL 419
            IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E       +++LL
Sbjct: 73  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHL 476
                   A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L
Sbjct: 132 --------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 178
Query: 477 TTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
              + GT  Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-----------LTDGRIVAVKKSKLVDET-NVEQFINEV 364
           D Y  ++ LG G  G V               +   R  A+  ++  D   NVE    E+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 66
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPIT---WELLL 419
            IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E       +++LL
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHL 476
                   A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L
Sbjct: 126 --------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 477 TTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
              + GT  Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-----------LTDGRIVAVKKSKLVDET-NVEQFINEV 364
           D Y  ++ LG G  G V               +   R  A+  ++  D   NVE    E+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 66
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPIT---WELLL 419
            IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E       +++LL
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHL 476
                   A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L
Sbjct: 126 --------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 477 TTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
              + GT  Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 317 DNYNANRILGQGGQGTVYKGM-----------LTDGRIVAVKKSKLVDET-NVEQFINEV 364
           D Y  ++ LG G  G V               +   R  A+  ++  D   NVE    E+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 66
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPIT---WELLL 419
            IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E       +++LL
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSVMVDQTHL 476
                   A+ YLH      I HRD+K  N+LL  +      K++DFG S+  ++ +T L
Sbjct: 126 --------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 477 TTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKP 519
              + GT  Y+ PE   S   + +    D +S GV+L   L+G  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 329 GQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
           G+GT  K +L      GR  A+K   K  +V +  V   + E  +L    H  +  L   
Sbjct: 19  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 78
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
               +    V E+   G L+ ++     E   + +       E+  AL YLHS  ++   
Sbjct: 79  FQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNV--V 133
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           +RD+K  N++LD     K++DFG  +  + D   +     GT  Y+ PE  + + +    
Sbjct: 134 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEVLEDNDYGRAV 192
Query: 502 DVYSFGVVLVEILTGQKPIRAINTDEDK 529
           D +  GVV+ E++ G+ P    N D +K
Sbjct: 193 DWWGLGVVMYEMMCGRLPF--YNQDHEK 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 23/261 (8%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRIV-AVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           Y     +G+G  G V   +    RI  A KK       +V++F  E+ I+  ++H NI++
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQ-YIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           L     +     LV E    G L++  +H ++           RI  +V  A+ Y H   
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCH--- 123
Query: 437 SIPIYHRDIKSANIL-LDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
            + + HRD+K  N L L D   +  K+ DFG +      +  + TKV GT  YV P+  +
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQVLE 181
Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYFL----QAINENRLFE 546
              +  + D +S GV++  +L G  P  A  TD +  L    G F       +N +   E
Sbjct: 182 -GLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDXEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 547 ALDARVLKEAKKEEIMTVATL 567
           +L  R+L ++ K+ I ++  L
Sbjct: 240 SLIRRLLTKSPKQRITSLQAL 260

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 23/261 (8%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRIV-AVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           Y     +G+G  G V   +    RI  A KK       +V++F  E+ I+  ++H NI++
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQ-YIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           L     +     LV E    G L++  +H ++           RI  +V  A+ Y H   
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCH--- 140
Query: 437 SIPIYHRDIKSANIL-LDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
            + + HRD+K  N L L D   +  K+ DFG +      +  + TKV GT  YV P+  +
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQVLE 198
Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV---GYFL----QAINENRLFE 546
              +  + D +S GV++  +L G  P  A  TD +  L    G F       +N +   E
Sbjct: 199 -GLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDXEVMLKIREGTFTFPEKDWLNVSPQAE 256
Query: 547 ALDARVLKEAKKEEIMTVATL 567
           +L  R+L ++ K+ I ++  L
Sbjct: 257 SLIRRLLTKSPKQRITSLQAL 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 316 TDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 369
           T+ Y     LG+G    V +      G      I+  KK    D   +E+   E  I   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRL 66
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQIEEFPITWELLLRIAVE 424
           + H NIV+L     E     L+++ +  G L++ I     +++ +      ++L      
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL------ 120
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ 481
              A+ + H      + HR++K  N+LL  K +    K++DFG +  V  +Q        
Sbjct: 121 --EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFA 174
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           GT GY+ PE  +   + +  D+++ GV+L  +L G  P      DED+
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF----WDEDQ 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 29/285 (10%)
Query: 312 LEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKL-VDETNVEQFINEVVI-LS 368
           +E   D+      LG+G  G V K   +  G+I+AVK+ +  V+    ++ + ++ I + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQIEEFPITWELLLRIAVEVS 426
            ++    V   G         +  E +       Y+ + ++ +  P   ++L +IAV + 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP--EDILGKIAVSIV 119
Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            AL +LHS  S+   HRD+K +N+L++   + K+ DFG S   +VD         G   Y
Sbjct: 120 KALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDIDA-GCKPY 175
Query: 487 VDPEY----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
           + PE          ++ KSD++S G+ ++E+   + P  +  T         F Q     
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--------FQQL---K 224
Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
           ++ E    ++  +    E +   +   +CL  N K RPT  E+  
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPELMQ 266

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQ--FINEVVILSQINHRNIVKLLGCC 382
           L +   G ++KG    G  + VK  K+ D +  +   F  E   L   +H N++ +LG C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 383 LETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                P   L+  ++P G+LY  +H     F +     ++ A++++  + +LH+   + I
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPL-I 134
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF---GYVDPEYFQSSQF 497
               + S ++++D+   A++S        M D    + +  G      +V PE  Q    
Sbjct: 135 PRHALNSRSVMIDEDMTARIS--------MAD-VKFSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 498 T---EKSDVYSFGVVLVEILTGQKPIRAINTDE 527
                 +D++SF V+L E++T + P   ++  E
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNME 218

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK---KSKLVDETNVEQFINEVVILSQ 369
           +D Y   + +G G  G     ++ D +   +VAVK   + + +DE    + IN       
Sbjct: 18  SDRYELVKDIGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEV 425
           + H NIV+     L      +V E+   G L++ I N      +E    ++ L      +
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSR-SVMVDQTHLTTKVQG 482
           SG  +    A ++ + HRD+K  N LLD     R K++DFG S+ SV+  Q        G
Sbjct: 126 SGVSY----AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV---G 178
Query: 483 TFGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
           T  Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK---KSKLVDETNVEQFINEVVILSQ 369
           +D Y   + +G G  G     ++ D +   +VAVK   + + +DE    + IN       
Sbjct: 17  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 70
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEV 425
           + H NIV+     L      +V E+   G L++ I N      +E    ++ L      +
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           SG + Y H   ++ + HRD+K  N LLD     R K+ DFG S+S ++     +T   GT
Sbjct: 125 SG-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GT 178
Query: 484 FGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
             Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 314 KATDNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           K  D Y   + +LG+G    V   + L +G+  AVK  +     +  +   EV  L Q  
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQ 68
Query: 372 -HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            ++NI++L+    +     LV+E +  G++  +I  Q            R+  +V+ AL 
Sbjct: 69  GNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRDVAAALD 125
Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQT-------HLTTKV 480
           +LH+     I HRD+K  NIL +   +    K+ DF     + ++ +        LTT  
Sbjct: 126 FLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 481 QGTFGYVDPEYF-----QSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            G+  Y+ PE       Q++ + ++ D++S GVVL  +L+G  P 
Sbjct: 183 -GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE-QFINEVVILSQINHR 373
           + ++    +LG+G  G V        G IVA+KK +  D+     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NI+ +               +I    +   +H  I    ++ + +     +   A+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGTFGYVDPE 490
            +  I   HRD+K +N+L++     KV DFG +R +     D +  T +  G   YV   
Sbjct: 130 GSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 491 YFQ-------SSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +++       S++++   DV+S G +L E+   ++PI
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNVE-----QFINEVVI 366
           +  Y+    LG G  G V+  +  +      +  +KK K++++  +E     +   E+ I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT-LYQYI--HNQIEEFPITWELLLRIAV 423
           LS++ H NI+K+L          LV E   +G  L+ +I  H +++E      L   I  
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFR 137
Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++  A+ YL       I HRDIK  NI++ + +  K+ DFG+  +  +++  L     GT
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS--AAYLERGKLFYTFCGT 192
Query: 484 FGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPI--------RAIN-----TDEDK 529
             Y  PE    + +   + +++S GV L  ++  + P          AI+     + E  
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM 252
Query: 530 SLVGYFLQAINENR 543
           SLV   LQ + E R
Sbjct: 253 SLVSGLLQPVPERR 266

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE-QFINEVVILSQINHR 373
           + ++    +LG+G  G V        G IVA+KK +  D+     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NI+ +               +I    +   +H  I    ++ + +     +   A+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGTFGYVDPE 490
            +  I   HRD+K +N+L++     KV DFG +R +     D +  T +  G   +V   
Sbjct: 130 GSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 491 YFQ-------SSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +++       S++++   DV+S G +L E+   ++PI
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V+ G    G  VAVK     +E +   E  I + V++    H NI+  +   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLM---RHENILGFIAAD 100
Query: 383 LE-----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS--- 434
           ++     T++  L+ ++  NG+LY Y+ +      +  + +L++A      L +LH+   
Sbjct: 101 IKGTGSWTQL-YLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 435 --AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL----TTKVQGTFGYVD 488
                  I HRD+KS NIL+       ++D G +   + D   +     T+V GT  Y+ 
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMP 214
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      Q    +D+YSFG++L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RN 374
           D+Y   R LG+G    V++ + +T+   V VK  K V +  +++   E+ IL  +    N
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPN 93
Query: 375 IVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           I+ L     +  +  P LV+E + N T ++ ++  + ++ I + +      E+  AL Y 
Sbjct: 94  IITLADIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIRFYMY-----EILKALDYC 147
Query: 433 HSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           HS     I HRD+K  N+++D ++R  ++ D+G +      Q +   +V   + +  PE 
Sbjct: 148 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPEL 202
Query: 492 FQSSQFTEKS-DVYSFGVVLVEILTGQKP 519
               Q  + S D++S G +L  ++  ++P
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 14/107 (13%)
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD---QTH 475
           L I ++++ A+ +LHS     + HRD+K +NI        KV DFG   ++  D   QT 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 476 LTTKVQ--------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
           LT            GT  Y+ PE    + ++ K D++S G++L E+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDE-TNVEQFINEVV 365
           +K  D Y+    LG G    V K      G+    + +  ++S+      + E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           IL Q+ H N++ L          +L+ E +  G L+ ++    ++  ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQ 481
              + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDE-TNVEQFINEVV 365
           +K  D Y+    LG G    V K      G+    + +  ++S+      + E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           IL Q+ H N++ L          +L+ E +  G L+ ++    ++  ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQ 481
              + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 111/250 (44%), Gaps = 48/250 (19%)
Query: 321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLL 379
           + +ILG G  GTV       GR VAVK+  L+D  ++   + E+ +L++  +H N+++  
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKR-MLIDFCDIA--LMEIKLLTESDDHPNVIRYY 75
Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHN----------QIEEFPITWELLLRIAVEVSGAL 429
            C   T+  L +   + N  L   + +          Q E  PI+   LLR   +++  +
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS---LLR---QIASGV 128
Query: 430 FYLHSAASIPIYHRDIKSANILLD-------------DKYRAKVSDFGTSRSVMVDQTHL 476
            +LH   S+ I HRD+K  NIL+              +  R  +SDFG  + +   Q+  
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 477 TTKVQ---GTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILT-GQKPIRAINT 525
            T +    GT G+  PE  + S       + T   D++S G V   IL+ G+ P     +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 526 DEDKSLVGYF 535
            E   + G F
Sbjct: 246 RESNIIRGIF 255

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDE-TNVEQFINEVV 365
           +K  D Y+    LG G    V K      G+    + +  ++S+      + E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           IL Q+ H N++ L          +L+ E +  G L+ ++    ++  ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQ 481
              + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDE-TNVEQFINEVV 365
           +K  D Y+    LG G    V K      G+    + +  ++S+      + E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           IL Q+ H N++ L          +L+ E +  G L+ ++    ++  ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQ 481
              + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE-QFINEVVILSQINHR 373
           + ++    +LG+G  G V        G IVA+KK +  D+     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NI+ +               +I    +   +H  I    ++ + +     +   A+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLT------TKVQGTF 484
            +  I   HRD+K +N+L++     KV DFG +R +     D +  T      T+   T 
Sbjct: 130 GSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 485 GYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            Y  PE    S++++   DV+S G +L E+   ++PI
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 67
Query: 383 LE---TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
            +   T   L LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH     
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+ 
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      +  +++D+Y+ G+V  EI
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 69
Query: 383 LE---TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
            +   T   L LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH     
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+ 
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      +  +++D+Y+ G+V  EI
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 317 DNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           D Y    ++G+G    V +      G     +IV V K       + E    E  I   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTL-YQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            H +IV+LL       +  +V+EF+    L ++ +      F  +  +      ++  AL
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ-GTFG 485
            Y H      I HRD+K  N+LL  K  +   K+ DFG +  + + ++ L    + GT  
Sbjct: 144 RYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPH 198
Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE  +   + +  DV+  GV+L  +L+G  P
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDE-TNVEQFINEVV 365
           +K  D Y+    LG G    V K      G+    + +  ++S+      + E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           IL Q+ H N++ L          +L+ E +  G L+ ++    ++  ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQ 481
              + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-IF 179
Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 66
Query: 383 LE---TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
            +   T   L LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+ 
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      +  +++D+Y+ G+V  EI
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 72
Query: 383 LE---TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
            +   T   L LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH     
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+ 
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      +  +++D+Y+ G+V  EI
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D Y+    LG G  G V++ +    GR+   K       +D+  V+   NE+ I++Q++H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             ++ L     +    +L+ EF+  G L+  I    E++ ++   ++    +    L ++
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 433 HSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           H  +   I H DIK  NI+ + K  +  K+ DFG +  +  D+    T     F    PE
Sbjct: 166 HEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA--PE 220
Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
                     +D+++ GV+   +L+G  P
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLL 379
           + +ILG G  GTV       GR VAVK+  L+D  ++   + E+ +L++  +H N+++  
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIA--LMEIKLLTESDDHPNVIRYY 93
Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHN----------QIEEFPITWELLLRIAVEVSGAL 429
            C   T+  L +   + N  L   + +          Q E  PI+   LLR   +++  +
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS---LLR---QIASGV 146
Query: 430 FYLHSAASIPIYHRDIKSANILLD-------------DKYRAKVSDFGTSRSVMVDQTHL 476
            +LH   S+ I HRD+K  NIL+              +  R  +SDFG  + +   Q   
Sbjct: 147 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 477 TTKVQ---GTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
              +    GT G+  PE  + S   + T   D++S G V   IL+ G+ P     + E  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 530 SLVGYF 535
            + G F
Sbjct: 264 IIRGIF 269

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 34/212 (16%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGC- 381
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 105
Query: 382 ----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH---- 433
                  T++  LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH    
Sbjct: 106 NKDNGTWTQL-WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 434 -SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYV 487
            +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 488 DPEYFQSS------QFTEKSDVYSFGVVLVEI 513
            PE    S      +  +++D+Y+ G+V  EI
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----EV 364
           K+ EK  D Y  + ++G+G  G V K     +   VA+K  K     N + F+N    EV
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEV 101
Query: 365 VILSQINHRN------IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
            +L  +N  +      IV L    +      LV+E + +  LY  + N      ++  L 
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRN-TNFRGVSLNLT 159
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHL 476
            + A ++  AL +L +   + I H D+K  NILL +  R+  K+ DFG+S  +      +
Sbjct: 160 RKFAQQMCTALLFL-ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRI 215
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
              +Q  F Y  PE      +    D++S G +LVE+ TG+
Sbjct: 216 YQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLL 379
           + +ILG G  GTV       GR VAVK+  L+D  ++   + E+ +L++  +H N+++  
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIA--LMEIKLLTESDDHPNVIRYY 93
Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHN----------QIEEFPITWELLLRIAVEVSGAL 429
            C   T+  L +   + N  L   + +          Q E  PI+   LLR   +++  +
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS---LLR---QIASGV 146
Query: 430 FYLHSAASIPIYHRDIKSANILLD-------------DKYRAKVSDFGTSRSVMVDQTHL 476
            +LH   S+ I HRD+K  NIL+              +  R  +SDFG  + +   Q   
Sbjct: 147 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 477 TTKVQ---GTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 529
              +    GT G+  PE  + S   + T   D++S G V   IL+ G+ P     + E  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 530 SLVGYF 535
            + G F
Sbjct: 264 IIRGIF 269

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 382
           +G+G  G V++G    G  VAVK     +E +   E  I + V+L    H NI+  +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 92
Query: 383 LE---TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH----- 433
            +   T   L LV ++  +G+L+ Y++     + +T E ++++A+  +  L +LH     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----GTFGYVD 488
           +     I HRD+KS NIL+       ++D G   +V  D    T  +      GT  Y+ 
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 489 PEYFQSS------QFTEKSDVYSFGVVLVEI 513
           PE    S      +  +++D+Y+ G+V  EI
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 384
           LG+G  G V++ + T  +   + K   V  T+      E+ IL+   HRNI+ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 444
            E  ++++EFI    +++ I+     F +    ++    +V  AL +LHS     I H D
Sbjct: 73  MEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 445 IKSANILLDDKYRA--KVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           I+  NI+   +  +  K+ +FG +R +   D   L         Y  PE  Q    +  +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP---EYYAPEVHQHDVVSTAT 184
Query: 502 DVYSFGVVLVEILTGQKPIRA 522
           D++S G ++  +L+G  P  A
Sbjct: 185 DMWSLGTLVYVLLSGINPFLA 205

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----EV 364
           K+ EK  D Y  + ++G+G  G V K     +   VA+K  K     N + F+N    EV
Sbjct: 28  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEV 82
Query: 365 VILSQINHRN------IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
            +L  +N  +      IV L    +      LV+E + +  LY  + N      ++  L 
Sbjct: 83  RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRN-TNFRGVSLNLT 140
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHL 476
            + A ++  AL +L +   + I H D+K  NILL +  R+  K+ DFG+S  +      +
Sbjct: 141 RKFAQQMCTALLFL-ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRI 196
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
              +Q  F Y  PE      +    D++S G +LVE+ TG+
Sbjct: 197 YQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 236

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 313 EKATDNYNANRILGQGGQGTVYK------GMLTDGRIVAVKKSKLVDETNV--EQFINEV 364
           +K  D Y+    LG G    V K      G+    + +  ++S+      V  E+   EV
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR-ASRRGVCREEIEREV 66
Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            IL Q+ H NI+ L          +L+ E +  G L+ ++    ++  ++ E       +
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ 123
Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKV 480
           +   + YLH+     I H D+K  NI+L DK       K+ DFG +  +  D       +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN-I 178
Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            GT  +V PE         ++D++S GV+   +L+G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 325 LGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQF-INEVVILSQINHRNIVKLLG 380
           LG+G  G V++  + D   G   AVKK +L      E F + E+V  + ++   IV L G
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYG 131
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL-LRIAVEVSGALFYLHSAASIP 439
              E     +  E +  G+L Q I  Q+   P    L  L  A+E    L YLH+     
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALE---GLEYLHTRR--- 184
Query: 440 IYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVD---QTHLTTK-VQGTFGYVDPEYFQS 494
           I H D+K+ N+LL  D  RA + DFG +  +  D   ++ LT   + GT  ++ PE    
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
                K D++S   +++ +L G  P
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 10  AKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 175 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK---KSKLVDETNVEQFINEVVILSQ 369
           +D Y   + +G G  G     ++ D +   +VAVK   + + +DE    + IN       
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEV 425
           + H NIV+     L      +V E+   G L++ I N      +E    ++ L      +
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           SG + Y H   ++ + HRD+K  N LLD     R K+  FG S+S ++     +T   GT
Sbjct: 126 SG-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GT 179
Query: 484 FGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
             Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 22/177 (12%)
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           I  ++L +IAV +  AL +LHS  S+   HRD+K +N+L++   + K  DFG S   +VD
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKXCDFGIS-GYLVD 189
Query: 473 QTHLTTKVQGTFGYVDPEY----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
                    G   Y  PE          ++ KSD++S G+  +E+   + P  +  T   
Sbjct: 190 DVAKDIDA-GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP-- 246
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                 F Q     ++ E    ++  +    E +   +   +CL  N K RPT  E+
Sbjct: 247 ------FQQL---KQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPEL 291

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 39/78 (50%)
Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HRD+K  NIL+     A + DFG + +   ++        GT  Y  PE F  S  T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 502 DVYSFGVVLVEILTGQKP 519
           D+Y+   VL E LTG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 218
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 219 LGVIMYILLCGYPP 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRI---VAVKK--SKLVDETNVEQFINEVVILSQINHR 373
           Y   + +G G  G V   +  DGR    VA+KK       E   ++   E+ +L  + H 
Sbjct: 27  YRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 374 NIVKLLGCCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           N++ LL      E         LV  F+         H ++ E  I +     +  ++  
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-----LVYQMLK 139
Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            L Y+H+A    I HRD+K  N+ +++    K+ DFG +R    +          T  Y 
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWYR 192
Query: 488 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
            PE      ++T+  D++S G ++ E++TG+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----EV 364
           K+ EK  D Y  + ++G+G  G V K     +   VA+K  K     N + F+N    EV
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEV 101
Query: 365 VILSQINHRN------IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
            +L  +N  +      IV L    +      LV+E + +  LY  + N      ++  L 
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRN-TNFRGVSLNLT 159
Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHL 476
            + A ++  AL +L +   + I H D+K  NILL +  R   K+ DFG+S  +      +
Sbjct: 160 RKFAQQMCTALLFL-ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL---GQRI 215
Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
              +Q  F Y  PE      +    D++S G +LVE+ TG+
Sbjct: 216 YQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 324 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGC 381
           +LG+G    V   + L   +  AVK  +        +   EV +L Q   HRN+++L+  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             E +   LV+E +  G++  +IH +     +   ++++   +V+ AL +LH+     I 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKG---IA 133
Query: 442 HRDIKSANILLDDKYR---AKVSDFGTSRSVMV--DQTHLTTK----VQGTFGYVDPEYF 492
           HRD+K  NIL +   +    K+ DFG    + +  D + ++T       G+  Y+ PE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 493 -----QSSQFTEKSDVYSFGVVLVEILTGQKP 519
                ++S + ++ D++S GV+L  +L+G  P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 202
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR---IVAVKKSKLVDE--TNVEQFINEVVILSQI 370
           +D Y   + +G G  G     ++ D +   +VAVK  +  ++   NV++   E++    +
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAANVKR---EIINHRSL 72
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEVS 426
            H NIV+     L      +V E+   G L++ I N      +E    ++ L      +S
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------IS 126
Query: 427 GALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           G + Y H   ++ + HRD+K  N LLD     R K+ DFG S+S ++     +T   GT 
Sbjct: 127 G-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTP 180
Query: 485 GYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
            Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 325 LGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 383
           LG G  G V+K     DGR+ AVK+S     +      +    L+++     V    CC+
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSM----SPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 384 ETEVPLLVYEFIPNGTLY---QYIHNQIEEFPITWELLLRIAVEVSG-------ALFYLH 433
             E       +   G LY   +     +++    W   L  A +V G       AL +LH
Sbjct: 121 RLE-----QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEA-QVWGYLRDTLLALAHLH 174
Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQ-GTFGYVDPEY 491
           S     + H D+K ANI L  + R K+ DFG    ++V+  T    +VQ G   Y+ PE 
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFG----LLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 492 FQSSQFTEKSDVYSFGVVLVEI 513
            Q S +   +DV+S G+ ++E+
Sbjct: 228 LQGS-YGTAADVFSLGLTILEV 248

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 203
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 204 LGVIMYILLCGYPP 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 210
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 211 LGVIMYILLCGYPP 224

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 248
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 249 LGVIMYILLCGYPP 262

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 254
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 255 LGVIMYILLCGYPP 268

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE-- 354
           +  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K ++ D   
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 355 -TNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEE 410
             N  +   EVV+L +++     +++LL      +  +L+ E   P   L+ +I    E 
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TER 151
Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSV 469
             +  EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG+  ++
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG-AL 207
Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPIRAINTDED 528
           + D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      DE+
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE 262
Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
                     I   ++F     RV  E +         L + CL L    RPT +E+ N
Sbjct: 263 ----------IIRGQVF--FRQRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 301

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 325 LGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQF-INEVVILSQINHRNIVKLLG 380
           +G+G  G V++  + D   G   AVKK +L      E F + E+V  + ++   IV L G
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYG 117
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL-LRIAVEVSGALFYLHSAASIP 439
              E     +  E +  G+L Q I  Q+   P    L  L  A+E    L YLH+     
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALE---GLEYLHTRR--- 170
Query: 440 IYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVD---QTHLTTK-VQGTFGYVDPEYFQS 494
           I H D+K+ N+LL  D  RA + DFG +  +  D   ++ LT   + GT  ++ PE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
                K D++S   +++ +L G  P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGR---IVAVK---KSKLVDETNVEQFINEVVILSQ 369
           +D Y   + +G G  G     ++ D +   +VAVK   + + +DE    + IN       
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN----QIEEFPITWELLLRIAVEV 425
           + H NIV+     L      +V E+   G L++ I N      +E    ++ L      +
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 426 SGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSR-SVMVDQTHLTTKVQG 482
           SG + Y H   ++ + HRD+K  N LLD     R K+  FG S+ SV+  Q   T    G
Sbjct: 126 SG-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV---G 178
Query: 483 TFGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKP 519
           T  Y+ PE     ++  K +DV+S GV L  +L G  P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 16/210 (7%)
Query: 325 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGCC 382
           L +   G ++KG    G  + VK  K+ D +  +   F  E   L   +H N++ +LG C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 383 LETEV--PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
                  P L+  + P G+LY  +H     F +     ++ A++ +    +LH+   + I
Sbjct: 77  QSPPAPHPTLITHWXPYGSLYNVLHEGT-NFVVDQSQAVKFALDXARGXAFLHTLEPL-I 134
Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT-- 498
               + S ++ +D+   A++S      S                 +V PE  Q       
Sbjct: 135 PRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP------AWVAPEALQKKPEDTN 188
Query: 499 -EKSDVYSFGVVLVEILTGQKPIRAINTDE 527
              +D +SF V+L E++T + P   ++  E
Sbjct: 189 RRSADXWSFAVLLWELVTREVPFADLSNXE 218

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 24/160 (15%)
Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK----VSDFGTSRSVMVDQTHLTT 478
           +E+  AL YL   +   + H D+K  NILLDD Y  K    V      + + + +T  T 
Sbjct: 144 IEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 479 KVQGTFG-----------------YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 521
                FG                 Y  PE   +  +   SD++SFG VL E+ TG    R
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 522 AINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI 561
                E  +++   +Q I +N L+EA      K   K+E+
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL 300

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 208
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 209 LGVIMYILLCGYPP 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           L+V E +  G L+  I ++ ++   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 151
Query: 449 NILLDDKYR---AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           N+L   K      K++DFG ++        LTT     + YV PE     ++ +  D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 209
Query: 506 FGVVLVEILTGQKP 519
            GV++  +L G  P
Sbjct: 210 LGVIMYILLCGYPP 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 10  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 175 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 19  NKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 184 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 33  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 92
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 93  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 140
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 198 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 186 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 34  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 199 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 186 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 186 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 102/232 (43%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG  R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 24  NKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 83
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 84  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 131
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 132 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 188
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 189 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 25  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 84
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 85  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 189
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 190 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 448
           +L+ E+   G ++     ++ E  ++   ++R+  ++   ++YLH      I H D+K  
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQ 160
Query: 449 NILLDDKY---RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           NILL   Y     K+ DFG SR +         ++ GT  Y+ PE       T  +D+++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 506 FGVVLVEILTGQKP 519
            G++   +LT   P
Sbjct: 219 IGIIAYMLLTHTSP 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 19  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 184 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 325 LGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQF-INEVVILSQINHRNIVKLLG 380
           +G+G  G V++  + D   G   AVKK +L      E F + E+V  + ++   IV L G
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYG 133
Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL-LRIAVEVSGALFYLHSAASIP 439
              E     +  E +  G+L Q I  Q+   P    L  L  A+E    L YLH+     
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALE---GLEYLHTRR--- 186
Query: 440 IYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVD---QTHLTTK-VQGTFGYVDPEYFQS 494
           I H D+K+ N+LL  D  RA + DFG +  +  D   ++ LT   + GT  ++ PE    
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP 519
                K D++S   +++ +L G  P
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 20  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 185 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            T        T  Y  PE    +  + +  D++S G ++ E+LTG+
Sbjct: 179 MTGYV----ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 48/250 (19%)
Query: 321 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLL 379
           + +ILG G  GTV       GR VAVK+  L+D  ++   + E+ +L++  +H N+++  
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKR-MLIDFCDIA--LMEIKLLTESDDHPNVIRYY 75
Query: 380 GCCLETEVPLLVYEFIPNGTLYQYIHN----------QIEEFPITWELLLRIAVEVSGAL 429
            C   T+  L +   + N  L   + +          Q E  PI+   LLR   +++  +
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS---LLR---QIASGV 128
Query: 430 FYLHSAASIPIYHRDIKSANILLD-------------DKYRAKVSDFGTSRSVMVDQTHL 476
            +LH   S+ I HRD+K  NIL+              +  R  +SDFG  + +   Q   
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 477 TTKVQ---GTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILT-GQKPIRAINT 525
              +    GT G+  PE  + S       + T   D++S G V   IL+ G+ P     +
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 526 DEDKSLVGYF 535
            E   + G F
Sbjct: 246 RESNIIRGIF 255

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 10  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R     
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 169
Query: 473 QTHLTTKVQG---TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
             H   ++ G   T  Y  PE       + +  D++S G ++ E+LTG+
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 16  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE 180
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 181 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 323 RILGQGGQGTVYKGMLTDGRI---VAVKK--SKLVDETNVEQFINEVVILSQINHRNIVK 377
           R +G G  G+V      D R+   VAVKK         +  +   E+ +L  + H N++ 
Sbjct: 34  RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 378 LLGC-CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           LL      T +      ++    +   ++N ++   ++ E +  +  ++   L Y+HSA 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I HRD+K +N+ +++    ++ DFG +R    + T          GYV   ++++ +
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT----------GYVATRWYRAPE 198
Query: 497 -------FTEKSDVYSFGVVLVEILTGQ 517
                  + +  D++S G ++ E+L G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 12  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 71
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 72  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 119
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 176
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 177 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 11  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 70
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 71  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 176 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 10  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 175 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 21/212 (9%)
Query: 316 TDNYNANRILGQGGQGT----VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           TD Y     +G G        ++K    +  +  + KSK      +E      ++L    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE------ILLRYGQ 74
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NI+ L     + +   +V E +  G L   I  Q  +F  +      +   ++  + Y
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KF-FSEREASAVLFTITKTVEY 131
Query: 432 LHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           LH+     + HRD+K +NIL  D+       ++ DFG ++ +  +   L T    T  +V
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFV 187
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            PE  +   +    D++S GV+L  +LTG  P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R     
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 173
Query: 473 QTHLTTKVQG---TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
             H   ++ G   T  Y  PE       + +  D++S G ++ E+LTG+
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R     
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 173
Query: 473 QTHLTTKVQG---TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
             H   ++ G   T  Y  PE       + +  D++S G ++ E+LTG+
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKK-SKLVDET-NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK SK      + ++   E+ 
Sbjct: 26  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR 85
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 191 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 185
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 186 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 34  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R     
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 193
Query: 473 QTHLTTKVQG---TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
             H   ++ G   T  Y  PE       + +  D++S G ++ E+LTG+
Sbjct: 194 --HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 11  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 70
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 71  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 176 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 26  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 85
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 191 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 26  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 85
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 191 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 16  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 181 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 20  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE 184
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 185 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 16  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 181 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQI------ 370
           Y   +++G+G  G V K    D ++      K+V  ++    Q   E+ IL  +      
Sbjct: 99  YEVLKVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           N  N++ +L          + +E + +  LY+ I  N+ + F +   L+ + A  +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
             LH      I H D+K  NILL  + R+  KV DFG+S     +   + T +Q  F Y 
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRF-YR 266
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE    +++    D++S G +L E+LTG  P+     + D+      L  +   +L +A
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY-PLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 548 LDARVLKEAKK-------EEIMTVATLAKRCLNLN------GKMR--PTMKEVTNELGG 591
                 K AK            TV TL+   + LN      GK+R  P  +E  N L G
Sbjct: 326 -----SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 33  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 92
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 93  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 140
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 198 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 19  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 184 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 16  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 181 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 13  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 72
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 73  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 120
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 177
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 178 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 179 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 25  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 84
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 85  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 189
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 190 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 34  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 199 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 21/225 (9%)
Query: 316 TDNYNANRILGQGG----QGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
           +D Y     +G G     +  V+K    +  +  + KSK      +E      ++L    
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE------ILLRYGQ 79
Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H NI+ L     + +   LV E +  G L   I  Q  +F    E    +   +   + Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFVLHT-IGKTVEY 136
Query: 432 LHSAASIPIYHRDIKSANILLDDKYR----AKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           LHS     + HRD+K +NIL  D+       ++ DFG ++ +  +   L T    T  +V
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFV 192
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
            PE  +   + E  D++S G++L  +L G  P     +D  + ++
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 37  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 96
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 97  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 201
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 202 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 44/299 (14%)
Query: 319 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQI------ 370
           Y   +++G+G  G V K    D ++      K+V  ++    Q   E+ IL  +      
Sbjct: 99  YEVLKVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGAL 429
           N  N++ +L          + +E + +  LY+ I  N+ + F +   L+ + A  +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
             LH      I H D+K  NILL  + R+  KV DFG+S     +   + T +Q  F Y 
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRF-YR 266
Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE    +++    D++S G +L E+LTG  P+     + D+      L  +   +L +A
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY-PLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 548 LDARVLKEAKK-------EEIMTVATLAKRCLNLN------GKMR--PTMKEVTNELGG 591
                 K AK            TV TL+   + LN      GK+R  P  +E  N L G
Sbjct: 326 -----SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 20  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 185 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 19  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 517
            T          GYV   ++++ +       + +  D++S G ++ E+LTG+
Sbjct: 184 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 365
           +K + +  + Y     +G G  G+V     T  G  VAVKK     ++  + ++   E+ 
Sbjct: 14  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 412
           +L  + H N++ LL              F P  +L ++             ++N ++   
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +T + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R     
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT--- 175
Query: 473 QTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 517
              +T  V  T  Y  PE       + +  D++S G ++ E+LTG+
Sbjct: 176 DDEMTGXV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	597
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-113
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-107
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-105
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-74
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-73
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-69
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-65
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-48
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-47
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-46
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-44
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-43
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-43
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-42
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-37
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-37
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-37
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-36
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-36
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-25
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-06

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  339 bits (871), Expect = e-113
 Identities = 109/298 (36%), Positives = 173/298 (58%), Gaps = 5/298 (1%)

Query: 294 LSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD 353
           LSS+     ++      DLE+AT+N++   ++G G  G VYKG+L DG  VA+K+     
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75

Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFP 412
              +E+F  E+  LS   H ++V L+G C E    +L+Y+++ NG L ++++ + +    
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV- 471
           ++WE  L I +  +  L YLH+     I HRD+KS NILLD+ +  K++DFG S+     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
           DQTHL+T V+GT GY+DPEYF   + TEKSDVYSFGVVL E+L  +  I      E  +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             + +++ N  +L + +D  +  + + E +      A +CL L+ + RP+M +V  +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  326 bits (837), Expect = e-107
 Identities = 107/292 (36%), Positives = 171/292 (58%), Gaps = 4/292 (1%)

Query: 298 ESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV 357
           E ++ + K F+ ++L+ A+DN++   ILG+GG G VYKG L DG +VAVK+ K       
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 358 E-QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE-EFPITW 415
           E QF  EV ++S   HRN+++L G C+     LLVY ++ NG++   +  + E + P+ W
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 475
               RIA+  +  L YLH      I HRD+K+ANILLD+++ A V DFG ++ +    TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI--RAINTDEDKSLVG 533
           +TT V+GT G++ PEY  + + +EK+DV+ +GV+L+E++TGQ+      +  D+D  L+ 
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 534 YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +    + E +L   +D  +    K EE+  +  +A  C   +   RP M EV
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  319 bits (819), Expect = e-105
 Identities = 98/317 (30%), Positives = 165/317 (52%), Gaps = 23/317 (7%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDN------YNANRILGQGGQGTVYKGMLTDGRIV 344
            + L  +++       F+  +L+  T+N            +G+GG G VYKG + +   V
Sbjct: 2   NKSLEVSDTR---FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTV 57

Query: 345 AVKKSKLVDETNVEQ----FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 400
           AVKK   + +   E+    F  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L
Sbjct: 58  AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117

Query: 401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
              +       P++W +  +IA   +  + +LH    I   HRDIKSANILLD+ + AK+
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 174

Query: 461 SDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           SDFG +R+     QT +T+++ GT  Y+ PE     + T KSD+YSFGVVL+EI+TG   
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233

Query: 520 IRAINTDEDKSLVGYFLQAINENRLFEAL-DARVLKEAKKEEIMTVATLAKRCLNLNGKM 578
           +      E + L+    +  +E +  E   D + + +A    +  + ++A +CL+     
Sbjct: 234 VD--EHREPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNK 290

Query: 579 RPTMKEVTNELGGIRTS 595
           RP +K+V   L  +  S
Sbjct: 291 RPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  241 bits (617), Expect = 3e-75
 Identities = 67/327 (20%), Positives = 124/327 (37%), Gaps = 41/327 (12%)

Query: 290 LQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKS 349
           +      + S ++      +++L   +       +  +G  G V+K  L     VAVK  
Sbjct: 1   MGHHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55

Query: 350 KLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIH 405
            + D+ +  Q   EV  L  + H NI++ +G             L+  F   G+L  ++ 
Sbjct: 56  PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114

Query: 406 NQIEEFPITWELLLRIAVEVSGALFYLHSAASI-------PIYHRDIKSANILLDDKYRA 458
                  ++W  L  IA  ++  L YLH             I HRDIKS N+LL +   A
Sbjct: 115 AN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170

Query: 459 KVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVE 512
            ++DFG +      ++   T  Q GT  Y+ PE  + +         + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230

Query: 513 ILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE----------AKKEEIM 562
           + +                +  F + I ++   E +   V+ +           K   + 
Sbjct: 231 LASRCTAADGPV----DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286

Query: 563 TVATLAKRCLNLNGKMRPTMKEVTNEL 589
            +    + C + + + R +   V   +
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  237 bits (608), Expect = 6e-74
 Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 30/280 (10%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLG 380
             +G G  GTV++     G  VAVK     D     V +F+ EV I+ ++ H NIV  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
              +     +V E++  G+LY+ +H       +     L +A +V+  + YLH+  + PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
            HR++KS N+L+D KY  KV DFG SR +       +    GT  ++ PE  +     EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
           SDVYSFGV+L E+ T Q+P   +N            Q +          A V  + K+ E
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLN----------PAQVV----------AAVGFKCKRLE 259

Query: 561 I-----MTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
           I       VA + + C       RP+   + + L  +  S
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  235 bits (601), Expect = 6e-73
 Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 26/276 (9%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
            ++G+G  G V K      + VA+K+  +  E+  + FI E+  LS++NH NIVKL G C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 383 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           L    P+ LV E+   G+LY  +H        T    +   ++ S  + YLHS     + 
Sbjct: 71  LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 442 HRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 500
           HRD+K  N+LL       K+ DFGT+  +   QTH+T    G+  ++ PE F+ S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183

Query: 501 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEE 560
            DV+S+G++L E++T +KP   I                N  R        ++K   K  
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHNGTRP------PLIKNLPKP- 232

Query: 561 IMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
              + +L  RC + +   RP+M+E+   +  +    
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  225 bits (575), Expect = 1e-69
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 45/287 (15%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN----VEQFINEVVILSQINHRNIVKL 378
            I+G GG G VY+     G  VAVK ++   + +    +E    E  + + + H NI+ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            G CL+     LV EF   G L + +  +     I  ++L+  AV+++  + YLH  A +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 439 PIYHRDIKSANILLDDKYR--------AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           PI HRD+KS+NIL+  K           K++DFG +R     +T   +   G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMAPE 184

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
             ++S F++ SDV+S+GV+L E+LTG+ P R I+           L              
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----------GLAVA----------Y 224

Query: 551 RVLKEAKKEEI-----MTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            V        I        A L + C N +   RP+   + ++L  I
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  222 bits (569), Expect = 2e-68
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 49/288 (17%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-------VEQFINEVVILSQINHRN 374
           + +G+GG G V+KG  + D  +VA+K   L D           ++F  EV I+S +NH N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           IVKL G       P +V EF+P G LY  + ++    PI W + LR+ ++++  + Y+ +
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 435 AASIPIYHRDIKSANILLDDK-----YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
             + PI HRD++S NI L          AKV+DFG S+       H  + + G F ++ P
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195

Query: 490 EYF--QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-RLFE 546
           E    +   +TEK+D YSF ++L  ILTG+ P    +  +    + +      E  R   
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRP-- 249

Query: 547 ALDARVLKEAKKEEI-----MTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                         I       +  + + C + + K RP    +  EL
Sbjct: 250 -------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  214 bits (548), Expect = 1e-65
 Identities = 56/279 (20%), Positives = 108/279 (38%), Gaps = 41/279 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLG 380
             L +   G ++KG    G  + VK  K+ D +      F  E   L   +H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 381 CCLETEVPLL--VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
            C     P    +  ++P G+LY  +H     F +     ++ A++++  + +LH+    
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL-EP 132

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 496
            I    + S ++++D+   A++S      S        +        +V PE  Q     
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186

Query: 497 -FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
                +D++SF V+L E++T + P   ++           ++             +V  E
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLS----------NMEIG----------MKVALE 226

Query: 556 AKKEEI-----MTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             +  I       V+ L K C+N +   RP    +   L
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  204 bits (520), Expect = 7e-61
 Identities = 55/282 (19%), Positives = 108/282 (38%), Gaps = 38/282 (13%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 380
            ++G+G  G VY G    G  VA++   +   +E  ++ F  EV+   Q  H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C+      ++       TLY  + +   +  +      +IA E+   + YLH   +  I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
            H+D+KS N+  D+  +  ++DFG            +        G   ++ PE  +   
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 497 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
                    F++ SDV++ G +  E+   + P +    +         +  +        
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNL 263

Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
               + KE        ++ +   C     + RPT  ++ + L
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDML 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  203 bits (519), Expect = 7e-61
 Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 33/289 (11%)

Query: 323 RILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
            +LG+G  G   K      G ++ +K+    DE     F+ EV ++  + H N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             + +    + E+I  GTL   I +   +    W   +  A +++  + YLH   S+ I 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-------------TKVQGTFGYVD 488
           HRD+ S N L+ +     V+DFG +R ++ ++T                  V G   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           PE      + EK DV+SFG+VL EI+           D     + + L        +   
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLPRTMDFGLNVRGFLDRYCPP 246

Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           +             +   +  RC +L+ + RP+  ++ + L  +R  + 
Sbjct: 247 NC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 9e-60
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 27/274 (9%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 380
           + +G G  GTVYKG       VAVK   +       ++ F NEV +L +  H NI+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 381 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 439
               T   L +V ++    +LY ++H    E     + L+ IA + +  + YLH+     
Sbjct: 88  YS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KS 140

Query: 440 IYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYVDPE---YFQSS 495
           I HRD+KS NI L +    K+ DFG +        +H   ++ G+  ++ PE      S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
            ++ +SDVY+FG+VL E++TGQ P   IN  +        ++ +    L   L ++V   
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDL-SKVRSN 253

Query: 556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
             K     +  L   CL      RP+   +  E+
Sbjct: 254 CPKR----MKRLMAECLKKKRDERPSFPRILAEI 283

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  198 bits (506), Expect = 1e-58
 Identities = 72/327 (22%), Positives = 126/327 (38%), Gaps = 48/327 (14%)

Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI 366
             + +     DN     ++G+G  G VYKG L D R VAVK        N + FINE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV---FSFANRQNFINEKNI 58

Query: 367 --LSQINHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
             +  + H NI + +              LLV E+ PNG+L +Y+          W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114

Query: 420 RIAVEVSGALFYLHSAASI------PIYHRDIKSANILLDDKYRAKVSDFGTSR------ 467
           R+A  V+  L YLH+           I HRD+ S N+L+ +     +SDFG S       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 468 -SVMVDQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQKP 519
                ++ +      GT  Y+ PE  + +          ++ D+Y+ G++  EI      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEI-----------MTVATLA 568
           +    +  +  +   F   +  +  FE +   V +E ++ +             ++    
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 569 KRCLNLNGKMRPTMKEVTNELGGIRTS 595
           + C + + + R T +     +  +   
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (470), Expect = 5e-54
 Identities = 62/298 (20%), Positives = 110/298 (36%), Gaps = 45/298 (15%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--LSQINHRNIVKLLG 380
             +G+G  G V++G    G  VAVK        + + +  E  +     + H NI+  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 381 CCLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
             + +        L+  +   G+LY Y+        +     LRI + ++  L +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 437 SI-----PIYHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYV 487
                   I HRD+KS NIL+    +  ++D G +     S          +V GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184

Query: 488 DPE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
            PE              ++ D+++FG+VL E+       R ++    +     F   +  
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-----RMVSNGIVEDYKPPFYDVVPN 239

Query: 542 NRLFEALDARVLKE----------AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           +  FE +   V  +               + ++A L K C   N   R T   +   L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (469), Expect = 2e-53
 Identities = 62/303 (20%), Positives = 112/303 (36%), Gaps = 43/303 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE--VVILSQINHRNIVKLLG 380
           + +G+G  G V+ G    G  VAVK     +E     +  E  +     + H NI+  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98

Query: 381 CCLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
             ++         L+ ++  NG+LY Y+ +      +  + +L++A      L +LH+  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 437 SI-----PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL---TTKVQGTFGYVD 488
                   I HRD+KS NIL+       ++D G +   + D   +        GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 489 PE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
           PE           Q    +D+YSFG++L E+         +   +       +   +  +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP-----YHDLVPSD 269

Query: 543 RLFEALDARVLKE----------AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
             +E +   V  +          +  E +  +  L   C   N   R T   V   L  +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 593 RTS 595
             S
Sbjct: 330 SES 332

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  180 bits (458), Expect = 9e-52
 Identities = 60/305 (19%), Positives = 115/305 (37%), Gaps = 45/305 (14%)

Query: 324 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE--VVILSQINHRNIVKLLGC 381
            +G+G  G V++G    G  VAVK            +  E  +     + H NI+  +  
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 382 CLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS--- 434
             +         LV ++  +G+L+ Y++       +T E ++++A+  +  L +LH    
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 435 --AASIPIYHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYVD 488
                  I HRD+KS NIL+       ++D G +     +          +V GT  Y+ 
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMA 219

Query: 489 PE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
           PE        +  +  +++D+Y+ G+V  EI              +   + Y+   +  +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLPYYDL-VPSD 274

Query: 543 RLFEALDARVLKE----------AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
              E +   V ++             E +  +A + + C   NG  R T   +   L  +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 593 RTSIG 597
               G
Sbjct: 335 SQQEG 339

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  169 bits (430), Expect = 2e-48
 Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 25/277 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
           ++Y     +G G  G   K    +DG+I+  K+     + E   +  ++EV +L ++ H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 374 NIVKLLGCCLETEVPLL--VYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALF 430
           NIV+     ++     L  V E+   G L   I    +E   +  E +LR+  +++ AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 431 YLHS--AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             H        + HRD+K AN+ LD K   K+ DFG +R +  D +   T V GT  Y+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           PE      + EKSD++S G +L E+     P  A +  E   L       I E + F  +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGK-FRRI 236

Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             R   E  +        +  R LNL    RP+++E+
Sbjct: 237 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  167 bits (424), Expect = 7e-47
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 24/272 (8%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
           + Y   + +G+G  G         DGR   +K+  +  +     E+   EV +L+ + H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NIV+      E     +V ++   G L++ I+ Q +      + +L   V++  AL ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 I HRDIKS NI L      ++ DFG +R V+     L     GT  Y+ PE  +
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICE 198

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
           +  +  KSD+++ G VL E+ T +    A +    K+LV      I     F  +     
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV----LKIISGS-FPPVSLHYS 250

Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            + +         L  +    N + RP++  +
Sbjct: 251 YDLRS--------LVSQLFKRNPRDRPSVNSI 274

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  164 bits (418), Expect = 2e-46
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 22/274 (8%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK---SKLVDETNVEQFINEVVILSQINH 372
            N+   + +G+G    VY+   L DG  VA+KK     L+D       I E+ +L Q+NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFY 431
            N++K     +E     +V E    G L + I +  ++   I    + +  V++  AL +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           +HS     + HRDIK AN+ +      K+ D G  R      T   + V GT  Y+ PE 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
              + +  KSD++S G +L E+   Q P       +  +L     +    +  +  L + 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCD--YPPLPSD 261

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              E  ++       L   C+N + + RP +  V
Sbjct: 262 HYSEELRQ-------LVNMCINPDPEKRPDVTYV 288

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  157 bits (400), Expect = 6e-44
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 319 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 372
           Y     LG GG  TVY     D      VA+K         E  +++F  EV   SQ++H
Sbjct: 13  YKIVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           +NIV ++    E +   LV E+I   TL +YI       P++ +  +    ++   + + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHA 127

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGYVDPE 490
           H      I HRDIK  NIL+D     K+ DFG +++  + +T LT    V GT  Y  PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             +     E +D+YS G+VL E+L G+ P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  156 bits (397), Expect = 2e-43
 Identities = 60/294 (20%), Positives = 117/294 (39%), Gaps = 46/294 (15%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 374
            ++   + LG+GG G V++     D    A+K+ +L + E   E+ + EV  L+++ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 375 IVKLLGCCLE---------TEVPLLVY---EFIPNGTLYQYIHNQIEEFPITWELLLRIA 422
           IV+     LE         +   + +Y   +      L  +++ +         + L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ- 481
           ++++ A+ +LHS     + HRD+K +NI        KV DFG   ++  D+   T     
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 482 ----------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
                     GT  Y+ PE    + ++ K D++S G++L E+L         +T  ++  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVR 235

Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
               L  +   + F  L  +               + +  L+ +   RP    +
Sbjct: 236 T---LTDVRNLK-FPPLFTQKYPCEYV--------MVQDMLSPSPMERPEAINI 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  155 bits (394), Expect = 6e-43
 Identities = 64/305 (20%), Positives = 116/305 (38%), Gaps = 36/305 (11%)

Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV 365
           F    +     +Y   + LG+GG   V     L DG   A+K+    ++ + E+   E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78

Query: 366 ILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYI-HNQIEEFPITWELLLR 420
           +    NH NI++L+  CL          L+  F   GTL+  I   + +   +T + +L 
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG---------TSRSVMV 471
           + + +   L  +H+       HRD+K  NILL D+ +  + D G               +
Sbjct: 139 LLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 472 DQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
                  +   T  Y  PE F         E++DV+S G VL  ++ G+ P       + 
Sbjct: 196 TLQDWAAQR-CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DM 248

Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
               G  +    +N+L      R      +        L    + ++   RP +  + ++
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQ--------LLNSMMTVDPHQRPHIPLLLSQ 300

Query: 589 LGGIR 593
           L  ++
Sbjct: 301 LEALQ 305

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  153 bits (389), Expect = 2e-42
 Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 48/286 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
            ++    ++G GG G V+K     DG+   +K+ K     N E+   EV  L++++H NI
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNI 66

Query: 376 VKLLGCCLETEVPL----------------LVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
           V   GC    +                   +  EF   GTL Q+I  +  E  +   L L
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
            +  +++  + Y+HS     + +RD+K +NI L D  + K+ DFG      +      T+
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTR 180

Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
            +GT  Y+ PE   S  + ++ D+Y+ G++L E+L       A  T +       F   +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSK-------FFTDL 231

Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            +      +     K+ K         L ++ L+   + RP   E+
Sbjct: 232 RDGI----ISDIFDKKEKT--------LLQKLLSKKPEDRPNTSEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  153 bits (389), Expect = 2e-42
 Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 55/301 (18%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
             ++    +LGQG  G V K     D R  A+KK +   E  +   ++EV++L+ +NH+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 375 IVKLLGCCLETEVPL-------------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           +V+     LE    +             +  E+  NGTLY  IH++        +   R+
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYWRL 121

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV------------ 469
             ++  AL Y+HS     I HRD+K  NI +D+    K+ DFG +++V            
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 470 --MVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
                  +LT+ + GT  YV  E    +  + EK D+YS G++  E++         +T 
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------FSTG 231

Query: 527 EDKSLVGYFLQAIN--ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
            ++  +   L+ +           D   +K  KK        + +  ++ +   RP  + 
Sbjct: 232 MERVNI---LKKLRSVSIEFPPDFDDNKMKVEKK--------IIRLLIDHDPNKRPGART 280

Query: 585 V 585
           +
Sbjct: 281 L 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  155 bits (393), Expect = 3e-42
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 35/280 (12%)

Query: 323 RILGQGGQGTVYKGMLTDGRI-VAVKKSK-LVDETNVEQFINEVVILSQINHRNIVKLLG 380
             +G+G  G V+ G L      VAVK  +  +      +F+ E  IL Q +H NIV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C + +   +V E +  G    ++  +     +  + LL++  + +  + YL S   I  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI-- 235

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 498
            HRD+ + N L+ +K   K+SDFG SR    D  +  +            PE     +++
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 499 EKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEALDARVL 553
            +SDV+SFG++L E  + G  P   ++  + +  V  G  L       + +F        
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF-------- 345

Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR 593
                  +M       +C       RP+   +  EL  IR
Sbjct: 346 ------RLME------QCWAYEPGQRPSFSTIYQELQSIR 373

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (389), Expect = 5e-42
 Identities = 52/207 (25%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+           VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL + V  L+ + +P G L  Y+    +      + LL   V+++  + YL    
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 493
            +   HRD+ + N+L+      K++DFG ++ +  ++       +G      ++  E   
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
              +T +SDV+S+GV + E++T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  152 bits (386), Expect = 8e-42
 Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 319 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 372
           Y    ILG GG   V+     D    R VAVK  ++ L  D +   +F  E    + +NH
Sbjct: 14  YELGEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 373 RNIVKLL--GC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
             IV +   G        +P +V E++   TL   +H    E P+T +  + +  +   A
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQA 128

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGY 486
           L + H      I HRD+K ANI++      KV DFG +R++      +T    V GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           + PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  156 bits (397), Expect = 9e-42
 Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGRI-VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             LG G  G VY+G+     + VAVK  K  D   VE+F+ E  ++ +I H N+V+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           C       ++ EF+  G L  Y+        ++  +LL +A ++S A+ YL     I   
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 340

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HR++ + N L+ + +  KV+DFG SR +  D        +    +  PE    ++F+ KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINENRLF------EALDARV 552
           DV++FGV+L EI T G  P   I+  +   L+   Y        R+       E +    
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RMERPEGCPEKVY--- 449

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                  E+M      + C   N   RP+  E+    
Sbjct: 450 -------ELM------RACWQWNPSDRPSFAEIHQAF 473

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  152 bits (385), Expect = 9e-42
 Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 18/209 (8%)

Query: 319 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 372
           Y   R++G+GG G VY+    D    RIVA+K     L  D     +   E     ++  
Sbjct: 36  YRLRRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            ++V +           +    I    L   +     + P+     + I  ++  AL   
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAA 150

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGYVDPE 490
           H+A      HRD+K  NIL+     A + DFG + +       LT      GT  Y+ PE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPE 205

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            F  S  T ++D+Y+   VL E LTG  P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  150 bits (380), Expect = 2e-41
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 11/200 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + LG G  G V  G       VAVK  K     + ++F  E   + +++H  +VK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     +V E+I NG L  Y+ +  +    +   LL +  +V   + +L S   I   H
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMAFLESHQFI---H 127

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 500
           RD+ + N L+D     KVSDFG +R V+ DQ    + V   F      PE F   +++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 501 SDVYSFGVVLVEILT-GQKP 519
           SDV++FG+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  151 bits (383), Expect = 2e-41
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 32/290 (11%)

Query: 323 RILGQGGQGTVYKGMLTD-----GRIVAVKKSK-LVDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G V            G +VAVK  K      +   +  E+ IL  + H +I+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 377 KLLGCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  GCC +       LV E++P G+L  Y+        I    LL  A ++   + YLH+
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYF 492
              I   HRD+ + N+LLD+    K+ DFG +++V     +   +  G     +  PE  
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
           +  +F   SDV+SFGV L E+LT             +   +      +   RL E L+  
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERG 267

Query: 552 VLKEAKKE------EIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
                  +       +M      K C       RPT + +   L  +   
Sbjct: 268 ERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKTVHEK 311

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  151 bits (383), Expect = 2e-41
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 30/291 (10%)

Query: 323 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           + LG+G  G+V            G +VAVKK +   E ++  F  E+ IL  + H NIVK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 378 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
             G C       L L+ E++P G+L  Y+    E        LL+   ++   + YL + 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 164

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 493
             I   HRD+ + NIL++++ R K+ DFG ++ +  D+ +   K  G     +  PE   
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
            S+F+  SDV+SFGVVL E+ T          ++ KS    F++ I  ++  + +   ++
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273

Query: 554 KEAKKEEIM--------TVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
           +  K    +         +  +   C N N   RP+ +++   +  IR  +
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  149 bits (379), Expect = 5e-41
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 12/229 (5%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD 353
           S+ E + E   L    +     D      +LG+G  G VY G  L++   +A+K+    D
Sbjct: 4   STEEGDCESDLLEYDYEY----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59

Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPI 413
               +    E+ +   + H+NIV+ LG   E     +  E +P G+L   + ++      
Sbjct: 60  SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVD 472
             + +     ++   L YLH      I HRDIK  N+L++      K+SDFGTS+ +   
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
                T   GT  Y+ PE        + + +D++S G  ++E+ TG+ P
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (378), Expect = 5e-41
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 37/305 (12%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDN--YNANRILGQGGQGTVYKGM-LTDGRIVAVK 347
           Q+E +  + +IE+ +   +K +  + D      +  +G+G   TVYKG+       VA  
Sbjct: 1   QEERNQQQDDIEELE---TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWC 57

Query: 348 KSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLY 401
           + +     ++  ++F  E  +L  + H NIV+       T       +LV E + +GTL 
Sbjct: 58  ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 402 QYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAK 459
            Y    ++ F  +  ++L     ++   L +LH+  + PI HRD+K  NI +       K
Sbjct: 118 TY----LKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVK 172

Query: 460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           + D G +    + +      V GT  ++ PE ++  ++ E  DVY+FG+ ++E+ T + P
Sbjct: 173 IGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228

Query: 520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR 579
                  E ++    + +  +  +   + D   + E K+        + + C+  N   R
Sbjct: 229 Y-----SECQNAAQIYRRVTSGVKP-ASFDKVAIPEVKE--------IIEGCIRQNKDER 274

Query: 580 PTMKE 584
            ++K+
Sbjct: 275 YSIKD 279

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  149 bits (378), Expect = 6e-41
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 30/292 (10%)

Query: 323 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           + LG+G  G+V            G +VAVKK +   E ++  F  E+ IL  + H NIVK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 378 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
             G C       L L+ E++P G+L  Y+    E        LL+   ++   + YL + 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 133

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 493
             I   HRD+ + NIL++++ R K+ DFG ++ +  D+     K  G     +  PE   
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
            S+F+  SDV+SFGVVL E+ T          ++ KS    F++ I  ++  + +   ++
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 554 KEAKKEEIM--------TVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           +  K    +         +  +   C N N   RP+ +++   +  IR ++ 
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  147 bits (373), Expect = 2e-40
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 11/200 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
           LE     LV EF+ +G L  Y+  Q   F      LL + ++V   + YL  A  I   H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMAYLEEACVI---H 127

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 500
           RD+ + N L+ +    KVSDFG +R V+ DQ   T+     F      PE F  S+++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 501 SDVYSFGVVLVEILT-GQKP 519
           SDV+SFGV++ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  147 bits (374), Expect = 2e-40
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 13/201 (6%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
             LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 383 LETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             T+ P+  + E++ NG+L  ++        +T   LL +A +++  + ++     I   
Sbjct: 78  --TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI--- 131

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 499
           HRD+++ANIL+ D    K++DFG +R +  ++   T +    F      PE      FT 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 500 KSDVYSFGVVLVEILT-GQKP 519
           KSDV+SFG++L EI+T G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  147 bits (374), Expect = 2e-40
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 11/200 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + LG G  G V  G       VA+K  K     + ++FI E  ++  ++H  +V+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
            +     ++ E++ NG L  Y+      F      LL +  +V  A+ YL S   +   H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKDVCEAMEYLESKQFL---H 143

Query: 443 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 500
           RD+ + N L++D+   KVSDFG SR V+ D+   T+ V   F      PE    S+F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSK 201

Query: 501 SDVYSFGVVLVEILT-GQKP 519
           SD+++FGV++ EI + G+ P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  148 bits (376), Expect = 3e-40
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 28/219 (12%)

Query: 322 NRILGQGGQGTVYKGMLTDG----RIVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 375
            R+LG+G  G+V +  L         VAVK  K+ ++  +++E+F+ E   + + +H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 376 VKLLGCCLETE------VPLLVYEFIPNGTLYQYIHN---QIEEFPITWELLLRIAVEVS 426
            KL+G  L +       +P+++  F+ +G L+ ++         F +  + L+R  V+++
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             + YL   +S    HRD+ + N +L +     V+DFG SR +     +     QG    
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200

Query: 487 V-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           +       E    + +T  SDV++FGV + EI+T GQ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (379), Expect = 3e-40
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 15/207 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 377
            ++G+G  G VY G L D        AVK    + D   V QF+ E +I+   +H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 378 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           LLG CL +E   L V  ++ +G L  +I N  E    T + L+   ++V+  + +L   A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 493
           S    HRD+ + N +LD+K+  KV+DFG +R +   +        G    V     E  Q
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
           + +FT KSDV+SFGV+L E++T G  P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  147 bits (373), Expect = 3e-40
 Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 15/207 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 377
            ++G+G  G VY G L D        AVK    + D   V QF+ E +I+   +H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 378 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           LLG CL +E   L V  ++ +G L  +I N  E    T + L+   ++V+  + YL S  
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK 148

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 493
            +   HRD+ + N +LD+K+  KV+DFG +R +   + +      G    V     E  Q
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
           + +FT KSDV+SFGV+L E++T G  P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  147 bits (372), Expect = 4e-40
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGRI-VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 381
             LG G  G VY+G+     + VAVK  K  D   VE+F+ E  ++ +I H N+V+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           C       ++ EF+  G L  Y+        ++  +LL +A ++S A+ YL     I   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 133

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 499
           HRD+ + N L+ + +  KV+DFG SR +  D    T      F      PE    ++F+ 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 500 KSDVYSFGVVLVEILT-GQKP 519
           KSDV++FGV+L EI T G  P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (374), Expect = 4e-40
 Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 51/299 (17%)

Query: 322 NRILGQGGQGTVYKGMLTDGR----IVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 375
            +ILG+G  G+V +G L         VAVK  K     +  +E+F++E   +   +H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 376 VKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHN---QIEEFPITWELLLRIAVEVSG 427
           ++LLG C+E        P+++  F+  G L+ Y+     +     I  + LL+  V+++ 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + YL   ++    HRD+ + N +L D     V+DFG S+ +     +     QG    +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211

Query: 488 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAI 539
                  E      +T KSDV++FGV + EI T G  P   +   E    +  G+ L+  
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271

Query: 540 NE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
            +  + L+              EIM        C   +   RPT   +  +L  +  S+
Sbjct: 272 EDCLDELY--------------EIMY------SCWRTDPLDRPTFSVLRLQLEKLLESL 310

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (375), Expect = 4e-40
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 29/289 (10%)

Query: 323 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
             LG+G  G+V            G +VAVK+ +         F  E+ IL  ++   IVK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 378 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
             G         L LV E++P+G L  ++         +   LL  + ++   + YL S 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSR 146

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 493
             +   HRD+ + NIL++ +   K++DFG ++ + +D+ +   +  G     +  PE   
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
            + F+ +SDV+SFGVVL E+ T   K      + E   ++G        +RL E L+   
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 553 LKEAKKE------EIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
              A         E+M      K C   + + RP+   +  +L  + + 
Sbjct: 262 RLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSG 304

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  150 bits (381), Expect = 7e-40
 Identities = 71/320 (22%), Positives = 140/320 (43%), Gaps = 41/320 (12%)

Query: 280 KFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT 339
            ++ ++   L  +  +   ++  +T+       E   ++      LGQG  G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206

Query: 340 DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNG 398
               VA+K  K     + E F+ E  ++ ++ H  +V+L      +E P+ +V E++  G
Sbjct: 207 GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263

Query: 399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 458
           +L  ++  +  ++ +    L+ +A +++  + Y+     +   HRD+++ANIL+ +    
Sbjct: 264 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319

Query: 459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 517
           KV+DFG +R +  ++       +    +  PE     +FT KSDV+SFG++L E+ T G+
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

Query: 518 KPIRAINTDEDKSLV--GYFLQAINENRLF------EALDARVLKEAKKEEIMTVATLAK 569
            P   +   E    V  GY        R+       E+L           ++M       
Sbjct: 380 VPYPGMVNREVLDQVERGY--------RMPCPPECPESLH----------DLM------C 415

Query: 570 RCLNLNGKMRPTMKEVTNEL 589
           +C     + RPT + +   L
Sbjct: 416 QCWRKEPEERPTFEYLQAFL 435

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (373), Expect = 7e-40
 Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 18/207 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           ++LG G  GTVYKG+           VA+K+ +        ++ ++E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG CL      L+ + +P G L  Y+    +      + LL   V+++  + YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 493
            +   HRD+ + N+L+      K++DFG ++ +  ++       +G      ++  E   
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
              +T +SDV+S+GV + E++T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  151 bits (384), Expect = 8e-40
 Identities = 68/277 (24%), Positives = 125/277 (45%), Gaps = 41/277 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
             LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 383 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             +E P+ +V E++  G+L  ++  +  ++ +    L+ +A +++  + Y+     +   
Sbjct: 332 --SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV--- 385

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 501
           HRD+++ANIL+ +    KV+DFG +R +  ++       +    +  PE     +FT KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 502 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINENRLF------EALDARV 552
           DV+SFG++L E+ T G+ P   +   E    V  GY        R+       E+L    
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCPPECPESLH--- 494

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                  ++M       +C     + RPT + +   L
Sbjct: 495 -------DLM------CQCWRKEPEERPTFEYLQAFL 518

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (372), Expect = 8e-40
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGR-----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIV 376
           ++LG G  GTV+KG+           V +K  +      + +   + ++ +  ++H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +LLG C       LV +++P G+L  ++           +LLL   V+++  ++YL    
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG 135

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 493
            +   HR++ + N+LL    + +V+DFG +  +  D                ++  E   
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ--LLYSEAKTPIKWMALESIH 190

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
             ++T +SDV+S+GV + E++T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (370), Expect = 8e-40
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)

Query: 322 NRILGQGGQGTVYKGMLTDGRI---VAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG     ++   VAVK  K++  D    ++ + E  ++ Q+++  IV
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C   E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 82  RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 494
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +  G +   +  PE    
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +F+ KSDV+SFGV++ E  + GQKP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  146 bits (370), Expect = 1e-39
 Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 15/207 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 377
           R++G+G  G VY G   D        A+K    + +   VE F+ E +++  +NH N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 378 LLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           L+G  L  E +P ++  ++ +G L Q+I +   +   T + L+   ++V+  + YL    
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 493
            +   HRD+ + N +LD+ +  KV+DFG +R ++  + +   + +     V     E  Q
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
           + +FT KSDV+SFGV+L E+LT G  P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (379), Expect = 1e-39
 Identities = 84/330 (25%), Positives = 147/330 (44%), Gaps = 51/330 (15%)

Query: 280 KFFKRNGGLLLQQ--ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM 337
           + +  +   L  +  +    E  +     F               + +G+G  G V  G 
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213

Query: 338 LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIP 396
              G  VAVK  K  ++   + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++ 
Sbjct: 214 YR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270

Query: 397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY 456
            G+L  Y+ ++     +  + LL+ +++V  A+ YL     +   HRD+ + N+L+ +  
Sbjct: 271 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDN 326

Query: 457 RAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
            AKVSDFG ++      T  T K  V+ T     PE  +  +F+ KSDV+SFG++L EI 
Sbjct: 327 VAKVSDFGLTKE--ASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIY 380

Query: 515 T-GQKPIRAINTDEDKSLV--GYFLQAINENRLF------EALDARVLKEAKKEEIMTVA 565
           + G+ P   I   +    V  GY        ++        A+           ++M   
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEKGY--------KMDAPDGCPPAVY----------DVM--- 419

Query: 566 TLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
              K C +L+   RPT  ++  +L  IRT 
Sbjct: 420 ---KNCWHLDAATRPTFLQLREQLEHIRTH 446

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (368), Expect = 1e-39
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGRI----VAVKKSK---LVDETNVEQFINEVVILSQINHRNI 375
             LG G  G V +G           VAVK  K   L     ++ FI EV  +  ++HRN+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           ++L G  L    P+ +V E  P G+L   +      F +    L R AV+V+  + YL S
Sbjct: 84  IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYF 492
              I   HRD+ + N+LL  +   K+ DFG  R++  +  H   +      +    PE  
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           ++  F+  SD + FGV L E+ T GQ+P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  144 bits (366), Expect = 2e-39
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 17/201 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + +G+G  G V  G    G  VAVK  K  ++   + F+ E  +++Q+ H N+V+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 383 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
           +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL     +   
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV--- 139

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 499
           HRD+ + N+L+ +   AKVSDFG ++         +T+  G        PE  +  +F+ 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFST 193

Query: 500 KSDVYSFGVVLVEILT-GQKP 519
           KSDV+SFG++L EI + G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (367), Expect = 3e-39
 Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 30/284 (10%)

Query: 323 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G V            G  VAVK  K      ++     E+ IL  + H NIV
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 377 KLLGCCLETEV-PL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           K  G C E     + L+ EF+P+G+L +Y+     +  I  +  L+ AV++   + YL S
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYF 492
              +   HRD+ + N+L++ +++ K+ DFG ++++  D+ + T K        +  PE  
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 493 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
             S+F   SDV+SFGV L E+LT        +          +    +   RL   L   
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVNTLKEG 259

Query: 552 VLKEAKKE------EIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                         ++M      ++C       R + + +    
Sbjct: 260 KRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGF 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  145 bits (367), Expect = 3e-39
 Identities = 59/273 (21%), Positives = 100/273 (36%), Gaps = 31/273 (11%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NH 372
            ++     LG G  G V+K     DGR+ AVK+S        +  + + EV    ++  H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
              V+L     E  +  L  E     +L Q+        P     +     +   AL +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE--AQVWGYLRDTLLALAHL 173

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + H D+K ANI L  + R K+ DFG      +         +G   Y+ PE  
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELL 228

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
           Q   +   +DV+S G+ ++E+    +                  Q + +  L     A +
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAGL 277

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             E +         +    L  + K+R T + +
Sbjct: 278 SSELRS--------VLVMMLEPDPKLRATAEAL 302

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  145 bits (367), Expect = 4e-39
 Identities = 73/292 (25%), Positives = 129/292 (44%), Gaps = 51/292 (17%)

Query: 322 NRILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRN 374
           +R LGQG  G VY+G+            VA+K            +F+NE  ++ + N  +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQY-------IHNQIEEFPITWELLLRIAVEVSG 427
           +V+LLG   + +  L++ E +  G L  Y       + N     P +   ++++A E++ 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + YL    +    HRD+ + N ++ + +  K+ DFG +R +     +     +G  G +
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202

Query: 488 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAI 539
                 PE  +   FT  SDV+SFGVVL EI T  ++P + ++ ++    V  G  L   
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262

Query: 540 NE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           +   + LF              E+M      + C   N KMRP+  E+ + +
Sbjct: 263 DNCPDMLF--------------ELM------RMCWQYNPKMRPSFLEIISSI 294

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  144 bits (366), Expect = 4e-39
 Identities = 65/312 (20%), Positives = 120/312 (38%), Gaps = 42/312 (13%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--- 347
               SS      +   F S  ++     Y+  + +G GG   V++ +    +I A+K   
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61

Query: 348 KSKLVDETNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 405
             +  D   ++ + NE+  L+++   +  I++L    +  +   +V E   N  L  ++ 
Sbjct: 62  LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119

Query: 406 NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
            + +               +  A+  +H      I H D+K AN L+ D    K+ DFG 
Sbjct: 120 KK-KSIDP--WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172

Query: 466 SRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLVEI 513
           +  +  D T +    Q GT  Y+ PE  +             + + KSDV+S G +L  +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 514 LTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLN 573
             G+ P + I     K      L AI +            K+ +         + K CL 
Sbjct: 233 TYGKTPFQQIINQISK------LHAIIDPNHEIEFPDIPEKDLQD--------VLKCCLK 278

Query: 574 LNGKMRPTMKEV 585
            + K R ++ E+
Sbjct: 279 RDPKQRISIPEL 290

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  145 bits (367), Expect = 5e-39
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +I+G G  G V  G L         VA+K  K    E     F++E  I+ Q +H NI++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G      + ++V E++ NG+L  ++     +F  T   L+ +   V   + YL     
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSS 495
           +   HRD+ + N+L+D     KVSDFG SR +  D     T   G        PE     
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKP 519
            F+  SDV+SFGVV+ E+L  G++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (363), Expect = 7e-39
 Identities = 62/202 (30%), Positives = 112/202 (55%), Gaps = 13/202 (6%)

Query: 325 LGQGGQGTVYKGMLT--DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG G  G+V +G+      +I VA+K  K   ++ + E+ + E  I+ Q+++  IV+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C    + +LV E    G L++++  + EE       +  +  +VS  + YL     +  
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 132

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 498
            HRD+ + N+LL +++ AK+SDFG S+++  D ++ T +  G +   +  PE     +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 499 EKSDVYSFGVVLVEILT-GQKP 519
            +SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (365), Expect = 9e-39
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 16/207 (7%)

Query: 323 RILGQGGQGTVYKGMLTDGRI-----VAVK--KSKLVDETNVEQFINEVVILSQINHRNI 375
           +++G G  G VYKGML          VA+K  K+   ++  V+ F+ E  I+ Q +H NI
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           ++L G   + +  +++ E++ NG L +++  +  EF  +   L+ +   ++  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANM 166

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQ 493
             +   HRD+ + NIL++     KVSDFG SR +  D     T   G        PE   
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 494 SSQFTEKSDVYSFGVVLVEILT-GQKP 519
             +FT  SDV+SFG+V+ E++T G++P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (360), Expect = 2e-38
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 323 RILGQGGQGTVYKGMLTDGRI----VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           RILG+G  G VY+G+ T+ +     VAVK  K      N E+F++E VI+  ++H +IVK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L+G   E E   ++ E  P G L  Y+        +    L+  ++++  A+ YL S   
Sbjct: 78  LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINC 134

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 494
           +   HRDI   NIL+      K+ DFG SR +  +      K   T     ++ PE    
Sbjct: 135 V---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKP 519
            +FT  SDV+ F V + EIL+ G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  144 bits (365), Expect = 3e-38
 Identities = 65/314 (20%), Positives = 121/314 (38%), Gaps = 41/314 (13%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDN---YNANRILGQGGQGTVYKGMLTDGRIVAVK 347
           +Q + S +   +     +S   E  +     Y+  + +G GG   V++ +    +I A+K
Sbjct: 27  RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86

Query: 348 KSKL--VDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNGTLYQY 403
              L   D   ++ + NE+  L+++      I++L    +  +   +V E   N  L  +
Sbjct: 87  YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145

Query: 404 IHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 463
           +  + +               +  A+  +H      I H D+K AN L+ D    K+ DF
Sbjct: 146 LKKK-KSIDP--WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198

Query: 464 GTSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLV 511
           G +  +  D T +    Q G   Y+ PE  +             + + KSDV+S G +L 
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258

Query: 512 EILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRC 571
            +  G+ P + I     K      L AI +            K+ +         + K C
Sbjct: 259 YMTYGKTPFQQIINQISK------LHAIIDPNHEIEFPDIPEKDLQD--------VLKCC 304

Query: 572 LNLNGKMRPTMKEV 585
           L  + K R ++ E+
Sbjct: 305 LKRDPKQRISIPEL 318

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  142 bits (361), Expect = 4e-38
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 38/284 (13%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINH--R 373
            Y+  + +G GG   V++ +    +I A+K   L   D   ++ + NE+  L+++     
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
            I++L    +  +   +V E   N  L  ++  + +               +  A+  +H
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDP--WERKSYWKNMLEAVHTIH 125

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEYF 492
                 I H D+K AN L+ D    K+ DFG +  +  D T +    Q GT  Y+ PE  
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 493 Q-----------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
           +            S+ + KSDV+S G +L  +  G+ P + I     K      L AI +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAIID 235

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                       K+ +         + K CL  + K R ++ E+
Sbjct: 236 PNHEIEFPDIPEKDLQD--------VLKCCLKRDPKQRISIPEL 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  145 bits (368), Expect = 4e-38
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
           + LG G  G V+         VAVK  K     +VE F+ E  ++  + H  +VKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 383 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 441
             T+ P+ ++ EF+  G+L  ++ +  E        L+  + +++  + ++     I   
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306

Query: 442 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 499
           HRD+++ANIL+      K++DFG +R +  ++   T +    F      PE      FT 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTI 364

Query: 500 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GY 534
           KSDV+SFG++L+EI+T G+ P   ++  E    +  GY
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (360), Expect = 1e-37
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           +++G G  G V  G L         VA+K  K+   E     F+ E  I+ Q +H NI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L G   +++  ++V E++ NG+L  ++     +F  T   L+ +   ++  + YL     
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGY 168

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSS 495
           +   HRD+ + NIL++     KVSDFG  R +  D     T   G        PE     
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKP 519
           +FT  SDV+S+G+VL E+++ G++P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  141 bits (356), Expect = 2e-37
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 22/239 (9%)

Query: 290 LQQELSSNESNIEKTKLF-TSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK 347
           L  E   NE  +   KL     +  +          +G+G  G V++      G   AVK
Sbjct: 30  LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89

Query: 348 KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--H 405
           K   V          E+V  + ++   IV L G   E     +  E +  G+L Q I   
Sbjct: 90  K---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM 144

Query: 406 NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFG 464
             + E     +  L    +    L YLH+   +   H D+K+ N+LL     RA + DFG
Sbjct: 145 GCLPE-----DRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFG 196

Query: 465 TSRSVMVDQTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            +  +  D    +      + GT  ++ PE         K D++S   +++ +L G  P
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (351), Expect = 2e-37
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 12/203 (5%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 377
           R +G+G  G V++G+          VA+K  K    ++  E+F+ E + + Q +H +IVK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
           L+G   E     ++ E    G L  ++  +     +    L+  A ++S AL YL S   
Sbjct: 81  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKRF 137

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 497
           +   HRDI + N+L+      K+ DFG SR +     +  +K +    ++ PE     +F
Sbjct: 138 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 498 TEKSDVYSFGVVLVEILT-GQKP 519
           T  SDV+ FGV + EIL  G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (366), Expect = 4e-37
 Identities = 62/202 (30%), Positives = 112/202 (55%), Gaps = 13/202 (6%)

Query: 325 LGQGGQGTVYKGMLT--DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLG 380
           LG G  G+V +G+      +I VA+K  K   ++ + E+ + E  I+ Q+++  IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
            C    + +LV E    G L++++  + EE P     +  +  +VS  + YL     +  
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 498
            HR++ + N+LL +++ AK+SDFG S+++  D ++ T +  G +      PE     +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 499 EKSDVYSFGVVLVEILT-GQKP 519
            +SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (351), Expect = 4e-37
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           R LG+G  G V+     +        +VAVK  K       + F  E  +L+ + H +IV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIAV 423
           K  G C + +  ++V+E++ +G L ++                +  +  +    +L IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           +++  + YL   AS    HRD+ + N L+      K+ DFG SR V     +   +V G 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194

Query: 484 FGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
              +      PE     +FT +SDV+SFGV+L EI T G++P
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  139 bits (352), Expect = 6e-37
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 31/221 (14%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
             LG+G  G V+     +        +VAVK  K   E+  + F  E  +L+ + H++IV
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQY------------IHNQIEEFPITWELLLRIAVE 424
           +  G C E    L+V+E++ +G L ++                +   P+    LL +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           V+  + YL   A +   HRD+ + N L+      K+ DFG SR +         +V G  
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219

Query: 485 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
             +      PE     +FT +SDV+SFGVVL EI T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (349), Expect = 6e-37
 Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 66/301 (21%)

Query: 323 RILGQGGQGTVYKGMLTDGRI--------VAVKKSKLVDETNVEQFINEVVILSQINHRN 374
             LGQG    ++KG+  +           V +K          E F     ++S+++H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           +V   G C+  +  +LV EF+  G+L  Y+        I W   L +A +++ A+ +L  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEE 131

Query: 435 AASIPIYHRDIKSANILLDDKYR--------AKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
              I   H ++ + NILL  +           K+SD G S +V+                
Sbjct: 132 NTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177

Query: 487 VDP---------EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GY 534
            +          E  +       +D +SFG  L EI + G KP+ A+++          +
Sbjct: 178 QERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235

Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
            L A     L                ++        C++     RP+ + +  +L  + T
Sbjct: 236 QLPAPKAAELA--------------NLIN------NCMDYEPDHRPSFRAIIRDLNSLFT 275

Query: 595 S 595
            
Sbjct: 276 P 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (351), Expect = 6e-37
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 25/230 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
             +  + ILGQG    V++G     G + A+K       +    V+  + E  +L ++NH
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66

Query: 373 RNIVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +NIVKL        T   +L+ EF P G+LY  +      + +     L +  +V G + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 431 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           +L       I HR+IK  NI+     D +   K++DFG +R  + D     +   GT  Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181

Query: 487 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           + P+ ++ +        ++    D++S GV      TG  P R       
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  139 bits (352), Expect = 7e-37
 Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
             Y   R LG+GG    ++    D   + A K   KS L+     E+   E+ I   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
           +++V   G   E    + +V E     +L +       + E P     L +I        
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 154

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH      + HRD+K  N+ L++    K+ DFG +  V  D       + GT  Y+ P
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E       + + DV+S G ++  +L G+ P       E   L   +   I +N    ++ 
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY-LRIKKNEY--SIP 261

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             +   A          L ++ L  +   RPT+ E+
Sbjct: 262 KHINPVAAS--------LIQKMLQTDPTARPTINEL 289

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  140 bits (355), Expect = 7e-37
 Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 37/306 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
             +  + ILGQG    V++G     G + A+K       +    V+  + E  +L ++NH
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66

Query: 373 RNIVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           +NIVKL        T   +L+ EF P G+LY  +      + +     L +  +V G + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 431 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           +L       I HR+IK  NI+     D +   K++DFG +R  + D     +   GT  Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181

Query: 487 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED------KSLV 532
           + P+ ++ +        ++    D++S GV      TG  P R             K + 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 533 GYFLQAINENRLFEALDARVLKEAKKEEIMT------VATLAKRCLNLNGKMRPTMKEVT 586
           G    AI+  +  E        +      ++      +  +    L  + +      +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 587 NELGGI 592
            E   I
Sbjct: 302 AETSDI 307

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  144 bits (366), Expect = 8e-37
 Identities = 46/249 (18%), Positives = 93/249 (37%), Gaps = 40/249 (16%)

Query: 319 YNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNI 375
           Y     +  GG G +Y       +GR V +K      D       + E   L+++ H +I
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 376 VKLL-----GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           V++             V  +V E++   +L +          +     +   +E+  AL 
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALS 196

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           YLHS     + + D+K  NI+L ++ + K+ D G    +  +       + GT G+  PE
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY---LYGTPGFQAPE 247

Query: 491 YFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN----RLF 545
                +  T  +D+Y+ G  L  +                   G ++  + E+    + +
Sbjct: 248 --IVRTGPTVATDIYTVGRTLAALTLDLPTRN-----------GRYVDGLPEDDPVLKTY 294

Query: 546 EALDARVLK 554
           ++    + +
Sbjct: 295 DSYGRLLRR 303

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  137 bits (347), Expect = 1e-36
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 31/283 (10%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 364
           +  + +  +++    +LG+G    VY+   +  G  VA+K   K  +     V++  NEV
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IA 422
            I  Q+ H +I++L     E    + LV E   NG + +Y+ N+++ F    E   R   
Sbjct: 63  KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFM 118

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            ++   + YLHS     I HRD+  +N+LL      K++DFG +  + +      T + G
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCG 174

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
           T  Y+ PE    S    +SDV+S G +   +L G+ P       +  ++       +   
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF------DTDTVKNTL-NKVVLA 227

Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                + + +  EAK         L  + L  N   R ++  V
Sbjct: 228 DY--EMPSFLSIEAKD--------LIHQLLRRNPADRLSLSSV 260

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  137 bits (347), Expect = 1e-36
 Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
             Y   R LG+GG    ++    D   + A K   KS L+     E+   E+ I   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
           +++V   G   E    + +V E     +L +       + E P     L +I        
Sbjct: 75  QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 128

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YLH      + HRD+K  N+ L++    K+ DFG +  V  D       + GT  Y+ P
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E       + + DV+S G ++  +L G+ P       E   L   +   I +N    ++ 
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY-LRIKKNEY--SIP 235

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             +   A          L ++ L  +   RPT+ E+
Sbjct: 236 KHINPVAAS--------LIQKMLQTDPTARPTINEL 263

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  141 bits (358), Expect = 1e-36
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 33/290 (11%)

Query: 305 KLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQF 360
            +F        +D Y   R+LG+G  G V        G+  AVK   K ++  +T+ E  
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 361 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 420
           + EV +L Q++H NI+KL     +     LV E    G L+  I   I     +     R
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAAR 130

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTHLT 477
           I  +V   + Y+H      I HRD+K  N+LL+ K      ++ DFG S      +  + 
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186

Query: 478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
            K+ GT  Y+ PE    + + EK DV+S GV+L  +L+G  P    N  +        L+
Sbjct: 187 DKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILK 237

Query: 538 AINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            + + +  FE     +V + AK         L ++ L     MR + ++ 
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKD--------LIRKMLTYVPSMRISARDA 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (345), Expect = 2e-36
 Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   R LG+G  G VY         I+A+K   K++L       Q   EV I S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IAVEVSGALF 430
            NI++L G        + L+ E+ P GT+Y+ +     +F    E        E++ AL 
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKL-SKFD---EQRTATYITELANALS 123

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y HS     + HRDIK  N+LL      K++DFG   SV    +  T    GT  Y+ PE
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLC-GTLDYLPPE 177

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             +     EK D++S GV+  E L G+ P  A    E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  137 bits (348), Expect = 2e-36
 Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 53/298 (17%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVK--KSKLVDETNVEQFINEVVILSQINHRN 374
           R LG G  G VY+G ++          VAVK       ++  ++ F+ E +I+S+ NH+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HNQIEEFPITWELLLRIAVEVSGALF 430
           IV+ +G  L++    ++ E +  G L  ++        +   +    LL +A +++    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 431 YLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           YL         HRDI + N LL        AK+ DFG +R +     +     +G    +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAML 207

Query: 488 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAI 539
                 PE F    FT K+D +SFGV+L EI + G  P  + +  E    V  G  +   
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267

Query: 540 NE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
                 ++               IMT      +C     + RP    +   +      
Sbjct: 268 KNCPGPVY--------------RIMT------QCWQHQPEDRPNFAIILERIEYCTQD 305

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  138 bits (349), Expect = 3e-36
 Identities = 74/366 (20%), Positives = 131/366 (35%), Gaps = 68/366 (18%)

Query: 270 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNAN------- 322
               +I   +  + +       Q      S +  + + T  +         ++       
Sbjct: 9   HHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEV 68

Query: 323 --------RILGQGGQGTVYKGMLTDGR------IVAVK--KSKLVDETNVEQFINEVVI 366
                   R LG G  G VY+G ++          VAVK       ++  ++ F+ E +I
Sbjct: 69  PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALI 127

Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HNQIEEFPITWELLLRIA 422
           +S+ NH+NIV+ +G  L++    ++ E +  G L  ++        +   +    LL +A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTK 479
            +++    YL         HRDI + N LL        AK+ DFG +R +     +    
Sbjct: 188 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY---- 240

Query: 480 VQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV- 532
            +G    +      PE F    FT K+D +SFGV+L EI + G  P  + +  E    V 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

Query: 533 -GYFLQAINE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            G  +         ++               IMT      +C     + RP    +   +
Sbjct: 301 SGGRMDPPKNCPGPVY--------------RIMT------QCWQHQPEDRPNFAIILERI 340

Query: 590 GGIRTS 595
                 
Sbjct: 341 EYCTQD 346

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (347), Expect = 5e-36
 Identities = 35/299 (11%), Positives = 70/299 (23%), Gaps = 52/299 (17%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
             L  G +  V+    +      A+K          + +E+        +++   +  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 379 LGCCLETEVP--------------------------LLVYEFIPNGTLYQYI----HNQI 408
                                               LL+     +  L           +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186

Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
                    L  +  ++      L S     + H      N+ +    R  + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 469 VMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
           V                Y   E+  +S   FT   + +  G+ +  +     P   +   
Sbjct: 244 V----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              S     L+    + L       +    K        TL  R LN + + R    E 
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK--------TLIGRFLNFDRRRRLLPLEA 350

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  139 bits (353), Expect = 6e-36
 Identities = 73/311 (23%), Positives = 121/311 (38%), Gaps = 41/311 (13%)

Query: 291 QQELSSNESNIEKTK-------LFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGR 342
               SS   N+           +F +      ++ Y   + LG G  G V          
Sbjct: 4   HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63

Query: 343 IVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 399
             A+K   K+ +    +  + + EV +L  ++H NI+KL     +     LV E    G 
Sbjct: 64  ERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---Y 456
           L+  I   I            I  +V   + YLH      I HRD+K  N+LL+ K    
Sbjct: 123 LFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176

Query: 457 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG 516
             K+ DFG S      +  +  ++ GT  Y+ PE  +   + EK DV+S GV+L  +L G
Sbjct: 177 LIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAG 233

Query: 517 QKPIRAINTDEDKSLVGYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNL 574
             P       E        L+ + + +  F++ +   V + AK         L K+ L  
Sbjct: 234 YPPFGGQTDQE-------ILRKVEKGKYTFDSPEWKNVSEGAKD--------LIKQMLQF 278

Query: 575 NGKMRPTMKEV 585
           + + R + ++ 
Sbjct: 279 DSQRRISAQQA 289

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  142 bits (358), Expect = 7e-36
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 18/227 (7%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQI 370
            +    +     LG GG G V + +    G  VA+K+  + +   N E++  E+ I+ ++
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 371 NHRNIVKLLGCCLETE-------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
           NH N+V       +         +PLL  E+   G L +Y++       +    +  +  
Sbjct: 70  NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKV 480
           ++S AL YLH      I HRD+K  NI+L     +   K+ D G ++  +      T  V
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV 184

Query: 481 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            GT  Y+ PE  +  ++T   D +SFG +  E +TG +P        
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  135 bits (343), Expect = 7e-36
 Identities = 72/308 (23%), Positives = 131/308 (42%), Gaps = 65/308 (21%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 375
           + LG+G  G V K      +       VAVK  K     + +   ++E  +L Q+NH ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQY---------------------IHNQIEEFPIT 414
           +KL G C +    LL+ E+   G+L  +                       +  +E  +T
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
              L+  A ++S  + YL   A + + HRD+ + NIL+ +  + K+SDFG SR V  + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 475 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
           +    V+ + G +       E      +T +SDV+SFGV+L EI+T G  P   I  +  
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261

Query: 529 KSLV--GYFLQAINE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
            +L+  G+ ++  +     ++               +M       +C       RP   +
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY--------------RLM------LQCWKQEPDKRPVFAD 301

Query: 585 VTNELGGI 592
           ++ +L  +
Sbjct: 302 ISKDLEKM 309

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  135 bits (342), Expect = 9e-36
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 54/303 (17%)

Query: 323 RILGQGGQGTVYKGMLTD------GRIVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 374
           + LG+G  G V +            R VAVK  K     +     ++E+ IL  I +H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 375 IVKLLGCCLETEVPLLV-YEFIPNGTL-------------YQYIHNQIEEFPITWELLLR 420
           +V LLG C +   PL+V  EF   G L             Y+     + +  +T E L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
            + +V+  + +L   AS    HRD+ + NILL +K   K+ DFG +R +  D  +    V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205

Query: 481 QGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY 534
           +     +      PE      +T +SDV+SFGV+L EI + G  P   +  DE+      
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------ 259

Query: 535 FLQAINENRLFEALDARVLKEAKKE--EIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
           F + + E     A D         E  + M        C +     RPT  E+   LG +
Sbjct: 260 FCRRLKEGTRMRAPD-----YTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLGNL 308

Query: 593 RTS 595
             +
Sbjct: 309 LQA 311

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  136 bits (344), Expect = 1e-35
 Identities = 83/383 (21%), Positives = 144/383 (37%), Gaps = 83/383 (21%)

Query: 266 YKFVKRRKEI--KLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNA-- 321
           +    +      KL ++   R    +  +  SS  SN    ++ T       T       
Sbjct: 7   HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66

Query: 322 -------------------NRILGQGGQGTVYKGMLTDGR--------IVAVKKSK-LVD 353
                               + LG+G  G V                  VAVK  K    
Sbjct: 67  EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126

Query: 354 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTL------------ 400
           E ++   ++E+ ++  I  H+NI+ LLG C +     ++ E+   G L            
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186

Query: 401 -YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 459
            Y Y  N++ E  +T++ L+    +++  + YL   AS    HRD+ + N+L+ +    K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 243

Query: 460 VSDFGTSRSVMVDQTHLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEIL 514
           ++DFG +R +     +     + T G +      PE      +T +SDV+SFGV++ EI 
Sbjct: 244 IADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

Query: 515 T-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEALDARVLKEAKKEEIMTVATLAK 569
           T G  P   I  +E   L+  G+ +       N L+               +M      +
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--------------MMM------R 339

Query: 570 RCLNLNGKMRPTMKEVTNELGGI 592
            C +     RPT K++  +L  I
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRI 362

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (341), Expect = 2e-35
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 60/306 (19%)

Query: 323 RILGQGGQGTVYKGMLTDGR--------IVAVKKSK-LVDETNVEQFINEVVILSQI-NH 372
           + LG+G  G V                  VAVK  K    E ++   ++E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHNQIEEFPITWELLL 419
           +NI+ LLG C +     ++ E+   G L             Y Y  N++ E  +T++ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               +++  + YL   AS    HRD+ + N+L+ +    K++DFG +R +     +    
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 480 VQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV- 532
            + T G +      PE      +T +SDV+SFGV++ EI T G  P   I  +E   L+ 
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

Query: 533 -GYFLQAINE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            G+ +       N L+               +M      + C +     RPT K++  +L
Sbjct: 274 EGHRMDKPANCTNELY--------------MMM------RDCWHAVPSQRPTFKQLVEDL 313

Query: 590 GGIRTS 595
             I T 
Sbjct: 314 DRILTL 319

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  137 bits (346), Expect = 2e-35
 Identities = 56/279 (20%), Positives = 111/279 (39%), Gaps = 33/279 (11%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIV 376
           ++    +LG G +GT+    + D R VAVK+   +          EV +L + + H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +      + +   +  E     TL +Y+  + ++F       + +  + +  L +LHS  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 437 SIPIYHRDIKSANILLDDK-----YRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVDP 489
              I HRD+K  NIL+         +A +SDFG  + + V +   +  + V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 490 EYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           E          T   D++S G V   +++        +           +     +    
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGACSLDCL 250

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             +      A+         L ++ + ++ + RP+ K V
Sbjct: 251 HPEKHEDVIAR--------ELIEKMIAMDPQKRPSAKHV 281

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  134 bits (339), Expect = 4e-35
 Identities = 83/364 (22%), Positives = 142/364 (39%), Gaps = 76/364 (20%)

Query: 261 GIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYN 320
           G+ + YK  K + +++ K          +++    ++ + I+ T+L  ++  E   +N  
Sbjct: 1   GVDYKYKQ-KPKYQVRWK----------IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQ 49

Query: 321 ANRILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NH 372
             + LG G  G V +              VAVK  K        E  ++E+ I+S +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-----------IHNQIEEFPITWELLLRI 421
            NIV LLG C      L++ E+   G L  +               I     +   LL  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 481
           + +V+  + +L   AS    HRD+ + N+LL + + AK+ DFG +R +M D         
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN------- 219

Query: 482 GTFGYVD------------PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
               Y+             PE      +T +SDV+S+G++L EI + G  P   I  +  
Sbjct: 220 ----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275

Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKE--EIMTVATLAKRCLNLNGKMRPTMKEVT 586
                 F + + +              A K    IM      + C  L    RPT +++ 
Sbjct: 276 ------FYKLVKDGYQMAQPA-----FAPKNIYSIM------QACWALEPTHRPTFQQIC 318

Query: 587 NELG 590
           + L 
Sbjct: 319 SFLQ 322

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (351), Expect = 5e-35
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 323 RILGQGGQGTVYKGMLTDGR----IVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           R +G+G  G V++G+          VA+K  K+   D    + F+ E + + Q +H +IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           KL+G   E  V  ++ E    G L  ++  +     +    L+  A ++S AL YL S  
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKR 511

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
            +   HRDI + N+L+      K+ DFG SR +     +  +K +    ++ PE     +
Sbjct: 512 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 497 FTEKSDVYSFGVVLVEILT-GQKP 519
           FT  SDV+ FGV + EIL  G KP
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKP 592

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  132 bits (335), Expect = 5e-35
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 17/217 (7%)

Query: 317 DNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D+++  R LG+G  G VY      +  I+A+K   KS+L  E    Q   E+ I S + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IAVEVSGALF 430
            NI+++          + L+ EF P G LY+ +      F    E        E++ AL 
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKH-GRFD---EQRSATFMEELADALH 128

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           Y H      + HRDIK  N+L+  K   K++DFG   SV        T + GT  Y+ PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT-MCGTLDYLPPE 182

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             +     EK D++  GV+  E L G  P  + +  E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (332), Expect = 2e-34
 Identities = 51/220 (23%), Positives = 101/220 (45%), Gaps = 27/220 (12%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 375
             LG+   G VYKG L           VA+K  K   +    E+F +E ++ +++ H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIA 422
           V LLG   + +   +++ +  +G L+++               ++  +  +     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
            +++  + YL   +S  + H+D+ + N+L+ DK   K+SD G  R V     +       
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-KLLGNS 190

Query: 483 TF--GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
                ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  135 bits (343), Expect = 2e-34
 Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 49/320 (15%)

Query: 291 QQELSSNESNIEKTKLFTSKDL------EKATDNYNANRILGQGGQGTVYKG-MLTDGRI 343
               SS   N+    +  +  +       K  ++Y   R LG G  G V           
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 344 VAVK---KSKLVD----------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 390
            A+K   KS+             E   E+  NE+ +L  ++H NI+KL     + +   L
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI 450
           V EF   G L++ I   I            I  ++   + YLH      I HRDIK  NI
Sbjct: 124 VTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177

Query: 451 LLDDK---YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 507
           LL++K      K+ DFG S     D   L  ++ GT  Y+ PE  +   + EK DV+S G
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCG 234

Query: 508 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVA 565
           V++  +L G  P    N  +        ++ + + +  F+  D   +  EAK+       
Sbjct: 235 VIMYILLCGYPPFGGQNDQD-------IIKKVEKGKYYFDFNDWKNISDEAKE------- 280

Query: 566 TLAKRCLNLNGKMRPTMKEV 585
            L K  L  +   R T +E 
Sbjct: 281 -LIKLMLTYDYNKRCTAEEA 299

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  134 bits (340), Expect = 2e-34
 Identities = 69/299 (23%), Positives = 122/299 (40%), Gaps = 50/299 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNI 375
           +   + +ILG G  GTV       GR VAVK+   +     +  + E+ +L++  +H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71

Query: 376 VKLLGCCLETEVPL-LVYEFIPNGTLYQYI---HNQIEEFPITWEL-LLRIAVEVSGALF 430
           ++   C   T+  L +  E   N  L   +   +   E   +  E   + +  +++  + 
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 431 YLHSAASIPIYHRDIKSANILLDDK-------------YRAKVSDFGTSRSVMVDQTHLT 477
           +LH   S+ I HRD+K  NIL+                 R  +SDFG  + +   Q+   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 478 TKVQ---GTFGYVDPEYFQSSQF-------TEKSDVYSFGVVLVEILT-GQKPIRAINTD 526
           T +    GT G+  PE  + S         T   D++S G V   IL+ G+ P     + 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           E   + G F    + + +    D  ++ EA          L  + ++ +   RPT  +V
Sbjct: 247 ESNIIRGIF----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPTAMKV 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  131 bits (331), Expect = 2e-34
 Identities = 55/295 (18%), Positives = 109/295 (36%), Gaps = 52/295 (17%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI-N 371
           T  ++    +G G  G+V+K +   DG I A+K+SK       + +  + EV   + +  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALF 430
           H ++V+      E +  L+  E+   G+L   I  N           L  + ++V   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 431 YLHSAASIPIYHRDIKSANILLD-------------------DKYRAKVSDFGTSRSVMV 471
           Y+HS +   + H DIK +NI +                    +K   K+ D G    +  
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 472 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 530
            Q       +G   ++  E  Q +     K+D+++  + +V     +   R  +      
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236

Query: 531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                   I + R    +   + +E  +        L K  ++ + + RP+   +
Sbjct: 237 -----WHEIRQGR-LPRIPQVLSQEFTE--------LLKVMIHPDPERRPSAMAL 277

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (333), Expect = 2e-34
 Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 55/304 (18%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 374
           + LG G  G V +              VAVK  K     T  E  ++E+ +LS + NH N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQY---------------IHNQIEEFPITWELLL 419
           IV LLG C      L++ E+   G L  +                  + +E  +  E LL
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
             + +V+  + +L   AS    HRD+ + NILL      K+ DFG +R +  D  ++   
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 480 -----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVG 533
                V+       PE   +  +T +SDV+S+G+ L E+ + G  P   +  D       
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256

Query: 534 YFLQAINENRLFEALDARVLKEAKKE--EIMTVATLAKRCLNLNGKMRPTMKEVTNELGG 591
            F + I E     + +      A  E  +IM      K C + +   RPT K++   +  
Sbjct: 257 -FYKMIKEGFRMLSPE-----HAPAEMYDIM------KTCWDADPLKRPTFKQIVQLIEK 304

Query: 592 IRTS 595
             + 
Sbjct: 305 QISE 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  132 bits (335), Expect = 3e-34
 Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 60/307 (19%)

Query: 322 NRILGQGGQGTVYKGMLTD--------GRIVAVKKSK-LVDETNVEQFINEVVILSQI-N 371
            + LG+G  G V                  VAVK  K    E ++   I+E+ ++  I  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHNQIEEFPITWELL 418
           H+NI+ LLG C +     ++ E+   G L             Y Y  +   E  ++ + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
           +  A +V+  + YL   AS    HRD+ + N+L+ +    K++DFG +R +     +   
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247

Query: 479 KVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 532
             + T G +      PE      +T +SDV+SFGV+L EI T G  P   +  +E   L+
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 533 --GYFLQAINE--NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
             G+ +   +   N L+               +M      + C +     RPT K++  +
Sbjct: 307 KEGHRMDKPSNCTNELY--------------MMM------RDCWHAVPSQRPTFKQLVED 346

Query: 589 LGGIRTS 595
           L  I   
Sbjct: 347 LDRIVAL 353

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 4e-34
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 34/221 (15%)

Query: 323 RILGQGGQGTVYKGMLTDG---RIVAVKKSK-LVDETNVEQFINEVVILSQI-NHRNIVK 377
            ++G+G  G V K  +         A+K+ K    + +   F  E+ +L ++ +H NI+ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 378 LLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIAVE 424
           LLG C       L  E+ P+G L  +                      ++ + LL  A +
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           V+  + YL   +     HRD+ + NIL+ + Y AK++DFG SR   V        V+ T 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 200

Query: 485 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           G +       E    S +T  SDV+S+GV+L EI++ G  P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (332), Expect = 4e-34
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 41/231 (17%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 375
           R +G+G  G V++             +VAVK  K          F  E  ++++ ++ NI
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQY---------------------IHNQIEEFPIT 414
           VKLLG C   +   L++E++  G L ++                       +     P++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
               L IA +V+  + YL   +     HRD+ + N L+ +    K++DFG SR++     
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 475 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 519
           +           +      PE    +++T +SDV+++GVVL EI + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  133 bits (336), Expect = 1e-33
 Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 39/301 (12%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSK 350
             +  +  +  L+         + YN   +LG+G  G V K       +  AVK   K+ 
Sbjct: 3   HHHHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59

Query: 351 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIE 409
             ++ +    + EV +L +++H NI+KL     E      +V E    G L+  I   I+
Sbjct: 60  AKNK-DTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEI---IK 114

Query: 410 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTS 466
               +     RI  +V   + Y+H      I HRD+K  NILL+ K      K+ DFG S
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171

Query: 467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
                +   +  ++ GT  Y+ PE  + + + EK DV+S GV+L  +L+G  P    N  
Sbjct: 172 TCFQQNTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228

Query: 527 EDKSLVGYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
           +        L+ +   +  F+      +  +AK         L ++ L  +  +R T  +
Sbjct: 229 D-------ILKRVETGKYAFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQ 273

Query: 585 V 585
            
Sbjct: 274 C 274

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 2e-33
 Identities = 75/309 (24%), Positives = 124/309 (40%), Gaps = 60/309 (19%)

Query: 323 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 374
           ++LG G  G V                VAVK  K   D +  E  ++E+ +++Q+ +H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQY--------------------IHNQIEEFPIT 414
           IV LLG C  +    L++E+   G L  Y                    +  + +   +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
           +E LL  A +V+  + +L         HRD+ + N+L+      K+ DFG +R +M D  
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 475 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 528
           +    V      +      PE      +T KSDV+S+G++L EI + G  P   I  D +
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283

Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKE--EIMTVATLAKRCLNLNGKMRPTMKEVT 586
                 F + I      +         A +E   IM      + C   + + RP+   +T
Sbjct: 284 ------FYKLIQNGFKMDQPF-----YATEEIYIIM------QSCWAFDSRKRPSFPNLT 326

Query: 587 NELGGIRTS 595
           + LG     
Sbjct: 327 SFLGCQLAD 335

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (324), Expect = 5e-33
 Identities = 63/310 (20%), Positives = 118/310 (38%), Gaps = 43/310 (13%)

Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV 365
           F  + +E         R+L +GG   VY+   +  GR  A+K+    +E      I EV 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77

Query: 366 ILSQI-NHRNIVKLLGCCLETEVP-------LLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
            + ++  H NIV+        +          L+   +  G L +++       P++ + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 477
           +L+I  +   A+ ++H     PI HRD+K  N+LL ++   K+ DFG++ ++     +  
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 478 TKVQ-----------GTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAI 523
           +  +            T  Y  PE           EK D+++ G +L  +   Q P    
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--- 253

Query: 524 NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
              ED + +      I   +                       L +  L +N + R ++ 
Sbjct: 254 ---EDGAKL-----RIVNGKYSIPPHDTQYTVFHS--------LIRAMLQVNPEERLSIA 297

Query: 584 EVTNELGGIR 593
           EV ++L  I 
Sbjct: 298 EVVHQLQEIA 307

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 5e-33
 Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 19/249 (7%)

Query: 283 KRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDG 341
                L  Q  + ++E      ++   +         ++   +G+G  G V        G
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQ--GDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70

Query: 342 RIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 401
           R VAVK   L  +   E   NEVVI+    H N+V++    L  E   ++ EF+  G L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130

Query: 402 QYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
             +   ++ E  I       +   V  AL YLH+   I   HRDIKS +ILL    R K+
Sbjct: 131 DIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKL 182

Query: 461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ--- 517
           SDFG    +  D     + V GT  ++ PE    S +  + D++S G++++E++ G+   
Sbjct: 183 SDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

Query: 518 ---KPIRAI 523
               P++A+
Sbjct: 242 FSDSPVQAM 250

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (320), Expect = 6e-33
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 13/226 (5%)

Query: 296 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 354
           S+E  +EK +   S         Y     +GQG  GTVY  M +  G+ VA+++  L  +
Sbjct: 1   SDEEILEKLRSIVSV--GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPI 413
              E  INE++++ +  + NIV  L   L  +   +V E++  G+L   +    ++E  I
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 473
                  +  E   AL +LHS   I   HRDIKS NILL      K++DFG    +  +Q
Sbjct: 119 A-----AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
           +  +T V GT  ++ PE      +  K D++S G++ +E++ G+ P
Sbjct: 171 SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 4e-32
 Identities = 45/255 (17%), Positives = 82/255 (32%), Gaps = 29/255 (11%)

Query: 290 LQQELSSNESNIEKT----KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----- 340
           L + +SS  +  E       +    + +  +     + +LG+G    VY+    D     
Sbjct: 34  LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93

Query: 341 -GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 399
             +   +K  K  +          +  L        +K     L     +LV E    GT
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 400 LYQYI--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
           L   I  +    E  +   L++  A+ +   +  +H      I H DIK  N +L + + 
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210

Query: 458 A-----------KVSDFGTSR--SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 504
                        + D G S    +    T  T K   T G+   E   +  +  + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYF 269

Query: 505 SFGVVLVEILTGQKP 519
                +  +L G   
Sbjct: 270 GVAATVYCMLFGTYM 284

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 6e-32
 Identities = 56/254 (22%), Positives = 110/254 (43%), Gaps = 33/254 (12%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--- 347
            +++ SN SN+     +  +  +K  ++Y   R L QG    +        +  A+K   
Sbjct: 6   MKDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYE 63

Query: 348 KSKLV--------------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVY 392
           KS L                ++  + F NE+ I++ I +   +   G  +     + ++Y
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIY 122

Query: 393 EFIPNGTLYQYIH-----NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 447
           E++ N ++ ++       ++     I  +++  I   V  +  Y+H+  +I   HRD+K 
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKP 180

Query: 448 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT--EKSDVYS 505
           +NIL+D   R K+SDFG   S  +    +     GT+ ++ PE+F +       K D++S
Sbjct: 181 SNILMDKNGRVKLSDFGE--SEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWS 237

Query: 506 FGVVLVEILTGQKP 519
            G+ L  +     P
Sbjct: 238 LGICLYVMFYNVVP 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (313), Expect = 1e-31
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
            + ++    LG+G  G+VYK +    G+IVA+K+  +  +  +++ I E+ I+ Q +  +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           +VK  G   +     +V E+   G+   + +  +  + E  I       I       L Y
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-----TILQSTLKGLEY 140

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LH    I   HRDIK+ NILL+ +  AK++DFG +  +        T + GT  ++ PE 
Sbjct: 141 LHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 523
            Q   +   +D++S G+  +E+  G+       P+RAI
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (311), Expect = 4e-31
 Identities = 77/346 (22%), Positives = 132/346 (38%), Gaps = 57/346 (16%)

Query: 270 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGG 329
           K+ +E++L ++  KR    L Q++         K       D EK          LG G 
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQ---------KVGELKDDDFEKI-------SELGAGN 45

Query: 330 QGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 387
            G V+K      G ++A K   L +      Q I E+ +L + N   IV   G       
Sbjct: 46  GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105

Query: 388 PLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI 445
             +  E +  G+L Q +    +I E     ++L ++++ V   L YL     I   HRD+
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHKI--MHRDV 158

Query: 446 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 505
           K +NIL++ +   K+ DFG S    +  +   + V GT  Y+ PE  Q + ++ +SD++S
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215

Query: 506 FGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVA 565
            G+ LVE+  G+ PI   +  E + + G  ++                      +     
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275

Query: 566 TL---------------------------AKRCLNLNGKMRPTMKE 584
            +                             +CL  N   R  +K+
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  121 bits (305), Expect = 1e-30
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHR 373
            + +     +G+G  G V+KG+     ++VA+K   L   E  +E    E+ +LSQ +  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYL 432
            + K  G  L+     ++ E++  G+    +    ++E  I       I  E+   L YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYL 135

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS   I   HRDIK+AN+LL +    K++DFG +  +   Q    T V GT  ++ PE  
Sbjct: 136 HSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKP 519
           + S +  K+D++S G+  +E+  G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  121 bits (305), Expect = 1e-30
 Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 43/289 (14%)

Query: 308 TSKDLEKATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFIN 362
           +  D +    NY   + +G+G    V     +LT GR VA+K   K++L + T++++   
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQL-NPTSLQKLFR 63

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 419
           EV I+  +NH NIVKL    +ETE  L L+ E+   G ++ Y+  H +++E     +   
Sbjct: 64  EVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKE-----KEAR 117

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S +       L   
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS-NEFTVGGKLDAF 173

Query: 480 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFL 536
             G   Y  PE FQ  ++   + DV+S GV+L  +++G  P    N  E  ++ L G + 
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY- 231

Query: 537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                      +   +  + +         L KR L LN   R T++++
Sbjct: 232 ----------RIPFYMSTDCEN--------LLKRFLVLNPIKRGTLEQI 262

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  120 bits (304), Expect = 2e-30
 Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 50/306 (16%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 350
            +  +++  TKL   K+ E     Y    +LG GG G+VY G+ ++D   VA+K   K +
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 351 LVDETNVEQFIN---EVVILSQINHR--NIVKLLGCCLETEVPL-LVYEFI-PNGTLYQY 403
           + D   +        EVV+L +++     +++LL    E      L+ E   P   L+ +
Sbjct: 81  ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139

Query: 404 I--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKV 460
           I     ++E     EL      +V  A+ + H+     + HRDIK  NIL+D ++   K+
Sbjct: 140 ITERGALQE-----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191

Query: 461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
            DFG+    ++  T  T    GT  Y  PE+ +  ++    + V+S G++L +++ G  P
Sbjct: 192 IDFGSGA--LLKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

Query: 520 IRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR 579
                  +++ + G                 RV  E +         L + CL L    R
Sbjct: 249 FE----HDEEIIRGQV-----------FFRQRVSSECQH--------LIRWCLALRPSDR 285

Query: 580 PTMKEV 585
           PT +E+
Sbjct: 286 PTFEEI 291

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (302), Expect = 2e-30
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 20/214 (9%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
            + +     LG G  G VYK      G + A K  +   E  +E +I E+ IL+  +H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           IVKLLG         ++ EF P G    +   +   + E  I       +  ++  AL +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY----- 486
           LHS   I   HRD+K+ N+L+  +   +++DFG S   +       + + GT  Y     
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT-PYWMAPE 187

Query: 487 -VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
            V  E  + + +  K+D++S G+ L+E+   + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (303), Expect = 8e-30
 Identities = 29/236 (12%), Positives = 63/236 (26%), Gaps = 42/236 (17%)

Query: 323 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQ--------- 369
            +LGQ       +      G    V     ++      ++Q   EV+ L           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 370 -------------INHRNIVKLLGCCLETEVPLLVYEFIP-------NGTLYQYIHNQIE 409
                        +      K++   L+     ++  F           T  + + +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 410 EF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 468
               +     L++ ++V   L  LH      + H  ++  +I+LD +    ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKP 519
                     +                Q      T   D ++ G+ +  I     P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  120 bits (303), Expect = 1e-29
 Identities = 69/289 (23%), Positives = 114/289 (39%), Gaps = 44/289 (15%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV-----DETNVEQFINEVVI 366
            D Y  ++ LG G  G V         + VA++   K K       +         E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVE 424
           L ++NH  I+K+     + E   +V E +  G L+  +  + +++E         ++   
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-ATCKLYFYQML-- 249

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTHLTTKVQ 481
              A+ YLH      I HRD+K  N+LL  +      K++DFG S+ ++ + + + T   
Sbjct: 250 --LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC- 302

Query: 482 GTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 538
           GT  Y+ PE   S          D +S GV+L   L+G  P     T             
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 356

Query: 539 INENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           I   +  F     A V ++A          L K+ L ++ K R T +E 
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 397

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (299), Expect = 1e-29
 Identities = 60/249 (24%), Positives = 97/249 (38%), Gaps = 41/249 (16%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV- 352
           + +  + +  +LF   D E     ++  R +G G  G VY    + +  +VA+KK     
Sbjct: 35  AGSLKDPDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91

Query: 353 --DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQI 408
                  +  I EV  L ++ H N ++  GC L      LV E+       L +     +
Sbjct: 92  KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 151

Query: 409 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG---- 464
           +E  I       +       L YLHS   I   HRD+K+ NILL +    K+ DFG    
Sbjct: 152 QEVEIAA-----VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203

Query: 465 -TSRSVMVDQTHLTTKVQGTFGYVDPE---YFQSSQFTEKSDVYSFGVVLVEILTGQ--- 517
               +  V          GT  ++ PE        Q+  K DV+S G+  +E+   +   
Sbjct: 204 MAPANSFV----------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

Query: 518 ---KPIRAI 523
                + A+
Sbjct: 254 FNMNAMSAL 262

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  118 bits (298), Expect = 1e-29
 Identities = 61/339 (17%), Positives = 117/339 (34%), Gaps = 91/339 (26%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 374
            ++   + +G+GG G V++     D    A+K+ +L + E   E+ + EV  L+++ H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 375 IVKLLGCCLETEVPLL-------------------------------------------- 390
           IV+     LET                                                 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 391 -VYEFIPNGTLY---QYIHN---------QIEEFPITWELLLRIAVEVSGALFYLHSAAS 437
            +    P   LY   Q             +         + L I ++++ A+ +LHS   
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----------GTFGY 486
             + HRD+K +NI        KV DFG   ++  D+   T               GT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           + PE    + ++ K D++S G++L E+L         +T  ++  +   +  +   + F 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVRI---ITDVRNLK-FP 292

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            L  +   +           + +  L+ +   RP   ++
Sbjct: 293 LLFTQKYPQEHM--------MVQDMLSPSPTERPEATDI 323

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (296), Expect = 1e-29
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRN 374
           D+Y    ++G G    V           VA+K+  L   +T++++ + E+  +SQ +H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL--LRIAV---EVSGAL 429
           IV      +  +   LV + +  G++   I + + +      +L    IA    EV   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF-G--- 485
            YLH    I   HRD+K+ NILL +    +++DFG S  +         KV+ TF G   
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 486 YVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKP 519
           ++ PE   Q   +  K+D++SFG+  +E+ TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  117 bits (295), Expect = 2e-29
 Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN-- 362
            KD E     Y    +LG+GG GTV+ G  LTD   VA+K   +++++  + +   +   
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 363 -EVVILSQIN----HRNIVKLLGCCLETEVPL-LVYEF-IPNGTLYQYI--HNQIEEFPI 413
            EV +L ++     H  +++LL    ET+    LV E  +P   L+ YI     + E   
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGE--- 138

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVD 472
                     +V  A+ + HS     + HRDIK  NIL+D +   AK+ DFG+    ++ 
Sbjct: 139 --GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGA--LLH 191

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
               T    GT  Y  PE+    Q+    + V+S G++L +++ G  P       + + L
Sbjct: 192 DEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEIL 246

Query: 532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                             A V  +           L +RCL      RP+++E+
Sbjct: 247 EAEL-----------HFPAHVSPDCCA--------LIRRCLAPKPSSRPSLEEI 281

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (296), Expect = 3e-29
 Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 33/301 (10%)

Query: 297 NESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDE 354
           +  +  K K+   +  +   ++      +G+G  G+V K +    G+I+AVK+ +  VDE
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 355 TNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFIPNG--TLYQYIHNQIEE 410
              +Q + ++ V++   +   IV+  G    E +   +  E +       Y+Y+++ +++
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDD 120

Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 470
             I  E+L +I +    AL +L     I   HRDIK +NILLD     K+ DFG S   +
Sbjct: 121 -VIPEEILGKITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS-GQL 176

Query: 471 VDQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
           VD    T    G   Y+ PE    S     +  +SDV+S G+ L E+ TG+ P    N+ 
Sbjct: 177 VDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 527 EDKSLVGYFLQAINEN---RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK 583
            D       L  + +    +L  + +                     CL  +   RP  K
Sbjct: 236 FD------QLTQVVKGDPPQLSNSEEREFSPSFI--------NFVNLCLTKDESKRPKYK 281

Query: 584 E 584
           E
Sbjct: 282 E 282

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  118 bits (297), Expect = 4e-29
 Identities = 47/221 (21%), Positives = 78/221 (35%), Gaps = 25/221 (11%)

Query: 316 TDNYNANRILGQGGQ--GTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI 370
              Y    ++G+G +   TV        G  V V++  L       V     E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAV---EVS 426
           NH NIV      +      +V  F+  G+    I     +           IA     V 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            AL Y+H    +   HR +K+++IL+    +  +S   ++ S++                
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 487 VD------PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 519
           V       PE  Q +   +  KSD+YS G+   E+  G  P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (292), Expect = 4e-29
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 27/268 (10%)

Query: 325 LGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEV-VILSQINHRNIVKLLGC 381
           LG+G  G V K      G+I+AVK+ +  V+    ++ + ++ + +  ++    V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 382 CL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 440
              E +V  +  E +       Y     +   I  ++L +IAV +  AL +LHS  S+ I
Sbjct: 75  LFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV-I 132

Query: 441 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE----YFQSSQ 496
            HRD+K +N+L++   + K+ DFG S   +VD         G   Y+ PE          
Sbjct: 133 -HRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPERINPELNQKG 189

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           ++ KSD++S G+ ++E+   + P  +  T   +      L+ + E    +    +   E 
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ------LKQVVEEPSPQLPADKFSAEF 243

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKE 584
                        +CL  N K RPT  E
Sbjct: 244 VD--------FTSQCLKKNSKERPTYPE 263

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (293), Expect = 9e-29
 Identities = 38/338 (11%), Positives = 84/338 (24%), Gaps = 74/338 (21%)

Query: 293 ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---K 348
            L S              +L +         +LGQ       +      G    V     
Sbjct: 49  SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108

Query: 349 SKLVDETNVEQFINEVVILSQI-------------------------NHRNIVKLLGCCL 383
           ++      ++Q   EV+ L  +                           + ++++     
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168

Query: 384 ETEVPLLVYEF-IPNGTLYQYI----HNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
           +  V    + +      L  +      +      +     L++ ++V   L  LH     
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 496
            + H  ++  +I+LD +    ++ F                   + G+  PE        
Sbjct: 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATI 280

Query: 497 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
                     T   D ++ G+V+  I     PI           +    + I +      
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ------ 334

Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                    +         L +  L    + R    + 
Sbjct: 335 -------PVRA--------LLEGFLRYPKEDRLLPLQA 357

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  114 bits (288), Expect = 1e-28
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 37/295 (12%)

Query: 300 NIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDET 355
           +  +  L+         + YN   +LG+G  G V K       +  AVK   K+   ++ 
Sbjct: 8   SSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK- 63

Query: 356 NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITW 415
           +    + EV +L +++H NI+KL     ++    +V E    G L+  I   I+    + 
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSE 120

Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVD 472
               RI  +V   + Y+H      I HRD+K  NILL+ K +    K+ DFG S      
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQ 176

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
            T +  ++ GT  Y+ PE  + + + EK DV+S GV+L  +L+G  P    N  +     
Sbjct: 177 NTKMKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----- 229

Query: 533 GYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              L+ +   +  F+      +  +AK         L ++ L  +  +R T  + 
Sbjct: 230 --ILKRVETGKYAFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (290), Expect = 2e-28
 Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 40/286 (13%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDET--NVEQFINEVVILSQ 369
            D Y    ++G+G    V + +    G+  AVK    +K       + E    E  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 370 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVE 424
           + H +IV+LL     ++  L +V+EF+    L   I  + +   +  E      +R  +E
Sbjct: 83  LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQ 481
              AL Y H      I HRD+K   +LL  K  +   K+  FG +  +         +V 
Sbjct: 142 ---ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV- 194

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
           GT  ++ PE  +   + +  DV+  GV+L  +L+G  P         + L     + I +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERL----FEGIIK 246

Query: 542 NRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            +        + + + AK         L +R L L+   R T+ E 
Sbjct: 247 GKYKMNPRQWSHISESAKD--------LVRRMLMLDPAERITVYEA 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 3e-28
 Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 22/244 (9%)

Query: 295 SSNESNIEKTKLFTS-KDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL- 351
           SS  S  +   L    +  +   ++      +G G  G V+K      G ++AVK+ +  
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61

Query: 352 VDETNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFIPNGT--LYQYIHNQ 407
            ++   ++ + ++ V+L   +   IV+  G  +  T+V  +  E +      L + +   
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGP 120

Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
           I E      +L ++ V +  AL+YL     + I HRD+K +NILLD++ + K+ DFG S 
Sbjct: 121 IPE-----RILGKMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGIS- 172

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRA 522
             +VD         G   Y+ PE           +  ++DV+S G+ LVE+ TGQ P + 
Sbjct: 173 GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

Query: 523 INTD 526
             TD
Sbjct: 232 CKTD 235

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  113 bits (284), Expect = 3e-28
 Identities = 25/209 (11%), Positives = 62/209 (29%), Gaps = 44/209 (21%)

Query: 325 LGQGGQGTVYKGMLTD---GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
            G       ++    D    R VA+       ++ +  +++ ++  + LS+I+   + ++
Sbjct: 39  HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 438
           L         L+V E+I  G+L +       +   +    +R    ++ A    H A   
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148

Query: 439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            +       + + +       ++   T                                 
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------------N 180

Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            + D+   G  L  +L  + P+       
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (284), Expect = 4e-28
 Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 43/296 (14%)

Query: 303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVE 358
           +  L+    ++   D +   R LG G  G V+     + G    +K   K +   +  +E
Sbjct: 11  RENLYFQGTID---DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPME 65

Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE- 416
           Q   E+ +L  ++H NI+K+     E    + +V E    G L + I +         E 
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124

Query: 417 ---LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVM 470
               L++  +    AL Y HS     + H+D+K  NIL  D       K+ DFG +  + 
Sbjct: 125 YVAELMKQMMN---ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LF 177

Query: 471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 530
               H T    GT  Y+ PE F+    T K D++S GVV+  +LTG  P    + +E   
Sbjct: 178 KSDEHSTNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--- 232

Query: 531 LVGYFLQAINENRL-FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                 Q        +      +  +A          L K+ L  + + RP+  +V
Sbjct: 233 ----VQQKATYKEPNYAVECRPLTPQAVD--------LLKQMLTKDPERRPSAAQV 276

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (286), Expect = 4e-28
 Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
              +    +LG G    V+       G++ A+K   KS    ++++E   NE+ +L +I 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64

Query: 372 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           H NIV L     E+     LV + +  G L+  I   +E    T +    +  +V  A+ 
Sbjct: 65  HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVK 120

Query: 431 YLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           YLH      I HRD+K  N+L    ++  +  ++DFG   S M     ++T   GT GYV
Sbjct: 121 YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL--SKMEQNGIMSTAC-GTPGYV 174

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-FE 546
            PE      +++  D +S GV+   +L G  P       +         + I E    FE
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYEFE 227

Query: 547 ALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +     + + AK              L  +   R T ++ 
Sbjct: 228 SPFWDDISESAKD--------FICHLLEKDPNERYTCEKA 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  114 bits (287), Expect = 5e-28
 Identities = 74/344 (21%), Positives = 125/344 (36%), Gaps = 72/344 (20%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 350
             + S+  +   F    L +    Y+    +GQG  G V   +      I A+K   K+K
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63

Query: 351 L--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI 408
           +  ++  +VE+   EV ++ +++H NI +L     + +   LV E    G L   ++  I
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 409 EEFPITWELLL-------------------------------------RIAVEVSGALFY 431
           ++      + +                                      I  ++  AL Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 432 LHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRSV----MVDQTHLTTKVQGTFG 485
           LH+     I HRDIK  N L      +  K+ DFG S+        +   +TTK  GT  
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPY 239

Query: 486 YVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 543
           +V PE   ++   +  K D +S GV+L  +L G  P   +N  +        +  +   +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-------TISQVLNKK 292

Query: 544 L-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           L FE  +   +   A+         L    LN N   R      
Sbjct: 293 LCFENPNYNVLSPLARD--------LLSNLLNRNVDERFDAMRA 328

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (282), Expect = 8e-28
 Identities = 68/283 (24%), Positives = 106/283 (37%), Gaps = 38/283 (13%)

Query: 313 EKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
                 Y     +G+G  G V            A K   K  + D   V++F  E+ I+ 
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMK 61

Query: 369 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
            ++H NI++L     E    + LV E    G L++ +   + +         RI  +V  
Sbjct: 62  SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLS 117

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           A+ Y H      + HRD+K  N L          K+ DFG +         + TKV GT 
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTP 172

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            YV P+  +   +  + D +S GV++  +L G  P  A    E        +  I E   
Sbjct: 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTF 224

Query: 545 -FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            F   D   V  +A+         L +R L  + K R T  + 
Sbjct: 225 TFPEKDWLNVSPQAES--------LIRRLLTKSPKQRITSLQA 259

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (281), Expect = 2e-27
 Identities = 70/296 (23%), Positives = 115/296 (38%), Gaps = 52/296 (17%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV-----DETNVEQFINE 363
           +   D Y  ++ LG G  G V         + VA+K   K K       +         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 364 VVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRI 421
           + IL ++NH  I+K+     + E   +V E +  G L+  +  + +++E           
Sbjct: 66  IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE---------AT 115

Query: 422 AVE----VSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQT 474
                  +  A+ YLH      I HRD+K  N+LL  +      K++DFG S+ ++ + +
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETS 171

Query: 475 HLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 531
            + T   GT  Y+ PE   S     +    D +S GV+L   L+G  P     T      
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--- 227

Query: 532 VGYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                  I   +  F     A V ++A          L K+ L ++ K R T +E 
Sbjct: 228 ---LKDQITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 272

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (285), Expect = 4e-27
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 42/284 (14%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           T+ Y     LG+G    V + + +  G+  A       KL    + ++   E  I   + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68

Query: 372 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVS 426
           H NIV+L       E    L+++ +  G L++ I   +     + E      ++  +E  
Sbjct: 69  HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDI---VAREYYS-EADASHCIQQILE-- 121

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGT 483
            A+ + H      + HR++K  N+LL  K +    K++DFG +  V  +Q        GT
Sbjct: 122 -AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 543
            GY+ PE  +   + +  D+++ GV+L  +L G  P    +            Q I    
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGA 229

Query: 544 L-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             F + +   V  EAK         L  + L +N   R T  E 
Sbjct: 230 YDFPSPEWDTVTPEAKD--------LINKMLTINPSKRITAAEA 265

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (279), Expect = 8e-27
 Identities = 76/316 (24%), Positives = 127/316 (40%), Gaps = 65/316 (20%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 350
            +    + +   F      K +DNY+    LG+G    V + +  T G   A K     K
Sbjct: 7   MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66

Query: 351 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIE 409
           L    + ++   E  I  ++ H NIV+L     + E    LV++ +  G L++ I   + 
Sbjct: 67  LSAR-DFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI---VA 121

Query: 410 EFPITWE----LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSD 462
               + E      ++  +E   ++ Y HS     I HR++K  N+LL  K +    K++D
Sbjct: 122 REFYS-EADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           FG +   + D         GT GY+ PE  +   +++  D+++ GV+L  IL        
Sbjct: 175 FGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILY-IL-------- 223

Query: 523 INTDEDKSLVGY--FLQAINENRLFEALDA-----------RVLKEAKKEEIMTVATLAK 569
                   LVGY  F    +++RL+  + A            V  EAK         L  
Sbjct: 224 --------LVGYPPF-WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS--------LID 266

Query: 570 RCLNLNGKMRPTMKEV 585
             L +N K R T  + 
Sbjct: 267 SMLTVNPKKRITADQA 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (274), Expect = 9e-27
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 49/287 (17%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           +DNY+    LG+G    V + +  T G   A K     KL    + ++   E  I  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63

Query: 372 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
           H NIV+L     + E    LV++ +  G L++ I   +     +         ++  ++ 
Sbjct: 64  HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIA 119

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           Y HS     I HR++K  N+LL  K +    K++DFG +   + D         GT GY+
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYL 174

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQAINENRLF 545
            PE  +   +++  D+++ GV+L  IL                LVGY  F    +++RL+
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILY-IL----------------LVGYPPFW-DEDQHRLY 216

Query: 546 EALDARVLK---EAKKEEIMTVATLAK----RCLNLNGKMRPTMKEV 585
                 +     +    E  TV   AK      L +N K R T  + 
Sbjct: 217 AQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  108 bits (273), Expect = 1e-26
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 318 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +Y     LG G  G V  G   LT G  VAVK   + K+     V +   E+  L    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
            +I+KL    + T     +V E++  G L+ YI  H ++EE         R+  ++  A+
Sbjct: 71  PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAV 124

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y H      + HRD+K  N+LLD    AK++DFG S ++M D   L T   G+  Y  P
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAP 179

Query: 490 EYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
           E      +   + D++S GV+L  +L G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (279), Expect = 1e-26
 Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 43/286 (15%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
               D Y+    LG G  G V++ +    GR+   K       +D+  V+   NE+ I++
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMN 103

Query: 369 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAV 423
           Q++H  ++ L     E +  + L+ EF+  G L+  I    E++ ++ E      +R A 
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMS-EAEVINYMRQAC 159

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQ 481
           E    L ++H  +   I H DIK  NI+ + K  +  K+ DFG +    ++   +     
Sbjct: 160 E---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTT 211

Query: 482 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 541
            T  +  PE          +D+++ GV+   +L+G  P    +  E        LQ +  
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKR 264

Query: 542 NRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
               F+    + V  EAK           K  L    + R T+ + 
Sbjct: 265 CDWEFDEDAFSSVSPEAKD--------FIKNLLQKEPRKRLTVHDA 302

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (275), Expect = 2e-26
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKL-----VDETNVEQFINEVVILS 368
            Y+    LG G  G V+  +     + V VK   K K+     +++  + +   E+ ILS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 369 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGT-LYQYI--HNQIEEFPITWELLLRIAVE 424
           ++ H NI+K+L    E +    LV E   +G  L+ +I  H +++E      L   I  +
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQ 138

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
           +  A+ YL       I HRDIK  NI++ + +  K+ DFG++ + +       T   GT 
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFC-GTI 193

Query: 485 GYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
            Y  PE    + +   + +++S GV L  ++  + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  109 bits (274), Expect = 2e-26
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 15/212 (7%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           +ILG+G   TV         R  A+K   K  ++ E  V     E  ++S+++H   VKL
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 436
                + +  L     +  NG L +YI      F    E   R    E+  AL YLH   
Sbjct: 96  YFTF-QDDEKLYFGLSYAKNGELLKYIRKI-GSFD---ETCTRFYTAEIVSALEYLHGKG 150

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 495
              I HRD+K  NILL++    +++DFGT++ +  +          GT  YV PE     
Sbjct: 151 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
              + SD+++ G ++ +++ G  P RA N   
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  108 bits (271), Expect = 2e-26
 Identities = 66/220 (30%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  + LG+G  G V   +       VAVK     + VD    E    E+ I   +NH
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 423
            N+VK  G          L  E+   G L+  I     + E      F    +L+    V
Sbjct: 65  ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKV 480
                  YLH      I HRDIK  N+LLD++   K+SDFG + +V         L    
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC 168

Query: 481 QGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
            GT  YV PE  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  110 bits (277), Expect = 3e-26
 Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 20/252 (7%)

Query: 289 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK 347
           L Q +  ++     +  +   K++    D++   +++G+G    V    +   G++ A+K
Sbjct: 33  LAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK 92

Query: 348 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 403
              K  ++    V  F  E  +L   + R I +L     + E  L LV E+   G L   
Sbjct: 93  IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTL 151

Query: 404 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 462
           +    E  P     + R    E+  A+  +H    +   HRDIK  NILLD     +++D
Sbjct: 152 LSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY-------SFGVVLVEILT 515
           FG+   +  D T  +    GT  Y+ PE  Q+      +  Y       + GV   E+  
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

Query: 516 GQKPIRAINTDE 527
           GQ P  A +T E
Sbjct: 266 GQTPFYADSTAE 277

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (279), Expect = 4e-26
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 11/219 (5%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           D +   R+LG+GG G V+   +   G++ A K   K +L      +  + E  IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 430
           R IV L     ET+  L LV   +  G +  +I+N  E+ P   E        ++   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 490
           +LH      I +RD+K  N+LLDD    ++SD G +  +   QT       GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359

Query: 491 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
                ++    D ++ GV L E++  + P RA     + 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (270), Expect = 6e-26
 Identities = 66/220 (30%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  + LG+G  G V   +       VAVK     + VD    E    E+ I   +NH
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 423
            N+VK  G          L  E+   G L+  I     + E      F    +L+    V
Sbjct: 65  ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKV 480
                  YLH      I HRDIK  N+LLD++   K+SDFG + +V         L    
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC 168

Query: 481 QGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
            GT  YV PE  +  +F  E  DV+S G+VL  +L G+ P
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  107 bits (269), Expect = 8e-26
 Identities = 69/291 (23%), Positives = 112/291 (38%), Gaps = 39/291 (13%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 364
                +  D    ++ LG+G      K +     +  AVK   K              E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56

Query: 365 VILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLL 419
             L     H NIVKL     +     LV E +  G L++ I  + + F    E     ++
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFS---ETEASYIM 112

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHL 476
           R  V    A+ ++H      + HRD+K  N+L  D+      K+ DFG +R    D   L
Sbjct: 113 RKLVS---AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
            T    T  Y  PE    + + E  D++S GV+L  +L+GQ P ++ +     +     +
Sbjct: 167 KTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225

Query: 537 QAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + I +    FE      V +EAK         L +  L ++   R  M  +
Sbjct: 226 KKIKKGDFSFEGEAWKNVSQEAK--------DLIQGLLTVDPNKRLKMSGL 268

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (269), Expect = 8e-26
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 19/237 (8%)

Query: 296 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 354
           +++S            L      +    ++G G  G VYKG  +  G++ A+K   +   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TG 61

Query: 355 TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQ 407
              E+   E+ +L +  +HRNI    G  ++   P       LV EF   G++   I N 
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
                +  E +  I  E+   L +LH    I   HRDIK  N+LL +    K+ DFG S 
Sbjct: 122 KGN-TLKEEWIAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSA 177

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE-----KSDVYSFGVVLVEILTGQKP 519
            +        T + GT  ++ PE     +  +     KSD++S G+  +E+  G  P
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  110 bits (277), Expect = 1e-25
 Identities = 60/329 (18%), Positives = 120/329 (36%), Gaps = 43/329 (13%)

Query: 270 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGG 329
           +R  ++  + K  +  G +    +    +   +          +   D+Y+ +  LG G 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 330 QGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET 385
            G V++      G   A K        D+  V     E+  +S + H  +V L     E 
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAF-ED 225

Query: 386 EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVSGALFYLHSAASIPI 440
           +  + ++YEF+  G L++ + ++  +     E      +R   +    L ++H       
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCK---GLCHMHENN---Y 276

Query: 441 YHRDIKSANILLDDK--YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 498
            H D+K  NI+   K     K+ DFG +    +D         GT  +  PE  +     
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334

Query: 499 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-FEALD-ARVLKEA 556
             +D++S GV+   +L+G  P    N DE        L+ +       +    + + ++ 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMDDSAFSGISEDG 387

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           K           ++ L  +   R T+ + 
Sbjct: 388 KD--------FIRKLLLADPNTRMTIHQA 408

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (267), Expect = 1e-25
 Identities = 64/291 (21%), Positives = 109/291 (37%), Gaps = 46/291 (15%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETN---VEQFINEVV 365
           +K  D Y+    LG G    V K    + G   A K   K +          E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 420
           IL Q+ H N++ L     E    + L+ E +  G L+ ++    ++  ++ E      ++
Sbjct: 68  ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHL 476
             ++    + YLH+     I H D+K  NI+L          K+ DFG +   + D    
Sbjct: 123 QILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
                GT  +V PE         ++D++S GV+   +L+G  P       E        L
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TL 227

Query: 537 QAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             I      F+    +   + AK           ++ L    + R T++E 
Sbjct: 228 ANITSVSYDFDEEFFSHTSELAKD--------FIRKLLVKETRKRLTIQEA 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 2e-25
 Identities = 70/291 (24%), Positives = 114/291 (39%), Gaps = 46/291 (15%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVV 365
           E   D Y+    LG G    V K    + G   A K   K +        + E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 420
           IL +I H N++ L     E +  + L+ E +  G L+ ++    E+  +T E      L+
Sbjct: 67  ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFL---AEKESLT-EEEATEFLK 121

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHL 476
             +     ++YLHS     I H D+K  NI+L D+       K+ DFG +    +D  + 
Sbjct: 122 QILN---GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
              + GT  +V PE         ++D++S GV+   +L+G  P       E        L
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TL 226

Query: 537 QAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             ++     FE    +     AK           +R L  + K R T+++ 
Sbjct: 227 ANVSAVNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 269

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (273), Expect = 2e-25
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)

Query: 318 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +Y     LG G  G V  G   LT G  VAVK   + K+     V +   E+  L    H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 423
            +I+KL    + T   + +V E++  G L+ YI  + +++E      F    ++L    V
Sbjct: 76  PHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF---QQILS--GV 129

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           +      Y H      + HRD+K  N+LLD    AK++DFG S ++M D   L T   G+
Sbjct: 130 D------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GS 178

Query: 484 FGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
             Y  PE      +   + D++S GV+L  +L G  P
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (264), Expect = 5e-25
 Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 64/299 (21%)

Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVIL 367
            + +  +D +     LG+G    VY+       +  A+K   K VD+  V     E+ +L
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102

Query: 368 SQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIA 422
            +++H NI+KL     ET   + LV E +  G L+  I   +E+   + E      ++  
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRI---VEKGYYS-ERDAADAVKQI 157

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 479
           +E   A+ YLH      I HRD+K  N+L          K++DFG S   +V+   L   
Sbjct: 158 LE---AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS--KIVEHQVLMKT 209

Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQ 537
           V GT GY  PE  +   +  + D++S G++   IL                L G+  F  
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITY-IL----------------LCGFEPFYD 252

Query: 538 AINENRLFEALDA-----------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              +  +F  +              V   AK         L ++ + L+ K R T  + 
Sbjct: 253 ERGDQFMFRRILNCEYYFISPWWDEVSLNAKD--------LVRKLIVLDPKKRLTTFQA 303

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (265), Expect = 5e-25
 Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 46/291 (15%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVV 365
           +K  D Y+    LG G    V K    + G   A K   K +          E+   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 366 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 420
           IL Q+ H NI+ L     E    + L+ E +  G L+ ++    ++  ++ E      ++
Sbjct: 68  ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFGTSRSVMVDQTHL 476
             ++    + YLH+     I H D+K  NI+L DK       K+ DFG +    ++    
Sbjct: 123 QILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVE 174

Query: 477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 536
              + GT  +V PE         ++D++S GV+   +L+G  P       E        L
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TL 227

Query: 537 QAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             I      F+    ++  + AK           ++ L    + R T++E 
Sbjct: 228 ANITAVSYDFDEEFFSQTSELAKD--------FIRKLLVKETRKRLTIQEA 270

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (261), Expect = 7e-25
 Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 35/222 (15%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN-EVVILSQINH 372
            Y    +LG+G  G V + +        AVK   K KL    N E  +  E+ +L ++ H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 373 RNIVKLLG-CCLETEVPL-LVYEFIPNGT--LYQYI-HNQIEE------FPITWELLLRI 421
           +N+++L+     E +  + +V E+   G   +   +   +         F    +L+   
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF---CQLID-- 120

Query: 422 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTK 479
            +E      YLHS     I H+DIK  N+LL      K+S  G +             T 
Sbjct: 121 GLE------YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT- 170

Query: 480 VQGTFGYVDPEYFQSSQFTE--KSDVYSFGVVLVEILTGQKP 519
            QG+  +  PE           K D++S GV L  I TG  P
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (265), Expect = 9e-25
 Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 51/248 (20%)

Query: 295 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE 354
             + + + K      K  E+    Y   +++G G  G V++  L +   VA+KK    D 
Sbjct: 18  LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-D- 75

Query: 355 TNVEQFIN-EVVILSQINHRNIVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYI-HN 406
              ++F N E+ I+  + H N+V L            EV L LV E++P  T+Y+   H 
Sbjct: 76  ---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY 131

Query: 407 QIEEFPITWEL-------LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRA 458
              +  +   L       LLR       +L Y+HS     I HRDIK  N+LLD      
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181

Query: 459 KVSDFGTSRSVMVDQ--THLTTKVQGTFGYV------DPE-YFQSSQFTEKSDVYSFGVV 509
           K+ DFG+++ ++  +              Y+       PE  F ++ +T   D++S G V
Sbjct: 182 KLIDFGSAKILIAGEPNVS----------YICSRYYRAPELIFGATNYTTNIDIWSTGCV 231

Query: 510 LVEILTGQ 517
           + E++ GQ
Sbjct: 232 MAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  107 bits (269), Expect = 1e-24
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 16/220 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           + +   R+LG+GG G V    +   G++ A K   K ++         +NE  IL ++N 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRI-AVEVSGAL 429
           R +V L     ET+  L LV   +  G L  +I++  +  FP   E      A E+   L
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGL 299

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
             LH      I +RD+K  NILLDD    ++SD G +  V   QT       GT GY+ P
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAP 354

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 529
           E  ++ ++T   D ++ G +L E++ GQ P +       +
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 1e-24
 Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 56/293 (19%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETN---VEQFINEVVILS 368
            D+Y     LG G    V K      G+  A K   K +L         E+   EV IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 369 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAV 423
           +I H NI+ L     E +  + L+ E +  G L+ ++    E+  +T E      L+  +
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL---AEKESLT-EDEATQFLKQIL 118

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHLTTK 479
           +    + YLHS     I H D+K  NI+L DK       K+ DFG +   +         
Sbjct: 119 D---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNI 171

Query: 480 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
             GT  +V PE         ++D++S GV+   +L+G  P               FL   
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL-GE 214

Query: 540 NENRLFEALDARVLK---EAKKEEIMTVATLAK----RCLNLNGKMRPTMKEV 585
            +          +     +  +E     + LAK    R L  + K R T+ + 
Sbjct: 215 TKQETLTN----ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (263), Expect = 1e-24
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 28/226 (12%)

Query: 307 FTSKDLEKATDNYNANR--ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQF 360
             +         Y  ++  ILG G  G V+K      G  +A K      + D    E+ 
Sbjct: 77  IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133

Query: 361 INEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--- 416
            NE+ +++Q++H N+++L     E++  + LV E++  G L+  I ++        E   
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT---ELDT 189

Query: 417 -LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQ 473
            L ++   E    + ++H      I H D+K  NIL  ++     K+ DFG +R     +
Sbjct: 190 ILFMKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

Query: 474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             L     GT  ++ PE       +  +D++S GV+   +L+G  P
Sbjct: 244 K-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (264), Expect = 2e-24
 Identities = 58/250 (23%), Positives = 107/250 (42%), Gaps = 18/250 (7%)

Query: 289 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK 347
           L +++         K      K +    +++   +++G+G  G V    L +  ++ A+K
Sbjct: 46  LRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK 105

Query: 348 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 403
              K +++       F  E  +L   + + I  L     + +  L LV ++   G L   
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTL 164

Query: 404 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 462
           +    +  P   E + R    E+  A+  +H    +   HRDIK  NIL+D     +++D
Sbjct: 165 LSKFEDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-----DVYSFGVVLVEILTGQ 517
           FG+   +M D T  ++   GT  Y+ PE  Q+ +  +       D +S GV + E+L G+
Sbjct: 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

Query: 518 KPIRAINTDE 527
            P  A +  E
Sbjct: 279 TPFYAESLVE 288

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (259), Expect = 2e-24
 Identities = 66/284 (23%), Positives = 106/284 (37%), Gaps = 43/284 (15%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           TD Y     +G G      + +        AVK   KSK      +E      ++L    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE------ILLRYGQ 74

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVSG 427
           H NI+ L     + +   +V E +  G L   I  Q + F    E     +L    +   
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFS---EREASAVLFTITK--- 127

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHLTTKVQGT 483
            + YLH+     + HRD+K +NIL  D+       ++ DFG ++ +  +   L T    T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 543
             +V PE  +   +    D++S GV+L  +LTG  P      D  + +    L  I   +
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----LARIGSGK 239

Query: 544 L-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                     V   AK         L  + L+++   R T   V
Sbjct: 240 FSLSGGYWNSVSDTAKD--------LVSKMLHVDPHQRLTAALV 275

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  103 bits (259), Expect = 3e-24
 Identities = 75/308 (24%), Positives = 113/308 (36%), Gaps = 74/308 (24%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 364
              +   +D Y+  + +G G  G            +VAVK   +   +DE NV++   E+
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQR---EI 67

Query: 365 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITW 415
           +    + H NIV+     + T   L ++ E+   G LY+ I    +  E      F    
Sbjct: 68  INHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF---Q 123

Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQ 473
           +LL    V       Y HS     I HRD+K  N LLD     R K+ DFG S    V  
Sbjct: 124 QLL--SGVS------YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLH 171

Query: 474 THLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
           +   + V GT  Y+ PE     ++  + +DV+S GV L  +L G  P       ED    
Sbjct: 172 SQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF------EDP--- 221

Query: 533 GYFLQAINENRLFEALDARVLK-------------EAKKEEIMTVATLAKRCLNLNGKMR 579
                   E R +     R+L              E           L  R    +   R
Sbjct: 222 -------EEPRDYRKTIQRILSVKYSIPDDIRISPECCH--------LISRIFVADPATR 266

Query: 580 PTMKEVTN 587
            ++ E+  
Sbjct: 267 ISIPEIKT 274

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (261), Expect = 3e-24
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 53/231 (22%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHR 373
             +Y   +++G G  G VY+  L D G +VA+KK         ++F N E+ I+ +++H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 374 NIVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYI-HNQIEEFPITWEL-------LL 419
           NIV+L      +     EV L LV +++P  T+Y+   H    +  +           L 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQ--THL 476
           R       +L Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  +     
Sbjct: 167 R-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215

Query: 477 TTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
                    Y+       PE  F ++ +T   DV+S G VL E+L GQ PI
Sbjct: 216 ---------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  101 bits (255), Expect = 5e-24
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 27/223 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINH 372
           + Y     +G+G  G VYK   + GRIVA+K+ +L  E   E      I E+ +L +++H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHH 78

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVS 426
            NIV L+          LV+EF+    L + +                ++LL        
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR------- 130

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             + + H      I HRD+K  N+L++     K++DFG +R+  +     T +V  T  Y
Sbjct: 131 -GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWY 185

Query: 487 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
             P+    S +++   D++S G +  E++TG KP+    TD+D
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (255), Expect = 6e-24
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 42/285 (14%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQ 369
           ++  + Y     LG+G  G V++ +  +  +    K  K K  D+  V+    E+ IL+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57

Query: 370 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVE 424
             HRNI+ L     E+   L +++EFI    +++ I+     F +  E      +    E
Sbjct: 58  ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINT--SAFELN-EREIVSYVHQVCE 113

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQG 482
              AL +LHS     I H DI+  NI+   +  +  K+ +FG +R   +        +  
Sbjct: 114 ---ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFT 165

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 542
              Y  PE  Q    +  +D++S G ++  +L+G  P  A    +        ++ I   
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNA 218

Query: 543 RL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              F+      +  EA             R L    K R T  E 
Sbjct: 219 EYTFDEEAFKEISIEAMD--------FVDRLLVKERKSRMTASEA 255

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (253), Expect = 6e-24
 Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 42/235 (17%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV--------------------- 352
            Y     +G+G  G V       D    A+K   K KL+                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 353 --DETNVEQFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHNQ 407
                 +EQ   E+ IL +++H N+VKL   L    E  +  +V+E +  G + +    +
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132

Query: 408 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
               P++ +       ++   + YLH      I HRDIK +N+L+ +    K++DFG S 
Sbjct: 133 ----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT---EKSDVYSFGVVLVEILTGQKP 519
                   L +   GT  ++ PE    ++     +  DV++ GV L   + GQ P
Sbjct: 186 -EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  104 bits (260), Expect = 7e-24
 Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 21/247 (8%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGML----TDGRIVA 345
           +    S+ S  E+ ++  +K   + T + +   ++LG+G  G V   +L      GR  A
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYA 177

Query: 346 VK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLY 401
           +K   K  +V +  V   + E  +L    H  +  L     +T   L  V E+   G L+
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELF 236

Query: 402 QYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
            ++  +   F    E   R    E+  AL YLHS  ++ +Y RD+K  N++LD     K+
Sbjct: 237 FHLSRE-RVFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKI 290

Query: 461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +DFG  +  + D   + T   GT  Y+ PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 291 TDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

Query: 521 RAINTDE 527
              + ++
Sbjct: 350 YNQDHEK 356

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  101 bits (255), Expect = 7e-24
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 22/211 (10%)

Query: 318 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
            Y     LG+G  G V       T  + VA+K   +  L       +   E+  L  + H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKT-QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 373 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 429
            +I+KL    + T   + +V E+   G L+ YI    ++ E     +   R   ++  A+
Sbjct: 69  PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-----DEGRRFFQQIICAI 121

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            Y H      I HRD+K  N+LLDD    K++DFG S ++M D   L T   G+  Y  P
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAP 176

Query: 490 EYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 519
           E      +   + DV+S G+VL  +L G+ P
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 9e-24
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKL-----VDETNVEQFINEVVI 366
              Y+   ++G+G    V + +    G   AVK    +         E   E    E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 367 LSQI-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 420
           L Q+  H +I+ L+    E+   + LV++ +  G L+ Y+    E+  ++ E     ++R
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYL---TEKVALS-EKETRSIMR 207

Query: 421 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 480
             +E   A+ +LH+     I HRD+K  NILLDD  + ++SDFG S   +     L    
Sbjct: 208 SLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC 260

Query: 481 QGTFGYVDPEYFQSSQF------TEKSDVYSFGVVL 510
            GT GY+ PE  + S         ++ D+++ GV+L
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (252), Expect = 9e-24
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 27/213 (12%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV------EQFINEVV 365
            +NY    ILG+G    V + +     +  AVK    +     +        E  + EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 366 ILSQIN-HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 423
           IL +++ H NI++L     ET     LV++ +  G L+ Y+    E+  ++ +   +I  
Sbjct: 76  ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
            +   +  LH      I HRD+K  NILLDD    K++DFG S   +     L     GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-GT 186

Query: 484 FGYVDPEYFQSSQF------TEKSDVYSFGVVL 510
             Y+ PE  + S         ++ D++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (253), Expect = 1e-23
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 59/306 (19%)

Query: 316 TDNYNANR-ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
            D Y     +LG+G    V   + L   +  AVK   K      + V     EV +L Q 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67

Query: 371 -NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEV 425
             HRN+++L+    E +   LV+E +  G++  +IH +   F    E    ++++   +V
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFN---ELEASVVVQ---DV 120

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSV-------MVDQTH 475
           + AL +LH+     I HRD+K  NIL +   +    K+ DF     +        +    
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 476 LTTKVQGTFGYVDPE-----YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 530
           L T   G+  Y+ PE       ++S + ++ D++S GV+L  +L+G  P        D  
Sbjct: 178 LLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDCG 235

Query: 531 LVGYFLQAINENRLFEA-----LD------ARVLKEAKKEEIMTVATLAKRCLNLNGKMR 579
                     +N LFE+      +      A +   AK         L  + L  + K R
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK--------DLISKLLVRDAKQR 287

Query: 580 PTMKEV 585
            +  +V
Sbjct: 288 LSAAQV 293

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 1e-23
 Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 19/249 (7%)

Query: 289 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVK 347
           L + +   N  +  K  +   +DL    ++Y   +++G+G  G V      +  ++ A+K
Sbjct: 41  LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100

Query: 348 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 403
              K +++  ++   F  E  I++  N   +V+L     + +  L +V E++P G L   
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNL 159

Query: 404 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 462
           + N   + P   E   R    EV  AL  +HS   +   HRD+K  N+LLD     K++D
Sbjct: 160 MSNY--DVP---EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQK 518
           FGT   +  +         GT  Y+ PE  +S      +  + D +S GV L E+L G  
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

Query: 519 PIRAINTDE 527
           P  A +   
Sbjct: 272 PFYADSLVG 280

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =   99 bits (250), Expect = 2e-23
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 371
             Y     +G+G  GTV+K        IVA+K+ +L D+   E      + E+ +L ++ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEV 425
           H+NIV+L       +   LV+EF     L +Y  +   +          ++LL       
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK------ 112

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L + HS     + HRD+K  N+L++     K+++FG +R+  +     + +V  T  
Sbjct: 113 --GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166

Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           Y  P+  F +  ++   D++S G +  E+    +P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (258), Expect = 3e-23
 Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 21/246 (8%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK-- 347
           Q+ + S++            ++    ++++ +RI+G+GG G VY     D G++ A+K  
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222

Query: 348 -KSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQ 402
            K ++  +      +NE ++LS ++      IV +      T   L  + + +  G L+ 
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHY 281

Query: 403 YIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 461
           ++      F    E  +R  A E+   L ++H+     + +RD+K ANILLD+    ++S
Sbjct: 282 HLSQH-GVFS---EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334

Query: 462 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 520
           D G +      + H    V GT GY+ PE  Q     + S D +S G +L ++L G  P 
Sbjct: 335 DLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

Query: 521 RAINTD 526
           R   T 
Sbjct: 392 RQHKTK 397

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINH 372
           + Y+    +G+G  G VYK     G   A+KK +L  E   E      I E+ IL ++ H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVS 426
            NIVKL       +  +LV+E +    L + +                 +LL        
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLN------- 111

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             + Y H      + HRD+K  N+L++ +   K++DFG +R+  +     T ++  T  Y
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166

Query: 487 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
             P+    S +++   D++S G +  E++ G  P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.4 bits (246), Expect = 8e-23
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHR 373
           + Y     +G+G  G V+K      G+IVA+KK    ++  V + I   E+ +L Q+ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSG 427
           N+V LL          LV+E+  + T+   +       P      ITW+ L         
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ-------- 113

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           A+ + H        HRD+K  NIL+      K+ DFG +R +     +   +V  T  Y 
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169

Query: 488 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
            PE     +Q+    DV++ G V  E+L+G 
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 371
           + Y     LG+G   TVYKG       +VA+K+ +L  E   E      I EV +L  + 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEV 425
           H NIV L       +   LV+E++    L QY+ +              ++LL       
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------- 110

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              L Y H      + HRD+K  N+L++++   K++DFG +R+  +       +V  T  
Sbjct: 111 -RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLW 165

Query: 486 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           Y  P+    S+ ++ + D++  G +  E+ TG +P+   +T E+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHR 373
           + Y    ++G+G  G V K      GRIVA+KK    D+  + + I   E+ +L Q+ H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSG 427
           N+V LL  C + +   LV+EF+ + T+   +                ++++         
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------- 135

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + + HS     I HRDIK  NIL+      K+ DFG +R++         +V  T  Y 
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191

Query: 488 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 517
            PE      ++ +  DV++ G ++ E+  G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 26/231 (11%)

Query: 303 KTKLFTSKDLEKATDNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV 357
            T+    + +E   + Y   ++ LG+G    V + +  + G+  A K   K +   +   
Sbjct: 14  GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CR 72

Query: 358 EQFINEVVILSQINHR-NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITW 415
            + ++E+ +L        ++ L     E    + L+ E+   G ++     ++ E  ++ 
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEM-VS- 129

Query: 416 E----LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRS 468
           E     L++  +E    ++YLH      I H D+K  NILL   Y     K+ DFG SR 
Sbjct: 130 ENDVIRLIKQILE---GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR- 182

Query: 469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 519
             +       ++ GT  Y+ PE       T  +D+++ G++   +LT   P
Sbjct: 183 -KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 43/232 (18%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQIN 371
            K  D +   R+ GQG  GTV  G     G  VA+KK  + D     + +  +  L+ ++
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77

Query: 372 HRNIVKLL------GCCLETEVPL-LVYEFIPNGTLYQYI-HNQIEEFPITWEL------ 417
           H NIV+L       G     ++ L +V E++P+ TL++   +    +      L      
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 418 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH 475
            L+R       ++  LH   S+ + HRDIK  N+L++      K+ DFG+++ +   + +
Sbjct: 137 QLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 476 LTTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +         Y+       PE  F +  +T   D++S G +  E++ G+ PI
Sbjct: 189 V--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 40/236 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 371
             Y     +GQG  G V+K      G+ VA+KK  + +E   E F    + E+ IL  + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74

Query: 372 HRNIVKLLGCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFP------ITWEL 417
           H N+V L+  C     P         LV++F  +  L   + N + +F       +   L
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS----VMVDQ 473
           L          L+Y+H      I HRD+K+AN+L+      K++DFG +R+         
Sbjct: 134 L--------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 474 THLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
              T +V  T  Y  PE       +    D++  G ++ E+ T   PI   NT++ 
Sbjct: 183 NRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 55/292 (18%)

Query: 316 TDNYNANR-ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
           TD+Y  ++ +LG G  G V +      G+  A+K    S    +        EV    Q 
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQA 78

Query: 371 -NHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIHNQIEEF-------PITWELL 418
               +IV +L             L++ E +  G L+  I  + ++         I  ++ 
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTH 475
                    A+ +LHS     I HRD+K  N+L   K +    K++DFG ++     Q  
Sbjct: 139 --------TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNA 185

Query: 476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 535
           L T    T  YV PE     ++ +  D++S GV++  +L G  P  +         +   
Sbjct: 186 LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--- 241

Query: 536 LQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            + I   +  F   + + V ++AK         L +  L  +   R T+ + 
Sbjct: 242 KRRIRLGQYGFPNPEWSEVSEDAK--------QLIRLLLKTDPTERLTITQF 285

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 27/233 (11%)

Query: 309 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----- 362
           + D++     Y     LG+G   TVYK       +IVA+KK KL   +  +  IN     
Sbjct: 2   ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWE 416
           E+ +L +++H NI+ LL          LV++F+    L   I +                
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLM 120

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
            L          L YLH      I HRD+K  N+LLD+    K++DFG ++S        
Sbjct: 121 TLQ--------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 477 TTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
           T +V  T  Y  PE  F +  +    D+++ G +L E+L    P    ++D D
Sbjct: 170 THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 19/225 (8%)

Query: 323 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 378
           R +G+G  G V      D  ++ A+K   K K V+   V     E+ I+  + H  +V L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 379 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 436
                + E  + +V + +  G L  ++  Q   F    E  +++   E+  AL YL +  
Sbjct: 81  W-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALDYLQNQR 135

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I HRD+K  NILLD+     ++DF  +  +  +    T  + GT  Y+ PE F S +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRK 190

Query: 497 FTEKS---DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 538
               S   D +S GV   E+L G++P    ++   K +V  F   
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 18/223 (8%)

Query: 315 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQ 369
           ++  +     LG G   TVYKG+  T G  VA+K+ KL  E   E      I E+ ++ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF---PITWELLLRIAVEVS 426
           + H NIV+L           LV+EF+ N  L +Y+ ++        +   L+     ++ 
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             L + H      I HRD+K  N+L++ + + K+ DFG +R+  +     +++V  T  Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174

Query: 487 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
             P+    S  ++   D++S G +L E++TG KP+     DE+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHR 373
            D+Y   R LG+G    V++ + +T+   V VK  K V +   ++   E+ IL  +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91

Query: 374 NIVKLLGCCL--ETEVPLLVYEFIPNGTLYQYIHNQIEEFPI---TWELLLRIAVEVSGA 428
           NI+ L        +  P LV+E + N    Q     + ++ I    +E+L         A
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLTDYDIRFYMYEILK--------A 142

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           L Y HS     I HRD+K  N+++D ++R  ++ D+G +      Q     +V  +  + 
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYFK 197

Query: 488 DPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 520
            PE     Q  + S D++S G +L  ++  ++P 
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 36/227 (15%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK--SKLVDETNVEQFIN---------EV 364
              Y   R +  G  G V  G+ ++G  VA+K+  + + D   V    +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 365 VILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQ---IEEFPITWE 416
            +L+  +H NI+ L    +  E P      LV E +    L Q IH+Q   I    I + 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 417 L--LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
           +  +L         L  LH A    + HRD+   NILL D     + DF  +R    D  
Sbjct: 140 MYHILL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA- 188

Query: 475 HLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           + T  V     Y  PE   Q   FT+  D++S G V+ E+    K +
Sbjct: 189 NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 23/240 (9%)

Query: 297 NESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---K 348
            ++  +  K + +     A  D ++  + LG G  G V   ML      G   A+K   K
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDK 76

Query: 349 SKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI 408
            K+V    +E  +NE  IL  +N   +VKL     +     +V E++  G ++ ++    
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI- 135

Query: 409 EEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
             F    E   R  A ++     YLHS     + +RD+K  N+L+D +   +V+DFG ++
Sbjct: 136 GRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            V       T  + GT   + PE   S  + +  D ++ GV++ E+  G  P  A    +
Sbjct: 190 RV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 55/262 (20%), Positives = 104/262 (39%), Gaps = 80/262 (30%)

Query: 312 LEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQ 369
           LE ++  Y+  + LG G  G V +    + G+  A+KK          ++ N E+ I+  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKV 56

Query: 370 INHRNIVKLLGC-------------------------------------CLETEVPL-LV 391
           ++H NI+KL+                                              L ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 392 YEFIPNGTLYQYIHNQIEEF-PITWEL-------LLRIAVEVSGALFYLHSAASIPIYHR 443
            E++P+ TL++ + + I     I   L       L R       A+ ++HS     I HR
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLG---ICHR 165

Query: 444 DIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV------DPE-YFQSS 495
           DIK  N+L++      K+ DFG+++ ++  +  +         Y+       PE    ++
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--------AYICSRFYRAPELMLGAT 217

Query: 496 QFTEKSDVYSFGVVLVEILTGQ 517
           ++T   D++S G V  E++ G+
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 21/220 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           ++++  ++LG+G  G V   +L      GR  A+K   K  ++ +  V   + E  +L  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 370 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSG 427
             H  +  L     +T   L  V E+   G L+ ++  +   F    E   R    E+  
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE-RVFT---EERARFYGAEIVS 116

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           AL YLHS     + +RDIK  N++LD     K++DFG  +  + D         GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYL 172

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
            PE  + + +    D +  GVV+ E++ G+ P    + + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 22/223 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 371
           D Y     LG+G  G VYK +       VA+K+ +L  E   E      I EV +L ++ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQ 91

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           HRNI++L           L++E+  N  L +Y+        ++  ++     ++   + +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNF 147

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRA-----KVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            HS       HRD+K  N+LL     +     K+ DFG +R+  +     T ++  T  Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203

Query: 487 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
             PE    S  ++   D++S   +  E+L    P+   +++ D
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEID 245

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 323 RILGQGGQGTVY---KGMLTD-GRIVAVK---KSKLVDETN-VEQFINEVVILSQINHRN 374
           R+LG+GG G V+   K    + G+I A+K   K+ +V           E  IL ++ H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 375 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYL 432
           IV L+    +T   L L+ E++  G L+  +  +   F    E        E+S AL +L
Sbjct: 83  IVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE-GIFM---EDTACFYLAEISMALGHL 137

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           H      I +RD+K  NI+L+ +   K++DFG  +  + D   +T    GT  Y+ PE  
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEIL 193

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             S      D +S G ++ ++LTG  P    N  +
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 22/247 (8%)

Query: 298 ESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVY----KGMLTDGRIVAVK---KS 349
               E      +   EK   +N+   ++LG G  G V+          G++ A+K   K+
Sbjct: 34  TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93

Query: 350 KLVDETN-VEQFINEVVILSQINHRN-IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHN 406
            +V +    E    E  +L  I     +V L     +TE  L L+ ++I  G L+ ++  
Sbjct: 94  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQ 152

Query: 407 QIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
           + E F    E  ++I   E+  AL +LH      I +RDIK  NILLD      ++DFG 
Sbjct: 153 R-ERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205

Query: 466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAI 523
           S+  + D+T       GT  Y+ P+  +       +  D +S GV++ E+LTG  P    
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

Query: 524 NTDEDKS 530
                ++
Sbjct: 266 GEKNSQA 272

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 90.3 bits (225), Expect = 6e-20
 Identities = 72/242 (29%), Positives = 116/242 (47%), Gaps = 22/242 (9%)

Query: 298 ESNIEKTKL--FTSKDLEKAT-DNYNANRILGQGGQGTVY----KGMLTDGRIVAVK--- 347
           E +I++  +     +  EKA    +   ++LGQG  G V+           ++ A+K   
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61

Query: 348 KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHN 406
           K+ L     V     E  IL ++NH  IVKL     +TE  L L+ +F+  G L+  +  
Sbjct: 62  KATLKVRDRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK 119

Query: 407 QIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 465
           +   F    E  ++    E++ AL +LHS     I +RD+K  NILLD++   K++DFG 
Sbjct: 120 E-VMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172

Query: 466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
           S+  + D         GT  Y+ PE       T+ +D +SFGV++ E+LTG  P +  + 
Sbjct: 173 SKESI-DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231

Query: 526 DE 527
            E
Sbjct: 232 KE 233

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
              Y   + +G G QG V         R VA+KK      ++T+ ++   E+V++  +NH
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 373 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 424
           +NI+ LL      +         +V E +    L Q I  +++   +++ L  +L     
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 138

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
               + +LHSA    I HRD+K +NI++      K+ DFG +R+     + + T    T 
Sbjct: 139 ---GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 190

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            Y  PE      + E  D++S G ++ E++ G   +
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 36/228 (15%)

Query: 314 KATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN-----EVVIL 367
            AT  Y     +G G  GTVYK      G  VA+K  ++ +       +      EV +L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 368 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEF-------P 412
            ++    H N+V+L+  C  +         LV+E +    L  Y+               
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           +  + L          L +LH+     I HRD+K  NIL+      K++DFG +R     
Sbjct: 125 LMRQFLR--------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
              LT  V  T  Y  PE    S +    D++S G +  E+    KP+
Sbjct: 174 MA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 50/290 (17%)

Query: 316 TDNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 370
            D+Y   +++LG G  G V +          A+K                  EV +  + 
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 111

Query: 371 -NHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
               +IV+++    E         L+V E +  G L+  I ++ ++   T E   R A E
Sbjct: 112 SQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FT-E---REASE 165

Query: 425 V----SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLT 477
           +      A+ YLHS   I I HRD+K  N+L   K      K++DFG ++      + LT
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221

Query: 478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 537
           T    T  YV PE     ++ +  D++S GV++  +L G  P  + +       +     
Sbjct: 222 TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT 277

Query: 538 AINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            I   +  F   + + V +E K         L +  L      R T+ E 
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVK--------MLIRNLLKTEPTQRMTITEF 319

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 40/223 (17%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
              Y +   +G G  G+V   +    G  VA+KK       E   ++   E+++L  + H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 373 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 424
            N++ LL                LV  F+    L + +  +  E  I + +  +L+    
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK---- 137

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
               L Y+HSA    + HRD+K  N+ +++    K+ DFG +R    + T          
Sbjct: 138 ---GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181

Query: 485 GYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           GYV       PE       + +  D++S G ++ E+LTG K +
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.3 bits (217), Expect = 8e-19
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 323 RILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ-INHRN 374
           +++G+G  G V   +L     +    AVK   K  ++ +   +  ++E  +L + + H  
Sbjct: 44  KVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 375 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYL 432
           +V L     +T   L  V ++I  G L+ ++  +   F    E   R  A E++ AL YL
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE-RCFL---EPRARFYAAEIASALGYL 155

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     I +RD+K  NILLD +    ++DFG  +  +   +  T+   GT  Y+ PE  
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVL 211

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
               +    D +  G VL E+L G  P  + NT E
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 89.3 bits (221), Expect = 9e-19
 Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 17/245 (6%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK- 347
             +    ++    +K   + + ++    ++N   +LG+G  G V          + AVK 
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI 373

Query: 348 --KSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 403
             K  ++ + +VE  + E  +L+       + +L   C +T   L  V E++  G L  +
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYH 432

Query: 404 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 462
           I      F    E      A E++  LF+L S     I +RD+K  N++LD +   K++D
Sbjct: 433 IQQV-GRFK---EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 485

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           FG  +  + D    T    GT  Y+ PE      + +  D ++FGV+L E+L GQ P   
Sbjct: 486 FGMCKENIWDGVT-TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

Query: 523 INTDE 527
            + DE
Sbjct: 545 EDEDE 549

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.4 bits (219), Expect = 1e-18
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
              Y   + +G G QG V         R VA+KK      ++T+ ++   E+V++  +NH
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 373 RNIVKLL-----GCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 424
           +NI+ LL        LE    + LV E +    L Q I  +++   +++ L  +L     
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 175

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 484
               + +LHSA    I HRD+K +NI++      K+ DFG +R+       +T  V  T 
Sbjct: 176 ---GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV-VTR 227

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            Y  PE      + E  D++S G ++ E++   K +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 32/235 (13%)

Query: 308 TSKDLEKATDNYN-ANRILGQGGQGTVYKGM---LTDGRIVAVKKSKL--VDETNVEQFI 361
            S + E+  D +      +G+G  G VYK       D +  A+K+ +   +  +      
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----C 66

Query: 362 NEVVILSQINHRNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLL 419
            E+ +L ++ H N++ L    L   +  + L++++  +  L+  I            + L
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 420 RIAVEVS------GALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSV 469
              +  S        + YLH+     + HRD+K ANIL+  +       K++D G +R  
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 470 MV---DQTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
                    L   V  TF Y  PE    +  +T+  D+++ G +  E+LT  +PI
Sbjct: 183 NSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)

Query: 314 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQF----INEVVIL 367
           +A   Y     +G+G  G V+K   +   GR VA+K+ ++  +T  E      I EV +L
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVL 65

Query: 368 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEF-------P 412
             +    H N+V+L   C  +         LV+E +    L  Y+    E          
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
           + ++LL          L +LHS     + HRD+K  NIL+    + K++DFG +R     
Sbjct: 125 MMFQLLR--------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
              LT+ V  T  Y  PE    S +    D++S G +  E+    KP+
Sbjct: 174 MA-LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 76/240 (31%), Positives = 111/240 (46%), Gaps = 22/240 (9%)

Query: 298 ESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSK 350
           ES+ E   +  +       DN+   R+LG+G  G V   ML      G + AVK   K  
Sbjct: 4   ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDV 60

Query: 351 LVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQI 408
           ++ + +VE  + E  ILS   NH  + +L  CC +T   L  V EF+  G L  +I    
Sbjct: 61  ILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS- 118

Query: 409 EEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 467
             F    E   R  A E+  AL +LH      I +RD+K  N+LLD +   K++DFG  +
Sbjct: 119 RRFD---EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

Query: 468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             + +    T    GT  Y+ PE  Q   +    D ++ GV+L E+L G  P  A N D+
Sbjct: 173 EGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 32/224 (14%)

Query: 317 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
            ++   R LG G  G V    L     +GR  A+K   K  +V    VE   +E ++LS 
Sbjct: 6   QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 370 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSG 427
           + H  I+++ G   +    + ++ ++I  G L+  +    + FP     + +  A EV  
Sbjct: 63  VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKS-QRFP---NPVAKFYAAEVCL 117

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF-G- 485
           AL YLHS     I +RD+K  NILLD     K++DFG ++ V  D T+       T  G 
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGT 166

Query: 486 --YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
             Y+ PE   +  + +  D +SFG+++ E+L G  P    NT +
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 29/241 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
            +++  R++G+G    V   +L       RI A+K   K  + D+ +++    E  +  Q
Sbjct: 9   QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 370 I-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 426
             NH  +V L   C +TE  L  V E++  G L  ++  Q  + P   E   R  + E+S
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 120

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            AL YLH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 176

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           + PE  +   +    D ++ GV++ E++ G+ P   + + ++            E+ LF+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQ 229

Query: 547 A 547
            
Sbjct: 230 V 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 50/234 (21%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN---------EVV 365
           + ++    +LG+G  G V        G IVA+KK        +E F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61

Query: 366 ILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIHNQI-EEFPITWEL- 417
           IL    H NI+ +                ++ E +   T L++ I  Q+  +  I + + 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIY 119

Query: 418 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 476
             LR       A+  LH +    + HRD+K +N+L++     KV DFG +R +       
Sbjct: 120 QTLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 477 TTKVQGTF---GYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +           +V       PE    S++++   DV+S G +L E+    +PI
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 41/224 (18%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
              Y   + +G G  G V   +    G  VA+KK       E   ++   E+ +L  + H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 373 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQI-EEFPITWEL--LLRIAV 423
            N++ LL      E         LV  F+    L + + ++   E  I + +  +L+   
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK--- 139

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
                L Y+H+A    I HRD+K  N+ +++    K+ DFG +R    + T         
Sbjct: 140 ----GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--------- 183

Query: 484 FGYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            GYV       PE      ++T+  D++S G ++ E++TG K +
Sbjct: 184 -GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 34/201 (16%)

Query: 401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
            +     + +  +T E L+  + +V+  + +L   AS    HRD+ + NILL +K   K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234

Query: 461 SDFGTSRSVMVDQTHLTTKVQGTFGYVD-----PEYFQSSQFTEKSDVYSFGVVLVEILT 515
            DFG +R +  D  +    V+     +      PE      +T +SDV+SFGV+L EI +
Sbjct: 235 CDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

Query: 516 -GQKPIRAINTDEDKSLVGYFLQAINE-NRLFEALDARVLKEAKKE--EIMTVATLAKRC 571
            G  P   +  DE+      F + + E  R+      R       E  + M        C
Sbjct: 291 LGASPYPGVKIDEE------FCRRLKEGTRM------RAPDYTTPEMYQTM------LDC 332

Query: 572 LNLNGKMRPTMKEVTNELGGI 592
            +     RPT  E+   LG +
Sbjct: 333 WHGEPSQRPTFSELVEHLGNL 353

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 29/220 (13%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 373
              Y     +G+G  G V           VA+KK S    +T  ++ + E+ IL +  H 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 374 NIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIHNQI-EEFPITWEL--LLRIAVE 424
           NI+ +        +       +V + +   T LY+ +  Q      I + L  +LR    
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILR---- 139

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH---LTTKVQ 481
               L Y+HSA    + HRD+K +N+LL+     K+ DFG +R    D  H   LT  V 
Sbjct: 140 ---GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV- 192

Query: 482 GTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            T  Y  PE    S  +T+  D++S G +L E+L+  +PI
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 29/241 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
            +++  R++G+G    V   +L       RI A++   K  + D+ +++    E  +  Q
Sbjct: 52  QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 370 I-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 426
             NH  +V L   C +TE  L  V E++  G L  ++  Q  + P   E   R  + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 163

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            AL YLH      I +RD+K  N+LLD +   K++D+G  +  +      T+   GT  Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 219

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           + PE  +   +    D ++ GV++ E++ G+ P   + + ++            E+ LF+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQ 272

Query: 547 A 547
            
Sbjct: 273 V 273

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
              Y   + LG GG G V+  +  D  + VA+KK  L D  +V+  + E+ I+ +++H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 375 IVKLL------GCCLETEVPL--------LVYEFIPNGT-LYQYIH-NQIEEFPITWEL- 417
           IVK+       G  L  +V          +V E++   T L   +    + E      + 
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMY 127

Query: 418 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQTH 475
            LLR        L Y+HSA    + HRD+K AN+ ++ +    K+ DFG +R +    +H
Sbjct: 128 QLLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 476 ---LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
              L+  +  T  Y  P      + +T+  D+++ G +  E+LTG K +
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQI-N 371
            ++N   +LG+G  G V          + AVK   K  ++ + +VE  + E  +L+    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 372 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGAL 429
              + +L   C +T   L  V E++  G L  +I      F    E      A E++  L
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFK---EPHAVFYAAEIAIGL 134

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
           F+L S     I +RD+K  N++LD +   K++DFG  +  + D    T    GT  Y+ P
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAP 190

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           E      + +  D ++FGV+L E+L GQ P    + DE
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 41/224 (18%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
            + Y     +G G  G+V     T  G  VAVKK         + ++   E+ +L  + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 373 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQI-EEFPITWEL--LLRIAV 423
            N++ LL                LV   +    L   +  Q   +  + + +  +LR   
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR--- 143

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
                L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    + T         
Sbjct: 144 ----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--------- 187

Query: 484 FGYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
            GYV       PE       + +  D++S G ++ E+LTG + +
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 22/221 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
           +++  +++LG+G  G V    L       +  A+K   K  ++ + +VE  + E  +LS 
Sbjct: 17  EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 370 -INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 426
              H  +  +  C  +T+  L  V E++  G L  +I +   +F           A E+ 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD---LSRATFYAAEII 128

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
             L +LHS     I +RD+K  NILLD     K++DFG  +  M+      T   GT  Y
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDY 184

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 527
           + PE     ++    D +SFGV+L E+L GQ P    + +E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 55/233 (23%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQIN---- 371
           Y   R LG G   TV+    + +   VA+K  +     +   E   +E+ +L ++N    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADN 77

Query: 372 -------HRNIVKLLGC-----------CLETEVPLL---VYEFIPNGTLYQYIHNQIEE 410
                    +I+KLL              +  E  +L   +   I           +   
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI--------KKYEHRG 127

Query: 411 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA------KVSDFG 464
            P+    + +I+ ++   L Y+H    I I H DIK  N+L++           K++D G
Sbjct: 128 IPL--IYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLG 183

Query: 465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            +     D+ H T  +Q    Y  PE    + +   +D++S   ++ E++TG 
Sbjct: 184 NAC--WYDE-HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 47/246 (19%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 372
            DNY    ++G+G  G VY     +  + VA+KK   +  D  + ++ + E+ IL+++  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 373 RNIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIH--NQIEEFPITWEL--LLRIA 422
             I++L    +  ++       +V E     + L +       + E  I   L  LL   
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLLL-- 140

Query: 423 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 482
                   ++H +    I HRD+K AN LL+     KV DFG +R++  ++         
Sbjct: 141 -----GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 483 TFGYVDP----------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
                 P           +                 +T+  D++S G +  E+L   +  
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252

Query: 521 RAINTD 526
               T+
Sbjct: 253 INDPTN 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 61/279 (21%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKS 349
           +++  S++      +  +   +    D Y    ++G G  G V +     + R+VA+KK 
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86

Query: 350 KLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGT-LY 401
             V  D  + ++ + E+ IL+++NH ++VK+L   +  +V       +V E     +   
Sbjct: 87  LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFK 144

Query: 402 QYIHNQIEEFPITWEL-------LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD 454
           +     +    +T          LL         + Y+HSA    I HRD+K AN L++ 
Sbjct: 145 KLFRTPV---YLTELHIKTLLYNLLV-------GVKYVHSAG---ILHRDLKPANCLVNQ 191

Query: 455 KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP---------------EY-------- 491
               KV DFG +R+V   +   +                            +        
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251

Query: 492 ----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 526
                    +TE  DV+S G +  E+L   K   A + D
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 56/242 (23%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQIN- 371
              Y   + LG+G  G V+K +    G +VAVKK      + T+ ++   E++IL++++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 372 HRNIVKLLGCCLETEVPL--------LVYEFIPNGT-LYQYIHNQI-EEFPITWEL--LL 419
           H NIV LL       V          LV++++   T L+  I   I E     + +  L+
Sbjct: 68  HENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLI 119

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 479
           +        + YLHS     + HRD+K +NILL+ +   KV+DFG SRS +  +      
Sbjct: 120 K-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 480 VQGTFGYVDP---------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQK 518
                   +          +Y              S+++T+  D++S G +L EIL G K
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-K 228

Query: 519 PI 520
           PI
Sbjct: 229 PI 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 43/220 (19%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHR-- 373
           Y   +++G+G  G V K       + VA+K  +++   +    Q   E+ IL  +  +  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDK 155

Query: 374 ----NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWELLL 419
               N++ +L         C+  E  LL   +YE I          N+ + F +   L+ 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKK--------NKFQGFSLP--LVR 203

Query: 420 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLT 477
           + A  +   L  LH      I H D+K  NILL  + R+  KV DFG+S     +   + 
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257

Query: 478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
           T +Q  F Y  PE    +++    D++S G +L E+LTG 
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 45/228 (19%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVIL 367
           EK  D Y  + ++G+G  G V K     +   VA+K  K     N + F      EV +L
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLL 104

Query: 368 SQINHR------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEF 411
             +N         IV L          CL  E  +L   +Y+ + N              
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN--------TNFRGV 154

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSV 469
            +   L  + A ++  AL +L +   + I H D+K  NILL +  R+  K+ DFG+S   
Sbjct: 155 SLN--LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--C 209

Query: 470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            + Q      +Q  F Y  PE      +    D++S G +LVE+ TG+
Sbjct: 210 QLGQRI-YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 74/375 (19%), Positives = 116/375 (30%), Gaps = 126/375 (33%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQI-- 370
              Y+  R LG G   TV+    +   + VA+K  KS    E   E  ++E+ +L  +  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92

Query: 371 ------NHRNIVKLLGC-----------CLETEVPLLVYEFIPNG-TLYQYIHNQIEEFP 412
                 N   +V+LL             C+       V+E    G  L ++I        
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWIIKS-NYQG 142

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-------------------- 452
           +    + +I  +V   L YLH+   I   H DIK  NILL                    
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 453 -----------------------------DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
                                         +K + K++D G +  V     H T  +Q T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQ-T 256

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS----------LVG 533
             Y   E    S +   +D++S   +  E+ TG       + +E             L+G
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

Query: 534 ---------------YF--------LQAINENRLFEALDARVLKEAKKEEIMTVATLAKR 570
                          +F        +  +    LFE L  +   E  +EE          
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLP 374

Query: 571 CLNLNGKMRPTMKEV 585
            L L  + R T  E 
Sbjct: 375 MLELIPEKRATAAEC 389

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 61/305 (20%), Positives = 96/305 (31%), Gaps = 84/305 (27%)

Query: 307 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN 362
              K      D    +++LG G  G V +          A+K                  
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------- 59

Query: 363 EVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 421
           EV +  +     +IV+++           VYE +  G     I   + E     EL  RI
Sbjct: 60  EVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLI---VMECLDGGELFSRI 106

Query: 422 ------------AVEV----SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSD 462
                       A E+      A+ YLHS     I HRD+K  N+L   K      K++D
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 163

Query: 463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 522
           FG              +  G   Y            +  D++S GV++  +L G  P  +
Sbjct: 164 FG-----------FAKETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYS 200

Query: 523 INTDEDKSLVGYFLQAINENRL-FEALD-ARVLKEAKKEEIMTVATLAKRCLNLNGKMRP 580
            +       +      I   +  F   + + V +E K         L +  L      R 
Sbjct: 201 NHGLAISPGM---KTRIRMGQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRM 249

Query: 581 TMKEV 585
           T+ E 
Sbjct: 250 TITEF 254

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 62/244 (25%), Positives = 89/244 (36%), Gaps = 69/244 (28%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQINHR 373
           +   R +G G  G V     + + +  AVK  +     N++++      E  IL +I + 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQND 91

Query: 374 -----NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWELL 418
                NIVK  G        CL  E   L   +YE I          N    F I  E +
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR--------NNYNGFHI--EDI 139

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-------------------- 458
               +E+  AL YL   +     H D+K  NILLDD Y                      
Sbjct: 140 KLYCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 459 -----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 513
                K+ DFG +        H  + +     Y  PE   +  +   SD++SFG VL E+
Sbjct: 197 KSTGIKLIDFGCA--TFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAEL 252

Query: 514 LTGQ 517
            TG 
Sbjct: 253 YTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 65/243 (26%)

Query: 316 TDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQ 369
            + Y     LG+G  G V + +        VA+K  +     NV ++      E+ +L +
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKK 72

Query: 370 INHR------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPI 413
           I  +        V +          C+  E  LL    +EF+          N  + +P+
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKE--------NNFQPYPL 122

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--------------- 458
               +  +A ++  AL +LH        H D+K  NIL  +                   
Sbjct: 123 --PHVRHMAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 459 ----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 514
               +V+DFG++     D  H TT V     Y  PE      + +  DV+S G +L E  
Sbjct: 178 NTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 515 TGQ 517
            G 
Sbjct: 234 RGF 236

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 38/239 (15%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRN 374
           + +   R +G G  G +Y G  +     VA+K   +  +T   Q + E  I   +     
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64

Query: 375 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           I  +    +E +  +LV + + P+  L    +    +  +  + +L +A ++   + ++H
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120

Query: 434 SAASIPIYHRDIKSANILLDDKYRAK---VSDFGTSRSVMVDQTHL------TTKVQGTF 484
           S + +   HRDIK  N L+    RA    + DFG ++      TH          + GT 
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 485 GYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINTDEDKSLVG 533
            Y       +S       E+S   D+ S G VL+  L G  P   ++A    +    + 
Sbjct: 178 RY-------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 65/240 (27%)

Query: 319 YNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQINH 372
           Y     LG+G  G V +       GR VAVK  K     NV+++      E+ +L  +N 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNT 70

Query: 373 R------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWE 416
                    V++L         C+  E  LL    Y+FI          N    F +  +
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE--------NGFLPFRL--D 118

Query: 417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRA----------------- 458
            + ++A ++  ++ +LHS       H D+K  NIL     Y                   
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 459 -KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 517
            KV DFG++     D+ H +T V     Y  PE   +  +++  DV+S G +L+E   G 
Sbjct: 176 IKVVDFGSA--TYDDEHH-STLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 15/165 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RN 374
           + Y   R +G G  G +Y G  +  G  VA+K   +  +T   Q   E  I   +     
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66

Query: 375 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           I  +  C  E +  ++V E + P+  L    +    +F +  + +L +A ++   + Y+H
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122

Query: 434 SAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTH 475
           S   I   HRD+K  N L+          + DFG ++     +TH
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 3e-09
 Identities = 35/254 (13%), Positives = 74/254 (29%), Gaps = 71/254 (27%)

Query: 315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--------EQFINEVVI 366
            T+       +G+G  G V++ +  D   VA+K   +     V        E+ + E++I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 367 LSQI---------NHRNIVKLLGCCL----------------------ETEVPL------ 389
             ++              + L                             + P       
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 390 --LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 447
             +V EF   G   + +  ++     +      I  +++ +L    +  S+   HRD+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 448 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---------------YVDPEYF 492
            N+LL      K+      +S  +    L   +   +                 +D + F
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI-IDYTLSRLERDGIVVFCDVSMDEDLF 249

Query: 493 QSSQFTEKSDVYSF 506
                  + D+Y  
Sbjct: 250 T-GDGDYQFDIYRL 262

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 5e-09
 Identities = 73/462 (15%), Positives = 123/462 (26%), Gaps = 128/462 (27%)

Query: 102 DDYHTVD----INSSTVFGGCLAISTCDPASRRGCYDFLCALSSNITQVF-----NANLS 152
           D     D    I S       +        + R  +  L +    + Q F       N  
Sbjct: 34  DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR-LFWTLLSKQEEMVQKFVEEVLRINYK 92

Query: 153 YIYSQNISRGCRSVSVVEENWVGSK---YLENPLVLKQQARDIP----------AL--LD 197
           ++ S  I    R  S++   ++  +   Y +N +  K    ++           AL  L 
Sbjct: 93  FLMSP-IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK---YNVSRLQPYLKLRQALLELR 148

Query: 198 WGEDIGHCAEDFSLYSTTICGDGEYRCSITFGSGYICRCRTTYRTDGFCAGCGGGLGLLF 257
             +++             I G          GSG          +               
Sbjct: 149 PAKNV------------LIDGVL--------GSGKTWVALDVCLSYKV---------QCK 179

Query: 258 LLVGIWWLYKFVKRRKE---IKLKQKFFKRNGGLLLQQ-------ELSSNESNIEKTKLF 307
           +   I+WL            +++ QK   +       +       +L  +    E  +L 
Sbjct: 180 MDFKIFWL-NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238

Query: 308 TSKDLEKA---TDN-YNAN---------RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE 354
            SK  E       N  NA          +IL      T +K  +TD  + A   + +  +
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCKIL----LTTRFKQ-VTD-FLSAATTTHISLD 292

Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEV---PLLVYEFIPNGTLYQYIHNQIEEF 411
            +                  +  LL   L+      P  V    P       I   I + 
Sbjct: 293 HHSMTL----------TPDEVKSLLLKYLDCRPQDLPREVLTTNP--RRLSIIAESIRDG 340

Query: 412 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK-SANILLDDKYRAKVSDFGTSRSVM 470
             TW+              + H   +       I+ S N+L   +YR          SV 
Sbjct: 341 LATWD-------------NWKHV--NCDKLTTIIESSLNVLEPAEYRKMFDRL----SVF 381

Query: 471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 512
               H+ T +     + D           K   YS    LVE
Sbjct: 382 PPSAHIPTILLSLI-WFDVIKSDVMVVVNKLHKYS----LVE 418

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 1e-08
 Identities = 55/377 (14%), Positives = 112/377 (29%), Gaps = 130/377 (34%)

Query: 64  VNFPIISLKNPSNARGVNLSGSPFTFSNIS----------NRFAAIGCDDYHTVDINSST 113
           ++     L  P       L+ +P   S I+          + +  + CD   T+ I SS 
Sbjct: 311 LDCRPQDL--PREV----LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI-IESS- 362

Query: 114 VFGGCLAISTCDPASRRGCYDFLCAL--SSNIT----QVFNANLSYIYSQNISRGCRSVS 167
                  ++  +PA  R  +D L     S++I      +   ++       +       S
Sbjct: 363 -------LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415

Query: 168 VVEENWVGSKY----LENPLVLKQQARDIPALLDWGEDIGHCAEDFSLYSTTICGDGEYR 223
           +VE+    S      +   L LK +  +  AL        H       Y+     D +  
Sbjct: 416 LVEKQPKESTISIPSIY--LELKVKLENEYAL--------H-RSIVDHYNIPKTFDSDD- 463

Query: 224 CSITFGSGYIC--------RCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLYKFVKRRKEI 275
               +   Y                R   F         ++FL       ++F+++    
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLF--------RMVFL------DFRFLEQ---- 505

Query: 276 KLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK 335
           K+      R+         S            T + L+                    YK
Sbjct: 506 KI------RHDSTAWNASGSILN---------TLQQLKF-------------------YK 531

Query: 336 GMLTDGRIVAVKKSKLVDETNVEQFI---NEVVILSQINHRNIVKLLGCCLETEVPLLVY 392
             + D      K  +LV+   +  F+    E +I S+  + +++++    L         
Sbjct: 532 PYICDND---PKYERLVNA--ILDFLPKIEENLICSK--YTDLLRI---ALMA------- 574

Query: 393 EFIPNGTLYQYIHNQIE 409
               +  +++  H Q++
Sbjct: 575 ---EDEAIFEEAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 1e-04
 Identities = 66/515 (12%), Positives = 135/515 (26%), Gaps = 140/515 (27%)

Query: 113 TVFG--GC----LAISTCDPASRRGCYDF--------LCALSSNITQVFNANLSYIYSQN 158
            + G  G     +A+  C     +   DF         C     + ++    L Y    N
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ-KLLYQIDPN 212

Query: 159 ISRGCRSVSVVEENWVGSK-YLENPLVLKQQARDIPAL--LD--WGEDIGHCAEDFSLYS 213
            +      S ++      +  L   L  K        L  L              F+L  
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN---CLLVLLNVQNAKA---WNAFNLSC 266

Query: 214 ----TTICGDGEYR-CSITF--GSGYICRCRTTYRTDGFCAGCGGGLGLLFLLVGIWWLY 266
               TT       R   +T    +         + +            LL   +      
Sbjct: 267 KILLTT-------RFKQVTDFLSAATTTHISLDHHSMTLTP--DEVKSLLLKYLDC---- 313

Query: 267 KFVKRRKEIK----LKQKFFKRNGGLLLQQELSSNE----SNIEKTKLFTSKDLEKATDN 318
           +     +E+      +           ++  L++ +     N +K        L      
Sbjct: 314 RPQDLPREVLTTNPRRLSII----AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

Query: 319 YNANRILGQGGQGTVYK--GMLTDGRIVAVKKSKL------VDETNVEQFINEVVILSQI 370
                          +    +        +    L      V +++V   +N++   S +
Sbjct: 370 EYRKM----------FDRLSVFPPS--AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417

Query: 371 NHRN---IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE---FPITWELLLRIAVE 424
             +     + +    LE +V       + N      +H  I +    P T++    I   
Sbjct: 418 EKQPKESTISIPSIYLELKVK------LEN---EYALHRSIVDHYNIPKTFDSDDLIPPY 468

Query: 425 VSGALFYLHSAASIPIYH-RDIKSA-------NILLDDKY-RAKVSDFGTSRSVMVDQTH 475
           +    FY H       +H ++I+          + LD ++   K+    T+ +      +
Sbjct: 469 LDQ-YFYSHIG-----HHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522

Query: 476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 535
                         ++++     +    Y                R +N   D      F
Sbjct: 523 TLQ---------QLKFYK-PYICDNDPKYE---------------RLVNAILD------F 551

Query: 536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKR 570
           L  I EN L  +    +L+ A   E   +   A +
Sbjct: 552 LPKIEEN-LICSKYTDLLRIALMAEDEAIFEEAHK 585

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 6e-04
 Identities = 46/305 (15%), Positives = 98/305 (32%), Gaps = 80/305 (26%)

Query: 338 LTDGRIVAVKKSKLV---DETNVEQFINEVV-------ILSQINHRNIVKLLGCCLETEV 387
                I++V +   V   D  +V+     ++       I+   +  +    L   L ++ 
Sbjct: 16  YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75

Query: 388 PLLVYEFI-----PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 442
             +V +F+      N   Y+++ + I+       ++ R+ +E    L+  +       Y+
Sbjct: 76  EEMVQKFVEEVLRIN---YKFLMSPIKTEQRQPSMMTRMYIEQRDRLY--NDNQVFAKYN 130

Query: 443 --R-----DIKSANILLDDKYRAKVS---DFGTSRSVMVDQTHLTTKVQG---------T 483
             R      ++ A  LL+ +    V      G+ ++ +     L+ KVQ           
Sbjct: 131 VSRLQPYLKLRQA--LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188

Query: 484 FGYVD-PE---------YFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
               + PE          +Q    +T +SD                 I+ +     ++ +
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSD-------------HSSNIK-LRIHSIQAEL 234

Query: 533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT--MKEVTNELG 590
              L+          L   VL   +  +          C     K+  T   K+VT+ L 
Sbjct: 235 RRLLK---SKPYENCLL--VLLNVQNAKA--WNAFNLSC-----KILLTTRFKQVTDFLS 282

Query: 591 GIRTS 595
              T+
Sbjct: 283 AATTT 287

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 39/183 (21%), Positives = 62/183 (33%), Gaps = 36/183 (19%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK--------LVDETNVEQFINEVVILS 368
            +   + +G GG G +Y           A    K        L  E    Q + +   + 
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 369 QINHRNIVKLLGCCLETEVPLLVY--EFIPNGTLY------------QYIHNQIEEFPIT 414
           +   R  +  LG      +PL          G  Y            Q I  Q   F   
Sbjct: 98  KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVD 472
              +L++ + +   L Y+H    +   H DIK+AN+LL  K   +V  +D+G S     +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

Query: 473 QTH 475
             H
Sbjct: 207 GNH 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 40/241 (16%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRN 374
            +Y   R +G+G  G +++G  L + + VA+K       ++  Q  +E      +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67

Query: 375 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           I  +     E    +LV + + P+  L   +     +F +  + +   A ++   +  +H
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123

Query: 434 SAASIPIYHRDIKSANILLDDKYRAK-----VSDFGTSRSVMVDQTHL------TTKVQG 482
             + +   +RDIK  N L+            V DFG  +      T           + G
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 483 TFGYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINTDEDKSLV 532
           T  Y        S       E+S   D+ + G V +  L G  P   ++A    +    +
Sbjct: 181 TARY-------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233

Query: 533 G 533
           G
Sbjct: 234 G 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 17/158 (10%)

Query: 318 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNI 375
           N+   + +G G  G +  G  L     VA+K   +  ++   Q   E     Q+ +   I
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67

Query: 376 VKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
            ++       +   +V E + P+  L          F +  + +L IA+++   + Y+HS
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVS-----DFGTSR 467
              I   +RD+K  N L+              DF  ++
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 29/180 (16%), Positives = 65/180 (36%), Gaps = 27/180 (15%)

Query: 318 NYNANRILGQGGQGTVYKGM---------LTDGRIVAVK----KSKLVDETNVEQF---- 360
            +       +  QG +Y+               +  ++K      +L +E N  Q     
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 361 --INEVVILSQINHRNIVKLLGC-CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
             +N+   L       I   +G    + +   LV   +  G   Q   +   +  ++   
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS 160

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVDQTH 475
           +L++A  +  AL +LH    +   H ++ + NI +D + +++V  + +G +        H
Sbjct: 161 VLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 31/182 (17%)

Query: 318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKK-----------SKLVDETNVEQFINEVVI 366
            +     +GQGG G +Y   +     V                 L  E    Q   +   
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 367 LSQINHRNIVKLLG-----CCLETEVPLLVYEFI------PNGTLYQYIHNQIEEFPITW 415
           + +      +K LG          +     Y F+       +  L +      + F    
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR-- 151

Query: 416 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVDQ 473
           + +L++++ +   L Y+H    +   H DIK++N+LL+ K   +V   D+G +     + 
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 474 TH 475
            H
Sbjct: 209 VH 210

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	597
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.57
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.09
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.97
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.31
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.88
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.88
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.33
1edm_B	39	Factor IX; epidermal growth factor, EGF, calcium-	85.74
1k36_A	46	Epiregulin; EGF-like fold, hormone/growth factor c	85.38
1egf_A	53	Epidermal growth factor; NMR {Mus musculus} SCOP:	85.04
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.11
1a3p_A	45	Epidermal growth factor; disulfide connectivities,	84.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.07
3u7u_G	55	Neuregulin 1; signaling protein, transferase-trans	81.65
1nql_B	53	Epidermal growth factor; cell surface receptor, ty	81.43

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-55  Score=445.27  Aligned_cols=260  Identities=28%  Similarity=0.481  Sum_probs=219.3

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||+++.......++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46888899999999999999863      478899999988777788899999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          391 VYEFIPNGTLYQYIHNQI----------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      ||||+++|+|.++|+...          ....++|.+++.++.||++||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999998642          2346999999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHH
Q 038707          461 SDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      +|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+       ....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            999999876543332 2334568999999999999999999999999999999998 899997654222       2223


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      +..+...         ..+...++++.+|+.+||+.||++|||++||++.|+++.+.
T Consensus       243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            3333221         12334566789999999999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.2e-55  Score=447.16  Aligned_cols=260  Identities=28%  Similarity=0.472  Sum_probs=213.0

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|.+.++||+|+||+||+|.+.      +++.||||+++..+....++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45777889999999999999864      478999999988778888999999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          391 VYEFIPNGTLYQYIHNQIE------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      ||||+++|+|.++++....            ..+++|.+++.|+.||++||+|||+++   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999986432            246999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+       ..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            9999999987643332 23445679999999999999999999999999999999999 899997644222       22


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+..+..         ...+...++++.+|+.+||+.||++||||+||+++|+.|.+.
T Consensus       271 ~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            22222221         112334566789999999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-54  Score=440.25  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=215.2

Q ss_pred             cCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      .++++.+.||+|+||+||+|.+.      +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667789999999999999863      4678999998753 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          390 LVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      |||||+++|+|.++|+....             ...+++.+++.++.|||+||+|||+++   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999975321             245999999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~  534 (597)
                      .+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+....+       
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999987653322 23445679999999999999999999999999999999998 899997654322       


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      +...+..+...         ..+...++.+.+|+.+||+.||++||||+||+++|+++.
T Consensus       256 ~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          256 VVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            23333333221         123445677999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=430.86  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=209.2

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .+++++.+.||+|+||+||+|.+++  .||||.++.  ......++|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567888999999999999998753  589998764  345567889999999999999999999998754 56899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.++|+...  .++++.+++.|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999998643  35999999999999999999999998   9999999999999999999999999998654322


Q ss_pred             -ceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          474 -THLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       474 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                       ........||+.|||||++.+   ..|+.++|||||||+||||+||+.||......+      .....+..+.....  
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~--  258 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASPD--  258 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCC--
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCC--
Confidence             233455679999999999864   468999999999999999999999997543221      12222222211110  


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                         ........++.+.+|+.+||+.||++||||.||++.|+.|+..+
T Consensus       259 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          259 ---LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             ---STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ---cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence               11123345667899999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-53  Score=435.33  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=205.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++..  ......+.+.+|+.+|++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999975 699999998764  345567889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.++|.... ...+++.+++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+..... 
T Consensus       104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            999999999997643 345899999999999999999999999   999999999999999999999999999875422 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      ........||+.|||||++.+..|+.++|||||||+||||++|+.||...+..      ..+ ..+..+...        
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~-~~i~~~~~~--------  243 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLV-LKIISGSFP--------  243 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHHTCCC--------
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcCCCC--------
Confidence            12234567999999999999999999999999999999999999999754321      112 222222211        


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ......++++.+||.+||+.||++|||++|+++
T Consensus       244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             112334567899999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-53  Score=432.27  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=211.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999986 69999999987665666678999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.+.    .+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...... .
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~  225 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P  225 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence            999999999753    3999999999999999999999999   9999999999999999999999999998765332 2


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+       ....+..+....       ..
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~-------~~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPR-------LK  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSCCC-------CS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC-------CC
Confidence            3455679999999999999999999999999999999999999997533211       122222221100       01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....++++.+||.+||+.||++|||++|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11234567889999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.5e-53  Score=433.22  Aligned_cols=271  Identities=28%  Similarity=0.429  Sum_probs=223.2

Q ss_pred             cCHHHHHHHhcCCccCCcccccCceEEEEEEecC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCC-Ccccee
Q 038707          307 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQINH-RNIVKL  378 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l  378 (597)
                      +..++.+...++|++.+.||+|+||+||+|.+..      ++.||||++... .....++|.+|+.+|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4455666667899999999999999999998642      368999998753 34456789999999999975 899999


Q ss_pred             eeEEEeC-CcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 038707          379 LGCCLET-EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD  444 (597)
Q Consensus       379 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~D  444 (597)
                      +|++.+. +..+|||||+++|+|.++|+....             ...+++.+++.++.|||+||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 568999999999999999986432             235899999999999999999999999   99999


Q ss_pred             CCCCCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCC
Q 038707          445 IKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA  522 (597)
Q Consensus       445 ik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~  522 (597)
                      |||+|||+++++.+||+|||+|+....+.. .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654433 33445679999999999999999999999999999999998 9999976


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ....+      .+...+..+..         ...+...++++.+|+.+||+.||++|||+.||+++|+++.++
T Consensus       291 ~~~~~------~~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDE------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSH------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHH------HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            54332      12233333221         112234456789999999999999999999999999988643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-52  Score=425.82  Aligned_cols=254  Identities=22%  Similarity=0.238  Sum_probs=209.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.|++.++||+|+||+||+|.+. +|+.||||+++....     ..+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            56788889999999999999976 699999999874321     247999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccCCCc
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++|+|.++|++..   .+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.......
T Consensus       133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999998643   4999999999999999999999999   99999999999999987 699999999987653322


Q ss_pred             e----eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          475 H----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       475 ~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      .    ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+.   .    ..+.....      
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~----~~i~~~~~------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C----LKIASEPP------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H----HHHHHSCC------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H----HHHHcCCC------
Confidence            1    12335699999999999999999999999999999999999999986554431   1    11111111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                       ...+.+...++.+.+||.+||+.||++|||+.|+++.|......
T Consensus       274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence             01122344567789999999999999999999999998876554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-52  Score=422.57  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=209.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|... +++.||||.+...   .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999975 6999999987632   3345678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..   .+++.++..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999998643   4999999999999999999999999   999999999999999999999999999876533


Q ss_pred             C-ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 Q-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . ........||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+       ....+..+..       
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~-------  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEY-------  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence            2 233456789999999999999999999999999999999999999997533211       1222222221       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  586 (597)
                         ..+...++++.+||.+||+.||++|||++|++
T Consensus       252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               11223455688999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.2e-52  Score=433.70  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=212.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 69999999988766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.++++..    .+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...... .
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~  302 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P  302 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence            999999999753    3999999999999999999999999   9999999999999999999999999998764332 2


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+       ....+..+....       ..
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~-------~~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPR-------LK  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCC-------CS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC-------Cc
Confidence            3455679999999999999999999999999999999999999997533211       122222221100       01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....++++.+||.+||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11234567889999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-51  Score=418.08  Aligned_cols=271  Identities=23%  Similarity=0.312  Sum_probs=204.3

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC----cceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE----VPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  392 (597)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++..... ....+..|+..+.+++|||||++++++.+.+    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4578889999999999999998 589999999864322 1122334666667889999999999998764    468999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ||+++|+|.++|+..    +++++.+++++.|+++||+|||++     ..++|+||||||+||||++++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999864    399999999999999999999987     12349999999999999999999999999998


Q ss_pred             cccCCCcee---eecccccccccCccccccC------CCCcccceeehHHHHHHHHhCCCCCCCCCCcCC--------Cc
Q 038707          468 SVMVDQTHL---TTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED--------KS  530 (597)
Q Consensus       468 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~--------~~  530 (597)
                      .........   .....||+.|||||++.+.      .++.++|||||||+||||+||++||......+.        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            765433322   2345699999999998754      467899999999999999999887754332111        01


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ........+........+...   ....+.++.+.+|+.+||+.||++||||.||+++|++|.++-
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            111222222222221111111   112355678999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-51  Score=408.68  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=200.4

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcceEE
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLV  391 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  391 (597)
                      |++.+.||+|+||+||+|.+. +++.||+|++..  ......+.|.+|+.+|++++|||||++++++.+    .+..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            356678999999999999976 589999998753  345567889999999999999999999999875    3457999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++|+|.+++++..   .+++..+..++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999998643   49999999999999999999999863 4999999999999984 7899999999997643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..   ......||+.|||||++.+ .|+.++|||||||+||||++|+.||......     . .....+..+.....   
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~-~~~~~i~~~~~~~~---  250 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----A-QIYRRVTSGVKPAS---  250 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----H-HHHHHHTTTCCCGG---
T ss_pred             CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----H-HHHHHHHcCCCCCC---
Confidence            22   2345679999999999865 6999999999999999999999999643221     1 12222322221111   


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           .+...++++.+||.+||+.||++|||++|+++
T Consensus       251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11223356889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-51  Score=408.09  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=192.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|... +|+.||||.+...   .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999975 6999999987532   3344667999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+ +|+|.+++.+..   .+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 689999998643   4999999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        .......||+.|||||++.+..+ +.++|||||||+||||++|+.||...+.      .. ....+..+..       
T Consensus       166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-~~~~i~~~~~-------  229 (275)
T 3hyh_A          166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-LFKNISNGVY-------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCC-------
T ss_pred             --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHcCCC-------
Confidence              23345679999999999998876 5799999999999999999999975321      11 2222222221       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..+...++++.+||.+||+.||++|||++|+++
T Consensus       230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               112234566889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-51  Score=413.63  Aligned_cols=247  Identities=27%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             cCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|+||+||+|...    .++.||||.+...  ......++.+|+.+|++++|||||++++++.+.+..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862    4789999987642  22334568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++.+..   .+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999998653   4999999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ... .......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+       ....+..+..      
T Consensus       178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------  243 (304)
T 3ubd_A          178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKL------  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred             CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC------
Confidence            322 23345679999999999999999999999999999999999999997543222       1122222211      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM-----KEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  587 (597)
                          ..+...++++.+||.+||+.||++|||+     +|+++
T Consensus       244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                1122345678899999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.8e-50  Score=404.80  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=193.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-------
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-------  387 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  387 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45899999999999999999976 68999999886533 4456789999999999999999999999976553       


Q ss_pred             -----ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          388 -----PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       388 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                           .+|||||+++|+|.+++..........+..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999987654445677889999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCce-----------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH
Q 038707          463 FGTSRSVMVDQTH-----------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL  531 (597)
Q Consensus       463 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~  531 (597)
                      ||+|+........           ......||+.|||||++.+..|+.++|||||||+||||++   ||....     ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence            9999876533211           1234569999999999999999999999999999999996   774211     11


Q ss_pred             HHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          532 VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       532 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      . .....+.......         ......+.+.+||.+||+.||++|||+.|+++
T Consensus       234 ~-~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 V-RTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H-HHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1 1111222222111         11233445678999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.4e-47  Score=389.18  Aligned_cols=286  Identities=37%  Similarity=0.607  Sum_probs=247.7

Q ss_pred             ccCHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      .++..++...+++|++.+.||+|+||+||+|.+.+++.||||+.........+.+.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34455666778999999999999999999999888999999998877777788999999999999999999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      +..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999976432 235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC-CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVD-QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99765432 22223445689999999999889999999999999999999999999988777776666666666666666


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      +.+.+++........+.+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            666666666666667888999999999999999999999999999998865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=400.81  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------Cc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------EV  387 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  387 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++..  .....+.+.+|+.+|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 6999999998643  344567889999999999999999999997643      56


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .||||||++ |+|.+++.+.   ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            799999995 7899999754   35999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCC---ceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          468 SVMVDQ---THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       468 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      .+....   ........||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+   .............
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~  283 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPS  283 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            764321   2234456799999999998775 56999999999999999999999997644222   1111111111000


Q ss_pred             h-----------hhhhhH------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 L-----------FEALDA------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~-----------~~~l~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .           ...+..      ..........++++.+||.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0           000000      0000011123456889999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-46  Score=387.42  Aligned_cols=199  Identities=18%  Similarity=0.350  Sum_probs=171.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec----CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcce
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  389 (597)
                      ..++|++.+.||+|+||+||+|..+    .++.||||++...  ....++.+|+++|+.+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999863    4688999987643  3346788999999998 6999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeecccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRS  468 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~~  468 (597)
                      |||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999984      2899999999999999999999999   9999999999999876 7999999999976


Q ss_pred             ccCCCc---------------------------eeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCC
Q 038707          469 VMVDQT---------------------------HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPI  520 (597)
Q Consensus       469 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~  520 (597)
                      ......                           .......||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            532211                           112345699999999998775 5899999999999999999999999


Q ss_pred             CCCC
Q 038707          521 RAIN  524 (597)
Q Consensus       521 ~~~~  524 (597)
                      ....
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            6543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.7e-46  Score=383.04  Aligned_cols=290  Identities=37%  Similarity=0.626  Sum_probs=243.8

Q ss_pred             cccccCHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCccceeeeE
Q 038707          303 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGC  381 (597)
Q Consensus       303 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  381 (597)
                      ..+.++..++....++|++.+.||+|+||.||+|...+++.||||++...... ....+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            45678899999999999999999999999999999888999999998753322 23368999999999999999999999


Q ss_pred             EEeCCcceEEEeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          382 CLETEVPLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       382 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      +.+.+..++||||+++|+|.+++..... ..++++..++.++.|++.||.|||++....|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            9999999999999999999999987543 345999999999999999999999992112999999999999999999999


Q ss_pred             eeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCC--CcCCCcHHHHHHHH
Q 038707          461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN--TDEDKSLVGYFLQA  538 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~  538 (597)
                      +|||++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||....  .........+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999998776555555566679999999999988899999999999999999999999996321  22333444444444


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ..........+...........++.+.+|+.+||+.||.+|||++||+++|++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            455555566666666666778889999999999999999999999999999854

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.6e-46  Score=409.45  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=212.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999976 6999999998877777788899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC--CcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~--~~~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.++|.+..  ..+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999997532  34999999999999999999999999   9999999999999854  89999999999876533


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .  ......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+       ....+......      .
T Consensus       311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~------~  375 (573)
T 3uto_A          311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN------M  375 (573)
T ss_dssp             S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC------C
T ss_pred             C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCC------C
Confidence            2  3345579999999999999999999999999999999999999997543222       12222222110      0


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ........++++.+||.+||+.||.+|||+.|+++
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01112234556889999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=370.83  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=218.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|.+.+.||+|+||+||++.+. +++.||+|++...+....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356889999999999999999976 6899999998777788889999999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++....  ..+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999998743  34999999999999999999999999   99999999999999999999999999987643322


Q ss_pred             ee-------------eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          475 HL-------------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       475 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ..             .....||+.|+|||++.+..++.++||||||+++|||++|..|+............         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------  234 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------  234 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence            11             11456999999999999999999999999999999999999998764433211100         


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                       .....++    ...+...++.+.+|+.+||+.||++|||+.++++.|++++..+
T Consensus       235 -~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          235 -NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence             0001111    1112334456889999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-45  Score=401.79  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc------ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|++.++||+|+||+||+|... +|+.||||.+...      ......+...++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999976 6999999987531      1112233344567778889999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |||||+++|+|.++|.+..   .+++..+..++.||+.||+|||+++   |+||||||+||||+.+|++||+|||+|+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999998653   4999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....   .....||+.|||||++.. ..|+.++|||||||+||||++|+.||......+   ..... ..+.....    
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~-~~i~~~~~----  411 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEID-RMTLTMAV----  411 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHH-HHHHHCCC----
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH-HhhcCCCC----
Confidence            4332   344679999999999964 579999999999999999999999997644332   11111 11111111    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                            ..+...++++.+||.+||+.||.+|++     ++||++
T Consensus       412 ------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  112334567889999999999999998     577654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-43  Score=360.74  Aligned_cols=285  Identities=32%  Similarity=0.543  Sum_probs=231.7

Q ss_pred             cccccCHHHHHHHhcCCccC------CcccccCceEEEEEEecCCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCC
Q 038707          303 KTKLFTSKDLEKATDNYNAN------RILGQGGQGTVYKGMLTDGRIVAVKKSKLV----DETNVEQFINEVVILSQINH  372 (597)
Q Consensus       303 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h  372 (597)
                      ....|+..++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999998877      8999999999999987 5889999987542    34456789999999999999


Q ss_pred             CccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       373 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      |||+++++++.+.+..++||||+++++|.+++.......++++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999987555567999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL  531 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~  531 (597)
                      ++++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999986543322 22334568999999998865 588999999999999999999999986544332211


Q ss_pred             HHHHHHHHh-cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          532 VGYFLQAIN-ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       532 ~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                        ....... ...+.+.++... .......++.+.+|+.+||+.||.+|||+++|++.|++++++
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          246 --IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             --HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             --HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence              1111111 112222222222 223466778899999999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3e-44  Score=358.08  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=216.2

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||.||++.+.++..||+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46799999999999999999999888899999987533 33467999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999998753  34899999999999999999999999   999999999999999999999999999876555444


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..         .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR---------L  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC---------C
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC---------C
Confidence            4445557788999999998899999999999999999999 999996543221       1111111110         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+...++.+.+|+.+||+.||++|||+.++++.|+.++++
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            11122345688999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-44  Score=360.52  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=215.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            35789999999999999999999888999999987533 33467999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            9999999997643  35899999999999999999999999   999999999999999999999999999866443333


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+.         ..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~---------~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF---------RL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC---------CC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc---------cC
Confidence            3344457788999999999999999999999999999999 999997533221       111221111         01


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+...++.+.+|+.+||+.||++|||+++++++|+++.++
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            11222345688999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-44  Score=373.36  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=215.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET  385 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  385 (597)
                      .++|++.+.||+|+||.||+|.+.        ++..||||.++.. .....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467999999999999999999862        3567999998754 344567899999999999 899999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999987532             235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCc
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS  530 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~  530 (597)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986543222 12233457889999999999999999999999999999999 999997654332   


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                          ....+..+..         ...+...+..+.+|+.+||+.||.+|||+.|+++.|+++.+.
T Consensus       314 ----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 ----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ----HHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                1122222211         112234456789999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=367.42  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=212.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||+||+|.+.    .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467899999999999999999974    3457999998754 45566789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.++++...  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999997642  34999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          471 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       471 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+       ....+..+..   
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~---  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYR---  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC---
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCC---
Confidence            33222  2233446788999999998999999999999999999999 999996543222       1122222111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                            ...+...++.+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                  111234456789999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-45  Score=370.18  Aligned_cols=268  Identities=27%  Similarity=0.449  Sum_probs=212.5

Q ss_pred             hcCCccCCcccccCceEEEEEEe-----cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      .++|++.+.||+|+||+||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999984     25889999999877777788999999999999999999999998654  468


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999987532  4899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch--
Q 038707          469 VMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL--  544 (597)
Q Consensus       469 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  544 (597)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....        .+.........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~  235 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ  235 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--------HHHHHHCTTCCTH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--------HHHhhhcCccccc
Confidence            643322  122334577889999999999999999999999999999999999854211        01111111111  


Q ss_pred             ------hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          545 ------FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       545 ------~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                            .+.+........+...++++.+|+.+||+.||++|||++|++++|+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence                  0111111111123345577999999999999999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-44  Score=365.74  Aligned_cols=267  Identities=30%  Similarity=0.433  Sum_probs=209.4

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      ++....++|++.+.||+|+||+||+|.. +++.||||++...  .....+++.+|+.++++++||||+++++++.+.+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3334457899999999999999999987 5889999987643  345567899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++........+++..++.++.||+.||+|||+.+. +|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999999875444459999999999999999999999873 499999999999999999999999999975


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      ...........    
T Consensus       189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~----  257 (309)
T 3p86_A          189 KAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKR----  257 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCC----
T ss_pred             cccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC----
Confidence            4322 122334568999999999999999999999999999999999999997543221      11111101100    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           ...+...++.+.+||.+||+.||.+|||+.++++.|+.+.++
T Consensus       258 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 111233455688999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-44  Score=377.12  Aligned_cols=260  Identities=25%  Similarity=0.430  Sum_probs=215.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||.++.. .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467899999999999999999986 6899999998753 3445567999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.++++...  ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999998643  34899999999999999999999999   999999999999999999999999999865332


Q ss_pred             Cceee-ecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          473 QTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       473 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..... ....+++.|+|||.+....++.++||||||++||||++ |..||......+       ....+..+..      
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~------  333 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR------  333 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence            21111 12235778999999998899999999999999999998 999997643221       1222222111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                         ...+...++.+.+|+.+||+.||++|||+++|++.|+++++.
T Consensus       334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence               111233456788999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.5e-44  Score=360.68  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=209.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            367999999999999999999964 6899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.+.    .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999764    3899999999999999999999999   99999999999999999999999999977643332


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ........... .       .
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~-------~  236 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-E-------L  236 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-C-------C
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-C-------C
Confidence             2344569999999999999999999999999999999999999996533211      11111111110 0       0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            112234556889999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.5e-44  Score=367.85  Aligned_cols=269  Identities=23%  Similarity=0.317  Sum_probs=212.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc----ceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV----PLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv  391 (597)
                      .++|++.+.||+|+||+||+|.+. ++.||||++... ......+..|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999875 799999998653 3334556679999999999999999999988554    5999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA----------ASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      |||+++|+|.++++..    .+++..++.++.||++||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999764    399999999999999999999998          8   9999999999999999999999


Q ss_pred             eccccccccCCCce-eeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH--
Q 038707          462 DFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG--  533 (597)
Q Consensus       462 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~--  533 (597)
                      |||+++........ ......||+.|+|||++.+     ..++.++||||||+++|||++|+.||.............  
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999776543322 2333568999999999876     356778999999999999999999998755433221111  


Q ss_pred             -------HHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          534 -------YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       534 -------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                             ..............+....   .....++++.+||.+||+.||++|||+.||+++|++|++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                   1111111111111111110   12345567999999999999999999999999999998753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.7e-44  Score=372.59  Aligned_cols=259  Identities=25%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||.||+|.+.    ++..||||.++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999875    4678999998754 44556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.++++...  ..+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999998643  35999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          471 VDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       471 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ......  .....+++.|+|||++.+..++.++||||||++||||++ |+.||......+       ....+..+     
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~-----  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEG-----  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTT-----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence            332221  222335778999999999999999999999999999998 999997543211       11222211     


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                          .........+..+.+|+.+||+.||++||++.+|+++|+++...
T Consensus       267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                11111234456789999999999999999999999999998653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.1e-44  Score=357.56  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=212.6

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..++|++.+.||+|+||+||++.+.++..||||++.... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            356799999999999999999999888899999987533 2346799999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999998642  34999999999999999999999999   99999999999999999999999999986644333


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..         
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~---------  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR---------  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC---------
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcccC---------
Confidence            33334456788999999998899999999999999999998 999997543221       1111211110         


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ...+...++.+.+|+.+||+.+|.+|||++++++.|+++.+.
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            111122345688999999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-43  Score=362.13  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..  ......+++.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467999999999999999999974 799999998754  34556778999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999997653   3999999999999999999999999   999999999999999999999999999765433


Q ss_pred             CceeeecccccccccCccccccCCCC-cccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .  ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||...+..+       ....+..+..       
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~-------  231 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY-------  231 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence            2  23456799999999999887765 89999999999999999999997543221       1222222211       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ..+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus       232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               1112234568899999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-43  Score=358.42  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=210.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||++.+. +++.||+|.+..   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999975 689999998743   3345567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....   ++++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999998653   4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+      .....+... ..     .
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~-~~-----~  231 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS-VP-----N  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC-CC-----C
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc-CC-----C
Confidence            43333445669999999999999999999999999999999999999997543211      111111111 10     0


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIRT  594 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~~  594 (597)
                      .........++.+.+++.+||+.||.+|| +++++.+.|+++..
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11112233456789999999999999998 99999999988753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9e-44  Score=370.17  Aligned_cols=272  Identities=28%  Similarity=0.424  Sum_probs=221.2

Q ss_pred             ccCHHHHHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccce
Q 038707          306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVK  377 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~  377 (597)
                      .+...+++...++|++.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            4556677777889999999999999999999842      4689999998753 344567899999999999 7899999


Q ss_pred             eeeEEEeCCc-ceEEEeccCCCChhhHHhhcCC-----------------------------------------------
Q 038707          378 LLGCCLETEV-PLLVYEFIPNGTLYQYIHNQIE-----------------------------------------------  409 (597)
Q Consensus       378 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  409 (597)
                      +++++.+.+. .++||||+++|+|.++++....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999987532                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          410 ----------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       410 ----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                                      ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            112899999999999999999999999   9999999999999999999999999998664332


Q ss_pred             c-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          474 T-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       474 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+      .+...+..+..       
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-------  314 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR-------  314 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCC-------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCC-------
Confidence            2 23445568999999999999999999999999999999998 999997654332      11122222111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                        ...+...++++.+|+.+||+.||.+|||+.||+++|+++...
T Consensus       315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence              111223445688999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-44  Score=385.66  Aligned_cols=265  Identities=24%  Similarity=0.405  Sum_probs=218.1

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      ..+.+...++|++.+.||+|+||+||+|.++++..||||+++... ...++|.+|+.+|++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344455667899999999999999999999888999999987543 45788999999999999999999999986 6678


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++|+|.++++... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999998542 234889999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      .............+++.|+|||++....++.++||||||++||||++ |+.||......+       ....+..+.    
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~----  402 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGY----  402 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTC----
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence            64322222233446788999999998999999999999999999999 999997543221       111221111    


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           ....+...++.+.+||.+||+.||++|||+++|++.|+.+.+.
T Consensus       403 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 -----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                 1111234456789999999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.4e-43  Score=357.77  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=216.0

Q ss_pred             cccCHHHHHHHhcC----------CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC
Q 038707          305 KLFTSKDLEKATDN----------YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHR  373 (597)
Q Consensus       305 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~  373 (597)
                      ..++.++++.+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35677777777654          677789999999999999986 6999999998876666778899999999999999


Q ss_pred             ccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       374 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      ||+++++++...+..++||||+++++|.+++...    .+++..+..++.||++||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            9999999999999999999999999999998753    4999999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH
Q 038707          454 DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG  533 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~  533 (597)
                      .++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------  248 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------  248 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence            999999999999987643322 2344569999999999999999999999999999999999999997533211      


Q ss_pred             HHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          534 YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       534 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       ....+........       ......++.+.+|+.+||+.||++|||+.|+++.
T Consensus       249 -~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          249 -AMKRLRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -HHHHHHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1111111111000       0112234568899999999999999999999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-43  Score=361.07  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=218.7

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      ++...++|.+.+.||+|+||.||+|...      +++.||||.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3344678999999999999999999862      3578999998753 45566889999999999999999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHR  443 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~  443 (597)
                      .+..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence            9999999999999999999987532                     234899999999999999999999999   9999


Q ss_pred             cCCCCCeEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCC
Q 038707          444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIR  521 (597)
Q Consensus       444 Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~  521 (597)
                      ||||+|||+++++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876543332 2233457889999999998899999999999999999999 999997


Q ss_pred             CCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          522 AINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .....+       ....+..+..         ...+...++.+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       255 ~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPER-------LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGG-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHH-------HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            654332       1122222211         111233456789999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-43  Score=353.14  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=201.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|..... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            34679999999999999999999743    457999997753 344567899999999999999999999997 456789


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999998642  35899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ............+++.|+|||.+....++.++||||||+++|||++ |..||......+       ....+..+...   
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~~~~~---  236 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL---  236 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC---
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHcCCCC---
Confidence            5433333344457789999999998999999999999999999997 999997654332       11122221111   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                            ..+...++.+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  11233456788999999999999999999999999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-43  Score=351.46  Aligned_cols=258  Identities=29%  Similarity=0.441  Sum_probs=214.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||.||++.+.+++.||+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357889999999999999999998889999999875433 3468999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++++|.+++....  ..+++..++.++.|+++||.|||+++   |+|+||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            9999999998643  34899999999999999999999999   999999999999999999999999999865433222


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..         .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~---------~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR---------L  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC---------C
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCc---------C
Confidence            2333457788999999998899999999999999999999 899997533211       1122222110         0


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+...+..+.+|+.+||+.||++|||+++++++|+++.++
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11122345688999999999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.7e-43  Score=382.06  Aligned_cols=259  Identities=28%  Similarity=0.458  Sum_probs=217.4

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ...+|++.+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++||||+++++++.+.+..+||||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45678899999999999999999874 8899999987533 346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.++++... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999998643 345899999999999999999999999   9999999999999999999999999998765443


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ........+++.|+|||++....++.++||||||++||||++ |+.||......+       ....+..+         .
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~  436 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD---------Y  436 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTT---------C
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------C
Confidence            333344456789999999998999999999999999999999 999997654332       11112111         1


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ....+...++.+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            112233445678999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-42  Score=356.92  Aligned_cols=264  Identities=17%  Similarity=0.211  Sum_probs=213.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|... +++.||||.+....  ..+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            467999999999999999999974 78999999876432  234688999999999 89999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc-----EEEeecccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRS  468 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-----~kl~Dfgl~~~  468 (597)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999864  235999999999999999999999999   999999999999998887     99999999987


Q ss_pred             ccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          469 VMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       469 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            6433221      1234569999999999999999999999999999999999999998765443221111111100000


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhcC
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG  597 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~  597 (597)
                      .      .   .......+ ++.+|+.+||+.||.+||++++|++.|+++...+|
T Consensus       240 ~------~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          240 P------I---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             C------H---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             C------H---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            0      0   00011123 79999999999999999999999999999877653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-42  Score=350.71  Aligned_cols=264  Identities=17%  Similarity=0.193  Sum_probs=215.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||.||+|... +++.||||.+...  ...+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999974 7899999987642  2345688999999999 79999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc-----EEEeecccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRS  468 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-----~kl~Dfgl~~~  468 (597)
                      |+ +++|.+++....  .++++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||++..
T Consensus        87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 999999998643  34999999999999999999999999   999999999999987766     99999999987


Q ss_pred             ccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          469 VMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       469 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221      2344569999999999999999999999999999999999999998765433222221111111111


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ..         .......++.+.+|+.+||+.||++|||+++|++.|+++.+++
T Consensus       241 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          241 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            10         1112234567999999999999999999999999999998765

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.1e-43  Score=373.65  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=212.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC-cceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  393 (597)
                      ..++|++.+.||+|+||.||+|.+. ++.||||.++...  ..+.|.+|+.+|++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467889999999999999999985 7899999987533  5578999999999999999999999988765 7899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.... ...+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            999999999998753 234799999999999999999999999   999999999999999999999999999754322 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                         .....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+       ....+..+..        
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~--------  404 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK--------  404 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCC--------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence               122357889999999999999999999999999999998 999998665433       1122222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                       ...+...++.+.+||.+||+.||++|||+.++++.|+.+++.
T Consensus       405 -~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          405 -MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence             112334556789999999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=362.93  Aligned_cols=264  Identities=24%  Similarity=0.407  Sum_probs=216.3

Q ss_pred             HHhcCCccCCcccccCceEEEEEEecC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      ...++|++.+.||+|+||.||+|.+.+      ++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            346789999999999999999999752      488999998754 3445678999999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI  445 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Di  445 (597)
                      ..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999987421                     146999999999999999999999999   999999


Q ss_pred             CCCCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCC
Q 038707          446 KSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI  523 (597)
Q Consensus       446 k~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~  523 (597)
                      ||+|||+++++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999976543221 22334557899999999998899999999999999999999 99999754


Q ss_pred             CCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          524 NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ...+       ....+..+...         ..+...+..+.+|+.+||+.||++|||+.+|++.|+++..+.
T Consensus       281 ~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          281 AHEE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             ChHH-------HHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            3221       22222222221         112334567899999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=366.78  Aligned_cols=264  Identities=27%  Similarity=0.428  Sum_probs=217.5

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCC  382 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  382 (597)
                      +...++|.+.+.||+|+||+||+|.+.        .+..||||++... ......++.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            344578999999999999999999863        2357999998653 445568899999999999 899999999999


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~N  449 (597)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999987532             235999999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcC
Q 038707          450 ILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE  527 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~  527 (597)
                      ||+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986543222 22334457889999999999999999999999999999999 999997543221


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                             ....+..+..         ...+...+.++.+|+.+||+.||++|||++||++.|+++...
T Consensus       302 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          302 -------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             -------HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                   2222222211         111223456788999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-42  Score=351.62  Aligned_cols=261  Identities=23%  Similarity=0.369  Sum_probs=205.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCccceeeeEEEeC----Ccce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ--INHRNIVKLLGCCLET----EVPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  389 (597)
                      .++|++.+.||+|+||+||+|.+ +++.||||++..   .....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 689999999763   344566677777776  7999999999997653    4578


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH--------SAASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      +||||+++|+|.++++..    .+++..++.++.||+.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            999999999999999643    4999999999999999999999        777   9999999999999999999999


Q ss_pred             eccccccccCCCcee---eecccccccccCccccccC------CCCcccceeehHHHHHHHHhC----------CCCCCC
Q 038707          462 DFGTSRSVMVDQTHL---TTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTG----------QKPIRA  522 (597)
Q Consensus       462 Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlG~il~ell~g----------~~p~~~  522 (597)
                      |||+++.........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997655433322   2334699999999998876      456799999999999999999          888865


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ........  ...............+..   .......++.+.+|+.+||+.||++|||+.+|+++|++|
T Consensus       236 ~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSF--EDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCH--HHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcch--hhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            54333221  111121111111111111   112345677899999999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.2e-43  Score=357.10  Aligned_cols=266  Identities=27%  Similarity=0.422  Sum_probs=218.1

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEe------cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCccceeeeEEEe
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLE  384 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  384 (597)
                      +...++|++.+.||+|+||.||+|.+      .+++.||||.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457899999999999999999985      246799999987543 34567899999999999 89999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIE---------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~N  449 (597)
                      .+..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+++   |+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            9999999999999999999987532               125899999999999999999999999   9999999999


Q ss_pred             eEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcC
Q 038707          450 ILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE  527 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~  527 (597)
                      ||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999876544332 2334457889999999999999999999999999999999 999997654322


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .      ....+..+.         ....+...+..+.+|+.+||+.||.+|||+.|++++|+++..+.
T Consensus       256 ~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          256 K------FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             H------HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H------HHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            1      111111111         11112234567899999999999999999999999999987653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=352.64  Aligned_cols=270  Identities=24%  Similarity=0.385  Sum_probs=215.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--cceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  391 (597)
                      .++|++.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357999999999999999999986 58999999976432 334677889999999999999999999998765  67899


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe----CCCCcEEEeeccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSR  467 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfgl~~  467 (597)
                      |||+++++|.+++........+++..++.++.||++||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999987655556999999999999999999999999   9999999999999    888889999999998


Q ss_pred             cccCCCceeeecccccccccCccccc--------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQ--------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      .......  .....||+.|+|||++.        +..++.++||||||+++|||++|+.||...........  ......
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~  240 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--VMYKII  240 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH--HHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH--HHHHHh
Confidence            7643322  23456899999999986        57789999999999999999999999976543322211  111221


Q ss_pred             hcCch---hhh-------h----hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          540 NENRL---FEA-------L----DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       540 ~~~~~---~~~-------l----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      .....   ...       +    ...............+.+|+.+||+.||++|||++|+++....-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11110   000       0    00011133467778899999999999999999999999988653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6e-43  Score=352.39  Aligned_cols=260  Identities=29%  Similarity=0.465  Sum_probs=219.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.. .....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4577999999999999999999986 488999999874 34456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999998743 345999999999999999999999999   9999999999999999999999999998776555


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+       ....+...         .
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~---------~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD---------Y  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTT---------C
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcc---------C
Confidence            455555667889999999999999999999999999999999 999997654332       11111111         1


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ....+...++.+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            1112233456789999999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-42  Score=354.78  Aligned_cols=269  Identities=21%  Similarity=0.332  Sum_probs=208.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..++|++.+.||+|+||+||+|.+.+++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999999889999999876432  333577899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++ ++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9997 58888887643  34899999999999999999999999   999999999999999999999999999875432


Q ss_pred             CceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh---h--
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF---E--  546 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~--  546 (597)
                      . .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.   ..............   .  
T Consensus       173 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 V-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             C-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred             c-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence            2 22334568999999999876 5689999999999999999999999986554331   11121211111000   0  


Q ss_pred             -----------hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhhh
Q 038707          547 -----------ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN--ELGGIR  593 (597)
Q Consensus       547 -----------~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~l~  593 (597)
                                 ..............++++.+||.+||+.||++|||++|+++  .++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                       00000001111223457889999999999999999999987  344443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=366.93  Aligned_cols=261  Identities=27%  Similarity=0.399  Sum_probs=213.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||+||+|.+.      +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999953      4678999998643 455567899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEe
Q 038707          389 LLVYEFIPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVS  461 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~  461 (597)
                      ++||||+++|+|.+++.....    ...+++..++.++.||++||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987532    235899999999999999999999999   99999999999999554   59999


Q ss_pred             eccccccccCCC-ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          462 DFGTSRSVMVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       462 Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      |||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+       ....+
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            999997553221 122334557899999999999999999999999999999998 999997543221       22222


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+..         ...+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       300 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            22211         111233455688999999999999999999999999988653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-43  Score=379.48  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=210.4

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+||
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            334457799999999999999999999888889999987543 345789999999999999999999999876 678999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999997532 234899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..........+++.|+|||.+....++.++||||||++||||++ |+.||......+       ....+..+..      
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~------  399 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR------  399 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC------
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence            33333334457889999999998999999999999999999999 999997543222       1122222211      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                         ...+...++.+.+|+.+||+.||++|||+++|++.|+.+.++
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence               111234556789999999999999999999999999988654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-43  Score=352.64  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=215.2

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +...++|++.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            33456799999999999999999998888899999886432 34578999999999999999999999986 45689999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++.... ...+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999997542 224899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .........+++.|+|||.+.+..++.++||||||++++||++ |+.||......+       ....+..+..       
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~-------  228 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYR-------  228 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC-------
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccC-------
Confidence            4333344557889999999998889999999999999999999 999997543221       1122211110       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                        ...+...++.+.+|+.+||+.||++|||+.++++.|+++.+..
T Consensus       229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence              1112234567899999999999999999999999999987653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.2e-43  Score=359.93  Aligned_cols=256  Identities=23%  Similarity=0.470  Sum_probs=204.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|+||+||+|.+. +++    +||+|.+.. ......+++.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56899999999999999999964 344    468887754 23445678999999999999999999999998765 789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999998753  34999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+       ....+..+..    
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~----  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER----  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCC----
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCCC----
Confidence            33322 2333457889999999999999999999999999999999 999997654333       1122222111    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                           ...+...+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 11123344568899999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.8e-43  Score=349.28  Aligned_cols=254  Identities=31%  Similarity=0.520  Sum_probs=198.7

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccCh----hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE----TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||+|.+. ++.||||.......    ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357899999999999999999975 88999998765322    2357789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC--------CCcEEEeec
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--------KYRAKVSDF  463 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~--------~~~~kl~Df  463 (597)
                      |||+++++|.+++...    .+++..++.++.|+++||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999998643    4999999999999999999999998656899999999999986        778999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      |++.......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......      ...... ...
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~  230 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVA-MNK  230 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHH-TSC
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhh-cCC
Confidence            9997654322   223468999999999999999999999999999999999999997543211      111111 111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      ..        ...+...++.+.+|+.+||+.||.+|||+.|++++|++|
T Consensus       231 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 LA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            10        111233456789999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.3e-42  Score=359.31  Aligned_cols=252  Identities=25%  Similarity=0.315  Sum_probs=207.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ..++|++.+.||+|+||+||++... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999976 689999998764322      135789999999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeec
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDF  463 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Df  463 (597)
                      .++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999999754   35999999999999999999999999   99999999999998877    7999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      |++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+       ....+....
T Consensus       164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~  234 (361)
T 2yab_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVS  234 (361)
T ss_dssp             SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTC
T ss_pred             CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcC
Confidence            9998764322  2344569999999999999899999999999999999999999997543221       112222221


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..  .++.    .....++.+.+||.+||+.||.+|||+.|+++
T Consensus       235 ~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 YD--FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC--CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            10  0111    11233456889999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.7e-43  Score=372.78  Aligned_cols=262  Identities=21%  Similarity=0.307  Sum_probs=210.9

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      ..++....++|++.++||+|+||+||+|.+. +++.||+|++....   ......+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444555788999999999999999999987 48899999876321   2223448899999999999999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      .+..+|||||+++|+|.+++.+..  ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999998632  34999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      +++..............||+.|+|||++.     ...++.++||||||++||||++|+.||...+..+      .+...+
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i~  294 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM  294 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhhh
Confidence            99877655555555567999999999986     4678999999999999999999999997543221      111111


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTN  587 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~  587 (597)
                      .......      ........++++.+||.+||..+|++  ||+++|+++
T Consensus       295 ~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          295 NHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             THHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1000000      00001124566889999999888888  999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-42  Score=356.27  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=207.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||+||++... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357999999999999999999976 6899999987642   234567789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999998643   4899999999999999999999999   99999999999999999999999999976432


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+       ....+.....       
T Consensus       158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~-------  222 (337)
T 1o6l_A          158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI-------  222 (337)
T ss_dssp             TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred             CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence            22 22345579999999999999999999999999999999999999997533211       1111111111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                         ..+...++++.+||.+||+.||++||     +++|+++.
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               11223456688999999999999999     89998763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=354.24  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=208.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 5889999988743 44567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC--CCcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfgl~~~~~~~  472 (597)
                      +++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999997542  35999999999999999999999999   999999999999987  789999999999876433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+       ....+..+...  .+.  
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--~~~--  224 (321)
T 1tki_A          158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDE--  224 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCH--
T ss_pred             C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC--CCh--
Confidence            2  2344568999999999998889999999999999999999999997533211       11112111110  001  


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              1112335678899999999999999999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=359.49  Aligned_cols=266  Identities=27%  Similarity=0.450  Sum_probs=214.2

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCL  383 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  383 (597)
                      .+...++|++.+.||+|+||.||+|.+.      +++.||||.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445678999999999999999999962      3568999998643 334457899999999999 8999999999999


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQIEE--------------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHR  443 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~  443 (597)
                      +.+..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999865321                    24899999999999999999999999   9999


Q ss_pred             cCCCCCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCC
Q 038707          444 DIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIR  521 (597)
Q Consensus       444 Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~  521 (597)
                      ||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986654332 23344557889999999998999999999999999999998 999997


Q ss_pred             CCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          522 AINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .....+      .+...+..+..         ...+...++.+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       277 ~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          277 GIPVDA------NFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             TCCCSH------HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cCCcHH------HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            654322      11222222111         111223456788999999999999999999999999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=356.29  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=200.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC-C---cEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD-G---RIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      ..++|++.+.||+|+||+||+|.+.. +   ..||||.+...  .....+++.+|+.++++++||||+++++++.+.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999999753 3   27999988753  455678899999999999999999999999887655


Q ss_pred             ------eEEEeccCCCChhhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEE
Q 038707          389 ------LLVYEFIPNGTLYQYIHNQIE---EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       389 ------~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                            ++||||+++++|.+++.....   ...+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  999999999999999976432   225899999999999999999999999   99999999999999999999


Q ss_pred             EeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHH
Q 038707          460 VSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYN  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HHH
Confidence            999999976543322 22233446789999999999999999999999999999999 999997654332       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+..+..         .......++.+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       251 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111         111233456789999999999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.5e-42  Score=346.75  Aligned_cols=257  Identities=29%  Similarity=0.442  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|.+.+.||+|+||+||+|.+..    +..||+|..... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4679999999999999999998643    346999998754 44567889999999999999999999999764 45789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++....  ..+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999998643  34899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+   .    ...+..+..     
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~----~~~~~~~~~-----  232 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---V----IGVLEKGDR-----  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---H----HHHHHHTCC-----
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---H----HHHHhcCCC-----
Confidence            443333444557889999999998999999999999999999998 999997544332   1    111111111     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                          ...+...++.+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                01122334568899999999999999999999999998865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-42  Score=355.84  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=204.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999976 689999998764332 334678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999999754   34999999999999999999999999   9999999999999999999999999997654322


Q ss_pred             c-eeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          474 T-HLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       474 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........     .+..........      
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~------  228 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYL------  228 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHHHHHTTCTTS------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHhcccccC------
Confidence            2 22345679999999999987765 7899999999999999999999976443221     111111111110      


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               1112334567899999999999999999999763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-43  Score=360.97  Aligned_cols=267  Identities=26%  Similarity=0.422  Sum_probs=216.7

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEecC-C-----cEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEE
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLTD-G-----RIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCC  382 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  382 (597)
                      +++...++|++.+.||+|+||.||+|.... +     ..||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            444556889999999999999999999752 2     47999988754 344567899999999999 899999999999


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIE-----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL  451 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIl  451 (597)
                      .+.+..++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999999986421           235899999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK  529 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~  529 (597)
                      ++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence            999999999999999865433322 2334457889999999998999999999999999999998 999997644322  


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                          .+......+.         ....+...++.+.+|+.+||+.||.+|||+.+|++.|+++...
T Consensus       275 ----~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 ----KFYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             ----HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                1111111111         0111222345688999999999999999999999999988653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.5e-42  Score=351.68  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=203.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV------  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  387 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999986 7999999998653 34456789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------ceEEEeccCCCChhhHHhhcCCCCCCCHH
Q 038707          388 ---------------------------------------------------PLLVYEFIPNGTLYQYIHNQIEEFPITWE  416 (597)
Q Consensus       388 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~  416 (597)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999987665667888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc-----------eeeeccccccc
Q 038707          417 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-----------HLTTKVQGTFG  485 (597)
Q Consensus       417 ~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~  485 (597)
                      .++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999999   99999999999999999999999999987654321           12233469999


Q ss_pred             ccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHH
Q 038707          486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVA  565 (597)
Q Consensus       486 y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~  565 (597)
                      |+|||++.+..++.++||||||+++|||++|..|+..        .. ...........         ........+.+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~-~~~~~~~~~~~---------~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RV-RIITDVRNLKF---------PLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HH-HHHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HH-HHHHHhhccCC---------CcccccCChhHH
Confidence            9999999999999999999999999999998776421        00 01111111111         111234455678


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 038707          566 TLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       566 ~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +||.+||+.||++|||+.|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-41  Score=344.19  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=210.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEE-EeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC-LETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  392 (597)
                      ..++|++.+.||+|+||+||+|.+. +++.||||.....  ....++.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999974 6899999975532  2234688999999999988877766655 5677889999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~  469 (597)
                      ||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 999999998543  24999999999999999999999999   9999999999999   78899999999999876


Q ss_pred             cCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          470 MVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       470 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543321      22345689999999999999999999999999999999999999987665554443322211111111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .         .......++.+.+|+.+||+.||++|||+++|++.|+++..+.
T Consensus       239 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          239 I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            0         0111223567899999999999999999999999999988765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=351.21  Aligned_cols=257  Identities=30%  Similarity=0.488  Sum_probs=202.7

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|+||+||++.+. ++.||||++..  ....+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56888999999999999999875 78899999863  445678999999999999999999999876  45899999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc-EEEeeccccccccCCCce
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-~kl~Dfgl~~~~~~~~~~  475 (597)
                      +++|.+++........+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999987654445889999999999999999999932222999999999999988876 799999999754322   


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    .. .......+..         ..
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~-~~~~~~~~~~---------~~  224 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FR-IMWAVHNGTR---------PP  224 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HH-HHHHHHTTCC---------CC
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HH-HHHHHhcCCC---------CC
Confidence             223458999999999999999999999999999999999999997543221    11 1111111111         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .....+..+.+|+.+||+.||++|||++++++.|+.+....
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            12233456889999999999999999999999999987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.5e-42  Score=353.98  Aligned_cols=262  Identities=26%  Similarity=0.442  Sum_probs=214.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLE  384 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  384 (597)
                      ..++|++.+.||+|+||.||+|.+.        +++.||||++... .....+++.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        4678999998753 345567899999999999 89999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL  451 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIl  451 (597)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999986532             134899999999999999999999999   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK  529 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~  529 (597)
                      ++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence            999999999999999876543322 2333457889999999988889999999999999999999 999997543221  


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           ....+..+..         ...+...+..+.+|+.+||+.||.+|||+.|+++.|+++.+.
T Consensus       268 -----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          268 -----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             -----HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 1122222111         111233456688999999999999999999999999998754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5e-42  Score=357.95  Aligned_cols=270  Identities=16%  Similarity=0.220  Sum_probs=209.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEecC------CcEEEEEEccccChhh-----------HHHHHHHHHHHhhcCCCccce
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDETN-----------VEQFINEVVILSQINHRNIVK  377 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  377 (597)
                      ..++|++.+.||+|+||+||+|.+..      ++.||||.+.......           ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999999764      4789999876543221           123455677788889999999


Q ss_pred             eeeEEEeC----CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          378 LLGCCLET----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       378 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      +++++.+.    ...+|||||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4579999999 999999998742  35999999999999999999999999   99999999999998


Q ss_pred             --CCCcEEEeeccccccccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Q 038707          454 --DKYRAKVSDFGTSRSVMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT  525 (597)
Q Consensus       454 --~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~  525 (597)
                        .++.+||+|||+++........      ......||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999776432221      11334599999999999999999999999999999999999999985332


Q ss_pred             cCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ..  .......... ...+.+.++..+.   ....++++.+|+..||+.+|.+||++.+|++.|+++...+
T Consensus       267 ~~--~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          267 DP--KYVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             CH--HHHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CH--HHHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            22  1111111111 1122222222111   1233567899999999999999999999999999987765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=353.70  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=206.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456999999999999999999976 689999998764322      2467899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg  464 (597)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999999753   34999999999999999999999999   99999999999999887    89999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      .. ..+.....
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~-~~~~~~~~  234 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVNY  234 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHTCC
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHHhcCC
Confidence            998764322  2334569999999999998999999999999999999999999997533211      11 11111110


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .  ...    ......+..+.+||.+||+.||++|||+.|+++
T Consensus       235 ~--~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 E--FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C--CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C--cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0  000    111223456889999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.1e-42  Score=344.75  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=208.3

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|.++ ++.||||.+...  .....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57899999999999999999985 889999987753  345567899999999999999999999999887  7889999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.... ...+++..++.++.||++||.|||+++. +|+||||||+|||+++++.+||.|||++..... 
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            9999999999998643 3358999999999999999999999763 499999999999999999999999988754322 


Q ss_pred             CceeeecccccccccCccccccCCCCc---ccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTE---KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                           ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+      ........+..     
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~-----  229 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR-----  229 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC-----
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC-----
Confidence                 2235799999999998755444   8999999999999999999997543221      11111111111     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                          ...+...++.+.+|+.+||+.||++|||++++++.|+++++
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 ----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                11123345678999999999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=359.18  Aligned_cols=249  Identities=29%  Similarity=0.405  Sum_probs=202.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcce
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  389 (597)
                      ..++|++.+.||+|+||+||++... +++.||||+++..   .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999976 5899999987642   234566788999999998 6999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |||||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999998653   3999999999999999999999999   999999999999999999999999999754


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+       ....+..+..     
T Consensus       175 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~-----  241 (353)
T 3txo_A          175 ICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV-----  241 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred             ccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            322 223445679999999999999899999999999999999999999997543221       1122222111     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM------KEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~  587 (597)
                           ..+...+..+.+||.+||+.||.+||++      +|+++
T Consensus       242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 1122244568899999999999999998      66654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=359.45  Aligned_cols=250  Identities=25%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.++||+|+||+||++... +++.||||+++..   .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 5889999987642   233445688999999887 89999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++.+..   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999998643   4999999999999999999999999   9999999999999999999999999997643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC--CcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED--KSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.  ........+.+.....    
T Consensus       205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  279 (396)
T 4dc2_A          205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  279 (396)
T ss_dssp             CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred             cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence            22 2234456799999999999999999999999999999999999999975433221  1111122222222111    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                            ..+...+.++.+||.+||+.||.+||++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  1123345668899999999999999996

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=364.17  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=206.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..++|++.+.||+|+||+||++... +|+.+|+|.+...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4577999999999999999999975 6899999987643  234567799999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC---CCCcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfgl~~~  468 (597)
                      |||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++   +++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999998643   4999999999999999999999999   99999999999998   567899999999976


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+       ....+..+....  
T Consensus       163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~--  232 (444)
T 3soa_A          163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDF--  232 (444)
T ss_dssp             CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC--
T ss_pred             ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCC--
Confidence            64332 22344679999999999999999999999999999999999999996533211       222222222110  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ........++++.+||.+||+.||++|||+.|+++
T Consensus       233 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 ----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                00011233566889999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-42  Score=355.54  Aligned_cols=271  Identities=26%  Similarity=0.461  Sum_probs=220.1

Q ss_pred             cccCHHHHHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccce
Q 038707          305 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVK  377 (597)
Q Consensus       305 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  377 (597)
                      ..+..++++...++|++.+.||+|+||.||+|.+.      +++.||||.+... ......++.+|+.++++++||||++
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34555666677789999999999999999999864      3678999998743 3345667999999999999999999


Q ss_pred             eeeEEEeCCcceEEEeccCCCChhhHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 038707          378 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI  450 (597)
Q Consensus       378 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NI  450 (597)
                      +++++.+.+..++||||+++++|.+++.....       ..++++..++.++.||+.||.|||+++   |+||||||+||
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI  169 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC  169 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence            99999999999999999999999999986321       135799999999999999999999999   99999999999


Q ss_pred             EeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCC
Q 038707          451 LLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED  528 (597)
Q Consensus       451 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~  528 (597)
                      |++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+ 
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  248 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-  248 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-
Confidence            9999999999999999765433222 1223346889999999999999999999999999999999 899987543221 


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ....+..+...         ......+..+.+|+.+||+.||.+|||+.|+++.|+++..
T Consensus       249 ------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 ------VLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                  12222222111         1123345668899999999999999999999999988743

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.2e-42  Score=356.68  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=207.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..++|++.+.||+|+||.||++... +++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999976 6899999987643  445667899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfgl~~~  468 (597)
                      |||+++|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999999754   34899999999999999999999999   99999999999998654   599999999976


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+..+....  
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~--  249 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY--  249 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence            64322  2334569999999999999899999999999999999999999997533211       122222221110  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                          ........++++.+||.+||+.||++|||+.|+++.
T Consensus       250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000112335568899999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-42  Score=345.77  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=212.2

Q ss_pred             cCCccCC-cccccCceEEEEEEec---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANR-ILGQGGQGTVYKGMLT---DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||.+... .....+++.+|+.++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 9999999999999864   5788999998764 445678899999999999999999999999 56678999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999999753  335999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          472 DQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       472 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+       ....+..+..    
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~----  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR----  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCC----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCc----
Confidence            33322  223346889999999988889999999999999999998 999997644322       1122222211    


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                           ...+...++.+.+||.+||+.||++||++.++++.|+++..+.
T Consensus       232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                 1112344567899999999999999999999999999987653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-42  Score=358.20  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=209.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999976 6899999998876666777899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC--CCcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999997542  34899999999999999999999999   999999999999974  577999999999876443


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      ..  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+......  .+   
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~~~--~~---  270 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE--FD---  270 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC--CC---
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CC---
Confidence            22  333469999999999999999999999999999999999999997533211       11111111110  00   


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       .......+.++.+||.+||+.||.+|||+.|+++.
T Consensus       271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             11112345668899999999999999999999873

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-42  Score=367.14  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=209.0

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      ++....++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999986 5899999987531   1222345889999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+|||||+++|+|.++++..    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999999754    3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCC----CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      +..............||+.|+|||++.+..    ++.++||||||++||||++|+.||...+..+      .+...+...
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~  289 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHK  289 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHH
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHhcc
Confidence            876554444445677999999999997655    8899999999999999999999997533221      111111100


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKM--RPTMKEVTNE  588 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  588 (597)
                      .       .+........+.++.+||.+||+.+|.+  ||+++||++.
T Consensus       290 ~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 N-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             H-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0       0000011134567889999999999988  9999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.2e-42  Score=347.42  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=208.5

Q ss_pred             cCCccCCcccccCceEEEEEEe-----cCCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--Ccc
Q 038707          317 DNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  388 (597)
                      +.|++.+.||+|+||.||++.+     .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4589999999999999999984     35889999997743 334567899999999999999999999999876  567


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999997643  34999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCC--------cCCCcHHHHHHHH
Q 038707          469 VMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT--------DEDKSLVGYFLQA  538 (597)
Q Consensus       469 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~~  538 (597)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.....        .............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6544332  23345588889999999999999999999999999999999998642110        0000000111111


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      +..+         .....+...++.+.+|+.+||+.||.+|||+.+++++|+++.
T Consensus       256 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111         111122344567999999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.6e-42  Score=351.33  Aligned_cols=271  Identities=28%  Similarity=0.433  Sum_probs=219.7

Q ss_pred             cCHHHHHHHhcCCccCCcccccCceEEEEEEe------cCCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCcccee
Q 038707          307 FTSKDLEKATDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKL  378 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l  378 (597)
                      +...+.....++|++.+.||+|+||+||+|.+      .+++.||||.+... .......+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556666678999999999999999999984      24689999998753 344567899999999999 69999999


Q ss_pred             eeEEEeCC-cceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 038707          379 LGCCLETE-VPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD  444 (597)
Q Consensus       379 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~D  444 (597)
                      ++++.+.+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988765 58999999999999999987533             123889999999999999999999999   99999


Q ss_pred             CCCCCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCC
Q 038707          445 IKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA  522 (597)
Q Consensus       445 ik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~  522 (597)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986644332 23344567899999999999999999999999999999998 9999976


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ....+      .+...+..+..         ...+...++.+.+++.+||+.||.+|||+.||++.|+++.+.
T Consensus       254 ~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          254 VKIDE------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCCSH------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhH------HHHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            44322      11122222111         111222345688999999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-42  Score=354.43  Aligned_cols=270  Identities=28%  Similarity=0.407  Sum_probs=211.0

Q ss_pred             CccCCcccccCceEEEEEEec-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--CcceE
Q 038707          319 YNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL  390 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  390 (597)
                      |++.+.||+|+||+||++.+.     +++.||||++... .....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999998653     5789999998753 345567899999999999999999999999884  56789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++...    .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999999764    3899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  ......+|..|+|||++.+..++.++||||||+++|+|++|+.||........ ..............+.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence            43322  23344578889999999998999999999999999999999999864221100 0000000000000111111


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ........+...+..+.+||.+||+.||++|||+.|+++.|+++.+++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            111112223345567999999999999999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.7e-41  Score=340.58  Aligned_cols=264  Identities=19%  Similarity=0.257  Sum_probs=212.6

Q ss_pred             hcCCccCCcccccCceEEEEEEe-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEE-EeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC-LETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||.||+|.. .+++.||||.+....  ...++.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999997 478999999876432  234688999999999988877666555 56677899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 999999997543  34999999999999999999999999   9999999999999   488899999999998765


Q ss_pred             CCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          471 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       471 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            43321      123456999999999999999999999999999999999999999876654444333222221111110


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                               .......++.+.+|+.+||+.||++|||+++|++.|+++....
T Consensus       240 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          240 ---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             ---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence                     0111234567899999999999999999999999999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-41  Score=346.75  Aligned_cols=271  Identities=24%  Similarity=0.374  Sum_probs=208.8

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc--CCCccceeeeEEEeC--
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI--NHRNIVKLLGCCLET--  385 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--  385 (597)
                      .......++|++.+.||+|+||.||+|.+. ++.||||++..   .....+..|.+++..+  +||||+++++++.+.  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            333445678999999999999999999985 89999998763   2334555666666655  899999999999887  


Q ss_pred             --CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeccCCCCCeEeCCC
Q 038707          386 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA--------ASIPIYHRDIKSANILLDDK  455 (597)
Q Consensus       386 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~~~~i~H~Dik~~NIll~~~  455 (597)
                        ...++||||+++|+|.++++..    .+++..++.++.|++.||.|||+.        +   |+||||||+|||++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN  178 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence              6789999999999999999754    399999999999999999999998        7   9999999999999999


Q ss_pred             CcEEEeeccccccccCCCcee---eecccccccccCccccccCCCCcc------cceeehHHHHHHHHhC----------
Q 038707          456 YRAKVSDFGTSRSVMVDQTHL---TTKVQGTFGYVDPEYFQSSQFTEK------SDVYSFGVVLVEILTG----------  516 (597)
Q Consensus       456 ~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDv~SlG~il~ell~g----------  516 (597)
                      +.+||+|||++..........   .....||+.|+|||++.+...+.+      +||||||+++|||++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997664332221   224569999999999987766655      9999999999999999          


Q ss_pred             CCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          517 QKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       517 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      +.||.........  ................+...   ......++++.+|+.+||+.||++|||+.+|+++|+++.++.
T Consensus       259 ~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          259 QLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHhhhcCCCCc--hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            6666544332221  11112222111111111111   112366788999999999999999999999999999998753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=358.75  Aligned_cols=268  Identities=27%  Similarity=0.439  Sum_probs=215.5

Q ss_pred             hcCCccCCcccccCceEEEEEEe-----cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--cc
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  388 (597)
                      .++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999984     358899999988777777889999999999999999999999987654  78


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++....  ..+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999999998753  34899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc---
Q 038707          469 VMVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---  543 (597)
Q Consensus       469 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  543 (597)
                      ........  .....++..|+|||.+.+..++.++||||||+++|+|++|..|+....        ..+........   
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--------~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--------AEFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--------HHHHHHHCTTCCTH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--------HHHHHhhccccchh
Confidence            65443321  223446778999999998889999999999999999999999875321        00111111110   


Q ss_pred             -----hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          544 -----LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       544 -----~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                           +.+.+........+...+.++.+||.+||+.||++|||+.||++.|+++++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                 00111111111122344567999999999999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.9e-43  Score=382.85  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=215.2

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            344457789999999999999999999888889999987543 345789999999999999999999999876 678999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.++++... ...+++.+++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999997532 234899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..........++..|+|||++....++.++||||||++||||++ |+.||......+       ....+..+..      
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~------  482 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR------  482 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCC------
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence            22222233446788999999998999999999999999999999 999997543221       1222222211      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                         ...+...++.+.+||.+||+.||++|||+++|+++|+.+..+
T Consensus       483 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          483 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence               111234456789999999999999999999999999988654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=348.22  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHh
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--------------------------TNVEQFINEVVILS  368 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~E~~~l~  368 (597)
                      .++|++.+.||+|+||.||+|... +++.||||.+.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999975 689999998754321                          12457899999999


Q ss_pred             hcCCCccceeeeEEEe--CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 038707          369 QINHRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK  446 (597)
Q Consensus       369 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik  446 (597)
                      +++||||+++++++.+  .+..++||||+++++|.+++..    .++++..++.++.||++||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  5678999999999999887543    35999999999999999999999999   9999999


Q ss_pred             CCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccCC---CCcccceeehHHHHHHHHhCCCCCCCC
Q 038707          447 SANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAI  523 (597)
Q Consensus       447 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlG~il~ell~g~~p~~~~  523 (597)
                      |+|||++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++||||||+++|+|++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987653322 234456999999999997655   478999999999999999999999643


Q ss_pred             CCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          524 NTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..      .. ....+......        .......++.+.+||.+||+.||++|||+.|+++
T Consensus       244 ~~------~~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RI------MC-LHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SH------HH-HHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cH------HH-HHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21      11 11111111110        0001233456889999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-41  Score=356.63  Aligned_cols=267  Identities=20%  Similarity=0.305  Sum_probs=206.3

Q ss_pred             hcCCccCCccccc--CceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQG--GQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|  +||+||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999986 6999999987643  34556788899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999998752 234999999999999999999999999   9999999999999999999999999986543


Q ss_pred             CCCce------eeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH---
Q 038707          471 VDQTH------LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI---  539 (597)
Q Consensus       471 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  539 (597)
                      .....      ......||+.|+|||++.+  ..++.++||||||+++|||++|+.||......+.  .........   
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence            22111      1122368899999999987  6799999999999999999999999976543321  000000000   


Q ss_pred             -h------------------cCchhhhhhH---------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          540 -N------------------ENRLFEALDA---------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       540 -~------------------~~~~~~~l~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       .                  .....+.+..         ..........++.+.+||.+||+.||++|||+.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence             0                  0000000000         00001123345678999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.7e-42  Score=344.22  Aligned_cols=255  Identities=33%  Similarity=0.569  Sum_probs=204.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhh-------HHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN-------VEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||.+.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367999999999999999999975 68999999876432211       167899999999999999999999986544 


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc-----EEEee
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSD  462 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-----~kl~D  462 (597)
                       ++||||+++++|.+++.+..  .++++..++.++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             79999999999999987643  35999999999999999999999987 34999999999999988776     99999


Q ss_pred             ccccccccCCCceeeecccccccccCcccc--ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      ||+++....    ......||+.|+|||.+  ....++.++||||||+++|+|++|+.||......+.    . ......
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~-~~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----K-FINMIR  243 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----H-HHHHHH
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----H-HHHHHh
Confidence            999975432    23445689999999998  445678999999999999999999999975443321    1 111111


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      .....        ...+...++.+.+|+.+||+.||.+|||++|+++.|++|
T Consensus       244 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EEGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HSCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ccCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11111        111233456789999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-41  Score=350.76  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=203.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||.||++... +++.||||.+...   .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56999999999999999999986 5899999987642   345567789999999998 899999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999998643   4999999999999999999999999   99999999999999999999999999976432


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC--cHHHHHHHHHhcCchhhhhh
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK--SLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..  .......+.+.....     
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  236 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  236 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence            22 2234567999999999999999999999999999999999999999754332211  111112222222111     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                           ..+...+..+.+||.+||+.||.+||++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 1122345668899999999999999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9e-42  Score=350.30  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=183.4

Q ss_pred             CCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccCCCC
Q 038707          322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  399 (597)
                      .+.||+|+||+||++.+. +++.||||++..   .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999986 689999999863   34567889999999997 9999999999999999999999999999


Q ss_pred             hhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEeeccccccccCCCcee
Q 038707          400 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      |.+++...   ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++...... ..
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~  165 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP  165 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence            99999864   34999999999999999999999999   99999999999997665   89999999998654322 22


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA  556 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  556 (597)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+..+....      ....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence            3445689999999999999999999999999999999999999976544322222222333333322210      0111


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       557 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ....++++.+||.+||+.||.+|||++|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1234567899999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-42  Score=348.58  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-C-------cEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-G-------RIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||+||+|.+.. +       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578999999999999999998653 3       5799999877667778899999999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc--------EE
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--------AK  459 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--------~k  459 (597)
                      .++||||+++++|.+++....  ..+++..++.++.||++||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999998743  34899999999999999999999999   999999999999998887        99


Q ss_pred             EeeccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCC-CCCCCCcCCCcHHHHHHH
Q 038707          460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKP-IRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p-~~~~~~~~~~~~~~~~~~  537 (597)
                      |+|||++......     ....+|+.|+|||++.+ ..++.++||||||+++|||++|..| +.......       ...
T Consensus       162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~  229 (289)
T 4fvq_A          162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQ  229 (289)
T ss_dssp             ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHH
T ss_pred             eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-------HHH
Confidence            9999998654321     23458899999999987 7799999999999999999996544 43322111       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ......           ..+...+.++.+|+.+||+.||++|||++++++.|+++.+.
T Consensus       230 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          230 FYEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HhhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111100           01111234578999999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.9e-42  Score=353.82  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=206.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      .++|++.+.||+|+||+||++... +++.||||.+...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999975 6899999987532     1224678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEeeccc
Q 038707          390 LVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGT  465 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfgl  465 (597)
                      +||||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998887542 2345899999999999999999999999   999999999999987654   99999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....       .. ....+..+...
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~-~~~~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ER-LFEGIIKGKYK  250 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HH-HHHHHHHTCCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HH-HHHHHHcCCCC
Confidence            98764332 22344569999999999999999999999999999999999999997521       11 11112111110


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+..    ....++.+.+||.+||+.||++|||+.|+++
T Consensus       251 --~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 --MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              01111    1223567889999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-42  Score=355.20  Aligned_cols=256  Identities=24%  Similarity=0.469  Sum_probs=205.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ++|++.+.||+|+||+||+|.+. +++    .||+|.+... .......+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46889999999999999999975 444    3788876532 2334467889999999999999999999886 456889


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999864  235899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+...   
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERL---  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBC---
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC---
Confidence            43322 2344567889999999999999999999999999999999 999998654333       11222221110   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ..+...+..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  1112233457789999999999999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-41  Score=347.57  Aligned_cols=264  Identities=25%  Similarity=0.436  Sum_probs=204.3

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ...++|.+.+.||+|+||.||+|.+.    .++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34577999999999999999999864    2458999997653  44556789999999999999999999999987653


Q ss_pred             -----ceEEEeccCCCChhhHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEE
Q 038707          388 -----PLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       388 -----~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                           .++||||+++++|.+++....   ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                 499999999999999996432   2346999999999999999999999999   99999999999999999999


Q ss_pred             EeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHH
Q 038707          460 VSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      |+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+       ...
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~  260 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYD  260 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHH
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHH
Confidence            999999976543322 12233457889999999999999999999999999999999 889987654332       111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .+..+..         ...+...++.+.+|+.+||+.||.+|||+.+++++|+++.+++
T Consensus       261 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLLHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            1111111         1112334567899999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=352.90  Aligned_cols=257  Identities=23%  Similarity=0.471  Sum_probs=203.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      .++|++.+.||+|+||+||+|.+. +++    +||+|.+.. ......+++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357999999999999999999965 444    457777653 33456788999999999999999999999998765 78


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +|+||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999999998753  34899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          470 MVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       470 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+..   
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~---  237 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER---  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCC---
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---
Confidence            43222 22333446889999999999999999999999999999999 999997654433       1122222111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ...+...+..+.+|+.+||+.||.+|||+.|+++.|+++..
T Consensus       238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                  11122344568899999999999999999999999998864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-41  Score=344.61  Aligned_cols=259  Identities=31%  Similarity=0.498  Sum_probs=206.8

Q ss_pred             cCCccCCcccccCceEEEEEEecC----CcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEE-eCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  390 (597)
                      .+|++.+.||+|+||+||+|.+.+    ...+|+|.+.. ......+.+.+|+.++++++||||+++++++. +.+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            568889999999999999999642    23689998765 34456678999999999999999999999865 4567899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus       105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999997633  34899999999999999999999999   9999999999999999999999999998664


Q ss_pred             CCCc---eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          471 VDQT---HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       471 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+   .    ...+..+..  
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~----~~~~~~~~~--  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----TVYLLQGRR--  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---H----HHHHHTTCC--
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---H----HHHHhcCCC--
Confidence            3322   12334457889999999999999999999999999999999 556665443322   1    111111111  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                             ...+...+..+.+|+.+||+.||++|||++|++++|+++...+
T Consensus       251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          251 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                   0111223456889999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.2e-42  Score=350.91  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=213.5

Q ss_pred             cCCccCCcccccCceEEEEEEe-----cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  389 (597)
                      ++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5799999999999999999984     3588999999987777778889999999999999999999999874  45688


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++++|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999986432  4999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcC--------CCcHHHHHHHHH
Q 038707          470 MVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--------DKSLVGYFLQAI  539 (597)
Q Consensus       470 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~~~  539 (597)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......        ..........  
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE--  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH--
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH--
Confidence            543332  2233457888999999999899999999999999999999999986422110        0000001111  


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                             .+........+...++.+.+||.+||+.||++|||++|++++|+.+...
T Consensus       256 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          256 -------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             -------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence                   1111111122334556799999999999999999999999999988653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.2e-42  Score=346.57  Aligned_cols=261  Identities=22%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||+||+|...+++.||+|++.....  .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999998765432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++ +|.+++....  ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            975 9999987643  34899999999999999999999999   9999999999999999999999999997654322 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch---hh----
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL---FE----  546 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~----  546 (597)
                      .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   ..............   ..    
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcc
Confidence            22334468999999999876 458999999999999999999999997543221   11111111111000   00    


Q ss_pred             -hhhHHh-------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 -ALDARV-------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 -~l~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ..++..       ........++++.+||.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000000       00111234567889999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.2e-41  Score=346.27  Aligned_cols=274  Identities=23%  Similarity=0.360  Sum_probs=216.9

Q ss_pred             cCHHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCccceeeeEEEe
Q 038707          307 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ--INHRNIVKLLGCCLE  384 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  384 (597)
                      .+........++|++.+.||+|+||.||+|.+ +++.||||.+..   .....+.+|++++..  ++||||+++++++.+
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33444456678899999999999999999998 589999999863   345678889999888  789999999999988


Q ss_pred             CC----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCeEe
Q 038707          385 TE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH--------SAASIPIYHRDIKSANILL  452 (597)
Q Consensus       385 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~i~H~Dik~~NIll  452 (597)
                      ..    ..++||||+++|+|.+++.+.    .+++..++.++.|++.||.|||        +.+   |+||||||+|||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            76    789999999999999999764    3899999999999999999999        777   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCce---eeecccccccccCccccccC------CCCcccceeehHHHHHHHHhC-------
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTG-------  516 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlG~il~ell~g-------  516 (597)
                      +.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++||||||+++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999776543332   22345689999999998765      334789999999999999999       


Q ss_pred             ---CCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          517 ---QKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       517 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                         +.||......+.. . ......+........+....   ...+.+..+.+|+.+||+.||++|||+.+|+++|+++.
T Consensus       261 ~~~~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPS-V-EEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCCTTTTTSCSSCC-H-HHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCccccCcCccc-H-HHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence               7788654433221 1 11222222222211111111   12456678999999999999999999999999999998


Q ss_pred             hhc
Q 038707          594 TSI  596 (597)
Q Consensus       594 ~~~  596 (597)
                      ++.
T Consensus       336 ~~~  338 (342)
T 1b6c_B          336 QQE  338 (342)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=347.44  Aligned_cols=244  Identities=28%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++... +|+.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57999999999999999999976 6899999987642   1234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999998643   4899999999999999999999999   999999999999999999999999999865322


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..      ..+.... ....        
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~--------  220 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKIL-NAEL--------  220 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HCCC--------
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC--------
Confidence                23456999999999999999999999999999999999999999753321      1111111 1111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                        ..+...+.++.+||.+||+.||++||     +++++++
T Consensus       221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence              11123345688999999999999999     8888874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-42  Score=363.27  Aligned_cols=261  Identities=24%  Similarity=0.294  Sum_probs=208.9

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      .++.....++|++.+.||+|+||+||++... +++.||||++...   .....+.+.+|+.++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444555688999999999999999999986 6999999987632   22234568899999999999999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      .+..+|||||+++|+|.+++.+..  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999998643  24999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccc-------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      +++..............||+.|+|||++.       ...++.++||||||+++|||++|+.||...+..+      .+..
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~  281 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYGK  281 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence            99876554444444567999999999987       3578999999999999999999999997543221      1111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR---PTMKEVTN  587 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~  587 (597)
                      .....   ..+.   ........+.++.+||.+||. +|.+|   |+++|+++
T Consensus       282 i~~~~---~~~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          282 IVHYK---EHLS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHTHH---HHCC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHhcc---cCcC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11100   0000   000112345678999999998 99998   58888865

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.3e-42  Score=354.99  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCc
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV  387 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  387 (597)
                      ....++|++.+.||+|+||.||+|..+ +++.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999986 6899999987642   133456788999999987 89999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999998643   4899999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+       ....+..+..   
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~---  235 (345)
T 1xjd_A          167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP---  235 (345)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC---
T ss_pred             hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCC---
Confidence            643222 22345679999999999999999999999999999999999999997543211       1122211111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK-EVT  586 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl  586 (597)
                             ..+...+.++.+||.+||+.||++||++. +++
T Consensus       236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   11122345688999999999999999997 554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=350.40  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=205.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      .++|.+.+.||+|+||.||+|.+..     +..||||.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567888999999999999998653     246999998753 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999998642  35999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          470 MVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       470 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+..  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~--  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR--  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC--
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCc--
Confidence            433221  1223346788999999998999999999999999999999 999996543211       1222222211  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                             ...+...+..+.+|+.+||+.||++||++.++++.|+++...
T Consensus       269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   111223456688999999999999999999999999987643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=342.61  Aligned_cols=258  Identities=26%  Similarity=0.455  Sum_probs=207.3

Q ss_pred             CCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc-eEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP-LLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  391 (597)
                      .|...++||+|+||+||+|.+.+    +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667899999999999998642    237999987753 345568899999999999999999999999876655 999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+.+++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999763  235899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CC---ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCC-CCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          472 DQ---THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI-RAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       472 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ..   ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+ ......+       ....+..+..   
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~---  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRR---  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCC---
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCC---
Confidence            22   11233445788999999999999999999999999999999965554 3322221       1111111111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                            ...+...++.+.+|+.+||+.||.+|||+++++++|+++.+++
T Consensus       247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                  1112233456889999999999999999999999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-42  Score=357.19  Aligned_cols=259  Identities=30%  Similarity=0.502  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEec--CC--cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe-CCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT--DG--RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  390 (597)
                      ..|++.+.||+|+||+||+|.+.  ++  ..||+|.+.. ......+++.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            34777889999999999999864  22  4689998764 344567889999999999999999999998765 457899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++....  ..+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999997643  34889999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCce---eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          471 VDQTH---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       471 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+   .    ...+..+... 
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~----~~~~~~~~~~-  315 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----TVYLLQGRRL-  315 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---H----HHHHHTTCCC-
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---H----HHHHHcCCCC-
Confidence            32211   2233457789999999999999999999999999999999 777886654333   1    1111121110 


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                              ..+...+..+.+|+.+||+.||++|||++|+++.|+++..++
T Consensus       316 --------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          316 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                    112234456889999999999999999999999999987654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.1e-42  Score=343.37  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=203.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-CcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||++..+ ++.||||.+...  ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467999999999999999999874 889999998743  3567899999999999999999999997655 478999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++.... ...+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            99999999997642 223889999999999999999999999   999999999999999999999999998754322  


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                        .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+.         .
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~  232 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY---------K  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTC---------C
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC---------C
Confidence              223357889999999998999999999999999999998 999997654322       111221111         1


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ...+...++.+.+|+.+||+.||++|||+.++++.|+++++.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            112233456789999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.6e-41  Score=351.70  Aligned_cols=244  Identities=23%  Similarity=0.300  Sum_probs=205.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||++... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999976 6899999987542   2234577899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999998643   3899999999999999999999999   999999999999999999999999999865432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       ....+..+..        
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~--------  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV--------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--------
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence                234569999999999999999999999999999999999999997533211       1222222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                        ..+...+..+.+||.+||+.||.+||+     ++||++
T Consensus       256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              112234566889999999999999998     777764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-41  Score=351.80  Aligned_cols=268  Identities=26%  Similarity=0.350  Sum_probs=208.5

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCccceeeeEEE
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCL  383 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  383 (597)
                      .++....++|++.+.||+|+||+||+|... +++.||+|.+...     .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            445667788999999999999999999975 6889999987532     3456678999999999999999999999999


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcCC-------------------------------------CCCCCHHHHHHHHHHHH
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQIE-------------------------------------EFPITWELLLRIAVEVS  426 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~qi~  426 (597)
                      +.+..++||||+++|+|.+++.....                                     ...+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            99999999999999999999963110                                     12246788899999999


Q ss_pred             HHHHHHHhCCCCCeEeccCCCCCeEeCCCC--cEEEeeccccccccCCC---ceeeecccccccccCcccccc--CCCCc
Q 038707          427 GALFYLHSAASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQ---THLTTKVQGTFGYVDPEYFQS--SQFTE  499 (597)
Q Consensus       427 ~~L~~LH~~~~~~i~H~Dik~~NIll~~~~--~~kl~Dfgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~  499 (597)
                      +||+|||+.+   |+||||||+|||++.++  .+||+|||++.......   ........||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999999   99999999999998776  89999999998654322   122345569999999999865  67899


Q ss_pred             ccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCC
Q 038707          500 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR  579 (597)
Q Consensus       500 ~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  579 (597)
                      ++||||||+++|||++|+.||......+      .............       .......++.+.+||.+||+.||.+|
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999997543221      1222222211111       01112235568899999999999999


Q ss_pred             CCHHHHHHH--Hhhhh
Q 038707          580 PTMKEVTNE--LGGIR  593 (597)
Q Consensus       580 Pt~~evl~~--L~~l~  593 (597)
                      ||+.++++.  |+++.
T Consensus       323 ps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          323 FDAMRALQHPWISQFS  338 (345)
T ss_dssp             CCHHHHHHSHHHHTTS
T ss_pred             CCHHHHhcChhhccCh
Confidence            999999873  44443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=355.72  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999976 5899999987532   2334678899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999864   34999999999999999999999999   999999999999999999999999999865432


Q ss_pred             CceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                        .......||+.|+|||++..   ..++.++||||||+++|||++|+.||...........    ...+....      
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~----~~~~~~~~------  236 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI----VHTFETTV------  236 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH----HHHHHHCC------
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH----HHHHhhcc------
Confidence              23345679999999999864   4589999999999999999999999976443331111    11111111      


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-MKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  587 (597)
                          ...+...+..+.+||.+||+.||.+||+ +++|++
T Consensus       237 ----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                1112334567899999999999999998 666654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.8e-42  Score=353.28  Aligned_cols=245  Identities=24%  Similarity=0.316  Sum_probs=202.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67999999999999999999974 6899999987532   1222457889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+ +|+|.+++....   .+++.+++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 789999987643   4999999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+....       +....        
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~~--------  224 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSCV--------  224 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSSC--------
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcCC--------
Confidence            2  2334569999999999988776 7899999999999999999999976543321110       00000        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ...+...++.+.+||.+||+.||.+|||++|+++
T Consensus       225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              0112233456889999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=346.52  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=209.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  390 (597)
                      .++|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999999974 789999999877677778899999999999999999999999873    347789


Q ss_pred             EEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ||||+++++|.+++.... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999998632 2346999999999999999999999999   999999999999999999999999998764


Q ss_pred             cCCCce--------eeecccccccccCccccccCC---CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHH
Q 038707          470 MVDQTH--------LTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       470 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      ......        ......||+.|+|||++....   ++.++||||||+++|+|++|+.||........ ...    ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA----LA  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH----HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh----HH
Confidence            321110        012234799999999987543   68999999999999999999999854221111 110    11


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ...         ..........+..+.+||.+||+.||.+|||+.++++.|++++..
T Consensus       260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            111         000111123456789999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-41  Score=348.60  Aligned_cols=264  Identities=24%  Similarity=0.399  Sum_probs=192.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357999999999999999999975 68999999886543 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIE---EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |++ ++|.+++.....   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 699999976421   234899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC--chhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEA  547 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  547 (597)
                      .... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   ............  .....
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence            3221 2334468999999999876 468999999999999999999999997644322   111111111100  00000


Q ss_pred             ------------------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 ------------------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 ------------------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                        +...+........+.++.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                              0000001111123457899999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=354.49  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             CCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      .+.||+|+||.||+|... +|+.||+|++........+++.+|+.++++++||||+++++++.+.+..+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999975 6899999998877667788999999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe--CCCCcEEEeeccccccccCCCceeee
Q 038707          401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL--DDKYRAKVSDFGTSRSVMVDQTHLTT  478 (597)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll--~~~~~~kl~Dfgl~~~~~~~~~~~~~  478 (597)
                      .+++....  ..+++..++.++.||++||.|||+.+   |+||||||+|||+  ++++.+||+|||+++......  ...
T Consensus       174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~  246 (373)
T 2x4f_A          174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK  246 (373)
T ss_dssp             HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence            99997642  34899999999999999999999999   9999999999999  677899999999998764332  223


Q ss_pred             cccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhH
Q 038707          479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKK  558 (597)
Q Consensus       479 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  558 (597)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||......+      ....... ..+.      .......
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~-~~~~------~~~~~~~  313 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILA-CRWD------LEDEEFQ  313 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-TCCC------SCSGGGT
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-ccCC------CChhhhc
Confidence            3469999999999998999999999999999999999999997543221      1111111 1110      0011112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          559 EEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       559 ~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..++++.+||.+||+.||.+|||+.|+++
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            34567899999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-41  Score=345.15  Aligned_cols=263  Identities=25%  Similarity=0.370  Sum_probs=204.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||+|... +++.||||++..   ......+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            467999999999999999999975 689999998764   3455677899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999997532 2345899999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......    ... ....+........   
T Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~---  258 (310)
T 2wqm_A          188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDYPPL---  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-HHHHHHTTCSCCC---
T ss_pred             CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-HHHHhhcccCCCC---
Confidence            322 2223446899999999999999999999999999999999999999653321    111 1122222111110   


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                           .....++++.+|+.+||+.||++|||+.+|++.|++|+..
T Consensus       259 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          259 -----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             -----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                 0123345688999999999999999999999999999865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.6e-42  Score=345.11  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=208.9

Q ss_pred             hcCCccCC-cccccCceEEEEEEec---CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          316 TDNYNANR-ILGQGGQGTVYKGMLT---DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       316 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      .++|.+.+ .||+|+||+||+|.+.   .++.||||.+...  .....+++.+|+.++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688877 9999999999999653   4688999987653  233467899999999999999999999999 667789


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++++|.+++....   .+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999998643   4899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          470 MVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       470 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      .......  .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+..+..  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER--  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence            5443322  222346788999999998889999999999999999999 999997543221       1222222211  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                             ...+...++.+.+|+.+||+.||.+||++.+|++.|+++-.+
T Consensus       239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                   111233456789999999999999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=344.53  Aligned_cols=245  Identities=23%  Similarity=0.261  Sum_probs=196.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.++||+|+||+||+|.+. +++.||||++..  .......++..|+..+.++ +||||+++++++.+.+..+||
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999986 699999998654  2334455666677666666 899999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+ +++|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 779999988753  35999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .  .......||+.|+|||++.+ .++.++||||||+++|||++|..|+....          ....+..+...    + 
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~----~-  271 (311)
T 3p1a_A          210 A--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLP----P-  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCC----H-
T ss_pred             C--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCC----c-
Confidence            2  22344568999999999875 79999999999999999999977664311          11112221111    1 


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ......++++.+||.+||+.||++|||++|+++
T Consensus       272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               112234567899999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-41  Score=343.87  Aligned_cols=260  Identities=23%  Similarity=0.273  Sum_probs=202.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..++|++.+.||+|+||.||++... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999976 6899999997643   23345789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++++|.+++....   ++++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999998643   4899999999999999999999999   9999999999999999999999999997665


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++|+.||......       .....+......     
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-----  253 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR-----  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC-----
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC-----
Confidence            43333344556899999999999999999999999999999999999999653211       111111111100     


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhhh
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIRT  594 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~~  594 (597)
                        ........+..+.+||.+||+.||++|| +++++++.|+++..
T Consensus       254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence              0111233455688999999999999999 99999999987754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=357.87  Aligned_cols=273  Identities=24%  Similarity=0.373  Sum_probs=217.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC--cceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  391 (597)
                      .++|.+.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357999999999999999999986 58999999976432 334677889999999999999999999998765  67999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe----CCCCcEEEeeccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSR  467 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfgl~~  467 (597)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999987655555999999999999999999999999   9999999999999    788889999999998


Q ss_pred             cccCCCceeeecccccccccCcccccc--------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQS--------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      ......  ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..........  .......
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKII  240 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHH
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHh
Confidence            764332  2234568999999999865        567889999999999999999999997644332221  1122222


Q ss_pred             hcCchhhh--h------------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          540 NENRLFEA--L------------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       540 ~~~~~~~~--l------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ........  +            +..............+.+++.+||+.||++||+++++++.|+.+...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            21110000  0            00011123466778899999999999999999999999999987653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-41  Score=343.86  Aligned_cols=262  Identities=22%  Similarity=0.324  Sum_probs=201.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||+|.+. +++.||||++...  .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999986 6899999987643  33445788999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++ +|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9975 6666665432  34999999999999999999999999   9999999999999999999999999998654322


Q ss_pred             ceeeecccccccccCccccccCC-CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh--hhhh-
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF--EALD-  549 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~-  549 (597)
                       .......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.......  ................  .... 
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcc
Confidence             2234456899999999987765 8999999999999999999888864322111  1111111111110000  0000 


Q ss_pred             ------------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ------------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                  ...........+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                        00000111234567889999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-41  Score=337.73  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=207.1

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4567999999999999999999976 478999999876555667889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+++++|.+++....   .+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999997643   4899999999999999999999999   9999999999999   788999999999997654


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ...  ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||......+       ....+..+....  . 
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--~-  227 (277)
T 3f3z_A          161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTF--P-  227 (277)
T ss_dssp             TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC--C-
T ss_pred             Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC--C-
Confidence            332  23345689999999998654 8999999999999999999999997543221       112222221110  0 


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .......++.+.+|+.+||+.||++|||+.++++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 ---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0001123567889999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-41  Score=349.58  Aligned_cols=258  Identities=27%  Similarity=0.449  Sum_probs=207.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcE--EEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRI--VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~--vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||.||+|.+. ++..  +|+|.+.. ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999975 5664  48998764 2344566799999999999 899999999999999999999


Q ss_pred             EeccCCCChhhHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          392 YEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      |||+++++|.+++....             ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999998643             2246999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||+++.....  .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+       ...
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  252 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence            99999998743221  11223346889999999998889999999999999999998 999997543221       112


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+..+.         ....+...++.+.+||.+||+.||.+|||+.++++.|+++...
T Consensus       253 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            222211         1111223456789999999999999999999999999988654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=352.84  Aligned_cols=266  Identities=20%  Similarity=0.251  Sum_probs=202.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec----CCcEEEEEEccccChh-----------hHHHHHHHHHHHhhcCCCccceeee
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVDET-----------NVEQFINEVVILSQINHRNIVKLLG  380 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  380 (597)
                      .++|++.+.||+|+||+||+|.+.    ++..+|||........           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999975    4678999987654321           1234678899999999999999999


Q ss_pred             EEEe----CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          381 CCLE----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       381 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      ++.+    ....++||||+ +++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 999999998653   5999999999999999999999999   99999999999998877


Q ss_pred             --cEEEeeccccccccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC
Q 038707          457 --RAKVSDFGTSRSVMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED  528 (597)
Q Consensus       457 --~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~  528 (597)
                        .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211      11344689999999999999999999999999999999999999964322211


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKE-AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                        .........     ...+....... .....++++.+|+.+||+.||++|||+++|++.|+++...
T Consensus       269 --~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          269 --AVQTAKTNL-----LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             --HHHHHHHHH-----HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             --HHHHHHHhh-----cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence              111111111     01111111100 0113456799999999999999999999999999987644

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=376.76  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             CCccCC-cccccCceEEEEEEec---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          318 NYNANR-ILGQGGQGTVYKGMLT---DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       318 ~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||.++.. .....+++.+|+.+|++++||||+++++++.+ +..+|||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999864   4668999998754 34467889999999999999999999999876 5689999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999999754  335999999999999999999999999   999999999999999999999999999876433


Q ss_pred             Ccee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ....  .....+++.|+|||++.+..++.++||||||++||||++ |+.||......+       ....+..+..     
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~-----  557 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR-----  557 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCC-----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            2221  222335689999999999999999999999999999998 999998654332       2222222221     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                          ...+...+.++.+||.+||+.||++||++.+|++.|+.+..++
T Consensus       558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                1122345567899999999999999999999999999886543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-41  Score=341.88  Aligned_cols=261  Identities=28%  Similarity=0.468  Sum_probs=200.6

Q ss_pred             HhcCCccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..++|++.+.||+|+||+||+|.+.  ..||||.++..  .....+.+.+|+.++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3568999999999999999999864  35999987643  455667899999999999999999999964 556789999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999997543  34999999999999999999999999   999999999999999999999999999765422


Q ss_pred             -CceeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          473 -QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       473 -~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                       .........||+.|+|||.+.   ...++.++||||||+++|+|++|+.||......+      .....+..+.....+
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcch
Confidence             222334456899999999986   5678899999999999999999999997543222      122222222221111


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                           .......++.+.+|+.+||+.||.+|||+.+++++|+++.+
T Consensus       248 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 -----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 11123445678999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-41  Score=344.95  Aligned_cols=260  Identities=23%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             hcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .+.|++. +.||+|+||+||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3568874 78999999999999965 6899999998766666678899999999995 7999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfgl~~~~  469 (597)
                      ||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999998653   4899999999999999999999999   999999999999988776   999999998765


Q ss_pred             cCCCc------eeeecccccccccCcccccc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH-------
Q 038707          470 MVDQT------HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL-------  531 (597)
Q Consensus       470 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~-------  531 (597)
                      .....      .......||+.|+|||++..     ..++.++||||||+++|||++|+.||......+..-.       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211      11223458999999999875     5688999999999999999999999986543321100       


Q ss_pred             -HHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          532 -VGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       532 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .......+..+... . ..    ......+..+.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~i~~~~~~-~-~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKYE-F-PD----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCCC-C-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCcc-c-Cc----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             01111222221110 0 00    001123567899999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-41  Score=355.63  Aligned_cols=264  Identities=27%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCC--c
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETE--V  387 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  387 (597)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++..  ........+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999975 689999998753  34556778899999999997 999999999998654  6


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999997 6899999763    4899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCC--------------------CceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCc
Q 038707          468 SVMVD--------------------QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTD  526 (597)
Q Consensus       468 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~  526 (597)
                      .....                    .........||+.|+|||++.+ ..++.++||||||++||||++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                    1122344579999999999876 67899999999999999999999999764322


Q ss_pred             CCCcHHHHHHHHHhcCch--------------------------------hhhhhHHhh-hhhhHHHHHHHHHHHHHhcc
Q 038707          527 EDKSLVGYFLQAINENRL--------------------------------FEALDARVL-KEAKKEEIMTVATLAKRCLN  573 (597)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~--------------------------------~~~l~~~~~-~~~~~~~~~~l~~li~~cl~  573 (597)
                      +.   .......+.....                                +........ .......++++.+|+.+||+
T Consensus       238 ~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HH---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HH---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            21   1111111100000                                000000000 00001234578999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 038707          574 LNGKMRPTMKEVTNE  588 (597)
Q Consensus       574 ~~p~~RPt~~evl~~  588 (597)
                      .||++|||++|+++.
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-41  Score=346.01  Aligned_cols=258  Identities=28%  Similarity=0.368  Sum_probs=200.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc---
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP---  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  388 (597)
                      .++|++.+.||+|+||.||++.+. +++.||||++...   .......+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467999999999999999999974 6899999998653   334456899999999999999999999999876654   


Q ss_pred             -eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          389 -LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       389 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                       ++||||+++++|.++++...   ++++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             99999999999999998643   4999999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          468 SVMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       468 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      .......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      .............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence            6543322  1233456899999999999999999999999999999999999999653321      1122222222111


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHH-HHHHhhh
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV-TNELGGI  592 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev-l~~L~~l  592 (597)
                      .       .......+.++.+||.+||+.||++||++.++ ...|.++
T Consensus       239 ~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             H-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0       01112345678899999999999999966554 4555544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-41  Score=346.57  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=195.2

Q ss_pred             hcCCccCCcccccCceEEEEEEe----cCCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGML----TDGRIVAVKKSKLV----DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||.||++..    .+++.||+|.++..    .......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999997    46899999987643    23345678899999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999998643   4899999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      .. ..+.....   
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~~---  238 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TI-DKILKCKL---  238 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHHTCC---
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhCCC---
Confidence            543222 22344569999999999999999999999999999999999999997533211      11 11111111   


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                             ..+...+..+.+||.+||+.||.+||     ++.|+++
T Consensus       239 -------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 -------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                   11223456688999999999999999     6777765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-41  Score=352.68  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=195.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999986 68999999886432 2336788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc--EEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999997643   4999999999999999999999999   999999999999987765  999999999753322


Q ss_pred             CceeeecccccccccCccccccCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                        .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........  ..... ..+.....       
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~-~~~~~~~~-------  239 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI-QRILSVKY-------  239 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-HHHHTTCC-------
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-HHHhcCCC-------
Confidence              22334569999999999988877655 8999999999999999999976443221  11111 11111110       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       ........++.+.+||.+||+.||++|||+.|+++.
T Consensus       240 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 -SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             000111234568899999999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=352.45  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCC--CccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||++...+++.||||++..  ......+.+.+|+.++++++|  |||+++++++.+.+..+||
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            467999999999999999999998899999998764  344556789999999999986  9999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      || +.+++|.+++....   .+++.++..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 45889999998643   4899999999999999999999999   99999999999997 56899999999987653


Q ss_pred             CCce-eeecccccccccCcccccc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          472 DQTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       472 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      .... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....     ........+
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence            3322 2345569999999999864           6789999999999999999999999964321     111111111


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                               ++......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       235 ---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                     1111111122223568899999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-41  Score=350.71  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=204.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||+||++... +++.||||.+...   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999986 4889999987642   233457788999999988 79999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999998643   3999999999999999999999999   9999999999999999999999999997643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+      .+ ..+.....      
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~~------  238 (353)
T 2i0e_A          173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LF-QSIMEHNV------  238 (353)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC------
T ss_pred             cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HH-HHHHhCCC------
Confidence            222 22345679999999999999999999999999999999999999997533211      11 12211111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                          ..+...+.++.+||.+||+.||.+||+     ++++++
T Consensus       239 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                112234567889999999999999996     466654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.8e-41  Score=335.83  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++..  ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999976 589999998754  34456678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfgl~~~~  469 (597)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999987653   4899999999999999999999999   999999999999986655   999999999765


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+..+....   
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~---  226 (284)
T 3kk8_A          159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY---  226 (284)
T ss_dssp             CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC---
T ss_pred             ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC---
Confidence            4322  2334568999999999999999999999999999999999999996533211       111222211110   


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ........++.+.+|+.+||+.||++|||+.|+++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               00011233456889999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-41  Score=353.84  Aligned_cols=269  Identities=25%  Similarity=0.263  Sum_probs=210.5

Q ss_pred             cccCHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----CCcccee
Q 038707          305 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----HRNIVKL  378 (597)
Q Consensus       305 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  378 (597)
                      ..++..+.....++|++.+.||+|+||+||+|.+. +++.||||++.. .......+..|+.+++.++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34555555566789999999999999999999975 689999999863 3445667888999999996     9999999


Q ss_pred             eeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC----
Q 038707          379 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----  454 (597)
Q Consensus       379 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~----  454 (597)
                      ++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            99999999999999999 9999999987532 34899999999999999999999999   999999999999975    


Q ss_pred             ---------------------CCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHH
Q 038707          455 ---------------------KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI  513 (597)
Q Consensus       455 ---------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~el  513 (597)
                                           ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999764322    2345689999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh---------------------------------hhhhhHHH
Q 038707          514 LTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV---------------------------------LKEAKKEE  560 (597)
Q Consensus       514 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------------------------------~~~~~~~~  560 (597)
                      ++|+.||......+   ............. ...+....                                 ........
T Consensus       253 l~g~~pf~~~~~~~---~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          253 YTGSLLFRTHEHME---HLAMMESIIQPIP-KNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHSSCSCCCSSHHH---HHHHHHHHTCCCC-HHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHCCCCCCCCcHHH---HHHHHHHhcCCCC-HHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            99999997643221   1111111100000 00000000                                 00000111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          561 IMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       561 ~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+.+.+||.+||+.||++|||++|+++
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            256889999999999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3e-41  Score=338.99  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe---------
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE---------  384 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  384 (597)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467999999999999999999986 79999999987543    357789999999999999999999865         


Q ss_pred             -------CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc
Q 038707          385 -------TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR  457 (597)
Q Consensus       385 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~  457 (597)
                             ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++   |+|+||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   345789999999999999998642 345999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      +||+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...         .....
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFT  229 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHH
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHH
Confidence            9999999998764332  223446899999999999999999999999999999999999886321         01111


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .+..+.+            ....+..+.+||.+||+.||.+|||+.|+++.|+.++++.
T Consensus       230 ~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          230 DLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             Hhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1111111            1223455789999999999999999999999999988753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=348.90  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=192.2

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ....++|++.+.||+|+||.||+|.+. +++.||||.+...  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            345678999999999999999999986 5889999988743  2446788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl~~~  468 (597)
                      |||+++++|.+++...   ..+++.+++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999999754   34899999999999999999999999   999999999999975   88999999999976


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+      .....+...... . 
T Consensus       201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~-  270 (349)
T 2w4o_A          201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-F-  270 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-C-
T ss_pred             cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-c-
Confidence            5322  22334568999999999999999999999999999999999999996533221      111111111110 0 


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          ........+..+.+||.+||+.||++|||+.|+++
T Consensus       271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00111234556889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-41  Score=346.80  Aligned_cols=260  Identities=27%  Similarity=0.405  Sum_probs=208.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||+|.+.      +++.||||.+... ......++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468999999999999999999842      4778999998643 455667899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEe
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEE----FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVS  461 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~  461 (597)
                      ++||||+++++|.+++......    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999875321    35899999999999999999999999   999999999999984   4569999


Q ss_pred             eccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          462 DFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       462 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      |||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+       ....+
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHHH
Confidence            9999976533222 22334557889999999998999999999999999999998 999986543211       12222


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ..+..         .......+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       259 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            22111         11122345568899999999999999999999999998865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.4e-41  Score=342.89  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=206.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....      ...+++.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999976 689999998764322      1367899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg  464 (597)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999754   34899999999999999999999999   99999999999999887    79999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....
T Consensus       165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVSY  235 (321)
T ss_dssp             TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC
T ss_pred             cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc
Confidence            998764322  2234568999999999999999999999999999999999999997533211       1111111111


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..++..    ....++.+.+||.+||+.||++|||+.|+++
T Consensus       236 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 --DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              011111    1223456889999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-41  Score=337.99  Aligned_cols=247  Identities=29%  Similarity=0.401  Sum_probs=202.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||+||+|... +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999976 57899999875321   22356789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999998653   4899999999999999999999999   99999999999999999999999999865432


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+       ....+....        
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~--------  223 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE--------  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC--------
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCC--------
Confidence            2   2234568999999999999999999999999999999999999997533211       111111111        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ...+...++.+.+||.+||+.||.+|||++|+++.
T Consensus       224 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              11122344568899999999999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=343.44  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=200.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||+|.+. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999986 58999999875432  3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999999988754   24899999999999999999999999   9999999999999999999999999997754322


Q ss_pred             ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh-----------c
Q 038707          474 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-----------E  541 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~  541 (597)
                       .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..   ........           .
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHT
T ss_pred             -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhccccccccccccc
Confidence             22334568999999999876 67899999999999999999999999764432211   11111100           0


Q ss_pred             Cchhhhh---hHH---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 NRLFEAL---DAR---VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 ~~~~~~l---~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .......   ++.   .........+..+.+|+.+||+.||.+|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000   000   0000012345568899999999999999999999863

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-41  Score=355.57  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC--CCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQIN--HRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||++...+++.||||++..  ......+.+.+|+.+|++++  ||||+++++++...+..+|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            56999999999999999999988899999998764  34556788999999999996  599999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      | +.+++|.+++....   .+++.+++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.....
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 56889999998653   4899999999999999999999999   99999999999996 579999999999876433


Q ss_pred             Cce-eeecccccccccCcccccc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          473 QTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       473 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      ... ......||+.|+|||++.+           ..++.++||||||++||||++|+.||.....     ....+...+ 
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~-  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII-  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH-
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh-
Confidence            222 2344569999999999865           4689999999999999999999999964321     111111111 


Q ss_pred             cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 ~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                              ++......+...+..+.+||.+||+.||.+|||+.|+++.
T Consensus       282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                    1111111112224568899999999999999999999863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=345.13  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhcC---CCccceeeeEEEeC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-----ETNVEQFINEVVILSQIN---HRNIVKLLGCCLET  385 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  385 (597)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++....     ......+.+|+.++++++   ||||+++++++.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999974 68999999876422     112345667777777664   99999999999876


Q ss_pred             C-----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          386 E-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       386 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      .     ..++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999996 699999987532 34899999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh
Q 038707          461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN  540 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  540 (597)
                      +|||+++.....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+   ..........
T Consensus       162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~  236 (308)
T 3g33_A          162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG  236 (308)
T ss_dssp             CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred             eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence            999999765422  22345668999999999999999999999999999999999999997543222   1111111111


Q ss_pred             cCchhhh-------------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFEA-------------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~~-------------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .......             ..+........+.++.+.+||.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000             0000001111234567889999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-41  Score=350.50  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=201.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +.|+..+.||+|+||+||+|... +++.||||++....   ....+++.+|+.++++++||||+++++++.+.+..+|||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45889999999999999999974 78999999876432   334567999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++ |+|.+++....  .++++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 68888886542  35999999999999999999999999   999999999999999999999999999765322


Q ss_pred             CceeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                           ....||+.|+|||++.   ...++.++||||||+++|||++|+.||......+      ........ ....   
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~-~~~~---  272 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-ESPA---  272 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-CCCC---
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc-CCCC---
Confidence                 2346899999999984   5678999999999999999999999996543211      11111111 1100   


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           ......++.+.+||.+||+.||++|||++++++.
T Consensus       273 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 0112334568899999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-41  Score=363.59  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||++... +++.||||.+..   ........+.+|+.++++++||||+++++++.+.+..+||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 689999998764   2344556788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999997643   48999999999999999999998 88   9999999999999999999999999997643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ... .......||+.|+|||++.+..++.++||||||++||||++|+.||......+       ....+.....      
T Consensus       301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------  366 (446)
T 4ejn_A          301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred             CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCC------
Confidence            322 23345679999999999999999999999999999999999999997533211       1111111111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                          ..+...++++.+||.+||+.||.+||     +++|+++
T Consensus       367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                11223446688999999999999999     9999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=344.44  Aligned_cols=267  Identities=25%  Similarity=0.403  Sum_probs=199.2

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHH--HhhcCCCccceeeeEEEe-----CCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--LSQINHRNIVKLLGCCLE-----TEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  388 (597)
                      .++|++.+.||+|+||.||+|.. +++.||||++...   ....+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999977 6899999998643   33444445554  445899999999986653     2256


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeccCCCCCeEeCCCCcEE
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA---------ASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                      ++||||+++|+|.+++....    .++..++.++.||++||.|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            89999999999999997643    68999999999999999999999         7   99999999999999999999


Q ss_pred             EeeccccccccCCC-------ceeeecccccccccCcccccc-------CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Q 038707          460 VSDFGTSRSVMVDQ-------THLTTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILTGQKPIRAINT  525 (597)
Q Consensus       460 l~Dfgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~  525 (597)
                      |+|||++.......       ........||+.|+|||++.+       ..++.++||||||+++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764322       112234469999999999876       4567899999999999999999777654332


Q ss_pred             cCC-CcHHH----------HHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          526 DED-KSLVG----------YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       526 ~~~-~~~~~----------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ... .....          ..............+...  .......++.+.+||.+||+.||++|||++|+++.|++|..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            221 11100          000111111100000000  01123456679999999999999999999999999999875


Q ss_pred             h
Q 038707          595 S  595 (597)
Q Consensus       595 ~  595 (597)
                      .
T Consensus       319 ~  319 (336)
T 3g2f_A          319 I  319 (336)
T ss_dssp             C
T ss_pred             H
Confidence            4

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=347.73  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEe------
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLE------  384 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~------  384 (597)
                      +....+|++.++||+|+||.||++.+. +++.||||++..........+.+|+.++.++. ||||+++++++..      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            334568999999999999999999975 68999999987667777788999999999996 9999999999953      


Q ss_pred             --CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          385 --TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       385 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                        ....++||||+. |+|.+++.......++++..++.++.||+.||.|||+.+. +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEec
Confidence              334789999995 7999999875455569999999999999999999999863 499999999999999999999999


Q ss_pred             ccccccccCCCce-----------eeecccccccccCcccc---ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC
Q 038707          463 FGTSRSVMVDQTH-----------LTTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED  528 (597)
Q Consensus       463 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~  528 (597)
                      ||++.........           ......+|+.|+|||++   .+..++.++||||||+++|+|++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9999876432221           11134589999999998   567789999999999999999999999964322110


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                                         +............+..+.+|+.+||+.||.+|||+.|+++.|+.+...
T Consensus       262 -------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          262 -------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                               000000111112223477899999999999999999999999988754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-40  Score=333.72  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999986 6899999987643 33456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++++|.+++...   ..+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999998753   34899999999999999999999999   9999999999999999999999999997654322


Q ss_pred             c-eeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          474 T-HLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       474 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........     ............      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~------  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYL------  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-----HHHHHHTTCTTS------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHhhhccccc------
Confidence            2 22344568999999999987665 7899999999999999999999976443221     011111111100      


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ......+..+.+|+.+||+.||++|||++|+++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               011233456889999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-40  Score=357.92  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=197.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||++...  .....+++.+|+.+|+.++||||+++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999976 6899999987643  4556778999999999999999999999997654      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+|||||+++ +|.+.+..     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            45999999975 57666643     2899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc-----
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-----  541 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  541 (597)
                      +.....  .......||+.|+|||++.+..++.++||||||++||||++|+.||.+.+..+   ...........     
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHH
Confidence            865432  23445679999999999999999999999999999999999999997644221   11111111000     


Q ss_pred             --------------Cc------hhhhhhHHh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 --------------NR------LFEALDARV---LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 --------------~~------~~~~l~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                    ..      +........   .........+++.+||.+||+.||++|||++|+++.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                          00      000000000   001112236678999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-41  Score=352.89  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHH-HhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||+||++... +++.||||.+...   .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999986 5889999987642   23344567777776 567899999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999998643   4899999999999999999999999   9999999999999999999999999998643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      .. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+      .+ ..+.....      
T Consensus       191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~~------  256 (373)
T 2r5t_A          191 EH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MY-DNILNKPL------  256 (373)
T ss_dssp             CC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HH-HHHHHSCC------
T ss_pred             cC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HH-HHHHhccc------
Confidence            22 223445679999999999999999999999999999999999999997533211      11 11111111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL  589 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  589 (597)
                          ..+...+..+.+||.+||+.||.+||++.+.++++
T Consensus       257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                11123445688999999999999999986544444

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-41  Score=375.09  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=202.9

Q ss_pred             CcccccCceEEEEEEec---CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLT---DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      +.||+|+||+||+|.+.   .++.||||+++..  .....+++.+|+.+|++++||||+++++++.+ +..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   4678999998753  34456889999999999999999999999864 567899999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce--
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--  475 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--  475 (597)
                      |+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++........  
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999997543   4899999999999999999999999   999999999999999999999999999876543321  


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      ......+|+.|+|||++.+..++.++||||||++||||++ |+.||......+       ....+..+..         .
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------M  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------C
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence            2233446789999999999999999999999999999998 999997644322       2222222221         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ..+...++++.+||.+||+.||++||++.+|+++|+++...
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            12234556789999999999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.6e-41  Score=359.38  Aligned_cols=246  Identities=25%  Similarity=0.371  Sum_probs=205.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999986 79999999876421   234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+.   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999999753   34999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+       ....+..+..       
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-------  233 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIF-------  233 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCC-------
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCc-------
Confidence            2  2334569999999999988765 789999999999999999999997543221       1122222211       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..+...++.+.+||.+||+.||.+|||++|+++
T Consensus       234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence               011223456889999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=351.55  Aligned_cols=265  Identities=15%  Similarity=0.205  Sum_probs=207.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecC---------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccce---------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD---------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK---------  377 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  377 (597)
                      .++|++.+.||+|+||.||+|.+..         ++.||||.....     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999763         789999987643     46889999999999999988         


Q ss_pred             ------eeeEEEe-CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 038707          378 ------LLGCCLE-TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI  450 (597)
Q Consensus       378 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NI  450 (597)
                            +++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 67889999999 999999998652 345999999999999999999999999   99999999999


Q ss_pred             EeCCCC--cEEEeeccccccccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCC
Q 038707          451 LLDDKY--RAKVSDFGTSRSVMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA  522 (597)
Q Consensus       451 ll~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~  522 (597)
                      |++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999776432221      12334689999999999999999999999999999999999999976


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      ......  ............. ....+..   ......++.+.+|+.+||+.||++|||+++|++.|+++.+..
T Consensus       271 ~~~~~~--~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          271 CLPNTE--DIMKQKQKFVDKP-GPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             GTTCHH--HHHHHHHHHHHSC-CCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCcCHH--HHHHHHHhccCCh-hhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            542221  1111111110000 0000000   000123467899999999999999999999999999998765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-41  Score=340.38  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=200.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec--CCc--EEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT--DGR--IVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||+||+|.+.  +++  .||||.+...   .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357999999999999999999864  233  6899987643   3456778999999999999999999999998765 8


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||+++++|.+++....  ..+++..++.++.||++||.|||+++   |+|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999998643  34899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          469 VMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       469 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      .......  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+      ........... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~-  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGER-  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCC-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCCC-
Confidence            6543322  2233457888999999998889999999999999999999 999997543221      11111111111 


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                              .......++.+.+++.+||+.||++|||+.++++.|++++..
T Consensus       244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                    011223456789999999999999999999999999988653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=337.08  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=201.6

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      |....+||+|+||.||+|.+. +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            445569999999999999975 6889999998876666778899999999999999999999999999999999999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeeccccccccCCCcee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      ++|.+++........+++..+..++.||+.||.|||+++   |+|+||||+|||++. ++.+||+|||++....... ..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~  179 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PC  179 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cc
Confidence            999999987655556789999999999999999999999   999999999999987 8999999999997654322 22


Q ss_pred             eecccccccccCccccccCC--CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .....|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.......    ..........          ...
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~----------~~~  245 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMFK----------VHP  245 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHHC----------CCC
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhcccc----------ccc
Confidence            33456899999999987643  8899999999999999999999996432211    0000000000          001


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+...+.++.+|+.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112334567889999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-40  Score=335.25  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999986 689999998764321      2467899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg  464 (597)
                      ++||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997642   4899999999999999999999999   99999999999998877    89999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ++.......  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~  228 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNY  228 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhccc
Confidence            997654322  2234568999999999998999999999999999999999999997543211       1111111111


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhhhh
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN--ELGGIRT  594 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~l~~  594 (597)
                      .  ...    ......++.+.+|+.+||+.||++|||+.|+++  .++.++.
T Consensus       229 ~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          229 D--FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             C--CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             C--Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            0  011    111223456889999999999999999999997  4566554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=348.46  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhh-HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|.+.+.||+|+||+||+|... +++.||||++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986 68999999886533222 22456899999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      ++ ++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 59999988653  34899999999999999999999999   9999999999999999999999999997654322 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc---CchhhhhhH
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NRLFEALDA  550 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~  550 (597)
                      .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   ...........   ..+...+..
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence            22334468999999999876 568999999999999999999999997644322   11111111111   000111000


Q ss_pred             Hh-------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RV-------------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..             ........++.+.+||.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00             00111233467889999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.5e-41  Score=335.83  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=185.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||+|... +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357999999999999999999974 78999999876321   22347789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....  .++++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999998642  35899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+..       ..+.....       
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-------  229 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLADY-------  229 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCC-------
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhccc-------
Confidence            222 223356899999999999889999999999999999999999999764433210       00000000       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..+...+.++.+||.+||+.||++|||++++++
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 ---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               011223456889999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.1e-40  Score=353.58  Aligned_cols=264  Identities=19%  Similarity=0.265  Sum_probs=211.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.++||+|+||.||+|.+. +++.||||+.....  ...++.+|+++++.++| +++..+..+..+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999974 68999999866432  23468899999999987 556666667778888899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++...
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 999999998643  24999999999999999999999999   9999999999999   688999999999998765


Q ss_pred             CCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          471 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       471 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      .....      ......||+.|+|||++.+..++.++||||||++||||++|+.||....................... 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-
Confidence            43321      12245699999999999999999999999999999999999999987654432222211111110000 


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                              ........+.++.+|+.+||+.+|++||++.+|+++|+.+....
T Consensus       237 --------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          237 --------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             --------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                    01111233567999999999999999999999999999986543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=347.29  Aligned_cols=243  Identities=23%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      ..++|++.+.||+|+||+||+|.+. +++.||||.+....        ......+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999975 68999999876432        12345678899999999999999999999999


Q ss_pred             CcceEEEeccCCC-ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          386 EVPLLVYEFIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       386 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      +..++||||+..| +|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999998643   4999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      ++.......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........             ..
T Consensus       176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~  240 (335)
T 3dls_A          176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------AA  240 (335)
T ss_dssp             TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------TC
T ss_pred             cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------hc
Confidence            998764332  2334568999999999988776 8899999999999999999999964221110             00


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                ...+...++++.+||.+||+.||++|||+.++++.
T Consensus       241 ----------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          241 ----------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00111234568899999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-40  Score=335.76  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|.+.+.||+|+||+||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357999999999999999999975 6899999987643 33456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeeccccccc
Q 038707          394 FIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~  469 (597)
                      |+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999997532 2345999999999999999999999999   9999999999999   45678999999999765


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...  .......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+       ............   
T Consensus       178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~---  244 (285)
T 3is5_A          178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYKEPNY---  244 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC---
T ss_pred             CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccCCccc---
Confidence            432  2234456899999999986 568999999999999999999999997543221       111111110000   


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          .......++.+.+|+.+||+.||++|||+.|+++
T Consensus       245 ----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 ----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000113456889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-41  Score=356.44  Aligned_cols=250  Identities=16%  Similarity=0.182  Sum_probs=195.9

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHH---HHHhhcCCCccceee-------e
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEV---VILSQINHRNIVKLL-------G  380 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~  380 (597)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++..   ......+.+.+|+   +++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3467999999999999999999964 699999999763   3445678899999   555566899999998       6


Q ss_pred             EEEeCCc-----------------ceEEEeccCCCChhhHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 038707          381 CCLETEV-----------------PLLVYEFIPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIP  439 (597)
Q Consensus       381 ~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  439 (597)
                      ++.+.+.                 .+|||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            6665532                 78999999 6899999986421    123446889999999999999999999   


Q ss_pred             eEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccC-----------CCCcccceeehHH
Q 038707          440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-----------QFTEKSDVYSFGV  508 (597)
Q Consensus       440 i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlG~  508 (597)
                      |+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999985321    3344567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-
Q 038707          509 VLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN-  587 (597)
Q Consensus       509 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~-  587 (597)
                      +||||++|+.||......+....               ...      .....++.+.+||.+||+.||++|||+.|+++ 
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~---------------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEW---------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGG---------------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccchhh---------------hhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999999975443321110               000      01223456889999999999999999999986 


Q ss_pred             -HHhhhhh
Q 038707          588 -ELGGIRT  594 (597)
Q Consensus       588 -~L~~l~~  594 (597)
                       .+++++.
T Consensus       361 p~f~~~~~  368 (377)
T 3byv_A          361 PEYEQLRT  368 (377)
T ss_dssp             HHHHHHHH
T ss_pred             hHHHHHHH
Confidence             4555544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-40  Score=338.51  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=204.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999976 689999999886555556778999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~~~  470 (597)
                      |+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||+   ++++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999997643   4899999999999999999999999   9999999999999   788999999999987543


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+       ....+..+...     
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~-----  225 (304)
T 2jam_A          161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE-----  225 (304)
T ss_dssp             CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC-----
T ss_pred             CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence            22   2233458999999999999999999999999999999999999997533211       12222222110     


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .........++.+.+||.+||+.||++|||+.|+++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             000111234567889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-40  Score=352.25  Aligned_cols=253  Identities=26%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      ...++|.+.+.||+|+||+||+|... +++.||||.+....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45678999999999999999999976 58999999875321        122345889999999999999999999975 


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---cEEEe
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVS  461 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~  461 (597)
                      .+..++||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            45579999999999999998754   34999999999999999999999999   99999999999997544   59999


Q ss_pred             eccccccccCCCceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHH
Q 038707          462 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       462 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      |||+++....  ........||+.|+|||++..   ..++.++||||||+++|+|++|+.||.......  .+    ...
T Consensus       285 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~----~~~  356 (419)
T 3i6u_A          285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SL----KDQ  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CH----HHH
T ss_pred             ecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HH----HHH
Confidence            9999987542  223345679999999999853   678899999999999999999999997543322  11    122


Q ss_pred             HhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       539 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +..+....  .+    ......++.+.+||.+||+.||++|||+.|+++
T Consensus       357 i~~~~~~~--~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYNF--IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCCC--CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCC--Cc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            22221110  01    111223566889999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-40  Score=334.94  Aligned_cols=247  Identities=22%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  390 (597)
                      ..++|++.+.||+|+||+||+|... +++.||||.+..  .......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999986 799999998764  3344567889999999999 89999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---------------
Q 038707          391 VYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---------------  454 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---------------  454 (597)
                      ||||+++++|.+++..... ...+++..++.++.||++||.|||+++   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999986422 245899999999999999999999999   999999999999984               


Q ss_pred             ----CCcEEEeeccccccccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC
Q 038707          455 ----KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK  529 (597)
Q Consensus       455 ----~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~  529 (597)
                          ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+....     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                4479999999998764332     23489999999998765 66789999999999999999998764211     


Q ss_pred             cHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          530 SLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                           ....+..+..         ...+...++.+.+|+.+||+.||++|||+.|+++.
T Consensus       236 -----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -----QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -----HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -----HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                 1111222211         11122345668899999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-41  Score=338.11  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=207.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  390 (597)
                      .++|++.+.||+|+||.||++... +++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999986 6899999987643  45567789999999999999999999998864  567899


Q ss_pred             EEeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          391 VYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999998643 2345999999999999999999999976  2349999999999999999999999999997


Q ss_pred             cccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA  547 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (597)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+       ....+..+...  
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~--  234 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR--  234 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhcccc--
Confidence            6543221 1233468999999999998899999999999999999999999997543211       12222222211  


Q ss_pred             hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 038707          548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGG  591 (597)
Q Consensus       548 l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  591 (597)
                             ..+...+..+.+||.+||+.||++|||+.||++.+..
T Consensus       235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                   1122345678999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-40  Score=362.93  Aligned_cols=253  Identities=26%  Similarity=0.339  Sum_probs=208.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.++||+|+||.||++... +|+.||||++...   .......+.+|+.+|++++||||+++++++.+.+..+||
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986 6999999987542   223456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++.....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999998643 334899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........   .....+....        
T Consensus       339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~--------  405 (576)
T 2acx_A          339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVP--------  405 (576)
T ss_dssp             TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCC--------
T ss_pred             Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhccc--------
Confidence            32  2334579999999999999899999999999999999999999998654322111   1111111111        


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                        ...+...+.++.+||.+||+.||.+||     +++||++
T Consensus       406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              111233456788999999999999999     7788875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-40  Score=335.51  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999986 5889999986542   345677899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....   .+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999987643   4899999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+      ... .+.....       
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~~~~~-------  232 (294)
T 2rku_A          168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIKKNEY-------  232 (294)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHTTCC-------
T ss_pred             Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHhhccC-------
Confidence            222 2334568999999999998889999999999999999999999996533211      111 1111111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                         ..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1112334568899999999999999999999873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-40  Score=337.23  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=206.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      +.|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56899999999999999999975 68999999876433 44568899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++...    ++++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++....... 
T Consensus       102 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  173 (303)
T 3a7i_A          102 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  173 (303)
T ss_dssp             CTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence            9999999999643    4899999999999999999999999   9999999999999999999999999997764332 


Q ss_pred             eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                      .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+..+..         .
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP---------P  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC---------C
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCC---------C
Confidence            22334568999999999999999999999999999999999999996533211       1111111110         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1122334568899999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-40  Score=341.80  Aligned_cols=263  Identities=21%  Similarity=0.298  Sum_probs=194.8

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      ...++|++.+.||+|+||+||+|... +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999975 689999999865432  235678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe-----CCCCcEEEeeccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-----DDKYRAKVSDFGT  465 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll-----~~~~~~kl~Dfgl  465 (597)
                      ||||++ ++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||+     ++++.+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999997 59999998653   3899999999999999999999999   9999999999999     4556699999999


Q ss_pred             cccccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc-
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-  543 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  543 (597)
                      +....... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+   ............. 
T Consensus       184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred             ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCch
Confidence            98654322 223344589999999998774 58999999999999999999999997543211   1111111110000 


Q ss_pred             -hhh--------------hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 -LFE--------------ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 -~~~--------------~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ...              ..............++++.+||.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             000              00000000111123467889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-40  Score=342.00  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=207.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+..   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999986 588999998653   2345677899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....   .+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999987643   4899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      ... .+..+..       
T Consensus       194 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~~~~~~~-------  258 (335)
T 2owb_A          194 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIKKNEY-------  258 (335)
T ss_dssp             TT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHHTCC-------
T ss_pred             Cc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHH-HHhcCCC-------
Confidence            22 22334568999999999999899999999999999999999999996533211      111 1111111       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..+...+..+.+||.+||+.||++|||++|+++
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111223456889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-41  Score=348.92  Aligned_cols=254  Identities=25%  Similarity=0.330  Sum_probs=205.6

Q ss_pred             hcCCccCCcccccCceEEEEEEe----cCCcEEEEEEcccc----ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCC
Q 038707          316 TDNYNANRILGQGGQGTVYKGML----TDGRIVAVKKSKLV----DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  386 (597)
                      .++|++.+.||+|+||.||++..    .+++.||||+++..    .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999997    36899999987642    123446678899999999 6999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+|||||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999998643   4899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      +..............||+.|+|||++.+  ..++.++||||||++||||++|+.||........  ............  
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~--  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC--
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC--
Confidence            8765444444445679999999999875  4578999999999999999999999976543322  111111111110  


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTNE  588 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  588 (597)
                               ...+...+..+.+||.+||+.||.+||     +++|+++.
T Consensus       283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                     111233445688999999999999999     99999865

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-40  Score=354.46  Aligned_cols=265  Identities=25%  Similarity=0.362  Sum_probs=187.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----Cc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  387 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||++..  ......+++.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999976 689999998754  3445667899999999999999999999999543     46


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||+ +++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 57999999754   34999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCc--------------------------eeeecccccccccCcccc-ccCCCCcccceeehHHHHHHHHh-----
Q 038707          468 SVMVDQT--------------------------HLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILT-----  515 (597)
Q Consensus       468 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlG~il~ell~-----  515 (597)
                      .......                          .......||+.|+|||++ ....++.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            7642211                          123445689999999976 56679999999999999999999     


Q ss_pred             ------CCCCCCCCCCcCC-----------------CcHHHHHHHHHhcCchhhhhh-------HHh-----------hh
Q 038707          516 ------GQKPIRAINTDED-----------------KSLVGYFLQAINENRLFEALD-------ARV-----------LK  554 (597)
Q Consensus       516 ------g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~-------~~~-----------~~  554 (597)
                            |+++|.+......                 ..........+.... .+.+.       ...           ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS-EEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC-HHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC-HHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                  5666654331100                 000000001000000 00000       000           00


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ......+.++.+||.+||+.||++|||++|+++.
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0112235678899999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.3e-41  Score=345.32  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=202.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..++|++.+.||+|+||+||++... +++.||||.+.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999986 689999999864332    345688888888 7999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC----CcEEEeecccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFGTSRS  468 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfgl~~~  468 (597)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999997643   4999999999999999999999999   9999999999998543    3599999999987


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   .. .....+..+...   
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~-~~~~~i~~~~~~---  241 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PE-EILARIGSGKFS---  241 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HH-HHHHHHHHCCCC---
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HH-HHHHHHccCCcc---
Confidence            643322 2334568999999999988889999999999999999999999997543222   11 122222222211   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .........++++.+||.+||+.||++|||+.++++
T Consensus       242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               001111234567889999999999999999999886

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-40  Score=347.61  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=194.3

Q ss_pred             hcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhh-cCCCccceeeeEEEe----CCcc
Q 038707          316 TDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQ-INHRNIVKLLGCCLE----TEVP  388 (597)
Q Consensus       316 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  388 (597)
                      .++|.+. ++||+|+||+||++.+. +++.||||++..     ...+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3456665 68999999999999976 689999999863     2456788888754 489999999999876    5578


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGT  465 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl  465 (597)
                      +|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999998642 235999999999999999999999999   999999999999997   78999999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ++.....  .......||+.|+|||++.+..++.++||||||++||||++|+.||......+.....   ...+..+...
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~  285 (400)
T 1nxk_A          211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE  285 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC
T ss_pred             ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc
Confidence            9865422  2234456899999999999999999999999999999999999999765443321111   1111111110


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .      ........+.++.+||.+||+.||++|||+.|+++.
T Consensus       286 ~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 F------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             C------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0      000012345668899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=339.98  Aligned_cols=257  Identities=22%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..  ......+++.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999975 699999999754  33445678999999999999999999999998763      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||+ +++|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 88999999763    3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +.....    .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||.+.+..+   ............ ..
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~-~~  247 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTP-PA  247 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC-CH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCC-CH
Confidence            865322    334568999999999877 679999999999999999999999997643221   111111111000 00


Q ss_pred             hhhh------------------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EALD------------------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l~------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +.+.                  ...........++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000                  000001112335678999999999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.1e-41  Score=348.19  Aligned_cols=263  Identities=27%  Similarity=0.419  Sum_probs=206.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||++.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999986 6899999987754 44556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999998653   489999999999999999999996 8   999999999999999999999999998755321


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH-------------------
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG-------------------  533 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~-------------------  533 (597)
                         ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+......                   
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               2234568999999999999999999999999999999999999997644222100000                   


Q ss_pred             ----HHHHHHhcCchhhhhhHHhhhh----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          534 ----YFLQAINENRLFEALDARVLKE----AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       534 ----~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          +...........+.++......    .....+.++.+||.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                0000000001111111111100    11123557899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-40  Score=332.76  Aligned_cols=245  Identities=27%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||.||+|... +++.||||.+....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999976 57899999875421   223467899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999998653   4899999999999999999999999   999999999999999999999999998765432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .   .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+       ....+.....        
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~--------  229 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVDL--------  229 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhcccc--------
Confidence            2   234568999999999999999999999999999999999999997533211       1111111110        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+...+..+.+||.+||+.||.+|||++++++
T Consensus       230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              111233456889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.2e-41  Score=339.45  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=188.7

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ...++|++.+.||+|+||.||+|... +++.||||.+.... ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999965 68999999876432 34467789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          392 YEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      |||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999999752     12345899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCc----eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          467 RSVMVDQT----HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       467 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ........    .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||........      .......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhcc
Confidence            76543211    12234568999999999876 5689999999999999999999999976543221      1111111


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      . .................+..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1 00000000000111223456889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.6e-40  Score=341.02  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhc-CCCccceeee
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------ETNVEQFINEVVILSQI-NHRNIVKLLG  380 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~  380 (597)
                      ......++|++.+.||+|+||.||+|.+. +|+.||||.+....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999986 69999999876432        12245688999999999 7999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                      ++...+..++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+|+||||+|||+++++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999998642   4999999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCCceeeecccccccccCcccccc------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       461 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      +|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|+|++|+.||......      . 
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~-  312 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L-  312 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H-
Confidence            9999997764332  2334569999999999863      35889999999999999999999999653211      1 


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ....+..+....  ....    ....+..+.+||.+||+.||++|||+.++++
T Consensus       313 ~~~~i~~~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLRMIMEGQYQF--SSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHTCCCC--CHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhCCCCC--CCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111222211110  0000    1123456889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=345.13  Aligned_cols=258  Identities=17%  Similarity=0.210  Sum_probs=208.4

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEE------ecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCccceeee
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGM------LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLG  380 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~  380 (597)
                      .+++...++|.+.+.||+|+||+||+|.      ..+++.||||++...   ...++..|+.++.+++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3444456789999999999999999994      346889999998754   3456777788887776   999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC----
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----  454 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~----  454 (597)
                      ++.+.+..+|||||+++|+|.+++....  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            9999999999999999999999998532  2345999999999999999999999999   999999999999998    


Q ss_pred             -------CCcEEEeeccccccccC-CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCc
Q 038707          455 -------KYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD  526 (597)
Q Consensus       455 -------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~  526 (597)
                             ++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   89999999999976532 2334455667999999999999999999999999999999999999998643321


Q ss_pred             CCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhhhh
Q 038707          527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMR-PTMKEVTNELGGIRT  594 (597)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~l~~  594 (597)
                      ...              ....+     ..  ....+.+.+++..||+.+|.+| |+++++.+.|+++..
T Consensus       292 ~~~--------------~~~~~-----~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          292 ECK--------------PEGLF-----RR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EEE--------------ECSCC-----TT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cee--------------echhc-----cc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            100              00000     00  0123457789999999999999 788888888887654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.6e-40  Score=369.47  Aligned_cols=264  Identities=27%  Similarity=0.440  Sum_probs=211.3

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      .+.+...++|++.+.||+|+||+||+|.+..    +..||||+.... .....+.+.+|+.++++++||||+++++++. 
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            3444456789999999999999999999742    467999997753 3445678999999999999999999999985 


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                      .+..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence            466899999999999999998642  35899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+       ....+..+.
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~  609 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGE  609 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCC
Confidence            998765443333344557889999999998999999999999999999997 999997543221       111222211


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .         ...+...++.+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       610 ~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 R---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1         111233456788999999999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-40  Score=343.34  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=200.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467999999999999999999986 5899999987543  3344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988876432   4999999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH-----------h
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI-----------N  540 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------~  540 (597)
                      . .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+.   ........           .
T Consensus       178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHH
T ss_pred             c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHhh
Confidence            2 223345689999999998775 789999999999999999999999976432211   11110000           0


Q ss_pred             cCchhh------hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          541 ENRLFE------ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       541 ~~~~~~------~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ......      ..............++.+.+||.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000      00000000111234567999999999999999999999886

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.7e-40  Score=355.71  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=204.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..++|++.+.||+|+||+||++... +++.||||++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999976 6899999987532  233467899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC---CCCcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfgl~~~  468 (597)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999997653   4999999999999999999999999   99999999999995   456799999999976


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....  .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+       ....+..+......
T Consensus       174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~  243 (486)
T 3mwu_A          174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDL  243 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSCS
T ss_pred             CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCCC
Confidence            5432  22344569999999999875 59999999999999999999999997543221       12222222211000


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                            ......++.+.+||.+||+.||.+|||+.++++.
T Consensus       244 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 ------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0112335568899999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-40  Score=343.85  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC--------
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--------  385 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  385 (597)
                      ++|++.+.||+|+||+||+|... +++.||||++....  ......+.+|+.++++++||||+++++++.+.        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67999999999999999999985 68999999875432  23356788999999999999999999999874        


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      +..++||||+++ +|.+.+....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            467899999975 8888876543  34999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCC---ceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          466 SRSVMVDQ---THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       466 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ++......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   ...........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~  247 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGS  247 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            98654221   222344568999999999876 568999999999999999999999997643222   11111111110


Q ss_pred             C--chhhhhhH-H--------------hhhh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 N--RLFEALDA-R--------------VLKE-AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~--~~~~~l~~-~--------------~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .  ......+. .              .... .....++.+.+||.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0  00000000 0              0000 00111456889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.5e-40  Score=329.84  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  389 (597)
                      ..|.+.+.||+|+||+||+|.+. ++..||+|.+..  ......+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34788889999999999999975 588999998764  345567889999999999999999999999876    34579


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEEEeecccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRS  468 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~~  468 (597)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+.+. +|+||||||+|||++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999998643   48999999999999999999999862 499999999999997 789999999999975


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....   .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.......     . ....+..+....  
T Consensus       182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~--  249 (290)
T 1t4h_A          182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPA--  249 (290)
T ss_dssp             CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCG--
T ss_pred             ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----H-HHHHHhccCCcc--
Confidence            43322   23456899999999887 458999999999999999999999996533211     1 112222221111  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            ......++.+.+||.+||+.||.+|||+.|+++
T Consensus       250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  111222356889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.6e-40  Score=335.41  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999986 5899999998876667788999999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999987643  34899999999999999999999999   9999999999999999999999999875432111 


Q ss_pred             eeeecccccccccCcccc-----ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          475 HLTTKVQGTFGYVDPEYF-----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .......||+.|+|||++     ....++.++||||||+++|+|++|+.||......+      .......... ...  
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~~--  242 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP-PTL--  242 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-CCC--
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC-ccc--
Confidence            112334589999999998     35678999999999999999999999997543211      1111111111 000  


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 012233456889999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.5e-40  Score=369.54  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcce
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  389 (597)
                      ..++|++.++||+|+||+||+|... +++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3578999999999999999999976 5889999987632   234456788999999988 6999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |||||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999998653   4999999999999999999999999   999999999999999999999999999864


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .... .......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+       ....+.....     
T Consensus       493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~-----  559 (674)
T 3pfq_A          493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV-----  559 (674)
T ss_dssp             CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCC-----
T ss_pred             ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC-----
Confidence            3322 23445679999999999999999999999999999999999999997643221       2222222211     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM-----KEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  587 (597)
                           ..+...+.++.+||.+||+.||++||++     +||++
T Consensus       560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 1123345678999999999999999998     56553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.7e-40  Score=329.10  Aligned_cols=248  Identities=26%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999986 68999999876422   23456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+|+||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999998653   4899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......      . ....+..+..      
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------  228 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------T-LFKKIRGGVF------  228 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H-HHHHhhcCcc------
Confidence            22  2234468999999999987765 68999999999999999999999643211      1 1122221111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                          ..+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       229 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                0112234568899999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.8e-40  Score=335.62  Aligned_cols=255  Identities=22%  Similarity=0.323  Sum_probs=200.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEe--CCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLE--TEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|... +++.||||.+..   ...+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67999999999999999999974 689999999874   33567899999999997 9999999999998  56789999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|.+++..      +++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999853      889999999999999999999999   99999999999999776 899999999986543


Q ss_pred             CCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ...  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||........  ...............+.++.
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHHHH
Confidence            322  334568999999999877 6789999999999999999999999964332211  11111111111111111100


Q ss_pred             H-----------------------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 R-----------------------VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .                       .........++++.+||.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0                       000011124567899999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.2e-40  Score=355.05  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=205.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.++||+|+||.||++... +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367899999999999999999986 6999999987642   123456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++|+|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999986432 345999999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ... ....+.....      
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~i~~~~~------  410 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRVLEQAV------  410 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHHHHHCCC------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHHHhhccc------
Confidence            3322 23345799999999999999999999999999999999999999976543221  111 1111111111      


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTM  582 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  582 (597)
                          ..+...+..+.+||.+||+.||.+||++
T Consensus       411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 ----TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                1123345678899999999999999976

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.2e-40  Score=356.05  Aligned_cols=252  Identities=26%  Similarity=0.369  Sum_probs=201.4

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..++|++.+.||+|+||+||+|... +++.||||.+....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999986 68999999876432  33457789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC---CcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfgl~~~  468 (597)
                      |||+++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999987643   4899999999999999999999999   9999999999999764   4599999999987


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+       ....+..+....  
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--  256 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF--  256 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence            64332  234456999999999986 569999999999999999999999997543221       222222222110  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .    .......++.+.+||.+||+.||.+|||+.|+++.
T Consensus       257 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 D----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0    00112334568899999999999999999999853

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-39  Score=355.07  Aligned_cols=251  Identities=29%  Similarity=0.386  Sum_probs=203.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh-------------hhHHHHHHHHHHHhhcCCCccceeee
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-------------TNVEQFINEVVILSQINHRNIVKLLG  380 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  380 (597)
                      ..++|.+.+.||+|+||+||+|... +++.||||.+.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999976 588999998764221             33577899999999999999999999


Q ss_pred             EEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC---c
Q 038707          381 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---R  457 (597)
Q Consensus       381 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~  457 (597)
                      ++.+....++||||+++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999997643   4999999999999999999999999   99999999999998775   6


Q ss_pred             EEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHH
Q 038707          458 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       458 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  537 (597)
                      +||+|||++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+       ...
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIK  257 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence            9999999998764332  234456999999999987 469999999999999999999999997643222       222


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+..+....  +..    .....++++.+||.+||+.||.+|||++|+++
T Consensus       258 ~i~~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            222222210  000    01223466889999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=344.43  Aligned_cols=266  Identities=23%  Similarity=0.272  Sum_probs=198.6

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhcCCCccceeeeEEEeCC
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDET-----NVEQFINEVVILSQINHRNIVKLLGCCLETE  386 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  386 (597)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......     ....+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999976 5899999998653222     1246889999999999999999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||+++ +|.+++....  ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999975 8999887643  35889999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|.+||......+   ...............
T Consensus       160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEE  235 (346)
T ss_dssp             STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred             eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChh
Confidence            8654322 22344568999999999865 458999999999999999999999987543211   111111111100000


Q ss_pred             hhh------h--------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EAL------D--------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l------~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...      +        ...........+..+.+||.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000      0        000001112334678999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-40  Score=339.30  Aligned_cols=260  Identities=21%  Similarity=0.321  Sum_probs=205.9

Q ss_pred             HHHHHHhcCCccC-CcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcC-CCccceeeeEEEe
Q 038707          310 KDLEKATDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQIN-HRNIVKLLGCCLE  384 (597)
Q Consensus       310 ~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  384 (597)
                      ...+...+.|.+. +.||+|+||+||+|... +++.||||.+...  ......++.+|+.++.++. ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3445556778887 89999999999999976 6899999987642  3344678999999999995 6999999999999


Q ss_pred             CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEe
Q 038707          385 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVS  461 (597)
Q Consensus       385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~  461 (597)
                      .+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999999986542 345999999999999999999999999   999999999999988   7899999


Q ss_pred             eccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          462 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       462 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      |||+++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      ...... .
T Consensus       177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~  247 (327)
T 3lm5_A          177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNIS-Q  247 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-H
T ss_pred             eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHH-h
Confidence            999998654322  2334569999999999999999999999999999999999999997543221      111111 1


Q ss_pred             CchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 ~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ...      ..........++.+.+||.+||+.||.+|||++++++.
T Consensus       248 ~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 VNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            100      00111112345568899999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.5e-40  Score=357.28  Aligned_cols=250  Identities=28%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||++... +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999986 6899999987532   244577899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---CCCCcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfgl~~~  468 (597)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999997643   4999999999999999999999999   9999999999999   5678999999999986


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+       ....+..+..... 
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~-  247 (484)
T 3nyv_A          179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFE-  247 (484)
T ss_dssp             BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC-
T ss_pred             ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCC-
Confidence            64332  2334569999999999875 69999999999999999999999997543221       2222222221100 


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           .......++.+.+||.+||+.||.+|||+.|+++
T Consensus       248 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 0111234566889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-39  Score=342.39  Aligned_cols=262  Identities=23%  Similarity=0.249  Sum_probs=205.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC--------CCccceeeeEEE---
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN--------HRNIVKLLGCCL---  383 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  383 (597)
                      .++|++.+.||+|+||+||+|... +++.||||++.. .....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999975 689999999874 3455678899999999995        788999999988   


Q ss_pred             -eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCC-----
Q 038707          384 -ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKY-----  456 (597)
Q Consensus       384 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~-----  456 (597)
                       +....+|||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             455789999999 667777766542 23599999999999999999999998 8   99999999999999775     


Q ss_pred             --------------------------------------------cEEEeeccccccccCCCceeeecccccccccCcccc
Q 038707          457 --------------------------------------------RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF  492 (597)
Q Consensus       457 --------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~  492 (597)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999765432    2334689999999999


Q ss_pred             ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh-cCch-hhhhh---------------------
Q 038707          493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-ENRL-FEALD---------------------  549 (597)
Q Consensus       493 ~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~l~---------------------  549 (597)
                      .+..++.++||||||++||||++|+.||......+............. .+.. ...+.                     
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999987655443222221111111 0000 00000                     


Q ss_pred             ------HH--hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ------AR--VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ------~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            ..  .........+..+.+||.+||+.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                  00  001124566778999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.5e-40  Score=340.71  Aligned_cols=269  Identities=23%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEcccc-----------ChhhHHHHHHHHHHHhhcCCCccce
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV-----------DETNVEQFINEVVILSQINHRNIVK  377 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~  377 (597)
                      ..++....++|++.+.||+|+||.||+|...+++.||||++...           .....+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45777888999999999999999999999888999999987532           2223478999999999999999999


Q ss_pred             eeeEEEeCC-----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          378 LLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       378 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      +++++...+     ..++||||++ |+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            999996533     5699999997 6898888754  335999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcH
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL  531 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~  531 (597)
                      +.++.+||+|||++......  .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---Q  242 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred             cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            99999999999999754322  22344568999999999876 678999999999999999999999997643221   1


Q ss_pred             HHHHHHHHhcCchhhhh-----------h-------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          532 VGYFLQAINENRLFEAL-----------D-------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       532 ~~~~~~~~~~~~~~~~l-----------~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .................           .       ...........++.+.+||.+||+.||++|||+.|+++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11111111111111000           0       000001112234668999999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-39  Score=340.13  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=194.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|++.+.||+|+||.||+|... +++.||||++..  ......+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999975 689999998764  34455678999999999999999999999998665      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||++ ++|.+++..     .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            6799999996 578888853     3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh------
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------  540 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------  540 (597)
                      +.....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+      .....+.      
T Consensus       175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~  246 (371)
T 2xrw_A          175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID------QWNKVIEQLGTPC  246 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHC-CCCCC
T ss_pred             cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCC
Confidence            765322  22344568999999999999999999999999999999999999997643211      1111110      


Q ss_pred             ----------------cCch-----hhhhhHHh----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          541 ----------------ENRL-----FEALDARV----LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       541 ----------------~~~~-----~~~l~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                      ....     .+.+.+..    ........+..+.+||.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                            0000     00000000    001123346789999999999999999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-39  Score=334.51  Aligned_cols=252  Identities=26%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      ..++|++.+.||+|+||.||+|... +++.||||.+....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4567999999999999999999976 58999999875421        22345688999999999999999999998765


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEee
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSD  462 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~D  462 (597)
                      + .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 79999999999999998754   34999999999999999999999999   999999999999987664   99999


Q ss_pred             ccccccccCCCceeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      ||++......  .......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.......  .+.    ..+
T Consensus       161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~~  232 (322)
T 2ycf_A          161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLK----DQI  232 (322)
T ss_dssp             CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHH----HHH
T ss_pred             Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHH----HHH
Confidence            9999765322  1223456899999999974   5678999999999999999999999997644332  111    111


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+....  .+    ......++.+.+||.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKYNF--IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCCCC--CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCcccc--Cc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1211110  01    111233567889999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=331.30  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ...++|++.+.||+|+||.||+|... +++.||||.+...  ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999976 5899999988643  34567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999743  234899999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......      ... .+.......      
T Consensus       179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~------  244 (314)
T 3com_A          179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIF-MIPTNPPPT------  244 (314)
T ss_dssp             B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCCC------
T ss_pred             c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHhcCCCcc------
Confidence            2 22334568999999999999899999999999999999999999997533211      111 111111000      


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             0011223456889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2e-39  Score=333.92  Aligned_cols=267  Identities=22%  Similarity=0.339  Sum_probs=208.9

Q ss_pred             hcCCccCCcccccCceEEEEEEe-c-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC------ccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGML-T-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHR------NIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||+||++.+ . +++.||||.+... ....+.+.+|+.+++.++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999997 3 6889999998743 44567889999999998765      49999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-------------
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-------------  454 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-------------  454 (597)
                      .++||||+ +++|.+++.... ..++++..++.++.||+.||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 889999998653 235899999999999999999999999   999999999999987             


Q ss_pred             ------CCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC
Q 038707          455 ------KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED  528 (597)
Q Consensus       455 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~  528 (597)
                            ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  668999999999764322    2345689999999999999999999999999999999999999976443221


Q ss_pred             CcHHHHHHHHHhcCchhhhhh--------------------------HH-----hhhhhhHHHHHHHHHHHHHhcccCCC
Q 038707          529 KSLVGYFLQAINENRLFEALD--------------------------AR-----VLKEAKKEEIMTVATLAKRCLNLNGK  577 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~--------------------------~~-----~~~~~~~~~~~~l~~li~~cl~~~p~  577 (597)
                         ............ ...+.                          ..     .........++.+.+||.+||+.||.
T Consensus       243 ---~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          243 ---LAMMERILGPLP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             ---HHHHHHHHCSCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             ---HHHHHHHhCCCC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence               111111110000 00000                          00     00011234567899999999999999


Q ss_pred             CCCCHHHHHHH--Hhhhhhhc
Q 038707          578 MRPTMKEVTNE--LGGIRTSI  596 (597)
Q Consensus       578 ~RPt~~evl~~--L~~l~~~~  596 (597)
                      +|||+.|+++.  |+.++++|
T Consensus       319 ~Rpt~~ell~hp~f~~~~~~~  339 (339)
T 1z57_A          319 KRITLREALKHPFFDLLKKSI  339 (339)
T ss_dssp             TSCCHHHHTTSGGGGGGGC--
T ss_pred             cccCHHHHhcCHHHHHHhccC
Confidence            99999999965  77777654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-39  Score=346.21  Aligned_cols=199  Identities=26%  Similarity=0.394  Sum_probs=168.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----Cc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  387 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..  ......+.+.+|+.+|++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999976 588999999864  3445567899999999999999999999999876     56


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||++ ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 6999999753   34999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCc---------------------eeeecccccccccCcccc-ccCCCCcccceeehHHHHHHHHhCCCCCC
Q 038707          468 SVMVDQT---------------------HLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIR  521 (597)
Q Consensus       468 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlG~il~ell~g~~p~~  521 (597)
                      .......                     .......||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            7643221                     123556789999999985 56679999999999999999998655443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-40  Score=348.83  Aligned_cols=254  Identities=13%  Similarity=0.060  Sum_probs=185.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhc--CCCccceee-------eEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQI--NHRNIVKLL-------GCC  382 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  382 (597)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456999999999999999999976 68999999987643   24456778885555544  699988755       455


Q ss_pred             EeCC-----------------cceEEEeccCCCChhhHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 038707          383 LETE-----------------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELL------LRIAVEVSGALFYLHSAASIP  439 (597)
Q Consensus       383 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~  439 (597)
                      ....                 ..+|||||++ |+|.+++.....  .+.+..+      +.++.||++||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            4332                 3699999998 899999987522  2455556      788899999999999999   


Q ss_pred             eEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCC
Q 038707          440 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQ  517 (597)
Q Consensus       440 i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~  517 (597)
                      |+||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++||||||++||||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986532    1224557799999999987  77999999999999999999999


Q ss_pred             CCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          518 KPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       518 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .||............        ....................++.+.+||.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999876433211100        00000000000111111234567889999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.9e-40  Score=341.32  Aligned_cols=261  Identities=22%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----Cc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV  387 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  387 (597)
                      ..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3568999999999999999999976 6889999998743 344557899999999999999999999999765     36


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||++ ++|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            799999997 5999998753    3999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          468 SVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       468 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ........  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.   .............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence            76433222  1234569999999998654 5589999999999999999999999976543331   1111111111000


Q ss_pred             hhhhh-------HHh-----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALD-------ARV-----------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~-------~~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       +.+.       ...           ........+.++.+||.+||+.||++|||+.|+++
T Consensus       254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 -EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             -HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0000       000           00011223467899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-39  Score=328.60  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---------hhhHHHHHHHHHHHhhcC-CCccceeeeEE
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---------ETNVEQFINEVVILSQIN-HRNIVKLLGCC  382 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  382 (597)
                      ...++|++.+.||+|+||.||+|... +++.||||.+....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999986 68999999876432         223567889999999995 99999999999


Q ss_pred             EeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          383 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                      .+.+..++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999999864   24899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCceeeecccccccccCccccc------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      ||++.......  ......+++.|+|||++.      ...++.++||||||+++|+|++|+.||......+       ..
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~  238 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------ML  238 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HH
Confidence            99997654322  233456899999999985      4568899999999999999999999996532211       11


Q ss_pred             HHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          537 QAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       537 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+..+....      ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1121111110      00111234567899999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-40  Score=332.82  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=189.4

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-h-hhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-E-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|+||+||++... +++.||||++.... . .....+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467999999999999999999975 68999999876532 2 23344555666688889999999999999999999999


Q ss_pred             eccCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          393 EFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       393 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||++ |+|.+++... .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888888652 2234699999999999999999999998 8   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccccccCcccc----ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYF----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ...  ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||......     .............  
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~--  232 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP--  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC--
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC--
Confidence            322  22334689999999996    5567899999999999999999999999643211     1112222221111  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 -------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   1111234556889999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=328.58  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=200.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC----hhhHHHHHHHHHHHhhcCCCccceeeeEEE--eCCc
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLGCCL--ETEV  387 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  387 (597)
                      ..++|++.+.||+|+||.||++... +++.||+|.+....    ....+.+.+|+.++++++||||+++++++.  +.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999975 68999999876432    234678999999999999999999999985  4557


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||++++ |.+++.... ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999876 777777643 345999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCC-CceeeecccccccccCccccccCC--CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          468 SVMVD-QTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       468 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ..... .........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||......      . ....+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------K-LFENIGKGSY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------H-HHHHHhcCCC
Confidence            65432 222334456899999999987643  478999999999999999999999753211      1 1122222111


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                                ..+...+..+.+||.+||+.||.+|||+.|+++.
T Consensus       231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      1122344568899999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=339.72  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             CHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe-
Q 038707          308 TSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE-  384 (597)
Q Consensus       308 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  384 (597)
                      ...++....++|++.+.||+|+||.||+|.+. +++.||||.+.... ...+.+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444456788999999999999999999975 68999999876433 3457789999999999 79999999999987 


Q ss_pred             -----CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEE
Q 038707          385 -----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK  459 (597)
Q Consensus       385 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k  459 (597)
                           .+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 467899999999999999998652 345899999999999999999999999   99999999999999999999


Q ss_pred             EeeccccccccCCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          460 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      |+|||++....... .......|++.|+|||++.     ...++.++||||||+++|+|++|+.||.......      .
T Consensus       170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~  242 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------A  242 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------H
T ss_pred             EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------H
Confidence            99999987653221 1233446899999999986     5678999999999999999999999996533211      1


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .. .+.......        ......+..+.+||.+||+.||.+|||+.++++
T Consensus       243 ~~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LF-LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HH-HHHHSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-HhhcCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11 111111100        011223456889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.8e-40  Score=343.70  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=185.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------C
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  386 (597)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..  ........+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999975 689999999864  3345667889999999999999999999999754      5


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++|+|++ +++|.+++...    .+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 78999998652    4999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+   ............ ..
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p-~~  251 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTP-GA  251 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSC-CH
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC-CH
Confidence            765322    334568999999999876 678999999999999999999999997643221   111111111100 00


Q ss_pred             hhhhH-------Hh-----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EALDA-------RV-----------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l~~-------~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +.+..       ..           ........++.+.+||.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000       00           000011234568899999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.7e-39  Score=343.40  Aligned_cols=199  Identities=26%  Similarity=0.339  Sum_probs=173.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc------CCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI------NHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  388 (597)
                      ..+|++.+.||+|+||+||+|... +++.||||++.. ......++.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999976 589999999874 344456788888888887      577999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc--EEEeecccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGTS  466 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--~kl~Dfgl~  466 (597)
                      ++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999995 69999998753 234899999999999999999999999   999999999999999887  999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                      ......    .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            654322    234568999999999999999999999999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=336.80  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEE-----------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL-----------  383 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  383 (597)
                      .++|++.+.||+|+||.||+|... +++.||||++...+....+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999986 48999999988777777889999999999999999999999874           


Q ss_pred             ---eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEE
Q 038707          384 ---ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAK  459 (597)
Q Consensus       384 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~k  459 (597)
                         +....++||||++ |+|.+++...    ++++..++.++.||+.||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3457789999997 6999998642    4899999999999999999999999   99999999999997 567999


Q ss_pred             EeeccccccccCCCc--eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHH
Q 038707          460 VSDFGTSRSVMVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL  536 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  536 (597)
                      |+|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||......+      ...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~  235 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQ  235 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence            999999986543211  12233457899999998765 678999999999999999999999997643221      111


Q ss_pred             HHHhcCch-------------hhhhhHHh------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          537 QAINENRL-------------FEALDARV------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       537 ~~~~~~~~-------------~~~l~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ........             ...+....      ........+.++.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            11111000             00000000      00111234567999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=341.07  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET-----  385 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  385 (597)
                      ++...++|++.+.||+|+||+||+|.+. +++.||||++.....    ...+|+.+++.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3455678999999999999999999975 689999998764322    234799999999999999999998543     


Q ss_pred             ---------------------------------CcceEEEeccCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 038707          386 ---------------------------------EVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFY  431 (597)
Q Consensus       386 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~  431 (597)
                                                       ...++||||++ ++|.+.+... .....+++..+..++.||++||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             23789999997 5888887652 123459999999999999999999


Q ss_pred             HHhCCCCCeEeccCCCCCeEeC-CCCcEEEeeccccccccCCCceeeecccccccccCccccccC-CCCcccceeehHHH
Q 038707          432 LHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVV  509 (597)
Q Consensus       432 LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~i  509 (597)
                      ||+.+   |+||||||+|||++ .++.+||+|||+++......  ......+|+.|+|||++.+. .++.++||||||++
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999   99999999999997 68899999999998664332  23345689999999998764 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh---------------hHHhhhhhhHHHHHHHHHHHHHhccc
Q 038707          510 LVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL---------------DARVLKEAKKEEIMTVATLAKRCLNL  574 (597)
Q Consensus       510 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---------------~~~~~~~~~~~~~~~l~~li~~cl~~  574 (597)
                      +|||++|+.||......+   ................+.               ........+...+..+.+|+.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            999999999997643222   111111111111000000               00001111223456689999999999


Q ss_pred             CCCCCCCHHHHHH
Q 038707          575 NGKMRPTMKEVTN  587 (597)
Q Consensus       575 ~p~~RPt~~evl~  587 (597)
                      ||.+|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.6e-40  Score=339.04  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChh-----------------hHHHHHHHHHHHhhcCCCcccee
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET-----------------NVEQFINEVVILSQINHRNIVKL  378 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l  378 (597)
                      .++|++.+.||+|+||.||+|.. +++.||||.+......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999987642111                 12789999999999999999999


Q ss_pred             eeEEEeCCcceEEEeccCCCChhhH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeE
Q 038707          379 LGCCLETEVPLLVYEFIPNGTLYQY------IHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANIL  451 (597)
Q Consensus       379 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIl  451 (597)
                      ++++.+.+..++||||+++++|.++      +... ....+++..++.++.||+.||.|||+ .+   |+|+||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999999      5432 13569999999999999999999999 88   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCCceeeecccccccccCccccccC-CCCc-ccceeehHHHHHHHHhCCCCCCCCCCcCCC
Q 038707          452 LDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTE-KSDVYSFGVVLVEILTGQKPIRAINTDEDK  529 (597)
Q Consensus       452 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~SlG~il~ell~g~~p~~~~~~~~~~  529 (597)
                      ++.++.+||+|||++......   ......+++.|+|||.+.+. .++. ++||||||+++|+|++|+.||.......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  259 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--  259 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence            999999999999999875432   33455689999999999877 6666 9999999999999999999997644311  


Q ss_pred             cHHHHHHHHHhcCchhhh---------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          530 SLVGYFLQAINENRLFEA---------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~---------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          .....+..+.....         .............+..+.+|+.+||+.||.+|||+.|+++
T Consensus       260 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                11222222211000         0000000011334567899999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=345.39  Aligned_cols=266  Identities=20%  Similarity=0.321  Sum_probs=184.8

Q ss_pred             hcCCcc-CCcccccCceEEEEEEec---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcce
Q 038707          316 TDNYNA-NRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPL  389 (597)
Q Consensus       316 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  389 (597)
                      .+.|++ .++||+|+||+||+|.+.   +++.||||++....  ....+.+|+.+|++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            344665 568999999999999965   47899999987432  23568899999999999999999999965  56789


Q ss_pred             EEEeccCCCChhhHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe----CCCCcEE
Q 038707          390 LVYEFIPNGTLYQYIHNQI------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAK  459 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~k  459 (597)
                      |||||++ ++|.+++....      ....+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 58888886422      1234999999999999999999999999   9999999999999    7788999


Q ss_pred             EeeccccccccCCCc--eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC------Cc
Q 038707          460 VSDFGTSRSVMVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED------KS  530 (597)
Q Consensus       460 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~------~~  530 (597)
                      |+|||+++.......  .......||+.|+|||++.+ ..++.++||||||++||||++|+.||.....+..      ..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987643222  22344568999999999877 4589999999999999999999999976543211      01


Q ss_pred             HHHHHHHHHhcCc---hhhh--------hhHHh-------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038707          531 LVGYFLQAINENR---LFEA--------LDARV-------------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       531 ~~~~~~~~~~~~~---~~~~--------l~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  586 (597)
                      ........+....   +...        +....             ...........+.+||.+||+.||.+|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            1111111111000   0000        00000             0000001145688999999999999999999998


Q ss_pred             H
Q 038707          587 N  587 (597)
Q Consensus       587 ~  587 (597)
                      +
T Consensus       333 ~  333 (405)
T 3rgf_A          333 Q  333 (405)
T ss_dssp             T
T ss_pred             c
Confidence            6

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-39  Score=343.79  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=195.4

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc------ce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV------PL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  389 (597)
                      ..+|.+.++||+|+||+||+|.+..+..+|+|++.....    ...+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457999999999999999999988777799998753221    22369999999999999999999975443      78


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEEEeecccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRS  468 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~~  468 (597)
                      +||||++++.+............+++..++.++.||++||+|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987544443332223446999999999999999999999999   99999999999998 799999999999987


Q ss_pred             ccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh-
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE-  546 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  546 (597)
                      ......  .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||.+....+   ................ 
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence            643322  3345689999999998664 58999999999999999999999997643221   1111111111000000 


Q ss_pred             -hhhHH-------------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 -ALDAR-------------VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 -~l~~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                       ...+.             .........++++.+||.+||+.||.+|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             00000             0001112245678999999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-39  Score=336.67  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=200.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----Ccc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  388 (597)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999976 6899999988643 344567789999999999999999999988764     578


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ++||||++ ++|.+++...    .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 6999998763    4999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCce---------eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHH
Q 038707          469 VMVDQTH---------LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA  538 (597)
Q Consensus       469 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  538 (597)
                      .......         ......||+.|+|||++.. ..++.++||||||+++|+|++|+.||......+   ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence            6432211         1223468999999998754 778999999999999999999999997643211   11111111


Q ss_pred             HhcCc----h--------hhhhhH------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          539 INENR----L--------FEALDA------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       539 ~~~~~----~--------~~~l~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....    .        .+.+..      ..........+.++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            10000    0        000000      0000111234567889999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-39  Score=331.82  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=200.1

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC--CCccceeeeEEEeCC
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQIN--HRNIVKLLGCCLETE  386 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  386 (597)
                      .+....++|++.+.||+|+||.||++...+++.||||.+..  ......+.+.+|+.++++++  ||||+++++++.+.+
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            33444577999999999999999999988899999998764  34556788999999999997  599999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||| +.+++|.+++....   .+++..++.++.||++||.|||+.+   |+||||||+|||+++ +.+||+|||++
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             EEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccc
Confidence            9999999 56889999998643   4899999999999999999999999   999999999999965 79999999999


Q ss_pred             ccccCCCce-eeecccccccccCcccccc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          467 RSVMVDQTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       467 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      ......... ......|++.|+|||.+.+           ..++.++||||||+++|+|++|+.||......     ...
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~  248 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK  248 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH
Confidence            866433221 2234568999999999865           46889999999999999999999999643221     111


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .....         ++......+...+..+.+|+.+||+.||.+||++.|+++.
T Consensus       249 ~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11111         1111111112224568899999999999999999999863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-39  Score=336.90  Aligned_cols=270  Identities=22%  Similarity=0.289  Sum_probs=193.0

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      ..+.....++|++.+.||+|+||+||+|.+. +++.||||++... ......+.+|++.++.++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3455667789999999999999999999985 6899999987542 3334567788888999999999999999976443


Q ss_pred             -------ceEEEeccCCCChhhHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeccCCCCCeEeCC-CC
Q 038707          388 -------PLLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLH--SAASIPIYHRDIKSANILLDD-KY  456 (597)
Q Consensus       388 -------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~i~H~Dik~~NIll~~-~~  456 (597)
                             .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999976 55554443 223446899999999999999999999  888   999999999999996 89


Q ss_pred             cEEEeeccccccccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~  535 (597)
                      .+||+|||++.......  ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+   .....
T Consensus       170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~  244 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI  244 (360)
T ss_dssp             EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence            99999999998664332  23345689999999998654 48999999999999999999999997643221   11111


Q ss_pred             HHHHhcCch--hhhhh----------------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          536 LQAINENRL--FEALD----------------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       536 ~~~~~~~~~--~~~l~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .........  ...++                ...........++++.+||.+||+.||.+|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111100000  00000                000111112245679999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6e-40  Score=335.46  Aligned_cols=263  Identities=21%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV  387 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  387 (597)
                      .+.+...++|++.+.||+|+||.||+|.+..  .+|+|.+...  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3444456789999999999999999999754  4899987643  23345668899999999999999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999999999997643  35899999999999999999999999   99999999999998 6799999999986


Q ss_pred             cccCCC----ceeeecccccccccCcccccc---------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHH
Q 038707          468 SVMVDQ----THLTTKVQGTFGYVDPEYFQS---------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY  534 (597)
Q Consensus       468 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~  534 (597)
                      ......    ........|++.|+|||++..         ..++.++||||||+++|||++|+.||......+       
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------  250 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------  250 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence            543211    112233458999999999864         457899999999999999999999997543221       


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      ....+..+......        ....+.++.+|+.+||+.||++|||+.+++++|+++++.
T Consensus       251 ~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 IIWQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHHHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11122221111100        112334588999999999999999999999999998865

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.5e-39  Score=326.70  Aligned_cols=252  Identities=27%  Similarity=0.471  Sum_probs=194.5

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe---------
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE---------  384 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  384 (597)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.. .....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3467999999999999999999975 689999998864 34556789999999999999999999999865         


Q ss_pred             ----CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEE
Q 038707          385 ----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV  460 (597)
Q Consensus       385 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl  460 (597)
                          .+..++||||+++++|.+++....  ..+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                346789999999999999998643  34889999999999999999999999   999999999999999999999


Q ss_pred             eeccccccccCCC-------------ceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCc
Q 038707          461 SDFGTSRSVMVDQ-------------THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTD  526 (597)
Q Consensus       461 ~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~  526 (597)
                      +|||++.......             ........|++.|+|||++.+. .++.++||||||+++|+|++   ||....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            9999997654221             1122345689999999998764 78999999999999999998   543210  


Q ss_pred             CCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          527 EDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .... ....+.....      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ---~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 ---ERVN-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---HHHH-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---hHHH-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               1111 1111111110      0111222334556889999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-38  Score=332.42  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc----
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  388 (597)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...  .......+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999976 6899999987653  344567899999999999999999999999877655    


Q ss_pred             --eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          389 --LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       389 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                        ++||||+. ++|.+++..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 688888743     3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +....    ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   ............ ..
T Consensus       192 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~~  263 (371)
T 4exu_A          192 RHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-GT  263 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-CH
T ss_pred             ccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-cH
Confidence            75432    2334568999999999877 789999999999999999999999997543221   111111100000 00


Q ss_pred             hhh---h----H----Hh-------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          546 EAL---D----A----RV-------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       546 ~~l---~----~----~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +..   .    .    ..       ........++.+.+||.+||+.||++|||+.|+++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000   0    0    00       000112235678999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.9e-39  Score=323.25  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=205.0

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ....++|++.+.||+|+||.||++... +++.||||.+...  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999986 6899999987542  3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC---CcEEEeecccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTS  466 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfgl~  466 (597)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+|+||||+|||++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999987643   4899999999999999999999999   9999999999999764   46999999999


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ........  .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+       ....+..+....
T Consensus       172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~  241 (287)
T 2wei_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF  241 (287)
T ss_dssp             GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred             eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence            76543221  223458999999999875 48999999999999999999999997543211       122222222110


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 DL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00      001233456889999999999999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-38  Score=332.73  Aligned_cols=262  Identities=22%  Similarity=0.265  Sum_probs=201.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----------CCccceeeeEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----------HRNIVKLLGCCL  383 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  383 (597)
                      .++|++.+.||+|+||+||+|... +++.||||.+.. .....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357999999999999999999975 689999999863 3445677889999999886           899999999998


Q ss_pred             eCC----cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeC-----
Q 038707          384 ETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLD-----  453 (597)
Q Consensus       384 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~-----  453 (597)
                      ..+    ..++|||++ +++|.+++.... ...+++..++.++.||+.||+|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 899999998743 23489999999999999999999998 8   99999999999994     


Q ss_pred             -CCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH
Q 038707          454 -DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV  532 (597)
Q Consensus       454 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~  532 (597)
                       ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4458999999999765422    23346899999999999999999999999999999999999999865433222211


Q ss_pred             HHHHHHHh-cCchhhhh----------------------------hH--HhhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038707          533 GYFLQAIN-ENRLFEAL----------------------------DA--RVLKEAKKEEIMTVATLAKRCLNLNGKMRPT  581 (597)
Q Consensus       533 ~~~~~~~~-~~~~~~~l----------------------------~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  581 (597)
                      ......+. .+.....+                            ..  ......+...++++.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111111 00000000                            00  0011234567788999999999999999999


Q ss_pred             HHHHHH
Q 038707          582 MKEVTN  587 (597)
Q Consensus       582 ~~evl~  587 (597)
                      +.|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.5e-39  Score=330.86  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             HhcCCccCCcccccCceEEEEEEec--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCccceeeeEEE----
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCL----  383 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  383 (597)
                      ..++|++.+.||+|+||.||+|.+.  +++.||||++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999973  68899999876422  22234566777777766   8999999999987    


Q ss_pred             -eCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEee
Q 038707          384 -ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD  462 (597)
Q Consensus       384 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D  462 (597)
                       .....++||||++ |+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999997 69999998753 234899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      ||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+   ............
T Consensus       164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~  238 (326)
T 1blx_A          164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP  238 (326)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCC
Confidence            99997654222  2334568999999999999899999999999999999999999997543211   111111111100


Q ss_pred             chhhh----------h---hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          543 RLFEA----------L---DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       543 ~~~~~----------l---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .....          .   ............+..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000          0   000011112334567889999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.5e-39  Score=341.19  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=193.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------cce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------VPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  389 (597)
                      .+|++.+.||+|+||.||+|.+. +++.||||++....    ....+|+++|++++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46999999999999999999986 58999999876422    22347999999999999999999986422      357


Q ss_pred             EEEeccCCCChhhHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-CcEEEeeccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSR  467 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfgl~~  467 (597)
                      +||||+++ +|.+++... .....+++..++.++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999975 676666542 22345999999999999999999999999   9999999999999955 578999999998


Q ss_pred             cccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+   ................
T Consensus       206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred             hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            754332  23345689999999998764 79999999999999999999999997643211   1111111111000000


Q ss_pred             h--hh--------HHh-----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 A--LD--------ARV-----LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~--l~--------~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      +  +.        +.+     ........+.++.+||.+||+.||.+|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0  00        000     00011223567899999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=326.40  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=197.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-----
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-----  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  387 (597)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..  ........+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999999975 689999998764  234456789999999999999999999999987654     


Q ss_pred             -ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          388 -PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       388 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                       .++||||++ ++|.+++..     .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 688888743     3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc--
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR--  543 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  543 (597)
                      ......    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+   .............  
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE  246 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence            764322    234568999999999876 678999999999999999999999997644221   1111111100000  


Q ss_pred             hhhhhhH----Hh-----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LFEALDA----RV-----------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~~~l~~----~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ..+.+..    ..           ........+..+.+||.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000    00           00111234567899999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.8e-38  Score=330.02  Aligned_cols=201  Identities=28%  Similarity=0.380  Sum_probs=172.8

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CC-----ccceeeeEEEeCC
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HR-----NIVKLLGCCLETE  386 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  386 (597)
                      ...++|++.+.||+|+||+||+|... +++.||||++.. ......++..|+.+++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999976 688999999874 3444677888999998885 55     4999999999999


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeccCCCCCeEeC--CCCcEEEee
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS--AASIPIYHRDIKSANILLD--DKYRAKVSD  462 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~~~~i~H~Dik~~NIll~--~~~~~kl~D  462 (597)
                      ..+|||||++ ++|.+++..... ..+++..+..++.||+.||.|||+  .+   |+||||||+|||++  .++.+||+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999996 599999987532 348999999999999999999995  45   99999999999994  578899999


Q ss_pred             ccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 038707          463 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN  524 (597)
Q Consensus       463 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~  524 (597)
                      ||++......    .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999765322    234568999999999999999999999999999999999999998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.9e-39  Score=328.18  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=180.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHH-HHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      .++|++.+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999986 6899999988653 3344556666666 777789999999999999999999999


Q ss_pred             eccCCCChhhHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQ--IEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 888887641  1234589999999999999999999998 8   999999999999999999999999999765


Q ss_pred             cCCCceeeecccccccccCcccc----ccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYF----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ....  ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||........     .... +..+.. 
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~-  247 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGDP-  247 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC-
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCCC-
Confidence            4322  22334689999999998    456789999999999999999999999975332110     0000 000000 


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                          +.+........+..+.+|+.+||+.||++|||+.++++
T Consensus       248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                00111111234456889999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6e-38  Score=325.23  Aligned_cols=258  Identities=21%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CC-cEEEEEEccccChhhHHHHHHHHHHHhhcCCCc------cceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DG-RIVAVKKSKLVDETNVEQFINEVVILSQINHRN------IVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  387 (597)
                      .++|++.+.||+|+||+||++... ++ +.||||.+.. .....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999975 34 7899999874 3445677889999999997665      8999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe---------------
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---------------  452 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll---------------  452 (597)
                      .++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 677888777642 235999999999999999999999999   9999999999999               


Q ss_pred             ----CCCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCC
Q 038707          453 ----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED  528 (597)
Q Consensus       453 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~  528 (597)
                          +.++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ 
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence                56789999999999764322    234568999999999999999999999999999999999999997543222 


Q ss_pred             CcHHHHHHHHHhcCchhhhh---------------------hHHh----------hhhhhHHHHHHHHHHHHHhcccCCC
Q 038707          529 KSLVGYFLQAINENRLFEAL---------------------DARV----------LKEAKKEEIMTVATLAKRCLNLNGK  577 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l---------------------~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~  577 (597)
                        ............. ...+                     +...          ........+..+.+||.+||+.||+
T Consensus       247 --~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          247 --HLVMMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             --HHHHHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             --HHHHHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence              1111111110000 0000                     0000          0001123456789999999999999


Q ss_pred             CCCCHHHHHH
Q 038707          578 MRPTMKEVTN  587 (597)
Q Consensus       578 ~RPt~~evl~  587 (597)
                      +|||+.|+++
T Consensus       324 ~Rpt~~e~l~  333 (355)
T 2eu9_A          324 QRITLAEALL  333 (355)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHhc
Confidence            9999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-38  Score=327.94  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=173.9

Q ss_pred             HhcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcc
Q 038707          315 ATDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVP  388 (597)
Q Consensus       315 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  388 (597)
                      ..++|.+. ++||+|+||+||+|.+. +++.||||++... ..   ...+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            45678885 46999999999999986 6899999998642 11   12223334566799999999999976    4457


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGT  465 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl  465 (597)
                      ++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999998653 245999999999999999999999999   999999999999976   45599999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +......   ......+|+.|+|||++....++.++||||||+++|+|++|+.||...........   ....+..... 
T Consensus       178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~-  250 (336)
T 3fhr_A          178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQY-  250 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcccc-
Confidence            9765422   22345689999999999888899999999999999999999999976443321100   0000000000 


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus       251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0000111234566889999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=324.42  Aligned_cols=246  Identities=28%  Similarity=0.413  Sum_probs=191.9

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhc----CCCcccee
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQI----NHRNIVKL  378 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l  378 (597)
                      .+.+...++|++.+.||+|+||.||+|... +++.||||.+.....      .....+.+|+.++.++    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            344556788999999999999999999975 689999999865332      2334567899999998    89999999


Q ss_pred             eeEEEeCCcceEEEec-cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCC
Q 038707          379 LGCCLETEVPLLVYEF-IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKY  456 (597)
Q Consensus       379 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~  456 (597)
                      ++++.+.+..++|||+ +.+++|.+++....   .+++..++.++.||++||.|||+++   |+||||||+|||++ +++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence            9999999999999999 78999999998643   4999999999999999999999999   99999999999999 889


Q ss_pred             cEEEeeccccccccCCCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~  535 (597)
                      .+||+|||++.......   .....|+..|+|||++.+..+ +.++||||||+++|+|++|+.||....           
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------  243 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------  243 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence            99999999998764322   234558999999999877666 459999999999999999999996321           


Q ss_pred             HHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          536 LQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       536 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ... ...          .......+..+.+||.+||+.||++|||++|+++
T Consensus       244 -~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -EIL-EAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HHH-HTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -HHh-hhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000 000          0112233456889999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-39  Score=329.17  Aligned_cols=250  Identities=27%  Similarity=0.425  Sum_probs=200.2

Q ss_pred             ccCHHHHHHHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcC--CCccc
Q 038707          306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQIN--HRNIV  376 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv  376 (597)
                      ..+..+.+...++|++.+.||+|+||.||+|... +++.||||.+.....      ...+.+.+|+.++++++  |+||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            3444555566788999999999999999999975 689999998764321      12356778999999996  59999


Q ss_pred             eeeeEEEeCCcceEEEeccCC-CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-C
Q 038707          377 KLLGCCLETEVPLLVYEFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-D  454 (597)
Q Consensus       377 ~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~  454 (597)
                      ++++++.+.+..++|||++.+ ++|.+++....   .+++..++.++.||++||.|||+.+   |+||||||+|||++ +
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN  185 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence            999999999999999999976 89999998643   4899999999999999999999999   99999999999999 7


Q ss_pred             CCcEEEeeccccccccCCCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHH
Q 038707          455 KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG  533 (597)
Q Consensus       455 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~  533 (597)
                      ++.+||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....         
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------  253 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------  253 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred             CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence            8899999999998764322   234568999999999887665 788999999999999999999995321         


Q ss_pred             HHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          534 YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       534 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..... ..          ......++++.+||.+||+.||++|||++|+++
T Consensus       254 ---~~~~~-~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ---EIIRG-QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---HHHHC-CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---hhhcc-cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00111 00          011223456889999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-38  Score=336.94  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=188.2

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.|...++||+|+||+||.+...+|+.||||++..   ...+.+.+|+.+++++ +||||+++++++.+.+..+|||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            34556789999999999877666899999998763   2345678999999986 8999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC-------------CcE
Q 038707          396 PNGTLYQYIHNQIEEF----PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-------------YRA  458 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~-------------~~~  458 (597)
                      + |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999998643211    1133456789999999999999999   9999999999999654             489


Q ss_pred             EEeeccccccccCCCce---eeecccccccccCcccccc-------CCCCcccceeehHHHHHHHHh-CCCCCCCCCCcC
Q 038707          459 KVSDFGTSRSVMVDQTH---LTTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE  527 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~  527 (597)
                      ||+|||++.........   ......||+.|+|||++.+       ..++.++||||||+++|||++ |+.||......+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543322   1234569999999999865       668999999999999999999 999996432211


Q ss_pred             CCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          528 DKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                              ............    .........+.++.+||.+||+.||.+|||+.+|++
T Consensus       248 --------~~i~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 --------SNIIRGIFSLDE----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --------HHHHHTCCCCCC----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HHHhcCCCCccc----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                    011111000000    001113456678999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-38  Score=333.97  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=188.0

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ..+|++.++||+|+||+|+.....+++.||||++....   ...+.+|+.+|+++ +||||+++++++.+.+..+|||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            35688899999999999765555679999999886422   23466899999999 799999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-----CCcEEEeeccccccc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRSV  469 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfgl~~~~  469 (597)
                      ++ |+|.+++.....  .+.+..++.++.||+.||.|||+++   |+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 699999986532  2455567789999999999999999   999999999999943     346889999999876


Q ss_pred             cCCCc--eeeecccccccccCccccc---cCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          470 MVDQT--HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       470 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      .....  .......||+.|+|||++.   ...++.++||||||+++|||++ |..||.......       .........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence            53322  2234466999999999987   4567889999999999999999 999985432111       111111111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       ....      .........+.+||.+||+.||.+|||+.||++
T Consensus       247 -~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 -LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             1111      111234456789999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=319.75  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=181.2

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhh-HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.... ... .+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467999999999999999999986 68999999876532 222 33455556678888999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+ ++.+..+....  ...+++..++.++.||++||.|||+. +   |+|+||||+|||++.++.+||+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 45555555432  23589999999999999999999995 8   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ...  ......+++.|+|||++.     ...++.++||||||+++|+|++|+.||......     ............. 
T Consensus       177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~-  248 (318)
T 2dyl_A          177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP-  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC-
T ss_pred             CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC-
Confidence            322  233446899999999984     456889999999999999999999999753221     1111111111110 


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .       .......+..+.+|+.+||+.||.+||++.++++
T Consensus       249 ~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 L-------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0       0001123456889999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-37  Score=312.41  Aligned_cols=233  Identities=13%  Similarity=0.126  Sum_probs=188.0

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999986 48999999987532   44567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++...     ....++.+++.||+.||+|||+++   |+||||||+|||+++++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999999642     355678899999999999999999   9999999999999999999998543       


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                                    |++|       ++.++||||||++||||++|+.||......+.....        ........  .
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~--~  223 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQP--I  223 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCB--C
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCC--C
Confidence                          3333       688999999999999999999999875543311000        00000000  0


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .........++.+.+||.+||+.||++| |+.|+++.|+++...
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0011123345668999999999999999 999999999988653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-38  Score=347.89  Aligned_cols=272  Identities=23%  Similarity=0.321  Sum_probs=204.5

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe------CCcc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLE------TEVP  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  388 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.. ......+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999975 689999998765 345567789999999999999999999998765      6678


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCc---EEEeeccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGT  465 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfgl  465 (597)
                      ++||||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999987655556999999999999999999999999   999999999999987665   99999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCC--cH-HHHHHHHHh--
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK--SL-VGYFLQAIN--  540 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~--~~-~~~~~~~~~--  540 (597)
                      +.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........-  .. .........  
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            98764332  234456899999999999999999999999999999999999999653110000  00 000000000  


Q ss_pred             --cCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHhhhh
Q 038707          541 --ENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE-----VTNELGGIR  593 (597)
Q Consensus       541 --~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----vl~~L~~l~  593 (597)
                        .+.....-............+..+.+|+.+||+.||++|||+.+     +.+.++.+.
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence              00000000000011223446678999999999999999999988     555665554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-37  Score=346.39  Aligned_cols=239  Identities=22%  Similarity=0.335  Sum_probs=196.0

Q ss_pred             cCCccCCcccccCceEEEEEEec--CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc-----c
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-----P  388 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  388 (597)
                      ++|++.+.||+|+||+||++.+.  +++.||||++.. ........+.+|+.++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999975  589999998764 344556789999999999999999999999988766     6


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      +|||||+++++|.+++..     .+++.+++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999988754     4999999999999999999999999   9999999999999986 999999999986


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....     ....||+.|+|||++.+.. +.++||||||++|++|++|..||.........                .  
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------~--  286 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------E--  286 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------T--
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------------c--
Confidence            5432     3456999999999987654 89999999999999999999988653222110                0  


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIR  593 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~  593 (597)
                           ........+.+.+||.+||+.||.+|| +++++...|..+.
T Consensus       287 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 -----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                 001122345688999999999999999 5677777776653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-37  Score=327.84  Aligned_cols=245  Identities=15%  Similarity=0.164  Sum_probs=184.1

Q ss_pred             HHhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCC-Cccce---------ee
Q 038707          314 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---TNVEQFINEVVILSQINH-RNIVK---------LL  379 (597)
Q Consensus       314 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~---------l~  379 (597)
                      ....+|...++||+|+||+||+|.+. +|+.||||++.....   ...+.+.+|+.+++.++| +|...         .+
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888899999999999999965 699999998774332   236789999999999987 32211         11


Q ss_pred             ------------eEEEe-----CCcceEEEeccCCCChhhHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038707          380 ------------GCCLE-----TEVPLLVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLHSAASI  438 (597)
Q Consensus       380 ------------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  438 (597)
                                  .+...     ....+++|+++ +++|.+++...    .....+++..++.++.||++||+|||+++  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                        11111     12345666665 68999998521    12345889999999999999999999999  


Q ss_pred             CeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCcccc----------ccCCCCcccceeehHH
Q 038707          439 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF----------QSSQFTEKSDVYSFGV  508 (597)
Q Consensus       439 ~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~SlG~  508 (597)
                       |+||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++||||||+
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence             999999999999999999999999998764322    344567 999999998          5566889999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          509 VLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       509 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      +||||++|+.||......+...               ..+.      .....++.+.+||.+||+.||++||++.++++.
T Consensus       306 il~elltg~~Pf~~~~~~~~~~---------------~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSE---------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSG---------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHCCCCCCCcchhhhHH---------------HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999997644332111               0000      011234668999999999999999998887653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.7e-36  Score=304.72  Aligned_cols=231  Identities=23%  Similarity=0.314  Sum_probs=179.5

Q ss_pred             hcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHH-hhcCCCccceeeeEEEe----CCcc
Q 038707          316 TDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVIL-SQINHRNIVKLLGCCLE----TEVP  388 (597)
Q Consensus       316 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  388 (597)
                      .++|.+. +.||+|+||.||++... +++.||||.+..     ...+.+|+.++ +.++||||+++++++.+    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 78999999999999975 689999999863     24567888888 55689999999999987    6678


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGT  465 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl  465 (597)
                      ++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999998753 235999999999999999999999999   999999999999998   78899999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +....                       +..++.++||||||+++|||++|+.||......+...       ........
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~~~~~  216 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRM  216 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCCSSCT
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHHHHhh
Confidence            86432                       2456789999999999999999999996543221000       00000000


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .  ............++++.+|+.+||+.||.+|||+.|+++
T Consensus       217 ~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          217 G--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             T--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0  000000001234567899999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-36  Score=313.60  Aligned_cols=242  Identities=17%  Similarity=0.220  Sum_probs=185.0

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcC---------CCcccee
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--------ETNVEQFINEVVILSQIN---------HRNIVKL  378 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  378 (597)
                      .++|++.+.||+|+||+||+|.+ +|+.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 68999999876532        334578899999999886         7777776


Q ss_pred             eeEEE-----------------e-------------CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 038707          379 LGCCL-----------------E-------------TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA  428 (597)
Q Consensus       379 ~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~  428 (597)
                      .+.+.                 +             .+..+|||||+++|++.+.+.+    ..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            66542                 2             6788999999999987777743    248999999999999999


Q ss_pred             HHHHH-hCCCCCeEeccCCCCCeEeCCCC--------------------cEEEeeccccccccCCCceeeeccccccccc
Q 038707          429 LFYLH-SAASIPIYHRDIKSANILLDDKY--------------------RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV  487 (597)
Q Consensus       429 L~~LH-~~~~~~i~H~Dik~~NIll~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~  487 (597)
                      |.||| +++   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 899   99999999999999887                    8999999999865432      236899999


Q ss_pred             CccccccCCCCcccceeehHHH-HHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHH
Q 038707          488 DPEYFQSSQFTEKSDVYSFGVV-LVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVAT  566 (597)
Q Consensus       488 aPE~~~~~~~~~~sDv~SlG~i-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~  566 (597)
                      |||++.+.. +.++|||||+.+ .++++.|..||...      .........+......   ............++++.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF---KTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC---SSCCCSHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc---CcccchhhhhhcCHHHHH
Confidence            999998766 899999998777 77888899998421      0000111111100000   000111223567788999


Q ss_pred             HHHHhcccCCCCCCCHHHHH
Q 038707          567 LAKRCLNLNGKMRPTMKEVT  586 (597)
Q Consensus       567 li~~cl~~~p~~RPt~~evl  586 (597)
                      ||.+||+.|     |++|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.2e-29  Score=278.35  Aligned_cols=184  Identities=18%  Similarity=0.126  Sum_probs=129.5

Q ss_pred             ccccCceEEEEEEe-cCCcEEEEEEcccc----------ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEEE
Q 038707          325 LGQGGQGTVYKGML-TDGRIVAVKKSKLV----------DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       325 lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +..|+.|.+..+.. ..|+.+++|.+...          .+...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566665555442 24788999986532          123456799999999999 6999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||++|++|.++|.+..   +++..   +|+.||+.||+|||+++   |+||||||+||||++++++||+|||+++....+
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998643   46654   57899999999999999   999999999999999999999999999876433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCC
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP  519 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p  519 (597)
                      . .......||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2 22345679999999999875 467789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.1e-26  Score=253.48  Aligned_cols=185  Identities=15%  Similarity=0.185  Sum_probs=146.9

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ...++||+|+||+||++.. .++.+++|+.....        ....+++.+|++++++++||||+++..+..+.+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 57788888743211        11245689999999999999999777777788888999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++++|.+++.+           +..++.|+++||.|||+++   |+||||||+|||+++  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999875           4589999999999999999   999999999999999  999999999987654


Q ss_pred             CCcee------eecccccccccCcccccc--CCCCcccceeehHHHHHHHHhCCCCCC
Q 038707          472 DQTHL------TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIR  521 (597)
Q Consensus       472 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlG~il~ell~g~~p~~  521 (597)
                      .....      .....||+.|||||++..  ..|+...|+||..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211      235679999999999987  678889999999999999888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=2.4e-23  Score=208.33  Aligned_cols=150  Identities=17%  Similarity=0.147  Sum_probs=121.5

Q ss_pred             HHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccCh------------------hhHHHHHHHHHHHhhcCCC
Q 038707          312 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE------------------TNVEQFINEVVILSQINHR  373 (597)
Q Consensus       312 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  373 (597)
                      +......|.+.+.||+|+||.||+|.+.+|+.||||.+.....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344556777799999999999999997799999998764221                  23567899999999999  


Q ss_pred             ccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC
Q 038707          374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD  453 (597)
Q Consensus       374 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~  453 (597)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            5 66666554 466799999999999988 421         124479999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCCceeeecccccccccCccccc
Q 038707          454 DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ  493 (597)
Q Consensus       454 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~  493 (597)
                       ++.+||+|||+++.              +..++|||++.
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence             99999999999963              33578899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.4e-19  Score=177.02  Aligned_cols=137  Identities=19%  Similarity=0.178  Sum_probs=107.8

Q ss_pred             CCccCCcccccCceEEEEEEe-cCCcE--EEEEEccccCh------------------------hhHHHHHHHHHHHhhc
Q 038707          318 NYNANRILGQGGQGTVYKGML-TDGRI--VAVKKSKLVDE------------------------TNVEQFINEVVILSQI  370 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vaiK~~~~~~~------------------------~~~~~~~~E~~~l~~l  370 (597)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||..+....                        .....+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998 67888  99998543211                        1124688999999999


Q ss_pred             CCCcc--ceeeeEEEeCCcceEEEeccCC-C----ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 038707          371 NHRNI--VKLLGCCLETEVPLLVYEFIPN-G----TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH-SAASIPIYH  442 (597)
Q Consensus       371 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~i~H  442 (597)
                      .|+++  +.++..    +..+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            88764  444432    467899999942 4    66665432      234567889999999999999 888   999


Q ss_pred             ccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          443 RDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       443 ~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |||||+|||+++  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=3.3e-17  Score=168.37  Aligned_cols=138  Identities=13%  Similarity=0.152  Sum_probs=100.0

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccC--------------hhhHH--------HHHHHHHHHhhcCCCcc
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--------------ETNVE--------QFINEVVILSQINHRNI  375 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--------------~~~~~--------~~~~E~~~l~~l~h~ni  375 (597)
                      -|++.+.||+|++|.||+|...+|+.||||..+...              .....        ....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            389999999999999999999899999999754310              00011        12346666666654443


Q ss_pred             ceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCC
Q 038707          376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK  455 (597)
Q Consensus       376 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~  455 (597)
                      .-..-+.  ....+|||||+++++|..+...         .....++.||+.+|.+||+.+   |+||||||.|||++++
T Consensus       176 ~vp~p~~--~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIA--QSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEE--EETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeeee--ccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence            2111111  1234799999999888665321         234568899999999999999   9999999999999877


Q ss_pred             C----------cEEEeeccccccc
Q 038707          456 Y----------RAKVSDFGTSRSV  469 (597)
Q Consensus       456 ~----------~~kl~Dfgl~~~~  469 (597)
                      +          .+.|+||+.+-..
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=2.9e-12  Score=126.26  Aligned_cols=146  Identities=14%  Similarity=0.076  Sum_probs=114.6

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEE
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  391 (597)
                      ......|.+...++.|+.+.||++... ++.+++|............+.+|+.+++.+. +..+++++++..+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888998999999999754 6889999876422233456889999999985 67888999999998899999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-----------------------------------  436 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------  436 (597)
                      |||++|.+|.+.+.        +......++.+++++|..||+..                                   
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999887632        11223478889999999999821                                   


Q ss_pred             ---------------------CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 ---------------------SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 ---------------------~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                                           ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 1338999999999999876566799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=4.6e-11  Score=117.14  Aligned_cols=136  Identities=15%  Similarity=0.166  Sum_probs=101.1

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--cceeeeEEEeCCcceEEEecc
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .+.+..+.+.|..+.||++...+|+.+++|.....   ....+.+|+.+++.+.+.+  +++++++..+.+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44444444456679999998777888999986543   2356788999999986544  566888888878889999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA---------------------------------------  436 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  436 (597)
                      ++.+|.  ...      ..   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  211      11   2256778888888888753                                       


Q ss_pred             ----------------CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 ----------------SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 ----------------~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                                      ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1129999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=7e-10  Score=114.43  Aligned_cols=141  Identities=13%  Similarity=0.174  Sum_probs=106.2

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHhhcC--CCccceeeeEEEeC---CcceEEEe
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSK--LVD-ETNVEQFINEVVILSQIN--HRNIVKLLGCCLET---EVPLLVYE  393 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  393 (597)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999988754 678888765  322 123457888999999997  45688899988776   34899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-------------------------------------  436 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  436 (597)
                      |+++.++.+...     ..++..++..++.++++.|..||+..                                     
T Consensus       122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999988754211     12778889999999999999999831                                     


Q ss_pred             ------------------CCCeEeccCCCCCeEeCCCCc--EEEeecccccc
Q 038707          437 ------------------SIPIYHRDIKSANILLDDKYR--AKVSDFGTSRS  468 (597)
Q Consensus       437 ------------------~~~i~H~Dik~~NIll~~~~~--~kl~Dfgl~~~  468 (597)
                                        ...++|+|+++.|||+++++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              235999999999999987753  69999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=3.3e-10  Score=114.04  Aligned_cols=186  Identities=22%  Similarity=0.246  Sum_probs=123.3

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCc--cceeeeEEEeCC---cceEEEecc
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRN--IVKLLGCCLETE---VPLLVYEFI  395 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  395 (597)
                      .+.++.|....||+..    ..+++|+...  ......+.+|+.+|+.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    4588888652  345678899999999884 332  445555443333   458999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA---------------------------------------  436 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  436 (597)
                      +|.+|.+....     .++..++..++.++++.|..||+..                                       
T Consensus        99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99888764332     2778888889999999999999621                                       


Q ss_pred             ----------------CCCeEeccCCCCCeEeCC--CCcEEEeeccccccccCCCce--eeec-----------cccccc
Q 038707          437 ----------------SIPIYHRDIKSANILLDD--KYRAKVSDFGTSRSVMVDQTH--LTTK-----------VQGTFG  485 (597)
Q Consensus       437 ----------------~~~i~H~Dik~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~--~~~~-----------~~gt~~  485 (597)
                                      ...++|+|++|.||++++  ...+.|+||+.+........-  ....           .....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134899999999999988  556899999987543210000  0000           000001


Q ss_pred             ccC-ccccccCCCCcccceeehHHHHHHHHhCCCCC
Q 038707          486 YVD-PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI  520 (597)
Q Consensus       486 y~a-PE~~~~~~~~~~sDv~SlG~il~ell~g~~p~  520 (597)
                      ..+ |+....  .....+.|+++.+++.+.+|..+|
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 221110  122368899999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=7.5e-07  Score=87.55  Aligned_cols=133  Identities=19%  Similarity=0.181  Sum_probs=99.1

Q ss_pred             ccccCce-EEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          325 LGQGGQG-TVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       325 lg~G~~g-~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      +..|..+ .||+.... ++..+++|+...   .....+.+|...|+.+. +--+.+++.++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445444 68988765 467789998653   34567888999998884 444788999999999999999999998887


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA---------------------------------------------  436 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------------  436 (597)
                      +.....       ......+..+++..|.-||+..                                             
T Consensus       109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            765432       1233456777778888888632                                             


Q ss_pred             ----------CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 ----------SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 ----------~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                                .+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1137999999999999988777899998774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.45  E-value=1.3e-06  Score=87.74  Aligned_cols=135  Identities=15%  Similarity=0.148  Sum_probs=96.7

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC---ccceeeeEEE-eCCcceEEEeccCCC
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR---NIVKLLGCCL-ETEVPLLVYEFIPNG  398 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  398 (597)
                      +.++.|....||+.    +..+++|+..  .......+..|+.+|+.+.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45788888899987    5668888753  234567889999999999752   3667777764 345678999999998


Q ss_pred             ChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 038707          399 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA------------------------------------------  436 (597)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------------  436 (597)
                      +|.+....     .++..+...++.++++.|..||+..                                          
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88764221     1455566666666666666666532                                          


Q ss_pred             ---------------CCCeEeccCCCCCeEeCC---CCc-EEEeecccccc
Q 038707          437 ---------------SIPIYHRDIKSANILLDD---KYR-AKVSDFGTSRS  468 (597)
Q Consensus       437 ---------------~~~i~H~Dik~~NIll~~---~~~-~kl~Dfgl~~~  468 (597)
                                     ...++|+|+++.|||+++   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           223699999999999987   455 58999987743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.25  E-value=1.3e-06  Score=89.62  Aligned_cols=80  Identities=3%  Similarity=-0.015  Sum_probs=56.2

Q ss_pred             Ccc-cccCceEEEEEEec-------CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcC-C--CccceeeeEEEeC---
Q 038707          323 RIL-GQGGQGTVYKGMLT-------DGRIVAVKKSKLVD---ETNVEQFINEVVILSQIN-H--RNIVKLLGCCLET---  385 (597)
Q Consensus       323 ~~l-g~G~~g~Vy~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  385 (597)
                      +.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+. +  ..+.+++.+..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 78888999988764       26778899765322   001246778888888884 3  3577888887665   


Q ss_pred             CcceEEEeccCCCChhh
Q 038707          386 EVPLLVYEFIPNGTLYQ  402 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~  402 (597)
                      +..++||||+++.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35789999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=2.1e-05  Score=81.92  Aligned_cols=75  Identities=15%  Similarity=0.188  Sum_probs=50.2

Q ss_pred             CCcccccCceEEEEEEec-CCcEEEEEEccccCh-------hhHHHHHHHHHHHhhcCC--Cc-cceeeeEEEeCCcceE
Q 038707          322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-------TNVEQFINEVVILSQINH--RN-IVKLLGCCLETEVPLL  390 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  390 (597)
                      .+.||.|..+.||++... +++.++||.......       ...+.+..|.++++.+..  +. +++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999864 468899997543211       123456789999888742  33 4455543  4556789


Q ss_pred             EEeccCCC
Q 038707          391 VYEFIPNG  398 (597)
Q Consensus       391 v~e~~~~g  398 (597)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.99  E-value=3e-05  Score=78.60  Aligned_cols=140  Identities=17%  Similarity=0.206  Sum_probs=79.1

Q ss_pred             CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC--CCccceeee------EEEeCCcceEEEec
Q 038707          323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN--HRNIVKLLG------CCLETEVPLLVYEF  394 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~  394 (597)
                      +.|+.|....||+....++ .+++|+... ..   .++..|+.+++.|.  .-.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3465567889999887554 488998764 22   33334555555542  113344443      12345677899999


Q ss_pred             cCCCChh--------------hHHhhcCCCC--C---------CCHHH-------------------------------H
Q 038707          395 IPNGTLY--------------QYIHNQIEEF--P---------ITWEL-------------------------------L  418 (597)
Q Consensus       395 ~~~gsL~--------------~~l~~~~~~~--~---------l~~~~-------------------------------~  418 (597)
                      +++.++.              ..+|......  +         -.|..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              1122211110  0         12211                               1


Q ss_pred             HHHHHHHHHHHHHHHh----------CCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          419 LRIAVEVSGALFYLHS----------AASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       419 ~~i~~qi~~~L~~LH~----------~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ..+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1112234456667763          123449999999999999888899999998763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.00017  Score=72.24  Aligned_cols=138  Identities=17%  Similarity=0.147  Sum_probs=91.9

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCccceeeeEEEeCCcceEEEeccCCC
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVYEFIPNG  398 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  398 (597)
                      .+.|+.|....+|+... ++..+++|....   .....+..|+..|+.|.   ...+++++.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            35689999999999876 467888897653   23567888999998884   367888999888888899999999987


Q ss_pred             Chhh-----------HHhhcCC--CC-----------------CCCHHHHH---HHH----------------HHHHHHH
Q 038707          399 TLYQ-----------YIHNQIE--EF-----------------PITWELLL---RIA----------------VEVSGAL  429 (597)
Q Consensus       399 sL~~-----------~l~~~~~--~~-----------------~l~~~~~~---~i~----------------~qi~~~L  429 (597)
                      .+..           .||....  ..                 .-+|....   ++.                .+++..+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           2233211  00                 11343321   111                1111122


Q ss_pred             -HHHHh-CCCCCeEeccCCCCCeEeCCCCcEEEeecc
Q 038707          430 -FYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFG  464 (597)
Q Consensus       430 -~~LH~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg  464 (597)
                       ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23432 2245699999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.71  E-value=0.00014  Score=71.98  Aligned_cols=79  Identities=18%  Similarity=0.143  Sum_probs=58.0

Q ss_pred             CCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC---CccceeeeEEEeCCcceEEEec
Q 038707          318 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH---RNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .....+.+|.|..+.||+....+|+.+++|+...........|..|+..|+.|..   --++++++.    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3444567899999999999999999999998664443334557889999988842   234555554    345899999


Q ss_pred             cCCCCh
Q 038707          395 IPNGTL  400 (597)
Q Consensus       395 ~~~gsL  400 (597)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.57  E-value=0.00035  Score=73.18  Aligned_cols=79  Identities=8%  Similarity=-0.020  Sum_probs=46.9

Q ss_pred             CCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccC---CCCcccceeehHHHHHHHH
Q 038707          438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEIL  514 (597)
Q Consensus       438 ~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlG~il~ell  514 (597)
                      ..++|+|+++.|||+++++ ++|+||+.+........-......-...|++|+.....   .-....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3499999999999998876 99999998865321100000000012345666654321   1122345567788888877


Q ss_pred             hCC
Q 038707          515 TGQ  517 (597)
Q Consensus       515 ~g~  517 (597)
                      .++
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.0019  Score=65.02  Aligned_cols=141  Identities=14%  Similarity=0.068  Sum_probs=72.9

Q ss_pred             cccccCceE-EEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--CccceeeeEEEeCCcceEEEeccCCCCh
Q 038707          324 ILGQGGQGT-VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       324 ~lg~G~~g~-Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      .|+.|+... +|+....+++.+++|.......   +.+..|+.+++.+..  -.+++++.+..  +.-+++||++++.++
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence            455554443 6676654467777876543221   334456676666642  33566776532  333789999987776


Q ss_pred             hhHHhhcC---------------------C-C-CCCCHHHHH-------H-------------HHHHHHHHHHHHH---h
Q 038707          401 YQYIHNQI---------------------E-E-FPITWELLL-------R-------------IAVEVSGALFYLH---S  434 (597)
Q Consensus       401 ~~~l~~~~---------------------~-~-~~l~~~~~~-------~-------------i~~qi~~~L~~LH---~  434 (597)
                      .+.+....                     . . ..+......       .             ....+...+..|.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            55443210                     0 0 011111100       0             0011112222221   1


Q ss_pred             CCCCCeEeccCCCCCeEeCCC----CcEEEeeccccccc
Q 038707          435 AASIPIYHRDIKSANILLDDK----YRAKVSDFGTSRSV  469 (597)
Q Consensus       435 ~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfgl~~~~  469 (597)
                      .....++|+|+.+.|||++.+    ..+.|+||+.+...
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            123349999999999999874    68999999987543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.0013  Score=65.41  Aligned_cols=72  Identities=14%  Similarity=0.112  Sum_probs=44.5

Q ss_pred             CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEecc-CCCC
Q 038707          322 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFI-PNGT  399 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  399 (597)
                      .+.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ .++++.  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            567888999999998     45888876542111 1123457777777743222 456543  344567999999 6655


Q ss_pred             hh
Q 038707          400 LY  401 (597)
Q Consensus       400 L~  401 (597)
                      |.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.16  E-value=0.0032  Score=63.02  Aligned_cols=158  Identities=14%  Similarity=0.178  Sum_probs=86.8

Q ss_pred             cCHHHHHHHhcCCccC-----CcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--cceee
Q 038707          307 FTSKDLEKATDNYNAN-----RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLL  379 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  379 (597)
                      ++.+++.....+|.+.     +.|+.|....+|+....++ .+++|.....  ...+++..|+.++..+...+  +++++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4455666665566552     3466788889999887655 5788876642  12234556777777664212  33333


Q ss_pred             eE------EEeCCcceEEEeccCCCChhh--------------HHhhcCCCC--C----C---CHHHHHH----------
Q 038707          380 GC------CLETEVPLLVYEFIPNGTLYQ--------------YIHNQIEEF--P----I---TWELLLR----------  420 (597)
Q Consensus       380 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~--~----l---~~~~~~~----------  420 (597)
                      ..      ....+..+++++|+++..+..              .+|......  +    .   .|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      123456789999998865421              122211110  0    1   1221110          


Q ss_pred             --HHHHHHHHHHHHHhC----CCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          421 --IAVEVSGALFYLHSA----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       421 --i~~qi~~~L~~LH~~----~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                        +...+.+.++.++..    ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              011244455555532    12348999999999999987656899998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.15  E-value=0.00054  Score=71.89  Aligned_cols=73  Identities=19%  Similarity=0.255  Sum_probs=49.4

Q ss_pred             CCcccccCceEEEEEEecC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEE
Q 038707          322 NRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVY  392 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  392 (597)
                      .+.|+.|-...+|+....+        ++.+++|+.....  ..+.+.+|+.+++.+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3467778889999998653        4788999874311  12456689999988853333 567765532    3899


Q ss_pred             eccCCCCh
Q 038707          393 EFIPNGTL  400 (597)
Q Consensus       393 e~~~~gsL  400 (597)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.09  E-value=0.0012  Score=67.86  Aligned_cols=140  Identities=19%  Similarity=0.224  Sum_probs=82.4

Q ss_pred             CcccccCceEEEEEEec--------CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEe
Q 038707          323 RILGQGGQGTVYKGMLT--------DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +.|..|-...+|+....        +++.+++|+.... ........+|..+++.|. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666777889998864        2478999986432 223456678999998885 3223567766543    39999


Q ss_pred             ccCCCChhhH-----------------HhhcCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 038707          394 FIPNGTLYQY-----------------IHNQIE--EFPI--TWELLLRIAVEVSG-------------------ALFYL-  432 (597)
Q Consensus       394 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~qi~~-------------------~L~~L-  432 (597)
                      |+++.+|..-                 ||....  ..+.  -+.++.++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665421                 111100  1111  24555555544422                   22333 


Q ss_pred             ---HhC-CCCCeEeccCCCCCeEeCCC----CcEEEeeccccc
Q 038707          433 ---HSA-ASIPIYHRDIKSANILLDDK----YRAKVSDFGTSR  467 (597)
Q Consensus       433 ---H~~-~~~~i~H~Dik~~NIll~~~----~~~kl~Dfgl~~  467 (597)
                         ... ....++|+|+.+.|||++++    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               222 22348999999999999876    789999998774

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.0084  Score=60.05  Aligned_cols=159  Identities=13%  Similarity=0.084  Sum_probs=88.2

Q ss_pred             ccCHHHHHHHhcCCcc-----CCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--Ccccee
Q 038707          306 LFTSKDLEKATDNYNA-----NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH--RNIVKL  378 (597)
Q Consensus       306 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l  378 (597)
                      .++.+++......|.+     .+.|+ |....||+....+|+.+++|...... ...+.+..|..+++.+..  -.++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3445555555444433     23466 77889999877677789999875321 134566678888877742  224444


Q ss_pred             eeE-----EEeCCcceEEEeccCCCChhh----H----------HhhcCC------CCCCCHHHH----HHH--------
Q 038707          379 LGC-----CLETEVPLLVYEFIPNGTLYQ----Y----------IHNQIE------EFPITWELL----LRI--------  421 (597)
Q Consensus       379 ~~~-----~~~~~~~~lv~e~~~~gsL~~----~----------l~~~~~------~~~l~~~~~----~~i--------  421 (597)
                      +..     ....+..+++||++++.++..    .          +|....      ....++...    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     122445578999998755421    1          121110      111222111    001        


Q ss_pred             -------HHHHHHHHHHHHhC----CCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          422 -------AVEVSGALFYLHSA----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       422 -------~~qi~~~L~~LH~~----~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                             ...+...++.+...    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   11111222333221    223489999999999999 4 899999987643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.00  E-value=0.0025  Score=67.18  Aligned_cols=73  Identities=15%  Similarity=0.064  Sum_probs=46.8

Q ss_pred             CcccccCceEEEEEEecC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc-ceeeeEEEeCCcceEEEeccCCCCh
Q 038707          323 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNGTL  400 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  400 (597)
                      +.|+.|-...+|+....+ +..+++|+....... .-.-.+|..+++.|...++ +++++.+.  +  .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467778889999998765 578888876432111 1112478888888865444 56777662  2  369999987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.97  E-value=0.0021  Score=59.61  Aligned_cols=99  Identities=18%  Similarity=0.122  Sum_probs=65.8

Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCceee
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT  477 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~  477 (597)
                      -+|.++|...  +.+++++++|.++.|.+.+|.-+-.....  ..+=+.|..|+|..+|.|-+.+ ..+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence            4899999864  45799999999999999998877321111  1222346899999999988764 2110          


Q ss_pred             ecccccccccCccccccCCCCcccceeehHHHHHHHHh
Q 038707          478 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT  515 (597)
Q Consensus       478 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~  515 (597)
                         .....+.|||... ...+.+.=|||||+++|.-+-
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence               0122466888764 455788999999999999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.0025  Score=65.31  Aligned_cols=73  Identities=12%  Similarity=0.086  Sum_probs=44.0

Q ss_pred             CcccccCceEEEEEEecC---------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-cceeeeEEEeCCcceEEE
Q 038707          323 RILGQGGQGTVYKGMLTD---------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  392 (597)
                      +.|+.|..-.+|+....+         ++.+++|...... ........|..+++.+...+ .+++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            456778888899988653         2688888765321 11123457888888775333 44666543    247899


Q ss_pred             eccCCCCh
Q 038707          393 EFIPNGTL  400 (597)
Q Consensus       393 e~~~~gsL  400 (597)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.31  E-value=0.015  Score=58.60  Aligned_cols=31  Identities=19%  Similarity=0.357  Sum_probs=26.9

Q ss_pred             CCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          438 IPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       438 ~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4499999999999999888899999976643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.44  E-value=0.12  Score=53.54  Aligned_cols=140  Identities=14%  Similarity=0.121  Sum_probs=82.7

Q ss_pred             CcccccCceEEEEEEecC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEe
Q 038707          323 RILGQGGQGTVYKGMLTD--------GRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +.|..|-...+|+....+        ++.+++|+...... ..-.-.+|..+++.+. +.-..++++.+    .-++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence            456678888899988753        57899998654221 1122356888888774 32245566533    2378999


Q ss_pred             ccCCCChhh-------H----------Hhhc-------C---CCCCCCHHHHHHHHHHHH-------------------H
Q 038707          394 FIPNGTLYQ-------Y----------IHNQ-------I---EEFPITWELLLRIAVEVS-------------------G  427 (597)
Q Consensus       394 ~~~~gsL~~-------~----------l~~~-------~---~~~~l~~~~~~~i~~qi~-------------------~  427 (597)
                      |+++.+|..       .          ||..       .   ...+.-+.++.++..++-                   .
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999866421       0          1110       0   111122444444443322                   2


Q ss_pred             HHHHHHh---------------------CCCCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          428 ALFYLHS---------------------AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       428 ~L~~LH~---------------------~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      .+..|..                     .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233321                     11234899999999999 7788999999988743

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.88  E-value=0.28  Score=50.52  Aligned_cols=29  Identities=34%  Similarity=0.487  Sum_probs=24.6

Q ss_pred             eEeccCCCCCeEe------CCCCcEEEeecccccc
Q 038707          440 IYHRDIKSANILL------DDKYRAKVSDFGTSRS  468 (597)
Q Consensus       440 i~H~Dik~~NIll------~~~~~~kl~Dfgl~~~  468 (597)
                      ++|+|+.+.|||+      +++..++|+||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999988743

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.88  E-value=1.5  Score=40.53  Aligned_cols=85  Identities=11%  Similarity=0.012  Sum_probs=60.7

Q ss_pred             CCCccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeccCCCCC
Q 038707          371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF-YLHSAASIPIYHRDIKSAN  449 (597)
Q Consensus       371 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~i~H~Dik~~N  449 (597)
                      .||++  -...-.+.+...+.++.-+++.=...++.      ++...+++++.+|+.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57887  33344566666666666544433333332      788999999999988776 5554     4577889999


Q ss_pred             eEeCCCCcEEEeecccccc
Q 038707          450 ILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       450 Ill~~~~~~kl~Dfgl~~~  468 (597)
                      |++|.++.+++.-.|+-..
T Consensus       115 L~f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES  133 (219)
T ss_dssp             EEECTTCCEEESCCEETTT
T ss_pred             EEEeCCCcEEEEEcCCccc
Confidence            9999999999988886543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.33  E-value=1.1  Score=41.41  Aligned_cols=116  Identities=10%  Similarity=0.084  Sum_probs=76.0

Q ss_pred             CCCccceeeeEEEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 038707          371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI  450 (597)
Q Consensus       371 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NI  450 (597)
                      .||++++. .+-.+.+...+.++.-+.+.=...++      .++...+++++.+|+....++++     -+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            57888866 45555665555555443222222222      27889999999999998866664     35778899999


Q ss_pred             EeCCCCcEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCC
Q 038707          451 LLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR  521 (597)
Q Consensus       451 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~  521 (597)
                      +++.++.+++.-.|+...++                  |.-     .+...=.-.+=+++..+++++..|.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999998888654332                  110     0111112245678888899888774

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A

Probab=85.74  E-value=0.77  Score=29.49  Aligned_cols=29  Identities=21%  Similarity=0.440  Sum_probs=21.6

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|..++.|.+.  ..+|.|.|+.||.+.- |.
T Consensus        10 pC~ngg~C~~~--~~~~~C~C~~G~~G~~-Ce   38 (39)
T 1edm_B           10 PCLNGGSCKDD--INSYECWCPFGFEGKN-CE   38 (39)
T ss_dssp             CCCTTCEEEEE--TTEEEEECCTTCCSTT-SC
T ss_pred             CCCCCCEeEcC--CCceEeECCCCCcCCc-cC
Confidence            67766778754  4579999999998754 53

>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A

Probab=85.38  E-value=0.51  Score=31.85  Aligned_cols=30  Identities=23%  Similarity=0.380  Sum_probs=22.5

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|.. +.|.+.....+|.|.|+.||.+.- |+
T Consensus        13 pC~n-G~C~~~~~~~~~~C~C~~GytG~~-Ce   42 (46)
T 1k36_A           13 YCLH-GQCIYLVDMSQNYCRCEVGYTGVR-CE   42 (46)
T ss_dssp             SCSS-EEEEEETTTTEEEEEECTTCSSTT-SC
T ss_pred             CCCC-CEeeccCCCCCEEEECCCCCccCC-CC
Confidence            5766 577665455689999999998765 64

>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A

Probab=85.04  E-value=0.71  Score=32.17  Aligned_cols=31  Identities=29%  Similarity=0.601  Sum_probs=23.0

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|..++.|.......+|.|.|+.||.+.- |+
T Consensus        13 pC~ngg~C~~~~~~~~~~C~C~~G~~G~~-Ce   43 (53)
T 1egf_A           13 YCLNGGVCMHIESLDSYTCNCVIGYSGDR-CQ   43 (53)
T ss_dssp             SSCSSCEEEEESSSSCEEEECCTTCCSSS-SC
T ss_pred             cCCCCcEEEeeCCCCCEEEECCCCCcCCc-CC
Confidence            57776778743345689999999998764 65

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.11  E-value=0.44  Score=31.56  Aligned_cols=22  Identities=27%  Similarity=0.333  Sum_probs=9.0

Q ss_pred             hHHHHHHHHHHHHHHHHHHHhh
Q 038707          252 GLGLLFLLVGIWWLYKFVKRRK  273 (597)
Q Consensus       252 ~~~~~~l~v~~~~~~~~~krrk  273 (597)
                      ++|+++++++++.+..++|||+
T Consensus        18 vVGvll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           18 VVGILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHhheehhh
Confidence            3443333333333334444443

>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1

Probab=84.06  E-value=0.61  Score=31.22  Aligned_cols=31  Identities=29%  Similarity=0.622  Sum_probs=22.4

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|..++.|.......+|.|.|+.||.+.- |+
T Consensus        10 pC~ngg~C~~~~~~~~~~C~C~~G~~G~~-Ce   40 (45)
T 1a3p_A           10 YCLNGGVXMHIESLDSYTCNCVIGYSGDR-CQ   40 (45)
T ss_dssp             CCSSSCEEEECTTTSSEEEECCTTEETTT-TC
T ss_pred             CCCCCCEEEeecCCCCEEEEcCCCCcCCc-CC
Confidence            57776778633345679999999998754 64

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.07  E-value=0.21  Score=52.47  Aligned_cols=62  Identities=10%  Similarity=0.046  Sum_probs=19.0

Q ss_pred             ccCCcccccCceEEEEEEecC-CcEEEE------EEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe
Q 038707          320 NANRILGQGGQGTVYKGMLTD-GRIVAV------KKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE  384 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~-~~~vai------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  384 (597)
                      .+.+.||   ||.||+|.+.. ..+||+      |..+.  ...+....+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3445676   99999999864 467888      65543  233445678899999999999999999988764

>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens}

Probab=81.65  E-value=1.1  Score=31.50  Aligned_cols=34  Identities=26%  Similarity=0.675  Sum_probs=24.1

Q ss_pred             ccccCCCCceecc---CCCCceeeecCCCCCCCccccc
Q 038707          214 TTICGDGEYRCSI---TFGSGYICRCRTTYRTDGFCAG  248 (597)
Q Consensus       214 ~~~C~s~~~c~~~---~~~~gy~C~C~~gy~~~g~c~~  248 (597)
                      +..|..++.|...   ....+|.|.|+.||.+.- |+.
T Consensus        13 s~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~~-CE~   49 (55)
T 3u7u_G           13 KTFCVNGGECFMVKDLSNPSRYLCKCPNEFTGDR-CQN   49 (55)
T ss_dssp             TTTSCTTCEEEEECCC--CCCEEEEECTTEESTT-SCE
T ss_pred             CCCCCCCCCcCCCCccCCCCCEeEeCCCCCcCCC-cCc
Confidence            3478877888642   234689999999998765 653

>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C*

Probab=81.43  E-value=0.67  Score=32.34  Aligned_cols=32  Identities=22%  Similarity=0.418  Sum_probs=23.6

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.......+|.|.|+.||.+.- |+
T Consensus        12 ~pC~nGG~C~~~~~~~~~~C~C~~GytG~~-Ce   43 (53)
T 1nql_B           12 GYCLHDGVCMYIEALDKYACNCVVGYIGER-CQ   43 (53)
T ss_dssp             CEECTTCEEEEETTTTEEEEEECTTEESTT-SC
T ss_pred             CCCCCCeEEeeecCCCCEEEecCCCCcCCC-CC
Confidence            368777788743345679999999998765 64

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	597
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-64
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-63
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-60
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-59
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-52
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-50
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-46
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-45
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-37
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-37
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 3e-72
 Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 21/290 (7%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 370
           D E         + +G G  GTVYKG       V +          ++ F NEV +L + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 371 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 430
            H NI+  +G     ++  +V ++    +LY ++H    E       L+ IA + +  + 
Sbjct: 62  RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMD 118

Query: 431 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-THLTTKVQGTFGYVDP 489
           YLH+     I HRD+KS NI L +    K+ DFG +        +H   ++ G+  ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 490 EYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           E  +      ++ +SDVY+FG+VL E++TGQ P   IN  +        +  +    L  
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP 229

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI 596
            L      + +      +  L   CL      RP   ++   +  +  S+
Sbjct: 230 DLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 2e-69
 Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 21/279 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           +       LG G  G V+ G       VAVK  K     + + F+ E  ++ Q+ H+ +V
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L     +  +  ++ E++ NG+L  ++        +T   LL +A +++  + ++    
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER- 128

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
                HRD+++ANIL+ D    K++DFG +R +  ++       +    +  PE      
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           FT KSDV+SFG++L EI+T  +      T+ +       +Q +              +E 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMV-RPDNCPEEL 239

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
            +        L + C     + RPT   + + L    T+
Sbjct: 240 YQ--------LMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 4e-69
 Identities = 73/303 (24%), Positives = 124/303 (40%), Gaps = 37/303 (12%)

Query: 312 LEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQ 369
           +E   D++     LG G  G V+K      G ++A K   L +      Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            N   IV   G         +  E +  G+L Q +        I  ++L ++++ V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGL 117

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL     I   HRD+K +NIL++ +   K+ DFG S  ++     +     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED--------------------- 528
           E  Q + ++ +SD++S G+ LVE+  G+ PI   +  E                      
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 529 --KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAK----RCLNLNGKMRPTM 582
             + L  Y + +     +FE LD  V +   K      +   +    +CL  N   R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 583 KEV 585
           K++
Sbjct: 293 KQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-67
 Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 21/279 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
                 + +G G  G V+ G   +   VA+K  +     + E FI E  ++ +++H  +V
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L G CLE     LV+EF+ +G L  Y+  Q        E LL + ++V   + YL  A 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              + HRD+ + N L+ +    KVSDFG +R V+ DQ   +T  +    +  PE F  S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           ++ KSDV+SFGV++ E+ +  K                  +  + + + E +        
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
            +     V  +   C     + RP    +  +L  I  S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 8e-67
 Identities = 70/279 (25%), Positives = 131/279 (46%), Gaps = 27/279 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
                 + +G+G  G V  G    G  VAVK   + ++   + F+ E  +++Q+ H N+V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 377 KLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           +LLG  +E +  L +V E++  G+L  Y+ ++     +  + LL+ +++V  A+ YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 436 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 495
                 HRD+ + N+L+ +   AKVSDFG ++     Q       +    +  PE  +  
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREK 175

Query: 496 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
           +F+ KSDV+SFG++L EI +  +        +D       +  + +    +A D      
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD-GCPPA 228

Query: 556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT 594
             +        + K C +L+  MRP+  ++  +L  I+T
Sbjct: 229 VYE--------VMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 1e-66
 Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
           ++Y     +G G  G   K    +DG+I+  K+     + E   +  ++EV +L ++ H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 374 NIVKLLGCCLETE--VPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALF 430
           NIV+     ++       +V E+   G L   I    +E   +  E +LR+  +++ AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 431 YLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
             H  S     + HRD+K AN+ LD K   K+ DFG +R +  D +       GT  Y+ 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           PE      + EKSD++S G +L E+     P  A +  E           I E + F  +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-FRRI 234

Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             R   E  +        +  R LNL    RP+++E+
Sbjct: 235 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (547), Expect = 7e-66
 Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 21/283 (7%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQ 369
             E    +      LG G  G VY+G+       VAVK  K  D   VE+F+ E  ++ +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           I H N+V+LLG C       ++ EF+  G L  Y+        ++  +LL +A ++S A+
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 128

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            YL         HRD+ + N L+ + +  KV+DFG SR +  D        +    +  P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E    ++F+ KSDV++FGV+L EI T                       I+ ++++E L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
                E  +     V  L + C   N   RP+  E+      +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-65
 Identities = 61/279 (21%), Positives = 119/279 (42%), Gaps = 21/279 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++      LGQG  G V+ G       VA+K  K     + E F+ E  ++ ++ H  +V
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L     E  +  +V E++  G+L  ++  +  ++      L+ +A +++  + Y+    
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
                HRD+++ANIL+ +    KV+DFG +R +  ++       +    +  PE     +
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           FT KSDV+SFG++L E+ T  +                    +    + + ++       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
             E   ++  L  +C     + RPT + +   L    TS
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 5e-64
 Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 21/273 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 376
            +    + LG G  G V  G       VA+K  K     + ++FI E  ++  ++H  +V
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +L G C +     ++ E++ NG L  Y+      F    + LL +  +V  A+ YL S  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
                HRD+ + N L++D+   KVSDFG SR V+ D+   +   +    +  PE    S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 497 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEA 556
           F+ KSD+++FGV++ EI +  K                  +    +   E +   +    
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222

Query: 557 KKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                  V T+   C +     RPT K + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 8e-64
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 25/291 (8%)

Query: 296 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 354
           S+E  +EK +   S         Y     +GQG  GTVY  M +  G+ VA+++  L  +
Sbjct: 1   SDEEILEKLRSIVSVG--DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 355 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
              E  INE++++ +  + NIV  L   L  +   +V E++  G+L   +        + 
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMD 114

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
              +  +  E   AL +LHS     + HRDIKS NILL      K++DFG    +  +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
             +T V GT  ++ PE      +  K D++S G++ +E++ G+ P    N          
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------ 224

Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            L  I  N   E  +   L    ++          RCL+++ + R + KE+
Sbjct: 225 -LYLIATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKEL 267

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-63
 Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 30/288 (10%)

Query: 310 KDLEKATDNYN-ANRILGQGGQGTVYKGML---TDGRIVAVKK-SKLVDETNVEQFINEV 364
           K L    DN   A+  LG G  G+V +G+         VA+K   +  ++ + E+ + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 365 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 424
            I+ Q+++  IV+L+G C + E  +LV E    G L++++  + EE P     +  +  +
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQG 482
           VS  + YL         HRD+ + N+LL +++ AK+SDFG S+++  D ++ T +   + 
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 483 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 541
              +  PE     +F+ +SDV+S+GV + E L+ GQKP + +   E        +  I +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            +  E        E           L   C     + RP    V   +
Sbjct: 228 GKRME-CPPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRM 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 4e-63
 Identities = 75/273 (27%), Positives = 113/273 (41%), Gaps = 30/273 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           +++   R LG+G  G VY         I+A+K   K++L       Q   EV I S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
            NI++L G   +     L+ E+ P GT+Y+ +           +       E++ AL Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + HRDIK  N+LL      K++DFG S      +      + GT  Y+ PE  
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
           +     EK D++S GV+  E L G+ P  A    E         + I+           V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--TFPDFV 227

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            + A+         L  R L  N   RP ++EV
Sbjct: 228 TEGARD--------LISRLLKHNPSQRPMLREV 252

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 6e-63
 Identities = 76/336 (22%), Positives = 139/336 (41%), Gaps = 51/336 (15%)

Query: 288 LLLQQELSSNESN---IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---- 340
           L + Q   S+++    ++  +       E   +N    ++LG G  G V           
Sbjct: 5   LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64

Query: 341 --GRIVAVKK-SKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIP 396
                VAVK   +  D +  E  ++E+ +++Q+ +H NIV LLG C  +    L++E+  
Sbjct: 65  GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124

Query: 397 NGTLYQYIHNQIEEF--------------------PITWELLLRIAVEVSGALFYLHSAA 436
            G L  Y+ ++ E+F                     +T+E LL  A +V+  + +L    
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQGTFGYVDPEYFQSS 495
                HRD+ + N+L+      K+ DFG +R +M D  ++     +    ++ PE     
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241

Query: 496 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK 554
            +T KSDV+S+G++L EI + G  P   I  D +          + +N           +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-------FYKLIQNGFKMDQPFYATE 294

Query: 555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG 590
           E           + + C   + + RP+   +T+ LG
Sbjct: 295 EIYI--------IMQSCWAFDSRKRPSFPNLTSFLG 322

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 6e-63
 Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 38/304 (12%)

Query: 307 FTSKDLEKATDN---------YNANRILGQGGQGTVYKGMLT----DGRIVAVKK-SKLV 352
           FT +D  +A                +++G G  G V  G L         VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 353 DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP 412
            E     F++E  I+ Q +H N++ L G   ++   +++ EF+ NG+L  ++        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124

Query: 413 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 472
            T   L+ +   ++  + YL         HRD+ + NIL++     KVSDFG SR +  D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 473 QTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 528
            +  T       +    +  PE  Q  +FT  SDV+S+G+V+ E+++  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232

Query: 529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                     +    +  A++         +    +  L   C   +   RP   ++ N 
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 589 LGGI 592
           L  +
Sbjct: 287 LDKM 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 9e-63
 Identities = 80/286 (27%), Positives = 137/286 (47%), Gaps = 29/286 (10%)

Query: 319 YNANRILGQGGQGTVYKGMLTD----GRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 373
            + N ++G+G  G VY G L D        AVK  +++ D   V QF+ E +I+   +H 
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88

Query: 374 NIVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           N++ LLG CL +E  PL+V  ++ +G L  +I N  E    T + L+   ++V+  + +L
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGTFGYVDP 489
            S       HRD+ + N +LD+K+  KV+DFG +R +     D  H  T  +    ++  
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 490 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
           E  Q+ +FT KSDV+SFGV+L E++T   P        D +     +  +   RL     
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLL--QP 256

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
                   +        +  +C +   +MRP+  E+ + +  I ++
Sbjct: 257 EYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  206 bits (525), Expect = 2e-62
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 36/291 (12%)

Query: 302 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV 357
           +  +LF   D EK    ++  R +G G  G VY    + +  +VA+K    S        
Sbjct: 3   DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 358 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 417
           +  I EV  L ++ H N ++  GC L      LV E+           ++    P+    
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116

Query: 418 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 477
           +  +       L YLHS     + HRD+K+ NILL +    K+ DFG++           
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPA 168

Query: 478 TKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
               GT  ++ PE   +    Q+  K DV+S G+  +E+   + P+  +N          
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------ 222

Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            L  I +N           +  +             CL    + RPT + +
Sbjct: 223 -LYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 5e-62
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 30/272 (11%)

Query: 322 NRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKL 378
           +  +G+G   TVYKG+ T+    VA  +   + + ++  ++F  E  +L  + H NIV+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 379 LGCCLET----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
                 T    +  +LV E + +GTL  Y+        +  ++L     ++   L +LH+
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130

Query: 435 AASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
             + PI HRD+K  NI +       K+ D G +    + +      V GT  ++ PE ++
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
             ++ E  DVY+FG+ ++E+ T + P                 + +       + D   +
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAI 239

Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            E K+        + + C+  N   R ++K++
Sbjct: 240 PEVKE--------IIEGCIRQNKDERYSIKDL 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-62
 Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 31/276 (11%)

Query: 322 NRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 376
           ++ LG G  GTV KG        + VAVK  K++  D    ++ + E  ++ Q+++  IV
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
           +++G C E E  +LV E    G L +Y+        +  + ++ +  +VS  + YL  + 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQS 494
                HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   +   +    +  PE    
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 495 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL 553
            +F+ KSDV+SFGV++ E  + GQKP R +   E           + +        A   
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG-CPAGCP 236

Query: 554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           +E           L   C   + + RP    V   L
Sbjct: 237 REMYD--------LMNLCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 7e-62
 Identities = 69/276 (25%), Positives = 107/276 (38%), Gaps = 26/276 (9%)

Query: 316 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 374
            D +     LG G  G VYK    +   + A K      E  +E ++ E+ IL+  +H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           IVKLL          ++ EF   G +   +     E P+T   +  +  +   AL YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
                I HRD+K+ NIL       K++DFG S           + + GT  ++ PE    
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184

Query: 495 SQ-----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD 549
                  +  K+DV+S G+ L+E+   + P   +N           L+         A  
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQP 238

Query: 550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +R     K           K+CL  N   R T  ++
Sbjct: 239 SRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 9e-62
 Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 29/298 (9%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 382
             +G+G  G V++G    G  VAVK     +E +      E+     + H NI+  +   
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66

Query: 383 LETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-- 436
            +         LV ++  +G+L+ Y++       +T E ++++A+  +  L +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 437 ---SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL---TTKVQGTFGYVDPE 490
                 I HRD+KS NIL+       ++D G +         +        GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 491 YFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE----DKSLVGYFLQAIN 540
               S      +  +++D+Y+ G+V  EI             +    D       ++ + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 541 ENRLFEALDARVLKEAKKEEIM-TVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG 597
           +    + L   +    +  E +  +A + + C   NG  R T   +   L  +    G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (519), Expect = 1e-61
 Identities = 62/312 (19%), Positives = 119/312 (38%), Gaps = 47/312 (15%)

Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFIN 362
             LE   +N    R +G+G  G V++             +VAVK   +         F  
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 363 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF----------- 411
           E  ++++ ++ NIVKLLG C   +   L++E++  G L +++ +                
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 412 ----------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 461
                     P++    L IA +V+  + YL         HRD+ + N L+ +    K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182

Query: 462 DFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           DFG SR++   D             ++ PE    +++T +SDV+++GVVL EI +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241

Query: 521 RAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP 580
                             +    +   +    +    +   + +  L + C +     RP
Sbjct: 242 --------------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287

Query: 581 TMKEVTNELGGI 592
           +   +   L  +
Sbjct: 288 SFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 6e-60
 Identities = 68/291 (23%), Positives = 125/291 (42%), Gaps = 28/291 (9%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGMLTDG-----RIVAVKK-SKLVDETNVEQFINEVVI 366
           E         +++G G  G VYKGML          VA+K       E     F+ E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 367 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 426
           + Q +H NI++L G   + +  +++ E++ NG L +++  +  EF      L+ +   ++
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120

Query: 427 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ--THLTTKVQGTF 484
             + YL +       HRD+ + NIL++     KVSDFG SR +  D   T+ T+  +   
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            +  PE     +FT  SDV+SFG+V+ E++T  +                    ++ + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222

Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS 595
            +A++         +    +  L  +C       RP   ++ + L  +  +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-60
 Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 24/273 (8%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHRN 374
           ++++  + LG+G  G V   +       VAVK           E    E+ I   +NH N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           +VK  G   E  +  L  E+   G L+  I   I    +      R   ++   + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYVDPEYFQ 493
                I HRDIK  N+LLD++   K+SDFG +     + +  L  K+ GT  YV PE  +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 494 SSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
             +F  E  DV+S G+VL  +L G+ P       +  S          E + +     ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                         L  + L  N   R T+ ++
Sbjct: 233 DSAPLA--------LLHKILVENPSARITIPDI 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-59
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 28/280 (10%)

Query: 313 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 368
           +K  +++   +ILG+G   TV     L   R  A+K   K  ++ E  V     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 369 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 428
           +++H   VKL     + E       +  NG L +YI                   E+  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120

Query: 429 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYV 487
           L YLH      I HRD+K  NILL++    +++DFGT++ +  + +        GT  YV
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE        + SD+++ G ++ +++ G  P RA N            Q I +      
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY--D 228

Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN 587
              +   +A+         L ++ L L+   R   +E+  
Sbjct: 229 FPEKFFPKARD--------LVEKLLVLDATKRLGCEEMEG 260

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-59
 Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 26/287 (9%)

Query: 311 DLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKK-SKLVDETNVEQFINEVV 365
           D E   +     R +G+G  G V++G+          VA+K       ++  E+F+ E +
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 366 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
            + Q +H +IVKL+G   E  V  ++ E    G L  ++  +   + +    L+  A ++
Sbjct: 61  TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
           S AL YL S       HRDI + N+L+      K+ DFG SR +     +  +K +    
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
           ++ PE     +FT  SDV+ FGV + EIL           + D       +  I      
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL 228

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
             +                  L  +C   +   RP   E+  +L  I
Sbjct: 229 P-MPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-59
 Identities = 68/316 (21%), Positives = 123/316 (38%), Gaps = 41/316 (12%)

Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVD 353
           I+ T+L      E   +  +  + LG G  G V +              VAVK       
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 354 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 411
            T  E  ++E+ +LS + NH NIV LLG C      L++ E+   G L  ++  + + F 
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126

Query: 412 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 457
                          +  E LL  + +V+  + +L S       HRD+ + NILL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183

Query: 458 AKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG 516
            K+ DFG +R +  D  + +    +    ++ PE   +  +T +SDV+S+G+ L E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 517 QKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNG 576
                     + K               ++ +       + +     +  + K C + + 
Sbjct: 244 GSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 577 KMRPTMKEVTNELGGI 592
             RPT K++   +   
Sbjct: 290 LKRPTFKQIVQLIEKQ 305

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (500), Expect = 3e-58
 Identities = 56/274 (20%), Positives = 112/274 (40%), Gaps = 27/274 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           D+Y+ +  LG G  G V++      G   A K      E++ E    E+  +S + H  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           V L     +    +++YEF+  G L++ + ++     ++ +  +    +V   L ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 436 ASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
                 H D+K  NI+   K     K+ DFG +  +   Q+   T   GT  +  PE  +
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEALDAR 551
                  +D++S GV+   +L+G  P    N DE        L+ +      + ++  + 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMDDSAFSG 251

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + ++ K           ++ L  +   R T+ + 
Sbjct: 252 ISEDGKD--------FIRKLLLADPNTRMTIHQA 277

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-58
 Identities = 66/295 (22%), Positives = 116/295 (39%), Gaps = 38/295 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDG---RIVAVKK-SKLVDETNVEQFINEVVILSQI-N 371
           ++     ++G+G  G V K  +         A+K+  +   + +   F  E+ +L ++ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-------------PITWELL 418
           H NI+ LLG C       L  E+ P+G L  ++                     ++ + L
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
           L  A +V+  + YL         HRD+ + NIL+ + Y AK++DFG SR   V      T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 538
             +    ++  E    S +T  SDV+S+GV+L EI++                       
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229

Query: 539 INENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR 593
           +    L+E L      E        V  L ++C       RP+  ++   L  + 
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 59/283 (20%), Positives = 124/283 (43%), Gaps = 29/283 (10%)

Query: 314 KATDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKK-SKLVDETNVEQFINEVVIL 367
           K T+ +   ++LG G  GTVYKG+           VA+K+  +       ++ ++E  ++
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           + +++ ++ +LLG CL + V  L+ + +P G L  Y+     +  I  + LL   V+++ 
Sbjct: 66  ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAK 122

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGY 486
            + YL       + HRD+ + N+L+      K++DFG ++ +  ++  +     +    +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           +  E      +T +SDV+S+GV + E++T                       I  + +  
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            L+            + V  +  +C  ++   RP  +E+  E 
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 5e-57
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 31/283 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 369
            +      LG G  G V +G           VAVK      L     ++ FI EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           ++HRN+++L G  L   +  +V E  P G+L   +     +       L R AV+V+  +
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYV 487
            YL S       HRD+ + N+LL  +   K+ DFG  R++  +  H  +    +  F + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
            PE  ++  F+  SD + FGV L E+ T GQ+P   +N  +        L  I++     
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERL 234

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
                  ++           +  +C     + RPT   + + L
Sbjct: 235 PRPEDCPQDIYN--------VMVQCWAHKPEDRPTFVALRDFL 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 8e-55
 Identities = 73/307 (23%), Positives = 132/307 (42%), Gaps = 33/307 (10%)

Query: 301 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVD 353
                ++   + E A +    +R LGQG  G VY+G+            VA+K  ++   
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 354 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------N 406
                +F+NE  ++ + N  ++V+LLG   + +  L++ E +  G L  Y+        N
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 407 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 466
                P +   ++++A E++  + YL++       HRD+ + N ++ + +  K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 467 RSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 525
           R +   D      K      ++ PE  +   FT  SDV+SFGVVL EI T  +      +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240

Query: 526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           +E        L+ + E  L +  D        +        L + C   N KMRP+  E+
Sbjct: 241 NEQ------VLRFVMEGGLLDKPD-NCPDMLFE--------LMRMCWQYNPKMRPSFLEI 285

Query: 586 TNELGGI 592
            + +   
Sbjct: 286 ISSIKEE 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  184 bits (469), Expect = 1e-54
 Identities = 77/289 (26%), Positives = 118/289 (40%), Gaps = 30/289 (10%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 371
           +D Y    ILG GG   V+    L   R VAVK        D +   +F  E    + +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 372 HRNIVKLLGCCLETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           H  IV +            +P +V E++   TL   +H +    P+T +  + +  +   
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL--TTKVQGTFG 485
           AL + H      I HRD+K ANI++      KV DFG +R++      +  T  V GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
           Y+ PE  +      +SDVYS G VL E+LTG+ P          S V    Q + E+ + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIR 593
            +     L             +  + L  N + R  T  E+  +L  + 
Sbjct: 234 PSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  186 bits (474), Expect = 2e-54
 Identities = 56/274 (20%), Positives = 105/274 (38%), Gaps = 27/274 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           D Y+    LG G  G V++ +    GR+   K        +     NE+ I++Q++H  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           + L     +    +L+ EF+  G L+  I  +  ++ ++   ++    +    L ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 436 ASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
               I H DIK  NI+ +       K+ DFG +    ++   +      T  +  PE   
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVD 201

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEALDAR 551
                  +D+++ GV+   +L+G  P    +  E        LQ +        E   + 
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSS 254

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           V  EAK           K  L    + R T+ + 
Sbjct: 255 VSPEAKD--------FIKNLLQKEPRKRLTVHDA 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 6e-54
 Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)

Query: 317 DNYNANRILGQGGQGTVYKGM------LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQ 369
           D     + LG+G  G V +            R VAVK   +    +     ++E+ IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 370 INHR-NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEF-------------PIT 414
           I H  N+V LLG C +   PL ++ EF   G L  Y+ ++  EF              +T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            E L+  + +V+  + +L S       HRD+ + NILL +K   K+ DFG +R +  D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 475 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 533
           ++     +    ++ PE      +T +SDV+SFGV+L EI +               +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244

Query: 534 YFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
            F + + E     A D     E  +            C +     RPT  E+   LG +
Sbjct: 245 EFCRRLKEGTRMRAPD-YTTPEMYQ--------TMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-53
 Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 26/273 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           + Y     LG+G  G V++ +  +  +    K  K+   T+      E+ IL+   HRNI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           + L       E  ++++EFI    +++ I+     F +    ++    +V  AL +LHS 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH 121

Query: 436 ASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
               I H DI+  NI+   +     K+ +FG +R   +        +     Y  PE  Q
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF-EALDARV 552
               +  +D++S G ++  +L+G  P  A    +           +N    F E     +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDEEAFKEI 230

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             EA             R L    K R T  E 
Sbjct: 231 SIEAMD--------FVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (463), Expect = 2e-53
 Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 20/278 (7%)

Query: 310 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVIL 367
           K  E   D Y+   +LG G    V         ++VA+K  +K   E       NE+ +L
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 368 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
            +I H NIV L           L+ + +  G L+  I  +      T     R+  +V  
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLD 118

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           A+ YLH    +    +        LD+  +  +SDFG S+  M D   + +   GT GYV
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYV 176

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA 547
            PE      +++  D +S GV+   +L G  P    N  +      +      E      
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEYEFDSP 231

Query: 548 LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
               +   AK           +  +  + + R T ++ 
Sbjct: 232 YWDDISDSAKD--------FIRHLMEKDPEKRFTCEQA 261

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 68/300 (22%), Positives = 118/300 (39%), Gaps = 42/300 (14%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKL-VDETNVEQFINEVVIL 367
           D     + LG+G  G V                  VAVK  K    E ++   I+E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 368 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------------IEEFPI 413
             I  H+NI+ LLG C +     ++ E+   G L +Y+  +               E  +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 414 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 473
           + + L+  A +V+  + YL S       HRD+ + N+L+ +    K++DFG +R +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 474 THLTTKVQ-GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 532
            +  T        ++ PE      +T +SDV+SFGV+L EI T                 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236

Query: 533 GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI 592
                 +    LF+ L      +        +  + + C +     RPT K++  +L  I
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  177 bits (449), Expect = 8e-52
 Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 38/286 (13%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK---------SKLVDETNVEQFINEVVI 366
           +NY    ILG+G    V + +     +  AVK          S    +   E  + EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 367 LSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           L +++ H NI++L           LV++ +  G L+ Y+  ++    ++ +   +I   +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 485
              +  LH      I HRD+K  NILLDD    K++DFG S    +D      +V GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPS 174

Query: 486 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 539
           Y+ PE  + S       + ++ D++S GV++  +L G  P                   +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIM 228

Query: 540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
           + N  F + +     +  K+       L  R L +  + R T +E 
Sbjct: 229 SGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-50
 Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 29/273 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVK---KSKLVDETNVEQFINEVVILS-QIN 371
           +++  +++LG+G  G V+        +  A+K   K  ++ + +VE  + E  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 372 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 431
           H  +  +       E    V E++  G L  +I +               A E+   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118

Query: 432 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           LHS     I +RD+K  NILLD     K++DFG  +  M+      T   GT  Y+ PE 
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174

Query: 492 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR 551
               ++    D +SFGV+L E+L GQ P    + +E          +I  +  F      
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRW 225

Query: 552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
           + KEAK         L  +      + R  ++ 
Sbjct: 226 LEKEAKD--------LLVKLFVREPEKRLGVRG 250

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  169 bits (428), Expect = 9e-49
 Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 20/283 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 374
           + Y+    +G+G  G VYK     G   A+KK +L   DE      I E+ IL ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 375 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           IVKL       +  +LV+E +              E  +         +++   + Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 435 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 494
                + HRD+K  N+L++ +   K++DFG +R+  +     T ++   +         S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 495 SQFTEKSDVYSFGVVLVEILTGQKP------------IRAINTDEDKSLVGYFLQAINEN 542
            +++   D++S G +  E++ G               I  I    +        +    +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
             F   +    +   K    +   L  + L L+   R T K+ 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (428), Expect = 2e-48
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 31/274 (11%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
            ++   R LG G  G V+      +GR  A+K   K  +V    VE   +E ++LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             I+++ G   + +   ++ ++I  G L+  +            +    A EV  AL YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     I +RD+K  NILLD     K++DFG ++ V      +T  + GT  Y+ PE  
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
            +  + +  D +SFG+++ E+L G  P    NT +         + I    L        
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--RFPPFF 224

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
            ++ K         L  R +  +   R    +  
Sbjct: 225 NEDVKD--------LLSRLITRDLSQRLGNLQNG 250

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  170 bits (431), Expect = 3e-48
 Identities = 60/280 (21%), Positives = 113/280 (40%), Gaps = 31/280 (11%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVV---ILSQ 369
           ++++ +RI+G+GG G VY     D G++ A+K   K ++  +      +NE +   ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 370 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
            +   IV +       +    + + +  G L+ ++         +   +   A E+   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 489
            ++H+     + +RD+K ANILLD+    ++SD G +      + H      GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174

Query: 490 EYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL 548
           E  Q    +   +D +S G +L ++L G  P R   T +   +    L    E      L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------L 228

Query: 549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE 588
                 E +         L +  L  +   R        +
Sbjct: 229 PDSFSPELRS--------LLEGLLQRDVNRRLGCLGRGAQ 260

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-47
 Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 20/284 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
           +N+     +G+G  G VYK      G +VA+KK +L    E      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NIVKLL          LV+EF+          + +   P    L+     ++   L + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V   +         
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKP------------IRAINTDEDKSLVGYFLQAINE 541
              ++   D++S G +  E++T +              I       D+ +        + 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 542 NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              F     +   +          +L  + L+ +   R + K  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-47
 Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 25/292 (8%)

Query: 314 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQ 369
           +A   Y     +G+G  G V+K   +   GR VA+K  + +  +E      I EV +L  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 370 I---NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAV 423
           +    H N+V+L   C  +         +    + Q      +++ E  +  E +  +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 424 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 483
           ++   L +LHS     + HRD+K  NIL+    + K++DFG +R          T V  T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 484 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-- 541
             Y  PE    S +    D++S G +  E+   +   R  +  +    +   +    E  
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 542 --------NRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                    + F +  A+ +++   +       L  +CL  N   R +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-47
 Identities = 62/281 (22%), Positives = 106/281 (37%), Gaps = 25/281 (8%)

Query: 323 RILGQGGQGTVYKGMLT-DGRIVAVKKSKL-----VDETNVEQFINEVVILSQINHRNIV 376
             LG+G   TVYK       +IVA+KK KL       +      + E+ +L +++H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 377 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 436
            LL          LV++F+          N      +T   +    +     L YLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 437 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 496
              I HRD+K  N+LLD+    K++DFG ++S        T +V  T  Y  PE    ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176

Query: 497 -FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE 555
            +    D+++ G +L E+L     +   +  +  + +   L    E +  +         
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 556 AKKEEIMTVAT-----------LAKRCLNLNGKMRPTMKEV 585
            K    + +             L +     N   R T  + 
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-47
 Identities = 55/289 (19%), Positives = 115/289 (39%), Gaps = 22/289 (7%)

Query: 316 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 373
              Y     +G+G  G V       +   VA+KK S    +T  ++ + E+ IL +  H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NI+ +        +  +   ++    +   ++  ++   ++ + +     ++   L Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVDPEY 491
           SA    + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 492 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA 550
             +S+ +T+  D++S G +L E+L+ +      +  +  + +   L + ++  L   ++ 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 551 RVLKEAKKEEIMTVAT--------------LAKRCLNLNGKMRPTMKEV 585
           +                             L  + L  N   R  +++ 
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-46
 Identities = 59/279 (21%), Positives = 108/279 (38%), Gaps = 30/279 (10%)

Query: 317 DNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHR 373
           D+Y   +++LG G  G V +          A+K  +     +  +   EV +  +     
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 65

Query: 374 NIVKLLGCC----LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           +IV+++          +  L+V E +  G L+  I ++ ++   T      I   +  A+
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAI 124

Query: 430 FYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
            YLHS     I HRD+K  N+L   K      K++DFG ++      +  T     T  Y
Sbjct: 125 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 179

Query: 487 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 546
           V PE     ++ +  D++S GV++  +L G  P  + +       +      + +     
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPN 238

Query: 547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
              + V +E K         L +  L      R T+ E 
Sbjct: 239 PEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-46
 Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 39/293 (13%)

Query: 306 LFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV------DETNVE 358
           +F  ++++   D Y+    LG G    V K    + G   A K  K           + E
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 359 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 418
               EV IL +I H N++ L          +L+ E +  G L+ ++  +     +T E  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEA 115

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQT 474
                ++   ++YLHS     I H D+K  NI+L D    K R K+ DFG +  +  D  
Sbjct: 116 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFG 170

Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 534
           +    + GT  +V PE         ++D++S GV+   +L+G  P       E       
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------ 224

Query: 535 FLQAINEN--RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
            L  ++       +   +     AK           +R L  + K R T+++ 
Sbjct: 225 -LANVSAVNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-45
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 28/289 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
            +Y   +++G G  G VY+  L D G +VA+KK       +      E+ I+ +++H NI
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNI 75

Query: 376 VKLLGCCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 429
           V+L      +          LV +++P        H    +  +    +     ++  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 430 FYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 488
            Y+HS     I HRDIK  N+LLD D    K+ DFG+++ ++  + +++  +   +    
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191

Query: 489 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL---- 544
              F ++ +T   DV+S G VL E+L GQ      +  +    +   L      ++    
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 545 -------FEALDARVLKEAKKEEIMTVAT-LAKRCLNLNGKMRPTMKEV 585
                  F  + A    +  +      A  L  R L      R T  E 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 5e-45
 Identities = 54/285 (18%), Positives = 113/285 (39%), Gaps = 22/285 (7%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
             Y     +G+G  GTV+K        IVA+K+ +L   DE      + E+ +L ++ H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 374 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 433
           NIV+L       +   LV+EF        +         +  E++     ++   L + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH 118

Query: 434 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 493
           S     + HRD+K  N+L++     K+++FG +R+  +     + +V   +       F 
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 494 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED-----KSLVGYFLQ----AINENRL 544
           +  ++   D++S G +  E+    +P+   N  +D       L+G   +    ++ +   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 545 FEALDARVLKEAKKEEIMTVATLAK----RCLNLNGKMRPTMKEV 585
           ++         +    +  +    +      L  N   R + +E 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-44
 Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 28/274 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 372
           ++++  ++LG+G  G V        GR  A+K   K  ++ +  V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
             +  L       +    V E+   G L+ ++  +      T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 492
           HS     + +RDIK  N++LD     K++DFG  +  + D   + T   GT  Y+ PE  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177

Query: 493 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV 552
           + + +    D +  GVV+ E++ G+ P    + +          + I    +       +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--RFPRTL 228

Query: 553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
             EAK         L    L  + K R       
Sbjct: 229 SPEAKS--------LLAGLLKKDPKQRLGGGPSD 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 5e-44
 Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 42/280 (15%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK------SKLVDETNVEQFINEVVILSQ 369
             Y    +LG GG G+VY G+ ++D   VA+K       S   +  N  +   EVV+L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 370 IN--HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           ++     +++LL      +  +L+ E               E   +  EL      +V  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121

Query: 428 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 486
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG+     + +  + T   GT  Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175

Query: 487 VDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
             PE+ +  ++    + V+S G++L +++ G  P                   I   ++F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQVF 222

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEV 585
                RV  E +         L + CL L    RPT +E+
Sbjct: 223 --FRQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 5e-43
 Identities = 51/284 (17%), Positives = 93/284 (32%), Gaps = 28/284 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
           + Y   R +G G  G +Y G  +  G  VA+K   +  +T   Q   E  I   +     
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64

Query: 376 VKLLG-CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 434
           +  +  C  E +  ++V E +       +          + + +L +A ++   + Y+HS
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121

Query: 435 AASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTH------LTTKVQGTFG 485
                  HRD+K  N L           + DFG ++     +TH          + GT  
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 486 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
           Y         + + + D+ S G VL+    G  P + +     +       +      + 
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
           E L      E               C +L    +P    +    
Sbjct: 238 EVLCKGYPSEFAT--------YLNFCRSLRFDDKPDYSYLRQLF 273

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-42
 Identities = 53/301 (17%), Positives = 111/301 (36%), Gaps = 28/301 (9%)

Query: 307 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQ 359
           F  +++ K        Y   + +G G  G V   +    G  VA+K        E   ++
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 360 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELL 418
              E+ +L  + H N++ LL      E      +F            ++ +   +  + +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 419 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 478
             +  ++   L Y+H+A    I HRD+K  N+ +++    K+ DFG +R      + +T 
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177

Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV------ 532
            V   +           ++T+  D++S G ++ E++TG+   +  +  +    +      
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 533 --------GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE 584
                       +A N  +    L+ +               L ++ L L+ + R T  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 585 V 585
            
Sbjct: 298 A 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 1e-41
 Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)

Query: 291 QQELSSNESNIEKTKLFTSKDLEKAT------DNYNANRILGQGGQGTVYKGM-LTDGRI 343
             E  S +  + K K    K  E  +      D ++  + LG G  G V        G  
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68

Query: 344 VAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 400
            A+K   K K+V    +E  +NE  IL  +N   +VKL     +     +V E++  G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128

Query: 401 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 460
           + ++         +       A ++     YLHS     + +RD+K  N+L+D +   +V
Sbjct: 129 FSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182

Query: 461 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 520
           +DFG ++ V          + GT   + PE   S  + +  D ++ GV++ E+  G  P 
Sbjct: 183 TDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

Query: 521 RAINTDE 527
            A    +
Sbjct: 239 FADQPIQ 245

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 3e-41
 Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 36/299 (12%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 373
             Y     +GQG  G V+K      G+ VA+KK  +    E      + E+ IL  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 374 NIVKLLGCCLETEVP--------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 425
           N+V L+  C     P         LV++F  +       +  +     T   + R+   +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126

Query: 426 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKVQG 482
              L  L+      I HRD+K+AN+L+      K++DFG +R+  + +    +  T    
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 483 TFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDE--------DKSLVG 533
           T  Y  PE     + +    D++  G ++ E+ T    ++                S+  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 534 YFLQAINENRLFEALDARVLKEAKKEEIMTVAT-------LAKRCLNLNGKMRPTMKEV 585
                ++   L+E L+    ++ K ++ +           L  + L L+   R    + 
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (364), Expect = 1e-39
 Identities = 43/285 (15%), Positives = 91/285 (31%), Gaps = 28/285 (9%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 375
            +Y   R +G+G  G +++G  L + + VA+K       ++  Q  +E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 376 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 435
           +  +    +  +  ++   +   +L   +         + + +   A ++   +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 436 ASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRSVMVDQT------HLTTKVQGTF 484
               + +RDIK  N L+            V DFG  +      T           + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 485 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 544
            Y+        + + + D+ + G V +  L G  P + +    +K             R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERI 228

Query: 545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNEL 589
            E   +  L+E                 NL     P    +    
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  141 bits (355), Expect = 5e-38
 Identities = 55/296 (18%), Positives = 107/296 (36%), Gaps = 41/296 (13%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRN 374
           D+Y   R LG+G    V++ + +T+   V VK    +     ++   E+ IL  +    N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91

Query: 375 IVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           I+ L     +  +  P LV+E + N    Q          +T   +     E+  AL Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145

Query: 433 HSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 491
           HS     I HRD+K  N+++D +  + ++ D+G +      Q +       +  +  PE 
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200

Query: 492 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTD----------------EDKSLVGY 534
               Q +    D++S G +L  ++  ++P    + +                 D      
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 535 FLQAINENRLFEALDARVLKEAKKEEIMTVAT-----LAKRCLNLNGKMRPTMKEV 585
                  N +      +  +     E   + +        + L  + + R T +E 
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-37
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 30/281 (10%)

Query: 317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETN-VEQFINEVVILS 368
           +N+   ++LG G  G V+          G++ A+K   K+ +V +    E    E  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 369 QINHR-NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
            I     +V L           L+ ++I  G L+ ++  +      T   +     E+  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
           AL +LH      I +RDIK  NILLD      ++DFG S+  + D+T       GT  Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 488 DPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 545
            P+  +       +  D +S GV++ E+LTG  P      D +K+      + I ++   
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISRRILKSEP- 253

Query: 546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVT 586
                 +   AK         L +R L  + K R       
Sbjct: 254 -PYPQEMSALAKD--------LIQRLLMKDPKKRLGCGPRD 285

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-37
 Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 45/303 (14%)

Query: 317 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 373
             Y   + +G G QG V         R VA+KK      ++T+ ++   E+V++  +NH+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 374 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 427
           NI+ LL          E +   LV E +                    E +  +  ++  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130

Query: 428 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 487
            + +LH   S  I HRD+K +NI++      K+ DFG +R+     + + T    T  Y 
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185

Query: 488 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN---------------TDEDKSLV 532
            PE      + E  D++S G ++ E++  +      +                 E    +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 533 GYFLQAINENRL------FEALDARVLKEAKKEEIMTVATLAK----RCLNLNGKMRPTM 582
              ++   ENR       F  L    L  A  E     A+ A+    + L ++   R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 583 KEV 585
            + 
Sbjct: 306 DDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-36
 Identities = 56/305 (18%), Positives = 107/305 (35%), Gaps = 36/305 (11%)

Query: 307 FTSKDLEKA----TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQ 359
           F  ++L K      + Y     +G G  G+V        G  VAVK          + ++
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 360 FINEVVILSQINHRNIVKLLGCC-----LETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 414
              E+ +L  + H N++ LL        LE    + +   +    L   +  Q     +T
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119

Query: 415 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 474
            + +  +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +        
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDD 173

Query: 475 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV-- 532
            +T  V   +            + +  D++S G ++ E+LTG+      +  +   L+  
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

Query: 533 ------------GYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP 580
                            A N  +    +                  L ++ L L+   R 
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

Query: 581 TMKEV 585
           T  + 
Sbjct: 294 TAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 55/318 (17%), Positives = 102/318 (32%), Gaps = 58/318 (18%)

Query: 319 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 377
           Y   R LG G   TV+    + +   VA+K  +  D+   E   +E+ +L ++N  +  K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 378 LLGCCLETEVPLLVY--EFIPNGTLYQYIH-----------NQIEEFPITWELLLRIAVE 424
                    + LL +     PNG     +             + E   I    + +I+ +
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 425 VSGALFYLHSAASIPIYHRDIKSANILLD------DKYRAKVSDFGTSRSVMVDQTHLTT 478
           +   L Y+H    I   H DIK  N+L++      +  + K++D G +       T+   
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188

Query: 479 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG----- 533
               T  Y  PE    + +   +D++S   ++ E++TG                      
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 534 -------------------YFLQAINENRLFEALDARVLKEAKKEEIMTVAT-------L 567
                               F  +    R    L    L++   E+              
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 568 AKRCLNLNGKMRPTMKEV 585
               L L+ + R     +
Sbjct: 308 LSPMLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 2e-19
 Identities = 25/157 (15%), Positives = 49/157 (31%), Gaps = 20/157 (12%)

Query: 323 RILGQGGQGTVYKGMLTDGRIVAVK----------KSKLVDETNVEQFINEVVILSQINH 372
           +++G+G +  V+           VK          K K   +     F    +  ++   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 373 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 432
           R + KL G  +        Y +  N  L + I  +             +   +   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN-PDEVLDMILEEVAKF 119

Query: 433 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 469
           +      I H D+   N+L+ +     + DF  S  V
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	597
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.66
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.62
d1gl4a2	40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	94.72
d1tpga1	41	Plasminogen activator (tissue-type), t-PA {Human (	93.09
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	92.77
d3egfa_	53	Epidermal growth factor, EGF {Mouse (Mus musculus)	89.44
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	89.04
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	88.26
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	88.23
d2c4fl1	37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	87.77
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	87.58
d1nqlb_	48	Epidermal growth factor, EGF {Human (Homo sapiens)	87.14
d1g1ta2	39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	86.81
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	86.7
d1g1sa2	40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	85.46
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	84.38
d1k36a_	46	Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI	84.11
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	81.89
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	81.32

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=419.86  Aligned_cols=257  Identities=28%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            468889999999999999999988899999998753 3445789999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +|+|.+++....  ..++++.++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999987643  34899999999999999999999999   9999999999999999999999999998765544444


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHhC-CCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....||+.|+|||++.+..++.++||||||++||||+++ ++||.....      .. ....+..+..         ..
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~-~~~~i~~~~~---------~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SE-VVEDISTGFR---------LY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HH-HHHHHHHTCC---------CC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HH-HHHHHHhcCC---------CC
Confidence            4456789999999999999999999999999999999995 555443221      11 1222222211         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+...++++.+||.+||+.||++||||+||+++|++|+++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            1223356788999999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=413.62  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=209.5

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|+++  ..||||+++.  .+....+.|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999864  3599998764  345667899999999999999999999998754 56899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.++++...  ..+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999997643  35999999999999999999999999   9999999999999999999999999997764322


Q ss_pred             -ceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          474 -THLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       474 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                       ........||+.|||||++.+   ..++.++|||||||+||||++|+.||......+      .....+..+.....  
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~--  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPD--  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCC--
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCc--
Confidence             233455679999999999864   458999999999999999999999997643222      12222222211111  


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                         ........++++.+|+.+||+.||++|||++||++.|+.|++++
T Consensus       231 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         231 ---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             ---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence               11223345567999999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=420.30  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=218.4

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.+|++++|||||++++++.+.+..+||||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3467899999999999999999986 5899999998743 3456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+++|+|.+++.+.. ...+++..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999998643 346999999999999999999999999   9999999999999999999999999998876555


Q ss_pred             ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhh
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVL  553 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  553 (597)
                      ........|++.|||||++.+..++.++||||||+++|||++|..|+......     . .....+..+         ..
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~-~~~~~i~~~---------~~  234 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----S-QVYELLEKD---------YR  234 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H-HHHHHHHTT---------CC
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----H-HHHHHHhcC---------CC
Confidence            55555667899999999999999999999999999999999977766432211     1 112222222         11


Q ss_pred             hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          554 KEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       554 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ...+...++++.+||.+||+.||++|||++||++.|+.+..
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            12233455678999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=416.46  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=213.8

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||+||+|.+++++.||||+++.. ....++|.+|+.++++++|||||++++++.+ +..+|||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            4678999999999999999999988899999998753 3445789999999999999999999998754 5679999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.... ..++++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999886542 235999999999999999999999999   999999999999999999999999999987655545


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|||||++.+..++.++||||||++||||+||..|+......     . .....+..+..         ..
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~-~~~~~i~~~~~---------~~  230 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----P-EVIQNLERGYR---------MV  230 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H-HHHHHHHTTCC---------CC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----H-HHHHHHHhcCC---------CC
Confidence            555667999999999999999999999999999999999966555332211     1 12222222211         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+...++++.+||.+||+.||++||||+||++.|+.+-++
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            1233456789999999999999999999999999987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=405.85  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=216.6

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP  396 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  396 (597)
                      ++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5799999999999999999999888899999987533 345789999999999999999999999999999999999999


Q ss_pred             CCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee
Q 038707          397 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL  476 (597)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~  476 (597)
                      +|+|.+++....  ..+++..+++++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999987643  34899999999999999999999999   9999999999999999999999999998766554444


Q ss_pred             eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          477 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       477 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+       ....+..+..         ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~---------~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR---------LY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC---------CC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCC---------CC
Confidence            555678999999999999999999999999999999998 899997654332       2222322211         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGI  592 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l  592 (597)
                      .+...++++.+||.+||+.||++|||+++|++.|..|
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1233446789999999999999999999999998654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-52  Score=409.88  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.+|++++||||+++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999985 68999999876533 33456799999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +++|+|.+++...   ..+++.++..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999753   35999999999999999999999999   99999999999999999999999999987653332


Q ss_pred             -eeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          475 -HLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       475 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                       .......||+.|||||++.+..+ +.++|||||||+||||++|+.||........  .   +.... .....       
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~---~~~~~-~~~~~-------  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWK-EKKTY-------  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H---HHHHH-TTCTT-------
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H---HHHHh-cCCCC-------
Confidence             23455679999999999988776 6789999999999999999999975443221  1   11111 11111       


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                       .......++++.+|+.+||+.||++|||++|+++
T Consensus       226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111233456789999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-51  Score=414.44  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=202.8

Q ss_pred             cCCccCCcccccCceEEEEEEec-CC---cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DG---RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.++||+|+||+||+|.+. ++   ..||||++.. ......++|.+|+++|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45778899999999999999975 23   3689998764 3455677899999999999999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++....  ..+++.+++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999988643  35999999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCce----eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          472 DQTH----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       472 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ....    ......||+.|||||.+.+..++.++|||||||+||||+| |+.||......+       ....+..+..  
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~--  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYR--  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC--
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence            3222    1223457899999999999999999999999999999998 899997543221       2222222211  


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                             ...+.+.++++.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                   11233456678999999999999999999999999998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=404.21  Aligned_cols=245  Identities=29%  Similarity=0.417  Sum_probs=207.6

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999986 6899999987532   2334677899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++.+..   .+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999998643   4999999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .   .....||+.|||||++.+..++.++|||||||+||||++|+.||...+..+       ....+.....        
T Consensus       160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~--------  221 (263)
T d2j4za1         160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--------  221 (263)
T ss_dssp             C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred             c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence            2   334579999999999999999999999999999999999999997533221       1222222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                        ..+...++++.+||.+||+.||++|||++|+++
T Consensus       222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              112234567889999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=404.55  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=210.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999975 69999999987665566788999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.+.    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++...... .
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S  171 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence            999999988753    3999999999999999999999999   9999999999999999999999999998764332 2


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|||||++.+..++.++|||||||+||+|++|+.||......      .........+...        ..
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~--------~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE--------LQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC--------CS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC--------CC
Confidence            334557999999999999999999999999999999999999999653321      1111222111110        01


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .+...++++.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12334567889999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=408.28  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=198.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--CCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  391 (597)
                      ++|++.+.||+|+||+||+|... +|+.||||.+...  .+...+.+.+|+++|++++|||||++++++.+  .+..+||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999975 6899999987643  45567789999999999999999999999875  4567899


Q ss_pred             EeccCCCChhhHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCeEeCCCCcEEEeecccccc
Q 038707          392 YEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGTSRS  468 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~  468 (597)
                      |||+++|+|.+++.+.. ....+++..++.++.||++||.|||+.+  ..+|+||||||+||||++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999997632 2346999999999999999999999865  23499999999999999999999999999987


Q ss_pred             ccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          469 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       469 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ..... .......||+.|||||++.+..++.++|||||||+||||++|+.||...+..+       ....+..+...   
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~---  232 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR---  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC---
T ss_pred             cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence            64332 23345679999999999999999999999999999999999999997543221       22223333221   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            ..+...++++.+||.+||+.||++|||++|+++
T Consensus       233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  112334567899999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=407.13  Aligned_cols=251  Identities=26%  Similarity=0.357  Sum_probs=209.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      +.|++.+.||+|+||+||+|.+. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999976 68999999988767777889999999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.+..  .++++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+...... .
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  165 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence            9999999987642  35999999999999999999999999   9999999999999999999999999997653221 1


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          476 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ......||+.|||||++.     ...|+.++|||||||+||||++|+.||......+   .   +.. +..+....    
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~-i~~~~~~~----  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLK-IAKSEPPT----  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHH-HHHSCCCC----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHH-HHcCCCCC----
Confidence            233456999999999984     4568999999999999999999999997654333   1   111 11111100    


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ...+...++++.+||.+||+.||++|||++|+++
T Consensus       235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0112234567889999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=405.36  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=211.1

Q ss_pred             cCCccCCc-ccccCceEEEEEEec---CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRI-LGQGGQGTVYKGMLT---DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||.++. ......++|.+|+++|++++|||||++++++.+ +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999864   356899999865 345567889999999999999999999999864 567999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.+++....  ..+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999986542  35999999999999999999999999   99999999999999999999999999987754


Q ss_pred             CCcee--eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          472 DQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       472 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      .....  .....||+.|||||++....++.++||||||+++|||++ |+.||......+       +...+..+...   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~---  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC---
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence            33322  234458999999999999999999999999999999998 999997654322       22333333221   


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                            ..+...++++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  1233455678999999999999999999999999987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=403.58  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=204.1

Q ss_pred             cCCccCCcccccCceEEEEEEecCC-----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDG-----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      +.|+..++||+|+||+||+|.++..     ..||||++.. .......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4578889999999999999997532     4799998764 344556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+.+++|.+++....  ..+++.+++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999887643  35999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          471 VDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       471 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....  .......||+.|||||++.+..++.++||||||++||||++|..|+......     . .....+..+.     
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~-~~~~~i~~~~-----  230 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H-EVMKAINDGF-----  230 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H-HHHHHHHTTC-----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----H-HHHHHHhccC-----
Confidence            4322  2233456899999999999999999999999999999999976665432211     1 1222222221     


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                          ....+...+.++.+||.+||+.||++||||.||+++|+++.+
T Consensus       231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                112233455678999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=402.35  Aligned_cols=248  Identities=28%  Similarity=0.424  Sum_probs=202.8

Q ss_pred             CcccccCceEEEEEEecC---CcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEeccCC
Q 038707          323 RILGQGGQGTVYKGMLTD---GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN  397 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  397 (597)
                      ++||+|+||+||+|.+.+   ++.||||+++.  .+....++|.+|+.+|++++|||||++++++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   56899998764  334456789999999999999999999999854 567899999999


Q ss_pred             CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCcee-
Q 038707          398 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-  476 (597)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-  476 (597)
                      |+|.+++++..   ++++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......... 
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998643   4999999999999999999999999   9999999999999999999999999998765443332 


Q ss_pred             -eecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          477 -TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       477 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       .....||+.|||||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+..         .
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~---------~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------M  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------C
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence             334568999999999999999999999999999999998 899997543221       2223332221         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                      ..+...++++.+||.+||+.||++|||+++|+++|+..-
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            122344567899999999999999999999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=410.89  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=209.6

Q ss_pred             hcCCccCCcccccCceEEEEEEecC-C-----cEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD-G-----RIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.++||+|+||+||+|.+.. +     ..||+|.+.. ........+.+|+.+|+++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678999999999999999999642 2     3689998754 3344557899999999998 89999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE--------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS  447 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~  447 (597)
                      .+|||||+++|+|.++|+....                    ...+++..++.++.||++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999986432                    135899999999999999999999999   99999999


Q ss_pred             CCeEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCC
Q 038707          448 ANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINT  525 (597)
Q Consensus       448 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~  525 (597)
                      +|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||++ |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876544332 3445668999999999999999999999999999999998 8999976543


Q ss_pred             cCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038707          526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELG  590 (597)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  590 (597)
                      .+      .+...+..+..         ...+...++++.+||.+||+.||++|||++||+++|.
T Consensus       273 ~~------~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA------NFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH------HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH------HHHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32      12222222211         1123344567899999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=402.76  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             hcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            3579999999999999999999988889999998743 3445789999999999999999999999854 5689999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.... ...+++.+++.++.||++||+|||+.+   |+||||||+||||++++++||+|||+++........
T Consensus        94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999999987643 234999999999999999999999999   999999999999999999999999999876544444


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLKE  555 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  555 (597)
                      ......||+.|+|||++....++.++||||||++||||++|..|+......     .. ....+..+..         ..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~-~~~~i~~~~~---------~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE-VLDQVERGYR---------MP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCC---------CC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHhcCC---------CC
Confidence            455567999999999999999999999999999999999976665432211     11 2222222211         11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          556 AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       556 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+...++++.+||.+||+.||++||++++|+++|+...++
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            2234456789999999999999999999999999886644

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=411.52  Aligned_cols=263  Identities=27%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.+..+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            568999999999999999999975 6899999987653 34456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      |+++|+|.+++.+..   .+++..+..++.||++||.|||+. +   |+||||||+||||++++++||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999998653   499999999999999999999974 7   999999999999999999999999999865432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH-----------------
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF-----------------  535 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~-----------------  535 (597)
                         ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+........                 
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               223457999999999999999999999999999999999999999765433210000000                 


Q ss_pred             ------HHHHhcCchhhhhhHHhhhh----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          536 ------LQAINENRLFEALDARVLKE----AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       536 ------~~~~~~~~~~~~l~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            ..........+.++......    .....+.++.+|+.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  00000000111111100000    00112457889999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=401.86  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|.+. +++.||||.+...   .....+.+.+|+++|++++||||+++++++.+.+..+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999985 6899999987532   2344577999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999988653   4999999999999999999999999   999999999999999999999999999876533


Q ss_pred             C-ceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          473 Q-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       473 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      . ........||+.|||||++.+..++.++|||||||+||||++|+.||...+..+       ....+..+..       
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~-------  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY-------  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC-------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCC-------
Confidence            2 223445679999999999999999999999999999999999999997533211       1122222211       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         ..+...++++.+||.+||+.||++|||++|+++
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               112234566889999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=389.65  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=199.6

Q ss_pred             CccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEe----CCcceEE
Q 038707          319 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLV  391 (597)
Q Consensus       319 y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  391 (597)
                      |++.+.||+|+||+||+|.+. +++.||+|++..  ......+.+.+|+++|++++|||||++++++.+    ....+||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999976 688999998764  345567789999999999999999999999875    3457899


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC-CCCcEEEeecccccccc
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfgl~~~~~  470 (597)
                      |||+++|+|.+++.+..   .+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999998653   4999999999999999999999976 3499999999999996 57899999999997643


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhH
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDA  550 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  550 (597)
                      ..   ......||+.|||||++.+ .++.++|||||||+||||++|+.||......+      .....+..+.....   
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~---  233 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPAS---  233 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGG---
T ss_pred             CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCcc---
Confidence            32   2335679999999999875 69999999999999999999999996432211      12222222221111   


Q ss_pred             HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          551 RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       551 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           .+...++++.+||.+||+.||++|||++|+++
T Consensus       234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 11223456889999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=396.96  Aligned_cols=257  Identities=27%  Similarity=0.443  Sum_probs=203.0

Q ss_pred             hcCCccCCcccccCceEEEEEEecC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceE
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL  390 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  390 (597)
                      .++|++.+.||+|+||+||+|.+..    +..||||.++.. .....+.|.+|+.+|++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3679999999999999999998642    457899988653 4445678999999999999999999999985 467899


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~  470 (597)
                      ||||+++|+|.+++....  .++++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999999987643  35899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          471 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...........||+.|+|||++.+..++.++||||||++||||++ |.+||......+       ....+..+...    
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~----  228 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL----  228 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC----
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence            544444555678999999999999999999999999999999998 899997655433       22222232211    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                           ..+...++++.+||.+||+.||++|||++||++.|+++.+
T Consensus       229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 1223455679999999999999999999999999998864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.8e-49  Score=405.78  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=211.8

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            458999999999999999999975 6999999998877777788899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC--CCCcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.+++.+..  ..+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.....
T Consensus       105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999996532  34999999999999999999999999   99999999999995  4678999999999876433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .  ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+      .+ ..+......      .
T Consensus       180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~-~~i~~~~~~------~  244 (350)
T d1koaa2         180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TL-RNVKSCDWN------M  244 (350)
T ss_dssp             S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCCC------S
T ss_pred             c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCCC------C
Confidence            2  2345679999999999999999999999999999999999999997543221      11 122211110      0


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ........++++.+||.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011112344568899999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=400.56  Aligned_cols=253  Identities=24%  Similarity=0.314  Sum_probs=193.0

Q ss_pred             HhcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          315 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       315 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ..+.|++.+.||+|+||+||+|.+. +++.||||.+.... ......+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999976 68999999876432 233466889999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC---CCCcEEEeeccccccc
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSV  469 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfgl~~~~  469 (597)
                      ||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999999764   34999999999999999999999999   99999999999994   5789999999999865


Q ss_pred             cCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      ...  .......||+.|||||++.+..++.++|||||||+||||++|+.||......+       ....+..+...    
T Consensus       161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~----  227 (307)
T d1a06a_         161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE----  227 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC----
T ss_pred             cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC----
Confidence            322  22344679999999999999999999999999999999999999997533211       11222221111    


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        .........++++.+||.+||+.||++|||++|+++.
T Consensus       228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              0011122345678999999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=392.54  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=203.0

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEe-CCcceEEEecc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLLVYEFI  395 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  395 (597)
                      ++|++.+.||+|+||.||+|.++ |+.||||+++.  ....++|.+|++++++++||||+++++++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            56888899999999999999984 78899999864  3455789999999999999999999999865 45689999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.+++.... ...+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            9999999997642 234899999999999999999999998   999999999999999999999999999765322   


Q ss_pred             eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHhhh
Q 038707          476 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARVLK  554 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  554 (597)
                       .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+       ....+..+..         .
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~---------~  219 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK---------M  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCC---------C
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence             233457899999999999999999999999999999998 788876544333       2222222211         1


Q ss_pred             hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          555 EAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       555 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      +.+...++++.+||.+||+.||++|||+.+|+++|++|++.
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            22333456788999999999999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-49  Score=401.02  Aligned_cols=263  Identities=24%  Similarity=0.400  Sum_probs=215.4

Q ss_pred             HHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCccceeeeEEEeC
Q 038707          313 EKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLET  385 (597)
Q Consensus       313 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  385 (597)
                      +...++|++.+.||+|+||+||+|++.      +++.||||++.... ....++|.+|+.+|++++||||+++++++.+.
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            334568999999999999999999864      35789999987543 34467899999999999999999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD  444 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~D  444 (597)
                      +..+++|||+++|+|.++++....                     ...+++..++.++.||+.||+|||+++   |+|||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD  165 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  165 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence            999999999999999999975321                     224899999999999999999999999   99999


Q ss_pred             CCCCCeEeCCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCC-CCCCC
Q 038707          445 IKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRA  522 (597)
Q Consensus       445 ik~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~-~p~~~  522 (597)
                      |||+||||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||++||||++|. +||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999999999999999999986543322 2334556899999999999999999999999999999999985 57765


Q ss_pred             CCCcCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          523 INTDEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ....+       ....+.++...+         .+...++++.+|+.+||+.+|++||||.||+++|++|.+
T Consensus       246 ~~~~e-------~~~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         246 MAHEE-------VIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             SCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCHHH-------HHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            43322       223333333221         123345678999999999999999999999999999853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-49  Score=400.96  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=202.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      +.|+..+.||+|+||+||+|.+. +++.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999975 68999999876432   344567999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|..++...   .++++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++......
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999998776543   35999999999999999999999999   999999999999999999999999999765322


Q ss_pred             CceeeecccccccccCcccccc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                           ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||......+      .+.... .+.....  
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~-~~~~~~~--  234 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNESPAL--  234 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCC--
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCCCCC--
Confidence                 33569999999999854   468999999999999999999999997533211      111111 1111111  


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                            .....++.+.+||.+||+.||++|||++|+++
T Consensus       235 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  11233567889999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-49  Score=403.16  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=211.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 6999999998876666777899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC--CCCcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.+++...  ..++++.+++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++.....
T Consensus       108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999999988653  235999999999999999999999999   99999999999997  6789999999999876543


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .  ......||+.|||||++.+..++.++|||||||+||||++|+.||.+....+       ....+..+...      .
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~------~  247 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE------F  247 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC------C
T ss_pred             C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------C
Confidence            2  2344568999999999999999999999999999999999999997543221       11222221110      0


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ........++++.+||.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111123345678899999999999999999999873

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=391.49  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=207.6

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc------ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP  388 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  388 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...      .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999985 6999999987532      122467899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC----cEEEeecc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG  464 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg  464 (597)
                      +|||||+++|+|.+++.+..   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999998653   4999999999999999999999999   99999999999998776    59999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      ++......  .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+       ....+.....
T Consensus       163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~  233 (293)
T d1jksa_         163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY  233 (293)
T ss_dssp             TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC
T ss_pred             hhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCC
Confidence            99876433  22344568999999999999999999999999999999999999997543222       1122222111


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .      .........++.+.+||.+||+.||++|||++|+++
T Consensus       234 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 E------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      001111234556889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=397.79  Aligned_cols=255  Identities=24%  Similarity=0.472  Sum_probs=205.6

Q ss_pred             CCccCCcccccCceEEEEEEec-CCc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      +|++.++||+|+||+||+|.+. +|+    +||+|+++. .+....++|.+|+.++++++|||||++++++.+. ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            5999999999999999999975 343    689998764 3445577899999999999999999999999865 56788


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      +|++.+|+|.+++....  ..+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            99999999999988753  35999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhh
Q 038707          472 DQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEALD  549 (597)
Q Consensus       472 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  549 (597)
                      .... ......||+.|||||++.+..++.++||||||++||||+| |+.||......+       +...+..+..     
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~-----  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER-----  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCC-----
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            3332 2344568999999999999999999999999999999998 889987655433       1222222211     


Q ss_pred             HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          550 ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       550 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                          ...+...++.+.+|+.+||+.||.+|||++||++.|+.+..
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                11223445678999999999999999999999999988753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=394.62  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             HHHHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeE
Q 038707          310 KDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGC  381 (597)
Q Consensus       310 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  381 (597)
                      ++++...++|++.+.||+|+||+||+|.+.      +++.||||+++. ......+++.+|+.++.++ +|+||++++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            333344568999999999999999999864      246899999874 3445567788898888887 68999999999


Q ss_pred             EEeCC-cceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 038707          382 CLETE-VPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS  447 (597)
Q Consensus       382 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~  447 (597)
                      +.+.+ ..++||||+++|+|.++++....             ...+++.+++.++.||++||.|||+++   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            87654 68999999999999999976432             235899999999999999999999999   99999999


Q ss_pred             CCeEeCCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHhC-CCCCCCCCC
Q 038707          448 ANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINT  525 (597)
Q Consensus       448 ~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g-~~p~~~~~~  525 (597)
                      +||||++++.+||+|||+|+........ ......||+.|||||++.+..++.++||||||+++|||++| ..||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876543332 33445699999999999999999999999999999999986 567765433


Q ss_pred             cCCCcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          526 DEDKSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      .+      .+...+..+...         ..+...++++.+||.+||+.||++|||++||+++|++|.+
T Consensus       243 ~~------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         243 DE------EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             SH------HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH------HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22      122233332221         1223345678999999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-48  Score=385.14  Aligned_cols=260  Identities=28%  Similarity=0.385  Sum_probs=207.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCc----
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV----  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  387 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||.++..   +....+.+.+|+.++++++||||+++++++.+.+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 6999999997642   34456789999999999999999999999987543    


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+|||||+++++|.+++....   ++++.+++.++.||++||+|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999987653   4999999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCc--eeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          468 SVMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       468 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      .......  .......||+.|||||++.+..++.++||||||++||||++|+.||...+.      ...+...+......
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence            6543222  234456799999999999999999999999999999999999999975332      22233333332221


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhhh
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-TMKEVTNELGGIRT  594 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~~  594 (597)
                      .       .......++++.+||.+||+.||++|| |++++++.|.+++.
T Consensus       234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1       111233456789999999999999999 89999999998863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=394.74  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=208.7

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|... +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999975 6999999987632   3345678899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999998753   4899999999999999999999999   999999999999999999999999999875433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      . .......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+       ....+..+..        
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~--------  222 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--------  222 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--------
T ss_pred             C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC--------
Confidence            2 23445679999999999999999999999999999999999999997644221       1222222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                        ..+...++++.+||.+||+.||.+||+     ++|+++
T Consensus       223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              112334566889999999999999995     778776

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-49  Score=388.85  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=200.7

Q ss_pred             cCCccCCcccccCceEEEEEEec--CC--cEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT--DG--RIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|++.+.||+|+||+||+|.+.  ++  ..||||+++.   ......++|.+|+.+|++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56899999999999999999864  22  4789998764   234556789999999999999999999999965 5678


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      +||||+++|+|.+++....  .++++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999999887643  34999999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCce--eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          470 MVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       470 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  ......++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+      ......+.+... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~-  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL-  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCC-
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCCC-
Confidence            544332  2334457889999999999999999999999999999998 899997543222      122222222111 


Q ss_pred             hhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhh
Q 038707          547 ALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIR  593 (597)
Q Consensus       547 ~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~  593 (597)
                              ..+...+..+.+||.+||+.||++|||+.||++.|++.+
T Consensus       235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence                    112334467899999999999999999999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-48  Score=389.14  Aligned_cols=254  Identities=30%  Similarity=0.484  Sum_probs=206.0

Q ss_pred             CCcccccCceEEEEEEecCC----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-CcceEEEecc
Q 038707          322 NRILGQGGQGTVYKGMLTDG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEFI  395 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~~~----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  395 (597)
                      .++||+|+||+||+|.+.++    ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    3689998864 4566778999999999999999999999998764 5789999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      ++|+|.++++...  ..+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999988643  34788999999999999999999999   999999999999999999999999999876543222


Q ss_pred             ---eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          476 ---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       476 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                         ......||+.|+|||.+....++.++||||||++||||++|+.||.......+      ....+..+...       
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~~-------  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRL-------  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCC-------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCC-------
Confidence               22335689999999999999999999999999999999998888764322111      11222222211       


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                        ..+...++++.+||.+||+.||++||+|.||+++|+++.++
T Consensus       254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              11223345788999999999999999999999999999865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=392.47  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCc--EEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGR--IVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.++||+|+||+||+|.+. ++.  .||||++.. ......++|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999976 444  578888654 3445667899999999999 799999999999999999999


Q ss_pred             EeccCCCChhhHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcE
Q 038707          392 YEFIPNGTLYQYIHNQ-------------IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA  458 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~  458 (597)
                      |||+++|+|.++|+..             .....+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999754             12346999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCC-CCCCCCCCcCCCcHHHHHHH
Q 038707          459 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLVGYFLQ  537 (597)
Q Consensus       459 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~  537 (597)
                      ||+|||+++......  ......||..|+|||.+.+..++.++||||||+++|||++|. +||...+..+       +..
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  237 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence            999999997643221  223345899999999999999999999999999999999965 5665433222       222


Q ss_pred             HHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          538 AINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       538 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                      .+..+..         ...+...++++.+||.+||+.||++||||+||++.|+++.+.
T Consensus       238 ~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            2222211         112234456799999999999999999999999999988753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-47  Score=389.03  Aligned_cols=244  Identities=29%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++..   ......+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56999999999999999999975 699999998763   22344678999999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+++|+|..++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999988653   3889999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.||...+..+       ....+..+..        
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~--------  218 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--------  218 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC--------
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC--------
Confidence                234679999999999999999999999999999999999999997533221       1122222111        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                        ..+...++++.+++.+||+.||.+||     |++++++
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              11223445688999999999999996     8999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=390.41  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=214.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec------CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeCCc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  387 (597)
                      .++|++.++||+|+||.||+|++.      +++.||||+++. .......+|.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467899999999999999999852      357899999875 3445667899999999999 69999999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIE---------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      .+|||||+++|+|.++++....               ...+++..+..++.||++||+|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            9999999999999999986431               235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCc-eeeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCc
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS  530 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~  530 (597)
                      +.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |.+||......+   
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987654433 33445678999999999999999999999999999999999 555554433222   


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                         .+...+..+         .....+...++.+.+||.+||+.||++|||++||+++|+++.+
T Consensus       256 ---~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 ---KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             ---HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence               112222222         1112223345678999999999999999999999999987543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-48  Score=387.33  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             hcCCccCCcccccCceEEEEEEecC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCccceeeeEEEeC
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET  385 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  385 (597)
                      .++|++.+.||+|+||.||+|+...        +..||||+++.. ......++.+|+..+.++ +|||||++++++.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578899999999999999998532        247999998653 345568899999999998 799999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEe
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL  452 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll  452 (597)
                      +..++||||+++|+|.++|.....             ...+++.+++.++.||+.||+|||+++   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999976431             235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHh-CCCCCCCCCCcCCCc
Q 038707          453 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS  530 (597)
Q Consensus       453 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~-g~~p~~~~~~~~~~~  530 (597)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            99999999999999876543322 3344568999999999999999999999999999999998 788886543221   


Q ss_pred             HHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhh
Q 038707          531 LVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTS  595 (597)
Q Consensus       531 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~  595 (597)
                          ....+..+...         ..+...++++.+||.+||+.||++|||+.||++.|++|-+.
T Consensus       246 ----~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 ----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ----HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                22333332211         12233456789999999999999999999999999998653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=383.47  Aligned_cols=270  Identities=22%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHH--HHHHHhhcCCCccceeeeEEEeCC----cceE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHRNIVKLLGCCLETE----VPLL  390 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l  390 (597)
                      ..|.+.+.||+|+||+||+|++ +|+.||||++...   ...++..  |+..+.+++||||+++++++.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4577888999999999999997 5889999988643   2334444  555556789999999999998765    5789


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-----ASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ||||+++|+|.+++++.    .+++..+++++.|++.||+|||+.     +..+|+||||||+||||++++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            99999999999999864    399999999999999999999974     122399999999999999999999999999


Q ss_pred             cccccCCCce---eeecccccccccCccccccC------CCCcccceeehHHHHHHHHhCCCCCCCCCCcCC--------
Q 038707          466 SRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED--------  528 (597)
Q Consensus       466 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~--------  528 (597)
                      ++........   ......||+.|||||++.+.      .++.++||||||++||||++|..|+......+.        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9876543322   23346799999999998754      267899999999999999999988754332211        


Q ss_pred             CcHHHHHHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhcC
Q 038707          529 KSLVGYFLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSIG  597 (597)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~  597 (597)
                      ...................+..   .....+.+..+.+|+.+||+.||++|||+.||+++|++|+.+.|
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            1111122222222222111111   11123456679999999999999999999999999999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-47  Score=377.77  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=206.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC---------hhhHHHHHHHHHHHhhcC-CCccceeeeEEEeC
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---------ETNVEQFINEVVILSQIN-HRNIVKLLGCCLET  385 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  385 (597)
                      ++|++.+.||+|+||+||+|... +++.||||++....         +...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999975 68999999875422         122456889999999997 99999999999999


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      +..+|||||+++|+|.++++...   ++++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999998643   4999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCceeeecccccccccCcccccc------CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHH
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI  539 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  539 (597)
                      ++......  ......||+.|+|||.+.+      ..++.++||||+|++||||++|+.||...+..+       ....+
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i  227 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMI  227 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHH
Confidence            98764332  2344679999999999853      357889999999999999999999997543221       12222


Q ss_pred             hcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          540 NENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       540 ~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ..+...      .........++++.+|+.+||+.||++|||++||++.
T Consensus       228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            222211      0111122345678999999999999999999999763

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=388.24  Aligned_cols=265  Identities=26%  Similarity=0.450  Sum_probs=216.2

Q ss_pred             HHHHHhcCCccCCcccccCceEEEEEEec------CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCccceeeeEEE
Q 038707          311 DLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCL  383 (597)
Q Consensus       311 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  383 (597)
                      +++...++|++.+.||+|+||+||+|.+.      +++.||||+++. ........|.+|+.++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34444578999999999999999999863      257899999864 34455667999999999999999999999999


Q ss_pred             eCCcceEEEeccCCCChhhHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC
Q 038707          384 ETEVPLLVYEFIPNGTLYQYIHNQI-------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY  456 (597)
Q Consensus       384 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~  456 (597)
                      ..+..++||||+++|+|.+++....       ....+++..+..++.|+++||.|||+++   |+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            9999999999999999999997532       1234799999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccccccccCCCce-eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCC-CCCCCCCCcCCCcHHHH
Q 038707          457 RAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLVGY  534 (597)
Q Consensus       457 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~-~p~~~~~~~~~~~~~~~  534 (597)
                      ++||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++||||++|. .||...+..+       
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------  243 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------  243 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            9999999999876543332 233345899999999999999999999999999999999985 6775433222       


Q ss_pred             HHHHHhcCchhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          535 FLQAINENRLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       535 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                      ....+..+...+         .+...++.+.+||.+||+.+|++|||+++|+++|++..+
T Consensus       244 ~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         244 VLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            122222222211         123345679999999999999999999999999987643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=385.37  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=207.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      .++|++.+.||+|+||+||+|.+. +++.||||.++... .+...+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999986 68999999987543 3446788999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC--CCcEEEeeccccccccCC
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfgl~~~~~~~  472 (597)
                      +++|+|.+++.+..  .++++.+++.++.||++||+|||+++   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999997642  35999999999999999999999999   999999999999985  458999999999876433


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                      .  ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+       ....+..+...  ++.. 
T Consensus       158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~-  225 (321)
T d1tkia_         158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEE-  225 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHH-
T ss_pred             C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CChh-
Confidence            2  2344568999999999999999999999999999999999999997543221       11222221110  0111 


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                         .....++++.+||.+||+.||++|||++|+++
T Consensus       226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11223456889999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-47  Score=389.24  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=206.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  392 (597)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++..   ......+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 699999998753   22344677899999999999999999999999999999999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD  472 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~  472 (597)
                      ||+.+|+|.+++.+..   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999998653   4999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHHh
Q 038707          473 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDARV  552 (597)
Q Consensus       473 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  552 (597)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.||.+.+..      . ....+..+..        
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~--------  255 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------Q-IYEKIVSGKV--------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC--------
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------H-HHHHHhcCCC--------
Confidence                23456999999999999999999999999999999999999999753211      1 1222222211        


Q ss_pred             hhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          553 LKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       553 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                        ..+...++++.+||.+||+.||.+|+     |++++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              11223456688999999999999994     8999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=385.86  Aligned_cols=247  Identities=25%  Similarity=0.369  Sum_probs=205.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---ChhhHHHHHHHHHHHh-hcCCCccceeeeEEEeCCcceEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILS-QINHRNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  391 (597)
                      ++|++.+.||+|+||+||+|.+. +++.||||++...   .....+.+..|+.++. .++||||+++++++.+.+..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999986 6999999997632   2344566777777765 68999999999999999999999


Q ss_pred             EeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccC
Q 038707          392 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV  471 (597)
Q Consensus       392 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~  471 (597)
                      |||+++|+|.++++...   .+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998653   3899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhhhHH
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEALDAR  551 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  551 (597)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+       ....+..+..       
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~-------  220 (320)
T d1xjda_         156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP-------  220 (320)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred             cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence            32 23445679999999999999999999999999999999999999997543222       2222222211       


Q ss_pred             hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 038707          552 VLKEAKKEEIMTVATLAKRCLNLNGKMRPTMK-EVTN  587 (597)
Q Consensus       552 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  587 (597)
                         ..+...++++.+||.+||+.||++||++. ++++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11223456688999999999999999996 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-46  Score=387.74  Aligned_cols=248  Identities=22%  Similarity=0.283  Sum_probs=199.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc---Chhh---HHHHHHHHHHHhhcCCCccceeeeEEEeCCcce
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETN---VEQFINEVVILSQINHRNIVKLLGCCLETEVPL  389 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  389 (597)
                      ++|++.++||+|+||+||+|... +|+.||||.+...   ....   ..+..+|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999976 6999999987531   1112   223344577788889999999999999999999


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      |||||+++|+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999998653   4899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....   .....||+.|||||++.. ..++.++|||||||+||||++|+.||......+.   .. .........     
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~-~~~~~~~~~-----  225 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMTLTMA-----  225 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HH-HHHHSSSCC-----
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HH-HHHhcccCC-----
Confidence            4332   334569999999999865 5689999999999999999999999986544331   11 111111110     


Q ss_pred             hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038707          549 DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPT-----MKEVTN  587 (597)
Q Consensus       549 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  587 (597)
                           ...+...++++.+||.+||+.||++|||     ++|+++
T Consensus       226 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 0112234566889999999999999999     577765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=383.39  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=200.2

Q ss_pred             hcCCccC-CcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCccceeeeEEEe----CCcc
Q 038707          316 TDNYNAN-RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE----TEVP  388 (597)
Q Consensus       316 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  388 (597)
                      .++|.+. ++||+|+||+||+|.+. +++.||||+++.     ...+.+|+.++.++ +|||||++++++.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            3578876 46999999999999974 689999999863     24577899987665 89999999999876    4568


Q ss_pred             eEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC---CCcEEEeeccc
Q 038707          389 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGT  465 (597)
Q Consensus       389 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfgl  465 (597)
                      +|||||+++|+|.++|.+.. ...+++.+++.++.||+.||+|||+.+   |+||||||+|||+++   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999998642 235999999999999999999999999   999999999999985   56799999999


Q ss_pred             cccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          466 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ++......  ......||+.|||||++.+..|+.++|||||||+||+|++|+.||.+....+...   .....+..+.. 
T Consensus       161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~-  234 (335)
T d2ozaa1         161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY-  234 (335)
T ss_dssp             CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred             eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCC-
Confidence            98765332  2345579999999999999999999999999999999999999997654332111   01111111111 


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                           ..........++++.+||.+||+.||++|||+.|+++
T Consensus       235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 0011112345667999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=379.83  Aligned_cols=256  Identities=23%  Similarity=0.260  Sum_probs=194.9

Q ss_pred             CCcccccCceEEEEEEec-CCcEEEEEEccccChhh-----HHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEecc
Q 038707          322 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN-----VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI  395 (597)
Q Consensus       322 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  395 (597)
                      .++||+|+||+||+|.+. +|+.||||+++......     .+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999975 68999999886533221     346889999999999999999999999999999999999


Q ss_pred             CCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCce
Q 038707          396 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH  475 (597)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~~  475 (597)
                      .++++..++..   ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            88877666543   334899999999999999999999999   99999999999999999999999999976543322 


Q ss_pred             eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhh-------
Q 038707          476 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEA-------  547 (597)
Q Consensus       476 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  547 (597)
                      ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+   .................       
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence            2334569999999999865 468999999999999999999999997543221   11111111110000000       


Q ss_pred             -------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          548 -------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       548 -------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                             .............++++.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                   0000000111223467899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=376.53  Aligned_cols=268  Identities=23%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++...  +...+++.+|+++|++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999975 69999999986432  2335789999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      |+.+ ++.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9965 555555433 2335999999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ceeeecccccccccCccccccCC-CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc--hhhhhh-
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR--LFEALD-  549 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~-  549 (597)
                       .......||+.|+|||.+.... ++.++||||||+++|+|++|+.||...+..+  .+.. .........  ...... 
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFR-IFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGG
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHH-HHHhcCCCchhhcccccc
Confidence             2334456999999999876655 5889999999999999999999997543211  1111 111100000  000000 


Q ss_pred             ------------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhhh
Q 038707          550 ------------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGIR  593 (597)
Q Consensus       550 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l~  593 (597)
                                  ...........++++.+|+.+||+.||++|||++|+++.  |+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                        000000112234678899999999999999999999985  55543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.1e-46  Score=372.45  Aligned_cols=261  Identities=21%  Similarity=0.303  Sum_probs=200.8

Q ss_pred             cCCccCCcccccCceEEEEEEecCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEec
Q 038707          317 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF  394 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  394 (597)
                      ++|++.++||+|+||+||+|.+++|+.||||++....  +...+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999999999999986543  33367899999999999999999999999999999999999


Q ss_pred             cCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCCc
Q 038707          395 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT  474 (597)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~~  474 (597)
                      +.++.+..+....   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            9877666665433   34999999999999999999999999   9999999999999999999999999998764332 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh---hh--
Q 038707          475 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE---AL--  548 (597)
Q Consensus       475 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l--  548 (597)
                      .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+   ................   ..  
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhh
Confidence            22334458999999999865 457999999999999999999999997543211   1111111111000000   00  


Q ss_pred             ----------hHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          549 ----------DARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       549 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                .+..........++.+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000001112233467889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=369.23  Aligned_cols=240  Identities=27%  Similarity=0.429  Sum_probs=196.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccC------hhhHHHHHHHHHHHhhcC--CCccceeeeEEEeCC
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD------ETNVEQFINEVVILSQIN--HRNIVKLLGCCLETE  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  386 (597)
                      .++|++.+.||+|+||+||+|... +|+.||||++....      .....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999975 68999999875321      112345778999999996  899999999999999


Q ss_pred             cceEEEeccCC-CChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-CCcEEEeecc
Q 038707          387 VPLLVYEFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFG  464 (597)
Q Consensus       387 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg  464 (597)
                      ..++||||+.+ +++.+++....   .+++.+++.++.||++||+|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 67888887543   4999999999999999999999999   999999999999985 4799999999


Q ss_pred             ccccccCCCceeeecccccccccCccccccCCC-CcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          465 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       465 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      +++.....   ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||....            ... .+.
T Consensus       157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~-~~~  220 (273)
T d1xwsa_         157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-RGQ  220 (273)
T ss_dssp             TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-HCC
T ss_pred             cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHh-hcc
Confidence            99765332   2345679999999999987665 677999999999999999999996421            011 111


Q ss_pred             hhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          544 LFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       544 ~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      .          ..+...++++.+||.+||+.||++|||++|+++
T Consensus       221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1          011223466889999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=370.05  Aligned_cols=267  Identities=24%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-C-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhc---CCCccceeeeEEEe----
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-D-GRIVAVKKSKLV--DETNVEQFINEVVILSQI---NHRNIVKLLGCCLE----  384 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  384 (597)
                      .++|++.+.||+|+||+||+|.+. + ++.||||+++..  .......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 678999987542  222334566777777666   79999999999864    


Q ss_pred             -CCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeec
Q 038707          385 -TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF  463 (597)
Q Consensus       385 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df  463 (597)
                       ....+++|||++++++.......  ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             24678999999887765554432  334899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc
Q 038707          464 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR  543 (597)
Q Consensus       464 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  543 (597)
                      |+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   .............
T Consensus       161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~  235 (305)
T d1blxa_         161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred             hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCc
Confidence            998765332  23345679999999999999999999999999999999999999997543221   1111111111000


Q ss_pred             hhhh-------------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhh
Q 038707          544 LFEA-------------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGI  592 (597)
Q Consensus       544 ~~~~-------------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l  592 (597)
                      ....             .............++.+.+||.+||+.||++|||++|+++.  |++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            0000             00000111122345668899999999999999999999874  4444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.9e-44  Score=357.22  Aligned_cols=264  Identities=17%  Similarity=0.190  Sum_probs=211.5

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CccceeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|++. +|+.||||.+...  ....++.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999975 6899999987542  233467889999999975 899999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCC-----CCcEEEeecccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRS  468 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfgl~~~  468 (597)
                      |+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 689999987643  34899999999999999999999999   999999999999974     57899999999987


Q ss_pred             ccCCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcC
Q 038707          469 VMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN  542 (597)
Q Consensus       469 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  542 (597)
                      .......      ......||+.|||||.+.+..++.++||||||+++|||++|+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6533221      2334569999999999999999999999999999999999999998655444222111111111110


Q ss_pred             chhhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhhhc
Q 038707          543 RLFEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRTSI  596 (597)
Q Consensus       543 ~~~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~  596 (597)
                      .         ..+.....++++.+++..|++.+|++||+++.+.+.|+++..+.
T Consensus       236 ~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         236 P---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             C---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             C---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0         11112234567899999999999999999999999998876543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-44  Score=359.15  Aligned_cols=262  Identities=19%  Similarity=0.253  Sum_probs=201.7

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccc-eeeeEEEeCCcceEEEe
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYE  393 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  393 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||.+....  ..+++..|++++++++|+|++ .+..+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999975 68999999866432  334688999999999877655 45566677888899999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeC---CCCcEEEeecccccccc
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVM  470 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfgl~~~~~  470 (597)
                      |+ +++|.+.+....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+...
T Consensus        84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             Ec-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99 567777766533  34999999999999999999999999   99999999999985   45579999999998765


Q ss_pred             CCCce------eeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCch
Q 038707          471 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL  544 (597)
Q Consensus       471 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  544 (597)
                      .....      ......||+.|||||.+.+..++.++||||||+++|||++|+.||......+...............  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--  235 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  235 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence            43221      2344569999999999999999999999999999999999999998755443222211110000000  


Q ss_pred             hhhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhhh
Q 038707          545 FEALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNELGGIRT  594 (597)
Q Consensus       545 ~~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~  594 (597)
                             .........++++.+|+.+||+.+|++||+++++.+.|+.+..
T Consensus       236 -------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         236 -------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             -------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                   0011122345678999999999999999999999999987754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=367.55  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=198.2

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC----cce
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETE----VPL  389 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  389 (597)
                      ..+|++.+.||+|+||+||+|.+. +|+.||||++... .....+++++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999975 7999999998643 3455678999999999999999999999997654    235


Q ss_pred             EEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccc
Q 038707          390 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV  469 (597)
Q Consensus       390 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~  469 (597)
                      ++++++.+|+|.+++...    .+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            566677799999999754    3999999999999999999999999   999999999999999999999999999866


Q ss_pred             cCCCce--eeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          470 MVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       470 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ......  ......||+.|+|||++.. ..++.++||||+|+++|+|++|+.||......+.   ........... ..+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~-~~~  235 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSP-SQE  235 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSC-CHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCC-Chh
Confidence            433222  2344568999999999854 5678999999999999999999999975432211   11110000000 000


Q ss_pred             hh---------hHHh---------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          547 AL---------DARV---------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       547 ~l---------~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      ..         ....         ........+.++.+|+.+||+.||.+|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00         0000         000111223568899999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-44  Score=363.48  Aligned_cols=263  Identities=23%  Similarity=0.335  Sum_probs=195.4

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEe--------C
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE--------T  385 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  385 (597)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...  .+....++.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999975 7999999987543  33445778999999999999999999999865        3


Q ss_pred             CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccc
Q 038707          386 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT  465 (597)
Q Consensus       386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl  465 (597)
                      ...++||||+.++.+..+...   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            457899999987766655433   234899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCce---eeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhc
Q 038707          466 SRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE  541 (597)
Q Consensus       466 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  541 (597)
                      ++........   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.   ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~  240 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGS  240 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCC
Confidence            9766532221   22334689999999998764 689999999999999999999999975432211   1111111100


Q ss_pred             C--c---------hhhhhh------HHhhhh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          542 N--R---------LFEALD------ARVLKE-AKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       542 ~--~---------~~~~l~------~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                      .  .         ....+.      ...... ......+.+.+||.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0  0         000000      000000 011123467789999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=366.78  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             CCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------cceE
Q 038707          318 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------VPLL  390 (597)
Q Consensus       318 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  390 (597)
                      .|+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+.+|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999986 699999999864322    2347999999999999999999986432      4689


Q ss_pred             EEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccc
Q 038707          391 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSV  469 (597)
Q Consensus       391 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~  469 (597)
                      ||||++++.+..+.+.......+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987644444433333456999999999999999999999999   99999999999999775 8999999999876


Q ss_pred             cCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhhhh
Q 038707          470 MVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEAL  548 (597)
Q Consensus       470 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  548 (597)
                      ....  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+   ........... ...+.+
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~-~~~~~~  247 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGT-PTREQI  247 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCC-CCHHHH
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCC-ChHHhh
Confidence            4332  2334569999999998765 578999999999999999999999997543221   11111111000 000000


Q ss_pred             hH----------------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhhh
Q 038707          549 DA----------------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGIR  593 (597)
Q Consensus       549 ~~----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l~  593 (597)
                      ..                ..........++++.+|+.+||+.||++|||+.|+++.  |++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            00                00001112345568899999999999999999999963  55543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=363.94  Aligned_cols=261  Identities=21%  Similarity=0.318  Sum_probs=196.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCC------
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  386 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++..  .++...+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999975 699999999864  34455678999999999999999999999998665      


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..+|||||+ +.+|..+++..    .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 56777776543    3999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCceeeecccccccccCcccccc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      +.....    .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+   ............ ..
T Consensus       169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~-~~  240 (346)
T d1cm8a_         169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTP-PA  240 (346)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC-CH
T ss_pred             eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCC-cH
Confidence            875432    244569999999999876 457899999999999999999999997643211   111111100000 00


Q ss_pred             hhh-----------hH-------HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhh
Q 038707          546 EAL-----------DA-------RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE--LGGI  592 (597)
Q Consensus       546 ~~l-----------~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l  592 (597)
                      +..           ..       ..........++.+.+||.+||+.||++|||++|+++.  |+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            000           00       00001112234568899999999999999999999975  5444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=360.94  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             cCCccCCcccccCceEEEEEEec----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCC-CccceeeeEEEeCCc
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQINH-RNIVKLLGCCLETEV  387 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  387 (597)
                      ++|++.+.||+|+||+||+|...    +|+.||||.++..    +....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            66999999999999999999852    4789999987532    23345678899999999976 899999999999999


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+++|||+.+|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999998654   3788999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCceeeecccccccccCccccccC--CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF  545 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (597)
                      ..............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+...   ..........  
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~~--  252 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSE--  252 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCC--
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccCC--
Confidence            7655444445566799999999998654  47889999999999999999999998765443211   1111111110  


Q ss_pred             hhhhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038707          546 EALDARVLKEAKKEEIMTVATLAKRCLNLNGKMRP-----TMKEVTN  587 (597)
Q Consensus       546 ~~l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  587 (597)
                              ...+...++++.+|+.+||++||++||     |++|+++
T Consensus       253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    111234567789999999999999999     4788876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=351.80  Aligned_cols=262  Identities=21%  Similarity=0.314  Sum_probs=204.3

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeCCcceEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      ++|++.+.||+|+||+||+|++. +++.||||+++..  .+...+++.+|+.+|++++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 6899999987543  34457889999999999999999999999999999999999


Q ss_pred             ccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccccccCCC
Q 038707          394 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ  473 (597)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~~~~~~~  473 (597)
                      ++.+++|..++...   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999988887654   34899999999999999999999999   9999999999999999999999999998765332


Q ss_pred             ceeeecccccccccCccccccCC-CCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCc--hhhhhh-
Q 038707          474 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR--LFEALD-  549 (597)
Q Consensus       474 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~-  549 (597)
                      . ......+++.|+|||++.... ++.++|||||||++|||++|+.||.......  .....+........  ...... 
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhh
Confidence            2 233345788899999987654 6899999999999999999999975422111  11111111111000  000000 


Q ss_pred             ------------HHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          550 ------------ARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       550 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                                  ...........++.+.+|+.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        00001112233456889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.9e-43  Score=356.13  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeC--CcceEEE
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVY  392 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  392 (597)
                      ++|++.++||+|+||+||+|++. +++.||||+++..   ..+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999975 6899999998643   3567889999999995 99999999999854  4688999


Q ss_pred             eccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCC-cEEEeeccccccccC
Q 038707          393 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMV  471 (597)
Q Consensus       393 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfgl~~~~~~  471 (597)
                      ||+++++|..+.+      .+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999977642      3899999999999999999999999   99999999999998654 699999999987643


Q ss_pred             CCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHh---------c
Q 038707          472 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---------E  541 (597)
Q Consensus       472 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------~  541 (597)
                      ..  ......+|+.|+|||.+.+. .++.++||||||++++||++|+.||.........  .........         .
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHH
T ss_pred             CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhh
Confidence            32  23445689999999997764 5799999999999999999999999754432211  000100000         0


Q ss_pred             Cch---hh---h--------hhHHhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          542 NRL---FE---A--------LDARVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       542 ~~~---~~---~--------l~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...   ..   .        .............++++.+||.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   00   0        0000000111223467889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-42  Score=354.01  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=191.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC------C
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------E  386 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  386 (597)
                      .++|++.++||+|+||+||+|.+. +|+.||||++..  .+.....++.+|+.+|++++||||+++++++...      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999976 699999999764  3455667899999999999999999999999643      5


Q ss_pred             cceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeecccc
Q 038707          387 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS  466 (597)
Q Consensus       387 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~  466 (597)
                      ..++||||+.++ +.+.+..     .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            779999999654 5555532     3899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHH--------------
Q 038707          467 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV--------------  532 (597)
Q Consensus       467 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~--------------  532 (597)
                      +....  ........+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+........              
T Consensus       167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            76543  22344556899999999999999999999999999999999999999754321100000              


Q ss_pred             --HHHHHHHhcCc------hhhhhhHHh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038707          533 --GYFLQAINENR------LFEALDARV---LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTNE  588 (597)
Q Consensus       533 --~~~~~~~~~~~------~~~~l~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  588 (597)
                        ...........      .........   ........++.+.+||.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              00000000000      000000000   011224456788999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=356.03  Aligned_cols=257  Identities=22%  Similarity=0.304  Sum_probs=195.9

Q ss_pred             hcCCccCCcccccCceEEEEEEec-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCccceeeeEEEeC-----Cc
Q 038707          316 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV  387 (597)
Q Consensus       316 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  387 (597)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...  +....+++.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999975 6999999998643  344567889999999999999999999998643     34


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      .+++++++.+|+|.+++...    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            46778888899999999653    3999999999999999999999999   9999999999999999999999999986


Q ss_pred             cccCCCceeeecccccccccCccccccC-CCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHHHHHHhcCchhh
Q 038707          468 SVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE  546 (597)
Q Consensus       468 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (597)
                      ....    ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+...   ............ ..+
T Consensus       170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~-~~~  241 (348)
T d2gfsa1         170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTP-GAE  241 (348)
T ss_dssp             CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-CHH
T ss_pred             ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCC-ChH
Confidence            5432    23345689999999987664 56899999999999999999999997543221   111111110000 000


Q ss_pred             hhh-------HHh-----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038707          547 ALD-------ARV-----------LKEAKKEEIMTVATLAKRCLNLNGKMRPTMKEVTN  587 (597)
Q Consensus       547 ~l~-------~~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  587 (597)
                      ...       ...           ........++++.+||.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000       000           00001123456889999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-37  Score=321.53  Aligned_cols=264  Identities=22%  Similarity=0.220  Sum_probs=194.0

Q ss_pred             cCCccCCcccccCceEEEEEEec-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----------CCccceeeeEEEe
Q 038707          317 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----------HRNIVKLLGCCLE  384 (597)
Q Consensus       317 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  384 (597)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999975 7999999998743 334567888999888875           5789999998865


Q ss_pred             C--CcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEeCCCC-----
Q 038707          385 T--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKY-----  456 (597)
Q Consensus       385 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~i~H~Dik~~NIll~~~~-----  456 (597)
                      .  ...+++|++...+..............+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4566777777665554444444445568999999999999999999998 77   99999999999997655     


Q ss_pred             -cEEEeeccccccccCCCceeeecccccccccCccccccCCCCcccceeehHHHHHHHHhCCCCCCCCCCcCCCcHHHHH
Q 038707          457 -RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF  535 (597)
Q Consensus       457 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlG~il~ell~g~~p~~~~~~~~~~~~~~~~  535 (597)
                       .+|++|||.+.....    ......||+.|+|||++....++.++||||+|+++++|++|+.||...............
T Consensus       169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             399999999876532    223456999999999999999999999999999999999999999765433222221111


Q ss_pred             HHHHh-cCch-hhhh---------------------------hH--HhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038707          536 LQAIN-ENRL-FEAL---------------------------DA--RVLKEAKKEEIMTVATLAKRCLNLNGKMRPTMKE  584 (597)
Q Consensus       536 ~~~~~-~~~~-~~~l---------------------------~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  584 (597)
                      ...+. -+.. .+..                           ..  ..........++++.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11110 0000 0000                           00  0011223566788999999999999999999999


Q ss_pred             HHHH
Q 038707          585 VTNE  588 (597)
Q Consensus       585 vl~~  588 (597)
                      +++.
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9873

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.9e-23  Score=194.50  Aligned_cols=164  Identities=16%  Similarity=0.179  Sum_probs=121.8

Q ss_pred             ccCCcccccCceEEEEEEecCCcEEEEEEccccC------------------hhhHHHHHHHHHHHhhcCCCccceeeeE
Q 038707          320 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD------------------ETNVEQFINEVVILSQINHRNIVKLLGC  381 (597)
Q Consensus       320 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~  381 (597)
                      .+.++||+|+||+||+|.+.+|+.||||..+...                  .........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999999889999999754211                  0112345678899999999999988765


Q ss_pred             EEeCCcceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEeCCCCcEEEe
Q 038707          382 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS  461 (597)
Q Consensus       382 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~  461 (597)
                      .    ..+++|||+++..+.+          ++......++.|++++|.|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998765433          344456789999999999999999   9999999999999965 59999


Q ss_pred             eccccccccCCCceeeecccccccccCc--cc---cccCCCCcccceeehHHHH
Q 038707          462 DFGTSRSVMVDQTHLTTKVQGTFGYVDP--EY---FQSSQFTEKSDVYSFGVVL  510 (597)
Q Consensus       462 Dfgl~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~sDv~SlG~il  510 (597)
                      |||+|.....+...         .|...  +.   +-...|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999765432221         11111  00   1135678899999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=5.4e-08  Score=92.97  Aligned_cols=150  Identities=15%  Similarity=0.117  Sum_probs=108.3

Q ss_pred             HHHHHHHhcCCccCCcccccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCc
Q 038707          309 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV  387 (597)
Q Consensus       309 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  387 (597)
                      ..++.....+|+..+..+.++...||+... ++..++||+...........+.+|...+..+. +--+.+++.+..+.+.
T Consensus         6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             CHHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            456777777888777766566678998864 45667788776544444556778888888774 4446788888888889


Q ss_pred             ceEEEeccCCCChhhHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 038707          388 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-------------------------------  436 (597)
Q Consensus       388 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------  436 (597)
                      .++||+++++.++.+.....        .....++.++++.|..||+..                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             eEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            99999999998886654321        112345666777777777532                               


Q ss_pred             -------------------------CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 -------------------------SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 -------------------------~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                                               ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1127999999999999987667799998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=4.7e-06  Score=78.57  Aligned_cols=129  Identities=16%  Similarity=0.155  Sum_probs=87.0

Q ss_pred             ccccC-ceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcC--CCccceeeeEEEeCCcceEEEeccCCCChh
Q 038707          325 LGQGG-QGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN--HRNIVKLLGCCLETEVPLLVYEFIPNGTLY  401 (597)
Q Consensus       325 lg~G~-~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  401 (597)
                      +..|. .+.||+...+++..+++|......   ...+..|+..++.+.  .-.+.+++.+..+.+..++||+++++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            34444 367999988888888999866433   234667777777764  334677888888888899999999886664


Q ss_pred             hHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 038707          402 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA---------------------------------------------  436 (597)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------------  436 (597)
                      +..        +..   ..++.++++.|.-||+..                                             
T Consensus        95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            321        111   112234444444444311                                             


Q ss_pred             ----------CCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          437 ----------SIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       437 ----------~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                                ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                      1237999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.66  E-value=0.00011  Score=73.76  Aligned_cols=76  Identities=17%  Similarity=0.219  Sum_probs=49.5

Q ss_pred             CcccccCceEEEEEEecC-CcEEEEEEccc----c---ChhhHHHHHHHHHHHhhcC-C--CccceeeeEEEeCCcceEE
Q 038707          323 RILGQGGQGTVYKGMLTD-GRIVAVKKSKL----V---DETNVEQFINEVVILSQIN-H--RNIVKLLGCCLETEVPLLV  391 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~----~---~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  391 (597)
                      +.||.|....||+....+ ++.++||....    .   -+....+...|...|+.+. +  ..+++++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998754 67899996432    1   1122344566888887763 3  345556543  56677899


Q ss_pred             EeccCCCCh
Q 038707          392 YEFIPNGTL  400 (597)
Q Consensus       392 ~e~~~~gsL  400 (597)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.63  E-value=0.0019  Score=64.32  Aligned_cols=72  Identities=18%  Similarity=0.193  Sum_probs=48.1

Q ss_pred             CcccccCceEEEEEEecC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCccceeeeEEEeCCcceEEEe
Q 038707          323 RILGQGGQGTVYKGMLTD--------GRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE  393 (597)
Q Consensus       323 ~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  393 (597)
                      +.|+.|-.=.+|+....+        .+.|+++.... . .......+|..+++.+. +.-.+++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            467778888899998654        24577776542 2 22334567888888885 4334577777642    68999


Q ss_pred             ccCCCCh
Q 038707          394 FIPNGTL  400 (597)
Q Consensus       394 ~~~~gsL  400 (597)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.38  E-value=0.0061  Score=58.78  Aligned_cols=69  Identities=14%  Similarity=0.097  Sum_probs=45.0

Q ss_pred             ceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcc--ceee-----eEEEeCCcceEEEeccCCCC
Q 038707          330 QGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI--VKLL-----GCCLETEVPLLVYEFIPNGT  399 (597)
Q Consensus       330 ~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gs  399 (597)
                      .-.||++...+|+.+++|..... ....+++..|...+..|....+  +..+     ......+..+.++++++|..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            35799999999999999987642 2234667778888887742222  1111     12234566788999987643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.62  E-value=0.039  Score=52.41  Aligned_cols=158  Identities=11%  Similarity=0.033  Sum_probs=81.8

Q ss_pred             cCHHHHHHHhcCCccCCcc-----cccCceEEEEEEecCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-----Cccc
Q 038707          307 FTSKDLEKATDNYNANRIL-----GQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-----RNIV  376 (597)
Q Consensus       307 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv  376 (597)
                      ++.+|++....+|.+.++.     ..|---+.|+...++|+ +++|+....  ...+++..|+.++..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            5678888888889886554     35555778998876654 788876532  122344456666666632     2221


Q ss_pred             eee---eEEEeCCcceEEEeccCCCChhh--------------HHhhcCCCC------------------------CCCH
Q 038707          377 KLL---GCCLETEVPLLVYEFIPNGTLYQ--------------YIHNQIEEF------------------------PITW  415 (597)
Q Consensus       377 ~l~---~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~------------------------~l~~  415 (597)
                      ...   ...........++.++.+.....              .++......                        ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110   01122344556666665532221              011000000                        0001


Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCeEeCCCCcEEEeeccccc
Q 038707          416 ELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSR  467 (597)
Q Consensus       416 ~~~~~i~~qi~~~L~~LH~~-~~~~i~H~Dik~~NIll~~~~~~kl~Dfgl~~  467 (597)
                      ......+..+...+.-.+.. -...++|+|+.++||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11122222222223332221 12238999999999999998777899999774

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=94.72  E-value=0.0025  Score=40.26  Aligned_cols=29  Identities=24%  Similarity=0.571  Sum_probs=22.5

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGF  245 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~  245 (597)
                      ..|..+..|.+.  .++|.|.|++||.+||+
T Consensus         7 ~~C~~~A~C~Nt--~Gsy~C~C~~Gy~GdG~   35 (40)
T d1gl4a2           7 HQCSVHAECRDY--ATGFCCRCVANYTGNGR   35 (40)
T ss_dssp             GGSCTTEEEEEC--SSCEEEEECTTEEECSS
T ss_pred             CCCCCCCEeecC--CCCeEeECCCCCcCCCC
Confidence            367666777753  45799999999999983

>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Plasminogen activator (tissue-type), t-PA
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.09  E-value=0.037  Score=34.94  Aligned_cols=32  Identities=19%  Similarity=0.544  Sum_probs=26.2

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.....+|.|.|+.||.+.- |.
T Consensus         4 nPC~ngG~C~~~~~~~~y~C~C~~g~~G~~-Ce   35 (41)
T d1tpga1           4 PRCFNGGTCQQALYFSDFVCQCPEGFAGKS-CE   35 (41)
T ss_dssp             CCSCTTCEEEEESSSSCEEEECCTTCBSSS-CC
T ss_pred             CCCCCCCEEecCCCCCCeEECCCCCCCCCC-cC
Confidence            368778889887778899999999998764 54

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.77  E-value=0.049  Score=33.89  Aligned_cols=31  Identities=19%  Similarity=0.433  Sum_probs=23.8

Q ss_pred             ccccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          214 TTICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       214 ~~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      +..|..++.|.+.  ..+|.|.|+.||.+.- |+
T Consensus         8 ~~PC~ngg~C~~~--~~~y~C~C~~g~~G~~-Ce   38 (39)
T d1edmb_           8 SNPCLNGGSCKDD--INSYECWCPFGFEGKN-CE   38 (39)
T ss_dssp             TCCCCTTCEEEEE--TTEEEEECCTTCCSTT-SC
T ss_pred             CCCCCCCcEEEcC--CCCEEEECCCCCCCCC-CC
Confidence            3478888888764  4589999999998764 53

>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epidermal growth factor, EGF
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=89.44  E-value=0.13  Score=34.26  Aligned_cols=31  Identities=29%  Similarity=0.601  Sum_probs=25.4

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|..++.|.......+|.|.|+.||.+.- |+
T Consensus        13 ~C~NgG~C~~~~~~~~~~C~C~~gy~G~~-Ce   43 (53)
T d3egfa_          13 YCLNGGVCMHIESLDSYTCNCVIGYSGDR-CQ   43 (53)
T ss_dssp             CSCSSCEEEEESSSSCEEEECCTTCCSSS-SC
T ss_pred             CCCCCcEeeccCCCCCeEeECCCCCcCCC-Cc
Confidence            58777888866677899999999999875 65

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.04  E-value=0.11  Score=31.38  Aligned_cols=28  Identities=14%  Similarity=0.256  Sum_probs=21.9

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDG  244 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g  244 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.-
T Consensus         6 ~PC~ngg~C~~~--~~~y~C~C~~g~~G~~   33 (35)
T d2vj3a3           6 SPCLHNGRCLDK--INEFQCECPTGFTGHL   33 (35)
T ss_dssp             CCSTTTCEEEEC--SSCEEEECCTTEESSS
T ss_pred             CCCCCCcEEECC--CCCeEEECCCCCCCCC
Confidence            478888888764  3479999999998754

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.26  E-value=0.13  Score=32.48  Aligned_cols=30  Identities=17%  Similarity=0.444  Sum_probs=22.7

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.  .++|.|.|+.||.+.- |+
T Consensus        11 ~pC~n~g~C~n~--~g~y~C~C~~G~~G~~-Ce   40 (42)
T d2vj3a1          11 NPCEHAGKCINT--LGSFECQCLQGYTGPR-CE   40 (42)
T ss_dssp             CSSSTTCEEEEC--SSSEEEECCTTEESTT-SC
T ss_pred             CCCCCCcEeECC--CCCEEeECCCCCcCCC-Cc
Confidence            368777888763  5579999999998764 54

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.23  E-value=0.13  Score=31.92  Aligned_cols=30  Identities=17%  Similarity=0.381  Sum_probs=23.0

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.- |.
T Consensus         7 ~PC~n~g~C~~~--~~~y~C~C~~G~~G~~-Ce   36 (39)
T d2vj3a2           7 NPCQNDATCLDQ--IGEFQCICMPGYEGVH-CE   36 (39)
T ss_dssp             CCCCSSCEEEEC--SSCEEEECCTTEESSS-SC
T ss_pred             CCCCCCCEEECC--CCCEEEeCCCCCccCc-Ce
Confidence            478777888864  5589999999998754 53

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=87.77  E-value=0.13  Score=31.39  Aligned_cols=28  Identities=21%  Similarity=0.476  Sum_probs=21.9

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDG  244 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g  244 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.-
T Consensus         8 ~PC~ngg~C~~~--~~~y~C~C~~g~~G~~   35 (37)
T d2c4fl1           8 SPCQNGGSCKDQ--LQSYICFCLPAFEGRN   35 (37)
T ss_dssp             CCCCTTCEEEEE--TTEEEEECCTTEESTT
T ss_pred             CCCCCCCEEECC--CCCeEEECCCCCcCCC
Confidence            478877888764  4579999999998653

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.58  E-value=0.17  Score=33.76  Aligned_cols=18  Identities=33%  Similarity=0.813  Sum_probs=13.8

Q ss_pred             ceeccCCCCceeeecCCCCC
Q 038707          222 YRCSITFGSGYICRCRTTYR  241 (597)
Q Consensus       222 ~c~~~~~~~gy~C~C~~gy~  241 (597)
                      .|.+.  .+||+|.|+.||.
T Consensus        25 ~C~Nt--~GsY~C~C~~Gy~   42 (53)
T d1apqa_          25 LCHNY--VGGYFCSCRPGYE   42 (53)
T ss_dssp             EEEEE--TTEEEEECSTTCE
T ss_pred             EeEcC--CCCeEeECCCCCe
Confidence            45543  4689999999997

>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epidermal growth factor, EGF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.14  E-value=0.12  Score=33.65  Aligned_cols=31  Identities=23%  Similarity=0.443  Sum_probs=25.2

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      .|..++.|.......+|.|.|+.||.+.- |+
T Consensus        11 ~C~ngG~C~~~~~~~~~~C~C~~gy~G~~-Ce   41 (48)
T d1nqlb_          11 YCLHDGVCMYIEALDKYACNCVVGYIGER-CQ   41 (48)
T ss_dssp             EECTTCEEEEETTTTEEEEEECTTEESTT-SC
T ss_pred             CCCCCcEEeeeCCCCCeEEeCCCCcccCC-CC
Confidence            58887888876667789999999998764 64

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.81  E-value=0.11  Score=32.17  Aligned_cols=30  Identities=20%  Similarity=0.488  Sum_probs=22.9

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.- |+
T Consensus         7 ~pC~ngg~C~~~--~~~~~C~C~~g~~G~~-Ce   36 (39)
T d1g1ta2           7 TSCSGHGECVET--INNYTCKCDPGFSGLK-CE   36 (39)
T ss_dssp             TGGGGSEEEEEE--TTEEEEEECTTEESTT-SC
T ss_pred             CcCCCCcEEECC--CCCEEEeCCCCCcCcC-cC
Confidence            367777788754  4589999999998765 64

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.70  E-value=0.14  Score=31.76  Aligned_cols=30  Identities=17%  Similarity=0.416  Sum_probs=23.0

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.- |+
T Consensus         6 ~PC~ngg~C~~~--~~~y~C~C~~G~~G~~-Ce   35 (39)
T d1xkba1           6 SPCQNQGKCKDG--LGEYTCTCLEGFEGKN-CE   35 (39)
T ss_dssp             CCCCSSCEECCC--SSSCCEECCTTEETTT-TC
T ss_pred             CCCCCCcEEECC--CCCEEEECCCCCCcCc-Ce
Confidence            478777888764  4579999999998764 54

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.46  E-value=0.16  Score=31.67  Aligned_cols=30  Identities=17%  Similarity=0.413  Sum_probs=22.5

Q ss_pred             cccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          215 TICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       215 ~~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      ..|..++.|.+.  ..+|.|.|+.||.+.- |+
T Consensus         7 ~pC~ngg~C~~~--~~~y~C~C~~g~~G~~-Ce   36 (40)
T d1g1sa2           7 MSCSKQGECLET--IGNYTCSCYPGFYGPE-CE   36 (40)
T ss_dssp             TGGGGSEEEEEC--SSSEEEEECTTEESTT-SC
T ss_pred             CcCCCCcEEECC--CCCeEEeCCCCccCCC-CC
Confidence            367777778754  4579999999998765 64

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.38  E-value=0.25  Score=31.44  Aligned_cols=21  Identities=14%  Similarity=0.491  Sum_probs=15.8

Q ss_pred             CceeccCCCCceeeecCCCCCCC
Q 038707          221 EYRCSITFGSGYICRCRTTYRTD  243 (597)
Q Consensus       221 ~~c~~~~~~~gy~C~C~~gy~~~  243 (597)
                      +.|.+.  -++|.|.|+.||..+
T Consensus        16 ~~C~Nt--~Gsy~C~C~~Gy~~~   36 (44)
T d1lmja1          16 GQCVNT--PGDFECKCDEGYESG   36 (44)
T ss_dssp             SCEEEE--TTEEEECCCSSEEEC
T ss_pred             CEeEcC--CCCeEEeCCCCCccC
Confidence            456543  568999999999765

>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epiregulin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.11  E-value=0.29  Score=31.42  Aligned_cols=30  Identities=23%  Similarity=0.380  Sum_probs=23.2

Q ss_pred             ccCCCCceeccCCCCceeeecCCCCCCCcccc
Q 038707          216 ICGDGEYRCSITFGSGYICRCRTTYRTDGFCA  247 (597)
Q Consensus       216 ~C~s~~~c~~~~~~~gy~C~C~~gy~~~g~c~  247 (597)
                      -|.. +.|+......+|.|+|+.||.+.- |+
T Consensus        13 yC~n-G~C~~~~~~~~~~C~C~~gY~G~R-Ce   42 (46)
T d1k36a_          13 YCLH-GQCIYLVDMSQNYCRCEVGYTGVR-CE   42 (46)
T ss_dssp             SCSS-EEEEEETTTTEEEEEECTTCSSTT-SC
T ss_pred             cCcC-CEEEEeCCCCccEeECCCCceecC-ce
Confidence            5665 567766666789999999999875 65

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.89  E-value=0.23  Score=31.43  Aligned_cols=22  Identities=23%  Similarity=0.437  Sum_probs=15.7

Q ss_pred             CceeccCCCCceeeecCCCCCCCc
Q 038707          221 EYRCSITFGSGYICRCRTTYRTDG  244 (597)
Q Consensus       221 ~~c~~~~~~~gy~C~C~~gy~~~g  244 (597)
                      +.|.+  ..++|.|.|+.||..+|
T Consensus        17 ~~C~N--t~Gsy~C~C~~Gy~~~g   38 (43)
T d1emoa1          17 GQCIN--TDGSYRCECPFGYILAG   38 (43)
T ss_dssp             SCCCC--CSSCCCCCCCTTEEESS
T ss_pred             CEeEC--CCCCeEeECCCCcccCC
Confidence            34543  35679999999998554

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.32  E-value=0.31  Score=30.19  Aligned_cols=21  Identities=14%  Similarity=0.328  Sum_probs=15.9

Q ss_pred             ceeccCCCCceeeecCCCCCCCc
Q 038707          222 YRCSITFGSGYICRCRTTYRTDG  244 (597)
Q Consensus       222 ~c~~~~~~~gy~C~C~~gy~~~g  244 (597)
                      .|.+  ..+||+|.|++||..+|
T Consensus        14 ~C~N--~~Gsy~C~C~~Gy~l~g   34 (40)
T d1dx5i3          14 VCHN--LPGTFECICGPDSALAG   34 (40)
T ss_dssp             EEEE--CSSSEEEEECSSSSCEE
T ss_pred             EeeC--CCCCeEeECCCCCeeCC
Confidence            4544  35689999999998765